Citrus Sinensis ID: 015018
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 414 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.934 | 0.86 | 0.673 | 1e-159 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.572 | 0.571 | 0.776 | 1e-116 | |
| Q9DC28 | 415 | Casein kinase I isoform d | yes | no | 0.572 | 0.571 | 0.776 | 1e-116 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.572 | 0.571 | 0.776 | 1e-116 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.572 | 0.571 | 0.776 | 1e-116 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.572 | 0.571 | 0.772 | 1e-116 | |
| Q5RC72 | 415 | Casein kinase I isoform d | yes | no | 0.572 | 0.571 | 0.772 | 1e-116 | |
| Q6P647 | 415 | Casein kinase I isoform d | yes | no | 0.565 | 0.563 | 0.777 | 1e-116 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.565 | 0.572 | 0.777 | 1e-115 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | no | no | 0.565 | 0.562 | 0.773 | 1e-115 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 563 bits (1450), Expect = e-159, Method: Compositional matrix adjust.
Identities = 279/414 (67%), Positives = 327/414 (78%), Gaps = 27/414 (6%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
G+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF HS
Sbjct: 62 GTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEALC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLT 301
Query: 242 T-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
P+RA+ P G S+ +PP +N+DR +G EEGR + SRRR SG L NS N+S
Sbjct: 302 APPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNISN 357
Query: 301 QKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 359
Q + + ++D+M+ S +L +S+GSSRRV + GS+ R RT D S
Sbjct: 358 QPTSSS-----ARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQRSRTGDVSR 412
Query: 360 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 413
G + S G+ +G+ST +++ES ++GI++L ++ H
Sbjct: 413 GVIPRNSPGE--------------AGKSTR--RHYESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 184/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 184/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 184/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 184/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 183/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5RC72|KC1D_PONAB Casein kinase I isoform delta OS=Pongo abelii GN=CSNK1D PE=2 SV=1 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 183/237 (77%), Positives = 216/237 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKT+L+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTILLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1073), Expect = e-116, Method: Compositional matrix adjust.
Identities = 182/234 (77%), Positives = 215/234 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 182/234 (77%), Positives = 215/234 (91%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235
+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 181/234 (77%), Positives = 216/234 (92%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HS
Sbjct: 62 GVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
K+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235
+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 242 KGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 414 | ||||||
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.990 | 0.868 | 0.838 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.985 | 0.866 | 0.821 | 0.0 | |
| 357454571 | 423 | Casein kinase I isoform delta-like prote | 0.995 | 0.973 | 0.805 | 0.0 | |
| 357454569 | 475 | Casein kinase I isoform delta-like prote | 0.992 | 0.865 | 0.800 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.987 | 0.862 | 0.822 | 0.0 | |
| 363807148 | 471 | uncharacterized protein LOC100795570 [Gl | 0.990 | 0.870 | 0.791 | 0.0 | |
| 356550412 | 472 | PREDICTED: casein kinase I isoform delta | 0.990 | 0.868 | 0.785 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.990 | 0.866 | 0.792 | 0.0 | |
| 224128674 | 470 | predicted protein [Populus trichocarpa] | 0.983 | 0.865 | 0.812 | 0.0 | |
| 392311590 | 483 | Chain A, Crystal Structure Of Casein Kin | 0.987 | 0.846 | 0.778 | 0.0 |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/414 (83%), Positives = 378/414 (91%), Gaps = 4/414 (0%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 242 T-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
P RA+GPGAGPSSGMPP+ AN+DRQ G EEGR T W S DP+RRRNSGP+ +S N SK
Sbjct: 302 NPPTRALGPGAGPSSGMPPSGANIDRQPGGEEGRPT-WPSMDPTRRRNSGPITSSVNFSK 360
Query: 301 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPG 360
QK P+AND SKDA +SS N LRSSG+SRR A+ +SR+AA+ G+++DP+ RTTDASP
Sbjct: 361 QKGPVANDLPLSKDAKLSSTNFLRSSGTSRRPAISSSRDAALTGNESDPTWSRTTDASPA 420
Query: 361 AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
KIS GQRSSP+VS+E +H +SGR+T+NIK FESTLRGIESLHFNN+ERV +
Sbjct: 421 V--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTFESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/415 (82%), Positives = 378/415 (91%), Gaps = 7/415 (1%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS
Sbjct: 62 GTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD++THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+S
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQIS 301
Query: 242 -TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
P+RA+GPGAGPS G+PPA AN+DRQSG E+GR +GWSSADPSRRR + P N +L K
Sbjct: 302 GPPSRALGPGAGPSHGIPPAVANMDRQSGGEDGRPSGWSSADPSRRRTTVPALNLGSL-K 360
Query: 301 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPG 360
QKSP+AND +KD++ ++ +R+SGSSRR AV +SR+A +VG ++DPSR R DASPG
Sbjct: 361 QKSPVANDSTMAKDSLSAN---VRASGSSRRGAVSSSRDAVIVGGESDPSRSR-ADASPG 416
Query: 361 AFQKISSGQRSSPVVSSENRHTTSGRST-SNIKNFESTLRGIESLHFNNNERVHH 414
A +KISSGQR SPV SSE++ +SGR+T SNIKNFESTL+GIESLHFNN ERV +
Sbjct: 417 ALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKNFESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454571|ref|XP_003597566.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486614|gb|AES67817.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/417 (80%), Positives = 376/417 (90%), Gaps = 5/417 (1%)
Query: 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 60
MAAGIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++H
Sbjct: 9 MAAGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYIH 68
Query: 61 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 120
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 69 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 128
Query: 121 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 180
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 129 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 188
Query: 181 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 240
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 189 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 248
Query: 241 STP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 299
+TP ARAIG GAGPSSG+PPA + +R SG E+GRH GWSS+DP+RRRNSGP+ N NLS
Sbjct: 249 ATPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNLS 308
Query: 300 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRV-AVPNSREAAVVGSDTDPSRPRTTDAS 358
+QK+P+ +D SK+ M+SS N R SGS+RRV AV NSR+ AVV S+ +PS P D S
Sbjct: 309 RQKAPVPSDSNGSKEVMLSSSNFFRPSGSTRRVGAVSNSRD-AVVSSEIEPSLPLARDGS 367
Query: 359 PGAFQKISSGQRSSPVVSSENRHTT-SGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
PGA K S QR+SP+ SSE++ TT SGR+TSN+KNFEST+RGIESL+F N+E+V +
Sbjct: 368 PGALLKTSGAQRNSPITSSEHKATTSSGRNTSNMKNFESTIRGIESLNF-NDEKVQY 423
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454569|ref|XP_003597565.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486613|gb|AES67816.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/416 (80%), Positives = 373/416 (89%), Gaps = 5/416 (1%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++HS
Sbjct: 62 GTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+LC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 242 TP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
TP ARAIG GAGPSSG+PPA + +R SG E+GRH GWSS+DP+RRRNSGP+ N NLS+
Sbjct: 302 TPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNLSR 361
Query: 301 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRV-AVPNSREAAVVGSDTDPSRPRTTDASP 359
QK+P+ +D SK+ M+SS N R SGS+RRV AV NSR+ AVV S+ +PS P D SP
Sbjct: 362 QKAPVPSDSNGSKEVMLSSSNFFRPSGSTRRVGAVSNSRD-AVVSSEIEPSLPLARDGSP 420
Query: 360 GAFQKISSGQRSSPVVSSENRHTT-SGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
GA K S QR+SP+ SSE++ TT SGR+TSN+KNFEST+RGIESL+F N+E+V +
Sbjct: 421 GALLKTSGAQRNSPITSSEHKATTSSGRNTSNMKNFESTIRGIESLNF-NDEKVQY 475
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/417 (82%), Positives = 381/417 (91%), Gaps = 8/417 (1%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEG+YNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVHS
Sbjct: 62 GTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDTATHQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE LC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301
Query: 242 T-PARAIGPGAGPSSGM-PPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 299
T P+R +GPGAG SSG+ PPA AN DRQSG EEGR G SS DPSRRR S G+ LS
Sbjct: 302 TPPSRVLGPGAGTSSGLPPPAVANADRQSG-EEGRPAGLSSMDPSRRRIS---GDGGGLS 357
Query: 300 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 358
KQKSP+A+D A SKDAM+SS + L RSSGSSRR AV +SR+AA++GS++DPSR TT+AS
Sbjct: 358 KQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVSSSRDAAIMGSESDPSRAHTTEAS 417
Query: 359 PG-AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
PG A ++ISSGQRSSPV SS+ + T+SGR+ +NIKN+EST+RGIE+L+F+N+ERVH+
Sbjct: 418 PGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKNYESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807148|ref|NP_001242599.1| uncharacterized protein LOC100795570 [Glycine max] gi|255641648|gb|ACU21096.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/413 (79%), Positives = 369/413 (89%), Gaps = 3/413 (0%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFG+EGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+HS
Sbjct: 62 GTGIPNVRWFGIEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+LC
Sbjct: 182 MNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 242 TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQ 301
TP R I P AG SSG+PPA N DRQ+G RHTGWSS+DP+RRRNSGP+ N S+Q
Sbjct: 302 TPVRVIVPTAGQSSGLPPAVVNADRQTGGVNSRHTGWSSSDPARRRNSGPIANDGMSSRQ 361
Query: 302 KSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPGA 361
K+P+ +D SKD M+SS N S S+RR AV +SR+AA VG++T+PS P T DASPGA
Sbjct: 362 KAPVPSDSTGSKDVMLSSSNFRSSG-STRRGAVSSSRDAA-VGNETEPSHPLTMDASPGA 419
Query: 362 FQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
+KIS+ QRSSP++S E+ T+SGR+TSN+KN+ESTLRGIE+L+F N+ER+ +
Sbjct: 420 LRKISNAQRSSPIMSFEHNRTSSGRNTSNMKNYESTLRGIETLNF-NDERLQY 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550412|ref|XP_003543581.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/414 (78%), Positives = 368/414 (88%), Gaps = 4/414 (0%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+HS
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK++RDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKHRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+LC
Sbjct: 182 MNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIESLC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
R YP+EFASYFHYCRSL+FDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RSYPSEFASYFHYCRSLQFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 242 T-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
T PARAIGP AGPSSG+PPA N DRQ+G E RHTGWSS+DP+RRRNSGP+ N LS+
Sbjct: 302 TPPARAIGPAAGPSSGLPPAVVNADRQTGGENSRHTGWSSSDPARRRNSGPIANDGMLSR 361
Query: 301 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPG 360
QK+P +D SKD M+SS N S S+RR V +SR+ A VG++T+PS P T DAS G
Sbjct: 362 QKAPFPSDSTRSKDVMLSSSNFRSSG-STRRGVVSSSRD-ATVGNETEPSHPLTVDASQG 419
Query: 361 AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
A +KIS QRSSP++ E+ T+SGR+TSN+KN+EST+RGIE+L+F N+ER+ +
Sbjct: 420 ALRKISGAQRSSPIMPFEHNRTSSGRNTSNMKNYESTIRGIETLNF-NDERLQY 472
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/414 (79%), Positives = 360/414 (86%), Gaps = 4/414 (0%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRK SLKTVLMLADQMINR+EFVHS
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKFSLKTVLMLADQMINRIEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRDT THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDTTTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYPTEFASYFHYCRSLRFDDKPDYAYLKR++RDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIREGFQFDYVFDWTILKYQQSQLA 301
Query: 242 TPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
P G GAG S+G+P P AN +R+ G EEGR G S+ D RRR SG L NS +L K
Sbjct: 302 APPARTGAGAGTSAGVPTPPVANPERKLGEEEGRAGGLSTGDGLRRRMSGSLLNSGSLLK 361
Query: 301 QKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 359
QKSP+ANDP SKD +SS NL RSSG +R A+P+SREA G+++DPSR RT +ASP
Sbjct: 362 QKSPLANDPTVSKDPTLSSTNLTGRSSGFLKRAAIPSSREAVTGGNESDPSRSRTAEASP 421
Query: 360 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 413
Q+ SSGQRSSPV SS+ + +SGR TS IKN+ESTL+GIESLHF ++ERVH
Sbjct: 422 STMQRFSSGQRSSPVGSSDAKQQSSGRITS-IKNYESTLKGIESLHF-DDERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128674|ref|XP_002329062.1| predicted protein [Populus trichocarpa] gi|222839733|gb|EEE78056.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/415 (81%), Positives = 362/415 (87%), Gaps = 8/415 (1%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS
Sbjct: 62 GTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC
Sbjct: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 242 TP-ARAIGPGAGPSSGMPPAAA-NVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 299
P RA GPGAGPSSG+PP A N DRQSG EEG S D +RRRNSGP+ NS NLS
Sbjct: 302 NPTTRAHGPGAGPSSGIPPPGANNADRQSGGEEGGPGW-PSIDHARRRNSGPIVNSGNLS 360
Query: 300 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 359
KQKSP+ ND + SKDA +SS N LRS SSR V +SR AA G+D+DPSRPRTTDAS
Sbjct: 361 KQKSPVTNDLSLSKDATLSSSNFLRSIVSSRNPVVSSSRGAA-FGNDSDPSRPRTTDAS- 418
Query: 360 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
F + +GQRSS +SSE +H++SGR+T NIK ESTL+GIESLH N R+HH
Sbjct: 419 --FAVLQNGQRSSAALSSEQKHSSSGRNT-NIKTLESTLKGIESLHVNIEGRLHH 470
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|392311590|pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/415 (77%), Positives = 365/415 (87%), Gaps = 6/415 (1%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
GIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEALC
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV- 240
RGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301
Query: 241 STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 300
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+K
Sbjct: 302 SAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAK 358
Query: 301 QKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 359
QK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ + + ++PSR R TDASP
Sbjct: 359 QKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDT-SEPSRTRATDASP 417
Query: 360 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
GAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 418 GAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 414 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.966 | 0.860 | 0.666 | 5.3e-143 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.850 | 0.782 | 0.674 | 8e-127 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.746 | 0.710 | 0.726 | 1.5e-125 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.570 | 0.545 | 0.817 | 1.4e-112 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.857 | 0.745 | 0.579 | 1.9e-108 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.946 | 0.832 | 0.537 | 3e-108 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.567 | 0.531 | 0.787 | 9.5e-105 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.570 | 0.492 | 0.792 | 1.6e-104 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.954 | 0.853 | 0.521 | 3.2e-104 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.954 | 0.853 | 0.519 | 2.9e-103 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
Identities = 270/405 (66%), Positives = 313/405 (77%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+PN++W+GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH KS
Sbjct: 64 GVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVHQKS 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD+ HQHIPYRENKNLTGTARYASMN
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS-NHQHIPYRENKNLTGTARYASMN 182
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEALCRG
Sbjct: 183 THLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEALCRG 242
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
YP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+ST
Sbjct: 243 YPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQISTP 302
Query: 244 XXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQK 302
+ +R SG +E R +GWSS P RRNSG + NS +L+KQK
Sbjct: 303 PPRHHGPVVGPSSALPPAITSAERPSGGDEARPSGWSSGIP--RRNSGQIFNSGSLAKQK 360
Query: 303 SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASPGAF 362
+P+++DPA SKD ++ AV +SREAAV+G+D++PS P+ +A G+
Sbjct: 361 APVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSSREAAVLGTDSEPSNPQIVEAGSGSN 420
Query: 363 QKIXXXXXXXXXXXXENRHTTSGRSTSNI-KNFESTLRGIESLHF 406
KI N+ ++ R+T+++ KN+E+ L+GIESLHF
Sbjct: 421 SKIPVSRNSPIVSSEINKLSSPSRATTSVMKNYEANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1218 (433.8 bits), Expect = 8.0e-127, Sum P(2) = 8.0e-127
Identities = 245/363 (67%), Positives = 268/363 (73%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF HSKS
Sbjct: 64 GVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFHSKS 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYASMN
Sbjct: 124 FLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYASMN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEALCRG
Sbjct: 184 THLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEALCRG 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
YP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 244 YPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLTAP 303
Query: 244 XXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQK 302
N+DR +G EEGR + SRRR SG L NS N+S Q
Sbjct: 304 PSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNISNQP 359
Query: 303 -SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASPGA 361
S A D ++ AV SR+ GS+ R RT D S G
Sbjct: 360 TSSSARDSMIPSSSLFAQSAGSSRRVT----AVSGSRDN-FPGSEELLQRSRTGDVSRGV 414
Query: 362 FQK 364
+
Sbjct: 415 IPR 417
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1186 (422.6 bits), Expect = 1.5e-125, Sum P(2) = 1.5e-125
Identities = 228/314 (72%), Positives = 250/314 (79%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+PN++WFGVEGDYN LV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ HSKS
Sbjct: 64 GVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFHSKS 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRD+KPDNFLMGLGRRANQV+IIDFGLAK+YRD THQHIPYRENKNLTGTARYASMN
Sbjct: 124 FLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYASMN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+LCRG
Sbjct: 184 THLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESLCRG 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
YP+EFASYFHYCRSLRFDDKPDY YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ++
Sbjct: 244 YPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLTAP 303
Query: 244 XXXXXXXXXXXXXXXX--XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQ 301
++DR G EEG G D SRRR SG L NS NLS +
Sbjct: 304 PSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEG---GRPPMDSSRRRMSGALENSGNLSSR 360
Query: 302 KSPMANDPAFSKDA 315
M + F++ A
Sbjct: 361 GPMMPSSSLFAQSA 374
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
Identities = 193/236 (81%), Positives = 217/236 (91%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIPN++W+GVEGDYNVLV+DLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+HSKS
Sbjct: 64 GIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIHSKS 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+LHRDIKPDNFLMGLGRRANQVYIID+GLAK+YRD++TH+HIPYRENK+L GT RYAS+N
Sbjct: 124 YLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYASLN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE LCRG
Sbjct: 184 THLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETLCRG 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 239
+PTEFASYFHYCRSLRFDDKPDYAYLKRLFR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 244 HPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQ 299
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
Identities = 212/366 (57%), Positives = 253/366 (69%)
Query: 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
+GIPN++WFGVEGDY+V+VIDLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H++
Sbjct: 63 SGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMHTR 122
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYAS+
Sbjct: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYASV 182
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 182
NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE LC+
Sbjct: 183 NTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVLCK 242
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 242
P+EF SYFHYCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q S+
Sbjct: 243 NQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG-SS 301
Query: 243 XXXXXXXXXXXXXXXXXXXXNVDRQS---GAEEGRHTGWSSADPSRRRNSGPLGNSANLS 299
++RQ G E R+ + + RR+ P S+
Sbjct: 302 SGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRH--PTTTSSPRD 359
Query: 300 KQKSPMANDPAFSKDA-----MMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRT 354
+ +S ++D FSK VA +SR ++ G + R
Sbjct: 360 RSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTSSRL 419
Query: 355 TDASPG 360
+S G
Sbjct: 420 VSSSGG 425
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
Identities = 216/402 (53%), Positives = 257/402 (63%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+PNL+W+GVEGDYNV+VIDLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H++
Sbjct: 64 GVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMHTRG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYAS+N
Sbjct: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYASVN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE LC+
Sbjct: 184 THLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVLCKN 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
P+EF SYF YCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q S+
Sbjct: 244 QPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGSSSG 303
Query: 244 XXXXXXXXXXXXXXXXXXXNVDRQS--GAEEGRHTGWSSADP--SRRR--NSGPLGNSAN 297
++++Q +E R +S A SRR S SA+
Sbjct: 304 SSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTRDRSAS 363
Query: 298 LSKQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDA 357
+ P++ P + A+P+S + G +D
Sbjct: 364 RNSVDGPLSKHPPGDSERPRSSSRYGSSSRR----AIPSSSRPSSAGGPSDSRSSSRLVT 419
Query: 358 SPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLR 399
S G + N TS S + E LR
Sbjct: 420 STGGVGTVSNRASTSQRIQAGNESRTSSFSRAARNTREDPLR 461
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
Identities = 185/235 (78%), Positives = 210/235 (89%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+P+++WFGVEG+YN + IDLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++HS+
Sbjct: 64 GVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMHSRG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGR+ANQVYIID+GLAK+YRD TH+HIPYRENKNLTGTARYAS+N
Sbjct: 124 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E LC+
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVLCKS 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
YP+EF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 187/236 (79%), Positives = 211/236 (89%)
Query: 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
+GIP+L+WFGV+GDYN +VIDLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++HS+
Sbjct: 67 SGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMHSR 126
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK+YRD TH+HIPYRENKNLTGTARYAS+
Sbjct: 127 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYASV 186
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCR 182
NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE LC+
Sbjct: 187 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVLCK 246
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238
YP EF SYF YCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 247 SYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 3.2e-104, P = 3.2e-104
Identities = 215/412 (52%), Positives = 266/412 (64%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H++
Sbjct: 64 GIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMHTRG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAK+YRD TH+HIPYRENKNLTGTARYAS+N
Sbjct: 124 FLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E LC+
Sbjct: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVLCKS 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+ +
Sbjct: 244 YPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSESNRL 300
Query: 244 XXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQK- 302
RQ + R +G + DP RR G+ +K +
Sbjct: 301 RSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTKHRN 356
Query: 303 ---SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASP 359
S +A A D + + +SR ++ G DP+R S
Sbjct: 357 ILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIPTSS 413
Query: 360 GAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 411
G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 414 GS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
Identities = 214/412 (51%), Positives = 265/412 (64%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H++
Sbjct: 64 GIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMHTRG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGR+A+QVY+ID+ LAK+YRD TH+HIPYRENKNLTGTARYAS+N
Sbjct: 124 FLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEALCRG 183
THLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E LC+
Sbjct: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVLCKS 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTX 243
YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+ +
Sbjct: 244 YPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSESNRL 300
Query: 244 XXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQK- 302
RQ + R +G + DP RR G+ +K +
Sbjct: 301 RSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTKHRN 356
Query: 303 ---SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASP 359
S +A A D + + +SR ++ G DP+R S
Sbjct: 357 ILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIPTSS 413
Query: 360 GAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 411
G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 414 GS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7763 | 0.5724 | 0.5710 | yes | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7763 | 0.5724 | 0.5710 | yes | no |
| Q6P647 | KC1D_XENTR | 2, ., 7, ., 1, 1, ., 1 | 0.7777 | 0.5652 | 0.5638 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6642 | 0.6328 | 0.7683 | yes | no |
| Q9DC28 | KC1D_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7763 | 0.5724 | 0.5710 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7721 | 0.5724 | 0.5710 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7922 | 0.5579 | 0.6328 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7763 | 0.5724 | 0.5710 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7094 | 0.5652 | 0.5318 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 414 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-22 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-21 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-04 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-04 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.001 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.002 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.002 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.002 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.003 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.003 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.003 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.003 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.003 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.003 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.003 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 19/197 (9%)
Query: 8 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 65
+ F + D+ LV++ DLF++ SR LS +A Q++ +E++HS +
Sbjct: 64 IDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 125
HRD+KP+N L+ V I DFGLAK+ GT Y +
Sbjct: 121 HRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVL 170
Query: 126 L-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 184
L G + D+ SLG +L L G P+ G + Q +I + G
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 185 PTEFASYFHYCRSLRFD 201
E C L D
Sbjct: 231 E-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.7 bits (239), Expect = 4e-22
Identities = 60/180 (33%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 60
I L F + LV++ + G SLEDL R LS L + Q+++ +E++H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 61 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 120
SK +HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y
Sbjct: 119 SKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYM 175
Query: 121 SMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 177
+ LG+ S D+ SLG L L G P++G K + + KI + + S+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
I L + ++ LV++ G SL+DL KLS +L + Q++ +E++HS
Sbjct: 53 IVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+HRD+KP+N L L +V + DFGL+K K + GT Y +
Sbjct: 113 IIHRDLKPENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPE 163
Query: 124 THLGI-EQSRRDDLESLGYVLMYFL 147
LG S + D+ SLG V++Y L
Sbjct: 164 VLLGKGYYSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 17 YNVLVIDLLGPSLEDLFN--FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74
Y ++++ L + +++F C K +K ++ M+ +E++H H DIKP+N
Sbjct: 101 YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPENI 157
Query: 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY-RENKNL-TGTARYASMNTHLGIEQSR 132
++ R YIID+G+A + +HI Y +E K+L GT YA ++ H G +R
Sbjct: 158 MVDGNNRG---YIIDYGIASHF--IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR 212
Query: 133 RDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEALCRGYPT 186
R DLESLGY ++ + LPW+G K +++ E K+
Sbjct: 213 RGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIK-------NAN 265
Query: 187 EFASYFHYCRS-LRFDDKPDYAYLKRLF 213
+F F C + L +++KPDY L ++F
Sbjct: 266 KFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 8e-14
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 14 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
+ D LV++ G L DL +LS Q+++ +E++HSK +HRD+KP+
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPE 126
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR 132
N L+ V + DFGLA++ GT Y + LG +
Sbjct: 127 NILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYMAPEVLLGKGYGK 175
Query: 133 RDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 176 AVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 29/183 (15%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----- 94
L K A +++ +E++HSK +HRD+KP+N L+ + + I DFG AK
Sbjct: 99 LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPN 155
Query: 95 --------RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146
+ + R + GTA Y S + DL +LG ++
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215
Query: 147 LRGSLPWQGLKAGTKKQKYEKISE----------KKVSTSIEALCRGYPTEFASYFHYCR 196
L G P++G + ++KI + IE L P +
Sbjct: 216 LTGKPPFRG---SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYD 272
Query: 197 SLR 199
L+
Sbjct: 273 ELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 29/164 (17%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---R 95
K S+ L + ++ +E+VHSK LHRD+KPDN L+GL +V I+D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKL 165
Query: 96 YRDTATHQHIPYREN--KNLT------GTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147
+ + R ++T GT Y + LG+ S D+ +LG +L L
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY 191
S P+ +++K KIS + V S P E A Y
Sbjct: 226 TLSFPY-------RRKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 6 PNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
PNL +++GVE + I + G +LE+L R L + + Q++ + ++HS
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTARYA 120
+HRDIKP N + + + DFG A + ++ T E ++L GT Y
Sbjct: 118 HGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPAYM 170
Query: 121 SMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 156
+ G + R D+ SLG V++ G PW L
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 31 DLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
+LF+ S+ + S + A +++ +E++HS ++RD+KP+N L L + + +
Sbjct: 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLT 135
Query: 89 DFGLAKR--YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY- 145
DFGLAK + T+ GT Y + LG + D SLG VL+Y
Sbjct: 136 DFGLAKELSSEGSRTNT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYE 185
Query: 146 FLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
L G P+ A +K+ YEKI + +
Sbjct: 186 MLTGKPPFY---AEDRKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 49/175 (28%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 15 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
DY LV++ L G L L +++ VE +H + +HRDIKP+N
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 133
L+ + + + DFGL++ ENK GT Y + T LG+ +
Sbjct: 128 LLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 134 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------SEKKVSTSIEAL 180
D SLG V+ FL G P+ A T ++ I E K S EA+
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 4e-10
Identities = 22/75 (29%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L+ + LS + + Q++ + + HS LHRD+KP N L+
Sbjct: 75 LVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN-- 132
Query: 80 RRANQVYIIDFGLAK 94
R + + DFGLA+
Sbjct: 133 -RDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G SL+DL ++ L+ + + +++ +E++HS +HRDIK N L+ +V
Sbjct: 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEV 137
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
+IDFGL+ + DT + + GT + +
Sbjct: 138 KLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK---RYRDTATHQHIP 106
++ E++H++ ++RD+KP+N L+ G V ++DFG AK + T T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWT----- 151
Query: 107 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA------- 158
GT Y + L D SLG +L+Y L G P+
Sbjct: 152 ------FCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 159 ----GTKKQKYEKISEKKVSTSIEALCRGYPTE 187
G K ++ +K I+ L R P E
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 20/138 (14%)
Query: 19 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78
VLV++ + L ++ R L V ++ V ++H+ +HRD+KP N L+
Sbjct: 75 VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS- 133
Query: 79 GRRANQVYIIDFGLAKRYRDTA----THQHIP--YRENKNLTGTARYASMNTHLGIEQSR 132
+ I DFGLA+ + + +HQ YR + L G +Y G+
Sbjct: 134 --ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP-----GV---- 182
Query: 133 RDDLESLGYVLMYFLRGS 150
DL ++G + L GS
Sbjct: 183 --DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 22/101 (21%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------QMINRVEFVHSKSFLHRDIKPDN 73
LV + + LE + VL AD + +E++HS LHRD+KP+N
Sbjct: 79 LVFEFMETDLEKVIK------DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132
Query: 74 FLMGLGRRAN-QVYIIDFGLAKRY---RDTATHQHIP--YR 108
L+ ++ + + DFGLA+ + THQ + YR
Sbjct: 133 LLIA----SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/169 (24%), Positives = 61/169 (36%), Gaps = 32/169 (18%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DL N RK +T +++ ++ VH F+HRDIKPDN L+ + +
Sbjct: 87 DLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLA 143
Query: 89 DFGLAKRYRDTAT-----------------HQHIPYRENKN-----LTGTARYASMNTHL 126
DFGL K+ + + GT Y +
Sbjct: 144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203
Query: 127 GIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
G D SLG V++Y L G P + T ++ Y KI K S
Sbjct: 204 GTPYGLECDWWSLG-VILYEMLYGFPP---FYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 7/124 (5%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 109
+++ +E++HS +HRD+KPDN L+ + + DFGL+K + + +E
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 110 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 169
+K + GT Y + LG S+ D SLG +L FL G P+ G T ++ ++ I
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNIL 214
Query: 170 EKKV 173
K+
Sbjct: 215 NGKI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 24/57 (42%), Positives = 34/57 (59%), Gaps = 3/57 (5%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
L +T+ L Q++ V+F+HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 7/76 (9%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP- 106
Q++ + + HS LHRD+KP N L + RR N + + DFGLA+ + T TH+ +
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 107 -YRENKNLTGTARYAS 121
YR + L G+ Y++
Sbjct: 168 WYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 46/191 (24%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
K + + Q++ ++++HS LHRDIK N L+ + + DFGLA+ Y
Sbjct: 96 KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPY-- 150
Query: 99 TATHQHIP----------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 148
T ++ YR + L G RY + D+ S+G +L
Sbjct: 151 --TKRNSADYTNRVITLWYRPPELLLGATRYGP-----EV------DMWSVGCILAELFL 197
Query: 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDY 206
G +QG T+ ++ EKI E LC G PT+ + L + + KP
Sbjct: 198 GKPIFQG---STELEQLEKIFE---------LC-GSPTD--ENWPGVSKLPWFENLKPKK 242
Query: 207 AYLKRLFRDLF 217
Y KR R+ F
Sbjct: 243 PY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 30/103 (29%), Positives = 46/103 (44%), Gaps = 8/103 (7%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ + ++HS +HRDIK N L+ + DFG AKR D T +
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GT 160
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
++ GT + + G E R D+ SLG ++ G PW
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ VE++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TGM 164
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 6 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 58
PN+ R++ +E D +V+DL+ G L + FN K + + + + QM+ + +
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 59 VH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95
+H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 129 LHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 15/121 (12%)
Query: 26 GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 84
G +L + C+ L T+L Q++ + VH+K LHRD+K N L+ +
Sbjct: 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--DKHKMV 140
Query: 85 VYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYV 142
V I DFG++K I ++K T GT Y S G +++ D+ +LG V
Sbjct: 141 VKIGDFGISK----------ILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCV 190
Query: 143 L 143
L
Sbjct: 191 L 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 14/132 (10%)
Query: 16 DYNVLVIDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71
D N L+I++ G +L D +L + VL Q+++ V ++H LHRDIK
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKT 129
Query: 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 131
N + +A + + DFG++K + + + GT Y S G++ +
Sbjct: 130 LNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPELCQGVKYN 179
Query: 132 RRDDLESLGYVL 143
+ D+ +LG VL
Sbjct: 180 FKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 19 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78
LV + + L L R L + Q++ + F HS LHRD+KP+N L+
Sbjct: 74 YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-- 131
Query: 79 GRRANQVYIIDFGLAKRYR---DTATHQ 103
+ + DFGLA+ + TH
Sbjct: 132 -NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 20/146 (13%)
Query: 31 DLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
+LF++ S + S T L A +++ +E++HSK ++RD+KP+N L+ + + +
Sbjct: 87 ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLT 143
Query: 89 DFGLAKRYRD-TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147
DFG AK+ RD T T L GT Y + ++ D +LG ++ L
Sbjct: 144 DFGFAKKLRDRTWT-----------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
Query: 148 RGSLPWQGLKAGTKKQKYEKISEKKV 173
G P+ YEKI K+
Sbjct: 193 VGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 31 DLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DLF+ KLS V + Q++ + +H + +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 89 DFGLAKR 95
D+GL K
Sbjct: 153 DYGLCKI 159
|
Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 21/72 (29%), Positives = 33/72 (45%), Gaps = 8/72 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKG 174
Query: 111 KNLTGTARYASM 122
GT +Y ++
Sbjct: 175 GGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
+ S + + Q++ + +H F HRD+KP+N L+ V I DFGLA+
Sbjct: 94 KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 19/153 (12%)
Query: 7 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKSF 64
NL + + + LV+DLL DL S+K+ V +++ +E++HSK
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-GTARYASMN 123
+HRDIKPDN L+ V+I DF +A + T GT Y +
Sbjct: 122 IHRDIKPDNILLD---EQGHVHITDFNIAT---------KVTPDTLTTSTSGTPGYMAPE 169
Query: 124 THLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 155
S D SLG V Y LRG P++G
Sbjct: 170 VLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 6/55 (10%)
Query: 42 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
+K LML Q+++ V +H LHRD+K N L+ + I DFGLA+ Y
Sbjct: 108 VKC-LML--QLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 23/66 (34%), Positives = 37/66 (56%), Gaps = 4/66 (6%)
Query: 29 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
L+DL + + L V Q++ +EF HS + +HRDIKP+N L+ ++ V +
Sbjct: 87 LDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLC 142
Query: 89 DFGLAK 94
DFG A+
Sbjct: 143 DFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 14/89 (15%)
Query: 13 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSL----KTVLMLADQMINRVEFVHSKSFLHRD 68
VEGD+ LV+D++ L+ + + RK+ L ++L Q++N + +H F+HRD
Sbjct: 90 VEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCILL--QILNGLNVLHKWYFMHRD 144
Query: 69 IKPDN-FLMGLGRRANQVYIIDFGLAKRY 96
+ P N F+ G I DFGLA+RY
Sbjct: 145 LSPANIFINSKG----ICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRD 98
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 10/77 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP 106
Q++ + + HS LHRD+KP N L+ R + + DFGLA+ + R T TH+ +
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVT 162
Query: 107 --YRENKNLTGTARYAS 121
YR + L G+ +Y++
Sbjct: 163 LWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 22/57 (38%), Positives = 35/57 (61%), Gaps = 3/57 (5%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
L +T+ L Q + ++F+H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV +L+G L ++ +KLS + V L Q++ ++++HS +HRD+KP N +
Sbjct: 97 LVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN-- 152
Query: 80 RRANQVYIIDFGLAKRYRDTAT 101
++ I+DFGLA++ D T
Sbjct: 153 -EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP 106
Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y T++ I
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 107 --YRENKNLTGTARY 119
YR + L G RY
Sbjct: 181 LWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 39/134 (29%), Positives = 59/134 (44%), Gaps = 39/134 (29%)
Query: 18 NVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------------------QMINR 55
NVL +D+L P D F ++ + T LM +D Q++
Sbjct: 60 NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIP-------Y 107
++++HS LHRDIKP N L+ +N + I DFGLA R + +H+ Y
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLA-RVEEPDESKHMTQEVVTQYY 170
Query: 108 RENKNLTGTARYAS 121
R + L G+ Y S
Sbjct: 171 RAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
KL+L +L+ A Q+ + ++HS+ ++HRD+ N L+ V I DFGLAK
Sbjct: 103 KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L+ F+ C+ + + V Q++ + F HS + LHRD+KP N L+
Sbjct: 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI--- 132
Query: 80 RRANQVYIIDFGLAKRY 96
+ ++ + DFGLA+ +
Sbjct: 133 NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L+ + C +S+ V + Q++ + + H + LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 80 RRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 121
++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 49 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 108
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K +++ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCK--------ENV-FG 149
Query: 109 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 166
+N+ T GT Y + G++ + D S G +L L G P+ G + + +E
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFE 206
Query: 167 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF-RDLFIREGF--- 222
I +V T HY R + + K L++LF RD R G
Sbjct: 207 SI---RVDTP----------------HYPRWITKESKD---ILEKLFERDPTRRLGVVGN 244
Query: 223 ----QFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGR 274
F +WT L+ R + P P P +N DR+ +E+ R
Sbjct: 245 IRGHPFFKTINWTALE---------KRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 8/158 (5%)
Query: 236 QQSQVSTPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGP--- 291
S S+ + + G G GP + P P A + + E S+ P +S
Sbjct: 234 ASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 292 LGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSR 351
S + S S A + + SS R S SS + S A V PSR
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSS----RESSSSSTSSSSESSRGAAVSPGPSPSR 349
Query: 352 PRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTS 389
+ P S +R P + + ++GR T
Sbjct: 350 SPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTR 387
|
Length = 1352 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q + V F H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 3e-05
Identities = 18/45 (40%), Positives = 26/45 (57%), Gaps = 5/45 (11%)
Query: 56 VEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 99
++++HS+ LHRDIKP N FL V + DFG++K T
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSST 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 29/107 (27%), Positives = 54/107 (50%), Gaps = 8/107 (7%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L+ + C +S+ V + Q++ + + H + LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-- 138
Query: 80 RRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 121
++ + DFGLA+ + T T+ + + YR L G++ Y++
Sbjct: 139 -ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI--PYR 108
QM+ ++ +HS +HRD+KP N ++ + + I+DFGLA+ TA + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR----TACTNFMMTPY- 182
Query: 109 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 168
T Y + LG+ D+ S+G ++ ++GS+ +QG ++ K+
Sbjct: 183 -----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKV 234
Query: 169 SEKKVSTSIEALCRGYPT 186
E+ + S E + R PT
Sbjct: 235 IEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 56 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------RYRDTATH 102
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 103 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 11/112 (9%)
Query: 6 PNL-RWFGVEGDYNV-LVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
NL R +GV + + +V +L LG L+ L + T+ A Q+ N + ++ S
Sbjct: 56 ENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 113
K F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 116 KRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTG 115
E++HSK ++RD+KP+N L L + + V + DFG AK+ D T T L G
Sbjct: 132 EYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT-----------LCG 177
Query: 116 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 173
T Y + + D ++G +L F+ G P+ T + YEKI ++
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRL 232
|
Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 14/115 (12%)
Query: 48 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 107
+Q++ + ++HSK LHRD+K DN L+ I DFG++K+ D +
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND---- 165
Query: 108 RENKNLTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
+N ++ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 166 -QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 13/105 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
+M V+ +H ++HRD+KP+NFL+ + + + DFGL+K A
Sbjct: 109 EMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA---------- 155
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
++ G+ Y + G D SLG +L FL G P+ G
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 46/167 (27%), Positives = 69/167 (41%), Gaps = 38/167 (22%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
S + A Q++ +E++HS ++RD+KP+N L+ + I DFG AKR
Sbjct: 95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV 151
Query: 97 RD-TATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 152
+ T T L GT Y + + G ++ D +LG +L+Y L G P
Sbjct: 152 KGRTYT-----------LCGTPEYLAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPP 197
Query: 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY-CRSL 198
+ Q YEKI E KV F S+F + L
Sbjct: 198 F---FDDNPIQIYEKILEGKV-------------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 20 LVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78
LV + L L+ + + L + Q++ + F HS LHRD+KP N L+
Sbjct: 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN- 134
Query: 79 GRRANQVYIIDFGLAKRY---RDTATHQHIP--YRENKNLTGTARYAS 121
+ + DFGLA+ + T TH+ + YR + L G Y++
Sbjct: 135 --TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 7/68 (10%)
Query: 31 DLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 86
DL NF RK L+L+ +L + Q+ + F+ SK+ +HRD+ N L+ G+
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK--- 181
Query: 87 IIDFGLAK 94
I DFGLA+
Sbjct: 182 ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 25/67 (37%), Positives = 33/67 (49%), Gaps = 9/67 (13%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 115
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG----D 164
Query: 116 TARYASM 122
R SM
Sbjct: 165 HHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N +
Sbjct: 99 LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-- 154
Query: 80 RRANQVYIIDFGLAKRYRDTAT 101
++ I+DFGLA+ D T
Sbjct: 155 -EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 28/107 (26%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L+ + C +++ V + Q++ + + H + LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 80 RRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 121
++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 8/75 (10%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP- 106
Q++ + F HS+ LHRD+KP N L+ + + DFGLA+ + TH+ +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
Query: 107 -YRENKNLTGTARYA 120
YR + L G+ RY+
Sbjct: 166 WYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 16/122 (13%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
S + A ++I ++F+H K ++RD+K DN L+ + + I DFG+ K
Sbjct: 90 SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK-- 144
Query: 97 RDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 153
+++ E K T GT Y + G + + D S G VL+Y L G P+
Sbjct: 145 ------ENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPF 196
Query: 154 QG 155
G
Sbjct: 197 HG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 48 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 107
+A Q+++ + ++H + +HRDIKP N L+ + V I DFG+++ T P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225
Query: 108 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 152
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 11/115 (9%)
Query: 47 MLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 105
+A Q++ ++++H+K +HRDIKP N L+ +V I DFG++K +T
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD---- 155
Query: 106 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160
+ GT Y S G S D+ SLG L+ G P+ +
Sbjct: 156 ---QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/44 (34%), Positives = 27/44 (61%), Gaps = 3/44 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q++ + + HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
V +LLG L L SR L + + Q++ +++VHS +HRD+KP N L+
Sbjct: 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-- 142
Query: 80 RRANQVYIIDFGLAK 94
+ I DFGLA+
Sbjct: 143 -ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
++ VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 21/67 (31%), Positives = 38/67 (56%), Gaps = 3/67 (4%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
SL D +++LK +L+ + Q+ ++++ S+ ++HRD+ N L+ + V I
Sbjct: 94 SLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKI 150
Query: 88 IDFGLAK 94
DFGLAK
Sbjct: 151 SDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 9 RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 65
R GV +G+ +LV++L LGP L+ L R++ + + LA Q+ + ++ SK F+
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAK------RYRDTATHQHIPYRENKNLTGTARY 119
HRD+ N L L R +Q I DFG+++ Y T P + Y
Sbjct: 118 HRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK---------WY 165
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 177
A + G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 166 APECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPR 219
Query: 178 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215
C P E S C R +D+P ++ L+ FR
Sbjct: 220 PEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 20/85 (23%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
SL DL +F L +A M E++ SK+F+HRD+ N L+G V I
Sbjct: 101 SLSDLLSFA---------LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKI 144
Query: 88 IDFGLAKRYRD----TATHQHIPYR 108
DFGL++ D +P R
Sbjct: 145 SDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 22/89 (24%)
Query: 15 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVHSKSFL 65
GD +V++ + G SL D+ +++ + I V E++HS++ +
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLHSQNVI 138
Query: 66 HRDIKPDNFLMGL-GRRANQVYIIDFGLA 93
HRDIK DN L+ G V + DFG A
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 20/85 (23%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
SL DL +F L +A M E++ SK+F+HRD+ N L+G V I
Sbjct: 100 SLSDLLSFA---------LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKI 143
Query: 88 IDFGLAKRYRDT----ATHQHIPYR 108
DFGL++ D +P R
Sbjct: 144 SDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/129 (23%), Positives = 59/129 (45%), Gaps = 13/129 (10%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQ 84
G SL+ + ++ + + +A ++ + ++H K +HRD+KP N L+ Q
Sbjct: 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQ 139
Query: 85 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144
+ + DFG++ + ++ K GT+ Y + G + S + D+ SLG L+
Sbjct: 140 IKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 145 YFLRGSLPW 153
G P+
Sbjct: 191 ELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 9/90 (10%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV +L+ +L +L R L K V Q++ ++ +H HRDIKP+N L+
Sbjct: 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI--- 133
Query: 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRE 109
+ + + + DFG + + PY E
Sbjct: 134 -KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 8 LRWFGV-EGDYNVLVIDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK 62
+R G+ E + +LV++L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 59 VRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 63 SFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNLT 114
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 115 NFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------ 163
Query: 115 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISE 170
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ---WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--G 214
Query: 171 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217
+++ + P E C + D++P +A ++ R+ +
Sbjct: 215 ERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 29/142 (20%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR- 95
LSLK +L A Q+ +E++ SK F+HRD+ N L+G V I DFGL++
Sbjct: 99 KSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDV 155
Query: 96 ----YRDTATHQHIPYR----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-- 145
Y T +P R E S+ + +S D+ S G VL++
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEI 200
Query: 146 FLRGSLPWQGLKAGTKKQKYEK 167
F G+ P+ GL + K
Sbjct: 201 FTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 33/117 (28%), Positives = 46/117 (39%), Gaps = 19/117 (16%)
Query: 61 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNLTGTA 117
+ LHRD+KP N FL N V + DFGLAK + ++ GT
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174
Query: 118 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
Y S + + D+ SLG ++ S P+ A + Q KI E K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 5/76 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV+ +G L L KLS + L QM+ ++++H+ +HRD+KP N +
Sbjct: 97 LVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-- 152
Query: 80 RRANQVYIIDFGLAKR 95
++ I+DFGLA++
Sbjct: 153 -EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 43 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 102
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 103 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 152
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/76 (31%), Positives = 43/76 (56%), Gaps = 7/76 (9%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV L+G L ++ +KLS + L Q++ ++++HS +HRD+KP N +
Sbjct: 97 LVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IA 150
Query: 80 RRAN-QVYIIDFGLAK 94
+ ++ I+DFGLA+
Sbjct: 151 VNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 7/104 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 109
Q++ + ++H +HRD+K N L+ G+R + I DFG A R T
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EF 164
Query: 110 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
L GT + + G + R D+ S+G V++ PW
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 10/117 (8%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
K L A ++I ++F+HSK ++RD+K DN L+ + I DFG+ K
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCK---- 144
Query: 99 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
+ + GT Y + LG + + D S G +L L G P+ G
Sbjct: 145 ---ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
Q++ ++F+HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 20/44 (45%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
+E VH F+HRDIKPDN L+ L + + DFGL +R T
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 17/37 (45%), Positives = 23/37 (62%), Gaps = 3/37 (8%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 92
+EF+HS +HRDIK DN L+G+ V + DFG
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 107
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 108 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 28/108 (25%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ + ++H + LHRD+KP N L+ ++ + DFGLA+ + +P
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA-------KSVPSHTY 160
Query: 111 KNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157
N T Y + LG E S D+ +G + + ++G + G+K
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 17/47 (36%), Positives = 28/47 (59%), Gaps = 9/47 (19%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 94
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 5/45 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 94
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 3/64 (4%)
Query: 31 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 90
DL LS V L QM+ ++++HS +HRD+KP N + ++ I+DF
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDF 161
Query: 91 GLAK 94
GLA+
Sbjct: 162 GLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 13/123 (10%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
S + A ++I +E +H++ ++RD+KP N L+ V I D GLA +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK 150
Query: 100 ATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
H + GT Y A G+ D SLG +L LRG P++ K
Sbjct: 151 KPHASV---------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 159 GTK 161
K
Sbjct: 202 KDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 15/125 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----DTATHQHIP 106
Q++ + ++H++ +HRDIK N L+ + I DFG++K+ T T+ P
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 107 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 166
+L G+ + + +R+ D+ SLG +++ L G P+ T+ Q
Sbjct: 171 -----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIF 222
Query: 167 KISEK 171
KI E
Sbjct: 223 KIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 20/60 (33%), Positives = 31/60 (51%), Gaps = 11/60 (18%)
Query: 46 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATH 102
LML Q++ ++++H +HRD+K N L+ G + I DFGLA+ Y A
Sbjct: 113 LML--QLLRGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTYGLPAKP 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 47 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 105
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+ +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 106 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 20/55 (36%), Positives = 33/55 (60%), Gaps = 10/55 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-RYRDTAT 101
Q++ ++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 170
K GT + + G E D +LG L + P+ + + EK+
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--------RARGEKVEN 206
Query: 171 KKVSTSIEALCRGYPTEF-ASYFHYCRSLRFDDKPDYAYLKRL-FRD 215
K++ I YP +F + +C +L P+ KRL FRD
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 20/147 (13%)
Query: 16 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEFVHSKSFLHRDI 69
D N L I + DL S++ + ++ + Q++ ++ +H + LHRD+
Sbjct: 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDL 129
Query: 70 KPDNFLMGLGRRANQVYII-DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 128
K N L AN + I D G++K + K GT Y + G
Sbjct: 130 KSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTPHYMAPEVWKGR 176
Query: 129 EQSRRDDLESLGYVLMYFLRGSLPWQG 155
S + D+ SLG +L + P++
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 17/46 (36%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
Q++ ++++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
L TV Q++ + F H LHRD+KP N L+ + ++ + DFGLA+
Sbjct: 95 GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 18/96 (18%), Positives = 40/96 (41%), Gaps = 15/96 (15%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-- 61
+P + G ++ L+++ + G +L+ ++S + +A+Q+ + +H
Sbjct: 55 VPKVLASGESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 62 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
H D+ P N L+ + IID+ A
Sbjct: 107 LLVLCHGDLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ V ++HS +HRDIK N L V + DFG +KR + +
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGM 166
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 40/186 (21%), Positives = 81/186 (43%), Gaps = 42/186 (22%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
+ L + +++ +A Q+ + ++ ++ +HRD+ N L+G + DFGLA+ +
Sbjct: 99 QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK---VADFGLARLIK 155
Query: 98 D---TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLP 152
+ ++ + IPY+ TA A+ + S + D+ S G +L+Y F G +P
Sbjct: 156 EDVYLSSDKKIPYK------WTAPEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVP 204
Query: 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGY--------PTEFASYFHYCRSLRFDDKP 204
+ G+ + Y++I+ GY P E C + +D+P
Sbjct: 205 YPGM---NNHEVYDQIT------------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249
Query: 205 DYAYLK 210
+ L+
Sbjct: 250 SFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 18/38 (47%), Positives = 24/38 (63%), Gaps = 3/38 (7%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93
+E VH F+HRDIKPDN L+ R + + DFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ + ++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGI 166
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
+++TGT + S G R+ D+ SLG ++ L PW +A
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 19/169 (11%)
Query: 11 FGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 68
+ + + N+ LV+D +G L L + +L +M+ ++ VH ++HRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 128
IKPDN LM + + + DFG + + T Q + GT Y S +
Sbjct: 128 IKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPEILQAM 178
Query: 129 EQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 172
E + D SLG + L G P+ A + + Y KI K
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 11/94 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRE 109
Q+I + + H +HRDIKP+N L+ N V + DFG A+ + + + Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY-- 161
Query: 110 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143
T Y S LG + D+ S+G +L
Sbjct: 162 ----VATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 20/184 (10%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 96
R + +TV Q+ + VE +HS+ +HRDIKP N F+ G V + D GL + +
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFF 156
Query: 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156
T H +L GT Y S + + D+ SLG +L P+ G
Sbjct: 157 SSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 157 KAG--TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214
K + QK E+ + T Y + C D +PD Y+ ++ +
Sbjct: 210 KMNLFSLCQKIEQCDYPPLPT------EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
Query: 215 DLFI 218
+ +
Sbjct: 264 QMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 12/104 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
+ + +EF+HS +HRDIK DN L+G+ V + DFG Q P +
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSK 172
Query: 111 KN-LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
++ + GT + + + D+ SLG + + + G P+
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 115
++ +HS ++RD+KP+N L+ + + DFGL+K D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 116 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 155
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 9/59 (15%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYR 108
Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+ A +H
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLAR----IADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
+KL L ++ +A Q+ + ++ S++++HRD+ N L+G I DFGLA+
Sbjct: 98 KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIE 154
Query: 98 D 98
D
Sbjct: 155 D 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 25/90 (27%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
R L KT+ Q++ V H +HRD+KP N L + ++ + I D GL + +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAF 161
Query: 97 R---DTATHQHIP--YRENKNLTGTARYAS 121
+ TH+ + YR + L G+ Y++
Sbjct: 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 23/129 (17%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR- 95
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I DFGLA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADFGLARDI 182
Query: 96 -----YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLR 148
YR T T+ +P K + A + + TH QS D+ S G VL++ F
Sbjct: 183 HHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG-VLLWEIFTL 230
Query: 149 GSLPWQGLK 157
G P+ G+
Sbjct: 231 GGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 35/202 (17%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G L+ L + L L ++ +A Q+ + + +V +++HRD++ N L+G N V
Sbjct: 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLV 140
Query: 86 -YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144
+ DFGLA+ D Y + ++ + L + + D+ S G +L
Sbjct: 141 CKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 145 YF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY----PTEFASYFH----YC 195
+G +P+ G+ ++V +E RGY P E H C
Sbjct: 195 ELTTKGRVPYPGM------------VNREVLDQVE---RGYRMPCPPECPESLHDLMCQC 239
Query: 196 RSLRFDDKPDYAYLKRLFRDLF 217
+++P + YL+ D F
Sbjct: 240 WRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 12/102 (11%)
Query: 43 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 101
+T+ Q+ + +E +HSK +HRDIKP N + A V + D GL + + T
Sbjct: 106 RTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTT 161
Query: 102 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143
H +L GT Y S + + D+ SLG +L
Sbjct: 162 AAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 20/77 (25%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L + + K +L + + ++N + ++H LHRD+K N L+
Sbjct: 96 LVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI--- 152
Query: 80 RRANQVYIIDFGLAKRY 96
+ + + DFGLA+ +
Sbjct: 153 TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 20/61 (32%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 44 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-DTATH 102
+L +A Q+ + +E++ K+F+HRD+ N L+G + V + DFGL++ DT T
Sbjct: 105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTA 161
Query: 103 Q 103
Sbjct: 162 H 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 17/142 (11%)
Query: 15 GDYNVLVIDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
GD +V++ L G SL D+ C + + V + + +EF+H+ +HRDIK D
Sbjct: 88 GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQVIHRDIKSD 144
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASMNTHLGIEQS 131
N L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 145 NVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 132 RRDDLESLGYVLMYFLRGSLPW 153
+ D+ SLG + + + G P+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 34/135 (25%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 19 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78
VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK D+ L+ L
Sbjct: 95 VLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152
Query: 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138
R V + DFG + + +P R K+L GT + + D+ S
Sbjct: 153 DGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 139 LGYVLMYFLRGSLPW 153
LG +++ + G P+
Sbjct: 203 LGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 21/78 (26%), Positives = 43/78 (55%), Gaps = 10/78 (12%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
+V+DL+ L + + L+ + + Q++ ++++HS + +HRD+KP N L+
Sbjct: 85 VVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV--- 140
Query: 80 RRANQ---VYIIDFGLAK 94
N+ + I DFG+A+
Sbjct: 141 ---NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 38/181 (20%), Positives = 76/181 (41%), Gaps = 21/181 (11%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRY 96
+ L L ++ +A Q+ + + ++ +++HRD++ N L+G N V I DFGLA+
Sbjct: 97 KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADFGLARLI 152
Query: 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG 155
D Y + ++ + L + + D+ S G +L + +G +P+ G
Sbjct: 153 EDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206
Query: 156 LKAGTKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214
+ ++ E +V C +G P C D++P + Y++
Sbjct: 207 M---VNREVLE-----QVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
Query: 215 D 215
D
Sbjct: 259 D 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 96
Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 21/59 (35%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 96
+L V L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 56 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLT 114
++ +H F+HRDIKPDN L+ V + DFGL + H+ YR N +L
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK--AHRTEFYRNLNHSLP 168
Query: 115 GTARYASMNTHLGIEQSRRD 134
+ +MN+ E +R+
Sbjct: 169 SDFTFQNMNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 237 QSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADP------SRRRNSG 290
+ + P G + P+S PP AA A T + D SR
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 291 PLGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSG----SSR-RVAVPNSREAAVVGS 345
A ++ +P A PA ++ ++LR++G S R A ++ AA +
Sbjct: 524 AAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA 583
Query: 346 DTDPSRPR 353
P+ PR
Sbjct: 584 APKPAAPR 591
|
Length = 830 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
QM+ + F+HS +HRD+K N L+ L V + DFG++ + + T
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 12/121 (9%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 96
R + KTV Q+ + +E +HS+ +HRDIKP N F+ G V + D GL + +
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFF 156
Query: 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156
T H +L GT Y S + + D+ SLG +L P+ G
Sbjct: 157 SSKTTAAH-------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 157 K 157
K
Sbjct: 210 K 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 31 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 2 AAGIPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 59
+AG NLR LV++ L P SL D +L + +L+ A Q+ +E++
Sbjct: 76 SAGRRNLR----------LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 60 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 125 GSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 20/72 (27%), Positives = 38/72 (52%), Gaps = 3/72 (4%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
S+ D+ ++ L+ + + + Q + +E++HS +HRDIK N L+ Q +
Sbjct: 84 SVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKL 140
Query: 88 IDFGLAKRYRDT 99
DFG++ + DT
Sbjct: 141 ADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 109
++++ +E++HS+ ++RDIK +N ++ + + I DFGL K D AT
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM------- 152
Query: 110 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
K GT Y + + R D LG V+ + G LP+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ V ++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGI 166
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158
K++TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 414 | |||
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.61 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.56 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.54 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.52 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.38 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.32 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.32 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.3 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.11 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.81 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.73 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.65 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.25 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.29 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.28 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.45 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.14 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.88 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.34 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 92.89 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.43 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.3 | |
| PLN02236 | 344 | choline kinase | 91.72 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.11 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.86 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 89.36 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.0 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.47 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.19 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 88.15 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 87.68 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 87.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 87.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 85.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 85.34 | |
| KOG2464 | 246 | consensus Serine/threonine kinase (haspin family) | 84.23 |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=401.24 Aligned_cols=234 Identities=63% Similarity=1.076 Sum_probs=228.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec-
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG- 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~- 79 (414)
|++|||++|+||+++.|..||||++|+||+|+++-|+++|+.++|+++|.||+..++|+|++.+|.|||||+||||+..
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~ 161 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG 161 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC
Confidence 7999999999999999999999999999999999999999999999999999999999999999999999999999863
Q ss_pred -CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 -RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
+..+.|+|+|||+|+.|.++.+++||||++.+.+.||++||+.++|+|.++++++|++|||-|++++|.|.+||+|+++
T Consensus 162 ~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 162 TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 4557899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
.+.+++|++|.+.+..+++++||.++|.||..++++.+.+++++.|||++|+.+|.++|.+.|..+|+.|||..+.
T Consensus 242 ~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 242 DTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred cchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=384.62 Aligned_cols=237 Identities=71% Similarity=1.265 Sum_probs=232.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
|+.|||.+++++.+.+|.+||||++|++|+++++.|++.|+++++++++.|++..|+|+|.+++|||||||+|||++.+.
T Consensus 69 ~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 69 GGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR 148 (341)
T ss_pred cCCCCchhhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..++++|||||||+++.+..+..|+||++....+||++|++...+.+.++++++|+.|+|++|+++..|.+||+|+.+.+
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 237 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~ 237 (414)
++|+|++|.+.++..+++.||+++|.||.-++.+|..+.+++.|+|.+|.++|+-++...+.+.|+.|||+.++.+.
T Consensus 229 k~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 229 KKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred HHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.94 Aligned_cols=213 Identities=23% Similarity=0.344 Sum_probs=181.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|+|+|++||..|+|+...|+|+||+ +|+|.++|++. +.|++..+..++.||+.+|+|||++|||||||||+||||+
T Consensus 132 ~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd-- 208 (604)
T KOG0592|consen 132 GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD-- 208 (604)
T ss_pred CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc--
Confidence 7899999999999999999999999 99999999864 6899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccc----cc--cCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPY----RE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~----~~--~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.+++++|+|||.|+.+.........+. .. ...++||+.|.+||++.....+..+|||+||||||.|+.|.+||
T Consensus 209 -~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 209 -KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred -CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 899999999999998766443211111 11 25699999999999999999999999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.+. +....+++|..-... +.+++|+.+.+||+.+|..||.+|++.++|++- .+...++|+.+
T Consensus 288 ra~---NeyliFqkI~~l~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H----------pFF~~Vdw~nl 349 (604)
T KOG0592|consen 288 RAA---NEYLIFQKIQALDYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH----------PFFEGVDWENL 349 (604)
T ss_pred ccc---cHHHHHHHHHHhccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhhC----------cccccCChhhh
Confidence 885 445556666654443 467899999999999999999999998777532 45566777775
Q ss_pred cc
Q 015018 234 KY 235 (414)
Q Consensus 234 ~~ 235 (414)
-.
T Consensus 350 w~ 351 (604)
T KOG0592|consen 350 WQ 351 (604)
T ss_pred hh
Confidence 43
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.92 Aligned_cols=192 Identities=22% Similarity=0.340 Sum_probs=169.5
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~ 78 (414)
+|+||.+|+.|.... ..+|+|||| ||||.++++. .+.+++..+-.|+.++++||.|||+ ++||||||||.|||+.
T Consensus 136 spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN- 213 (364)
T KOG0581|consen 136 SPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN- 213 (364)
T ss_pred CCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec-
Confidence 799999999999988 599999999 9999999985 4689999999999999999999996 9999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-- 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~-- 156 (414)
..|.|||||||.++.+.+.. .++++||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 214 --skGeVKicDFGVS~~lvnS~---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~ 282 (364)
T KOG0581|consen 214 --SKGEVKICDFGVSGILVNSI---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP 282 (364)
T ss_pred --cCCCEEeccccccHHhhhhh---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence 78999999999998876642 36789999999999999999999999999999999999999999763
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~-~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+.+..|+...... ++.+ +++||++||..|+++||.+||++.+|.
T Consensus 283 ~~~~~~~Ll~~Iv~~ppP~----lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 283 PYLDIFELLCAIVDEPPPR----LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred CCCCHHHHHHHHhcCCCCC----CCcccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 2345667777777654433 4444 899999999999999999999976653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=303.76 Aligned_cols=210 Identities=21% Similarity=0.276 Sum_probs=179.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|.|+++++.|++.+..|||+||+ ||.|...+++ .+.|++..+..++.+|+.||.|||++|||||||||+||||+
T Consensus 84 hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd--- 159 (357)
T KOG0598|consen 84 HPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD--- 159 (357)
T ss_pred CCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---
Confidence 699999999999999999999999 9999999985 67999999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..|+|+|+||||++....... ...+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+ .+
T Consensus 160 ~~GHi~LtDFgL~k~~~~~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~ 229 (357)
T KOG0598|consen 160 EQGHIKLTDFGLCKEDLKDGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---ED 229 (357)
T ss_pred CCCcEEEeccccchhcccCCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---cc
Confidence 889999999999996544332 22468999999999999999999999999999999999999999987 56
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC----HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 236 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~----~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~ 236 (414)
..+.+++|...+... ...-++.+.++++..++..+|++|.. +.+| ....+...++|+.+...
T Consensus 230 ~~~~~~~I~~~k~~~----~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~inW~~l~~k 295 (357)
T KOG0598|consen 230 VKKMYDKILKGKLPL----PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKGINWEKLLAK 295 (357)
T ss_pred HHHHHHHHhcCcCCC----CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCcccccCCHHHHHhc
Confidence 678888888877332 12336789999999999999999963 3332 23355677899987654
Q ss_pred ccc
Q 015018 237 QSQ 239 (414)
Q Consensus 237 ~~~ 239 (414)
...
T Consensus 296 ~l~ 298 (357)
T KOG0598|consen 296 KLS 298 (357)
T ss_pred CCC
Confidence 433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=316.91 Aligned_cols=202 Identities=24% Similarity=0.337 Sum_probs=177.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++|.+|++.+++|||+|+| .++|..+++ ..+.|++.++..++.||+.||.|||+++|||||||..||+|+
T Consensus 76 ~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~-- 152 (592)
T KOG0575|consen 76 KHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN-- 152 (592)
T ss_pred CCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec--
Confidence 3799999999999999999999999 999999998 577999999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.+.+|||+|||||..+..+.. .+.+++||+.|+|||++.....+..+||||+|||||.||.|++||+. .
T Consensus 153 -~~~~VKIgDFGLAt~le~~~E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k 221 (592)
T KOG0575|consen 153 -ENMNVKIGDFGLATQLEYDGE-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---K 221 (592)
T ss_pred -CcCcEEecccceeeeecCccc-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---c
Confidence 788999999999998875432 24578999999999999999999999999999999999999999976 4
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 224 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 224 (414)
+.++.|.+|....... +..++.+..+||..+|+.+|.+||+++++ |.+-|...|+..
T Consensus 222 ~vkety~~Ik~~~Y~~-----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff~~g~~p 278 (592)
T KOG0575|consen 222 TVKETYNKIKLNEYSM-----PSHLSAEAKDLIRKLLRPNPSERPSLDEV---LDHPFFKSGFTP 278 (592)
T ss_pred hHHHHHHHHHhcCccc-----ccccCHHHHHHHHHHhcCCcccCCCHHHH---hcCHhhhCCCcC
Confidence 6688888888766542 34678899999999999999999996655 455555555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=309.90 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=166.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++..++.||||||+ ||.|.+.+-. ++.+.+..-..+++||+.||.|||++||+||||||+|||+..+.
T Consensus 235 HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 235 HPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA 313 (475)
T ss_pred CCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC
Confidence 799999999999999999999999 9999999863 67899999999999999999999999999999999999998776
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+..+||+|||+|+...... ..++++||+.|.|||++.+.. +..++|+||+||+||-+|+|.+||.+..
T Consensus 314 e~~llKItDFGlAK~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred cceEEEecccchhhccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 77899999999999876432 236789999999999998654 3458899999999999999999998743
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ....++.|...+... .+..+..++++..+||..+|..||++||+.++++
T Consensus 386 ~--~~sl~eQI~~G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 386 T--DPSLKEQILKGRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred C--CccHHHHHhcCcccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 2 222445555555432 2334567889999999999999999999977654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.48 Aligned_cols=203 Identities=23% Similarity=0.347 Sum_probs=172.8
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~g-ivHRDIKP~NILl~ 77 (414)
+|||++++..+.+.. ..+|||||+ +|+|.+++.. ..+.+++..++.|+.||++||+|||+++ ||||||||+||||+
T Consensus 98 HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~ 177 (362)
T KOG0192|consen 98 HPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD 177 (362)
T ss_pred CCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc
Confidence 799999999999988 689999999 9999999986 3789999999999999999999999999 99999999999996
Q ss_pred ecCCCC-eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 78 LGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 78 ~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
... .+||+|||+++....... ......||..|||||++. ...|+.++||||||++||||++|+.||.
T Consensus 178 ---~~~~~~KI~DFGlsr~~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 178 ---LKGKTLKIADFGLSREKVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred ---CCCCEEEECCCccceeeccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 554 999999999987655321 113368999999999999 5589999999999999999999999999
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
++.. .+....+....... .+...+|+.+..+|+.||..||..||++.+|...|+.+....
T Consensus 248 ~~~~---~~~~~~v~~~~~Rp---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 248 DLAP---VQVASAVVVGGLRP---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCH---HHHHHHHHhcCCCC---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 8754 33333333333222 234458999999999999999999999999999999887543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.90 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=160.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+||||.|+++..++++.||||||| ||+|.+++.. .+.+++.++..++.||+.||++||+++||||||||+||||+...
T Consensus 68 H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~ 146 (429)
T KOG0595|consen 68 HPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTA 146 (429)
T ss_pred CcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCC
Confidence 699999999999999999999999 9999999985 45899999999999999999999999999999999999998652
Q ss_pred CC---CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RA---NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.. -.+||+|||+|+.+.... ...+++|++-|||||++....|+.|+|+||+|+|+|++++|+.||...
T Consensus 147 ~~~~~~~LKIADFGfAR~L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~- 217 (429)
T KOG0595|consen 147 RNDTSPVLKIADFGFARFLQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE- 217 (429)
T ss_pred CCCCCceEEecccchhhhCCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc-
Confidence 22 679999999999877533 245789999999999999999999999999999999999999999764
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+..+.+..+..... .+..+...+.....+++...+..++.+|-++.+
T Consensus 218 --t~~eL~~~~~k~~~--~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 218 --TPKELLLYIKKGNE--IVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred --CHHHHHHHHhcccc--ccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 44555444433222 222333344556678888888999989987643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.70 Aligned_cols=213 Identities=22% Similarity=0.298 Sum_probs=181.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|.++++++.+.+.++.||||||+ ||-|..++.. .++|++..+..++.||+.||+|||+++|++|||||+||||+
T Consensus 103 ~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD--- 178 (355)
T KOG0616|consen 103 HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD--- 178 (355)
T ss_pred CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---
Confidence 689999999999999999999999 9999999986 56999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..|.+||+|||+|+..... ..+.+||+.|+|||++....|+..+|+|+|||++|||+.|..||... +
T Consensus 179 ~~G~iKitDFGFAK~v~~r----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~---~ 245 (355)
T KOG0616|consen 179 QNGHIKITDFGFAKRVSGR----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD---N 245 (355)
T ss_pred cCCcEEEEeccceEEecCc----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC---C
Confidence 8899999999999987653 24679999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 240 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~~~ 240 (414)
..+.|++|.+.+.. ++..+..++++|+..+++.|-.+|- ..++.=.+++ .+..+....+|.....+..+.
T Consensus 246 ~~~iY~KI~~~~v~-----fP~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~dI---k~H~wF~~v~W~~i~~r~ie~ 315 (355)
T KOG0616|consen 246 PIQIYEKILEGKVK-----FPSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVEDI---KNHPWFKGVDWEAILQRKIEP 315 (355)
T ss_pred hHHHHHHHHhCccc-----CCcccCHHHHHHHHHHHhhhhHhhh--cCcCCCcccc---ccCcccccccHHHHhhccccC
Confidence 58899999998875 3456789999999999999988882 2222111222 234566788999876554443
Q ss_pred C
Q 015018 241 S 241 (414)
Q Consensus 241 ~ 241 (414)
+
T Consensus 316 P 316 (355)
T KOG0616|consen 316 P 316 (355)
T ss_pred C
Confidence 3
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=302.42 Aligned_cols=202 Identities=22% Similarity=0.337 Sum_probs=175.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+++|++++..+..++..||||||| .|+|.+++.. .+..+...+.+.++.|||+|++||+++++|||||-..||||+
T Consensus 260 H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~-- 337 (468)
T KOG0197|consen 260 HEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD-- 337 (468)
T ss_pred ccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec--
Confidence 589999999999999999999999 9999999986 467799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.+..|||+|||||+...+.. |.......-...|.|||.+....++.++|||||||+||||++ |+.||.++..
T Consensus 338 -~~~~vKIsDFGLAr~~~d~~------Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 338 -EDLVVKISDFGLARLIGDDE------YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred -cCceEEEcccccccccCCCc------eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 77899999999999655443 333344556788999999999999999999999999999998 9999998644
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+.++.+.+..... .+++||.++.++|..||..+|++||+|+.|...|++++..
T Consensus 411 ---~ev~~~le~GyRlp----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 411 ---EEVLELLERGYRLP----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---HHHHHHHhccCcCC----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 44455555444432 3468999999999999999999999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=297.59 Aligned_cols=215 Identities=21% Similarity=0.314 Sum_probs=173.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+||+||+.|++.+++||||||+ ||++..+|.. ...|++..+..++.+++.||+.||..|||||||||+|+||+
T Consensus 200 s~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD--- 275 (550)
T KOG0605|consen 200 SPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID--- 275 (550)
T ss_pred CCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---
Confidence 689999999999999999999999 9999999975 56899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCC------------------cccccc----c------------------ccCCCCCCcccc
Q 015018 81 RANQVYIIDFGLAKRYRDTAT------------------HQHIPY----R------------------ENKNLTGTARYA 120 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~------------------~~~~~~----~------------------~~~~~~Gt~~Y~ 120 (414)
..|+|||+||||+..+..... ....+. + -....+|||.||
T Consensus 276 ~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYi 355 (550)
T KOG0605|consen 276 AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYI 355 (550)
T ss_pred CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcccc
Confidence 889999999999964322100 000000 0 112468999999
Q ss_pred chhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCC
Q 015018 121 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF 200 (414)
Q Consensus 121 aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp 200 (414)
|||++.+..|+..+|+|||||||||||.|.+||.+ .+..+.+.+|...+.....+. ...+..+..+||..|+. ||
T Consensus 356 APEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s---~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 356 APEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS---ETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred chHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CH
Confidence 99999999999999999999999999999999988 466777777776553221111 12355899999999998 99
Q ss_pred CCCCC---HHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 201 DDKPD---YAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 201 ~~RP~---~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
++|.. +++|+ ...+...++|+.+..
T Consensus 431 ~~RLG~~G~~EIK----------~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 431 ENRLGSKGAEEIK----------KHPFFKGVDWDHLRE 458 (550)
T ss_pred HHhcCcccHHHHh----------cCCccccCCcchhhc
Confidence 99986 44443 235667889998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=295.12 Aligned_cols=196 Identities=22% Similarity=0.295 Sum_probs=167.3
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++|++.+.+.+ ..|+|||||..+|+++++..++.|++.++..|+.||+.||+|+|.+||+||||||||||+.
T Consensus 68 hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~--- 144 (538)
T KOG0661|consen 68 HPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS--- 144 (538)
T ss_pred CCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---
Confidence 699999999999988 9999999999999999998899999999999999999999999999999999999999995
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
....|||+|||||+...... || ..++.|.+|.|||+++. ..|+.+.|+|++|||++|+.+-++.|.|..+.
T Consensus 145 ~~~~iKiaDFGLARev~Skp-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 145 GNDVIKIADFGLAREVRSKP-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred ccceeEecccccccccccCC-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 58899999999999876533 23 46899999999999875 55899999999999999999999999996544
Q ss_pred chHHHHHHHHhh-------------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEK-------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~-------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+. +-+|++- .....+..|...++.+..++|..|+.+||++||+++++++
T Consensus 217 Dq---i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 217 DQ---IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HH---HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 33 3333321 1112344556667899999999999999999999887754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=289.62 Aligned_cols=198 Identities=23% Similarity=0.348 Sum_probs=159.7
Q ss_pred CCCCcEEEEeeEeCC--EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGD--YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~--~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+||||+.++...... ..+|.|||+ ||+|.++++..+.+|++..++.++.||++||+|||++|||||||||+|||++
T Consensus 73 ~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~- 151 (313)
T KOG0198|consen 73 HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD- 151 (313)
T ss_pred CCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe-
Confidence 689999998744433 789999999 9999999987655899999999999999999999999999999999999996
Q ss_pred cCC-CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRR-ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
. ++.+||+|||+++........ ......+.||+.|||||++.. ....+.+|||||||++.||+||+.||...
T Consensus 152 --~~~~~~KlaDFG~a~~~~~~~~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 152 --PSNGDVKLADFGLAKKLESKGTK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred --CCCCeEEeccCcccccccccccc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 5 689999999999876641111 112345799999999999994 44456999999999999999999999874
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....+.+.++.... ..+.++..++++..+|+..|+..+|++||++++|++
T Consensus 226 --~~~~~~~~~ig~~~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 226 --FEEAEALLLIGRED---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred --cchHHHHHHHhccC---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12222223333222 223566778999999999999999999999877643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=291.33 Aligned_cols=190 Identities=23% Similarity=0.276 Sum_probs=165.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.+.......||||||+ ||+|.+++.. .+++.+.++..++.||+.||+|||++||+||||||+|||++
T Consensus 79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld--- 154 (370)
T KOG0583|consen 79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD--- 154 (370)
T ss_pred CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---
Confidence 689999999999999999999999 9999999987 78999999999999999999999999999999999999997
Q ss_pred CC-CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RA-NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-RRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s-~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+ +.+||+|||++........ ...+.+||+.|+|||++.+.. |. .++||||+||+||.|++|.+||..
T Consensus 155 ~~~~~~Kl~DFG~s~~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-- 225 (370)
T KOG0583|consen 155 GNEGNLKLSDFGLSAISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-- 225 (370)
T ss_pred CCCCCEEEeccccccccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--
Confidence 55 8999999999987631111 235789999999999999977 75 899999999999999999999987
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCC-cHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~-p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+....+.+|...... ++..+ +.+...++..|+..+|..|+++.+|.
T Consensus 226 -~~~~~l~~ki~~~~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 226 -SNVPNLYRKIRKGEFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -ccHHHHHHHHhcCCcc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 3445556666555443 23345 88999999999999999999988776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=283.38 Aligned_cols=232 Identities=44% Similarity=0.713 Sum_probs=198.5
Q ss_pred CCCCCcEEEEee-EeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFG-VEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g-~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
|.+||+.+++.| ..+.+.||||+++|.+|.++..... +.|+..++++|+.|++.+|++||+.|+|||||||+|++++.
T Consensus 78 ~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~ 157 (322)
T KOG1164|consen 78 GPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQ 157 (322)
T ss_pred CCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecC
Confidence 467999999999 5899999999999999999997554 88999999999999999999999999999999999999985
Q ss_pred cC--CCCeEEEeeeceeE--EcccCCCcccccccc-cCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 79 GR--RANQVYIIDFGLAK--RYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 79 ~~--~~~~vkL~DFGla~--~~~~~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.. ....++|+|||+++ .+.......+.+.+. ...+.||.+|+++++|.+.++++++|+|||+|++.+|+.|.+||
T Consensus 158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 43 22679999999999 544433332345555 34678999999999999999999999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.+.......+.+........... ++...|.++.+++..+..+++.++|+|..+..+|.+.+...+...+.++||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK 314 (322)
T ss_pred ccccccchHHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence 98876666666655554444332 455678999999999999999999999999999999999999999999999976
Q ss_pred cc
Q 015018 234 KY 235 (414)
Q Consensus 234 ~~ 235 (414)
..
T Consensus 315 ~~ 316 (322)
T KOG1164|consen 315 LR 316 (322)
T ss_pred cc
Confidence 43
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.61 Aligned_cols=196 Identities=23% Similarity=0.311 Sum_probs=163.3
Q ss_pred CCCCcEEEE-eeEe-CCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCC
Q 015018 2 AAGIPNLRW-FGVE-GDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKP 71 (414)
Q Consensus 2 ~p~I~~l~~-~g~~-~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~--~g--ivHRDIKP 71 (414)
+|||+++|. .+.+ ..-.+|||||| +|+|..+++. ..+.|+++++++++.|++.||..+|. .. |+||||||
T Consensus 77 HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 77 HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred CchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 699999987 3444 44489999999 9999999863 35679999999999999999999999 45 99999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCC
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
.||+|+ .+|.|||.||||++.+....+ ....++||+-||+||.+.+..|+.++||||+||++|||+.-+.
T Consensus 157 aNIFl~---~~gvvKLGDfGL~r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 157 ANIFLT---ANGVVKLGDFGLGRFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred hheEEc---CCCceeeccchhHhHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 999997 889999999999998876543 2346899999999999999999999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhh-cCCcHHHHHHHHHHHcCCCCCCCC-HHHHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFR 214 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~-~~~p~e~~~li~~c~~~dp~~RP~-~~~l~~~l~ 214 (414)
||.|. +-.+.-.+|.+..... ++ +.++.++..+|..|+..|++.||+ ...+.++..
T Consensus 227 PF~g~---n~~~L~~KI~qgd~~~----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 227 PFYGD---NLLSLCKKIEQGDYPP----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Ccccc---cHHHHHHHHHcCCCCC----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99985 4455556666665432 23 357789999999999999999998 444444433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=282.63 Aligned_cols=203 Identities=17% Similarity=0.291 Sum_probs=162.9
Q ss_pred CCCCcEEEEeeEeC-CEEEEEEecC-CCCHHHHHHHcC------------------------------------------
Q 015018 2 AAGIPNLRWFGVEG-DYNVLVIDLL-GPSLEDLFNFCS------------------------------------------ 37 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------ 37 (414)
+|||+++++++... ...++||||+ |++|.+++....
T Consensus 70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (338)
T cd05102 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRF 149 (338)
T ss_pred CcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccc
Confidence 69999999987754 4689999999 999999986421
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEccc
Q 015018 38 -------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98 (414)
Q Consensus 38 -------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 98 (414)
..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 150 QPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeeccccccccc
Confidence 3488899999999999999999999999999999999996 678899999999986543
Q ss_pred CCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchH
Q 015018 99 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 177 (414)
Q Consensus 99 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 177 (414)
... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .....+.....
T Consensus 227 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~---- 295 (338)
T cd05102 227 DPD-----YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR---- 295 (338)
T ss_pred Ccc-----hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----
Confidence 221 111233456788999999999899999999999999999997 999998754321 11222222111
Q ss_pred HHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 178 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 178 ~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
......+++++.+++..||..+|++||++.+|.+.|++++.
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12245678999999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=293.09 Aligned_cols=192 Identities=18% Similarity=0.320 Sum_probs=163.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..++..|+||||| |++|.|++.. ..+++.++..|+.+++.||+|||.+||+|||||.+|||++
T Consensus 329 H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~--- 403 (550)
T KOG0578|consen 329 HPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT--- 403 (550)
T ss_pred chHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---
Confidence 589999999999999999999999 9999999983 4699999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.|||+|||++..+...... ..+.+||+-|||||+.....|+.+.||||||+|++||+.|.+||-. ++
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~K-------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~ 473 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQSK-------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---EN 473 (550)
T ss_pred cCCcEEEeeeeeeeccccccCc-------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CC
Confidence 7788999999999988765532 2578999999999999999999999999999999999999999976 23
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..|....... -...+.++++|++|+..||..|+++|+++.+|+
T Consensus 474 PlrAlyLIa~ng~P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 474 PLRALYLIATNGTPK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELL 521 (550)
T ss_pred hHHHHHHHhhcCCCC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHh
Confidence 333333333222111 122456789999999999999999999977664
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.71 Aligned_cols=202 Identities=26% Similarity=0.494 Sum_probs=159.7
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
.+||+++++.+.... +.+++|+++..++.+++.. ...+++..++.|+.||+.||+|||+++|+||||||+|||++
T Consensus 82 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 82 HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160 (294)
T ss_pred CCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 578999998777654 6689999998899888874 34578899999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 161 ---~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 161 ---GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred ---CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 67889999999998775422211111112234579999999999999999999999999999999999999998763
Q ss_pred ccchHHH------HHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 158 AGTKKQK------YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 158 ~~~~~~~------~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
....... +..+...+ .....+|+++.+++..||.++|++||+|++|++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 3221111 11111111 12356789999999999999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=290.39 Aligned_cols=189 Identities=20% Similarity=0.261 Sum_probs=168.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||.++|+.+++..+.|+|+||+ ||-|.+++-. .++|++.++.+++.||+.|+.|+|..+|+||||||+|+||+
T Consensus 71 HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd--- 146 (786)
T KOG0588|consen 71 HPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD--- 146 (786)
T ss_pred CCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---
Confidence 699999999999999999999999 9999999875 66999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.|||+|||+|..-.... -..+.+|.+.|++||++.|.+| +.++||||-|||||.||+|++||++ .
T Consensus 147 ~~~nIKIADFGMAsLe~~gk--------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---d 215 (786)
T KOG0588|consen 147 VKNNIKIADFGMASLEVPGK--------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---D 215 (786)
T ss_pred cccCEeeeccceeecccCCc--------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---c
Confidence 55669999999997644322 1246799999999999999998 5899999999999999999999985 5
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+....+.+++...+. ++..++.+..+|+..|+..||.+|.+.++|.
T Consensus 216 Nir~LLlKV~~G~f~-----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 216 NIRVLLLKVQRGVFE-----MPSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred cHHHHHHHHHcCccc-----CCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 677788888887774 4578999999999999999999999966553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=272.15 Aligned_cols=199 Identities=19% Similarity=0.259 Sum_probs=164.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.||+|.+.+.|......+||+|||.-++.+.+....+.++.+.+..|++|++.|+.|+|++++|||||||+||||+ .
T Consensus 60 H~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~ 136 (396)
T KOG0593|consen 60 HENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---Q 136 (396)
T ss_pred cchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---c
Confidence 5899999999999999999999999999999987788899999999999999999999999999999999999997 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.+||||||+|+.+..+.. ....++-|.+|.|||.+.| ..|+..+|||++||++.||++|.+.|.|..+.+
T Consensus 137 ~gvvKLCDFGFAR~L~~pgd-------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 137 NGVVKLCDFGFARTLSAPGD-------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred CCcEEeccchhhHhhcCCcc-------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 89999999999998764321 1245789999999999998 679999999999999999999999999975544
Q ss_pred hHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..-.+.+..-. .-..+++.-..++..-+.+|++.|+..||++|++.++|.
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 33333322111 111111222223446788999999999999999988885
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.13 Aligned_cols=212 Identities=20% Similarity=0.251 Sum_probs=177.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|.++++|..|+..++.|+||||+ ||+|..+++ .+.|++..+..|+..|+.||.|||++||||||||.+||||+
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD-- 502 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD-- 502 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc--
Confidence 4799999999999999999999999 998555443 57899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..|.+||+|||+++....... ...+++||+.|||||++.+..|+..+|+|+|||+|||||.|..||.|.
T Consensus 503 -~eGh~kiADFGlcKe~m~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--- 571 (694)
T KOG0694|consen 503 -TEGHVKIADFGLCKEGMGQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--- 571 (694)
T ss_pred -ccCcEEecccccccccCCCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---
Confidence 889999999999986542221 236799999999999999999999999999999999999999999984
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH-----HHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~-----~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.++.|....... +..++.|...+|+.++..+|++|..+ ++|+ ...+.-..+|+.+.
T Consensus 572 dEee~FdsI~~d~~~y-----P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~----------~hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 572 DEEEVFDSIVNDEVRY-----PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK----------KHPFFRSIDWDDLL 636 (694)
T ss_pred CHHHHHHHHhcCCCCC-----CCcccHHHHHHHHHHhccCcccccCCCCCCchhhh----------hCCccccCCHHHHh
Confidence 4566677776655543 34678999999999999999999865 3332 12445667899887
Q ss_pred ccccccCC
Q 015018 235 YQQSQVST 242 (414)
Q Consensus 235 ~~~~~~~~ 242 (414)
..+.+++-
T Consensus 637 ~r~i~PPf 644 (694)
T KOG0694|consen 637 NRRIKPPF 644 (694)
T ss_pred hccCCCCC
Confidence 66655544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=273.10 Aligned_cols=206 Identities=17% Similarity=0.245 Sum_probs=160.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHS 61 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------------------~~ls~~~v~~ia~Qll~gL~yLH~ 61 (414)
.+|||++++.++.+.+..||||||+ +++|.+++.... ..+++..++.++.||+.||+|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3699999999999999999999999 999999986421 247888999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHH
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 141 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGv 141 (414)
+||+||||||+|||++ ..+.+||+|||+++....... +.......++..|+|||++.+..++.++|||||||
T Consensus 157 ~~ivH~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 157 LNFVHRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred CCccccCcchhheEEc---CCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999999999996 678899999999986543221 11123345688999999999888999999999999
Q ss_pred HHHHHHh--CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 142 VLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 142 vl~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
++|+|++ +..||.+............................+|..+.+++..||..+|.+||++.+|.+.|+
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 9999986 678888754322221111111111111111123467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=278.86 Aligned_cols=197 Identities=19% Similarity=0.271 Sum_probs=164.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 51 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~-- 127 (312)
T cd05585 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD-- 127 (312)
T ss_pred CCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC--
Confidence 4799999999999999999999999 9999999875 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 128 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--- 196 (312)
T cd05585 128 -YQGHIALCDFGLCKLNMKDDD-------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--- 196 (312)
T ss_pred -CCCcEEEEECcccccCccCCC-------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---
Confidence 678899999999875432211 123467999999999999999999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
...+.+..+..... .+...+++++.+++..||..||.+||++..+.++|.+.
T Consensus 197 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 197 NVNEMYRKILQEPL-----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CHHHHHHHHHcCCC-----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 33444444443322 23456789999999999999999999876666666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=278.70 Aligned_cols=189 Identities=20% Similarity=0.258 Sum_probs=158.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~--- 129 (323)
T cd05571 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD--- 129 (323)
T ss_pred CCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---
Confidence 689999999999999999999999 9999998874 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+. +
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~ 199 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---D 199 (323)
T ss_pred CCCCEEEeeCCCCcccccCCC-------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC---C
Confidence 678899999999875432211 123467999999999999999999999999999999999999999763 2
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYL 209 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l 209 (414)
....+..+..... .+...+++++.++|..||..||++|| ++.+|
T Consensus 200 ~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 200 HEKLFELILMEEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 3333333333222 23456889999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.70 Aligned_cols=194 Identities=17% Similarity=0.331 Sum_probs=166.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+.+...|.....+||||||| .|-|..+++ .+++++....+.|..+|+.|+.|||.+.|||||||.-||||.
T Consensus 171 H~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs--- 246 (904)
T KOG4721|consen 171 HPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS--- 246 (904)
T ss_pred CcceeeEeeeecCCceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---
Confidence 689999999999999999999999 999999998 478999999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+..|||+|||.++...+..++ -.|.||..|||||+++.++.+.|+|||||||||||||||..||.+.+...
T Consensus 247 ~~d~VKIsDFGTS~e~~~~STk--------MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 247 YDDVVKISDFGTSKELSDKSTK--------MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred ccceEEeccccchHhhhhhhhh--------hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 7789999999999987765432 25799999999999999999999999999999999999999997754311
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
.+-.+....+.. .++..||.-|.-||+.||+..|.+||+|.+|+.-|
T Consensus 319 ---IIwGVGsNsL~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 319 ---IIWGVGSNSLHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ---eEEeccCCcccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 111111111111 13467899999999999999999999999987655
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=264.34 Aligned_cols=194 Identities=21% Similarity=0.225 Sum_probs=167.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|+|+|++++++++...+.|+|+|+| .|.|.|++.. .-.++++....|+.||++|++|||.++||||||||+|||++
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-- 157 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-- 157 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec--
Confidence 8999999999999999999999999 9999999974 55799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC------CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
++.+|+|+|||+|+.+..... ....+||+.|+|||++.. ..|+..+|+|+.||+||.|+.|..||
T Consensus 158 -dn~~i~isDFGFa~~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 158 -DNMNIKISDFGFACQLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred -cccceEEeccceeeccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 889999999999998765432 235799999999999874 34788999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... ....++..|.+.+....-+ -+.+++.+..+||..|+..||.+|.+..+.+
T Consensus 229 wHR---kQmlMLR~ImeGkyqF~sp-eWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 229 WHR---KQMLMLRMIMEGKYQFRSP-EWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred hHH---HHHHHHHHHHhcccccCCc-chhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 763 2334556677776654333 3467888999999999999999999977664
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=269.15 Aligned_cols=196 Identities=21% Similarity=0.221 Sum_probs=163.8
Q ss_pred CCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NIL 75 (414)
+|||+++++++.+ ..+.+|||||+ |++|.+++.. .+.+++...+.++.|++.||.|||.. +++||||||+|||
T Consensus 77 h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nil 155 (283)
T PHA02988 77 SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFL 155 (283)
T ss_pred CCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEE
Confidence 6899999999877 45789999999 9999999975 56799999999999999999999984 9999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
++ .++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 l~---~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf 222 (283)
T PHA02988 156 VT---ENYKLKIICHGLEKILSSPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222 (283)
T ss_pred EC---CCCcEEEcccchHhhhcccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCC
Confidence 96 67899999999987654321 13468899999999976 67899999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.+.. ..+.+..+....... .+...+|+++.+++..||+.||++||++.++.+.|+.+.
T Consensus 223 ~~~~---~~~~~~~i~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 223 ENLT---TKEIYDLIINKNNSL---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCC---HHHHHHHHHhcCCCC---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 8753 344444443322221 123368899999999999999999999999999998764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=275.47 Aligned_cols=208 Identities=19% Similarity=0.236 Sum_probs=168.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~-- 130 (325)
T cd05602 54 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-- 130 (325)
T ss_pred CCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC--
Confidence 3699999999999999999999999 9999999874 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 131 -~~~~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--- 199 (325)
T cd05602 131 -SQGHIVLTDFGLCKENIEHNG-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--- 199 (325)
T ss_pred -CCCCEEEccCCCCcccccCCC-------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC---
Confidence 678899999999975432221 123467999999999999999999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-HHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~-l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... +...++.++.+++..|+..+|.+|++..+ +.+++ +..+...++|+...
T Consensus 200 ~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~-------~~~~~~~~~~~~~~ 263 (325)
T cd05602 200 NTAEMYDNILNKPLQ-----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK-------NHIFFSPINWDDLI 263 (325)
T ss_pred CHHHHHHHHHhCCcC-----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh-------cCcccCCCCHHHHH
Confidence 334445554443221 23467899999999999999999998643 22222 22344567787654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=272.70 Aligned_cols=188 Identities=20% Similarity=0.260 Sum_probs=158.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+..+++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~-- 130 (316)
T cd05592 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD-- 130 (316)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC--
Confidence 3799999999999999999999999 9999999875 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 131 -~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-- 200 (316)
T cd05592 131 -KDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-- 200 (316)
T ss_pred -CCCCEEEccCcCCeECCCCCC-------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--
Confidence 678899999999986533221 1234679999999999999999999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
..+.+..+..... .+...++.++.+++..||..+|.+||+..
T Consensus 201 -~~~~~~~i~~~~~-----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 201 -EDELFDSILNDRP-----HFPRWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred -HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 2334444332211 22345788999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=272.66 Aligned_cols=187 Identities=20% Similarity=0.258 Sum_probs=156.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~-- 130 (316)
T cd05620 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD-- 130 (316)
T ss_pred CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC--
Confidence 3689999999999999999999999 9999998875 46799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 131 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-- 200 (316)
T cd05620 131 -RDGHIKIADFGMCKENVFGDN-------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-- 200 (316)
T ss_pred -CCCCEEeCccCCCeecccCCC-------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--
Confidence 678899999999875322111 1234679999999999999999999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.++.+.... ..+...++.++.+++..||..||++|++.
T Consensus 201 -~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~R~~~ 241 (316)
T cd05620 201 -EDELFESIRVDT-----PHYPRWITKESKDILEKLFERDPTRRLGV 241 (316)
T ss_pred -HHHHHHHHHhCC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence 233333333221 12234577899999999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=270.93 Aligned_cols=215 Identities=20% Similarity=0.293 Sum_probs=173.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|.+|.||..++.+++.||||||| ||+|..++++. ++.|++..+..++.+++.||+|||-.|||+|||||+||||.
T Consensus 136 HPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr-- 213 (459)
T KOG0610|consen 136 HPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR-- 213 (459)
T ss_pred CCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe--
Confidence 688999999999999999999999 99999999754 67799999999999999999999999999999999999995
Q ss_pred CCCCeEEEeeeceeEEcccCCC--------------------------------cc--------------c--ccc-ccc
Q 015018 80 RRANQVYIIDFGLAKRYRDTAT--------------------------------HQ--------------H--IPY-REN 110 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~--------------------------------~~--------------~--~~~-~~~ 110 (414)
.+|+|.|+||.|+.......+ .. . .|- ...
T Consensus 214 -edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RS 292 (459)
T KOG0610|consen 214 -EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARS 292 (459)
T ss_pred -cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccc
Confidence 889999999999865321000 00 0 000 012
Q ss_pred CCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHH
Q 015018 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 190 (414)
Q Consensus 111 ~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~ 190 (414)
..++||-.|+|||++.|+..+..+|+|+|||++|||+.|..||.|. +..+.+..|..+....+-. ...+...++
T Consensus 293 nSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~---~~~~Tl~NIv~~~l~Fp~~---~~vs~~akD 366 (459)
T KOG0610|consen 293 NSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGS---NNKETLRNIVGQPLKFPEE---PEVSSAAKD 366 (459)
T ss_pred cccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCC---CchhhHHHHhcCCCcCCCC---CcchhHHHH
Confidence 3588999999999999999999999999999999999999999984 5566677776655543211 144578999
Q ss_pred HHHHHHcCCCCCCCC----HHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 191 YFHYCRSLRFDDKPD----YAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 191 li~~c~~~dp~~RP~----~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
||+.+|.+||.+|.. +++|+ ...+...++|.....
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK----------~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIK----------RHPFFEGVNWALIRC 405 (459)
T ss_pred HHHHHhccChhhhhccccchHHhh----------cCccccCCChhheec
Confidence 999999999999997 44443 235667788986653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=263.93 Aligned_cols=200 Identities=12% Similarity=0.203 Sum_probs=164.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++..+++.||||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 64 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~-- 141 (266)
T cd05064 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN-- 141 (266)
T ss_pred CCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc--
Confidence 3799999999999999999999999 8899999876566899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+...
T Consensus 142 -~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 142 -SDLVCKISGFRRLQEDKSEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred -CCCcEEECCCcccccccccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 678899999998764322111 01112355678999999999999999999999999999775 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.+.+..+...... .....+|..+.+++..||..+|++||++++|.+.|..+
T Consensus 215 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 215 ---QDVIKAVEDGFRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---HHHHHHHHCCCCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2233333332211 13456899999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=268.23 Aligned_cols=189 Identities=17% Similarity=0.246 Sum_probs=156.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|+|+++++.+.++++.|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 59 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~-- 136 (285)
T cd05631 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-- 136 (285)
T ss_pred CCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC--
Confidence 689999999999999999999999 89999887543 34699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 137 -~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 137 -DRGHIRISDLGLAVQIPEGET--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred -CCCCEEEeeCCCcEEcCCCCe--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 678899999999987543221 12457999999999999999999999999999999999999999875543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
...+.+..... .....+...++.++.+|+..||..||++||+
T Consensus 208 ~~~~~~~~~~~----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 208 VKREEVDRRVK----EDQEEYSEKFSEDAKSICRMLLTKNPKERLG 249 (285)
T ss_pred hhHHHHHHHhh----cccccCCccCCHHHHHHHHHHhhcCHHHhcC
Confidence 22222221111 1112234568899999999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=276.76 Aligned_cols=201 Identities=22% Similarity=0.260 Sum_probs=170.6
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++|.+.-.+. ...|||+|||.-+|..++....-+|++.++..|+.||+.||+|||.+||+|||||..||||+
T Consensus 174 ~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid- 252 (560)
T KOG0600|consen 174 DHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID- 252 (560)
T ss_pred CCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc-
Confidence 479999999988876 68999999999999999986677999999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.+||+|||||+.|...... .....+-|.+|.+||+++|.. |+...|+||.||||.||+.|++.|+|..
T Consensus 253 --n~G~LKiaDFGLAr~y~~~~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 253 --NNGVLKIADFGLARFYTPSGSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred --CCCCEEeccccceeeccCCCCc------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 8899999999999988764432 134568899999999999864 9999999999999999999999999977
Q ss_pred ccchHHHHHHHHhhhc---------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKV---------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~---------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+..++.+++-... ...+.+.++.+|....+|+..+|.+||++|.++...+
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 6666666665552211 1123344567789999999999999999999976553
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=279.02 Aligned_cols=203 Identities=20% Similarity=0.327 Sum_probs=163.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------------------------------------------
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------------------------------ 37 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------ 37 (414)
++|||+++++.+..++..||||||+ +++|.+++....
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 3799999999999999999999999 999999885321
Q ss_pred ---------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeee
Q 015018 38 ---------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 90 (414)
Q Consensus 38 ---------------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DF 90 (414)
..+++..++.|+.||+.||+|||++||+||||||+|||++ .++.++|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~Df 256 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDF 256 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeec
Confidence 2478899999999999999999999999999999999996 6788999999
Q ss_pred ceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHH
Q 015018 91 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 169 (414)
Q Consensus 91 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~ 169 (414)
|+++.+..... ........++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .+..+.
T Consensus 257 Gla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~ 328 (374)
T cd05106 257 GLARDIMNDSN-----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMV 328 (374)
T ss_pred eeeeeccCCcc-----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHH
Confidence 99986543221 111223446678999999998899999999999999999997 999997753321 122222
Q ss_pred hhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 170 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 170 ~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
...... .....+|+++.+++..||..+|++||++.+|.+.|++++
T Consensus 329 ~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 329 KRGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HcccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111111 122346899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=273.05 Aligned_cols=183 Identities=20% Similarity=0.285 Sum_probs=158.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~-- 152 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD-- 152 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC--
Confidence 3699999999999999999999999 9999999875 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 -~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--- 218 (329)
T PTZ00263 153 -NKGHVKVTDFGFAKKVPDRT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--- 218 (329)
T ss_pred -CCCCEEEeeccCceEcCCCc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---
Confidence 67899999999998764322 2357999999999999999999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
...+.+..+...... +...++.++.+++..||..||.+|++
T Consensus 219 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 219 TPFRIYEKILAGRLK-----FPNWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CHHHHHHHHhcCCcC-----CCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 334455555544322 23457789999999999999999996
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=272.85 Aligned_cols=187 Identities=19% Similarity=0.221 Sum_probs=157.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~-- 130 (321)
T cd05591 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD-- 130 (321)
T ss_pred CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC--
Confidence 3699999999999999999999999 9999988874 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 131 -~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-- 200 (321)
T cd05591 131 -AEGHCKLADFGMCKEGILNGV-------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-- 200 (321)
T ss_pred -CCCCEEEeecccceecccCCc-------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--
Confidence 678999999999976433221 1234579999999999999999999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.+..+...... ....++.++.+++..|+..+|++|+++
T Consensus 201 -~~~~~~~i~~~~~~-----~p~~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 201 -EDDLFESILHDDVL-----YPVWLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred -HHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 34444554443321 223468899999999999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.79 Aligned_cols=200 Identities=21% Similarity=0.300 Sum_probs=165.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||++++.++.++...|++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++|
T Consensus 66 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i 145 (283)
T cd05048 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF 145 (283)
T ss_pred CCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3689999999999999999999999 899999987531 468899999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+|+||||+||+++ .++.++|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|
T Consensus 146 ~H~dlkp~Nil~~---~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 146 VHRDLAARNCLVG---EGLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred eccccccceEEEc---CCCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 9999999999996 678899999999986543221 11223446788999999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
||++ |..||.+... .+.+..+...... .....+|.++.+|+..||+.+|++||++.+|.+.|+.
T Consensus 218 el~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 218 EIFSYGLQPYYGFSN---QEVIEMIRSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCCCCCCCCCH---HHHHHHHHcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 9997 9999987543 3334444333222 2345789999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=273.27 Aligned_cols=188 Identities=18% Similarity=0.214 Sum_probs=158.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+.+.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 55 h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~--- 130 (320)
T cd05590 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD--- 130 (320)
T ss_pred CCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---
Confidence 699999999999999999999999 9999998875 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--- 200 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNGK-------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--- 200 (320)
T ss_pred CCCcEEEeeCCCCeecCcCCC-------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---
Confidence 678899999999875432111 1234579999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
..+.+..+...... +...++.++.+++..|+..||++|++..+
T Consensus 201 ~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 201 EDDLFEAILNDEVV-----YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHHHHHHhcCCCC-----CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 34444544433221 23457889999999999999999998744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.71 Aligned_cols=201 Identities=17% Similarity=0.254 Sum_probs=164.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..|..++..|+||.|| +||+.++++.. ...|.+..+.-|.+++++||.|||.+|.||||||+.||||+
T Consensus 83 HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~-- 160 (516)
T KOG0582|consen 83 HPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID-- 160 (516)
T ss_pred CCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc--
Confidence 799999999999999999999999 99999999743 45699999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+|.|||+|||....+.+..... .++. +++.||+.|||||++.. ..|+.|+||||||++..||.+|..||..+.
T Consensus 161 -~dG~VkLadFgvsa~l~~~G~R~--~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 161 -SDGTVKLADFGVSASLFDSGDRQ--VTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred -CCCcEEEcCceeeeeecccCcee--eEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 88999999999987766544222 2233 78999999999999653 458999999999999999999999998865
Q ss_pred ccchHHHHHHHHhhhccc----hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVST----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~----~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+. +..+.++....... .....-+.++..|++++..|+..||.+||++++|+
T Consensus 237 Pm--kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 237 PM--KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred hH--HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 42 22333333322211 11112345678999999999999999999988774
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=275.50 Aligned_cols=182 Identities=20% Similarity=0.275 Sum_probs=156.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 89 ~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~-- 165 (340)
T PTZ00426 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD-- 165 (340)
T ss_pred CCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC--
Confidence 3799999999999999999999999 9999999975 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 166 -~~~~ikL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--- 231 (340)
T PTZ00426 166 -KDGFIKMTDFGFAKVVDTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--- 231 (340)
T ss_pred -CCCCEEEecCCCCeecCCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC---
Confidence 6789999999999865431 12457999999999999988999999999999999999999999864
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
+....+..+..... .+...++.++.++|..|++.+|++|+
T Consensus 232 ~~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 232 EPLLIYQKILEGII-----YFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 33444555544332 23456788999999999999999996
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.66 Aligned_cols=200 Identities=19% Similarity=0.245 Sum_probs=158.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||+++++++.++++.++||||++++|.+++..+...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~--- 137 (288)
T cd07871 61 KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN--- 137 (288)
T ss_pred CCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---
Confidence 36999999999999999999999997799999887677799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 138 ~~~~~kl~DfG~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 138 EKGELKLADFGLARAKSVPTK-------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred CCCCEEECcCcceeeccCCCc-------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 678899999999976543221 1133578999999999876 56899999999999999999999999875432
Q ss_pred chHHHHHHHHhhhcc----------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~----------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+..+...... .........++.++.+++..|+..||.+||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 222111111100000 001112234678899999999999999999988775
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=270.36 Aligned_cols=188 Identities=20% Similarity=0.248 Sum_probs=159.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~-- 130 (323)
T cd05575 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD-- 130 (323)
T ss_pred CCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC--
Confidence 3699999999999999999999999 9999998874 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 131 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--- 199 (323)
T cd05575 131 -SQGHVVLTDFGLCKEGIEHSK-------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--- 199 (323)
T ss_pred -CCCcEEEeccCCCcccccCCC-------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---
Confidence 678999999999875332111 123457999999999999999999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
+..+.+..+...... +...++.++.++|..|+..+|.+||+..
T Consensus 200 ~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 200 DTAEMYDNILNKPLR-----LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 334455555443322 3346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.10 Aligned_cols=195 Identities=20% Similarity=0.225 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||++++.++..+++.||||||+ |++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 123 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll 202 (478)
T PTZ00267 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202 (478)
T ss_pred CCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE
Confidence 3689999999999999999999999 99999887532 3469999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ ..+.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 203 ~---~~~~~kL~DFgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 203 M---PTGIIKLGDFGFSKQYSDSVS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred C---CCCcEEEEeCcCceecCCccc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 6 678999999999987654321 11123467999999999999999999999999999999999999999764
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ..+.+..+...... .+...++.++.++|..||..+|++||+++++.
T Consensus 275 ~---~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 275 S---QREIMQQVLYGKYD----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred C---HHHHHHHHHhCCCC----CCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 3 33334444333222 12345788999999999999999999988875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=269.69 Aligned_cols=182 Identities=24% Similarity=0.345 Sum_probs=156.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.++++.|+||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 60 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~--- 135 (291)
T cd05612 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD--- 135 (291)
T ss_pred CCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---
Confidence 699999999999999999999999 9999999975 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~ 202 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRDRT----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---N 202 (291)
T ss_pred CCCCEEEEecCcchhccCCc----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---C
Confidence 67889999999997654321 2357999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
..+.+..+...... +...++.++.++|..||..||.+|++
T Consensus 203 ~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 203 PFGIYEKILAGKLE-----FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred HHHHHHHHHhCCcC-----CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 34445554443322 33456789999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=275.01 Aligned_cols=192 Identities=21% Similarity=0.290 Sum_probs=158.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 60 h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~--- 135 (333)
T cd05600 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID--- 135 (333)
T ss_pred CCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---
Confidence 699999999999999999999999 9999999974 55799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 136 ~~~~~kL~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-- 203 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-- 203 (333)
T ss_pred CCCCEEEEeCcCCccccc----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--
Confidence 678999999999976543 12346899999999999999999999999999999999999999987433
Q ss_pred hHHHHHHHHhhhccchHHHh---hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEAL---CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l---~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+............ ...++.++.+++..|+..+|++||++.+++
T Consensus 204 -~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 204 -NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred -HHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 3333333321111100001 124678999999999999999999976664
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=289.61 Aligned_cols=205 Identities=23% Similarity=0.322 Sum_probs=176.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------CCC----CCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------SRK----LSLKTVLMLADQMINRVEFVHSKSFLHR 67 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------~~~----ls~~~v~~ia~Qll~gL~yLH~~givHR 67 (414)
+||||+|++.+.+++..|||+||| .|+|.+++..+ +.. |+..+.+.||.||+.||+||-++.||||
T Consensus 548 H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHR 627 (774)
T KOG1026|consen 548 HPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHR 627 (774)
T ss_pred CCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccccc
Confidence 699999999999999999999999 99999999744 223 8999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ell 147 (414)
||-..|+||+ ....|||+||||++..-..+. |+....-.-..+||+||.|...+++.++||||+||+|||++
T Consensus 628 DLATRNCLVg---e~l~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 628 DLATRNCLVG---ENLVVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred chhhhhceec---cceEEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 9999999997 788999999999986554443 22222334578999999999999999999999999999999
Q ss_pred h-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 148 R-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 148 t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
+ |+.||.++.. .+.++.|...... ..+++||.+++.||..||+.+|.+||+|.+|...|++......
T Consensus 700 syG~QPy~glSn---~EVIe~i~~g~lL----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 700 SYGKQPYYGLSN---QEVIECIRAGQLL----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ccccCcccccch---HHHHHHHHcCCcc----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 7 9999999754 4455555555542 3467899999999999999999999999999999998875443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.61 Aligned_cols=214 Identities=20% Similarity=0.262 Sum_probs=166.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|++++..+.+.++.||||||+ |++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 55 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~--- 130 (327)
T cd05617 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD--- 130 (327)
T ss_pred CCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---
Confidence 689999999999999999999999 9999988874 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc-
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG- 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~- 159 (414)
..+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~ 203 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPGD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203 (327)
T ss_pred CCCCEEEeccccceeccCCCC-------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc
Confidence 678899999999975332211 123467999999999999999999999999999999999999999753221
Q ss_pred ---chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 160 ---TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 160 ---~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
.....+..+..... .+...++.++.+++..|+..||.+|+++... ..++++. ...+....+|+....
T Consensus 204 ~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i~---~h~~f~~~~~~~~~~ 273 (327)
T cd05617 204 DMNTEDYLFQVILEKPI-----RIPRFLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDIK---SHTFFRSIDWDLLEK 273 (327)
T ss_pred ccccHHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHHH---cCCCCCCCCHHHHHh
Confidence 11222222222221 2344678899999999999999999985321 1111111 234455677887643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=272.19 Aligned_cols=184 Identities=20% Similarity=0.283 Sum_probs=154.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+...++.||||||+ |++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--- 129 (323)
T cd05595 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD--- 129 (323)
T ss_pred CCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---
Confidence 689999999999999999999999 9999988874 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 130 ~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--- 199 (323)
T cd05595 130 KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--- 199 (323)
T ss_pred CCCCEEecccHHhccccCCCC-------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---
Confidence 678899999999875322111 1124579999999999999999999999999999999999999997643
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
....+..+..... .+...+++++.++|..||..+|++|+
T Consensus 200 ~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 200 HERLFELILMEEI-----RFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 2333333332222 13456789999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=274.56 Aligned_cols=195 Identities=21% Similarity=0.286 Sum_probs=162.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 56 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 132 (318)
T cd05582 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-- 132 (318)
T ss_pred CCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC--
Confidence 4799999999999999999999999 9999999864 55799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||..|++||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 133 -~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--- 201 (318)
T cd05582 133 -EEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--- 201 (318)
T ss_pred -CCCcEEEeeccCCcccCCCCC-------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---
Confidence 678899999999876543211 123467999999999999988999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH--HHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFR 214 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~--l~~~l~ 214 (414)
+..+.+..+...... +...+++++.+++..||+.||++||++.+ +.+++.
T Consensus 202 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 202 DRKETMTMILKAKLG-----MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 334444444433221 33467899999999999999999999766 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=270.72 Aligned_cols=185 Identities=20% Similarity=0.240 Sum_probs=156.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++++.||||||+ |++|..++. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 61 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~--- 135 (324)
T cd05589 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD--- 135 (324)
T ss_pred CCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---
Confidence 799999999999999999999999 999998876 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--- 205 (324)
T cd05589 136 TEGFVKIADFGLCKEGMGFGD-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--- 205 (324)
T ss_pred CCCcEEeCcccCCccCCCCCC-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---
Confidence 678999999999875332111 1234679999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.+..+...... +...++.++.++|..||..||.+||+.
T Consensus 206 ~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 206 EEEVFDSIVNDEVR-----YPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 33334444333221 234678999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=272.51 Aligned_cols=190 Identities=19% Similarity=0.274 Sum_probs=157.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.||||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~--- 129 (328)
T cd05593 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD--- 129 (328)
T ss_pred CCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---
Confidence 689999999999999999999999 9999988864 56799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 130 ~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--- 199 (328)
T cd05593 130 KDGHIKITDFGLCKEGITDAA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--- 199 (328)
T ss_pred CCCcEEEecCcCCccCCCccc-------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---
Confidence 678899999999875332111 1134579999999999999899999999999999999999999997643
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~ 210 (414)
..+.+..+..... .+...++.++.++|..||..+|.+|+ ++.+|+
T Consensus 200 ~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 200 HEKLFELILMEDI-----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred HHHHHHHhccCCc-----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 2233333322221 23456789999999999999999997 555553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.05 Aligned_cols=191 Identities=21% Similarity=0.268 Sum_probs=159.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+..+++.|+||||+ |++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||++
T Consensus 58 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-- 134 (323)
T cd05584 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD-- 134 (323)
T ss_pred CCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--
Confidence 3699999999999999999999999 9999999875 55789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 135 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-- 204 (323)
T cd05584 135 -AQGHVKLTDFGLCKESIHEGT-------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-- 204 (323)
T ss_pred -CCCCEEEeeCcCCeecccCCC-------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--
Confidence 678999999999875433221 1134579999999999999889999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~ 210 (414)
..+.+..+..... .+...+++++.++|..||..+|++|| ++++++
T Consensus 205 -~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 205 -RKKTIDKILKGKL-----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred -HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 3334444443322 23456788999999999999999999 655553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=262.98 Aligned_cols=204 Identities=21% Similarity=0.301 Sum_probs=168.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++..+++.++||||+ +++|.+++... ...+++..++.++.||+.+|+|||++||
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 144 (291)
T cd05094 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF 144 (291)
T ss_pred CCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3689999999999999999999999 99999999642 2348999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.++|+|||+++....... ........++..|++||++.+..++.++|||||||++|
T Consensus 145 ~H~dlkp~Nil~~---~~~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 216 (291)
T cd05094 145 VHRDLATRNCLVG---ANLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216 (291)
T ss_pred eecccCcceEEEc---cCCcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHH
Confidence 9999999999996 678999999999976543221 01123346788999999999988999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
+|++ |..||..... .+.++.+...... .....+|.++.+++..||..+|++||++.++.+.|+++...
T Consensus 217 el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 217 EIFTYGKQPWFQLSN---TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCCCCCH---HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9998 9999977533 2333333332222 23345789999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=270.26 Aligned_cols=215 Identities=19% Similarity=0.271 Sum_probs=165.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+.++++.||||||+ |++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~-- 130 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-- 130 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC--
Confidence 4799999999999999999999999 9999988864 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 131 -~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 131 -SEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred -CCCCEEEeeCCccccccCCCC-------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc
Confidence 678999999999875332211 123467999999999999999999999999999999999999999642211
Q ss_pred ------chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 160 ------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 160 ------~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.....+..+..... .++..++.++.+++..||..||++|+++..+. .+.+++ ...+...++|...
T Consensus 203 ~~~~~~~~~~~~~~i~~~~~-----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i~---~hp~f~~~~~~~~ 273 (329)
T cd05618 203 DNPDQNTEDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADIQ---GHPFFRNVDWDLM 273 (329)
T ss_pred CCcccccHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHHh---cCCCCCCCCHHHH
Confidence 11112222222221 23456788999999999999999999842110 011111 2344455678765
Q ss_pred cc
Q 015018 234 KY 235 (414)
Q Consensus 234 ~~ 235 (414)
..
T Consensus 274 ~~ 275 (329)
T cd05618 274 EQ 275 (329)
T ss_pred Hc
Confidence 43
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=263.50 Aligned_cols=195 Identities=21% Similarity=0.242 Sum_probs=157.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++.+.++.+.|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 51 ~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~- 129 (277)
T cd05607 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD- 129 (277)
T ss_pred CCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc-
Confidence 4799999999999999999999999 99999887543 34699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 130 --~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 130 --DQGNCRLSDLGLAVELKDGKT--------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred --CCCCEEEeeceeeeecCCCce--------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 678899999999987644221 1234789999999999988899999999999999999999999976432
Q ss_pred c-chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 G-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~-~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ...+....+..... ......++.++.+++..||+.+|++||++.++.
T Consensus 200 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 200 KVAKEELKRRTLEDEV----KFEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred hhhHHHHHHHhhcccc----ccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 2 11222222221111 111235789999999999999999999986553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.81 Aligned_cols=191 Identities=18% Similarity=0.230 Sum_probs=154.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~--- 139 (332)
T cd05614 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD--- 139 (332)
T ss_pred CCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---
Confidence 689999999999999999999999 9999999874 55799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+...... ......||..|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 140 ~~~~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 140 SEGHVVLTDFGLSKEFLSEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred CCCCEEEeeCcCCccccccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 6789999999999865432211 112457999999999998754 788999999999999999999999764332
Q ss_pred chH-HHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKK-QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~-~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
... .....+.... ..+...++.++.+++..||..||++||+..
T Consensus 214 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 214 NTQSEVSRRILKCD-----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCHHHHHHHHhcCC-----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 222 2222222211 123345789999999999999999999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=263.07 Aligned_cols=195 Identities=19% Similarity=0.235 Sum_probs=157.9
Q ss_pred CCCCcEEEEeeE-----eCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~-----~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++.+. .....++||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 63 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil 142 (290)
T cd07862 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 142 (290)
T ss_pred CCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 699999998875 34568999999988999998753 345999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.++|+|||+++.+.... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 143 ~~---~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 143 VT---SSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred Ec---CCCCEEEccccceEeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 96 67899999999998764321 12345789999999999988899999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... +.+..+.... ....++.+...+++.+.+++..|+..+|++||++.+++
T Consensus 212 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 212 SSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCHH---HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 5432 2233322110 11122334456788899999999999999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=251.97 Aligned_cols=195 Identities=22% Similarity=0.255 Sum_probs=169.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++|+.....+.+.|||+|++ |++|..-|-. ..-+++..+-.++.||+++|.|+|.+||||||+||+|+|+.-..
T Consensus 69 HP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~ 147 (355)
T KOG0033|consen 69 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA 147 (355)
T ss_pred CCcEeehhhhhcccceeEEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc
Confidence 699999999999999999999999 9888744432 24689999999999999999999999999999999999997666
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
...-|||+|||+|..+.+... ...+.||+.||+||+++..+|+..+|||+-|||||-||.|.+||.+ .+
T Consensus 148 ~~A~vKL~~FGvAi~l~~g~~--------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~ 216 (355)
T KOG0033|consen 148 KGAAVKLADFGLAIEVNDGEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---ED 216 (355)
T ss_pred CCCceeecccceEEEeCCccc--------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---cc
Confidence 667899999999998874322 2468999999999999999999999999999999999999999987 46
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
+...|+.|.......+-+ .++.+.++.++|+..|+..||.+|.++.+.
T Consensus 217 ~~rlye~I~~g~yd~~~~-~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSP-EWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred HHHHHHHHhccccCCCCc-ccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 677888888777654432 346788999999999999999999997654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=277.69 Aligned_cols=194 Identities=22% Similarity=0.239 Sum_probs=171.3
Q ss_pred CCCCcEEEEeeEeCCE-EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDY-NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~-~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.|||+.+++.+++++. .||||+|| ||+|.+.++... ..|+++.+..|+.||+.||.|||+++|+|||||+.||++.
T Consensus 62 hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt- 140 (426)
T KOG0589|consen 62 HPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT- 140 (426)
T ss_pred CCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc-
Confidence 6999999999998877 99999999 999999998554 6799999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
+++.|+|.|||+|+....... ...+..||+-||+||++.+.+|+.++|+|||||++|||++-+.+|..
T Consensus 141 --k~~~VkLgDfGlaK~l~~~~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--- 208 (426)
T KOG0589|consen 141 --KDKKVKLGDFGLAKILNPEDS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--- 208 (426)
T ss_pred --ccCceeecchhhhhhcCCchh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---
Confidence 778889999999998776541 23568999999999999999999999999999999999999999977
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
.+......+|.+.... .+...+..+++.+|+.|+..+|+.||++.+|+..
T Consensus 209 ~~m~~Li~ki~~~~~~----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 209 SNMSELILKINRGLYS----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cchHHHHHHHhhccCC----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4555566666665533 3566788999999999999999999999888755
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=263.55 Aligned_cols=200 Identities=18% Similarity=0.193 Sum_probs=155.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++.+..+++.||||||+.+.+.+.+......+++..+..++.||+.||+|||+.+|+||||||+||+++ .
T Consensus 59 h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~ 135 (287)
T cd07848 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---H 135 (287)
T ss_pred CccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---C
Confidence 6899999999999999999999994455555554566799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
++.++|+|||++......... ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.+......
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 136 NDVLKLCDFGFARNLSEGSNA------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred CCcEEEeeccCcccccccccc------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 788999999999875432211 11245789999999999998899999999999999999999999987543222
Q ss_pred HHHHHHHHhhhc------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 162 KQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 162 ~~~~~~i~~~~~------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+..... ..........++.++.+|+..|+..||++||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 211111110000 0000111234678899999999999999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=268.13 Aligned_cols=185 Identities=19% Similarity=0.243 Sum_probs=155.7
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
++|++++.++.+.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~ 136 (324)
T cd05587 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---A 136 (324)
T ss_pred CceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---C
Confidence 56889999999999999999999 9999999874 55799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
++.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.. .
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~ 206 (324)
T cd05587 137 EGHIKIADFGMCKENIFGGK-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---E 206 (324)
T ss_pred CCCEEEeecCcceecCCCCC-------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---H
Confidence 78899999999875332111 1234579999999999999999999999999999999999999998743 3
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
.+.+..+..... .+...++.++.+++..||..+|.+|++.
T Consensus 207 ~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 207 DELFQSIMEHNV-----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 444444443332 2345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=262.91 Aligned_cols=198 Identities=19% Similarity=0.236 Sum_probs=155.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||++++.++.++++.|+||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~--- 137 (303)
T cd07869 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--- 137 (303)
T ss_pred CCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---
Confidence 36999999999999999999999998899998876667799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 138 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~- 209 (303)
T cd07869 138 DTGELKLADFGLARAKSVPSH-------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD- 209 (303)
T ss_pred CCCCEEECCCCcceeccCCCc-------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-
Confidence 678899999999975433211 1134578999999999876 4578899999999999999999999987543
Q ss_pred chHHHHHHHHhhhc-------------------------cchHHHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKV-------------------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~-------------------------~~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+..... ...+.... ..++.++.+|+..|+..||.+||++.++.
T Consensus 210 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 210 -IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred -HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 2222222211000 00000111 12457889999999999999999977664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=272.35 Aligned_cols=190 Identities=20% Similarity=0.274 Sum_probs=157.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
+|||+++++.+.+.++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||++
T Consensus 54 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-- 130 (325)
T cd05594 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-- 130 (325)
T ss_pred CCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC--
Confidence 689999999999999999999999 9999988864 5679999999999999999999997 7999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 131 -~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-- 200 (325)
T cd05594 131 -KDGHIKITDFGLCKEGIKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-- 200 (325)
T ss_pred -CCCCEEEecCCCCeecCCCCc-------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--
Confidence 678899999999875432211 1134579999999999999999999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~ 210 (414)
..+.+..+..... .+...+++++.+++..||..||++|+ ++.++.
T Consensus 201 -~~~~~~~i~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 201 -HEKLFELILMEEI-----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred -HHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 2233333332222 13456789999999999999999997 655553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=268.67 Aligned_cols=187 Identities=21% Similarity=0.238 Sum_probs=157.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.+.+..||||||+ |++|...+.. ...+++..+..++.||+.||+|||++||+||||||+||||+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~-- 130 (321)
T cd05603 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD-- 130 (321)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC--
Confidence 3699999999999999999999999 9999888864 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 131 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--- 199 (321)
T cd05603 131 -SQGHVVLTDFGLCKEGVEPEE-------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--- 199 (321)
T ss_pred -CCCCEEEccCCCCccCCCCCC-------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC---
Confidence 678999999999875322211 123457999999999999988999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
+..+.+..+..... .+....+.++.+++..|++.+|.+|++.
T Consensus 200 ~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 200 DVSQMYDNILHKPL-----QLPGGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred CHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHccCCHhhcCCC
Confidence 33444555544332 2334677899999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=268.61 Aligned_cols=186 Identities=19% Similarity=0.248 Sum_probs=157.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|+|++++..+.+.++.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--- 135 (323)
T cd05616 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD--- 135 (323)
T ss_pred CCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---
Confidence 578999999999999999999999 9999998874 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--- 205 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--- 205 (323)
T ss_pred CCCcEEEccCCCceecCCCCC-------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---
Confidence 678999999999975432211 1234679999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.+..+...... ++..++.++.+++..|+..+|++|++.
T Consensus 206 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 206 EDELFQSIMEHNVA-----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHHhCCCC-----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 34445555443322 345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=267.54 Aligned_cols=187 Identities=21% Similarity=0.271 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.+.++.||||||+ |++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 55 hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~--- 130 (316)
T cd05619 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD--- 130 (316)
T ss_pred CCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---
Confidence 699999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--- 200 (316)
T cd05619 131 TDGHIKIADFGMCKENMLGDA-------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--- 200 (316)
T ss_pred CCCCEEEccCCcceECCCCCC-------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---
Confidence 678899999999975432211 1234579999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
..+.+..+..... .+...++.++.+++..||..+|++||++.
T Consensus 201 ~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 201 EEELFQSIRMDNP-----CYPRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHhCCC-----CCCccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 2333333332221 12234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.75 Aligned_cols=190 Identities=17% Similarity=0.245 Sum_probs=155.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+.+.++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~-- 130 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD-- 130 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC--
Confidence 3799999999999999999999999 9999988864 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||+++....... ......||..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 131 -~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 131 -AEGHIKLTDYGMCKEGIRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred -CCCCEEECcCccccccccCCC-------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccc
Confidence 678899999999874322111 123467999999999999999999999999999999999999999643211
Q ss_pred c------hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 T------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~------~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
. ....+..+..... .+...++.++.+++..|+..||.+|+++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 203 DNPDQNTEDYLFQVILEKQI-----RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ccccccchHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1 1112222222221 2345678899999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=268.14 Aligned_cols=187 Identities=20% Similarity=0.245 Sum_probs=157.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.+.++.|+||||+ |++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-- 130 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD-- 130 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC--
Confidence 3699999999999999999999999 9999998874 45899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||..|+|||++.+..++.++|+|||||++|+|++|..||.+..
T Consensus 131 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-- 200 (318)
T cd05570 131 -SEGHIKIADFGMCKEGILGGV-------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-- 200 (318)
T ss_pred -CCCcEEecccCCCeecCcCCC-------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--
Confidence 678999999999875322211 1134579999999999999999999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.+..+...... +...++.++.++|..||..||.+||++
T Consensus 201 -~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 201 -EDELFQSILEDEVR-----YPRWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred -HHHHHHHHHcCCCC-----CCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence 33334444333221 234678999999999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=260.86 Aligned_cols=204 Identities=23% Similarity=0.322 Sum_probs=167.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHR 67 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------------~~ls~~~v~~ia~Qll~gL~yLH~~givHR 67 (414)
.+|||++++.++..+++.|+||||+ +++|.+++.... ..+++..++.++.||+.+|+|||++||+||
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~ 144 (288)
T cd05093 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHR 144 (288)
T ss_pred CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3699999999999999999999999 999999986432 248999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ell 147 (414)
||||+|||++ ..+.++|+|||+++....... ........++..|+|||++.+..++.++|+|||||++|+|+
T Consensus 145 dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 216 (288)
T cd05093 145 DLATRNCLVG---ENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216 (288)
T ss_pred ccCcceEEEc---cCCcEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999996 678899999999976533221 11112345678899999999888999999999999999999
Q ss_pred h-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 148 R-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 148 t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
+ |..||..... ...+..+...... .....++.++.+++..||+.+|.+||++.++...|+++...
T Consensus 217 t~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 217 TYGKQPWYQLSN---NEVIECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred hCCCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 8 9999977532 2333444333221 23346789999999999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=255.50 Aligned_cols=200 Identities=19% Similarity=0.304 Sum_probs=161.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++. ++..++||||+ +++|.+++.. ...+++..++.++.||+.+|+|||++||+||||||.|||++
T Consensus 54 ~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~-- 129 (257)
T cd05116 54 DNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV-- 129 (257)
T ss_pred CCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc--
Confidence 4799999998875 45679999999 8899999874 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ +.......++..|+|||.+....++.++|+|||||++|||++ |..||.+...
T Consensus 130 -~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 130 -TQHYAKISDFGLSKALGADENY----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred -CCCeEEECCCccccccCCCCCe----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6788999999999866443211 111122345678999999988889999999999999999997 9999987533
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
......+..... ..++..+|+++.++|..||..+|++||+++.|.+.|++.
T Consensus 205 ---~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 205 ---NEVTQMIESGER----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---HHHHHHHHCCCC----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 233333333221 123456889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.40 Aligned_cols=188 Identities=20% Similarity=0.229 Sum_probs=158.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+..++..||||||+ |++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~-- 130 (325)
T cd05604 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD-- 130 (325)
T ss_pred CCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC--
Confidence 4799999999999999999999999 9999988864 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 131 -~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--- 199 (325)
T cd05604 131 -SQGHVVLTDFGLCKEGIAQSD-------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--- 199 (325)
T ss_pred -CCCCEEEeecCCcccCCCCCC-------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC---
Confidence 678999999999875322111 123467999999999999999999999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
+..+.+..+..... .+...++.++.+++..|+..+|.+||+..
T Consensus 200 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 200 DVAEMYDNILHKPL-----VLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CHHHHHHHHHcCCc-----cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 33344444443322 12345788999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=275.17 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=159.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
|...|++|++|-..+.+.|||||+-..+|..+++.....+..-.+..|..||+.++.++|..||||.||||.|||+
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl---- 493 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL---- 493 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----
Confidence 5678999999999999999999999999999998765555555899999999999999999999999999999999
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-----------CCchhHHHHHHHHHHHHHhC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRG 149 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----------~s~~~DvwSlGvvl~elltG 149 (414)
-.|.+||||||+|..+....+.. + ....+||+.||+||.+.... .++++||||||||||+|+.|
T Consensus 494 VkG~LKLIDFGIA~aI~~DTTsI---~--kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 494 VKGRLKLIDFGIANAIQPDTTSI---V--KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred EeeeEEeeeechhcccCccccce---e--eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 57899999999999876644321 1 23569999999999987433 46889999999999999999
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.||.... +...++..|.+......++.+... .++.++|+.||..||.+||+..+|+
T Consensus 569 ktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 569 KTPFGQII--NQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CCchHHHH--HHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHh
Confidence 99997642 344455555554433333333322 3499999999999999999977764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=257.68 Aligned_cols=201 Identities=19% Similarity=0.306 Sum_probs=161.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+. .+..|+||||+ +++|.+++......+++..++.++.||+.+|+|||++|++||||||+|||++
T Consensus 54 h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~--- 129 (257)
T cd05115 54 NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV--- 129 (257)
T ss_pred CCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---
Confidence 689999998875 45789999999 9999999876566899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+...... +.......++..|+|||++.+..++.++|||||||++|++++ |..||.+....
T Consensus 130 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 130 NQHYAKISDFGLSKALGADDSY----YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred CCCcEEeccCCccccccCCccc----eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 6788999999999765432210 111112234678999999998889999999999999999996 99999875432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.....+..... ..+...+++++.+++..||..+|++||++.++.+.|+.++
T Consensus 206 ---~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 ---EVMSFIEQGKR----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ---HHHHHHHCCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 22232222221 1233567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=260.51 Aligned_cols=200 Identities=20% Similarity=0.294 Sum_probs=162.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC----------------SRKLSLKTVLMLADQMINRVEFVHSKS 63 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~----------------~~~ls~~~v~~ia~Qll~gL~yLH~~g 63 (414)
.+|||+++++++..++..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++|
T Consensus 65 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 144 (283)
T cd05090 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF 144 (283)
T ss_pred CCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC
Confidence 3699999999999999999999999 89999998532 124889999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHH
Q 015018 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143 (414)
Q Consensus 64 ivHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl 143 (414)
|+||||||+|||++ ..+.++|+|||+++....... ........++..|++||++.+..++.++|||||||++
T Consensus 145 i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 145 FVHKDLAARNILIG---EQLHVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred eehhccccceEEEc---CCCcEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999999999996 667899999999987643221 1112344567889999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 144 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 144 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
|||++ |..||.+... ....+.+..... ...+..++.++.+++..||..+|++||++.+|.+.|..
T Consensus 217 ~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 217 WEIFSFGLQPYYGFSN---QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCCCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 99998 9999977532 222222222221 12445788999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=273.35 Aligned_cols=201 Identities=20% Similarity=0.292 Sum_probs=161.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-------------------------------------------
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------------------------------- 37 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------- 37 (414)
+|||+++++++.++++.++||||| |++|.+++....
T Consensus 98 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 177 (375)
T cd05104 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSY 177 (375)
T ss_pred CcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccc
Confidence 699999999999999999999999 999999886421
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEE
Q 015018 38 -------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 86 (414)
Q Consensus 38 -------------------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vk 86 (414)
..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~k 254 (375)
T cd05104 178 VVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITK 254 (375)
T ss_pred ccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEE
Confidence 2478889999999999999999999999999999999996 667899
Q ss_pred EeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 015018 87 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 165 (414)
Q Consensus 87 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~ 165 (414)
|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ..+
T Consensus 255 l~DfG~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~ 327 (375)
T cd05104 255 ICDFGLARDIRNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY 327 (375)
T ss_pred EecCccceeccCccc-----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH
Confidence 999999987644221 111223456678999999999999999999999999999997 899997754321 222
Q ss_pred HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 166 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 166 ~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
..+..... . ..+...|.++.+++..||..||++||++.+|.+.|++.
T Consensus 328 ~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYR-M---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCcc-C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 22222111 1 12234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=266.47 Aligned_cols=201 Identities=16% Similarity=0.216 Sum_probs=154.5
Q ss_pred CCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++... ...|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 58 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll 136 (338)
T cd07859 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136 (338)
T ss_pred CCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 68999999877543 35799999998899999874 5579999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+ .++.+||+|||+++......... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 137 ~---~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 137 N---ADCKLKICDFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred C---CCCcEEEccCccccccccccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 6 77899999999998653322111 01134679999999999876 578899999999999999999999997
Q ss_pred CCCccchHHHH------------HHHHh-----------hhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKY------------EKISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~------------~~i~~-----------~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.........+ ..+.. .............+++++.+++..||..+|++||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 210 GKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 75322111111 11110 0111112223345778899999999999999999987765
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=259.86 Aligned_cols=190 Identities=19% Similarity=0.250 Sum_probs=155.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++.+..+.+.||||||+ |++|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 52 ~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 131 (280)
T cd05608 52 SRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD 131 (280)
T ss_pred CCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 689999999999999999999999 9999887743 245699999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++..+..... ......||..|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 132 ---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 132 ---NDGNVRISDLGLAVELKDGQS-------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ---CCCCEEEeeCccceecCCCCc-------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 678899999999987654321 1234579999999999999999999999999999999999999997643
Q ss_pred ccch-HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 158 AGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 158 ~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
.... ......+.... ..+...++.++.+++..||+.+|++||++
T Consensus 202 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 202 EKVENKELKQRILNDS-----VTYPDKFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred cchhHHHHHHhhcccC-----CCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 3211 11111111111 12345688999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=257.05 Aligned_cols=199 Identities=19% Similarity=0.338 Sum_probs=164.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+..++..++||||+ +++|.+++... ...+++..++.++.|++.+|+|||++||+||||||+|||++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~-- 138 (263)
T cd05052 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-- 138 (263)
T ss_pred CCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc--
Confidence 689999999999999999999999 89999998754 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.++|+|||++........ .......++..|++||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 139 -~~~~~kl~df~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 139 -ENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred -CCCcEEeCCCcccccccccee------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 678899999999986654221 11122345678999999999899999999999999999998 9999977432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.+.+..+.... .......+|.++.+++..||..+|++||++.++.+.|+.+
T Consensus 212 ---~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 212 ---SQVYELLEKGY----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHHHHHHHCCC----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22233332211 1123467899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=270.92 Aligned_cols=215 Identities=19% Similarity=0.287 Sum_probs=162.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.++.+.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~-- 135 (363)
T cd05628 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD-- 135 (363)
T ss_pred CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC--
Confidence 3689999999999999999999999 9999999975 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcc-------ccc---------------------ccccCCCCCCccccchhhhcCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQ-------HIP---------------------YRENKNLTGTARYASMNTHLGIEQS 131 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~-------~~~---------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s 131 (414)
..+.++|+|||+++.+....... ..+ ........||+.|+|||++.+..++
T Consensus 136 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 136 -SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred -CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 67889999999997653211000 000 0001245799999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCC---CCCCHHH
Q 015018 132 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAY 208 (414)
Q Consensus 132 ~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~---~RP~~~~ 208 (414)
.++|||||||++|||++|..||.+. +..+.+.++........++. ...+++++.+++..++. ++. .||++++
T Consensus 215 ~~~DvwSlGvil~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 215 KLCDWWSLGVIMYEMLIGYPPFCSE---TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred CchhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 9999999999999999999999874 33445555544222111111 11356788999888553 344 4577666
Q ss_pred HHHHHHHHHHHhCCCCCCcccccccc
Q 015018 209 LKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 209 l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
|++ ..+....+|+...
T Consensus 290 i~~----------hp~f~~~~~~~~~ 305 (363)
T cd05628 290 IKT----------NPFFEGVDWEHIR 305 (363)
T ss_pred HhC----------CCCCCCCCHHHHH
Confidence 632 2444566787764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=260.72 Aligned_cols=204 Identities=15% Similarity=0.298 Sum_probs=165.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHH
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-----------------------SRKLSLKTVLMLADQMINRV 56 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-----------------------~~~ls~~~v~~ia~Qll~gL 56 (414)
.+|||+++++.+..++..|+||||+ +++|.+++... ...+++..++.++.|++.+|
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 140 (290)
T cd05045 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGM 140 (290)
T ss_pred CCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHH
Confidence 3699999999999999999999999 89999998642 13588999999999999999
Q ss_pred HHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHH
Q 015018 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 136 (414)
Q Consensus 57 ~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dv 136 (414)
+|||+++|+||||||+|||++ .++.++|+|||+++....... +.......++..|++||.+.+..++.++||
T Consensus 141 ~~LH~~~ivH~dikp~nill~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 212 (290)
T cd05045 141 QYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212 (290)
T ss_pred HHHHHCCeehhhhhhheEEEc---CCCcEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccCCcchHhHH
Confidence 999999999999999999996 678899999999976543221 111122356778999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 137 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 137 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
||||+++|+|++ |..||.+... .+....+... ... .....++.++.+++..||+.+|++||++.++.+.|++
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAP---ERLFNLLKTG-YRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhCC-CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 999999999998 9999977532 2222222211 111 1234678999999999999999999999999999999
Q ss_pred HHHH
Q 015018 216 LFIR 219 (414)
Q Consensus 216 ~~~~ 219 (414)
++.+
T Consensus 286 ~~~~ 289 (290)
T cd05045 286 MMVK 289 (290)
T ss_pred HHhc
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=272.98 Aligned_cols=201 Identities=15% Similarity=0.175 Sum_probs=161.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++..+..+...|+|||+++++|.+++. ....+++..++.|+.||+.||+|||++|||||||||+|||++ .
T Consensus 145 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~ 220 (392)
T PHA03207 145 HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---E 220 (392)
T ss_pred CCCccceeeeEeeCCEEEEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---C
Confidence 689999999999999999999999889999885 356899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.++|+|||+++.+...... .......||..|+|||++.+..++.++|||||||++|||++|..||.+......
T Consensus 221 ~~~~~l~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 221 PENAVLGDFGAACKLDAHPDT-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred CCCEEEccCccccccCccccc-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 789999999999765543211 112346899999999999999999999999999999999999999988654433
Q ss_pred HHHHHHHHhhhccc---------------------------hHHHh--hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 162 KQKYEKISEKKVST---------------------------SIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 162 ~~~~~~i~~~~~~~---------------------------~~~~l--~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+..+....... .++.+ ...++.++.++|..|+..+|++||++.+++.
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 33333322210000 00000 1245678899999999999999999877753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=266.56 Aligned_cols=215 Identities=19% Similarity=0.287 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~ 78 (414)
.+|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~- 138 (333)
T cd06650 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 138 (333)
T ss_pred CCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-
Confidence 3699999999999999999999999 9999999975 45799999999999999999999985 799999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.+||+|||++..+.... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 139 --~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 139 --SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred --CCCCEEEeeCCcchhhhhhc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 66789999999987653321 1345789999999999998899999999999999999999999975432
Q ss_pred cchHHHHH-------------------------------------HHHhhhccchHHHhh-cCCcHHHHHHHHHHHcCCC
Q 015018 159 GTKKQKYE-------------------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRF 200 (414)
Q Consensus 159 ~~~~~~~~-------------------------------------~i~~~~~~~~~~~l~-~~~p~e~~~li~~c~~~dp 200 (414)
......+. .+...........++ ..++.++.+||.+||..||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 287 (333)
T cd06650 208 KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287 (333)
T ss_pred hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCc
Confidence 11110000 000000000000111 1356889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHhC-CCCCCccccc
Q 015018 201 DDKPDYAYLKRLFRDLFIREG-FQFDYVFDWT 231 (414)
Q Consensus 201 ~~RP~~~~l~~~l~~~~~~~~-~~~d~~~~w~ 231 (414)
++||++.+|+ .+.+.+.. .+......|.
T Consensus 288 ~~Rpt~~ell---~h~~~~~~~~~~~~~~~~~ 316 (333)
T cd06650 288 AERADLKQLM---VHAFIKRSEAEEVDFAGWL 316 (333)
T ss_pred ccCcCHHHHh---hCHHHhcCccccccHHHHH
Confidence 9999987774 33443332 2333455664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=259.23 Aligned_cols=199 Identities=18% Similarity=0.280 Sum_probs=161.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
++|||++++.++.++.+.++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+++|+|||
T Consensus 67 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlk 146 (277)
T cd05062 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLA 146 (277)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcc
Confidence 4799999999999999999999999 999999986432 236788999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G 149 (414)
|+|||++ .++.++|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|+|++ |
T Consensus 147 p~Nil~~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 218 (277)
T cd05062 147 ARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218 (277)
T ss_pred hheEEEc---CCCCEEECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 9999996 678899999999876543221 111122356788999999998889999999999999999998 7
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
..||.+... .+.+..+..... ..+...++.++.+++..||..+|++||++.++.+.|+
T Consensus 219 ~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 219 EQPYQGMSN---EQVLRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 999977532 233333332222 1234567899999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=265.92 Aligned_cols=198 Identities=22% Similarity=0.267 Sum_probs=158.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|+|+++++.+.++++.||||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~-- 136 (332)
T cd05623 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-- 136 (332)
T ss_pred CCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC--
Confidence 3689999999999999999999999 9999999986667899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.++.++|+|||++..+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 137 -~~~~~kL~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 137 -MNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred -CCCCEEEeecchheecccCCcc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 6788999999999765432211 1123579999999999863 457889999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~--RP~~~~l~ 210 (414)
+. +..+.+.++........+...+..++.++.+++..|+..+++. |+++++++
T Consensus 210 ~~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~ 264 (332)
T cd05623 210 AE---SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK 264 (332)
T ss_pred CC---CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh
Confidence 64 3445555555443332233334567899999999998665433 45655443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=257.82 Aligned_cols=199 Identities=22% Similarity=0.334 Sum_probs=163.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 66 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-------------~~ls~~~v~~ia~Qll~gL~yLH~~givH 66 (414)
.+|||+++++++..+.+.|+||||+ |++|.+++...+ ..+++..+..++.||+.+|.|||++||+|
T Consensus 66 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h 145 (280)
T cd05049 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVH 145 (280)
T ss_pred CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 3689999999999999999999999 999999997432 35889999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
|||||+||+++ .++.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|+|
T Consensus 146 ~dlkp~nili~---~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 146 RDLATRNCLVG---YDLVVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred cccccceEEEc---CCCeEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99999999996 678999999999976533221 1112234567899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 147 LR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 147 lt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
++ |..||.+... .+....+...... .....+|.++.+++..||..+|++||++.++++.|+
T Consensus 218 ~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSN---EEVIECITQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 9999977533 2333333322221 223467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=271.42 Aligned_cols=188 Identities=20% Similarity=0.230 Sum_probs=155.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+.+.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~-- 130 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD-- 130 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC--
Confidence 4799999999999999999999999 9999988874 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 131 -~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-- 200 (330)
T cd05586 131 -ATGHIALCDFGLSKANLTDNK-------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-- 200 (330)
T ss_pred -CCCCEEEecCCcCcCCCCCCC-------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--
Confidence 678899999999875332211 12346799999999999764 4789999999999999999999999763
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
+..+.+..+........ ...++.++.+++..||..+|.+||+.
T Consensus 201 -~~~~~~~~i~~~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 201 -DTQQMYRNIAFGKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -CHHHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 33444444443332211 12467899999999999999999953
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=271.16 Aligned_cols=196 Identities=21% Similarity=0.277 Sum_probs=159.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+.++++.||||||+ |++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~-- 136 (330)
T cd05601 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID-- 136 (330)
T ss_pred CCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC--
Confidence 4789999999999999999999999 9999999987667899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc------CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
..+.+||+|||++..+...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 137 -~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf 209 (330)
T cd05601 137 -RTGHIKLADFGSAARLTANKMV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209 (330)
T ss_pred -CCCCEEeccCCCCeECCCCCce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence 7789999999999876543221 112347899999999987 456788999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... ....+..+.........+ ....++.++.+|+..|+. +|.+||++++++
T Consensus 210 ~~~~---~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 210 HEGT---SAKTYNNIMNFQRFLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CCCC---HHHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 7643 333444443322111111 112468899999999997 999999987663
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=259.85 Aligned_cols=190 Identities=18% Similarity=0.222 Sum_probs=154.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++.+..+++.|+||||+ |++|.+++... ...+++..+..++.||+.||+|||+.+|+||||||+||+++
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~- 136 (285)
T cd05605 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD- 136 (285)
T ss_pred CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC-
Confidence 3689999999999999999999999 89999887543 35699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++........ .....|+..|++||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 137 --~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 137 --DYGHIRISDLGLAVEIPEGET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred --CCCCEEEeeCCCceecCCCCc--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 678899999999987543221 1235789999999999998999999999999999999999999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
......+..... ......+..++..+.+++..||..||.+||+
T Consensus 207 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 207 KVKREEVERRVK----EDQEEYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred hhHHHHHHHHhh----hcccccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 222222211111 1111233457889999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=264.13 Aligned_cols=197 Identities=18% Similarity=0.304 Sum_probs=155.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~ 78 (414)
.+|||++++.++.+++..+|||||+ |++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~- 138 (331)
T cd06649 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN- 138 (331)
T ss_pred CCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-
Confidence 3699999999999999999999999 9999999975 45799999999999999999999986 699999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 139 --~~~~~kl~Dfg~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 139 --SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred --CCCcEEEccCcccccccccc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 67889999999987654322 1345799999999999999999999999999999999999999975432
Q ss_pred cchHHHHHH---------------------------------------HHhhhccchHHHh-hcCCcHHHHHHHHHHHcC
Q 015018 159 GTKKQKYEK---------------------------------------ISEKKVSTSIEAL-CRGYPTEFASYFHYCRSL 198 (414)
Q Consensus 159 ~~~~~~~~~---------------------------------------i~~~~~~~~~~~l-~~~~p~e~~~li~~c~~~ 198 (414)
......+.. ............. ...++.++.+||..||..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 287 (331)
T cd06649 208 KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK 287 (331)
T ss_pred HHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC
Confidence 111100000 0000000000000 124678999999999999
Q ss_pred CCCCCCCHHHHH
Q 015018 199 RFDDKPDYAYLK 210 (414)
Q Consensus 199 dp~~RP~~~~l~ 210 (414)
||++||++.+|.
T Consensus 288 ~P~~Rpt~~ell 299 (331)
T cd06649 288 NPAERADLKMLM 299 (331)
T ss_pred CcccCCCHHHHh
Confidence 999999987764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=272.13 Aligned_cols=200 Identities=23% Similarity=0.283 Sum_probs=160.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+.++++.|+||||+ |++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~--- 135 (350)
T cd05573 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID--- 135 (350)
T ss_pred CCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---
Confidence 689999999999999999999999 99999999753 6899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCccc----------------------ccccccCCCCCCccccchhhhcCCCCCchhHHHH
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQH----------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~----------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwS 138 (414)
.++.++|+|||+++.+........ ..........||+.|+|||++.+..++.++||||
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 215 (350)
T cd05573 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215 (350)
T ss_pred CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe
Confidence 778999999999986654320000 0001123467999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHH
Q 015018 139 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 210 (414)
Q Consensus 139 lGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-~~~l~ 210 (414)
|||++|+|++|+.||.+.. ....+.++........+.. ...+++++.++|..|+. +|.+|++ +++++
T Consensus 216 lG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 216 LGVILYEMLYGFPPFYSDT---LQETYNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred cchhhhhhccCCCCCCCCC---HHHHHHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9999999999999998754 3334444443111111111 12368999999999997 9999999 87775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=272.50 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=164.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc--------------------------------------------
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-------------------------------------------- 36 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-------------------------------------------- 36 (414)
+|||+++++++.++...||||||| +++|.+++...
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (400)
T cd05105 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD 179 (400)
T ss_pred CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence 799999999999999999999999 99999988542
Q ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015018 37 ---------------------------------------------------SRKLSLKTVLMLADQMINRVEFVHSKSFL 65 (414)
Q Consensus 37 ---------------------------------------------------~~~ls~~~v~~ia~Qll~gL~yLH~~giv 65 (414)
...+++..++.++.||+.||+|||+++|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 259 (400)
T cd05105 180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV 259 (400)
T ss_pred cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 12478889999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~e 145 (414)
||||||+|||++ .++.++|+|||+++.+..... +.......++..|+|||.+.+..++.++|||||||++|+
T Consensus 260 H~dikp~Nill~---~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~e 331 (400)
T cd05105 260 HRDLAARNVLLA---QGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331 (400)
T ss_pred CCCCChHhEEEe---CCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHH
Confidence 999999999996 677899999999987644221 112233467789999999999889999999999999999
Q ss_pred HHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 146 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 146 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
|++ |..||...... ...+..+...... .....+|.++.+++..||..+|++||++.+|.+.|+.++
T Consensus 332 llt~g~~P~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 332 IFSLGGTPYPGMIVD--STFYNKIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHCCCCCCcccchh--HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 997 99999775322 1122222222111 123467899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=257.11 Aligned_cols=202 Identities=19% Similarity=0.317 Sum_probs=160.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
.+|||+++++++.+.+..|+||||+ |++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~n 146 (277)
T cd05036 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARN 146 (277)
T ss_pred CCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhe
Confidence 3689999999999999999999999 999999997542 258999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~P 152 (414)
||++.......+||+|||+++....... +........+..|++||++.+..++.++|||||||++|+|++ |..|
T Consensus 147 il~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 147 CLLTCKGPGRVAKIADFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred EEEeccCCCcceEeccCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 9997433345799999999986633211 111122344678999999998899999999999999999996 9999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
|.+... ...+..+..... ......+|.++.+++..||..+|++||++.++.+.|.
T Consensus 222 f~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 222 YPGRTN---QEVMEFVTGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCH---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 987433 222222222111 1224567899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=254.82 Aligned_cols=200 Identities=19% Similarity=0.197 Sum_probs=163.4
Q ss_pred CCCCCcEEEEeeE--eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGV--EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~--~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+.|...-+ +-+..|||||||..+|..++....++|...++.-++.|+++||+|||.+.|+|||||+.|+|+.
T Consensus 133 ~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~- 211 (419)
T KOG0663|consen 133 RHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS- 211 (419)
T ss_pred CCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec-
Confidence 5799999987654 5567999999999999999998889999999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..|.+||+|||+|+.|..+.. .....+-|.+|.|||.+.|.. |+...|+||+|||+.||+++++.|.|..
T Consensus 212 --~~G~lKiaDFGLAR~ygsp~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 212 --HKGILKIADFGLAREYGSPLK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred --cCCcEEecccchhhhhcCCcc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 889999999999999987632 224568899999999999865 8999999999999999999999999976
Q ss_pred ccchHHHHHHHHhhhcc-------------------chHHHhh---c--CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVS-------------------TSIEALC---R--GYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~-------------------~~~~~l~---~--~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..++..++.++.-..-. .+...+. . .+.+.-.+|+..++.+||.+|.++++.+
T Consensus 283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 65555444433211100 0111111 1 1347778999999999999999987653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=260.87 Aligned_cols=205 Identities=18% Similarity=0.257 Sum_probs=166.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
++|||++++.++..++..|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 161 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC 161 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4799999999999999999999999 899999997532 358999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.++|+|||+++........ .......++..|+|||++.+..++.++|+|||||++|
T Consensus 162 ~H~dlkp~Nill~---~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 162 IHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred ccccccHHheEEc---CCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9999999999996 6788999999998765432110 0111234457899999999988999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
+|++ |..||.+.. ..+....+..... ...+..++.++.+++..||..+|++||++.++.+.|..++...
T Consensus 234 el~~~g~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 234 EIFTLGGSPYPGVP---VEELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHcCCCCCCCcCC---HHHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 9998 899997643 2233333322221 1234467899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=254.72 Aligned_cols=197 Identities=16% Similarity=0.243 Sum_probs=161.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+.++.|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||.||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~-- 134 (256)
T cd05113 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-- 134 (256)
T ss_pred CCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc--
Confidence 4799999999999999999999999 8999999976555799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......++..|++||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 135 -~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 135 -DQGCVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred -CCCCEEECCCccceecCCCce------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 678899999999886544221 11123356778999999998889999999999999999998 9999976543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
......+...... ......+.++.+++..||..+|++||++.+|.+.|
T Consensus 208 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 208 ---SETVEKVSQGLRL----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 2233333332221 12234678999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=256.73 Aligned_cols=198 Identities=19% Similarity=0.216 Sum_probs=163.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFL 65 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~giv 65 (414)
+|||++++.++.+.+..++++||+ +++|.+++... ...+++..++.++.|++.||+|||++||+
T Consensus 67 h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~ 146 (283)
T cd05091 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146 (283)
T ss_pred CCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 699999999999999999999999 89999998521 23588999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~e 145 (414)
||||||+|||+. .++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 147 H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 147 HKDLATRNVLVF---DKLNVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred ccccchhheEec---CCCceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999999999996 667899999999886543221 111233456789999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 146 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 146 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
|++ |..||.+.. ..+.++.+...... .+...+|.++.+++..||+.+|++||++.+|...|+
T Consensus 219 l~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 219 VFSYGLQPYCGYS---NQDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCCCCCCCCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 998 889997743 33444444444332 234678999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=269.79 Aligned_cols=201 Identities=20% Similarity=0.271 Sum_probs=154.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~-- 135 (377)
T cd05629 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID-- 135 (377)
T ss_pred CCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC--
Confidence 4799999999999999999999999 9999999874 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCccc-------ccc---------------------------------cccCCCCCCccc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQH-------IPY---------------------------------RENKNLTGTARY 119 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~-------~~~---------------------------------~~~~~~~Gt~~Y 119 (414)
..+.++|+|||+++.+........ ... .......||+.|
T Consensus 136 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 214 (377)
T cd05629 136 -RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214 (377)
T ss_pred -CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence 678999999999975432110000 000 000125799999
Q ss_pred cchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 120 ~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+........+.. ...++.++.++|..|+. +
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 215 IAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSEN---SHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred cCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCC---HHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-C
Confidence 99999999999999999999999999999999997643 2333444433211111100 12467899999999997 7
Q ss_pred CCCCC---CHHHHH
Q 015018 200 FDDKP---DYAYLK 210 (414)
Q Consensus 200 p~~RP---~~~~l~ 210 (414)
|.+|+ ++.+++
T Consensus 290 ~~~r~~r~~~~~~l 303 (377)
T cd05629 290 AENRLGRGGAHEIK 303 (377)
T ss_pred HhhcCCCCCHHHHh
Confidence 77765 655443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=260.20 Aligned_cols=202 Identities=20% Similarity=0.285 Sum_probs=163.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFL 65 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~giv 65 (414)
+|||+++++++......|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+
T Consensus 62 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv 141 (297)
T cd05089 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI 141 (297)
T ss_pred CCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 699999999999999999999999 899999986421 3588999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~e 145 (414)
||||||+|||++ .++.+||+|||++....... .......+..|++||++.+..++.++|||||||++|+
T Consensus 142 H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 210 (297)
T cd05089 142 HRDLAARNVLVG---ENLASKIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210 (297)
T ss_pred cCcCCcceEEEC---CCCeEEECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHH
Confidence 999999999996 67889999999986422110 0111233567999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 146 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 146 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
|++ |..||.+... .+.+.++..... ......++.++.+++..||..+|.+||+++++.+.|++++....
T Consensus 211 l~t~g~~pf~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 211 IVSLGGTPYCGMTC---AELYEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHcCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 997 9999977533 233333332211 11234578999999999999999999999999999998886553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=283.31 Aligned_cols=207 Identities=19% Similarity=0.208 Sum_probs=159.7
Q ss_pred CCCCCcEEEE-eeEe------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCC
Q 015018 1 MAAGIPNLRW-FGVE------GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDI 69 (414)
Q Consensus 1 g~p~I~~l~~-~g~~------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDI 69 (414)
|+||||.+++ .... .-.++|+|||| |++|.|+++.. ...|++.+|++|+.|+++||.+||... ||||||
T Consensus 93 gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDL 172 (738)
T KOG1989|consen 93 GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDL 172 (738)
T ss_pred CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhh
Confidence 8999999998 2221 12468999999 79999999743 556999999999999999999999998 999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCC-Cccccccc-ccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHH
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTA-THQHIPYR-ENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~-~~~~~~~~-~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~ 144 (414)
|-|||||+ .++.+||||||.|....... ....+.+. +.-....|+.|.+||++. +...+.|+|||+|||+||
T Consensus 173 KiENvLls---~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 173 KIENVLLS---ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred hhhheEEc---CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 99999996 77899999999987433322 22222221 222456799999999986 677899999999999999
Q ss_pred HHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 145 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 145 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.||....||.+.-. ..|...+...+. ...++..|.+||..||+.+|++||+.-++.+.+..+....
T Consensus 250 kLCy~t~PFe~sg~-------laIlng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 250 KLCYFTTPFEESGK-------LAILNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHHhCCCcCcCcc-------eeEEeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 99999999976411 112222222211 1467889999999999999999999777776666665433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=274.50 Aligned_cols=190 Identities=20% Similarity=0.257 Sum_probs=165.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+.++++|+...+.|+|.||+-|+|..++.+ +.+++++.+..|++|++.||.|||+.+|+|||+||+|||++ +
T Consensus 60 Hpniv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~ 135 (808)
T KOG0597|consen 60 HPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---K 135 (808)
T ss_pred CcchhhHHHhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---C
Confidence 6999999999999999999999995599999985 77999999999999999999999999999999999999996 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.+|+||||+|+....... + .....||+.|||||+..+..|+..+|+||||||+||+..|++||.. ...
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t~-v------ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si 205 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNTS-V------LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSI 205 (808)
T ss_pred CCceeechhhhhhhcccCce-e------eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHH
Confidence 89999999999997655221 1 2346899999999999999999999999999999999999999965 344
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+....|.......+ .....+|..|++-++.+||..|.+..+|.
T Consensus 206 ~~Lv~~I~~d~v~~p-----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 206 TQLVKSILKDPVKPP-----STASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred HHHHHHHhcCCCCCc-----ccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 555556655544432 35678999999999999999999987764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=255.58 Aligned_cols=201 Identities=18% Similarity=0.203 Sum_probs=162.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++. +...++||||+ +++|.+++......+++..++.|+.||+.||+|||+++++||||||+|||++
T Consensus 67 ~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~-- 143 (279)
T cd05111 67 DHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-- 143 (279)
T ss_pred CCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc--
Confidence 3799999999875 45678899999 9999999987677899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++......... ......++..|++||.+.+..++.++|||||||++||+++ |..||.+...
T Consensus 144 -~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 144 -SDSIVQIADFGVADLLYPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred -CCCcEEEcCCccceeccCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 67889999999998664322111 1123467788999999998889999999999999999998 9999987532
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
. .+..+........ ....++.++..++..||..+|++||++.++.+.|..+.
T Consensus 218 ---~-~~~~~~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 218 ---H-EVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---H-HHHHHHHCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1222222111111 22346788999999999999999999999999888775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=258.04 Aligned_cols=204 Identities=16% Similarity=0.252 Sum_probs=167.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
++|||++++.++......|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi 158 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC 158 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4799999999999999999999999 899999987531 358889999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ ..+.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|
T Consensus 159 vH~dlkp~Nili~---~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 159 IHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred eecccccceEEEc---CCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999999999996 6788999999999876543221 1112335667899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
+|++ |..||.+.. ..+.+..+...... .....++.++.+++..||..+|++||++.++.+.|+.++.-
T Consensus 231 el~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 231 EIFTLGGSPYPGIP---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHcCCCCCcccCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 9998 889997643 33333333332221 12346789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=264.25 Aligned_cols=213 Identities=21% Similarity=0.281 Sum_probs=163.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|++++..+.++++.||||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 60 ~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~--- 136 (331)
T cd05624 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD--- 136 (331)
T ss_pred CCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---
Confidence 689999999999999999999999 9999999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.+||+|||+++.+...... ......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+
T Consensus 137 ~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 137 MNGHIRLADFGSCLKMNQDGTV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCEEEEeccceeeccCCCce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 6788999999999876543211 1123579999999999876 4578899999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
. +..+.+.++........+......++.++.+++..|+..++ +|+....+.+++.+ .+...++|+...
T Consensus 211 ~---~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h-------~~f~~~~~~~~~ 278 (331)
T cd05624 211 E---SLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKH-------AFFEGIDWENIR 278 (331)
T ss_pred C---CHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcC-------CCcCCCCHHHHh
Confidence 4 33444555443322222222234578999999999988654 44432223333222 233456787654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=263.78 Aligned_cols=186 Identities=19% Similarity=0.243 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|+|++++.++.+.++.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~--- 135 (323)
T cd05615 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD--- 135 (323)
T ss_pred CCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---
Confidence 478899999999999999999999 9999999874 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||+++....... ......||..|+|||++.+..++.++|+|||||++|+|++|..||.+..
T Consensus 136 ~~~~ikL~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--- 205 (323)
T cd05615 136 SEGHIKIADFGMCKEHMVDGV-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--- 205 (323)
T ss_pred CCCCEEEeccccccccCCCCc-------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---
Confidence 678899999999875432211 1234579999999999999899999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..+.+..+...... +...++.++.+++..|+..+|.+|++.
T Consensus 206 ~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 206 EDELFQSIMEHNVS-----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHHhCCCC-----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 34444444443322 334678899999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=270.38 Aligned_cols=195 Identities=21% Similarity=0.284 Sum_probs=157.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||+ |++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 101 ~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~-- 176 (370)
T cd05596 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-- 176 (370)
T ss_pred CCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc--
Confidence 3699999999999999999999999 999999987 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC----CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+
T Consensus 177 -~~~~~kL~DfG~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 177 -KSGHLKLADFGTCMKMDANGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred -CCCCEEEEeccceeeccCCCc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 778999999999987643221 012346799999999998754 378899999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~--RP~~~~l~ 210 (414)
.. ....+..+.........+. ...++.++.++|..|+..+|++ |+++++|+
T Consensus 250 ~~---~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 250 DS---LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred CC---HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 43 3344555543322111111 1246899999999999988887 89877664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=254.14 Aligned_cols=198 Identities=17% Similarity=0.319 Sum_probs=163.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+.+++..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+++||||||+||+++
T Consensus 60 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~-- 137 (261)
T cd05072 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS-- 137 (261)
T ss_pred CCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec--
Confidence 689999999999999999999999 99999998643 45789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.++|+|||++......... ......++..|++||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 138 -~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 138 -ESLMCKIADFGLARVIEDNEYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred -CCCcEEECCCccceecCCCcee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 6788999999999876542211 1123456778999999998889999999999999999998 9999976432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
......+...... .....+|.++.+++..||..+|++||+++++.++|++
T Consensus 211 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 211 ---SDVMSALQRGYRM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2223333322111 1224678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=269.94 Aligned_cols=204 Identities=19% Similarity=0.293 Sum_probs=158.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 60 h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~--- 135 (364)
T cd05599 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD--- 135 (364)
T ss_pred CCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---
Confidence 689999999999999999999999 9999999875 55799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccc-----------------c---------cc-----ccCCCCCCccccchhhhcCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHI-----------------P---------YR-----ENKNLTGTARYASMNTHLGIE 129 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~-----------------~---------~~-----~~~~~~Gt~~Y~aPE~~~~~~ 129 (414)
.++.++|+|||+++.+......... + +. ......||+.|+|||++.+..
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 7789999999999865432110000 0 00 011346999999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 130 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 130 ~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
++.++|||||||++|+|++|..||.+.. ..+.+..+........... ...+++++.++|..|+. +|.+|++...+
T Consensus 216 ~~~~~DiwSlG~il~el~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVGYPPFCSDN---PQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred CCCeeeeecchhHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999999999999999999999997743 3344444433221111111 12467899999999996 89999984334
Q ss_pred HHHHH
Q 015018 210 KRLFR 214 (414)
Q Consensus 210 ~~~l~ 214 (414)
.+++.
T Consensus 291 ~~ll~ 295 (364)
T cd05599 291 NEIKS 295 (364)
T ss_pred HHHhc
Confidence 44443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=254.14 Aligned_cols=201 Identities=16% Similarity=0.229 Sum_probs=156.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~----~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
++|||+++++.+.++...||||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 53 ~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 132 (269)
T cd05042 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQ 132 (269)
T ss_pred CCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheE
Confidence 4799999999999999999999999 899999987532 23567889999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-------CCCCchhHHHHHHHHHHHHHh
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~~~DvwSlGvvl~ellt 148 (414)
++ .++.++|+|||++........ +.......++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 133 l~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 133 LT---ADLSVKIGDYGLALEQYPEDY-----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred ec---CCCcEEEeccccccccccchh-----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 96 678899999999865432211 111123456778999999753 356789999999999999998
Q ss_pred -CCCCCCCCCccchHHHHHH-HHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 149 -GSLPWQGLKAGTKKQKYEK-ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 149 -G~~Pf~~~~~~~~~~~~~~-i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
|..||..... .+.+.. +...........+...+++++.+++..|| .||++||+++++.++|
T Consensus 205 ~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 205 AADQPYPDLSD---EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCCCCcCCH---HHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 8899976532 222222 22222222223445578899999999999 5999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=251.41 Aligned_cols=198 Identities=20% Similarity=0.334 Sum_probs=162.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++..++..|+||||+ |++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++
T Consensus 60 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-- 137 (261)
T cd05068 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-- 137 (261)
T ss_pred CCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc--
Confidence 689999999999999999999999 99999999753 35799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.++|+|||+++.+...... .......+..|++||.+.+..++.++|+||||+++|+|++ |+.||.+...
T Consensus 138 -~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 138 -ENNICKVADFGLARVIKEDIYE------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred -CCCCEEECCcceEEEccCCccc------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 6788999999999877532211 1112233568999999998889999999999999999999 9999987532
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
.+.+..+...... .....++..+.+++..|++.+|++||++.+|.+.|++
T Consensus 211 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 211 ---AEVLQQVDQGYRM----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2333333322111 1224578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=274.20 Aligned_cols=200 Identities=17% Similarity=0.224 Sum_probs=152.1
Q ss_pred CCCCCcEEEEeeEe--------CCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 1 MAAGIPNLRWFGVE--------GDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 1 g~p~I~~l~~~g~~--------~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
.+|||++++.++.. ..+.++||||++++|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 117 ~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDL 196 (440)
T PTZ00036 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196 (440)
T ss_pred CCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCc
Confidence 37999999877643 236789999998899888753 3567999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHh
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~ellt 148 (414)
||+||||+ ...+.+||+|||+|+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 197 Kp~NILl~--~~~~~vkL~DFGla~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 197 KPQNLLID--PNTHTLKLCDFGSAKNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred CHHHEEEc--CCCCceeeeccccchhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999996 2335799999999986643221 1245789999999998764 68999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhh---------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
|.+||.+.........+..+.... .......++..+|.++.+||..||..+|.+||++.
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999998754322211111110000 00011122345788999999999999999999987
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 347 e~l 349 (440)
T PTZ00036 347 EAL 349 (440)
T ss_pred HHh
Confidence 764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=251.07 Aligned_cols=196 Identities=17% Similarity=0.235 Sum_probs=161.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.+..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~--- 134 (256)
T cd05114 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS--- 134 (256)
T ss_pred CCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---
Confidence 689999999999999999999999 9999999875455799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-- 206 (256)
T cd05114 135 STGVVKVSDFGMTRYVLDDEY------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-- 206 (256)
T ss_pred CCCeEEECCCCCccccCCCce------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--
Confidence 678899999999876543221 11123346678999999998889999999999999999999 999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
..+.+..+...... ......+.++.+++..||..+|++||++++|.+.|
T Consensus 207 -~~~~~~~i~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 207 -NYEVVEMISRGFRL----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -HHHHHHHHHCCCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 33344444432221 11234678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=259.64 Aligned_cols=199 Identities=19% Similarity=0.253 Sum_probs=158.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++..+++.|+||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 63 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~ 139 (309)
T cd07872 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---E 139 (309)
T ss_pred CCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---C
Confidence 6999999999999999999999998899999876667799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.++|+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+
T Consensus 140 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 140 RGELKLADFGLARAKSVPTK-------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred CCCEEECccccceecCCCcc-------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 78899999999976533221 1123467999999999875 457899999999999999999999998754433
Q ss_pred hHHHHHHHHhhhcc----------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~----------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+......... .........+++++.++|..|+..||.+||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 22222211110000 001112235678999999999999999999987765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=262.35 Aligned_cols=189 Identities=23% Similarity=0.327 Sum_probs=165.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++|..|++.+..+|||||. ||.|+|++..+ +.|++.++..++.||..++.|+|.+++||||||.+|||++
T Consensus 111 NHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD-- 187 (668)
T KOG0611|consen 111 NHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD-- 187 (668)
T ss_pred CCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec--
Confidence 3799999999999999999999999 99999999874 5899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+||||+-.|.+... ..+++|++.|++||++.|.+| ++.+|.|||||+||.|+.|..||+|.
T Consensus 188 -~N~NiKIADFGLSNly~~~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-- 256 (668)
T KOG0611|consen 188 -QNNNIKIADFGLSNLYADKKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-- 256 (668)
T ss_pred -CCCCeeeeccchhhhhccccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--
Confidence 789999999999988766442 357899999999999999998 58999999999999999999999984
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+-+..+..|....... ..-|....-||..|+..+|++|-+.++|.
T Consensus 257 -Dhk~lvrQIs~GaYrE------P~~PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 257 -DHKRLVRQISRGAYRE------PETPSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred -hHHHHHHHhhcccccC------CCCCchHHHHHHHHHhcCcccchhHHHHh
Confidence 4455556665544432 34577889999999999999999977665
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=252.25 Aligned_cols=197 Identities=20% Similarity=0.277 Sum_probs=160.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++...++.|+||||+ |++|.+++......+++..++.++.||+.+|+|||++||+||||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~-- 134 (256)
T cd05059 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG-- 134 (256)
T ss_pred CCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC--
Confidence 3689999999999999999999999 9999999975555799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||+++...+... .......++..|++||.+.+..++.++|+|||||++|++++ |..||.+...
T Consensus 135 -~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 135 -EDNVVKVSDFGLARYVLDDQY------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred -CCCcEEECCcccceecccccc------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 678899999999986543221 01112234568999999998889999999999999999998 8999976432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
.+.+..+..... ......+|.++.+++.+||..+|++||++.++.+.|
T Consensus 208 ---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 208 ---SEVVESVSAGYR----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 233333332211 112345789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-31 Score=260.26 Aligned_cols=206 Identities=17% Similarity=0.270 Sum_probs=167.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
++|||++++.++..+++.|+||||+ +++|.+++... ...+++.+++.++.||+.||+|||++||
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 155 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC 155 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4799999999999999999999999 89999998642 2358889999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.++|+|||+++....... +.......++..|++||++.+..++.++|||||||++|
T Consensus 156 vH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 156 IHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred eccccccceEEEc---CCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999999999996 678899999999986644221 11112234567899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
+|++ |..||.+.. ....+..+...... .....++.++.+++..||..+|++||++.+|++.|+.++....
T Consensus 228 el~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 228 EIFTLGGSPYPGIP---VEELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHhcCCCCCCCCC---HHHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 9998 899997743 23333333322211 1234678899999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=276.22 Aligned_cols=205 Identities=19% Similarity=0.287 Sum_probs=171.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+.||+.+.+++....+ .||.-+| |.+|+.++.....+|.+.+.+.|+.||+.|+.|||.++|||||||..||+|.
T Consensus 447 H~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~--- 522 (678)
T KOG0193|consen 447 HENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH--- 522 (678)
T ss_pred hhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---
Confidence 4689999999988888 9999999 8899999987778999999999999999999999999999999999999995
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.|||+||||+.....-...+ -...-.|...|||||+++.. +|+..+||||||+|+|||++|.+||..
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-- 595 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-- 595 (678)
T ss_pred cCCcEEEecccceeeeeeecccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--
Confidence 56999999999997543221111 11345799999999999854 588999999999999999999999983
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
....+.+-.+..............+||+++.+|+..||..++++||.|.+|...|++++.
T Consensus 596 -~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 596 -QNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -CChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 334455544555545555556677899999999999999999999999999998888763
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=259.25 Aligned_cols=204 Identities=18% Similarity=0.281 Sum_probs=165.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
++|||++++.++.++.+.|+||||+ +++|.+++... ...+++.+++.++.||+.||+|||++||
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 155 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC 155 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3799999999999999999999999 99999999643 1358999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.+||+|||+++........ .......++..|++||++.+..++.++|+|||||++|
T Consensus 156 ~H~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 156 IHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred eeccccceeEEEc---CCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9999999999996 6788999999999865432210 0111223456899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
+|++ |..||.+... .+.+..+...... .....++.++.+++..||..+|++||++.++.+.|.++...
T Consensus 228 el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 228 EIFTLGGSPYPGIPV---EELFKLLREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 9998 8999976432 3333333332211 22356788999999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=270.39 Aligned_cols=199 Identities=15% Similarity=0.176 Sum_probs=154.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++..+.+.|+|||+++++|..++.. ...+++..++.|+.||+.||+|||++|||||||||+|||++ .
T Consensus 142 HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~ 217 (391)
T PHA03212 142 HPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---H 217 (391)
T ss_pred CCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---C
Confidence 7999999999999999999999998899988874 45799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc-
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT- 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~- 160 (414)
.+.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+
T Consensus 218 ~~~vkL~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 218 PGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred CCCEEEEeCCccccccccccc------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 788999999999754332111 1234679999999999999999999999999999999999998875432110
Q ss_pred ---hHHHHHHHHhhh--------------------------cc----chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 161 ---KKQKYEKISEKK--------------------------VS----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 161 ---~~~~~~~i~~~~--------------------------~~----~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
....+..+.... .. .........+|.++.+||..||..||.+||++.
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~ 371 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE 371 (391)
T ss_pred cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH
Confidence 001111111000 00 000001123577899999999999999999987
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 372 elL 374 (391)
T PHA03212 372 ALL 374 (391)
T ss_pred HHh
Confidence 765
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=251.97 Aligned_cols=199 Identities=18% Similarity=0.278 Sum_probs=159.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++..+.+.||||||+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~-- 128 (252)
T cd05084 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT-- 128 (252)
T ss_pred CCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc--
Confidence 3799999999999999999999999 9999999975556799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++.......... .......+..|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 129 -~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 129 -EKNVLKISDFGMSREEEDGVYAS-----TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred -CCCcEEECccccCcccccccccc-----cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 67789999999987543211100 0011233567999999998889999999999999999997 9999976433
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
......+.. .... .....+|.++.+++..|+..+|++||++.++.+.|.
T Consensus 203 ---~~~~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 203 ---QQTREAIEQ-GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---HHHHHHHHc-CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222222221 1111 223467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=255.76 Aligned_cols=202 Identities=18% Similarity=0.303 Sum_probs=163.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
++|||++++..+.+.++.|+||||+ +++|.+++.... ..++...++.++.||+.||.|||+++|+|||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dik 146 (288)
T cd05061 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLA 146 (288)
T ss_pred CCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCC
Confidence 4799999999999999999999999 999999996422 235778899999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G 149 (414)
|+|||++ .++.++|+|||+++....... ........++..|++||.+.+..++.++|+|||||++|||++ |
T Consensus 147 p~nili~---~~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~ 218 (288)
T cd05061 147 ARNCMVA---HDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 218 (288)
T ss_pred hheEEEc---CCCcEEECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence 9999996 678899999999986543221 111223356778999999998889999999999999999998 7
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..||.+... .+.+..+..... ...+..+++++.+++..|++.+|++||++.++.+.|++.+
T Consensus 219 ~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 219 EQPYQGLSN---EQVLKFVMDGGY----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCH---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 999977432 222232222211 1234467899999999999999999999999998888775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=271.36 Aligned_cols=205 Identities=21% Similarity=0.290 Sum_probs=176.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++.+.+.+. ..|||||++ -|.|..+++.....++..+...++.||+.+|.|||++.+|||||-..|||++
T Consensus 450 HphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs--- 525 (974)
T KOG4257|consen 450 HPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS--- 525 (974)
T ss_pred Ccchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---
Confidence 69999999998866 569999999 9999999998778899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
...+|||+||||++.+.+... .......-...|||||.+.-..++..+|||-|||+|||++. |..||+|.++.
T Consensus 526 Sp~CVKLaDFGLSR~~ed~~y------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 526 SPQCVKLADFGLSRYLEDDAY------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred Ccceeeecccchhhhccccch------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 788999999999998776542 22233445678999999999999999999999999999986 99999998876
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 223 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~ 223 (414)
+....+++ .... .++++||+.++.|+.+||+.+|.+||.|.+|+..|.+.++.+...
T Consensus 600 DVI~~iEn---GeRl----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 600 DVIGHIEN---GERL----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred ceEEEecC---CCCC----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 65444433 2222 245689999999999999999999999999999999999865543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=252.30 Aligned_cols=200 Identities=17% Similarity=0.332 Sum_probs=159.9
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
+|||++++..+.. ....++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||
T Consensus 59 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 138 (272)
T cd05075 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDL 138 (272)
T ss_pred CCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 6899999987643 23568999999 89999887421 345899999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR- 148 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt- 148 (414)
||+|||++ ..+.++|+|||+++.+..... +.......++..|++||.+.+..++.++|||||||++|+|++
T Consensus 139 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 139 AARNCMLN---ENMNVCVADFGLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred chhheEEc---CCCCEEECCCCcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 99999996 678899999999987644221 111223456788999999999899999999999999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
|..||.+.. ..+.+..+...... .....++..+.+++..||..+|++||++++|.+.|+++
T Consensus 211 g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 211 GQTPYPGVE---NSEIYDYLRQGNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCC---HHHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899997743 23344444332221 12346789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=263.64 Aligned_cols=195 Identities=22% Similarity=0.270 Sum_probs=154.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.++++.||||||+ |++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~--- 136 (331)
T cd05597 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD--- 136 (331)
T ss_pred CCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---
Confidence 689999999999999999999999 9999999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.++|+|||++..+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 137 KNGHIRLADFGSCLRLLADGTV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCEEEEECCceeecCCCCCc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 6788999999999876443211 1123469999999999974 3467899999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC---CCCHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYL 209 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~---RP~~~~l 209 (414)
. ...+.+..+........+......++.++.++|..|+.. +.+ |++++++
T Consensus 211 ~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~ 263 (331)
T cd05597 211 E---SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDF 263 (331)
T ss_pred C---CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHH
Confidence 4 334444554433222222222345789999999998865 344 5564444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=260.43 Aligned_cols=202 Identities=20% Similarity=0.277 Sum_probs=163.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++.++++.|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 145 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 145 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3799999999999999999999999 999999986432 258999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ ..+.++|+|||+++...... ......++..|++||.+.+..++.++|||||||++|
T Consensus 146 ~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 146 IHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred cccccchheEEec---CCCcEEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9999999999996 67889999999986322110 111223467899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
+|++ |..||.+... .+.+..+...... .....++.++.+++..||..+|++||++++++..|..++...
T Consensus 215 ellt~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 215 EIVSLGGTPYCGMTC---AELYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHhcCCCCcccCCh---HHHHHHHhcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9998 9999976543 2223332221111 122357889999999999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=257.00 Aligned_cols=205 Identities=17% Similarity=0.261 Sum_probs=159.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~----------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
+|||+++++++.++++.|+||||+ +++|.+++.... ..+++.++..++.||+.||+|||++||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 689999999999999999999999 899999987432 247788999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh--
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-- 148 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-- 148 (414)
|+|||++ ..+.++|+|||+++.+..... ........++..|++||.+.+..++.++|+|||||++|||++
T Consensus 158 p~Nili~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 158 TRNCLVG---KNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred hheEEEc---CCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 9999996 678899999999986543221 111123345678999999988889999999999999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
|..||..............................+|..+.+++..||..+|++||++.+|.+.|+
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 789997653322111111111110000111123457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=253.77 Aligned_cols=203 Identities=17% Similarity=0.232 Sum_probs=156.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
++|||++++.++.+..+.|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||+
T Consensus 53 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil 132 (269)
T cd05087 53 QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCL 132 (269)
T ss_pred CCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 4799999999999999999999999 89999998642 234677888999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-------CCCchhHHHHHHHHHHHHHh
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-------~~s~~~DvwSlGvvl~ellt 148 (414)
++ ..+.++|+|||+++....... +.......++..|+|||++.+. .++.++|+||||+++|||++
T Consensus 133 ~~---~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 133 LT---ADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred Ec---CCCcEEECCccccccccCcce-----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 96 678899999999865433221 1112335678899999998642 35789999999999999996
Q ss_pred -CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 149 -GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 149 -G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
|..||........ ....+...........+...+++.+.++++.|| .+|++||++++|...|+
T Consensus 205 ~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 205 LGSQPYRHLSDEQV--LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCCChHHH--HHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 9999976543221 111122222222222334457789999999999 68999999999987764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=252.85 Aligned_cols=200 Identities=14% Similarity=0.256 Sum_probs=164.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..++..|+||||+ +++|.+++......+++..++.++.|++.||+|||+++|+|+||||+|||++
T Consensus 64 h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~--- 140 (266)
T cd05033 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN--- 140 (266)
T ss_pred CCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---
Confidence 689999999999999999999999 9999999976666899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++.+....... ......++..|++||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~- 214 (266)
T cd05033 141 SNLVCKVSDFGLSRRLEDSEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN- 214 (266)
T ss_pred CCCCEEECccchhhcccccccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-
Confidence 67889999999998775222110 0112345678999999998889999999999999999997 9999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.+....+...... .....+|..+.+++..||+.+|++||++.++.+.|.++
T Consensus 215 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 215 --QDVIKAVEDGYRL----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2333333322111 12346789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=255.11 Aligned_cols=198 Identities=22% Similarity=0.304 Sum_probs=161.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 66 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~--------------~~ls~~~v~~ia~Qll~gL~yLH~~givH 66 (414)
+|||++++.++.+++..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|
T Consensus 66 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H 145 (280)
T cd05092 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVH 145 (280)
T ss_pred CCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 689999999999999999999999 999999987432 25899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
|||||+|||++ ..+.++|+|||++........ +.......++..|++||.+.+..++.++|||||||++|+|
T Consensus 146 ~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 146 RDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred ccccHhhEEEc---CCCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99999999996 678899999999976543221 1122334567889999999998999999999999999999
Q ss_pred Hh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 147 LR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 147 lt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
++ |.+||..... ...+..+...... .....+|..+.+++..||..+|++||++.+|.+.|+
T Consensus 218 ~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSN---TEAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCH---HHHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 9999976432 2333333322111 123468899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=268.03 Aligned_cols=194 Identities=21% Similarity=0.281 Sum_probs=154.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+.++++.|+||||+ |++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 101 ~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~-- 176 (371)
T cd05622 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-- 176 (371)
T ss_pred CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC--
Confidence 4799999999999999999999999 9999999973 4689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 177 -~~~~ikL~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 177 -KSGHLKLADFGTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred -CCCCEEEEeCCceeEcCcCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 678999999999987643221 1123467999999999997643 78899999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC---CCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~---RP~~~~l~ 210 (414)
. +....+..+........+. ....++.++.++|..|+. ++.. |+++++|+
T Consensus 250 ~---~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 250 D---SLVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred C---CHHHHHHHHHcCCCcccCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 4 3344555554432211111 113578899999999997 5555 45554443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=253.40 Aligned_cols=202 Identities=14% Similarity=0.240 Sum_probs=165.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++..+++.|+||||+ |++|.+++......+++.+++.++.|++.||+|||+++|+||||||+|||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~-- 140 (267)
T cd05066 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN-- 140 (267)
T ss_pred CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC--
Confidence 3799999999999999999999999 8999999986666799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++..+....... .......++..|++||.+.+..++.++|+|||||++|++++ |..||.+...
T Consensus 141 -~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 141 -SNLVCKVSDFGLSRVLEDDPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred -CCCeEEeCCCCccccccccccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 67889999999998765422111 01112334578999999998889999999999999999886 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.+.+..+.+.... .....+|+++.+++..||+.+|++||++.++.+.|.++
T Consensus 216 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 216 ---QDVIKAIEEGYRL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---HHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2233333322111 12345789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=249.60 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=165.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~--------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
++|||++++.++.++...++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++|+|+||||
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p 133 (262)
T cd00192 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA 133 (262)
T ss_pred CCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCc
Confidence 3689999999999999999999999 99999999865 47899999999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CC
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GS 150 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~ 150 (414)
+||+++ .++.++|+|||.+........ +.......++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 134 ~nili~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 205 (262)
T cd00192 134 RNCLVG---EDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA 205 (262)
T ss_pred ceEEEC---CCCcEEEcccccccccccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCC
Confidence 999996 668999999999987654321 122344578899999999998889999999999999999998 69
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
.||..... .+....+..... ......+|.++.+++..||..+|++||++.++.+.|
T Consensus 206 ~p~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 206 TPYPGLSN---EEVLEYLRKGYR----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCH---HHHHHHHHcCCC----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 99987632 333333333211 123346789999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=269.33 Aligned_cols=195 Identities=21% Similarity=0.264 Sum_probs=154.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.++++.||||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 101 ~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~-- 176 (370)
T cd05621 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD-- 176 (370)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC--
Confidence 4799999999999999999999999 9999999973 4689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.+||+|||+++....... .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+
T Consensus 177 -~~~~~kL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 177 -KHGHLKLADFGTCMKMDETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred -CCCCEEEEecccceecccCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 678999999999987643221 1123567999999999998643 77899999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~--RP~~~~l~ 210 (414)
. +....+..+........++. ...++..+.+++..|+..++.+ |+++++++
T Consensus 250 ~---~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 250 D---SLVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred C---CHHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 4 33445555544322111111 1245788999999999754432 67766554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=272.57 Aligned_cols=191 Identities=19% Similarity=0.300 Sum_probs=162.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||.++|..+..+...|++|||| ||++.++++. +..+.+..+..++.+++.||.|||.++.+|||||+.|||+.
T Consensus 70 ~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s--- 145 (467)
T KOG0201|consen 70 SPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS--- 145 (467)
T ss_pred cchHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---
Confidence 478999999999999999999999 9999999984 55669999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.|||+|||.+-...+... ...+++||+-|||||++++..|+.++||||||++.+||.+|.+||..+.+..
T Consensus 146 ~~g~vkl~DfgVa~ql~~~~~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 146 ESGDVKLADFGVAGQLTNTVK-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred ccCcEEEEecceeeeeechhh-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 568999999999988766442 1267999999999999999999999999999999999999999998876532
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+ .+ ...+.+-..+.+.|++||..|++++|+.||++.+|+
T Consensus 219 vlflI---pk----~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 219 VLFLI---PK----SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred EEEec---cC----CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 11111 11 112233457888999999999999999999987664
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=252.39 Aligned_cols=201 Identities=16% Similarity=0.348 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCE------EEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 015018 1 MAAGIPNLRWFGVEGDY------NVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 68 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~------~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRD 68 (414)
.+|||++++.++...+. .++||||+ +++|..++... ...+++..++.++.||+.||+|||+++|+|||
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~d 138 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRD 138 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 37899999988766554 79999999 99999888532 23689999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt 148 (414)
|||+||+++ ..+.+||+|||+++....... +.......++..|++||.+.+..++.++|||||||++|||++
T Consensus 139 lkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 139 LAARNCMLR---EDMTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred cchheEEEC---CCCeEEECCccceeecccccc-----ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence 999999996 678999999999987654322 111222345778999999988889999999999999999998
Q ss_pred -CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 149 -GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 149 -G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
|..||.+... .+.++.+...... ..+..++.++.+++..||..+|++||++.++.+.|+++
T Consensus 211 ~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 211 RGQTPYPGVEN---HEIYDYLRHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCCH---HHHHHHHHcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999977432 2333333332211 23456889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=253.63 Aligned_cols=199 Identities=20% Similarity=0.284 Sum_probs=160.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++......|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i 133 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 133 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3799999999999999999999999 999999986421 248899999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ ..+.++|+|||++....... .......+..|++||++.+..++.++|+|||||++|
T Consensus 134 ~H~dikp~nili~---~~~~~kl~dfgl~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 134 IHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred eecccccceEEEc---CCCeEEECCCCCccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9999999999996 67889999999985322110 111223466799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
+|++ |..||.+... ...+..+...... .....++.++.+++..||..+|.+||+++++...|+.++
T Consensus 203 el~~~g~~pf~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 203 EIVSLGGTPYCGMTC---AELYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHcCCCCCccccCH---HHHHHHHhCCCCC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9996 9999976432 2233333222111 123457789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=249.89 Aligned_cols=200 Identities=19% Similarity=0.330 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++. +++.|+||||+ +++|.+++... ...+++..++.++.|++.+|+|||+.+|+||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~- 136 (262)
T cd05071 59 RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG- 136 (262)
T ss_pred CCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc-
Confidence 3689999998774 45679999999 88999999743 34689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.++|+|||+++.+..... .......++..|++||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 137 --~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 137 --ENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred --CCCcEEeccCCceeecccccc------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 678899999999986644221 11123456778999999998889999999999999999999 899997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..+.+..+...... .....+|..+.+++..|++.+|++||++.++.+.|++++
T Consensus 209 ---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 209 ---NREVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ---hHHHHHHHhcCCCC----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 23333333222111 123467899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=266.13 Aligned_cols=191 Identities=20% Similarity=0.270 Sum_probs=150.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ +++|.+. ..+.+..+..++.||+.||+|||++||+||||||+|||++
T Consensus 131 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--- 202 (353)
T PLN00034 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN--- 202 (353)
T ss_pred CCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---
Confidence 689999999999999999999999 8888643 2456788899999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.+||+|||+++.+..... ......||..|++||++.. ...+.++|||||||++|||++|+.||..
T Consensus 203 ~~~~~kL~DfG~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQTMD-------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred CCCCEEEcccccceecccccc-------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 678899999999987643221 1234579999999998743 2345689999999999999999999974
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....+.......+.... .......++.++.+||..||..+|++||++.+|++
T Consensus 276 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 276 GRQGDWASLMCAICMSQ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCccHHHHHHHHhccC----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 33332222222222111 11233467899999999999999999999877753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=256.75 Aligned_cols=202 Identities=18% Similarity=0.283 Sum_probs=160.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~----------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
+|||++++.++..+++.++|||++ +++|.+++.... ..+++..++.++.|++.||+|||++||+|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 689999999999999999999999 899999987543 269999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh--
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-- 148 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-- 148 (414)
|+||+++ ..+.++|+|||+++........ .......++..|++||.+.+..++.++|||||||++|+|++
T Consensus 158 p~Nili~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 158 TRNCLVG---KNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred hhceeec---CCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 9999996 6689999999999865432211 11223456789999999998889999999999999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHhhh---ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKK---VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~---~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
+..||..... .+.+..+.... ...........+|.++.+++..||+.+|++||++.+|.+.|+
T Consensus 230 ~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 230 REQPYEHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7888876432 22223222210 000011123456789999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=253.49 Aligned_cols=201 Identities=17% Similarity=0.234 Sum_probs=161.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++... ..+++|||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 67 ~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~-- 143 (279)
T cd05109 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK-- 143 (279)
T ss_pred CCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc--
Confidence 368999999988754 568999999 9999999976566799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.+||+|||+++.+........ .....++..|++||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 144 -~~~~~kL~dfG~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 144 -SPNHVKITDFGLARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred -CCCcEEECCCCceeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 667899999999987654322110 112345678999999998889999999999999999998 9999976433
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
......+...... .....++.++.+++..||..||++||++.++.+.|+++.
T Consensus 218 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 218 ---REIPDLLEKGERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---HHHHHHHHCCCcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2222222221111 123457889999999999999999999999998887774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=262.10 Aligned_cols=203 Identities=20% Similarity=0.302 Sum_probs=161.3
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHcC------------------------------------------
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFCS------------------------------------------ 37 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------ 37 (414)
+|||+++++++.. +...++||||+ +++|.+++....
T Consensus 70 h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (337)
T cd05054 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIE 149 (337)
T ss_pred CcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccccc
Confidence 5899999987764 56788999999 999999985321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccC
Q 015018 38 ------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99 (414)
Q Consensus 38 ------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 99 (414)
..+++..+..++.||+.||+|||++||+||||||+|||++ ..+.++|+|||+++.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 150 DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKD 226 (337)
T ss_pred CcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccC
Confidence 2689999999999999999999999999999999999996 6788999999999865332
Q ss_pred CCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHH
Q 015018 100 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 178 (414)
Q Consensus 100 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 178 (414)
.. ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+...... ....+......
T Consensus 227 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~~~---- 295 (337)
T cd05054 227 PD-----YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGTRM---- 295 (337)
T ss_pred cc-----hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccCCC----
Confidence 11 111233566788999999999999999999999999999997 9999977432211 11111111111
Q ss_pred HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 179 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 179 ~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.....+++++.+++..||+.+|++||++.+|.+.|++++.
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1234567899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=257.53 Aligned_cols=202 Identities=21% Similarity=0.286 Sum_probs=163.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||++++.++...+..|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+|+||||+|||++
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~- 175 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT- 175 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc-
Confidence 3799999999999999999999999 899999997432 3489999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
..+.++|+|||+++.+..... +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 176 --~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 176 --HGKIVKICDFGLARDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred --CCCeEEECCCcccccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 677899999999986543221 111223456788999999998889999999999999999998 999998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.. ..+.+........ ......++++.+++..|+..+|++||++.++.+.|+++
T Consensus 249 ~~---~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 249 VD---SKFYKLIKEGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ch---HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 32 1222222111111 12235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=254.02 Aligned_cols=193 Identities=17% Similarity=0.171 Sum_probs=153.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++......+|||||+ +++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++..
T Consensus 62 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 141 (262)
T cd05077 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE 141 (262)
T ss_pred CCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecC
Confidence 3799999999999999999999999 889988887656679999999999999999999999999999999999999732
Q ss_pred CC----CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHH-hCCCCC
Q 015018 80 RR----ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPW 153 (414)
Q Consensus 80 ~~----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~ell-tG~~Pf 153 (414)
.. ...++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||
T Consensus 142 ~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 142 GIDGECGPFIKLSDPGIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred CccCCCCceeEeCCCCCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 11 124899999998654321 2346788999999887 566889999999999999998 589998
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
........ ......... +....+.++.++|..||+.||++||++.+|.+.|
T Consensus 211 ~~~~~~~~----~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 211 KDKTLAEK----ERFYEGQCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCcchhHH----HHHHhcCcc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 76432211 111111111 1223457899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=260.55 Aligned_cols=200 Identities=19% Similarity=0.248 Sum_probs=161.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++..+ ..++|+||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~--- 143 (316)
T cd05108 68 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK--- 143 (316)
T ss_pred CCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---
Confidence 69999999988875 467899999 9999999986666799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+....... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 144 TPQHVKITDFGLAKLLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred CCCcEEEccccccccccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 67889999999998765432211 1122345678999999999999999999999999999997 99999875322
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
+ +..+....... .....++.++.+++..||..+|++||++.++...|..+.
T Consensus 219 ---~-~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 219 ---E-ISSILEKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---H-HHHHHhCCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2 22222222111 112457789999999999999999999999999888775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=256.74 Aligned_cols=202 Identities=20% Similarity=0.296 Sum_probs=164.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||++++.++..+...|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 153 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC 153 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3799999999999999999999999 99999998632 3569999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.++|+|||+++.+..... +.......++..|++||++.+..++.++|||||||++|
T Consensus 154 vH~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 154 IHRDLAARNVLVT---EDHVMKIADFGLARDIHHIDY-----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred cccccceeeEEEc---CCCeEEeCccccccccccccc-----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9999999999996 678999999999987654321 11112234567899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
++++ |..||.+... .+.+..+...... .....++.++.+++..||..+|++||++.++.+.|++++
T Consensus 226 el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 226 EIFTLGGSPYPGIPV---EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHhcCCCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9997 9999976432 2233332222211 123456789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=254.52 Aligned_cols=198 Identities=18% Similarity=0.214 Sum_probs=156.1
Q ss_pred CCCCcEEEEeeEe-----CCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVE-----GDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~-----~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.. +...++|||++.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 61 h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nil 140 (288)
T cd07863 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140 (288)
T ss_pred CCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 6999999988764 35689999999779999887543 45999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.++|+|||+++.+..... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 141 i~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 141 VT---SGGQVKLADFGLARIYSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred EC---CCCCEEECccCccccccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 96 678899999999986543221 1235789999999999998999999999999999999999999976
Q ss_pred CCccchHHHHHHHHhh-------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEK-------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~-------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.........+...... ........+...++.++.+++..|+..||++||++.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 210 NSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 4332222221111100 001112234456788999999999999999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=248.32 Aligned_cols=193 Identities=23% Similarity=0.290 Sum_probs=161.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+.++++.|+||||+ |++|.+++... ...++...+..++.||+.+|.|||++||+|+||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~-- 135 (256)
T cd08529 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD-- 135 (256)
T ss_pred CCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe--
Confidence 689999999999999999999999 99999999754 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||+++.+..... ......|+..|++||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 136 -~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 205 (256)
T cd08529 136 -AYDNVKIGDLGVAKLLSDNTN-------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-- 205 (256)
T ss_pred -CCCCEEEcccccceeccCccc-------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--
Confidence 678899999999987654321 1234578899999999999889999999999999999999999997653
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.......+...... .+...++.++.+++..||+.+|++||++.++.+
T Consensus 206 -~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 206 -QGALILKIIRGVFP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -HHHHHHHHHcCCCC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 23333333332222 223367899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=268.79 Aligned_cols=202 Identities=21% Similarity=0.225 Sum_probs=154.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||.+||+||||||+||||+
T Consensus 59 ~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~-- 135 (381)
T cd05626 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID-- 135 (381)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC--
Confidence 4799999999999999999999999 9999999874 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCccc------c----------------------------------cccccCCCCCCccc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQH------I----------------------------------PYRENKNLTGTARY 119 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~------~----------------------------------~~~~~~~~~Gt~~Y 119 (414)
..+.++|+|||+++.+........ + .........||..|
T Consensus 136 -~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 136 -LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred -CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 678999999999864321100000 0 00001245799999
Q ss_pred cchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHH--c
Q 015018 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--S 197 (414)
Q Consensus 120 ~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~--~ 197 (414)
+|||++.+..++.++|||||||++|||++|..||..... .+...++........++ ....+++++.++|..++ .
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCc
Confidence 999999998899999999999999999999999977432 22222222211111111 11246789999999844 5
Q ss_pred CCCCCCCCHHHHH
Q 015018 198 LRFDDKPDYAYLK 210 (414)
Q Consensus 198 ~dp~~RP~~~~l~ 210 (414)
.++..|+++++|+
T Consensus 291 ~~~~~R~~~~~~l 303 (381)
T cd05626 291 EERLGRNGADDIK 303 (381)
T ss_pred ccccCCCCHHHHh
Confidence 5555699987775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=269.94 Aligned_cols=217 Identities=18% Similarity=0.253 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 60 ~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~--- 135 (360)
T cd05627 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD--- 135 (360)
T ss_pred CCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---
Confidence 689999999999999999999999 9999999874 56799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCccc----------------------------ccccccCCCCCCccccchhhhcCCCCCc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQH----------------------------IPYRENKNLTGTARYASMNTHLGIEQSR 132 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~----------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ 132 (414)
..+.++|+|||+++.+........ ..........||+.|+|||++.+..++.
T Consensus 136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 678999999999875432110000 0000112457999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 133 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 133 ~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
++|||||||++|||++|..||.+.. ....+.++........++. ...+++++.++|..++ .+|.+|++...+.++
T Consensus 216 ~~DiwSlGvilyel~tG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 216 LCDWWSLGVIMYEMLIGYPPFCSET---PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred cceeccccceeeecccCCCCCCCCC---HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 9999999999999999999998743 3344444443221111111 1135788999998876 499999974434444
Q ss_pred HHHHHHHhCCCCCCcccccccc
Q 015018 213 FRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 213 l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+.+ .+...++|....
T Consensus 291 ~~h-------p~f~~~~~~~~~ 305 (360)
T cd05627 291 KSH-------PFFEGVDWGHIR 305 (360)
T ss_pred hcC-------CCCCCCCHHHHh
Confidence 332 344557887754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=289.99 Aligned_cols=209 Identities=24% Similarity=0.324 Sum_probs=174.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
++.|+++++.|++++|.||||||+ ||+|..++.... +++++-+..|+..|+.||.-||+.|+|||||||+||||+
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld--- 209 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD--- 209 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---
Confidence 467999999999999999999999 999999998766 899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc----C-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~-~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..|+|||+|||.+-++....+ . .....+|||.|++||++. + ..|++.+|+||+||++|||++|..||..
T Consensus 210 ~~GHikLADFGsClkm~~dG~-V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 210 KSGHIKLADFGSCLKMDADGT-V-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ccCcEeeccchhHHhcCCCCc-E-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 899999999999987764332 1 124579999999999986 3 5689999999999999999999999965
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC---HHHHHHHHHHHHHHhCCCCCCcccccc
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRLFRDLFIREGFQFDYVFDWTI 232 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~---~~~l~~~l~~~~~~~~~~~d~~~~w~~ 232 (414)
....+.|-+|..-+-...++... .++++..+||...+. +++.|.. +++|+ ...|....+|+.
T Consensus 284 ---dslveTY~KIm~hk~~l~FP~~~-~VSeeakdLI~~ll~-~~e~RLgrngiedik----------~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 284 ---DSLVETYGKIMNHKESLSFPDET-DVSEEAKDLIEALLC-DREVRLGRNGIEDIK----------NHPFFEGIDWDN 348 (1317)
T ss_pred ---HHHHHHHHHHhchhhhcCCCccc-ccCHHHHHHHHHHhc-ChhhhcccccHHHHH----------hCccccCCChhh
Confidence 56677888888764444333222 378999999998875 6788887 66554 235566779977
Q ss_pred ccc
Q 015018 233 LKY 235 (414)
Q Consensus 233 ~~~ 235 (414)
++.
T Consensus 349 iR~ 351 (1317)
T KOG0612|consen 349 IRE 351 (1317)
T ss_pred hhh
Confidence 653
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=251.36 Aligned_cols=201 Identities=13% Similarity=0.216 Sum_probs=163.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.++.|+||||+ +++|.+++......+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~--- 141 (268)
T cd05063 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN--- 141 (268)
T ss_pred CCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---
Confidence 689999999999999999999999 8899999976567899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||++........... .......+..|++||++.+..++.++|||||||++|++++ |..||.....
T Consensus 142 ~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~- 216 (268)
T cd05063 142 SNLECKVSDFGLSRVLEDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN- 216 (268)
T ss_pred CCCcEEECCCccceecccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-
Confidence 678899999999976643221110 0111233567999999998889999999999999999997 9999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
......+...... .....+|.++.+++..||..+|++||++.++.+.|+++
T Consensus 217 --~~~~~~i~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 --HEVMKAINDGFRL----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2333333322111 11235789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=251.19 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=163.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||+++++++.+.++.++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+++|+|+||||+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred CCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 3699999999999999999999999 8899998853 23458999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ ..+.++|+|||++..+..... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 140 ~---~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 140 T---ATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred c---CCCCEEECccccceeccchhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 6 677899999999987654221 112357889999999999888999999999999999999999999654
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.. ........+....... .....++..+.+++..||..+|++||++.++++.|+.+
T Consensus 210 ~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 210 KM-NLFSLCQKIEQCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cc-cHHHHHHHHhcCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 32 2222223322212111 11235678899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=269.33 Aligned_cols=205 Identities=20% Similarity=0.346 Sum_probs=174.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+||+++|...|..+..+|||.||| .|+|.+++..|++. ++.-.++.++-||..|++||..++||||||-..|+|++
T Consensus 322 HpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-- 399 (1157)
T KOG4278|consen 322 HPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-- 399 (1157)
T ss_pred CccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc--
Confidence 689999999999999999999999 99999999998765 77778889999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.+..|||+||||++.+.... |.......-...|.|||.+....++.++|||+|||+|||+.| |.-||.|.+-
T Consensus 400 -EnhiVKvADFGLsRlMtgDT------YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 400 -ENHIVKVADFGLSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred -ccceEEeeccchhhhhcCCc------eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 78899999999999766543 223334455788999999999999999999999999999987 9999999644
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 222 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~ 222 (414)
.+.|.-+..... ..-+.+||+.+++||..||++.|.+||.|.+|.+.|+.+|....+
T Consensus 473 ---SqVY~LLEkgyR----M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 473 ---SQVYGLLEKGYR----MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred ---HHHHHHHhcccc----ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 444443332222 223569999999999999999999999999999999999865543
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=253.58 Aligned_cols=199 Identities=18% Similarity=0.291 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
++|||++++.++..+.+.|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+|+|||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~ 146 (277)
T cd05032 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLA 146 (277)
T ss_pred CCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 4689999999999999999999999 899999986421 247888999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G 149 (414)
|+|||++ ..+.++|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|++++ |
T Consensus 147 p~nill~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 147 ARNCMVA---EDLTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred hheEEEc---CCCCEEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccC
Confidence 9999996 678899999999976544321 112234567889999999988889999999999999999998 9
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
..||.+.. ..+....+..... ..+...++.++.+++..||..+|++||++.+|...|+
T Consensus 219 ~~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 219 EQPYQGLS---NEEVLKFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCccCC---HHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99997643 2333333332211 1234567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=248.25 Aligned_cols=195 Identities=19% Similarity=0.283 Sum_probs=158.5
Q ss_pred CCCCCcEEEEeeE-eCCEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~-~~~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
.+|||+++++++. ++...|+||||+ +++|.+++..... .+++..++.++.||+.+|+|||++||+||||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 3689999998654 556789999999 8999999875433 489999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 156 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~ 156 (414)
.++.+||+|||+++...... ....++..|++||++.+..++.++|||||||++|+|++ |+.||...
T Consensus 137 ---~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 137 ---EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---CCCcEEecCCccceeccccC----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 67899999999987654322 12345678999999998889999999999999999997 99999763
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
. ..+....+..... ..+...+|.++.+++.+||..+|++||++.++.+.|++
T Consensus 204 ~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 204 P---LKDVVPRVEKGYK----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C---HHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2 2333333322211 12345688999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=265.84 Aligned_cols=197 Identities=22% Similarity=0.271 Sum_probs=170.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|+|||++++..+++.++.++|||+| |+.|.+.+... .+++..+..++.|++.+++|||+.|||||||||+|||+...
T Consensus 94 ~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~ 171 (382)
T KOG0032|consen 94 GHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASK 171 (382)
T ss_pred CCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccc
Confidence 5899999999999999999999999 99999998754 49999999999999999999999999999999999999754
Q ss_pred CC-CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RR-ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.. .+.++++|||++..+.... .....+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.
T Consensus 172 ~~~~~~ik~~DFGla~~~~~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-- 241 (382)
T KOG0032|consen 172 DEGSGRIKLIDFGLAKFIKPGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE-- 241 (382)
T ss_pred cCCCCcEEEeeCCCceEccCCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC--
Confidence 33 4589999999999876622 124579999999999999999999999999999999999999999884
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+....+..|........ ...+..++....+++..++..||..|+++.++++
T Consensus 242 -~~~~~~~~i~~~~~~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 242 -TEFEIFLAILRGDFDFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -ChhHHHHHHHcCCCCCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 44455556666665332 2345677899999999999999999999887765
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=255.15 Aligned_cols=206 Identities=17% Similarity=0.270 Sum_probs=159.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRD 68 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-----------~~ls~~~v~~ia~Qll~gL~yLH~~givHRD 68 (414)
.+|||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++|||
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 154 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD 154 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 3689999999999999999999999 999999986421 1378899999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt 148 (414)
|||+||+++ .++.+||+|||++........ +.......++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 155 lkp~Nill~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 155 LATRNCLVG---NHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred cChhhEEEc---CCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 999999996 667899999999976543221 111223456788999999998889999999999999999987
Q ss_pred --CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 149 --GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 149 --G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
+..||.........+....................+|+.+.+++..||..+|++||+++++.+.|+
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 678887654322211111111111111111123457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=249.56 Aligned_cols=198 Identities=18% Similarity=0.244 Sum_probs=160.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.+++..|++|||+ +++|.+++......+++.++..++.|++.+|+|||+++|+|+||||+||+++
T Consensus 58 ~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~-- 135 (262)
T cd06613 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT-- 135 (262)
T ss_pred CCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC--
Confidence 3699999999999999999999999 8899999876557899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..+.++|+|||++........ ......++..|++||.+.+. .++.++|+|||||++|+|++|..||.+.
T Consensus 136 -~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 136 -EDGDVKLADFGVSAQLTATIA-------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -CCCCEEECccccchhhhhhhh-------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 678899999999876543211 12345789999999999877 7889999999999999999999999775
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.. .+....+...............++.++.++++.||..+|.+||++.+++.
T Consensus 208 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 208 HP---MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CH---HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 42 22222222221111111123346788999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=252.99 Aligned_cols=200 Identities=15% Similarity=0.131 Sum_probs=165.0
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
|+||||.+++.+.+ -....||||.| ||.|.+-|... .+.|++.++..|+.||..|+.|||+.+|.||||||+|+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 79999999988765 45778999999 99999999754 45699999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|......+..+||+|||+|+....... ..+-+-|+-|.|||++..+.|+..+|+||+||+||-|++|.+||.
T Consensus 193 Lyt~t~~na~lKLtDfGFAK~t~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 193 LYTTTSPNAPLKLTDFGFAKETQEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred eeecCCCCcceEecccccccccCCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 998777788999999999987654222 234578999999999999999999999999999999999999997
Q ss_pred CCCcc-chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 155 GLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 155 ~~~~~-~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
..... ....+-.+|.......+-+ .+..++++..++|+.++..+|.+|.+.+++
T Consensus 265 S~hg~aispgMk~rI~~gqy~FP~p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 265 SNHGLAISPGMKRRIRTGQYEFPEP-EWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred ccCCccCChhHHhHhhccCccCCCh-hHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 54321 1233344555555544333 345678899999999999999999996555
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=253.20 Aligned_cols=204 Identities=21% Similarity=0.293 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.. ....|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~- 141 (283)
T cd05080 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD- 141 (283)
T ss_pred CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc-
Confidence 6899999988765 44789999999 9999999974 4699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++.+...... +.......++..|++||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 142 --~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 142 --NDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred --CCCcEEEeecccccccCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 6788999999999876542211 1111223566779999999988899999999999999999999999965432
Q ss_pred cchH-----------HHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKK-----------QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~-----------~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.... ..+......... ......+|.++.+++..||..+|++||+++++.+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1000 000000000000 0113457899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=248.36 Aligned_cols=203 Identities=15% Similarity=0.263 Sum_probs=160.3
Q ss_pred CCCCcEEEEeeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++. .++..++||||+ +++|.+++......+++..++.++.||+.||+|||+.+|+||||||+|||++
T Consensus 55 h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~-- 132 (262)
T cd05058 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD-- 132 (262)
T ss_pred CCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc--
Confidence 689999998765 466789999999 9999999976556688889999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.+||+|||+++........ .........++..|+|||.+.+..++.++|||||||++|||++ |.+||....
T Consensus 133 -~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~- 207 (262)
T cd05058 133 -ESFTVKVADFGLARDIYDKEYY---SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD- 207 (262)
T ss_pred -CCCcEEECCccccccccCCcce---eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 6788999999999765432110 0111123456788999999998889999999999999999999 566776532
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..+....+...... .....+|..+.+++..||..+|++||++.++.+.|++++
T Consensus 208 --~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 208 --SFDITVYLLQGRRL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --HHHHHHHHhcCCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 22222222221111 112346889999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=268.18 Aligned_cols=196 Identities=22% Similarity=0.249 Sum_probs=151.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.++++.||||||| |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~-- 135 (382)
T cd05625 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID-- 135 (382)
T ss_pred CCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 3689999999999999999999999 9999999875 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCccc----------------------------------------ccccccCCCCCCccc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQH----------------------------------------IPYRENKNLTGTARY 119 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~----------------------------------------~~~~~~~~~~Gt~~Y 119 (414)
.++.+||+|||++..+........ ..........||+.|
T Consensus 136 -~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 136 -RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred -CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 678999999999864321100000 000001235799999
Q ss_pred cchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 120 ~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
+|||++.+..++.++|||||||++|||++|+.||.+.. ..+...++.........+ ....+++++.++|..++ .+
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~ 289 (382)
T cd05625 215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT---PLETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RG 289 (382)
T ss_pred CCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCC---HHHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cC
Confidence 99999999999999999999999999999999998743 233333333221111111 11346788999998876 59
Q ss_pred CCCCCC
Q 015018 200 FDDKPD 205 (414)
Q Consensus 200 p~~RP~ 205 (414)
|.+|++
T Consensus 290 p~~R~~ 295 (382)
T cd05625 290 PEDRLG 295 (382)
T ss_pred HhHcCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=247.02 Aligned_cols=197 Identities=18% Similarity=0.285 Sum_probs=160.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++...+..|+||||+ +++|.+++......+++..++.++.|++.+|.|||++|++|+||||+||+++
T Consensus 51 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~--- 127 (250)
T cd05085 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG--- 127 (250)
T ss_pred CCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---
Confidence 689999999999999999999999 9999999875556789999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ .......++..|++||++.+..++.++|+||||+++|++++ |..||.+...
T Consensus 128 ~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~- 200 (250)
T cd05085 128 ENNVLKISDFGMSRQEDDGIY------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN- 200 (250)
T ss_pred CCCeEEECCCccceecccccc------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-
Confidence 678899999999875433211 11122344678999999998889999999999999999998 9999977532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
......+...... .....++.++.+++..|+..+|++||++.++.+.|.
T Consensus 201 --~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 201 --QQAREQVEKGYRM----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2222222222111 223467899999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=268.74 Aligned_cols=201 Identities=21% Similarity=0.246 Sum_probs=154.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-- 135 (376)
T cd05598 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID-- 135 (376)
T ss_pred CCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC--
Confidence 3689999999999999999999999 9999999975 45789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCccc------------------------------------ccccccCCCCCCccccchh
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQH------------------------------------IPYRENKNLTGTARYASMN 123 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~------------------------------------~~~~~~~~~~Gt~~Y~aPE 123 (414)
..+.++|+|||+|..+........ ..........||+.|+|||
T Consensus 136 -~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 214 (376)
T cd05598 136 -RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE 214 (376)
T ss_pred -CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence 678999999999854321000000 0000112357999999999
Q ss_pred hhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCC
Q 015018 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 203 (414)
Q Consensus 124 ~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~R 203 (414)
++.+..++.++|||||||++|+|++|+.||.+... .+.+..+........+ .....+++++.++|..|+ .+|.+|
T Consensus 215 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP---AETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred HHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH---HHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999999999999999999999987543 2222222221111111 112357789999999976 599999
Q ss_pred C---CHHHHH
Q 015018 204 P---DYAYLK 210 (414)
Q Consensus 204 P---~~~~l~ 210 (414)
+ ++.+++
T Consensus 290 ~~~~t~~ell 299 (376)
T cd05598 290 LGKNGADEIK 299 (376)
T ss_pred CCCCCHHHHh
Confidence 9 555553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=247.15 Aligned_cols=199 Identities=22% Similarity=0.286 Sum_probs=161.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++. ++..++||||+ +++|.+++.. ...+++..++.++.||+.+|+|||.++|+|+||||+|||++
T Consensus 55 h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~--- 129 (257)
T cd05060 55 HPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV--- 129 (257)
T ss_pred CCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---
Confidence 689999998776 55679999999 8999999975 34799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++........ +.......++..|++||.+.+..++.++|+|||||++|++++ |..||.....
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~- 204 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDY----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG- 204 (257)
T ss_pred CCCcEEeccccccceeecCCcc----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 6788999999999866442211 111122345678999999998889999999999999999997 9999976532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.+....+...... .....++..+.+++..||..+|++||++.+|.+.|++.
T Consensus 205 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 205 --AEVIAMLESGERL----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2333333322211 22356789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=250.63 Aligned_cols=203 Identities=22% Similarity=0.300 Sum_probs=164.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
++|||++++.++.++++.++||||+ |++|.+++... ...+++..+..++.||+.+|+|||++||+|+||||+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred cCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4689999999999999999999999 89999988642 4568999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ .++.++|+|||++..+..... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 140 ~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 140 T---ATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred c---CCCCEEECcchhhhccccCCc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 6 677899999999876543221 112357899999999999888999999999999999999999999764
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.. ........+....... .....++.++.+++..||..+|++||++.++.+.++++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 210 KM-NLYSLCKKIEQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cc-hHHHHhhhhhcCCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 32 1122222222211111 112347789999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=255.14 Aligned_cols=199 Identities=19% Similarity=0.199 Sum_probs=160.9
Q ss_pred CCCCcEEEEeeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVE-----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
++||+.+++.+.. -+-.|+|+|+|+.+|..+++. ++.++.+.+..+.+||++||.|+|+.+|+||||||.|+|+
T Consensus 80 HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 80 HENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL 158 (359)
T ss_pred CCCcceEEeecccccccccceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee
Confidence 6899999887765 446799999999999999983 5569999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
. .+..+||||||+|+........ ...+.++-|.+|.|||++. ..+|+...||||+||||.||++|+..|.|
T Consensus 159 n---~~c~lKI~DFGLAR~~~~~~~~-----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 159 N---ADCDLKICDFGLARYLDKFFED-----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred c---cCCCEEeccccceeeccccCcc-----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 6 7788999999999987543111 1225678999999999876 46799999999999999999999999998
Q ss_pred CCccchHHHHH------------HHHhh-----------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 156 LKAGTKKQKYE------------KISEK-----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 156 ~~~~~~~~~~~------------~i~~~-----------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
.+.....+.+. .+... ........+.++..++..+|+++|+..||.+|+++++.
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA 307 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA 307 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence 65443333322 22211 11223345566778999999999999999999997655
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=260.55 Aligned_cols=198 Identities=20% Similarity=0.274 Sum_probs=160.3
Q ss_pred CCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||+++.++|... -|..+||||+..+|..+++.. +++++...+.-++.||++||.|||+.||+||||||+|
T Consensus 76 HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqN 155 (364)
T KOG0658|consen 76 HPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQN 155 (364)
T ss_pred CcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChhe
Confidence 69999998887742 266799999999999999843 6789999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~P 152 (414)
+|++ ...+.+||||||.|+.+.... ++..+..|.-|.|||.+.|. +|+.+.||||.||||.||+.|++-
T Consensus 156 lLvD--~~tg~LKicDFGSAK~L~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 156 LLVD--PDTGVLKICDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred EEEc--CCCCeEEeccCCcceeeccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc
Confidence 9997 456999999999999876543 23567899999999999985 589999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchH---------------------HHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSI---------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~---------------------~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
|.|....+....+-++.-..-...+ ..+....+++..+|+..++..+|.+|.+..++
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 9996544443333332211111000 11335578999999999999999999986555
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=251.50 Aligned_cols=203 Identities=13% Similarity=0.249 Sum_probs=162.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++...++||||+ +++|.+++......+++.+++.++.|++.||+|||++||+|+||||+||+++
T Consensus 64 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~--- 140 (269)
T cd05065 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN--- 140 (269)
T ss_pred CcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---
Confidence 699999999999999999999999 8899999986667799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||++.......... .+........+..|++||.+.+..++.++|||||||++||+++ |..||.....
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~- 217 (269)
T cd05065 141 SNLVCKVSDFGLSRFLEDDTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN- 217 (269)
T ss_pred CCCcEEECCCccccccccCcccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-
Confidence 67889999999987654322110 0111111123467999999998899999999999999999886 9999976533
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
......+.... .. .....+|.++.+++..||..+|++||++.++...|+.+
T Consensus 218 --~~~~~~i~~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 218 --QDVINAIEQDY-RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HHHHHHHHcCC-cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22333332211 11 11246789999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=248.31 Aligned_cols=197 Identities=18% Similarity=0.309 Sum_probs=163.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.++++.|+||||+ +++|.+++... +..+++..+..++.||+.||+|||++||+|+||||+||+++
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~-- 138 (261)
T cd05148 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG-- 138 (261)
T ss_pred CcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc--
Confidence 689999999999999999999999 89999999743 45699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++ |+.||.+..
T Consensus 139 -~~~~~kl~d~g~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~- 209 (261)
T cd05148 139 -EDLVCKVADFGLARLIKEDVY-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN- 209 (261)
T ss_pred -CCceEEEccccchhhcCCccc-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-
Confidence 678899999999976543221 1123456778999999998889999999999999999998 899997753
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
..+.+..+...... .....+++++.+++..||..+|++||++.+|.+.|+.
T Consensus 210 --~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 210 --NHEVYDQITAGYRM----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --HHHHHHHHHhCCcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 33344443322111 1235678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=248.69 Aligned_cols=202 Identities=18% Similarity=0.300 Sum_probs=160.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
.+|||++++.++...++.++||||+ |++|.+++... ...+++..++.++.||+.+|+|||+++++|+||||+|
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (269)
T cd05044 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136 (269)
T ss_pred CCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence 3699999999999999999999999 99999998642 2348899999999999999999999999999999999
Q ss_pred EEEeecC--CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CC
Q 015018 74 FLMGLGR--RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GS 150 (414)
Q Consensus 74 ILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~ 150 (414)
|+++.+. ....++|+|||+++....... ........++..|++||.+.+..++.++|||||||++|+|++ |.
T Consensus 137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred EEEecCCCCCCcceEECCcccccccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCC
Confidence 9997322 123899999999976543221 111223456788999999998889999999999999999998 99
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
.||..... .+....+...... .....+|.++.+++..||..+|++||+++++.+.|.
T Consensus 212 ~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 212 QPYPALNN---QEVLQHVTAGGRL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCcccCH---HHHHHHHhcCCcc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99976432 2233333221111 123457899999999999999999999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=269.76 Aligned_cols=215 Identities=20% Similarity=0.286 Sum_probs=177.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|.|+++|-.|.+..|.||+||-| ||.|+.++.. .+.|+..++..|+.-+++|++|||.+|||+|||||+|+|++
T Consensus 479 s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd--- 554 (732)
T KOG0614|consen 479 SDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD--- 554 (732)
T ss_pred chHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---
Confidence 578999999999999999999999 9999999975 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..|-+||.|||+|+++..... ..+++||+.|.|||+++....+..+|.|+||+++|||++|.+||.+.++
T Consensus 555 ~~Gy~KLVDFGFAKki~~g~K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-- 624 (732)
T KOG0614|consen 555 NRGYLKLVDFGFAKKIGSGRK--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-- 624 (732)
T ss_pred cCCceEEeehhhHHHhccCCc--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--
Confidence 789999999999999877543 3578999999999999999999999999999999999999999999654
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 239 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~~ 239 (414)
...|..|...-- .-+++..++....+||+.++..+|.+|..+. ..-+.++- ...+...|||+.++....+
T Consensus 625 -mktYn~ILkGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~--~~gI~DIk---kH~Wf~gfdweglr~~~L~ 694 (732)
T KOG0614|consen 625 -MKTYNLILKGID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQ--KGGINDIK---KHRWFEGFDWEGLRSRTLP 694 (732)
T ss_pred -HHHHHHHHhhhh---hhhcccccchhHHHHHHHHHhcCcHhhhccc--cCChHHHH---hhhhhhcCChhhhhhccCC
Confidence 445555443211 1234456788899999999999999997632 22222221 2245678999998765443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.07 Aligned_cols=194 Identities=21% Similarity=0.229 Sum_probs=160.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++..+.++++.|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~- 134 (255)
T cd08219 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT- 134 (255)
T ss_pred CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC-
Confidence 3689999999999999999999999 89999988643 45689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 135 --~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~- 204 (255)
T cd08219 135 --QNGKVKLGDFGSARLLTSPGA-------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS- 204 (255)
T ss_pred --CCCcEEEcccCcceeeccccc-------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-
Confidence 678899999999976644221 1234578999999999999889999999999999999999999997632
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....+..+...... .+...++.++.+++..||+.+|++||++.+|..
T Consensus 205 --~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 205 --WKNLILKVCQGSYK----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred --HHHHHHHHhcCCCC----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 23333333322221 233457889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=251.80 Aligned_cols=196 Identities=17% Similarity=0.229 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..++..|+||||+ +++|.+++.. ...+++..+..++.|++.+|+|||+++|+||||||+||+++
T Consensus 65 h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~--- 140 (267)
T cd06646 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT--- 140 (267)
T ss_pred CCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---
Confidence 689999999999999999999999 8899998874 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++........ ......|+..|++||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 141 DNGDVKLADFGVAAKITATIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred CCCCEEECcCccceeeccccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 677899999999987643211 123457889999999985 3346789999999999999999999997543
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.. +....+...............++.++.+++..||..+|++||++++|.+
T Consensus 214 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 214 PM---RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred hh---hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 21 1111111111111111123456889999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=248.42 Aligned_cols=198 Identities=19% Similarity=0.358 Sum_probs=160.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++. ++..|+||||+ +++|.+++... ...+++..+..++.||+.||+|||+.||+|+||||+||+++
T Consensus 59 ~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~- 136 (260)
T cd05069 59 RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG- 136 (260)
T ss_pred CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc-
Confidence 3689999988764 56789999999 88999999753 34589999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.++|+|||++........ .......++..|++||.+.+..++.++|+|||||++|+|++ |.+||.+..
T Consensus 137 --~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 137 --DNLVCKIADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred --CCCeEEECCCccceEccCCcc------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 678899999999986643221 11223456788999999998889999999999999999999 999998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
. .+.+..+...... .....+|.++.+++..||..+|++||+++++.+.|++
T Consensus 209 ~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 209 N---REVLEQVERGYRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred H---HHHHHHHHcCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3 2333333222111 1234678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.76 Aligned_cols=196 Identities=22% Similarity=0.292 Sum_probs=159.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+++..++||||+ |++|.+++.. ...++...+..++.||+.||.|||+.||+||||||+||+++
T Consensus 63 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~--- 138 (263)
T cd06625 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD--- 138 (263)
T ss_pred CCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---
Confidence 689999999999999999999999 9999999875 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||+++......... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-- 212 (263)
T cd06625 139 SAGNVKLGDFGASKRLQTICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-- 212 (263)
T ss_pred CCCCEEEeecccceecccccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--
Confidence 67889999999998654321100 011235688999999999998899999999999999999999999976422
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+..+..... ...+...++.++.+++..||..+|++||++.+++.
T Consensus 213 -~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 213 -MAAIFKIATQPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred -HHHHHHHhccCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 222222222111 12234567899999999999999999999887764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=250.93 Aligned_cols=192 Identities=18% Similarity=0.178 Sum_probs=153.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..+++.++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 58 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~ 137 (258)
T cd05078 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREE 137 (258)
T ss_pred CCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccc
Confidence 699999999999999999999999 8999999986566799999999999999999999999999999999999997321
Q ss_pred C-----CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhC-CCCC
Q 015018 81 R-----ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRG-SLPW 153 (414)
Q Consensus 81 ~-----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG-~~Pf 153 (414)
. ...++++|||++...... ....++..|++||++.+ ..++.++|||||||++|+|++| ..||
T Consensus 138 ~~~~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 138 DRKTGNPPFIKLSDPGISITVLPK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred ccccCCCceEEecccccccccCCc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 1 134799999988654321 23567889999999986 4578999999999999999998 4666
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
......... .+.... ..++...+.++.+++..||+.+|++||++++|.+.|
T Consensus 207 ~~~~~~~~~----~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 207 SALDSQKKL----QFYEDR-----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred hhccHHHHH----HHHHcc-----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 553321111 111111 112334567899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=274.21 Aligned_cols=195 Identities=24% Similarity=0.258 Sum_probs=157.6
Q ss_pred CCCCcEEEEeeEeCC--------EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 2 AAGIPNLRWFGVEGD--------YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~--------~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
.+||++++..+...+ ..+|||||+ +++|.++++.. ...+++..+..++.||+.||+|||+++|+||||
T Consensus 90 h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDL 169 (496)
T PTZ00283 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDI 169 (496)
T ss_pred CCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 467888776654322 468999999 99999998642 457999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhC
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 149 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG 149 (414)
||+|||++ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 170 KP~NILl~---~~~~vkL~DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 170 KSANILLC---SNGLVKLGDFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred CHHHEEEe---CCCCEEEEecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999996 6789999999999876543211 112346799999999999999999999999999999999999
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+.||.+.. ....+..+..... ..+...+++++.+++..||..+|.+||++.+++.
T Consensus 242 ~~Pf~~~~---~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 242 KRPFDGEN---MEEVMHKTLAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCCCC---HHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 99997642 3333333333222 2245678899999999999999999999988764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=247.78 Aligned_cols=199 Identities=23% Similarity=0.326 Sum_probs=162.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+.+ ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus 55 h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~-- 131 (257)
T cd05040 55 HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA-- 131 (257)
T ss_pred CCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe--
Confidence 6899999999888 8999999999 999999997544 5799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+...... +.......++..|++||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 132 -~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 132 -SDDKVKIGDFGLMRALPQNEDH----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred -cCCEEEeccccccccccccccc----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6689999999999876542211 112223567889999999998889999999999999999998 9999976533
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
.+.+..+...... ......+|.++.+++..||..+|++||++.++.+.|.
T Consensus 207 ---~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 207 ---SQILKKIDKEGER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---HHHHHHHHhcCCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2333333221111 1123457899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=251.52 Aligned_cols=192 Identities=16% Similarity=0.210 Sum_probs=153.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++.+.||||||+ +++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++...
T Consensus 75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 699999999999999999999999 9999999876567899999999999999999999999999999999999996321
Q ss_pred ----CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHH-hCCCCCC
Q 015018 81 ----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQ 154 (414)
Q Consensus 81 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~ell-tG~~Pf~ 154 (414)
....++|+|||++...... ....++..|++||.+.+ ..++.++|||||||++||++ +|..||.
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cccCccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 1235899999988643221 12357788999998875 56899999999999999985 6999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
+......... ..... .+....+.++.++|..||..+|++||++.+|.+.|
T Consensus 224 ~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 224 ERTPSEKERF----YEKKH-----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccChHHHHHH----HHhcc-----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 7543222111 11111 11223456899999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=252.62 Aligned_cols=190 Identities=20% Similarity=0.258 Sum_probs=155.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.++|+.+++.+.++++.|+||||+ |++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||+++
T Consensus 59 ~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~-- 136 (285)
T cd05630 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD-- 136 (285)
T ss_pred CCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC--
Confidence 589999999999999999999999 99999988543 34699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 137 -~~~~~~l~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 137 -DHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred -CCCCEEEeeccceeecCCCcc--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 677899999999876433211 12347899999999999999999999999999999999999999875432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
........+... ....+...++.++.+|+..||..||++||++
T Consensus 208 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 208 IKREEVERLVKE----VQEEYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred chHHHHHhhhhh----hhhhcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 222222222111 1112345678899999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=245.60 Aligned_cols=199 Identities=18% Similarity=0.174 Sum_probs=165.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+.+.+.|.+.+..-||+||+..+|+.+++.....|+..++..|+.|+++||+|||.+.|+||||||.|+||+ .
T Consensus 60 h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~ 136 (318)
T KOG0659|consen 60 HPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---S 136 (318)
T ss_pred CcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---C
Confidence 6899999999999999999999999999999998888899999999999999999999999999999999999997 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+|+.+....... ...+-|.+|.|||.+.|. .|+...|+||.|||+.||+.|.+-|.|..+.+
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQ-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred CCcEEeecccchhccCCCCccc-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 8999999999999988765422 123789999999999885 48999999999999999999999888865444
Q ss_pred hHHHHHHHHhhhc--------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKV--------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~--------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..++..+.-... ......++..++.+..+|+..++..||.+|.++.+..
T Consensus 210 QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred HHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 3333332211111 1112224445677889999999999999999977654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=248.39 Aligned_cols=196 Identities=17% Similarity=0.224 Sum_probs=155.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.|+||||+ +++|.+++.. ...+++.+++.++.||+.+|+|||+.||+|+||||+||+++
T Consensus 65 h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~--- 140 (267)
T cd06645 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT--- 140 (267)
T ss_pred CCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---
Confidence 689999999999999999999999 8899999874 55899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++|..||....
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 141 DNGHVKLADFGVSAQITATI-------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred CCCCEEECcceeeeEccCcc-------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 67889999999997654321 1223467999999999974 4457889999999999999999999997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... .+..................++..+.+++..|+..+|++||++++|++
T Consensus 214 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 214 PMR---ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred chh---hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 211 111111111111100011246788999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=262.68 Aligned_cols=196 Identities=18% Similarity=0.233 Sum_probs=157.3
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+||||+|++.-.+ .++.|||+||| .|.+...- +... +++.++.+|+..++.||+|||.+|||||||||.|+||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 5899999988765 67899999999 66654332 2445 99999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
..++|||+|||.+..+........- .......||+.|+|||+..+.. -+.+.||||+||+||+|+.|++||
T Consensus 245 ---~~g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 245 ---SDGTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred ---CCCcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 7799999999999866332110000 0112368999999999998733 357889999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+ ....+.+++|....+..+.. +.+.+++.+||..+|.+||+.|.+..+|+
T Consensus 320 ~~---~~~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 320 FD---DFELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred cc---chHHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 77 45677888888877654322 23568899999999999999999977765
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=247.14 Aligned_cols=201 Identities=20% Similarity=0.299 Sum_probs=164.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.+ +..|+||||+ +++|.+++......+++..++.++.||+.||+|||+.+++|+||||+|||++
T Consensus 65 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~-- 141 (270)
T cd05056 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS-- 141 (270)
T ss_pred CCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe--
Confidence 36899999998875 4578999999 9999999986556799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.++|+|||+++....... + ......++..|++||.+.+..++.++||||||+++|++++ |..||.+...
T Consensus 142 -~~~~~~l~d~g~~~~~~~~~~-----~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 142 -SPDCVKLGDFGLSRYLEDESY-----Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred -cCCCeEEccCceeeecccccc-----e-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 678899999999986644321 1 1112345578999999988889999999999999999986 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+....+...... ..+..+|.++.+++..|+..+|++||++.++.+.|.++..
T Consensus 215 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 215 ---NDVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2333333322211 2345788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=248.24 Aligned_cols=198 Identities=20% Similarity=0.319 Sum_probs=161.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.++||||+ +++|.+++.. ...+++..+..++.|++.+|+|||++||+||||||+||+++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~--- 140 (267)
T cd06628 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD--- 140 (267)
T ss_pred CCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---
Confidence 699999999999999999999999 8999999975 46799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++.+........ .........|+..|++||.+.+..++.++|+|||||++|+|++|..||.+...
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 217 (267)
T cd06628 141 NKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-- 217 (267)
T ss_pred CCCCEEecccCCCcccccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--
Confidence 778899999999987653221110 01112345689999999999988889999999999999999999999987432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+..+... ....+...++.++.++|+.||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 -LQAIFKIGEN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHHHHHHhcc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 2223222221 112234567899999999999999999999888764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=249.92 Aligned_cols=198 Identities=22% Similarity=0.385 Sum_probs=157.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||+++++++...+..++||||+ +++|.+++... ...+++..+..|+.||+.||.|||+++|+|+||++.|||++
T Consensus 59 ~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~- 137 (259)
T PF07714_consen 59 RHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD- 137 (259)
T ss_dssp SBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 3799999999999888899999999 89999999875 56899999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.+||+|||++......... .......+...|+|||.+.+..++.++||||||+++|||++ |..||.+.
T Consensus 138 --~~~~~Kl~~f~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~- 209 (259)
T PF07714_consen 138 --SNGQVKLSDFGLSRPISEKSKY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY- 209 (259)
T ss_dssp --TTTEEEEESTTTGEETTTSSSE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-
T ss_pred --cccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 6789999999999876322111 11233467889999999998889999999999999999999 78999775
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
+..+....+.+.... .....+|..+.+++..||..+|++||++.+|.+.|
T Consensus 210 --~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 --DNEEIIEKLKQGQRL----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --CHHHHHHHHHTTEET----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ccccccccccccccc----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 334444444333332 13346899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=251.75 Aligned_cols=191 Identities=19% Similarity=0.261 Sum_probs=155.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+.+||+.+++.+.++++.|+||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~- 136 (285)
T cd05632 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD- 136 (285)
T ss_pred CCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC-
Confidence 3689999999999999999999999 89999888643 34699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++........ .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+...
T Consensus 137 --~~~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 137 --DYGHIRISDLGLAVKIPEGES--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred --CCCCEEEecCCcceecCCCCc--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 667899999999976543211 1235789999999999999999999999999999999999999987533
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
... ...+.... ......+...++.++.+|+..|+..+|++||+.
T Consensus 207 ~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 207 KVK---REEVDRRV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred HHH---HHHHHHhh-hccccccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 211 12221111 111112345678899999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=262.27 Aligned_cols=196 Identities=20% Similarity=0.226 Sum_probs=150.0
Q ss_pred CCCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||++++.++...+ ..|+||||++++|.+.+. ..++...+..++.||+.||+|||++||+||||||+||
T Consensus 78 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 154 (359)
T cd07876 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154 (359)
T ss_pred CCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 3799999998876543 579999999888887765 3589999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ .++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 155 l~~---~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 155 VVK---SDCTLKILDFGLARTACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred EEC---CCCCEEEecCCCccccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 996 678999999999975433211 134578999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhc----------------------cchHHHh------------hcCCcHHHHHHHHHHHcCCC
Q 015018 155 GLKAGTKKQKYEKISEKKV----------------------STSIEAL------------CRGYPTEFASYFHYCRSLRF 200 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~----------------------~~~~~~l------------~~~~p~e~~~li~~c~~~dp 200 (414)
+.........+........ ......+ ...++.++.+||..||..||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 303 (359)
T cd07876 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303 (359)
T ss_pred CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCc
Confidence 7543221111111000000 0000000 11235678999999999999
Q ss_pred CCCCCHHHHH
Q 015018 201 DDKPDYAYLK 210 (414)
Q Consensus 201 ~~RP~~~~l~ 210 (414)
++||++.+++
T Consensus 304 ~~R~t~~e~l 313 (359)
T cd07876 304 DKRISVDEAL 313 (359)
T ss_pred ccCCCHHHHh
Confidence 9999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=250.94 Aligned_cols=186 Identities=23% Similarity=0.321 Sum_probs=152.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+.+++.+..++..|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~--- 131 (279)
T cd05633 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD--- 131 (279)
T ss_pred CCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---
Confidence 689999999999999999999999 9999998874 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ....|+..|++||.+. +..++.++|+|||||++|+|++|..||......
T Consensus 132 ~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 202 (279)
T cd05633 132 EHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (279)
T ss_pred CCCCEEEccCCcceeccccCc---------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence 678899999999876543211 2346899999999986 456889999999999999999999999865443
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
.... ..... . .....++..++.++.++|..|+..||.+|++
T Consensus 203 ~~~~-~~~~~---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 203 DKHE-IDRMT---L-TVNVELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHH-HHHHh---h-cCCcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 3221 11111 1 1111245568899999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=250.91 Aligned_cols=195 Identities=18% Similarity=0.273 Sum_probs=157.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+..+++.|+||||+ +++|..++......+++..+..++.||+.+|+|||+.||+||||||+|||++
T Consensus 60 ~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~-- 137 (282)
T cd06643 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT-- 137 (282)
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc--
Confidence 3689999999999999999999999 8899888765566899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
..+.++|+|||++........ ......++..|++||++. +..++.++|+|||||++|+|++|..||.
T Consensus 138 -~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 138 -LDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred -cCCCEEEcccccccccccccc-------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 678899999999876543211 123457899999999984 4457789999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... ..+.+..+....... ......++.++.++|..||..+|++||++++++
T Consensus 210 ~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 210 ELN---PMRVLLKIAKSEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred ccC---HHHHHHHHhhcCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 643 223333332221111 112345788999999999999999999987764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=252.74 Aligned_cols=206 Identities=17% Similarity=0.204 Sum_probs=152.2
Q ss_pred CCCCCcEEEEeeEe--CCEEEEEEecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVE--GDYNVLVIDLLGPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~--~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
.+|||++++..+.. +.+.|+||||++++|.+++... ...+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlk 135 (317)
T cd07868 56 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 135 (317)
T ss_pred CCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence 36999999988754 5678999999988999988632 1258999999999999999999999999999999
Q ss_pred CCcEEEeec-CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHh
Q 015018 71 PDNFLMGLG-RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 71 P~NILl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~ellt 148 (414)
|+|||+... ...+.+||+|||+++.+..... +........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 211 (317)
T cd07868 136 PANILVMGEGPERGRVKIADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred HHHEEEecCCCCcCcEEEeecCceeccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence 999999532 3457899999999987654321 11122356889999999999874 58999999999999999999
Q ss_pred CCCCCCCCCccch------HHHHHHHHhhh-------------cc---c-----------------hHHHhhcCCcHHHH
Q 015018 149 GSLPWQGLKAGTK------KQKYEKISEKK-------------VS---T-----------------SIEALCRGYPTEFA 189 (414)
Q Consensus 149 G~~Pf~~~~~~~~------~~~~~~i~~~~-------------~~---~-----------------~~~~l~~~~p~e~~ 189 (414)
|+.||.+...... ...+..+.... .. . .++......+.++.
T Consensus 212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (317)
T cd07868 212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291 (317)
T ss_pred CCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHH
Confidence 9999975432110 11111111100 00 0 00000112245688
Q ss_pred HHHHHHHcCCCCCCCCHHHHH
Q 015018 190 SYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 190 ~li~~c~~~dp~~RP~~~~l~ 210 (414)
++|..|+..||.+||+++++.
T Consensus 292 dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 292 HLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred HHHHHHhccCcccCCCHHHHh
Confidence 999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=271.37 Aligned_cols=197 Identities=17% Similarity=0.203 Sum_probs=148.0
Q ss_pred CCCcEEEEeeEeC-CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecC
Q 015018 3 AGIPNLRWFGVEG-DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 3 p~I~~l~~~g~~~-~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~ 80 (414)
++|++++.++..+ .+.|||||++|++|.+++.. ...+++..+..|+.||+.||+|||+ .|||||||||+|||++.+.
T Consensus 191 ~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD 269 (467)
T ss_pred cceeeeEEEEEcCCceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCC
Confidence 4688888887764 58899999999999998875 4579999999999999999999998 5999999999999996321
Q ss_pred C-------------CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 015018 81 R-------------ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 81 ~-------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ell 147 (414)
. ...+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||+
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 1 12599999998754222 123468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhcc---------------------------chHHHhhc-------CCcHHHHHHHH
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVS---------------------------TSIEALCR-------GYPTEFASYFH 193 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~~l~~-------~~p~e~~~li~ 193 (414)
+|++||.+.........+.++...... ..+..+.. ...+.+.+||.
T Consensus 340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 419 (467)
T PTZ00284 340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY 419 (467)
T ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence 999999875432222222111100000 00000000 01356789999
Q ss_pred HHHcCCCCCCCCHHHHH
Q 015018 194 YCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 194 ~c~~~dp~~RP~~~~l~ 210 (414)
.||..||++||++++++
T Consensus 420 ~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 420 GLLHYDRQKRLNARQMT 436 (467)
T ss_pred HhCCcChhhCCCHHHHh
Confidence 99999999999987775
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=248.20 Aligned_cols=190 Identities=20% Similarity=0.277 Sum_probs=155.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.|+||||+ |++|.++++.. ..+++.++..++.||+.||+|||+.||+||||||+||+++
T Consensus 68 h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--- 143 (267)
T PHA03390 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD--- 143 (267)
T ss_pred CCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence 689999999999999999999999 99999999853 4899999999999999999999999999999999999996
Q ss_pred CCC-eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+ .++|+|||+++..... ....++..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred CCCCeEEEecCccceecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 445 8999999998765432 2346899999999999988999999999999999999999999854332
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-~~~l~ 210 (414)
.. ....+.... . ......+.+++.+.++|..||+.+|++||+ +++|+
T Consensus 213 ~~--~~~~~~~~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 213 EL--DLESLLKRQ-Q-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred hh--hHHHHHHhh-c-ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 11 011111111 1 111233468899999999999999999995 56665
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=263.30 Aligned_cols=203 Identities=23% Similarity=0.301 Sum_probs=163.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------------------------------------------
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------------------------------ 37 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------ 37 (414)
++|||+++++.+...+..||||||+ +++|.+++....
T Consensus 99 ~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (401)
T cd05107 99 PHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGY 178 (401)
T ss_pred CCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccc
Confidence 4799999999999999999999999 999999986431
Q ss_pred -------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 015018 38 -------------------------------------------------------RKLSLKTVLMLADQMINRVEFVHSK 62 (414)
Q Consensus 38 -------------------------------------------------------~~ls~~~v~~ia~Qll~gL~yLH~~ 62 (414)
..+++..++.|+.||+.||+|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 258 (401)
T cd05107 179 MDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK 258 (401)
T ss_pred cccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 1367788999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHH
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 142 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvv 142 (414)
+|+||||||+|||++ ..+.++|+|||+++.+..... ........++..|++||.+.+..++.++|||||||+
T Consensus 259 ~ivHrdlkp~NiLl~---~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 259 NCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred CcCcccCCcceEEEe---CCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999999999999996 678899999999986543221 111223467889999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 143 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 143 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
+|||++ |..||...... ......+... ... .....++.++.+++..||..+|++||++++|...|++++
T Consensus 331 l~e~l~~g~~P~~~~~~~--~~~~~~~~~~-~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 331 LWEIFTLGGTPYPELPMN--EQFYNAIKRG-YRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCCCCCCCCch--HHHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 999998 89999765321 1112222211 111 123457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=249.62 Aligned_cols=199 Identities=22% Similarity=0.339 Sum_probs=161.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHH
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEF 58 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------------~~ls~~~v~~ia~Qll~gL~y 58 (414)
.+|||+++++++.+++..|+||||+ +++|.+++.... ..+++..++.++.||+.+|+|
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~ 145 (288)
T cd05050 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145 (288)
T ss_pred CCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 3799999999999999999999999 889999986321 247888999999999999999
Q ss_pred HHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHH
Q 015018 59 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138 (414)
Q Consensus 59 LH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwS 138 (414)
||.++++||||||.||+++ ..+.++|+|||++..+..... +........+..|+|||.+.+..++.++||||
T Consensus 146 lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 146 LSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred HHhCCeecccccHhheEec---CCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 9999999999999999996 678899999999876533211 11122334567899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 139 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 139 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
|||++|+|++ |..||.+... .+.+..+...... .....+|.++.+++..||..+|++||++.+|.+.|+
T Consensus 218 lG~il~el~~~~~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 9999999997 8899976532 3333333332221 123467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=248.96 Aligned_cols=205 Identities=21% Similarity=0.279 Sum_probs=162.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|+++++.+..+++.|+||||+ |++|.+++.. ...+++..++.|+.|++.||+|||+.+|+||||||+||+++
T Consensus 56 ~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~--- 131 (278)
T cd05606 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--- 131 (278)
T ss_pred CCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---
Confidence 689999999999999999999999 9999998874 55799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+.... .....|+..|++||++.+ ..++.++|+||+||++|+|++|..||.+....
T Consensus 132 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~ 202 (278)
T cd05606 132 EHGHVRISDLGLACDFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (278)
T ss_pred CCCCEEEccCcCccccCccC---------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc
Confidence 67889999999987553321 124578999999999974 46899999999999999999999999875433
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
........+... ...++..++.++.+++..|+..+|.+|| ++.++++ ..+...++|+...
T Consensus 203 ~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----------~~~~~~~~~~~~~ 267 (278)
T cd05606 203 DKHEIDRMTLTM-----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------HPFFRSLDWQMVF 267 (278)
T ss_pred chHHHHHHhhcc-----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----------CccccCCCchHhh
Confidence 222221111111 1123445789999999999999999999 7666642 2333445677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.51 Aligned_cols=198 Identities=21% Similarity=0.365 Sum_probs=162.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++..+...++||||+ +++|.+++... +..+++..+..++.||+.||+|||+++|+|+||||+||+++
T Consensus 60 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~-- 137 (261)
T cd05034 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG-- 137 (261)
T ss_pred CCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc--
Confidence 689999999999989999999999 89999999743 35799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++..+.... +.......++..|++||.+.+..++.++|+|||||++|++++ |+.||.+...
T Consensus 138 -~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 138 -ENLVCKIADFGLARLIEDDE------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred -CCCCEEECccccceeccchh------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 67899999999998765321 111123345678999999998889999999999999999998 9999976432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
...+..+..... ......+|.++.+++..|+..+|++||+++++.+.|++
T Consensus 211 ---~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 ---REVLEQVERGYR----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 333333332211 11234568999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=249.65 Aligned_cols=203 Identities=18% Similarity=0.301 Sum_probs=164.1
Q ss_pred CCCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 1 MAAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 1 g~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~~-------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
.+|||+++++++.. +...+++++|+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||
T Consensus 66 ~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p 145 (280)
T cd05043 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145 (280)
T ss_pred CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCH
Confidence 37999999998776 57789999999 899999987542 4599999999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CC
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GS 150 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~ 150 (414)
+||+++ ..+.+||+|||+++.+.....+. ......++..|+|||++.+..++.++|||||||++|++++ |+
T Consensus 146 ~nil~~---~~~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 146 RNCVID---EELQVKITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred hhEEEc---CCCcEEECCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 999996 67899999999998664432211 1122356778999999998889999999999999999998 99
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
+||..... .+....+...... .....+|+++.+++..||..+|++||++.++...|.++.+
T Consensus 218 ~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 218 TPYVEIDP---FEMAAYLKDGYRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCcCcCCH---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99976433 2223322222111 1123578999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=245.01 Aligned_cols=198 Identities=19% Similarity=0.287 Sum_probs=160.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+..+.|+||||+ |++|.+++......+++..++.++.|++.+|+|||+++|+||||||+|||++
T Consensus 51 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~--- 127 (251)
T cd05041 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG--- 127 (251)
T ss_pred CCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---
Confidence 689999999999999999999999 9999999976556789999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.++|+|||++......... .......++..|++||.+.+..++.++|+|||||++|+|++ |..||.+....
T Consensus 128 ~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 128 ENNVLKISDFGMSREEEGGIYT-----VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred CCCcEEEeeccccccccCCcce-----eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 6789999999999765421110 00112234677999999998889999999999999999998 89999775432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
. ....+... ... .....+|.++.+++..||..+|++||++.++.+.|+
T Consensus 203 ~---~~~~~~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 203 Q---TRERIESG-YRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred H---HHHHHhcC-CCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2 22222211 111 123467899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=246.94 Aligned_cols=198 Identities=23% Similarity=0.341 Sum_probs=164.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..+++.|+||||+ |++|.++++. ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++
T Consensus 56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~--- 131 (260)
T cd05611 56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID--- 131 (260)
T ss_pred CCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---
Confidence 689999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++.... .....++..|++||.+.+..++.++||||||+++|+|++|..||....
T Consensus 132 ~~~~~~l~dfg~~~~~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--- 197 (260)
T cd05611 132 QTGHLKLTDFGLSRNGLE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--- 197 (260)
T ss_pred CCCcEEEeecccceeccc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---
Confidence 678899999999875432 123578899999999998888999999999999999999999997643
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+.+..+....... .......+++++.+++..||..+|++||++..+.+++.+.+.
T Consensus 198 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 198 PDAVFDNILSRRINW-PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHhcccCC-CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 233334333322211 112234578999999999999999999988777777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=247.31 Aligned_cols=202 Identities=16% Similarity=0.224 Sum_probs=163.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.. ...++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+.
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~-- 143 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK-- 143 (279)
T ss_pred CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc--
Confidence 37999999999887 7889999999 9999999986666799999999999999999999999999999999999995
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.++|+|||+++......... ......++..|++||.+....++.++|+|||||++||+++ |..||.+...
T Consensus 144 -~~~~~kL~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 144 -TPQHVKITDFGLAKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred -CCCeEEECCCcccccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 67889999999998665322111 0112234678999999988889999999999999999998 9999987533
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+....+...... .....++.++.+++..||..+|.+||++.+|.+.|.+++.
T Consensus 218 ---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 ---VEIPDLLEKGERL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---HHHHHHHhCCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222222221111 1223467889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=247.84 Aligned_cols=200 Identities=17% Similarity=0.185 Sum_probs=155.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.++++.|+||||+.++|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+|||++
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~-- 135 (285)
T cd07861 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID-- 135 (285)
T ss_pred CCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc--
Confidence 689999999999999999999999779998886432 5799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++........ ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+...
T Consensus 136 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 136 -NKGVIKLADFGLARAFGIPVR-------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred -CCCcEEECcccceeecCCCcc-------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 678899999999976543211 11234678999999998764 468899999999999999999999986432
Q ss_pred cchHHHH---------------------HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKY---------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~---------------------~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....... ..................+++++.++|..||..||++||++.+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111100 0000000111112223457889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=247.03 Aligned_cols=197 Identities=18% Similarity=0.342 Sum_probs=160.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++. .++.|+||||+ +++|.+++... +..+++.++..++.|++.+|+|||+.|++||||||+||+++
T Consensus 60 h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~-- 136 (260)
T cd05067 60 HPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS-- 136 (260)
T ss_pred CcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc--
Confidence 689999998864 55789999999 99999998643 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++........ .......++..|++||++.+..++.++|+||||+++|++++ |.+||.+...
T Consensus 137 -~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 137 -ETLCCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred -CCCCEEEccCcceeecCCCCc------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 678899999999987653221 11123456788999999998889999999999999999998 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
.+.+..+...... .....+|.++.+++..||..+|++||++++|..+|++
T Consensus 210 ---~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 210 ---PEVIQNLERGYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2222322222111 2335678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=246.03 Aligned_cols=198 Identities=19% Similarity=0.342 Sum_probs=159.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++. ....|+||||+ +++|.+++... ...+++..++.++.||+.+|+|||+.+|+||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~- 136 (260)
T cd05070 59 RHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG- 136 (260)
T ss_pred CCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe-
Confidence 3689999998875 45679999999 89999998743 35699999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.++|+|||++..+..... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..
T Consensus 137 --~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 137 --DGLVCKIADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred --CCceEEeCCceeeeeccCccc------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 678899999999987643221 11123345678999999998889999999999999999999 999997743
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
. .+....+..... ......++.++.+++..|+..+|++||++++|.++|++
T Consensus 209 ~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 209 N---REVLEQVERGYR----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred H---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2 223333322111 11234678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.65 Aligned_cols=201 Identities=20% Similarity=0.224 Sum_probs=155.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++..++..|||||++.++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .
T Consensus 219 HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~ 295 (461)
T PHA03211 219 HPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---G 295 (461)
T ss_pred CCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---C
Confidence 6999999999999999999999998899998876566899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc--
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-- 159 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~-- 159 (414)
.+.++|+|||+++.+...... .......||..|++||++.+..++.++|||||||+||||++|..|+......
T Consensus 296 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 296 PEDICLGDFGAACFARGSWST-----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred CCCEEEcccCCceeccccccc-----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 788999999999865432211 0112457999999999999999999999999999999999987665432211
Q ss_pred ---chHHHHHHHHhhhcc-----c-------------------------hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 ---TKKQKYEKISEKKVS-----T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ---~~~~~~~~i~~~~~~-----~-------------------------~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
...+....+...... . ....+ ..++.++.+||..||..||.+||++
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCH
Confidence 112222222211100 0 00000 1244578999999999999999998
Q ss_pred HHHHH
Q 015018 207 AYLKR 211 (414)
Q Consensus 207 ~~l~~ 211 (414)
.++++
T Consensus 450 ~elL~ 454 (461)
T PHA03211 450 AELLR 454 (461)
T ss_pred HHHhh
Confidence 87754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.65 Aligned_cols=199 Identities=19% Similarity=0.196 Sum_probs=155.0
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++...+ +.|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 58 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili 136 (372)
T cd07853 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136 (372)
T ss_pred CCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE
Confidence 689999999998877 8899999998899988863 5689999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ .++.+||+|||+++........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 137 ~---~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 137 N---SNCVLKICDFGLARVEEPDESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred C---CCCCEEeccccceeecccCccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 6 6789999999999865432211 11234688999999999875 478999999999999999999999987
Q ss_pred CCccchHHHHHHHHh--------------------hh-ccchHH---HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISE--------------------KK-VSTSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~--------------------~~-~~~~~~---~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.........+..... .. ...... .+...+++++.+||..|+..||.+||++.+++
T Consensus 208 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 543322222111100 00 000011 12234578899999999999999999987663
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=255.63 Aligned_cols=205 Identities=15% Similarity=0.201 Sum_probs=153.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++..+++.|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 57 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~- 135 (327)
T cd08227 57 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS- 135 (327)
T ss_pred CCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe-
Confidence 3799999999999999999999999 99999998643 34699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..+.++++||+.+.....................++..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 136 --~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 136 --VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred --cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 67789999998765443211110000001123457788999999976 45889999999999999999999999764
Q ss_pred CccchHHHHHHHHhhhccc-----------------------------------------hHHHhhcCCcHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVST-----------------------------------------SIEALCRGYPTEFASYFHYC 195 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~-----------------------------------------~~~~l~~~~p~e~~~li~~c 195 (414)
.... .+.......... ........+++++.+|+..|
T Consensus 214 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 290 (327)
T cd08227 214 PATQ---MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQC 290 (327)
T ss_pred chhH---HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHH
Confidence 3211 111111100000 00001123467899999999
Q ss_pred HcCCCCCCCCHHHHHH
Q 015018 196 RSLRFDDKPDYAYLKR 211 (414)
Q Consensus 196 ~~~dp~~RP~~~~l~~ 211 (414)
|..||++||+++++.+
T Consensus 291 l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 291 LQRNPDARPSASTLLN 306 (327)
T ss_pred HhhCchhcCCHHHHhc
Confidence 9999999999887753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=248.04 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=165.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~~~ 80 (414)
||+|++.|.+|..+..++|.||+|+.-++.+++...+++++.-+-++...+++||.||-++ +|+||||||.|||++
T Consensus 150 cpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD--- 226 (391)
T KOG0983|consen 150 CPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD--- 226 (391)
T ss_pred CCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---
Confidence 8999999999999999999999998889999988888999999999999999999999975 899999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..|+|||||||++-.+.+...+ ..-.|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.+-+
T Consensus 227 e~GniKlCDFGIsGrlvdSkAh--------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDSKAH--------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred cCCCEEeecccccceeeccccc--------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 8899999999999887775543 33578999999999874 358899999999999999999999998853
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+-+|.+... ..+. ...++++.|.+|+..|+.+|+.+||.|.+|+
T Consensus 299 --tdFe~ltkvln~eP-P~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 299 --TDFEVLTKVLNEEP-PLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred --ccHHHHHHHHhcCC-CCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 34555556655332 2111 1235889999999999999999999998875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.61 Aligned_cols=203 Identities=18% Similarity=0.276 Sum_probs=169.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
+|||+++.+.+.+....+|++||| ||+|..+|... ...+++.+.+.++.||++|++||+++++|||||-..|+
T Consensus 754 HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNC 833 (1025)
T KOG1095|consen 754 HPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNC 833 (1025)
T ss_pred CcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhhe
Confidence 699999999999999999999999 99999999877 66799999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 153 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf 153 (414)
||+ ....|||+|||+|+.+.+.+. |+......-..+|||||.+...-++.++|||||||+|||+++ |..||
T Consensus 834 LL~---~~r~VKIaDFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY 905 (1025)
T KOG1095|consen 834 LLD---ERRVVKIADFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPY 905 (1025)
T ss_pred eec---ccCcEEEcccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCC
Confidence 997 568999999999994333221 222233345679999999999999999999999999999998 99999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+... .+.+..+.+.-.. .-+..||..+.++|..||+.+|++||+|..|.+.+.+....
T Consensus 906 ~~~~n---~~v~~~~~~ggRL----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 906 PSRSN---FEVLLDVLEGGRL----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCcch---HHHHHHHHhCCcc----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 88644 2333322222221 12467999999999999999999999999999987777643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=251.72 Aligned_cols=199 Identities=18% Similarity=0.248 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++..+++.|+||||++++|.+++......+++..+..++.||+.||+|||+.||+|+||||+|||++ .
T Consensus 63 h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~ 139 (301)
T cd07873 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---E 139 (301)
T ss_pred CCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---C
Confidence 6899999999999999999999998899999886677899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.++|+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|++||.+.....
T Consensus 140 ~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 140 RGELKLADFGLARAKSIPTK-------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred CCcEEECcCcchhccCCCCC-------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 78899999999875433211 11234678999999998764 47889999999999999999999998754322
Q ss_pred hHHHHHHHHhhhc----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKV----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+..... ..........+++++.++|..|+..||.+||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1111111110000 0001122345788999999999999999999987765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=259.24 Aligned_cols=199 Identities=18% Similarity=0.224 Sum_probs=152.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||+++++++..+.+.|+|||++.++|.+++......+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 115 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~--- 191 (357)
T PHA03209 115 NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN--- 191 (357)
T ss_pred CCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---
Confidence 36999999999999999999999998899999876677899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..|+.......
T Consensus 192 ~~~~~kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 192 DVDQVCIGDLGAAQFPVVAP--------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred CCCCEEEecCccccccccCc--------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 67889999999987432211 1134579999999999999999999999999999999998544443222111
Q ss_pred hHH-------HHHHHHhh------hcc-----chHH-----------------Hh-hcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 161 KKQ-------KYEKISEK------KVS-----TSIE-----------------AL-CRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 161 ~~~-------~~~~i~~~------~~~-----~~~~-----------------~l-~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
... .+..+... ... .... .+ ...++.++.++|..||..||.+||
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 343 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc
Confidence 100 01111100 000 0000 00 124567788899999999999999
Q ss_pred CHHHHH
Q 015018 205 DYAYLK 210 (414)
Q Consensus 205 ~~~~l~ 210 (414)
++.+++
T Consensus 344 ta~e~l 349 (357)
T PHA03209 344 SAEEIL 349 (357)
T ss_pred CHHHHh
Confidence 987764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=241.77 Aligned_cols=194 Identities=20% Similarity=0.244 Sum_probs=158.0
Q ss_pred CCCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
++|||++++..+.. +...|+||||+ +++|.+++... ...+++.+++.++.||+.+|+|||++||+|+||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~ 136 (257)
T cd08223 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT 136 (257)
T ss_pred CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe
Confidence 46899999887764 45789999999 89999998753 45699999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++..+..... ......+++.|+|||++.+..++.++|+|||||++++|++|+.||....
T Consensus 137 ---~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 137 ---RTNIIKVGDLGIARVLENQCD-------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ---cCCcEEEecccceEEecccCC-------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 678899999999987644221 1234678999999999999999999999999999999999999997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.......+..... ..+...+++++.+++..|+..+|++||++.++.+
T Consensus 207 ---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 207 ---MNSLVYRIIEGKL----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---HHHHHHHHHhcCC----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2222223332222 1234567899999999999999999999877753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=243.91 Aligned_cols=193 Identities=18% Similarity=0.257 Sum_probs=157.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++..+..+ ..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||++|++||||||+||+++
T Consensus 57 ~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~- 134 (254)
T cd05083 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS- 134 (254)
T ss_pred CCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc-
Confidence 368999999988765 469999999 899999997543 4689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.++|+|||++....... .....+..|++||.+.+..++.++|+|||||++|+|++ |+.||....
T Consensus 135 --~~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 135 --EDGVAKVSDFGLARVGSMGV----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred --CCCcEEECCCccceeccccC----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 67889999999997653321 12234578999999998889999999999999999997 999997753
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
. .+....+..... ......+|.++.+++..||+.+|++||++++|.+.|+
T Consensus 203 ~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 203 L---KEVKECVEKGYR----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred H---HHHHHHHhCCCC----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 3 222222222111 1124568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=245.17 Aligned_cols=191 Identities=17% Similarity=0.197 Sum_probs=152.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.. ...|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 60 h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 60 HKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred CcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence 7999999999988 7789999999 9999999976455799999999999999999999999999999999999997322
Q ss_pred ----CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC--CCCchhHHHHHHHHHHHHHh-CCCCC
Q 015018 81 ----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPW 153 (414)
Q Consensus 81 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~~DvwSlGvvl~ellt-G~~Pf 153 (414)
....++|+|||++...... ....++..|++||++.+. .++.++|+|||||++|+|++ |..||
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred cccCCceeEEeCCCCcccccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 1127999999998764331 224567789999999876 78999999999999999998 68888
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
...........+. .... +......++.+++..||..+|++||++.++.+.|
T Consensus 208 ~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 208 STLSSSEKERFYQ---DQHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ccCCchhHHHHHh---cCCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7764322222211 1110 1111226899999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=244.68 Aligned_cols=201 Identities=22% Similarity=0.310 Sum_probs=163.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
++||++++..+.++++.++||||+ |++|.+++... ...+++..++.++.||+.+|.|||+.||+|+||||+||+++
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140 (267)
T ss_pred CCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC
Confidence 689999999999999999999999 89999998642 45689999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++..+..... ......++..|++||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 141 ---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 141 ---ATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ---CCCcEEEeccceeeeccCCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 678899999999876543221 1123568899999999998889999999999999999999999996543
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
. ......+.+........ ....++.++.+++..||..+|++||++.+|.+.|+++
T Consensus 211 ~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 211 M-NLYSLCKKIEKCDYPPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred c-cHHHHHhhhhcCCCCCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 22222233222222111 1125678999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.41 Aligned_cols=196 Identities=19% Similarity=0.295 Sum_probs=159.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.|+||||+ +++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||+++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~-- 133 (256)
T cd06612 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN-- 133 (256)
T ss_pred CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC--
Confidence 3799999999999999999999999 8999999986677899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......++..|++||++.+..++.++||||||+++|+|++|+.||......
T Consensus 134 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 134 -EEGQAKLADFGVSGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred -CCCcEEEcccccchhcccCcc-------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 678899999999987654321 122356889999999999989999999999999999999999999764332
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
. ....+...... .......++.++.+++..||+.+|++||++.+++.
T Consensus 206 ~---~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 206 R---AIFMIPNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred h---hhhhhccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1 11111111000 00112346789999999999999999999887753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=241.65 Aligned_cols=193 Identities=20% Similarity=0.261 Sum_probs=162.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..++||||+ |++|.+++... ...+++..+..++.|++.+|+|||+.||+|+||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~-- 135 (256)
T cd08221 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-- 135 (256)
T ss_pred CCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe--
Confidence 689999999999999999999999 99999999753 45699999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 136 -~~~~~kl~d~~~~~~~~~~~~-------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--- 204 (256)
T cd08221 136 -KAGLIKLGDFGISKILGSEYS-------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--- 204 (256)
T ss_pred -CCCCEEECcCcceEEcccccc-------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---
Confidence 677899999999987644331 113457899999999999888899999999999999999999999763
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+..+.+..+....... ....++.++.+++..||..+|++||++.++.+
T Consensus 205 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 205 NPLNLVVKIVQGNYTP----VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CHHHHHHHHHcCCCCC----CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 3334444444333222 22567899999999999999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=249.47 Aligned_cols=206 Identities=19% Similarity=0.244 Sum_probs=159.5
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
.+|||++++.++.+. ...++||||+ |++|.+++......+++.+++.++.||+.+|+|||++||+||||||+||+++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143 (284)
T ss_pred CCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc
Confidence 368999999988875 6789999999 9999999976555799999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||+++.+...... +.......++..|+|||++.+..++.++|||||||++|+|+++..|+....
T Consensus 144 ---~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 144 ---SEHQVKIGDFGLTKAIETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred ---CCCCEEECCCccccccccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 6788999999999866443221 111234567888999999998889999999999999999999876653211
Q ss_pred c-----------cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 158 A-----------GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 158 ~-----------~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
. ............... .......++.++.+|+..||+.+|++||++.++.+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 000000000011000 0112346789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=259.22 Aligned_cols=191 Identities=18% Similarity=0.238 Sum_probs=167.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++||+........|||+|+- ||+|.|+|-++...+.+..+.+|+.||+.++.|+|...+|||||||+|+.+- .
T Consensus 76 HpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--E 153 (864)
T KOG4717|consen 76 HPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--E 153 (864)
T ss_pred CcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--e
Confidence 699999999999999999999999 9999999988888999999999999999999999999999999999999875 4
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
+-|.|||+|||++-++..... ..+.+|...|-|||+++|..|+ +.+||||||||||.|++|++||+..++.
T Consensus 154 KlGlVKLTDFGFSNkf~PG~k--------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 154 KLGLVKLTDFGFSNKFQPGKK--------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred ecCceEeeeccccccCCCcch--------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 779999999999987765432 3568999999999999999996 6789999999999999999999986543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.+-.|...+.. ++..++.+.++||..|+..||.+|.+.++|.
T Consensus 226 ---ETLTmImDCKYt-----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 226 ---ETLTMIMDCKYT-----VPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred ---hhhhhhhccccc-----CchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 444555555553 2345678999999999999999999888775
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=245.70 Aligned_cols=201 Identities=17% Similarity=0.221 Sum_probs=154.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||++++..+.+..+.||||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 54 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~ 133 (268)
T cd05086 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133 (268)
T ss_pred CcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc
Confidence 689999999999999999999999 89999998743 23467788899999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-------CCCCchhHHHHHHHHHHHHHh-C
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~~~DvwSlGvvl~ellt-G 149 (414)
..+.++|+|||++........ ........++..|++||++.. ..++.++|||||||++|||++ |
T Consensus 134 ---~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 134 ---SDLTVKVGDYGIGPSRYKEDY-----IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ---CCccEEecccccccccCcchh-----hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 678899999999854221110 011234578899999998753 245789999999999999996 6
Q ss_pred CCCCCCCCccchHHHHHHHHhh-hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
..||..... .+.+..+... ........++..+++.+.+++..|| .+|++||++++|.+.|.
T Consensus 206 ~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 206 AQPYSHLSD---REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCCH---HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 788876432 2333333222 2221222334457788999999999 68999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=258.43 Aligned_cols=193 Identities=18% Similarity=0.233 Sum_probs=149.5
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||++++..+... ...|+||||++++|.+.+.. .++...+..++.||+.||+|||++||+||||||+||
T Consensus 74 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni 150 (355)
T cd07874 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150 (355)
T ss_pred CCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 379999999887643 35799999998888887753 589999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ .++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 151 ll~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 151 VVK---SDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred EEC---CCCCEEEeeCcccccCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 996 678999999999976543211 134578999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhh----------ccch---------------HHH------------hhcCCcHHHHHHHHHHHc
Q 015018 155 GLKAGTKKQKYEKISEKK----------VSTS---------------IEA------------LCRGYPTEFASYFHYCRS 197 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~----------~~~~---------------~~~------------l~~~~p~e~~~li~~c~~ 197 (414)
+...... +..+.... .... ... .....+.++.++|..|+.
T Consensus 220 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 220 GRDYIDQ---WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCHHHH---HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 7532211 11111000 0000 000 011234678999999999
Q ss_pred CCCCCCCCHHHHH
Q 015018 198 LRFDDKPDYAYLK 210 (414)
Q Consensus 198 ~dp~~RP~~~~l~ 210 (414)
.||++||++.+++
T Consensus 297 ~dP~~Rps~~ell 309 (355)
T cd07874 297 IDPAKRISVDEAL 309 (355)
T ss_pred CCchhcCCHHHHh
Confidence 9999999987765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=257.65 Aligned_cols=194 Identities=21% Similarity=0.323 Sum_probs=151.2
Q ss_pred CCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||++++.++... ...|++|+++|++|.++++ ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil 150 (343)
T cd07878 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVA 150 (343)
T ss_pred CCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEE
Confidence 68999998776543 4579999999999999886 457999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 151 ~~---~~~~~kl~Dfg~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 151 VN---EDCELRILDFGLARQADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred EC---CCCCEEEcCCccceecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 96 67889999999998654321 24578999999999987 568899999999999999999999997
Q ss_pred CCCccchHHHHHHHH------------hhhc-----------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKIS------------EKKV-----------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~------------~~~~-----------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.........+.... .... ......+..++++.+.+|+..|+..||++||++.+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 643221111111100 0000 0011122344567789999999999999999987765
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=245.46 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=159.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+.++.++|||++ +++|.+++. ....+++..++.++.||+.+|++||+++|+|+||||+||+++
T Consensus 57 ~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--- 132 (260)
T PF00069_consen 57 HPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--- 132 (260)
T ss_dssp BTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---
T ss_pred cccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc---
Confidence 689999999999999999999999 669999998 356899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++....... .......++..|+|||++. +..++.++|+||||+++|+|++|..||......
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~ 205 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSENN-------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD 205 (260)
T ss_dssp TTSEEEESSGTTTEESTSTT-------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH
T ss_pred cccccccccccccccccccc-------cccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 78899999999998752211 1224568899999999998 888999999999999999999999999876322
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+....+............. .....+.++.+++..||+.+|++||++.+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 206 DQLEIIEKILKRPLPSSSQ-QSREKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp HHHHHHHHHHHTHHHHHTT-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred hhhhhhhhccccccccccc-ccchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 3333333322222111110 0112248999999999999999999988775
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=258.76 Aligned_cols=192 Identities=19% Similarity=0.267 Sum_probs=149.1
Q ss_pred CCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||++++..+... ...|+||||++++|.+++.. .++...+..++.||+.||+|||++||+||||||+|||
T Consensus 82 h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 158 (364)
T cd07875 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158 (364)
T ss_pred CCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 68999998876543 35799999998888888753 5899999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 l~---~~~~~kL~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 159 VK---SDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EC---CCCcEEEEeCCCccccCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 96 678999999999976533211 1345789999999999999999999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhccc-------------------------hHHHh------------hcCCcHHHHHHHHHHHcC
Q 015018 156 LKAGTKKQKYEKISEKKVST-------------------------SIEAL------------CRGYPTEFASYFHYCRSL 198 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l------------~~~~p~e~~~li~~c~~~ 198 (414)
.... ..+.++....... ..+.+ ......++.++|..|+..
T Consensus 228 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 304 (364)
T cd07875 228 TDHI---DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304 (364)
T ss_pred CCHH---HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence 5432 2222221110000 00000 011235789999999999
Q ss_pred CCCCCCCHHHHH
Q 015018 199 RFDDKPDYAYLK 210 (414)
Q Consensus 199 dp~~RP~~~~l~ 210 (414)
||.+||++++++
T Consensus 305 dP~~R~t~~e~L 316 (364)
T cd07875 305 DASKRISVDEAL 316 (364)
T ss_pred CcccCCCHHHHh
Confidence 999999987664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=250.95 Aligned_cols=207 Identities=17% Similarity=0.206 Sum_probs=162.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+.|||+++++.+..+++.|+||||+ |++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~-- 135 (305)
T cd05609 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-- 135 (305)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC--
Confidence 3689999999999999999999999 8999999975 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCccc--------ccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQH--------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~--------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
..+.++|+|||+++.......... ..........++..|++||.+.+..++.++|+|||||++|+|++|..
T Consensus 136 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 136 -SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred -CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 678899999999874221111000 00001123567889999999998889999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
||.+.. ..+.+..+........ .....+|.++.++|.+||..+|++||+...+.+++++.
T Consensus 215 pf~~~~---~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 215 PFFGDT---PEELFGQVISDDIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred CCCCCC---HHHHHHHHHhcccCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 997643 2333333332221111 11125789999999999999999999987777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=247.62 Aligned_cols=199 Identities=18% Similarity=0.214 Sum_probs=158.0
Q ss_pred CCC-CcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 2 AAG-IPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 2 ~p~-I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~---~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
.+| |+.|++++...+ ..+|||||+.-+|..++..+. ..++...++.++.||+.||+|||+++|+||||||
T Consensus 69 ~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKP 148 (323)
T KOG0594|consen 69 HANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKP 148 (323)
T ss_pred CCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCc
Confidence 456 999999999888 789999999999999999776 4688899999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCC
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~ 150 (414)
+||||+ ..+.+||+|||+|+.+.-+. +.....++|.+|.|||++.|. .|+...|+||+|||++||++++
T Consensus 149 QNlLi~---~~G~lKlaDFGlAra~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 149 QNLLIS---SSGVLKLADFGLARAFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred ceEEEC---CCCcEeeeccchHHHhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 999997 68999999999998654322 233456899999999999997 6899999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhc----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKV----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
..|.|..+.+....+..+....- ...+....+...+...+++..|+..+|.+|.++..
T Consensus 219 ~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 219 PLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 99999765333222222211100 00011111222347889999999999999999765
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
..
T Consensus 299 al 300 (323)
T KOG0594|consen 299 AL 300 (323)
T ss_pred Hh
Confidence 53
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=268.14 Aligned_cols=147 Identities=24% Similarity=0.318 Sum_probs=130.5
Q ss_pred CCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 82 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~ 82 (414)
||++++++|...++.|||+|+++.+|+++++.. -..|++..+..++.||+.||.+||+.+|||+|||||||||..-. .
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r 327 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-R 327 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-c
Confidence 799999999999999999999999999999864 34699999999999999999999999999999999999996543 3
Q ss_pred CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 83 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 83 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
..|||||||.+......- .+++-+.-|.|||+++|.+|+.+.||||||||++||++|.+.|.|....+.
T Consensus 328 ~~vKVIDFGSSc~~~q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred CceeEEecccccccCCcc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 489999999998654321 257889999999999999999999999999999999999999988554433
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=247.68 Aligned_cols=195 Identities=18% Similarity=0.266 Sum_probs=155.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+..+.+.|+||||+ |++|..++......+++..++.++.||+.+|+|||+++|+||||||+||+++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~-- 144 (292)
T cd06644 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT-- 144 (292)
T ss_pred CCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc--
Confidence 3689999999999999999999999 8999888765566899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.++.++|+|||++........ ......++..|++||++. ...++.++|+|||||++|+|++|..||.
T Consensus 145 -~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 145 -LDGDIKLADFGVSAKNVKTLQ-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred -CCCCEEEccCccceecccccc-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 678899999999875433211 123456889999999985 3446789999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... .+.+.++...... .......++.++.++|..||..+|++||++++++
T Consensus 217 ~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 217 ELNP---MRVLLKIAKSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred cccH---HHHHHHHhcCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 6432 2223332221111 1112345678999999999999999999987764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=243.04 Aligned_cols=194 Identities=20% Similarity=0.280 Sum_probs=160.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.|||++++.++.+++..|+||||+ +++|.+++.... ..+++..++.++.|++.+|.|||++||+|+||||+||+++
T Consensus 59 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~-- 136 (256)
T cd05039 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS-- 136 (256)
T ss_pred CcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe--
Confidence 689999999999999999999999 889999997543 3699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||+++....... ...++..|++||.+.+..++.++|+||||+++|++++ |..||....
T Consensus 137 -~~~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~- 204 (256)
T cd05039 137 -EDLVAKVSDFGLAKEASQGQD----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP- 204 (256)
T ss_pred -CCCCEEEcccccccccccccc----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence 678899999999986533211 2345678999999998889999999999999999997 999997643
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
..+....+..... ......+|+++.+++..||..+|++||++.++.+.|+.
T Consensus 205 --~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 205 --LKDVVPHVEKGYR----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --HHHHHHHHhcCCC----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2222222222211 12235678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=250.46 Aligned_cols=202 Identities=17% Similarity=0.225 Sum_probs=161.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++... ..++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 67 ~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~-- 143 (303)
T cd05110 67 DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK-- 143 (303)
T ss_pred CCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec--
Confidence 379999999988754 467999999 8999999986666799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.+||+|||+++.+...... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 144 -~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 144 -SPNHVKITDFGLARLLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred -CCCceEEccccccccccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 5678999999999865432211 01123456778999999999899999999999999999997 9999977532
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
. .+..+....... .....++..+.+++..||..+|++||++.++.+.|+.+..
T Consensus 218 ~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 218 R----EIPDLLEKGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred H----HHHHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 122222211111 1124567899999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=246.04 Aligned_cols=192 Identities=19% Similarity=0.300 Sum_probs=158.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+.++.+.||||||+ |++|.+++. ..++++..+..++.|++.+|+|||+.+++|+||+|+||+++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~-- 135 (277)
T cd06640 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS-- 135 (277)
T ss_pred CCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc--
Confidence 3689999999999999999999999 999999987 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ ......++..|++||++.+..++.++|+|||||++|+|++|..||......
T Consensus 136 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 136 -EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred -CCCCEEEcccccceeccCCcc-------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 678899999999987644221 112356888999999999888999999999999999999999999765322
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.....+.... ...+...+|.++.+++..||..+|++||++.++..
T Consensus 208 ---~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 208 ---RVLFLIPKNN----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred ---hHhhhhhcCC----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 2222221111 12233457889999999999999999999888743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=248.32 Aligned_cols=198 Identities=18% Similarity=0.208 Sum_probs=155.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++.+.|+||||++++|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++ .
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~ 134 (284)
T cd07839 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---K 134 (284)
T ss_pred CCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---C
Confidence 6899999999999999999999998899998876567899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.++|+|||+++.+..... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.... +
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~ 205 (284)
T cd07839 135 NGELKLADFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--D 205 (284)
T ss_pred CCcEEECccchhhccCCCCC-------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--C
Confidence 78899999999976543221 112346789999999987754 6899999999999999999988864322 1
Q ss_pred hHHHHHHHHhhhc------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....+..+..... ..........+++++.++|..||..+|.+||+++++..
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 206 VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 2222222211000 00011223456789999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=244.66 Aligned_cols=199 Identities=20% Similarity=0.202 Sum_probs=155.7
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||++++.++.++ ++.++||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~- 134 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK- 134 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc-
Confidence 479999999999988 89999999997799988875556799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
. +.++|+|||+++....... .....++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+..
T Consensus 135 --~-~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 135 --D-DILKLADFGSCRGIYSKPP--------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred --C-CCeEEEecccccccccCCC--------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 4 8999999999986543221 123568899999997654 456889999999999999999999997743
Q ss_pred ccchHHHHHHHHhh---------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEK---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~---------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..........+... .....+..+...++.++.++|..||..+|++||+++++..
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 32211111110000 0001122233467899999999999999999999887753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=247.75 Aligned_cols=191 Identities=20% Similarity=0.320 Sum_probs=153.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+..+++.++||||+ +++|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||++
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~-- 129 (279)
T cd06619 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN-- 129 (279)
T ss_pred CCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC--
Confidence 3699999999999999999999999 8888543 2578999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++..+.... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 130 -~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 199 (279)
T cd06619 130 -TRGQVKLCDFGVSTQLVNSI---------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199 (279)
T ss_pred -CCCCEEEeeCCcceeccccc---------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence 67899999999998664322 23457899999999999989999999999999999999999999764322
Q ss_pred chH----HHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKK----QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~----~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... +....+....... .....+++++.+++..||..+|++||+++++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 200 QGSLMPLQLLQCIVDEDPPV---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ccccchHHHHHHHhccCCCC---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111 1111111111110 012346789999999999999999999877653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=247.21 Aligned_cols=207 Identities=20% Similarity=0.225 Sum_probs=168.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|++||++|.+||++++.+|||||-| ||.|...|.+ .+.|++.++.++..+|+.||.|||.+||.||||||+|||-...
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p 212 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP 212 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC
Confidence 7899999999999999999999999 9999988875 5689999999999999999999999999999999999998644
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---C--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---G--IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~--~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+.-.-||||||.|...+.....-..+.-.+..+-+|+..|||||+.. + ..|+.++|+||||||+|-||.|.+||.
T Consensus 213 n~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 213 NKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 45567999999998654433322222233445678999999999865 2 348899999999999999999999998
Q ss_pred CCCcc------------chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 155 GLKAG------------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 155 ~~~~~------------~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
|.-.. -.+..++.|.+.+...+- +-+..++.+..+++..++..++.+|..+..+
T Consensus 293 G~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd-kdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 293 GHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD-KDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred CccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh-hhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 74322 134567778888776544 3456688999999999999999888765444
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=244.19 Aligned_cols=194 Identities=19% Similarity=0.299 Sum_probs=153.5
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
++|||++++..+... ++.|+||||+ +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 368999999988753 5689999999 88999998753 456999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHH
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~ell 147 (414)
||+++ ..+.++|+|||++........ ......|+..|++||++. +..++.++|+|||||++|+|+
T Consensus 141 nili~---~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~ 210 (272)
T cd06637 141 NVLLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210 (272)
T ss_pred HEEEC---CCCCEEEccCCCceecccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence 99996 677899999999986543221 123467899999999986 345788999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+|..||..... ......+...... ......++.++.+++..||..+|.+||++.++.
T Consensus 211 ~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 211 EGAPPLCDMHP---MRALFLIPRNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred hCCCCccccCH---HHHHHHHhcCCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999976432 1122111111111 112235788999999999999999999988775
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=236.96 Aligned_cols=189 Identities=21% Similarity=0.265 Sum_probs=166.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.|||.++|.+|-+....||++||. +|.|...+.. ...+|++.....++.|++.||.|+|.++||||||||+|+|++
T Consensus 81 hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg-- 158 (281)
T KOG0580|consen 81 HPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG-- 158 (281)
T ss_pred CccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC--
Confidence 699999999999999999999999 8999888863 356799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||-+..-.... ..+++||..|.+||+..+..++..+|+|++|++.|||+.|..||....
T Consensus 159 -~~~~lkiAdfGwsV~~p~~k---------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-- 226 (281)
T KOG0580|consen 159 -SAGELKIADFGWSVHAPSNK---------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-- 226 (281)
T ss_pred -CCCCeeccCCCceeecCCCC---------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--
Confidence 88999999999986544322 256899999999999999999999999999999999999999997743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.|.+|....... +..++.+.+++|.+|+.++|.+|....++.
T Consensus 227 -~~etYkrI~k~~~~~-----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 227 -HSETYKRIRKVDLKF-----PSTISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred -hHHHHHHHHHccccC-----CcccChhHHHHHHHHhccCccccccHHHHh
Confidence 566777777666543 356889999999999999999999865543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=248.22 Aligned_cols=194 Identities=18% Similarity=0.286 Sum_probs=153.6
Q ss_pred CCCCCcEEEEeeE------eCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 1 MAAGIPNLRWFGV------EGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 1 g~p~I~~l~~~g~------~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
++|||+++++++. .+++.|+||||+ +++|.+++... ...+++..+..++.||+.+|+|||+.||+|+||||+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 3689999998885 356889999999 88999998743 456889999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHH
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~ell 147 (414)
||+++ ..+.++|+|||++........ ......|+..|+|||.+. +..++.++|+|||||++|+|+
T Consensus 151 nili~---~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~ 220 (282)
T cd06636 151 NVLLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220 (282)
T ss_pred HEEEC---CCCCEEEeeCcchhhhhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence 99996 678899999999875533211 123457899999999986 345788999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+|..||..... ...+..+..... .......++.++.++|..||..+|.+||++.+|.
T Consensus 221 ~g~~p~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 221 EGAPPLCDMHP---MRALFLIPRNPP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred hCCCCccccCH---HhhhhhHhhCCC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 99999976432 122222221111 1112346789999999999999999999998875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=249.90 Aligned_cols=194 Identities=21% Similarity=0.322 Sum_probs=157.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+..+.+.|+||||+ |++|.+++. ...+++.+++.++.||+.||+|||.+||+||||||+|||++
T Consensus 75 ~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~-- 150 (296)
T cd06654 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-- 150 (296)
T ss_pred CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc--
Confidence 4799999999999999999999999 999999986 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......|+..|++||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 151 -~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 151 -MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred -CCCCEEECccccchhcccccc-------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 678899999999876433221 112357899999999999888899999999999999999999999764321
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+. +...... .......++..+.+++..||..+|++||++.+++.
T Consensus 223 --~~~~~-~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 223 --RALYL-IATNGTP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --HhHHH-HhcCCCC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11111 1111110 11123457789999999999999999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=247.98 Aligned_cols=194 Identities=18% Similarity=0.278 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~ 77 (414)
+|||++++..+..+++.|+||||+ |++|..++... ...+++..+..++.||+.+|+|||+ .+|+|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred CCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 689999999999999999999999 99999988743 2379999999999999999999997 5999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC------CCchhHHHHHHHHHHHHHhCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~~~DvwSlGvvl~elltG~~ 151 (414)
..+.++|+|||++..+..... ....++..|++||.+.+.. ++.++|+|||||++|+|++|..
T Consensus 138 ---~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 138 ---GNGQVKLCDFGVSGNLVASLA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred ---CCCCEEEeecCCcccccCCcc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 578899999999976543221 2346888999999986543 4789999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
||...........+..+..... ..+...++.++.++|..||..+|++||++++|..
T Consensus 206 pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 206 PYPPETYANIFAQLSAIVDGDP----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCcchhhHHHHHHHHhhcCC----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 9976433222222222222221 1234457899999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=242.75 Aligned_cols=198 Identities=18% Similarity=0.327 Sum_probs=160.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.++||++++..+.+ ...++||||+ +++|.+++... ...+++..++.++.||+.+|+|||++|++|+||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~- 136 (260)
T cd05073 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS- 136 (260)
T ss_pred CCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc-
Confidence 36899999999887 7789999999 89999999642 45689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
..+.++|+|||++........ .......++..|++||++.+..++.++|+|||||++|++++ |..||.+..
T Consensus 137 --~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 137 --ASLVCKIADFGLARVIEDNEY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred --CCCcEEECCCcceeeccCCCc------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 678999999999986643221 11123456778999999998889999999999999999998 999998753
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
.. .....+...... .....+|.++.+++..||..+|++||++.++.++|++
T Consensus 209 ~~---~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 209 NP---EVIRALERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HH---HHHHHHhCCCCC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 32 222222222111 1235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=248.85 Aligned_cols=198 Identities=17% Similarity=0.298 Sum_probs=154.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~----~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NIL 75 (414)
++|||++++.++..+...+++|||++.+|.++... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 37999999999999999999999998888776542 246799999999999999999999974 9999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~P 152 (414)
++ ..+.++|+|||+++.+..... .....|+..|++||++.+. .++.++|||||||++|+|++|+.|
T Consensus 141 ~~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 141 LD---RNGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred Ec---cCCcEEEeecchhHHhccCCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 96 678899999999876543221 1234688999999999876 688999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
|.... ...+.+..+...............++.++.+|+..||..+|++||++++|..
T Consensus 210 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 210 YPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred chhcc--hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 97643 1122222222111111111112347889999999999999999999887753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=266.00 Aligned_cols=201 Identities=21% Similarity=0.285 Sum_probs=162.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~l--s~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+.||+++.+.+.++.+.-|.||-+ ||+|.+++...-+++ .+.++-.+..||++||.|||++.|||||||-+|+||.
T Consensus 631 HkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN- 709 (1226)
T KOG4279|consen 631 HKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN- 709 (1226)
T ss_pred hHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe-
Confidence 468999999999999999999999 999999998666677 8899999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.-.|.+||.|||.++.+..-. ....+++||..|||||++.... |+..+|||||||++.||.||++||..+
T Consensus 710 -TySGvlKISDFGTsKRLAgin-------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 710 -TYSGVLKISDFGTSKRLAGIN-------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred -eccceEEecccccchhhccCC-------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 467999999999998764422 1345799999999999998654 889999999999999999999999876
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
-.. ...++.....+..+ .++..++.+.+.||..|+..+|.+||++.+| |.+-|..
T Consensus 782 gsp-qAAMFkVGmyKvHP----~iPeelsaeak~FilrcFepd~~~R~sA~~L---L~DpFlq 836 (1226)
T KOG4279|consen 782 GSP-QAAMFKVGMYKVHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDL---LQDPFLQ 836 (1226)
T ss_pred CCh-hHhhhhhcceecCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHh---ccCcccc
Confidence 332 12222222222221 2233456788999999999999999997654 4555433
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=252.17 Aligned_cols=194 Identities=16% Similarity=0.306 Sum_probs=156.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+..+++.|+||||+ +++|.+++. ...+++..+..++.||+.||+|||+++|+||||||+||+++
T Consensus 77 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-- 152 (292)
T cd06658 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT-- 152 (292)
T ss_pred CCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--
Confidence 4689999999999999999999999 889999886 34799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+...
T Consensus 153 -~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~- 223 (292)
T cd06658 153 -SDGRIKLSDFGFCAQVSKEVP-------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP- 223 (292)
T ss_pred -CCCCEEEccCcchhhcccccc-------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 668899999999875433211 12345789999999999988899999999999999999999999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+.+..+... ....+ .....++..+.+++..||..+|.+||+++++++
T Consensus 224 --~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 224 --LQAMRRIRDN-LPPRV-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred --HHHHHHHHhc-CCCcc-ccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2222222211 11111 112346788999999999999999999877753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=246.80 Aligned_cols=194 Identities=22% Similarity=0.312 Sum_probs=157.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..+.+.|+||||+ +++|.+++......+++..++.++.|++.+|.|||+++|+|+||||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~--- 137 (280)
T cd06611 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT--- 137 (280)
T ss_pred CCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---
Confidence 689999999999999999999999 8899999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.++|+|||++........ ......++..|++||.+. +..++.++|+||||+++|+|++|..||.+
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 138 LDGDVKLADFGVSAKNKSTLQ-------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred CCCCEEEccCccchhhccccc-------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 678999999999875433221 112356899999999985 33467899999999999999999999977
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... .+.+..+....... ......++.++.++|..||..+|++||++.+++
T Consensus 211 ~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 211 LNP---MRVLLKILKSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred CCH---HHHHHHHhcCCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 532 23333333221111 011235788999999999999999999987664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=239.83 Aligned_cols=197 Identities=24% Similarity=0.353 Sum_probs=161.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++.+.+..|+||||+ |++|.+++...... +++..+..++.||+.+|+|||+.+|+|+||||+||+++
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~- 137 (258)
T smart00219 59 DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG- 137 (258)
T ss_pred CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc-
Confidence 4689999999999999999999999 99999999754333 99999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
..+.++|+|||+++........ .. ....++..|++||.+.+..++.++|+||||+++++|++ |..||...
T Consensus 138 --~~~~~~l~dfg~~~~~~~~~~~-----~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~- 208 (258)
T smart00219 138 --ENLVVKISDFGLSRDLYDDDYY-----KK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM- 208 (258)
T ss_pred --cCCeEEEcccCCceeccccccc-----cc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 6778999999999876554221 11 12337789999999988889999999999999999998 89999763
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
+..+.+..+....... ....++.++.+++..|+..+|++||++.++++.|
T Consensus 209 --~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 --SNEEVLEYLKKGYRLP----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CHHHHHHHHhcCCCCC----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 3333344443333221 2345789999999999999999999999887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=243.27 Aligned_cols=198 Identities=19% Similarity=0.276 Sum_probs=155.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++..+++.++||||+ ++.|..++. ....+++..++.++.||+.+|+|||+.||+|+||||+||+++
T Consensus 59 h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~--- 134 (286)
T cd07847 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT--- 134 (286)
T ss_pred CCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---
Confidence 689999999999999999999999 666666654 355799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||.+....
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGD-------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred CCCcEEECccccceecCCCcc-------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678899999999987654321 1123567899999999876 45788999999999999999999999875432
Q ss_pred chHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
............ ............++..+.+++..||..+|++||++.++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 208 DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 222111111000 000112223456788999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=250.75 Aligned_cols=206 Identities=16% Similarity=0.179 Sum_probs=150.8
Q ss_pred CCCCCcEEEEeeEe--CCEEEEEEecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVE--GDYNVLVIDLLGPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~--~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
.+|||++++.++.. +.+.|+||||++++|.+++... ...+++..+..++.||+.||+|||+++|+|||||
T Consensus 56 ~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlk 135 (317)
T cd07867 56 KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLK 135 (317)
T ss_pred CCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence 36899999988753 5688999999988999887532 1258899999999999999999999999999999
Q ss_pred CCcEEEeec-CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHh
Q 015018 71 PDNFLMGLG-RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 71 P~NILl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~ellt 148 (414)
|+|||+... ...+.+||+|||+++.+...... ........||..|+|||++.+. .++.++|||||||++|||++
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t 211 (317)
T cd07867 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (317)
T ss_pred HHHEEEccCCCCCCcEEEeeccceeccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh
Confidence 999999432 35578999999999876543221 1122346789999999999874 57899999999999999999
Q ss_pred CCCCCCCCCccch------HHHHHHHHhhhc---------------------------------cchHHHhhcCCcHHHH
Q 015018 149 GSLPWQGLKAGTK------KQKYEKISEKKV---------------------------------STSIEALCRGYPTEFA 189 (414)
Q Consensus 149 G~~Pf~~~~~~~~------~~~~~~i~~~~~---------------------------------~~~~~~l~~~~p~e~~ 189 (414)
|..||........ ...+..+..... ....+.........+.
T Consensus 212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (317)
T cd07867 212 SEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF 291 (317)
T ss_pred CCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHH
Confidence 9999975332110 000111000000 0000000112245688
Q ss_pred HHHHHHHcCCCCCCCCHHHHH
Q 015018 190 SYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 190 ~li~~c~~~dp~~RP~~~~l~ 210 (414)
+++..|+..||.+||++++++
T Consensus 292 ~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 292 LLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred HHHHHHhccCcccccCHHHHh
Confidence 899999999999999988775
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=253.46 Aligned_cols=203 Identities=19% Similarity=0.284 Sum_probs=159.4
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHcC------------------------------------------
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFCS------------------------------------------ 37 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~~------------------------------------------ 37 (414)
+|||++++.++.. +...++||||+ +++|.+++....
T Consensus 70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (343)
T cd05103 70 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSAS 149 (343)
T ss_pred CccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccc
Confidence 5899999987654 55789999999 999999986421
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 38 ------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 38 ------------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.++|+|||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~ 226 (343)
T cd05103 150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLA 226 (343)
T ss_pred ccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccc
Confidence 2378889999999999999999999999999999999996 6788999999999
Q ss_pred EEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhh
Q 015018 94 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK 172 (414)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 172 (414)
........ +.......++..|++||.+.+..++.++|||||||++|+|++ |..||.+.... .+....+....
T Consensus 227 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~ 299 (343)
T cd05103 227 RDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGT 299 (343)
T ss_pred cccccCcc-----hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccC
Confidence 86533211 111223456778999999998889999999999999999996 99999764321 11222222111
Q ss_pred ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 173 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 173 ~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.. .....+++++.+++..||..+|++||++.+|.+.|+.++.
T Consensus 300 ~~----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 300 RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 1223467889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=245.96 Aligned_cols=205 Identities=20% Similarity=0.271 Sum_probs=161.2
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.. +.+.++||||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||+||+++
T Consensus 65 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~- 143 (284)
T cd05038 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE- 143 (284)
T ss_pred CCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc-
Confidence 6899999998887 66899999999 8999999986555799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++......... +.......++..|++||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 144 --~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 144 --SEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred --CCCCEEEcccccccccccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 6689999999999876532211 1111223456679999999988899999999999999999999999865432
Q ss_pred cch-----------HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTK-----------KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~-----------~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
... ............. ......+|.++.+++..||..+|++||++.++.+.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEGER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hhccccccccccccHHHHHHHHHcCCc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 110 1111111111110 111245788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=238.52 Aligned_cols=196 Identities=19% Similarity=0.259 Sum_probs=159.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|||+++++++....+.|+||||+ +++|.+++......+++..+..++.|++.+|+|||+++|+|+||||.||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~--- 134 (256)
T cd05112 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG--- 134 (256)
T ss_pred CCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---
Confidence 689999999999999999999999 9999999976556799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ .......++..|++||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-- 206 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQY------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-- 206 (256)
T ss_pred CCCeEEECCCcceeecccCcc------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--
Confidence 677899999999986543221 11122345678999999998889999999999999999998 999997633
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
.......+...... ......+.++.+++..||..+|++||++.++.+.|
T Consensus 207 -~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 207 -NSEVVETINAGFRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -HHHHHHHHhCCCCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 22233332221111 11234678999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=254.98 Aligned_cols=190 Identities=21% Similarity=0.253 Sum_probs=162.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+.||.+-+.++..+..||||.+| ||+|.-.|-.. +..|++..++.++.+|+.||++||..+||+|||||+|||++
T Consensus 244 s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD-- 321 (591)
T KOG0986|consen 244 SPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD-- 321 (591)
T ss_pred cCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec--
Confidence 467899999999999999999999 99998666433 45699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
+.|+|.|+|+|||..+...... ...+||..|||||++.++.|+...|+|+|||+||||+.|+.||..-+..
T Consensus 322 -d~GhvRISDLGLAvei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 322 -DHGHVRISDLGLAVEIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred -cCCCeEeeccceEEecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 8899999999999988765432 3459999999999999999999999999999999999999999875554
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
.+.+.+++ ......+++.+.++++..+|++.++..||.+|..+
T Consensus 393 vk~eEvdr----r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 VKREEVDR----RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhHHHHHH----HHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 44433322 22233445667899999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.97 Aligned_cols=201 Identities=20% Similarity=0.243 Sum_probs=152.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||+++++++.++++.|+||++++++|.+++... ........++.|+.||+.||+|||++|||||||||+||||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 379999999999999999999999988888877532 2234567788999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ ..+.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..++.+.
T Consensus 301 ~---~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 301 N---CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred C---CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 6 6788999999999876543221 112467999999999999999999999999999999999987544332
Q ss_pred CccchHHHHHHHHh------hhcc-------------------chHHHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 157 KAGTKKQKYEKISE------KKVS-------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 157 ~~~~~~~~~~~i~~------~~~~-------------------~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
........+.++.. ..+. ..+..+. ..++.++.++|..|+..||.+||++.++
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 22222222211111 0000 0111111 2457788899999999999999998877
Q ss_pred H
Q 015018 210 K 210 (414)
Q Consensus 210 ~ 210 (414)
+
T Consensus 452 L 452 (501)
T PHA03210 452 L 452 (501)
T ss_pred h
Confidence 5
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=247.39 Aligned_cols=197 Identities=18% Similarity=0.295 Sum_probs=154.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~ 78 (414)
++|||+++++.+.++++.|+||||+ |++|.++++. ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~- 134 (308)
T cd06615 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN- 134 (308)
T ss_pred CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe-
Confidence 4699999999999999999999999 8999999975 4679999999999999999999998 5999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++....... .....|+..|++||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 135 --~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 135 --SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred --cCCcEEEccCCCcccccccc---------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 67789999999987553321 1346789999999999988899999999999999999999999965332
Q ss_pred cchHHHHHHH-----------------------------HhhhccchHHHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 159 GTKKQKYEKI-----------------------------SEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 159 ~~~~~~~~~i-----------------------------~~~~~~~~~~~l~-~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
......+... .+.........++ ..++.++.+++..||..+|++||++.+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred hhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111111000 0000000000011 136778999999999999999999766
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
+.
T Consensus 284 ll 285 (308)
T cd06615 284 LT 285 (308)
T ss_pred Hh
Confidence 64
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.46 Aligned_cols=203 Identities=24% Similarity=0.300 Sum_probs=169.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++|+...+....+||||+| ||+|.++++.....++..+.+.++.+.+.||+|||++++|||||-.+|+|++
T Consensus 219 ~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~-- 296 (474)
T KOG0194|consen 219 NHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS-- 296 (474)
T ss_pred CCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec--
Confidence 3799999999999999999999999 9999999987666799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccC-CCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
..+.+||+|||+++.-.... ..+ ...-..+|+|||++...-|+.++|||||||++||+++ |..||.++.
T Consensus 297 -~~~~vKISDFGLs~~~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 297 -KKGVVKISDFGLSRAGSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred -CCCeEEeCccccccCCccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 66778999999987543111 111 1234688999999999999999999999999999998 889999975
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.. +...+|....... ......|.++..++..||..+|++||++.++.+.|+.+....
T Consensus 368 ~~---~v~~kI~~~~~r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 368 NY---EVKAKIVKNGYRM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HH---HHHHHHHhcCccC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 53 3444442222221 123467899999999999999999999999999999887443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=243.51 Aligned_cols=190 Identities=19% Similarity=0.313 Sum_probs=158.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++.+.|+||||+ +++|.+++.. ..+++..+..++.||+.+|.|||+++|+|+||+|+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~--- 132 (274)
T cd06609 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS--- 132 (274)
T ss_pred CCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---
Confidence 689999999999999999999999 8999999984 3899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||+++....... ......++..|++||.+.+..++.++|||||||++|+|++|..||.....
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-- 203 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMS-------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-- 203 (274)
T ss_pred CCCCEEEcccccceeeccccc-------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--
Confidence 678899999999987754321 12345788999999999998899999999999999999999999976432
Q ss_pred hHHHHHHHHhhhccchHHHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~-~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+...... .+... ++.++.+++..||..+|++||+++++.
T Consensus 204 -~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 204 -MRVLFLIPKNNPP----SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred -HHHHHHhhhcCCC----CCcccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 2222222222111 12223 789999999999999999999987774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=242.39 Aligned_cols=199 Identities=18% Similarity=0.260 Sum_probs=160.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|||+++++++.++++.|+||||+ |++|.+++.. ...+++..+..++.||+.+|+|||+.+|+|+||||+||+++
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--- 136 (265)
T cd06631 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM--- 136 (265)
T ss_pred CCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---
Confidence 689999999999999999999999 9999999975 45789999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++........... .........|+..|++||++.+..++.++|+|||||++|+|++|..||......
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~- 214 (265)
T cd06631 137 PNGIIKLIDFGCARRLAWVGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL- 214 (265)
T ss_pred CCCeEEeccchhhHhhhhcccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-
Confidence 678999999999876532111100 001123457899999999999988999999999999999999999999764321
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+.. .......+...++.++.++|..||..+|++||++.+++
T Consensus 215 --~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 215 --AAMFYIGA--HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred --HHHHHhhh--ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 11111111 11222334567889999999999999999999988775
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=245.07 Aligned_cols=196 Identities=19% Similarity=0.287 Sum_probs=152.9
Q ss_pred CCCCCcEEEEeeE-----eCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 1 MAAGIPNLRWFGV-----EGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 1 g~p~I~~l~~~g~-----~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
++|||++++.++. .+++.|+||||+ |++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 152 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG 152 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence 3699999998873 456899999999 9999998752 245689999999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHH
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~el 146 (414)
+||+++ ..+.++|+|||+++.+..... ......|+..|+|||++.. ..++.++|||||||++|+|
T Consensus 153 ~nili~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 153 NNILLT---TEGGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred HhEEEC---CCCCEEEccCCceeecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 999996 667899999999987643221 1123468999999999853 3478899999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
++|..||...... ..+..+...... .......++.++.++|..||..+|++||++.++++
T Consensus 223 ~~g~~p~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 223 GDGDPPLADLHPM---RALFKIPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hcCCCCCCCCchh---HHHhhccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999765331 111111111100 01122346788999999999999999999888764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=243.43 Aligned_cols=200 Identities=21% Similarity=0.302 Sum_probs=159.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.+++..++||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++ .
T Consensus 62 h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~ 138 (268)
T cd06630 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--S 138 (268)
T ss_pred CCceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--C
Confidence 689999999999999999999999 9999999975 45799999999999999999999999999999999999995 2
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
....++|+|||++..+........ .......++..|++||.+.+..++.++|+|+||+++|+|++|..||.......
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 139 TGQRLRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred CCCEEEEcccccccccccccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 334799999999987654322111 11234578999999999998889999999999999999999999997543322
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.......+... .....+...+++++.+++..|+..+|++||++.+++
T Consensus 216 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 216 HLALIFKIASA---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred hHHHHHHHhcc---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 22222221111 111223345678999999999999999999988875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=247.58 Aligned_cols=210 Identities=19% Similarity=0.268 Sum_probs=172.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|.+..|.+.|+..+..|+||||. ||.|.-.+.. .+.|++..+..+...|+.||.|||+++||+||||.+|+|++
T Consensus 227 HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD--- 302 (516)
T KOG0690|consen 227 HPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD--- 302 (516)
T ss_pred CcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---
Confidence 466778889999999999999999 9999877764 66899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++|++||+||||++.-..... ..++++||+.|+|||++....|++.+|+|.+|||||||++|++||...+.
T Consensus 303 kDGHIKitDFGLCKE~I~~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-- 373 (516)
T KOG0690|consen 303 KDGHIKITDFGLCKEEIKYGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-- 373 (516)
T ss_pred cCCceEeeecccchhcccccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--
Confidence 889999999999985332221 23679999999999999999999999999999999999999999977432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC--CHHHHHHHHHHHHHHhCCCCCCccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 237 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP--~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~ 237 (414)
...++-|.-..+. ++..+.++...|+.-++.+||.+|. ..++.+++.++-| ....+|+....+.
T Consensus 374 -~kLFeLIl~ed~k-----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F-------F~~v~W~~~~~Kk 439 (516)
T KOG0690|consen 374 -EKLFELILMEDLK-----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF-------FASVDWEATYRKK 439 (516)
T ss_pred -hHHHHHHHhhhcc-----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh-------hccCCHHHHHHhc
Confidence 2333333333322 3456789999999999999999997 3667777776665 3456888755443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=247.99 Aligned_cols=195 Identities=21% Similarity=0.272 Sum_probs=155.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++.+.++++.|+||||+ |++|.+++... +..+++..+..++.||+.+|+|||+.||+|+||||+||+++
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-- 137 (316)
T cd05574 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH-- 137 (316)
T ss_pred CCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc--
Confidence 689999999999999999999999 99999998743 46799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccc----------------------cccccCCCCCCccccchhhhcCCCCCchhHHH
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLE 137 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~----------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dvw 137 (414)
.++.++|+|||++............ .-.....+.|+..|++||++.+..++.++|||
T Consensus 138 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 216 (316)
T cd05574 138 -ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWW 216 (316)
T ss_pred -CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHH
Confidence 6788999999998765332111000 00011245789999999999998899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 138 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 138 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
|||+++|+|++|..||.+... ...+..+........ ....++.++.+++..||..+|++||+
T Consensus 217 slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 217 TLGILLYEMLYGTTPFKGSNR---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred HHHHHHHHHhhCCCCCCCCch---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 999999999999999977532 233333332222111 11226899999999999999999998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-29 Score=269.82 Aligned_cols=194 Identities=18% Similarity=0.261 Sum_probs=152.1
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecC
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRD 68 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~-------givHRD 68 (414)
+|||++++.++.+ ....||||||+ +++|.++|... ...|++..++.|+.||+.||+|||.. +|||||
T Consensus 71 HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRD 150 (1021)
T PTZ00266 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRD 150 (1021)
T ss_pred CCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceecc
Confidence 6999999988755 46789999999 89999998643 35799999999999999999999984 499999
Q ss_pred CCCCcEEEeec--------------CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCc
Q 015018 69 IKPDNFLMGLG--------------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSR 132 (414)
Q Consensus 69 IKP~NILl~~~--------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ 132 (414)
|||+||||+.+ .....+||+|||++..+..... .....||+.|+|||++.+ ..++.
T Consensus 151 LKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~ 222 (1021)
T PTZ00266 151 LKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDD 222 (1021)
T ss_pred CcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCc
Confidence 99999999632 1234589999999986543221 134579999999999965 34788
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 133 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 133 ~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
++||||||||||+|++|..||..... ..+.+..+.... .. ....++.++.+||..||..+|++||++.+++
T Consensus 223 KSDVWSLG~ILYELLTGk~PF~~~~~--~~qli~~lk~~p-~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 223 KSDMWALGCIIYELCSGKTPFHKANN--FSQLISELKRGP-DL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCc--HHHHHHHHhcCC-CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99999999999999999999976432 222222222211 11 1235688999999999999999999987775
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=247.37 Aligned_cols=192 Identities=20% Similarity=0.310 Sum_probs=157.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..++..|+||||+ |++|..++. ...+++.+++.++.|++.+|+|||++||+|+||||+||+++
T Consensus 75 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~--- 149 (296)
T cd06655 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG--- 149 (296)
T ss_pred CCceeeeeeeEecCceEEEEEEecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---
Confidence 689999999999999999999999 999999887 34699999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||++........ ......++..|++||.+.+..++.++|+|||||++|+|++|..||.+....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~- 221 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL- 221 (296)
T ss_pred CCCCEEEccCccchhcccccc-------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 678899999999876543221 112357889999999999888999999999999999999999999775332
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+..... ........++.++.++|..||..+|++||++.+|.
T Consensus 222 --~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 222 --RALYLIATNGT--PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred --HHHHHHHhcCC--cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 11112211111 11112346788999999999999999999987775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=242.62 Aligned_cols=197 Identities=19% Similarity=0.238 Sum_probs=158.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++.++.+.|+||||+|++|.+++......+++.++..++.||+.+|+|||+.||+|+||||+||+++ .
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~ 134 (286)
T cd07832 58 HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---A 134 (286)
T ss_pred CCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---C
Confidence 6899999999999999999999999999999976667899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.++|+|||++........ .......|+..|++||++.+.. ++.++|||||||++|+|++|..||.+....
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~- 207 (286)
T cd07832 135 DGVLKIADFGLARLFSEEEP------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI- 207 (286)
T ss_pred CCcEEEeeeeecccccCCCC------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-
Confidence 78899999999986654321 1123457899999999987544 588999999999999999998888764322
Q ss_pred hHHHHHHHHhhh-------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+..+.... ....+..+...++.++.+++..|+..+|++||+++++.
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 208 --EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred --HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 2222211100 00012233346678999999999999999999987765
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=249.29 Aligned_cols=194 Identities=16% Similarity=0.283 Sum_probs=158.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++..+++.|+||||+ +++|..++. ...+++..++.++.||+.||+|||+.||+||||||+||+++
T Consensus 76 ~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~-- 151 (297)
T cd06659 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT-- 151 (297)
T ss_pred CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc--
Confidence 4799999999999999999999999 899999876 35799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 152 -~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-- 221 (297)
T cd06659 152 -LDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-- 221 (297)
T ss_pred -cCCcEEEeechhHhhcccccc-------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 678999999999875433221 1234578999999999998889999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+....... ......++.++.+++..||..+|++||++.+++.
T Consensus 222 -~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 222 -PVQAMKRLRDSPPPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred -HHHHHHHHhccCCCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 223333332221111 1123457889999999999999999999887765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=243.09 Aligned_cols=205 Identities=20% Similarity=0.232 Sum_probs=156.1
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.. ....|+||||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 64 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~- 142 (284)
T cd05081 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE- 142 (284)
T ss_pred CCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC-
Confidence 6899999887643 45789999999 9999999976556799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++......... +.......++..|++||++.+..++.++|+|||||++|||++|..++.....
T Consensus 143 --~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 143 --SENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred --CCCeEEECCCcccccccCCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 6788999999999876442211 0011122345569999999988899999999999999999998877654321
Q ss_pred cchH------------HHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 159 GTKK------------QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 159 ~~~~------------~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
.-.. ..+..+..... .......++.++.+++..||..+|++||++.+|.+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1000 00000000000 0012245788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=239.18 Aligned_cols=193 Identities=21% Similarity=0.266 Sum_probs=159.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+..++..++||||+ |++|.+++... ...+++..+..++.|++.+|+|||++||+|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~-- 135 (256)
T cd08220 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD-- 135 (256)
T ss_pred CCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 689999999999999999999999 89999999754 44689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.++|+|||++........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||.+...
T Consensus 136 ~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~- 206 (256)
T cd08220 136 KHKMVVKIGDFGISKILSSKSK--------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL- 206 (256)
T ss_pred CCCCEEEEccCCCceecCCCcc--------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-
Confidence 3446789999999987654321 1235788999999999988889999999999999999999999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+..+..... ..+...++.++.+++..||..+|++||++.++..
T Consensus 207 --~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 207 --PALVLKIMSGTF----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --HHHHHHHHhcCC----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 223333322221 1234567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=241.87 Aligned_cols=198 Identities=18% Similarity=0.313 Sum_probs=160.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~--------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
.|||++++.++.+.++.|+||||+ +++|.+++.... ..+++..+..++.||+.+|+|||+++|+||||||+
T Consensus 67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~ 146 (275)
T cd05046 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAAR 146 (275)
T ss_pred CcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccc
Confidence 689999999999999999999999 899999997432 16899999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~ 151 (414)
|||++ ..+.++|+|||+++...... +.......++..|++||.+.+..++.++||||||+++|+|++ |..
T Consensus 147 Nili~---~~~~~~l~~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 147 NCLVS---SQREVKVSLLSLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred eEEEe---CCCcEEEcccccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99996 67889999999987543221 112233466788999999988888999999999999999998 899
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
||.+... .+.+..+....... .....+|..+.+++..||..+|++||++.++...|.
T Consensus 218 p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 218 PFYGLSD---EEVLNRLQAGKLEL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cccccch---HHHHHHHHcCCcCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 9976432 23333333222211 123468899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=244.95 Aligned_cols=192 Identities=21% Similarity=0.289 Sum_probs=158.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+..+++.|+||||+ +++|.+++. ...+++..+..++.||+.+|.|||+++|+|+||+|+||+++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~-- 135 (277)
T cd06642 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS-- 135 (277)
T ss_pred CCCccHhhhcccccCCceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe--
Confidence 4799999999999999999999999 899999886 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+..... ......|+..|++||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 136 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06642 136 -EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM 207 (277)
T ss_pred -CCCCEEEccccccccccCcch-------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 678899999999976543221 112356889999999999988999999999999999999999999765432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... ..+.... ...+...++.++.+++..||..+|++||++.++..
T Consensus 208 ~~~---~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 208 RVL---FLIPKNS----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hHH---hhhhcCC----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 211 1111111 11233457889999999999999999999888865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=241.28 Aligned_cols=191 Identities=18% Similarity=0.304 Sum_probs=155.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..+.+.|+||||+ |++|.+++.. ..+++..++.++.||+.+|.|||+.||+|+||+|+||+++
T Consensus 61 ~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~--- 135 (277)
T cd06917 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT--- 135 (277)
T ss_pred CCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---
Confidence 799999999999999999999999 9999999873 4899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++..+..... ......|+..|++||.+.+ ..++.++|+|||||++|+|++|..||.+...
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~- 207 (277)
T cd06917 136 NTGNVKLCDFGVAALLNQNSS-------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA- 207 (277)
T ss_pred CCCCEEEccCCceeecCCCcc-------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 678999999999987654331 1123578999999999875 4578899999999999999999999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhc-CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~-~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+..+.... ...+.. .++.++.+++..||..+|++||++.++..
T Consensus 208 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 208 --FRAMMLIPKSK----PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --hhhhhccccCC----CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111111111 111222 37889999999999999999999887754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=245.51 Aligned_cols=195 Identities=20% Similarity=0.365 Sum_probs=154.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl 76 (414)
++|||++++.++..+...|+||||+.++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+|||+
T Consensus 58 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 58 DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred CCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 369999999999999999999999988998888642 34699999999999999999999997 99999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC----CCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
+ .++.+||+|||++..+..... .....++..|++||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus 138 ~---~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 138 N---RNGQVKLCDFGISGYLVDSVA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred C---CCCCEEEeecccccccccccc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 6 678999999999986543211 122468899999999865 3468899999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
|..... ..+.+..+....... + ....+|+++.++|..||..+|++||++.++++
T Consensus 207 ~~~~~~--~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 207 YDSWKT--PFQQLKQVVEEPSPQ-L--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcccc--CHHHHHHHHhcCCCC-C--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 965322 122222222211111 0 11347899999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=239.62 Aligned_cols=197 Identities=21% Similarity=0.329 Sum_probs=161.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NIL 75 (414)
.+|||++++.++.++++.|+||||+ |++|.+++.. ....+++..++.++.|++.+|.|||+ .+|+|+||||+|||
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil 146 (269)
T cd08528 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIM 146 (269)
T ss_pred CCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEE
Confidence 3689999999999999999999999 8999998743 34579999999999999999999996 78999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ ..+.++|+|||++....... ......|+..|++||++.+..++.++|+||||+++|+|++|..||..
T Consensus 147 ~~---~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 147 LG---EDDKVTITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred EC---CCCcEEEecccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 96 67889999999998754432 11345789999999999988899999999999999999999999965
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 214 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~ 214 (414)
.. .......+........ ....+++++.++|..||..+|++||++.++...++
T Consensus 216 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 216 TN---MLSLATKIVEAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC---HHHHHHHHhhccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 42 2222333332222111 11256789999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=243.13 Aligned_cols=197 Identities=17% Similarity=0.307 Sum_probs=156.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+...++.||||||+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ .+|+||||||+||+++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-- 138 (284)
T cd06620 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN-- 138 (284)
T ss_pred CCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC--
Confidence 689999999999999999999999 8999999875 4579999999999999999999997 6999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ ....|+..|++||++.+..++.++|+|||||++|+|++|..||......
T Consensus 139 -~~~~~~l~d~gl~~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 139 -SRGQIKLCDFGVSGELINSIA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred -CCCcEEEccCCcccchhhhcc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 678899999999875433211 2357899999999998888999999999999999999999999864431
Q ss_pred -----chHHHHHHHHhhhccchHHHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 160 -----TKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 160 -----~~~~~~~~i~~~~~~~~~~~l~-~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
....... ............+. ..+|.++.+++..|+..+|++||+++++.+.
T Consensus 209 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 209 DDGQDDPMGILD-LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhhhhhHHHH-HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111111 11111111111111 2377899999999999999999999887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=239.56 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=154.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~l--s~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
.+|||++++.++..+++.++||||+ +++|.+++......+ +...++.++.||+.||+|||.+||+||||||+||+++
T Consensus 63 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~ 142 (268)
T cd06624 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN 142 (268)
T ss_pred CCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 3689999999999999999999999 899999987543455 8899999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
...+.++|+|||++..+..... ......|+..|++||.+.+.. ++.++|+||||+++|+|++|..||..
T Consensus 143 --~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 143 --TYSGVVKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred --CCCCeEEEecchhheecccCCC-------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 2357899999999876543221 112346899999999987643 78899999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...... ..+ .+. .......+...+++++.+++..||..+|++||++.++.
T Consensus 214 ~~~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 214 LGEPQA-AMF-KVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred ccChhh-hHh-hhh---hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 432111 111 111 01111123456788999999999999999999988775
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=242.97 Aligned_cols=197 Identities=19% Similarity=0.191 Sum_probs=156.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.|+||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~ 137 (298)
T cd07841 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---S 137 (298)
T ss_pred CCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---C
Confidence 6899999999999999999999999999999975334799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.++|+|||+++.+..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~- 209 (298)
T cd07841 138 DGVLKLADFGLARSFGSPNR-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI- 209 (298)
T ss_pred CCCEEEccceeeeeccCCCc-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-
Confidence 78899999999987654321 1123456888999999865 45788999999999999999998888764432
Q ss_pred hHHHHHHHHhhh-----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.++.... .......+....+.++.++|..||..+|++||++.++++
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 210 --DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred --HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 2222222110 001111223455788999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=241.12 Aligned_cols=193 Identities=20% Similarity=0.366 Sum_probs=158.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+..++..||||||+ +++|.+++......+++..+..++.||+.+|+|||+ .|++|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~-- 135 (265)
T cd06605 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN-- 135 (265)
T ss_pred CCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC--
Confidence 689999999999999999999999 799999998655789999999999999999999999 9999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA- 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~- 158 (414)
..+.++|+|||++........ ....++..|++||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 136 -~~~~~~l~d~g~~~~~~~~~~---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 205 (265)
T cd06605 136 -SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205 (265)
T ss_pred -CCCCEEEeecccchhhHHHHh---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Confidence 678899999999876543221 125788999999999998999999999999999999999999976421
Q ss_pred -cchHHHHHHHHhhhccchHHHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 -GTKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 -~~~~~~~~~i~~~~~~~~~~~l~~~-~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+....+...... .+... ++.++.++|..||..+|++||++.++.
T Consensus 206 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 206 PDGIFELLQYIVNEPPP----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred cccHHHHHHHHhcCCCC----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 1122222222222111 12222 788999999999999999999988775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=242.91 Aligned_cols=193 Identities=19% Similarity=0.300 Sum_probs=157.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++..+++.|+||||+ |++|.+++.. .++++..+..++.||+.+|+|||++||+||||||+||+++
T Consensus 74 ~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~-- 149 (285)
T cd06648 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT-- 149 (285)
T ss_pred CCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc--
Confidence 4799999999999999999999999 9999999874 5799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......|+..|++||.+.+..++.++|+|||||++|+|++|..||.+..
T Consensus 150 -~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-- 219 (285)
T cd06648 150 -SDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-- 219 (285)
T ss_pred -CCCcEEEcccccchhhccCCc-------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--
Confidence 678999999998865433211 1123578999999999998889999999999999999999999997633
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+....... . .....++.++.+++..||..+|++||++.++.
T Consensus 220 -~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 220 -PLQAMKRIRDNLPPK-L-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred -HHHHHHHHHhcCCCC-C-cccccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 233333333321111 1 11223778999999999999999999987765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=247.80 Aligned_cols=196 Identities=19% Similarity=0.369 Sum_probs=157.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++.++.+.|+||||++++|.+++......+++..+..++.||+.+|+|||+ .||+||||+|+||+++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-- 149 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-- 149 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc--
Confidence 4799999999999999999999999889999887666789999999999999999999997 5999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.++|+|||++..+..... .....++..|++||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 150 -~~~~~kL~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 150 -ASGNVKLCDFGISGRLVDSKA--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred -CCCCEEECccccchhccCCCc--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 678999999999876543221 11235788999999987654 78899999999999999999999965
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... ..+.+..+....... .. ....++.++.+++..||..+|++||+++++..
T Consensus 221 ~~~--~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 221 CKT--EFEVLTKILQEEPPS-LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred chh--HHHHHHHHhcCCCCC-CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 321 122333332222111 10 11247889999999999999999999888753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=271.73 Aligned_cols=209 Identities=25% Similarity=0.356 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~----------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
.+|||++++..+.+++..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 60 ~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDL 139 (932)
T PRK13184 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDL 139 (932)
T ss_pred CCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 3699999999999999999999999 99999998632 234667888999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcc-----------cccccccCCCCCCccccchhhhcCCCCCchhHHHH
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-----------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwS 138 (414)
||+|||++ ..+.++|+|||+++......... ...........||+.|+|||++.+..++.++||||
T Consensus 140 KPeNILLd---~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWS 216 (932)
T PRK13184 140 KPDNILLG---LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216 (932)
T ss_pred chheEEEc---CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHH
Confidence 99999996 67889999999998762211000 00011123467999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHH-HhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHH
Q 015018 139 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL 216 (414)
Q Consensus 139 lGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-~l~~~~p~e~~~li~~c~~~dp~~RP-~~~~l~~~l~~~ 216 (414)
|||++|||++|..||....... ..+. ........ .....+|+.+.+++..|+..+|++|+ +.+++.+.|+..
T Consensus 217 LGVILyELLTG~~PF~~~~~~k--i~~~----~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 217 LGVILYQMLTLSFPYRRKKGRK--ISYR----DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHHHHHHHHHCCCCCCCcchhh--hhhh----hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999997633211 1111 11111110 11246789999999999999999997 577888888877
Q ss_pred HH
Q 015018 217 FI 218 (414)
Q Consensus 217 ~~ 218 (414)
+.
T Consensus 291 lq 292 (932)
T PRK13184 291 LQ 292 (932)
T ss_pred Hh
Confidence 64
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=239.41 Aligned_cols=198 Identities=21% Similarity=0.370 Sum_probs=158.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|||+++++++...+..++||||+ |++|.+++... ..++...+..++.||+.+|.|||+++++|+||||+||+++
T Consensus 67 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~--- 142 (272)
T cd06629 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD--- 142 (272)
T ss_pred CCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---
Confidence 689999999999999999999999 99999999754 5799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ .......|+..|++||.+.... ++.++|+||||+++|++++|..||....
T Consensus 143 ~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~- 216 (272)
T cd06629 143 ADGICKISDFGISKKSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE- 216 (272)
T ss_pred CCCeEEEeeccccccccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-
Confidence 6789999999999764432111 1123456899999999988655 7889999999999999999999996532
Q ss_pred cchHHHHHHHHhhh-ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKK-VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~-~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+.... ...........++.++.+++..||..+|++||++++++.
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 217 --AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred --hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 222222222111 111222334567899999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=239.62 Aligned_cols=189 Identities=18% Similarity=0.229 Sum_probs=156.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.++++.|+||||+ |++|.+++.. ...++...+..++.||+.||+|||+++++|+||||+||+++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~-- 127 (262)
T cd05572 51 NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD-- 127 (262)
T ss_pred CCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc--
Confidence 3689999999999999999999999 9999999975 45699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ .....++..|++||.+.+..++.++|+|+||+++|+|++|..||.....
T Consensus 128 -~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 197 (262)
T cd05572 128 -SNGYVKLVDFGFAKKLKSGQK--------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE- 197 (262)
T ss_pred -CCCCEEEeeCCcccccCcccc--------cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-
Confidence 678899999999987654321 1234688999999999888899999999999999999999999987543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
+..+.+..+....... .....++.++.++|..||..+|++||+
T Consensus 198 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 198 DPMEIYNDILKGNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred CHHHHHHHHhccCCCC---CCCcccCHHHHHHHHHHccCChhhCcC
Confidence 2333333333211111 122345789999999999999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=242.22 Aligned_cols=181 Identities=24% Similarity=0.310 Sum_probs=154.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+.++++.|+||||+ +++|.+++.. ...+++..+..++.||+.+|+|||++||+|+||+|.|||++
T Consensus 60 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~--- 135 (290)
T cd05580 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD--- 135 (290)
T ss_pred CCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---
Confidence 699999999999999999999999 9999999975 46899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||+++..... .....+++.|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 136 ~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 202 (290)
T cd05580 136 SDGYIKITDFGFAKRVKGR----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--- 202 (290)
T ss_pred CCCCEEEeeCCCccccCCC----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---
Confidence 6788999999998875442 123578999999999988888999999999999999999999997643
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
..+.+..+..... .+...++..+.+++..||..+|.+|+
T Consensus 203 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 203 PIQIYEKILEGKV-----RFPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred HHHHHHHHhcCCc-----cCCccCCHHHHHHHHHHccCCHHHcc
Confidence 2333333332222 23345688999999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=259.52 Aligned_cols=197 Identities=19% Similarity=0.335 Sum_probs=169.3
Q ss_pred CCCCcEEEEeeEeCCE--EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGDY--NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~--~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NILl 76 (414)
+|||+++|.++.+.+. ..+|.|++ .|+|..|+++ .++++.+.+..|++||++||.|||++. |||||||.+||+|
T Consensus 100 H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFi 178 (632)
T KOG0584|consen 100 HPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFV 178 (632)
T ss_pred CCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEE
Confidence 6999999999998665 78999999 9999999986 568999999999999999999999985 9999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
. ..-|.|||.|+|||........ +..+|||.|||||+.. +.|...+||||||++|+||+|+..||..-
T Consensus 179 n--G~~G~VKIGDLGLAtl~r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 179 N--GNLGEVKIGDLGLATLLRKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred c--CCcCceeecchhHHHHhhcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 6 5679999999999987655432 3469999999999998 78999999999999999999999999765
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+..|.|.++.....+..+..+. .+++++||+.|+.. ..+|+++. ++|.+.|...
T Consensus 247 --~n~AQIYKKV~SGiKP~sl~kV~---dPevr~fIekCl~~-~~~R~sa~---eLL~d~Ff~~ 301 (632)
T KOG0584|consen 247 --TNPAQIYKKVTSGIKPAALSKVK---DPEVREFIEKCLAT-KSERLSAK---ELLKDPFFDE 301 (632)
T ss_pred --CCHHHHHHHHHcCCCHHHhhccC---CHHHHHHHHHHhcC-chhccCHH---HHhhChhhcc
Confidence 35788999998877776655443 48999999999998 89999965 4455555443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=245.79 Aligned_cols=194 Identities=21% Similarity=0.322 Sum_probs=156.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+..+++.|+||||+ |++|.+++. ...+++..+..++.|++.+|.|||+.||+||||||+|||++
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~-- 149 (297)
T cd06656 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG-- 149 (297)
T ss_pred CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC--
Confidence 3699999999999999999999999 999999987 35689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......+++.|++||.+.+..++.++|+|||||++|++++|..||.+....
T Consensus 150 -~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 150 -MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred -CCCCEEECcCccceEccCCcc-------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 678899999999986543221 112357889999999999988999999999999999999999999764321
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.. .+ .+.... .........++..+.+++..||..+|++||++.++.+
T Consensus 222 ~~--~~-~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 222 RA--LY-LIATNG--TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred hh--ee-eeccCC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11 111100 0001122456788999999999999999999877753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=241.47 Aligned_cols=197 Identities=20% Similarity=0.241 Sum_probs=153.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.|+||||++++|.+++......+++..+..++.||+.||+|||+++|+||||||+||+++ .
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~ 138 (291)
T cd07844 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---E 138 (291)
T ss_pred CcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---C
Confidence 5899999999999999999999997799999886666899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.++|+|||+++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+....
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~- 210 (291)
T cd07844 139 RGELKLADFGLARAKSVPSK-------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV- 210 (291)
T ss_pred CCCEEECccccccccCCCCc-------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-
Confidence 78899999999875432111 1122356889999999876 45789999999999999999999999764311
Q ss_pred hHHHHHHHHhh-------------------------hccchHHHhhcCCc--HHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEK-------------------------KVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~-------------------------~~~~~~~~l~~~~p--~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+... .....+......+. .++.+++..|+..+|++||++.+++
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 211 -EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred -HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 1111111100 00011111122333 7888999999999999999988765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=235.81 Aligned_cols=193 Identities=20% Similarity=0.209 Sum_probs=160.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+...++.|+||||+ +++|.+++... ...+++..++.++.|++.+|.|||+++++|+||+|+|||++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~-- 135 (256)
T cd08218 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-- 135 (256)
T ss_pred CCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--
Confidence 689999999999999999999999 99999998753 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++..+..... ......|+..|++||++.+..++.++|+|||||++|+|++|..||...
T Consensus 136 -~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--- 204 (256)
T cd08218 136 -KDGTIKLGDFGIARVLNSTVE-------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--- 204 (256)
T ss_pred -CCCCEEEeeccceeecCcchh-------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---
Confidence 677899999999987654321 112346889999999999888999999999999999999999999653
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+....+..+...... .....++.++.++|..||+.+|++||++.++.+
T Consensus 205 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 NMKNLVLKIIRGSYP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHHHHHHHHhcCCCC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 333344443332222 234567889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=239.63 Aligned_cols=196 Identities=20% Similarity=0.313 Sum_probs=153.7
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
.+|||++++.++.+. ++.|+||||+ +++|.+++... +..+++..+..++.||+.||+|||+++|+|+||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~ 140 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 368999999998764 4589999999 88999998643 4679999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-----CCCchhHHHHHHHHHHH
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMY 145 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~~~DvwSlGvvl~e 145 (414)
|+||+++ .++.++|+|||++........ ......|+..|+|||++... .++.++|||||||+||+
T Consensus 141 p~ni~~~---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 141 GQNILLT---KNAEVKLVDFGVSAQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred HHHEEEc---cCCeEEECCCccceecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 9999996 678899999999986543221 11345789999999988643 36778999999999999
Q ss_pred HHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 146 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 146 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
|++|..||..... ...+..+........ .....+++++.+++..||..||++||++.+|.+
T Consensus 211 l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHP---MRALFKIPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccch---HHHHHHhhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999975432 222222222211110 011246789999999999999999999888753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=240.74 Aligned_cols=198 Identities=19% Similarity=0.215 Sum_probs=155.9
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++... .+.||||||++++|.+++......+++..++.++.||+.||+|||+++|+|+||||+||+++
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~- 140 (293)
T cd07843 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN- 140 (293)
T ss_pred CCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC-
Confidence 369999999988877 89999999997799999986666799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++..+..... ......++..|++||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 141 --~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 141 --NRGILKICDFGLAREYGSPLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred --CCCcEEEeecCceeeccCCcc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999987655321 112346788999999987644 6889999999999999999999998754
Q ss_pred ccchHHHHHHHHhhhc---c----------------------chHHHhhcC--CcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKV---S----------------------TSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~---~----------------------~~~~~l~~~--~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... .+.++..... . ..+...... +++.+.++|..||..+|++||++.+++
T Consensus 212 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 212 EID---QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred hHH---HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 322 2222211100 0 000011111 477899999999999999999988775
Q ss_pred H
Q 015018 211 R 211 (414)
Q Consensus 211 ~ 211 (414)
.
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=236.16 Aligned_cols=193 Identities=23% Similarity=0.304 Sum_probs=158.8
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCC
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH-----~~givHRDIK 70 (414)
+|||++++.++.. +...|++|||+ +++|.+++... ..++++..++.++.||+.+|+||| +.+|+|+|||
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~ 137 (265)
T cd08217 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137 (265)
T ss_pred CCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCC
Confidence 6899999987754 55789999999 89999998754 567999999999999999999999 8999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~ 150 (414)
|+||+++ ..+.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|.
T Consensus 138 p~nili~---~~~~~kl~d~g~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 138 PANIFLD---ANNNVKLGDFGLAKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred HHHEEEe---cCCCEEEecccccccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 9999996 678999999999987654321 012357899999999999888999999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.||.... ..+....+..... ..+...++.++.+++..|+..+|++||++.+|++
T Consensus 208 ~p~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 208 PPFTARN---QLQLASKIKEGKF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CcccCcC---HHHHHHHHhcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9998743 2233333332222 2344567899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=239.20 Aligned_cols=191 Identities=20% Similarity=0.246 Sum_probs=154.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++..+...++.|+||||+ |++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||+|+||+++
T Consensus 52 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~-- 129 (277)
T cd05577 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD-- 129 (277)
T ss_pred CCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC--
Confidence 689999999999999999999999 899999886433 3699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++....... ......++..|++||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 130 -~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 200 (277)
T cd05577 130 -DHGNVRISDLGLAVELKGGK--------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200 (277)
T ss_pred -CCCCEEEccCcchhhhccCC--------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence 67889999999987543311 123456888999999999888999999999999999999999999775432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
.....+ ...... ....+...+++++.++|..||+.+|.+||++.
T Consensus 201 ~~~~~~---~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 244 (277)
T cd05577 201 VEKEEL---KRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244 (277)
T ss_pred ccHHHH---Hhcccc-ccccCCccCCHHHHHHHHHHccCChhHccCCC
Confidence 222211 111111 11123456789999999999999999999443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=241.98 Aligned_cols=196 Identities=19% Similarity=0.279 Sum_probs=153.5
Q ss_pred CCCCCcEEEEeeEeC-----CEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 1 MAAGIPNLRWFGVEG-----DYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 1 g~p~I~~l~~~g~~~-----~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
++|||++++.++... ...|+||||+ |++|.++++. ....+++..+..++.|++.+|+|||+++|+||||||
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp 156 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG 156 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 368999999988754 3689999999 9999998863 356799999999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-----CCchhHHHHHHHHHHHH
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYF 146 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~~~DvwSlGvvl~el 146 (414)
+||+++ ..+.++|+|||++........ ......|+..|++||.+.... ++.++|+|||||++|+|
T Consensus 157 ~nili~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 157 NNILLT---TEGGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred HHEEEc---CCCCEEEeecccchhcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 999996 677899999999876543221 112346899999999986432 57899999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
++|+.||..... ...+..+........ .....++.++.++|..||..+|++||++.+|..
T Consensus 227 ~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 227 GDGDPPLFDMHP---VKTLFKIPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hhCCCCCCCCcH---HHHHHHHhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999999976432 223333322221111 112345678999999999999999999887753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=239.66 Aligned_cols=199 Identities=20% Similarity=0.279 Sum_probs=154.3
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
++|||++++.++.+. ...||||||+ |++|.+++.. ....+++..+..++.||+.+|.|||+.+++|+||+|+||
T Consensus 57 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~ni 136 (287)
T cd06621 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNI 136 (287)
T ss_pred CCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 479999999887654 4789999999 8999988753 245689999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+++ ..+.++|+|||++........ ....++..|++||.+.+..++.++|+|+|||++|+|++|..||.
T Consensus 137 l~~---~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 137 LLT---RKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred EEe---cCCeEEEeecccccccccccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 996 667899999999865433211 23467889999999999899999999999999999999999998
Q ss_pred CCCc--cchHHHHHHHHhhhccchHHHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKA--GTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~--~~~~~~~~~i~~~~~~~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.... ....+....+............. ..+++++.+++..||..+|.+||++.++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 6532 12223333222211111100111 134678999999999999999999876653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=235.22 Aligned_cols=195 Identities=24% Similarity=0.355 Sum_probs=163.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++..++..++||||+ +++|.+++.. ...+++..++.++.||+.+|+|||+ .+++|+||+|+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~-- 134 (264)
T cd06623 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN-- 134 (264)
T ss_pred CCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC--
Confidence 689999999999999999999999 8999999975 3689999999999999999999999 9999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++......... .....++..|++||.+.+..++.++|+|+||+++|+|++|..||......
T Consensus 135 -~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 206 (264)
T cd06623 135 -SKGEVKIADFGISKVLENTLDQ-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206 (264)
T ss_pred -CCCCEEEccCccceecccCCCc-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc
Confidence 6789999999999876443221 12356889999999999888999999999999999999999999876533
Q ss_pred chHHHHHHHHhhhccchHHHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~-~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+....+..... ..+... ++..+.+++..|+..+|++||++.++.+
T Consensus 207 ~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 207 SFFELMQAICDGPP----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CHHHHHHHHhcCCC----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33444444332222 223344 7899999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=251.21 Aligned_cols=205 Identities=23% Similarity=0.319 Sum_probs=156.7
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~v~~ia~Qll~gL~yLH~~g---ivHRDIKP~NIL 75 (414)
+|||++|++||.+++ ..+||+||+ .|+|.+.+..... .++|...++|+.++++||+|||... |||||||+.|||
T Consensus 130 H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 130 HPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred CcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 699999999999999 599999999 8999999975444 8999999999999999999999854 999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCC-CCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|+ .+...||+|||+|+....... +. ... .||..|++||++.....+.++||||||++|+||++|+.+..
T Consensus 210 LD---~~~~aKlsDFGLa~~~~~~~~--~~-----~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 210 LD---EDFNAKLSDFGLAKLGPEGDT--SV-----STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred EC---CCCCEEccCccCcccCCcccc--ce-----eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 96 789999999999965433111 10 112 79999999999998889999999999999999999998887
Q ss_pred CCCccchHHHHH----HHHhhhccchHH-Hhh-cCCc--HH---HHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 155 GLKAGTKKQKYE----KISEKKVSTSIE-ALC-RGYP--TE---FASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 155 ~~~~~~~~~~~~----~i~~~~~~~~~~-~l~-~~~p--~e---~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
...........+ .+.+......+. .+. ..++ .+ +..+...|++.++.+||++.++.+.|+.+
T Consensus 280 ~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 280 QSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 543211111111 111111211111 111 2333 22 56677899999999999999987777444
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=240.05 Aligned_cols=196 Identities=19% Similarity=0.205 Sum_probs=159.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++.+++..++||||++++|.+++......+++..+..++.||+.+|+|||+.+|+|+||||+||+++ .
T Consensus 57 ~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~ 133 (283)
T cd05118 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---T 133 (283)
T ss_pred CCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---C
Confidence 6899999999999999999999997799999876667899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.++|+|||.+........ ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||.+....
T Consensus 134 ~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~- 205 (283)
T cd05118 134 EGVLKLADFGLARSFGSPVR-------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI- 205 (283)
T ss_pred CCcEEEeeeeeeEecCCCcc-------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 78899999999987655331 11235688899999999876 6889999999999999999999999764322
Q ss_pred hHHHHHHHHhhh-------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.+.++.+.. .......+...++.++.++|..||..+|.+||++.++.
T Consensus 206 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 206 --DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred --HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 2222221110 00111223445788999999999999999999988775
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=244.28 Aligned_cols=206 Identities=17% Similarity=0.246 Sum_probs=155.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++..+.+.+..|++|||+ +++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||+++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~- 135 (314)
T cd08216 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS- 135 (314)
T ss_pred CCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe-
Confidence 3689999999999999999999999 89999998743 45699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.++.++|+|||.+..+..................++..|++||++.+. .++.++|+|||||++|+|++|..||...
T Consensus 136 --~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 136 --GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred --cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 668899999999876643222111111112345678899999998763 4788999999999999999999999864
Q ss_pred CccchHHHHHHHHhhh---------------cc-------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 157 KAGTKKQKYEKISEKK---------------VS-------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~---------------~~-------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
... ....+++.... .. .........+..++.+++..||..+|++||++++
T Consensus 214 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 214 PAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred CHH--HHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 321 11112211000 00 0000011123467899999999999999999876
Q ss_pred HHH
Q 015018 209 LKR 211 (414)
Q Consensus 209 l~~ 211 (414)
+++
T Consensus 292 ll~ 294 (314)
T cd08216 292 LLN 294 (314)
T ss_pred Hhc
Confidence 653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=237.48 Aligned_cols=200 Identities=21% Similarity=0.314 Sum_probs=159.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++..+..++..|+|||++ |++|.+++... ...+++..+..++.||+.+|+|||+.||+|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~- 136 (267)
T cd06610 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG- 136 (267)
T ss_pred CCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc-
Confidence 589999999999999999999999 99999999753 24699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++..+....... ........|+..|++||++... .++.++|+|||||++|+|++|+.||....
T Consensus 137 --~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 137 --EDGSVKIADFGVSASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred --CCCCEEEcccchHHHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 66889999999987765533211 0122445789999999998876 68899999999999999999999997653
Q ss_pred ccchHHHHHHHHhhhccchHHHh--hcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l--~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.. +.+..+....... .... ...+++++.+++..||..+|++||++.+|++
T Consensus 212 ~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 212 PM---KVLMLTLQNDPPS-LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hh---hhHHHHhcCCCCC-cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 32 2222222221111 1111 1357889999999999999999999887753
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=238.66 Aligned_cols=191 Identities=19% Similarity=0.307 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++..+++.|+||||+ +++|.+++. ...+++..+..++.|++.+|.|||++|++|+||||.||+++
T Consensus 61 h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~--- 135 (277)
T cd06641 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS--- 135 (277)
T ss_pred CCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---
Confidence 689999999999999999999999 889999987 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++........ ......++..|++||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-- 206 (277)
T cd06641 136 EHGEVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-- 206 (277)
T ss_pred CCCCEEEeecccceecccchh-------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--
Confidence 678899999999876643221 11235688999999999888889999999999999999999999976432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
......+..... ..+...++.++.+++..||..+|++||++.++..
T Consensus 207 -~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 207 -MKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred -HHHHHHHhcCCC----CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 222222222211 1234467899999999999999999999888876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=248.95 Aligned_cols=216 Identities=19% Similarity=0.231 Sum_probs=177.9
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
|.+++++..++.-+..|+||||+ ||+|-..|++ -++|.+..++.++.+|+-||-|||++|||+||||.+||||+ .
T Consensus 410 pFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~ 485 (683)
T KOG0696|consen 410 PFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---S 485 (683)
T ss_pred chHHHHHHHhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---c
Confidence 56788999999999999999999 9999988886 45899999999999999999999999999999999999996 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.|||+|||+++.-.-... ..++++||+.|+|||++...+|+..+|+||+||+||||+.|+.||.|. +.
T Consensus 486 eGHiKi~DFGmcKEni~~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE 555 (683)
T KOG0696|consen 486 EGHIKIADFGMCKENIFDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DE 555 (683)
T ss_pred CCceEeeecccccccccCCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CH
Confidence 89999999999985332221 235789999999999999999999999999999999999999999984 55
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-H-HHHHHHHHHHhCCCCCCccccccccccccc
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-L-KRLFRDLFIREGFQFDYVFDWTILKYQQSQ 239 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~-l-~~~l~~~~~~~~~~~d~~~~w~~~~~~~~~ 239 (414)
.+.+..|.+.... .++.++.|...++...+.+.|.+|....- - .++-+ ..+.-..||+.+...+.+
T Consensus 556 ~elF~aI~ehnvs-----yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~-------H~FFR~iDWek~E~~eiq 623 (683)
T KOG0696|consen 556 DELFQAIMEHNVS-----YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIRE-------HPFFRRIDWEKLERREIQ 623 (683)
T ss_pred HHHHHHHHHccCc-----CcccccHHHHHHHHHHhhcCCccccCCCCccccchhh-------CcchhhccHHHHhhccCC
Confidence 6667777776654 35678899999999999999999974211 1 11111 133456799988777666
Q ss_pred cCCCC
Q 015018 240 VSTPA 244 (414)
Q Consensus 240 ~~~p~ 244 (414)
++-.+
T Consensus 624 PPfkP 628 (683)
T KOG0696|consen 624 PPFKP 628 (683)
T ss_pred CCCCC
Confidence 55433
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=238.24 Aligned_cols=198 Identities=19% Similarity=0.198 Sum_probs=153.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++++.|+||||++++|.+++... ...+++..+..++.||+.||+|||+++|+|+||||+||+++ .
T Consensus 60 h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~ 137 (294)
T PLN00009 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--R 137 (294)
T ss_pred CCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--C
Confidence 68999999999999999999999987898887643 23478899999999999999999999999999999999996 2
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||++........ ......++..|++||.+.+. .++.++|||||||++|+|++|..||......
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 138 RTNALKLADFGLARAFGIPVR-------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred CCCEEEEcccccccccCCCcc-------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 346799999999975533211 11234678999999998764 5788999999999999999999999764322
Q ss_pred chHHHHHHHHhhh------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKK------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.++.... ...........+++++.+++..|++.+|++||++.++++
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 211 ---DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ---HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222211100 001111223457789999999999999999999887753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=237.54 Aligned_cols=198 Identities=19% Similarity=0.247 Sum_probs=152.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||+++++++.++++.|+||||++++|.+.+......+++..+..++.||+.||+|||++||+|+||||+|||++
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~--- 137 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS--- 137 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---
Confidence 36899999999999999999999998888887765456788999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||+++....... ......++..|++||.+.+. .++.++|||||||++|+|++|..||.+...
T Consensus 138 ~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~- 209 (291)
T cd07870 138 YLGELKLADFGLARAKSIPSQ-------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD- 209 (291)
T ss_pred CCCcEEEeccccccccCCCCC-------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-
Confidence 678899999999975433221 11234678999999998764 578899999999999999999999986532
Q ss_pred chHHHHHHHHhh-------------hc------------cchHHHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK-------------KV------------STSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~-------------~~------------~~~~~~l~~--~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+... .. ......+.. ..+.++.+++..|+..||.+||++.++.
T Consensus 210 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 210 -VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred -HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 12222221110 00 000111111 1256899999999999999999987764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=237.79 Aligned_cols=199 Identities=20% Similarity=0.247 Sum_probs=154.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.++++.+|||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 57 h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~-- 134 (284)
T cd07836 57 HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN-- 134 (284)
T ss_pred CCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC--
Confidence 589999999999999999999999779999886433 4699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++........ ......++..|++||++.+. .++.++|+|+|||++|+|++|+.||.+...
T Consensus 135 -~~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 135 -KRGELKLADFGLARAFGIPVN-------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred -CCCcEEEeecchhhhhcCCcc-------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 678899999999875433211 11234678899999998764 468899999999999999999999987543
Q ss_pred cchHHHHHHHHhhhcc---------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVS---------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~---------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+......... .....+...++.++.+++..|++.+|++||++.++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 207 EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 2221111111000000 011122235678899999999999999999987775
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-31 Score=282.83 Aligned_cols=195 Identities=20% Similarity=0.317 Sum_probs=161.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++.|+.-++.+..+|-|||| ||+|.+++. .++-.++.....+..|++.||.|||+.|||||||||+||+|+
T Consensus 1293 HpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld--- 1368 (1509)
T KOG4645|consen 1293 HPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD--- 1368 (1509)
T ss_pred CccccccCceeecHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---
Confidence 689999999999999999999999 999999997 477888989999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+|+.|||.|.++..... .++ .+.+.+.||+.|||||++.+.. -..++||||||||+.||+||+.||..++
T Consensus 1369 ~~g~iK~~DFGsa~ki~~~~~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1369 FNGLIKYGDFGSAVKIKNNAQ--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred cCCcEEeecccceeEecCchh--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 778999999999998876531 122 3456789999999999998654 5678999999999999999999998875
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
. ..+.+-++.....+. ++..++.+-.+|++.|+..||..|-+..+|
T Consensus 1446 n--e~aIMy~V~~gh~Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1446 N--EWAIMYHVAAGHKPQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred c--hhHHHhHHhccCCCC----CchhhhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 4 333333333333322 334477899999999999999999665443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=241.53 Aligned_cols=196 Identities=19% Similarity=0.202 Sum_probs=154.6
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.+. +..|+||||++++|.+++......+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-- 142 (309)
T cd07845 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-- 142 (309)
T ss_pred CCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 68999999988765 57899999998899999986667899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++..+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 143 -~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 143 -DKGCLKIADFGLARTYGLPAK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred -CCCCEEECccceeeecCCccC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 678899999999987654321 1122345788999999876 4578999999999999999999999986543
Q ss_pred cchHHHHHHHHhhhcc-------------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVS-------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+...... ..+......+++++.++|..|+..||++||++.+++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 215 ---IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred ---HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 3333332221000 001111223578899999999999999999987665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=242.56 Aligned_cols=190 Identities=18% Similarity=0.258 Sum_probs=154.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++.+++..||||||+.++|.+++......+++..+..++.||+.+|.|||+.+|+|+||+|+||+++ .
T Consensus 74 h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~ 150 (307)
T cd06607 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---E 150 (307)
T ss_pred CCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---C
Confidence 6999999999999999999999998899888876667899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
++.++|+|||++...... ....++..|++||++. ...++.++||||||+++|+|++|..||.+...
T Consensus 151 ~~~~kL~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 151 PGTVKLADFGSASLVSPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CCCEEEeecCcceecCCC-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 788999999998754321 2357888999999875 34578899999999999999999999976432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
......+........ ....++.++.+++..||..+|++||++.+|..
T Consensus 220 ---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 220 ---MSALYHIAQNDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---HHHHHHHhcCCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111112221111110 12246789999999999999999999887754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=256.74 Aligned_cols=187 Identities=20% Similarity=0.223 Sum_probs=156.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+.++.+.|+|||++ |+-|.+-+-. .+.+. .++..|+.||+.++.|||++|||||||||+|||+.
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-- 449 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-- 449 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--
Confidence 4799999999999999999999999 7766665542 33344 78888999999999999999999999999999994
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
+..++++|+|||.++...... .+-+-|..|.|||+....+|+..+|+||||++||+||+|+.||..-...
T Consensus 450 ~~~g~lrltyFG~a~~~~~~~----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERSC----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred CCCCcEEEEEechhhhCchhh----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 377899999999998766541 1235689999999999999999999999999999999999999875433
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+...+.. ..++.+.++|+..|++.+|.+|++++++.
T Consensus 520 --~ei~~~i~~~~~s-------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 520 --IEIHTRIQMPKFS-------ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred --HHHHHhhcCCccc-------cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 4455555554443 35789999999999999999999998874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=238.60 Aligned_cols=197 Identities=19% Similarity=0.197 Sum_probs=152.5
Q ss_pred CCCCcEEEEeeEeCCE-----EEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVEGDY-----NVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~-----~~lVmE~~g~sL~~ll~~~----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+|||++++..+...+. .|+||||+.++|.+++... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 60 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ 139 (295)
T cd07837 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139 (295)
T ss_pred CCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChH
Confidence 5899999999887665 8999999977899888643 245899999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
||+++ ...+.++|+|||+++.+..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 140 nil~~--~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 140 NLLVD--KQKGLLKIADLGLGRAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred HEEEe--cCCCeEEEeecccceecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 99997 2268899999999986543211 1122356888999998875 457899999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhh-----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
||.+.... ..+.++.... ....+....+.+++++.++|..||..+|.+||++++
T Consensus 211 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 211 LFPGDSEL---QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred CCCCCCHH---HHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 99874332 2222211100 011112223467899999999999999999999877
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 288 il 289 (295)
T cd07837 288 AL 289 (295)
T ss_pred Hh
Confidence 64
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=233.34 Aligned_cols=192 Identities=21% Similarity=0.299 Sum_probs=158.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..+..++.||+.+|+|||+.||+|+||+|+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~--- 136 (258)
T cd06632 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD--- 136 (258)
T ss_pred CCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---
Confidence 689999999999999999999999 8999999974 45699999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++....... ......|+..|++||.+.... ++.++|+|||||++|+|++|..||....
T Consensus 137 ~~~~~kl~d~~~~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-- 206 (258)
T cd06632 137 TNGVVKLADFGMAKQVVEFS--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-- 206 (258)
T ss_pred CCCCEEEccCccceeccccc--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--
Confidence 67899999999988654422 123457899999999998766 8999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+....+... .....+...+++++.+++..||..+|++||++.++..
T Consensus 207 -~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 207 -GVAAVFKIGRS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -HHHHHHHHHhc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 22222222211 1112234567899999999999999999999887753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=240.32 Aligned_cols=211 Identities=17% Similarity=0.228 Sum_probs=165.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+..+...||||||+ |++|.+++.. ...+++..++.++.|++.+|+|||+.+++||||||.||+++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~-- 139 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD-- 139 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC--
Confidence 4689999999999999999999999 8899998864 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||+++....... .......|+..|++||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 140 -~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 140 -SEGHVVLTDFGLSKEFLAEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred -CCCCEEEEECccccccccccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 668899999999876543221 1122356899999999987765 6789999999999999999999996432
Q ss_pred ccchHHHH-HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 158 AGTKKQKY-EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 158 ~~~~~~~~-~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.......+ ..+... .......++.++.+++..||+.+|++||++..+.++|.+.+ ....+|+..
T Consensus 213 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~-------~~~~~~~~~ 277 (288)
T cd05583 213 EQNSQSEISRRILKS-----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF-------FQGIDWDDL 277 (288)
T ss_pred ccchHHHHHHHHHcc-----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc-------cccCCHHHH
Confidence 22111111 111111 11223457789999999999999999999888888776654 334567654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=236.47 Aligned_cols=194 Identities=22% Similarity=0.283 Sum_probs=152.0
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.+ +...++||||+ +++|.+++.. ...+++..++.++.||+.+|+|||+++|+||||||+||+++
T Consensus 63 h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~- 140 (266)
T cd06651 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD- 140 (266)
T ss_pred CCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-
Confidence 6899999988775 46789999999 8999999874 45799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 141 --~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 141 --SAGNVKLGDFGASKRLQTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred --CCCCEEEccCCCcccccccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 6778999999998765331110 0011235689999999999998899999999999999999999999976432
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+.... ....+...+++.+..++ .||..+|++||++++|+
T Consensus 215 ---~~~~~~~~~~~---~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 215 ---MAAIFKIATQP---TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred ---HHHHHHHhcCC---CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 22222221111 11122334667888888 68889999999988775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=257.75 Aligned_cols=194 Identities=19% Similarity=0.296 Sum_probs=163.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|++|+..|..++..||++||| ||-+..++-..++.|++.++..+++|++.+|.|||+++|||||||..|||+.
T Consensus 88 HP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T--- 164 (1187)
T KOG0579|consen 88 HPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT--- 164 (1187)
T ss_pred ChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---
Confidence 689999999999999999999999 8899888888899999999999999999999999999999999999999998
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
-+|.|+|+|||.+.+....-. ....++||+.|||||+.. ..+|++++||||||++|.||..+.+|-..
T Consensus 165 ldGdirLADFGVSAKn~~t~q-------kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 165 LDGDIRLADFGVSAKNKSTRQ-------KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ecCcEeeecccccccchhHHh-------hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 678999999999865433211 124689999999999865 45799999999999999999999999988
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+++.. .+-+|.....++.+ -+..+...|.+|+..|+.++|+.||+.++|.
T Consensus 238 lnpMR---VllKiaKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 238 LNPMR---VLLKIAKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cchHH---HHHHHhhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 75533 33344333333221 1345778999999999999999999988775
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=239.67 Aligned_cols=205 Identities=20% Similarity=0.208 Sum_probs=155.2
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~----~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.+. ++.||||||++++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil 140 (316)
T cd07842 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANIL 140 (316)
T ss_pred CCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEE
Confidence 69999999999988 8999999999888988876432 36899999999999999999999999999999999999
Q ss_pred Eee-cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 76 MGL-GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 76 l~~-~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
++. +...+.+||+|||+++........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 141 VMGEGPERGVVKIGDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred EcCCCCccceEEECCCccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 973 122789999999999865443221 1122345789999999998764 5789999999999999999999999
Q ss_pred CCCCccc------hHHHHHHHHhhh----------------------------cc-chHH-Hhh--cCCcHHHHHHHHHH
Q 015018 154 QGLKAGT------KKQKYEKISEKK----------------------------VS-TSIE-ALC--RGYPTEFASYFHYC 195 (414)
Q Consensus 154 ~~~~~~~------~~~~~~~i~~~~----------------------------~~-~~~~-~l~--~~~p~e~~~li~~c 195 (414)
.+..... ....+..+...- .. ..+. .+. ...+.++.+++..|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 296 (316)
T cd07842 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296 (316)
T ss_pred cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence 8754322 001111111000 00 0000 011 14567899999999
Q ss_pred HcCCCCCCCCHHHHH
Q 015018 196 RSLRFDDKPDYAYLK 210 (414)
Q Consensus 196 ~~~dp~~RP~~~~l~ 210 (414)
+..+|++||++.++.
T Consensus 297 l~~~P~~Rps~~eil 311 (316)
T cd07842 297 LEYDPTKRITAEEAL 311 (316)
T ss_pred hcCCcccCcCHHHHh
Confidence 999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=240.41 Aligned_cols=194 Identities=16% Similarity=0.287 Sum_probs=157.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..+..+++.|+||||+ +++|.+++. ...+++..+..++.|++.+|+|||+.||+|+||||+||+++
T Consensus 75 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~-- 150 (292)
T cd06657 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT-- 150 (292)
T ss_pred CCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC--
Confidence 4689999999999999999999999 889998876 45789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......|+..|++||.+.+..++.++|+||||+++|+|++|..||.+...
T Consensus 151 -~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~- 221 (292)
T cd06657 151 -HDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP- 221 (292)
T ss_pred -CCCCEEEcccccceecccccc-------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 667899999999876543221 12335789999999999888889999999999999999999999976432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+.+..+... ...... ....++.++.+++..||..+|.+||++.+++.
T Consensus 222 --~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 222 --LKAMKMIRDN-LPPKLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --HHHHHHHHhh-CCcccC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2222222211 111111 12356889999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=243.87 Aligned_cols=204 Identities=13% Similarity=0.150 Sum_probs=152.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||++++.++..+++.|+||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 57 ~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~- 135 (328)
T cd08226 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS- 135 (328)
T ss_pred CCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe-
Confidence 3699999999999999999999999 89999998753 34699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..+.++++||+.+.............+.......++..|++||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 136 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 136 --GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred --CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 678899999986543322111111111111223456789999999764 4789999999999999999999999765
Q ss_pred CccchHHHHHHHHhhhcc------------------------------------------chHHHhhcCCcHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVS------------------------------------------TSIEALCRGYPTEFASYFHY 194 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~------------------------------------------~~~~~l~~~~p~e~~~li~~ 194 (414)
... +.+..+...... .........++.++.+|+..
T Consensus 214 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 214 LRT---QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290 (328)
T ss_pred ChH---HHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH
Confidence 321 111111100000 00000112356789999999
Q ss_pred HHcCCCCCCCCHHHHH
Q 015018 195 CRSLRFDDKPDYAYLK 210 (414)
Q Consensus 195 c~~~dp~~RP~~~~l~ 210 (414)
||..||++||++.+++
T Consensus 291 ~l~~dP~~Rpta~e~l 306 (328)
T cd08226 291 CLQQDPEKRPSASSLL 306 (328)
T ss_pred HccCCcccCCCHHHHh
Confidence 9999999999988874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=237.71 Aligned_cols=194 Identities=20% Similarity=0.338 Sum_probs=157.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..++..|+||||+ |++|.+++......++...+..++.||+.+|+|||+.||+|+||||+||+++
T Consensus 74 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~--- 150 (286)
T cd06614 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS--- 150 (286)
T ss_pred CCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---
Confidence 689999999999999999999999 7999999986444899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||++........ ......++..|++||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 151 ~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-- 221 (286)
T cd06614 151 KDGSVKLADFGFAAQLTKEKS-------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-- 221 (286)
T ss_pred CCCCEEECccchhhhhccchh-------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--
Confidence 678899999999865443221 11234678899999999988899999999999999999999999976432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+....... . .....++.++.++|..||+.+|.+||++.+++
T Consensus 222 -~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 222 -LRALFLITTKGIPP-L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred -HHHHHHHHhcCCCC-C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 22222222221111 1 01234789999999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=236.99 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=162.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..++..|+||||+ |++|.+++... ..+++..+..++.||+.+|+|||+++|+|+||+|+||+++
T Consensus 52 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~--- 127 (265)
T cd05579 52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID--- 127 (265)
T ss_pred CcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---
Confidence 689999999999999999999999 88999999854 3899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcc-cccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQ-HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++.......... ...........++..|++||.+.+..++.++|+||||+++|++++|..||....
T Consensus 128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-- 205 (265)
T cd05579 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-- 205 (265)
T ss_pred CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Confidence 67899999999987543321100 000112234578899999999998889999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
..+.+..+....... ... ..++.++.+++..||..+|++||++..+.++|..-
T Consensus 206 -~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 206 -PEEIFQNILNGKIEW--PED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred -HHHHHHHHhcCCcCC--Ccc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 333333333322211 111 12489999999999999999999997777776544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=238.25 Aligned_cols=198 Identities=22% Similarity=0.274 Sum_probs=154.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++..+++.|+||||+ +++|..+.. ....+++..++.++.||+.+|+|||+.+|+|+||+|+||+++
T Consensus 59 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~--- 134 (286)
T cd07846 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS--- 134 (286)
T ss_pred CcchhhHHHhcccCCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---
Confidence 689999999999999999999999 777777665 345699999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......++..|++||++.+. .++.++||||||+++|+|++|..||.+....
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPGE-------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred CCCcEEEEeeeeeeeccCCcc-------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 678999999999987544321 11335689999999998763 4678999999999999999999999764321
Q ss_pred chHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+..+... ...........+++..+.+++..||..+|++||++.++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 111111110000 000111223456789999999999999999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=236.50 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=154.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++.+.+++..|+||||+++++.+.+......+++..+..++.||+.||+|||..+|+|+||+|+||+++ .
T Consensus 59 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~ 135 (288)
T cd07833 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---E 135 (288)
T ss_pred CCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---C
Confidence 5899999999999999999999995555555444456799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.++|+|||++........ .......++..|++||++.+. .++.++|+||||+++|+|++|..||.+....+
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 136 SGVLKLCDFGFARALRARPA------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred CCCEEEEeeecccccCCCcc------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 78999999999887654322 012345788999999999888 78999999999999999999999997643221
Q ss_pred hHHHHHHHHh-----------------------hhccchHH-HhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISE-----------------------KKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~-----------------------~~~~~~~~-~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.......+.. ......+. .....++.++.++|..||..+|++||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 1111111000 00000011 11223588999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=238.10 Aligned_cols=196 Identities=17% Similarity=0.198 Sum_probs=155.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++++.|+||||++++|.+++.... ..+++..++.++.||+.+|+|||+++++|+||+|+||+++
T Consensus 57 ~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~--- 133 (283)
T cd07835 57 HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID--- 133 (283)
T ss_pred CCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---
Confidence 689999999999999999999999889999987433 3699999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+..... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+....
T Consensus 134 ~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 206 (283)
T cd07835 134 REGALKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI 206 (283)
T ss_pred CCCcEEEeecccccccCCCcc-------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 578999999999875433211 11223568899999988764 4688999999999999999999999764321
Q ss_pred chHHHHHHHHhh------------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. .+.++... ............++.++.+++..||+.+|++||+..++.
T Consensus 207 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 207 D---QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred H---HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 1 11111110 001112223456778999999999999999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=236.76 Aligned_cols=179 Identities=17% Similarity=0.180 Sum_probs=148.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|||++++.++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 44 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~--- 119 (237)
T cd05576 44 VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD--- 119 (237)
T ss_pred CCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---
Confidence 689999999999999999999999 8999999864 34699999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++....... ....++..|++||.+.+..++.++|+||+||++|+|++|..||......
T Consensus 120 ~~~~~~l~df~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~- 188 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDSC----------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG- 188 (237)
T ss_pred CCCCEEEecccchhcccccc----------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-
Confidence 67889999999876543321 1235577899999998888999999999999999999999887542110
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
+.. ... ..+...++.++.++|..|++.||++|++.
T Consensus 189 -------~~~-~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 189 -------INT-HTT---LNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -------ccc-ccc---cCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 000 000 01234578899999999999999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=240.69 Aligned_cols=190 Identities=20% Similarity=0.295 Sum_probs=154.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||++++.++.+++..|+||||+.++|.+++......+++.+++.++.||+.+|.|||++||+|+||||+||+++
T Consensus 79 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~--- 155 (313)
T cd06633 79 KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT--- 155 (313)
T ss_pred CCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---
Confidence 36899999999999999999999998889988876677899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++..... .....|+..|++||++. ...++.++|||||||++|+|++|..||....
T Consensus 156 ~~~~~kL~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 156 EPGQVKLADFGSASKSSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred CCCCEEEeecCCCcccCC-----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 678899999998854221 23457899999999984 3557889999999999999999999997753
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ......+....... .....++..+.+++..||+.+|.+||++.++.
T Consensus 225 ~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 225 A---MSALYHIAQNDSPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred h---HHHHHHHHhcCCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 2 22222222211111 12235678899999999999999999988775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=237.74 Aligned_cols=199 Identities=17% Similarity=0.187 Sum_probs=154.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.|+||||+.++|.+++... ...+++..++.++.||+.||+|||+.+++|+||+|+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~--- 134 (284)
T cd07860 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN--- 134 (284)
T ss_pred CCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---
Confidence 69999999999999999999999977899888643 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......++..|++||.+.+.. ++.++|+|||||++|+|++|+.||.+....
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 135 TEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred CCCCEEEeeccchhhcccCcc-------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 678899999999875533211 112345788999999887644 588999999999999999999999764322
Q ss_pred chHHHHHHHHhh---------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~---------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+...... ........+...++.++.++|..||..||++||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 111111100000 001112223345678899999999999999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=246.21 Aligned_cols=193 Identities=21% Similarity=0.268 Sum_probs=150.5
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||++++..+... .+.||||||++++|.+.+.. .++...+..++.||+.||+|||.+||+||||||+||
T Consensus 73 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni 149 (353)
T cd07850 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 149 (353)
T ss_pred CCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 368999999887643 35799999998899998863 399999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+++ .++.++|+|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus 150 l~~---~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 150 VVK---SDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred EEC---CCCCEEEccCccceeCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 996 678899999999987543221 123568899999999999999999999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhcc-------------------------chHHHh-------------hcCCcHHHHHHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVS-------------------------TSIEAL-------------CRGYPTEFASYFHYCR 196 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l-------------~~~~p~e~~~li~~c~ 196 (414)
..+.. ..+..+...... ..+..+ ....+.++.++|..||
T Consensus 219 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 219 GTDHI---DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCHH---HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 64322 122221110000 000010 1134567899999999
Q ss_pred cCCCCCCCCHHHHH
Q 015018 197 SLRFDDKPDYAYLK 210 (414)
Q Consensus 197 ~~dp~~RP~~~~l~ 210 (414)
..||.+||++.+++
T Consensus 296 ~~dP~~R~t~~eiL 309 (353)
T cd07850 296 VIDPEKRISVDDAL 309 (353)
T ss_pred CCChhhCcCHHHHh
Confidence 99999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=239.50 Aligned_cols=192 Identities=19% Similarity=0.257 Sum_probs=156.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||++++.++.+++..||||||+.++|.+++.....++++..+..++.||+.+|.|||+++|+||||+|+||+++
T Consensus 83 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~--- 159 (317)
T cd06635 83 KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT--- 159 (317)
T ss_pred CCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---
Confidence 36899999999999999999999997789888876677899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++..... .....|+..|++||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 160 ~~~~~kl~dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 160 EPGQVKLADFGSASIASP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred CCCCEEEecCCCccccCC-----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 678899999999865432 12357889999999984 3457889999999999999999999997642
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
....+..+....... .....+++.+.+++..||..+|.+||++.++.+.
T Consensus 229 ---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 229 ---AMSALYHIAQNESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred ---HHHHHHHHHhccCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 222222222221111 1123567889999999999999999998887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=235.34 Aligned_cols=195 Identities=22% Similarity=0.259 Sum_probs=156.0
Q ss_pred CCCCcEEEEeeEeCCE-----EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGDY-----NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~-----~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++...+. .+++|||++++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+
T Consensus 60 h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nil 139 (287)
T cd07838 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNIL 139 (287)
T ss_pred CCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEE
Confidence 6899999999998887 99999999779999887543 36999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.++|+|||++..+..... .....++..|++||.+.+..++.++|+|||||++|+|++|..||.+
T Consensus 140 i~---~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 140 VT---SDGQVKIADFGLARIYSFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred Ec---cCCCEEEeccCcceeccCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 96 668999999999987644321 1223578899999999998899999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... +.+.++.... ...........++.++.+++..||..||++||++.++.
T Consensus 209 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 209 TSEA---DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred CChH---HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 5432 2222222110 00111122234567889999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=234.47 Aligned_cols=194 Identities=21% Similarity=0.264 Sum_probs=152.5
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+. ...++||||+ |++|.+++.. ...+++..++.++.||+.+|+|||+++|+|+||||+||+++
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~- 140 (265)
T cd06652 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD- 140 (265)
T ss_pred CCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec-
Confidence 68999999988763 5788999999 8999999875 35689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||++......... ........|+..|++||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 141 --~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 141 --SVGNVKLGDFGASKRLQTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred --CCCCEEECcCcccccccccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence 6788999999998765332110 1112345689999999999988899999999999999999999999976422
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+...... ..+...++..+.+++..|+ .+|.+||++++|+
T Consensus 215 ---~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il 259 (265)
T cd06652 215 ---MAAIFKIATQPTN---PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELL 259 (265)
T ss_pred ---HHHHHHHhcCCCC---CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHh
Confidence 2222222211111 1123345678899999999 4899999988775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=240.15 Aligned_cols=192 Identities=18% Similarity=0.249 Sum_probs=155.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||++++.++..++..|+||||+.++|.+++......+++.++..++.|++.+|.|||+++++||||||+|||++
T Consensus 73 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~--- 149 (308)
T cd06634 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--- 149 (308)
T ss_pred CCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---
Confidence 36899999999999999999999997789888876677799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++...... ....++..|++||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 150 EPGLVKLGDFGSASIMAPA-----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred CCCcEEECCcccceeecCc-----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 6788999999998765331 23578899999999853 456789999999999999999999997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
.. .....+....... .....++.++.++|..||..+|++||+++++...
T Consensus 219 ~~---~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 219 AM---SALYHIAQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HH---HHHHHHhhcCCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 22 1111122111111 1123577899999999999999999998877643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=233.27 Aligned_cols=194 Identities=21% Similarity=0.251 Sum_probs=157.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++.+.++.+.|+||||+ +++|.+++... ...+++..++.++.||+.+|+|||+.+|+|+||||+||+++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~-- 135 (257)
T cd08225 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS-- 135 (257)
T ss_pred CCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--
Confidence 689999999999999999999999 99999998643 33589999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.....++|+|||++......... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 136 ~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-- 206 (257)
T cd08225 136 KNGMVAKLGDFGIARQLNDSMEL-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-- 206 (257)
T ss_pred CCCCeEEecccccchhccCCccc-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--
Confidence 23356799999998766442211 123468999999999988888999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+..... ......++.++.+++..||..+|++||++.++..
T Consensus 207 -~~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 207 -LHQLVLKICQGYF----APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -HHHHHHHHhcccC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2223333222222 2233467889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=238.77 Aligned_cols=203 Identities=18% Similarity=0.167 Sum_probs=152.4
Q ss_pred CCCCcEEEEeeEeCC--------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVEGD--------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~--------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||+++++++.... ..|+||||++++|.+++......+++.+++.++.||+.||+|||++||+|+||||+|
T Consensus 70 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~n 149 (310)
T cd07865 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAAN 149 (310)
T ss_pred CCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 689999999877654 459999999889999887655679999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~P 152 (414)
|+++ ..+.++|+|||++..+....... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..|
T Consensus 150 il~~---~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 150 ILIT---KDGILKLADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred EEEC---CCCcEEECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 9996 67899999999998765432211 01123456789999999987643 68899999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhcc------------------c-----hHHHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVS------------------T-----SIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~------------------~-----~~~~l~-~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
|.+.........+..+...... . ....+. ......+.++|..||..+|++||++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 9875432222222222110000 0 000000 012456789999999999999999887
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
+.
T Consensus 304 ~l 305 (310)
T cd07865 304 AL 305 (310)
T ss_pred Hh
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=243.04 Aligned_cols=204 Identities=17% Similarity=0.215 Sum_probs=155.8
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++++... ...||||||++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 65 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~- 141 (337)
T cd07852 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN- 141 (337)
T ss_pred CCCCccceeeeeccCCCceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc-
Confidence 479999999987653 46899999998899998873 3889999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++..+....... .......+.|+..|++||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 142 --~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 142 --SDCRVKLADFGLARSLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred --CCCcEEEeeccchhccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 77899999999998664432210 0112234678999999998865 457889999999999999999999997654
Q ss_pred ccchHHHHHHHHh-----------------------hhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISE-----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~-----------------------~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.......+..... .........+...++.++.++|..||..+|++||++.++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 3222111111100 00111222334557899999999999999999999877754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=229.73 Aligned_cols=192 Identities=23% Similarity=0.397 Sum_probs=158.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..+...++||||+ |++|.+++......+++..+..++.|++.+|+|||.+|++|+||+|+||+++
T Consensus 56 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~--- 132 (253)
T cd05122 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT--- 132 (253)
T ss_pred CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---
Confidence 589999999999999999999999 7999999986556899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 133 ~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 202 (253)
T cd05122 133 SDGEVKLIDFGLSAQLSDTKA--------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-- 202 (253)
T ss_pred cCCeEEEeecccccccccccc--------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--
Confidence 678999999999876654321 2345788999999999988889999999999999999999999976432
Q ss_pred hHHHHHHHHhhhccchHHHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~--~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
......+...... .+.. .++.++.+++..||..+|++||++.++.+
T Consensus 203 -~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 203 -MKALFKIATNGPP----GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -HHHHHHHHhcCCC----CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222222211111 1122 24789999999999999999999887753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=232.92 Aligned_cols=191 Identities=18% Similarity=0.252 Sum_probs=158.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++.+.++...|+||||+ +++|.+++... ...+++..+..++.||+.||+|||+.|++|+||+|.||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~ 137 (256)
T cd08530 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV 137 (256)
T ss_pred CCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe
Confidence 589999999999999999999999 99999988642 35799999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++....... .....++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 138 ---~~~~~kl~d~g~~~~~~~~~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 138 ---ANDLVKIGDLGISKVLKKNM---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ---cCCcEEEeeccchhhhccCC---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 57889999999997665431 123468899999999999889999999999999999999999997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
. ......+..... ..+...++.++.+++..|+..+|++||++.++..
T Consensus 206 ~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 206 M---QDLRYKVQRGKY----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred H---HHHHHHHhcCCC----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2 222222222222 2233467899999999999999999999988753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=231.16 Aligned_cols=193 Identities=22% Similarity=0.262 Sum_probs=161.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||++++..+..+++.++|||++ |++|.+++... ...+++..+..++.||+.||+|||++|++|+||+|+||+++
T Consensus 58 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~ 137 (258)
T cd08215 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137 (258)
T ss_pred CCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc
Confidence 689999999999999999999999 88999999754 36799999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++........ ......|++.|++||.+.+..++.++|+|+||+++|+|++|..||....
T Consensus 138 ---~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 138 ---SNGLVKLGDFGISKVLSSTVD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ---CCCcEEECCccceeecccCcc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 678899999999987654321 1234578999999999998889999999999999999999999997643
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+....+.... ...+...++.++.+++..||..+|++||++.++.+
T Consensus 208 ---~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 ---LLELALKILKGQ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---HHHHHHHHhcCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 223333322222 22344578899999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=236.62 Aligned_cols=190 Identities=25% Similarity=0.277 Sum_probs=157.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++..+.++++.|+||||+ |++|.+++... ..+++..+..++.||+.+|.|||+++|+|+||||+||+++
T Consensus 58 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~-- 134 (258)
T cd05578 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD-- 134 (258)
T ss_pred CCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc--
Confidence 3699999999999999999999999 99999999753 5899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++........ .....|+..|++||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 135 -~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 135 -EQGHVHITDFNIATKVTPDTL--------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred -CCCCEEEeecccccccCCCcc--------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 678899999999876544221 12356889999999999888999999999999999999999999876543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
...+.... ... ........+|.++.++|..||..+|++||++.
T Consensus 206 ~~~~~~~~-~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 206 IRDQIRAK-QET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred HHHHHHHH-hcc----ccccCcccCcHHHHHHHHHHccCChhHcCCcc
Confidence 22222211 111 12233456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=234.10 Aligned_cols=200 Identities=16% Similarity=0.300 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~-g~sL~~ll~~~-----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
+|||+++++++...+ ..++++||+ +++|.+++... ...++...++.++.||+.||+|||++||+||||
T Consensus 60 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~di 139 (273)
T cd05074 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139 (273)
T ss_pred CCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 699999999887543 347899999 89998886421 125889999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR- 148 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt- 148 (414)
||+||+++ .++.++|+|||+++....... +.......++..|++||.+.+..++.++|||||||++|+|++
T Consensus 140 kp~nili~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 140 AARNCMLN---ENMTVCVADFGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred chhhEEEc---CCCCEEECcccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 99999996 678899999999986543221 111123456678999999998889999999999999999998
Q ss_pred CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
|+.||.+... ...+..+...... .....++.++.+++..||..+|++||++.++...|+++
T Consensus 212 g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 212 GQTPYAGVEN---SEIYNYLIKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCH---HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8999976532 2233333222111 11235778999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.40 Aligned_cols=203 Identities=17% Similarity=0.206 Sum_probs=154.3
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
++|||++++..+.. ....|++|||++++|.+++.. ...+++..++.++.||+.||+|||.+||+||||||+|||+
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 47899999886543 256799999998899999864 5689999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ .++.++|+|||+++.+....... ........|+..|++||.+.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 139 ~---~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 139 N---ADCELKICDFGLARGFSENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred c---CCCCEEeCcCCCceecccccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 6 67889999999998765432210 111234678999999998876 4688999999999999999999999976
Q ss_pred CCccchHH------------HHHHHHhhh-----------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQ------------KYEKISEKK-----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~------------~~~~i~~~~-----------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.......+ .+..+.... ....+..+...++.++.+++..|+..+|.+||++.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 43211111 111111100 01112233345678999999999999999999987764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=244.80 Aligned_cols=202 Identities=17% Similarity=0.213 Sum_probs=154.9
Q ss_pred CCCCcEEEEeeE----eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~----~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||++++.++. .+.+.|+||||++++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||+++
T Consensus 63 h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~ 141 (334)
T cd07855 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN 141 (334)
T ss_pred CCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 689999887765 3467899999998899999864 55799999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.++.+||+|||++.......... ........|+..|++||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 142 ---~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 142 ---EDCELRIGDFGMARGLSSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ---CCCcEEecccccceeecccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 77899999999998765432211 011124578999999999865 45789999999999999999999999765
Q ss_pred CccchHHHHHHH-----------------------HhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKI-----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i-----------------------~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
........+... ...........+...++.++.++|..||+.+|++||+++++.
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 332111111100 001111122334456789999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=240.65 Aligned_cols=193 Identities=20% Similarity=0.302 Sum_probs=155.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+..+++.|+||||+ +++|.+++. ...+++..+..++.||+.+|.|||++|++|+||||+||+++
T Consensus 74 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~-- 149 (293)
T cd06647 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-- 149 (293)
T ss_pred CCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc--
Confidence 3699999999999999999999999 999999987 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++..+..... ......|+..|++||.+.+..++.++|+|||||++|++++|..||......
T Consensus 150 -~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 150 -MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred -CCCCEEEccCcceeccccccc-------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 678899999999876544321 112357889999999998888899999999999999999999999764321
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+..+...... .......++.++.+++..||..+|++||++.++.
T Consensus 222 ---~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 222 ---RALYLIATNGTP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ---hheeehhcCCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 111111111000 0011234678899999999999999999987765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=243.82 Aligned_cols=201 Identities=18% Similarity=0.192 Sum_probs=152.6
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||++++.++.... +.|+||||++++|..++. .+.+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 62 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill 139 (336)
T cd07849 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 139 (336)
T ss_pred CCCcCchhheeecccccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 689999988766543 579999999889998886 5689999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ ..+.++|+|||++........... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 140 ~---~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 140 N---TNCDLKICDFGLARIADPEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred C---CCCCEEECcccceeeccccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 6 678899999999987654322111 1234578999999998765 4688999999999999999999999976
Q ss_pred CCccchHHHH------------HHHHhhh-----------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 156 LKAGTKKQKY------------EKISEKK-----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 156 ~~~~~~~~~~------------~~i~~~~-----------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.........+ ..+.... .......+...++.++.+++..||+.+|++||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 213 KDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4321111111 1000000 001112233456788999999999999999999876653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=235.60 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=161.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+.|||++++..+.+++..++|||++ +++|.+++.. ...+++..++.++.||+.+|+|||+.|++|+||||+||+++
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~-- 136 (280)
T cd05581 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD-- 136 (280)
T ss_pred cCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC--
Confidence 3799999999999999999999999 9999999985 44799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccc-------------cccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHI-------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~-------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
.++.++|+|||++............ .........++..|++||++.+..++.++|+||||++++++
T Consensus 137 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l 215 (280)
T cd05581 137 -KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215 (280)
T ss_pred -CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 6788999999999876543221000 01223456789999999999988899999999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH----HHHH
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLK 210 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~----~~l~ 210 (414)
++|..||.... ..+.+..+..... .+...+++.+.+++..||+.+|++||++ ++|+
T Consensus 216 ~~g~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 216 LTGKPPFRGSN---EYLTFQKILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HhCCCCCCCcc---HHHHHHHHHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 99999998653 2333333332211 2335678999999999999999999998 5554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=228.52 Aligned_cols=191 Identities=20% Similarity=0.293 Sum_probs=159.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++.+.++||||+ +++|.+++.. ...+++..+..++.|++.+|.|||++||+|+||||+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~--- 133 (254)
T cd06627 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT--- 133 (254)
T ss_pred CCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---
Confidence 689999999999999999999999 8899999975 36899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++......... .....++..|++||.+.+..++.++|+|+||+++|+|++|..||.....
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-- 204 (254)
T cd06627 134 KDGVVKLADFGVATKLNDVSKD-------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-- 204 (254)
T ss_pred CCCCEEEeccccceecCCCccc-------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--
Confidence 5788999999999876553321 2345789999999999888889999999999999999999999976532
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+..... ..+...++.++.+++..||..+|++||++.++.
T Consensus 205 -~~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 205 -MAALFRIVQDDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred -HHHHHHHhccCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 222222221111 123456789999999999999999999988775
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=234.73 Aligned_cols=190 Identities=16% Similarity=0.243 Sum_probs=151.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++..++.+...|+||||+ +++|.+++.. ...+++..+..++.||+.+|+|||+.|++||||||+|||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~-- 139 (290)
T cd05613 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD-- 139 (290)
T ss_pred cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC--
Confidence 3689999999999999999999999 8999999875 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.++|+|||++..+...... ......|+..|++||.+.+. .++.+.||||||+++|+|++|..||....
T Consensus 140 -~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 140 -SNGHVVLTDFGLSKEFHEDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred -CCCCEEEeeCccceeccccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 6789999999999875432211 11235689999999998753 36788999999999999999999997532
Q ss_pred ccchHHH-HHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 158 AGTKKQK-YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 158 ~~~~~~~-~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
....... ...+.... ..+...++..+.+++..||..+|++||+
T Consensus 213 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 213 EKNSQAEISRRILKSE-----PPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ccccHHHHHHHhhccC-----CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 2211111 11111111 1123457889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=235.85 Aligned_cols=199 Identities=20% Similarity=0.239 Sum_probs=155.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|+|||++++..+.+++..|+||||++++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||||+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~-- 133 (283)
T cd07830 56 EHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS-- 133 (283)
T ss_pred CCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc--
Confidence 5799999999999999999999999889999887543 4789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||+++....... .....++..|++||++.+ ..++.++|+||||+++|+|++|..||.+...
T Consensus 134 -~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 134 -GPEVVKIADFGLAREIRSRPP--------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred -CCCCEEEeecccceeccCCCC--------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 678999999999986644221 123578899999998754 4578899999999999999999999976543
Q ss_pred cchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.......+.... ....+..+....+.++.+++..||..+|++||+..++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred HHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 22211111110000 00111222233468899999999999999999987775
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=237.57 Aligned_cols=201 Identities=20% Similarity=0.228 Sum_probs=155.0
Q ss_pred CCCCcEEEEeeEeCC----------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 2 AAGIPNLRWFGVEGD----------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
+|||+++++++.+.+ +.||||||++++|.+++......+++..+..++.||+.||+|||+.||+|+||||
T Consensus 65 h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 144 (302)
T cd07864 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144 (302)
T ss_pred CCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 689999998887655 8999999997788888875555799999999999999999999999999999999
Q ss_pred CcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCC
Q 015018 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 72 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~ 150 (414)
+||+++ ..+.+||+|||++..+..... .......++..|++||.+.+. .++.++|||||||++|+|++|+
T Consensus 145 ~nili~---~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 145 SNILLN---NKGQIKLADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred HHEEEC---CCCcEEeCcccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999996 678999999999986644321 011223567889999988754 4688999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhcc----------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~----------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
.||...........+......... ......+..+|.++.+++..||..+|.+||++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999764322222222221111110 0111233457899999999999999999999887
Q ss_pred HHH
Q 015018 209 LKR 211 (414)
Q Consensus 209 l~~ 211 (414)
++.
T Consensus 296 il~ 298 (302)
T cd07864 296 ALN 298 (302)
T ss_pred Hhc
Confidence 753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=227.10 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=161.3
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++..+.+. +..++||||+ +++|.+++... ..+++..+..++.|++.+|+|||+.+++|+||+|+||++.
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~- 135 (260)
T cd06606 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD- 135 (260)
T ss_pred CCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc-
Confidence 68999999999998 8999999999 99999999754 3899999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.++|+|||.+......... .......++..|++||.+.+..++.++|||+||+++|+|++|..||....
T Consensus 136 --~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~- 207 (260)
T cd06606 136 --SDGVVKLADFGCAKRLGDIETG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG- 207 (260)
T ss_pred --CCCCEEEcccccEEeccccccc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 5789999999999877654321 01234578999999999998889999999999999999999999998754
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+.......+.. ......+...++.++.+++..|+..+|++||++.++..
T Consensus 208 -~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 208 -NPMAALYKIGS---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -chHHHHHhccc---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 22222222221 11222344566899999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=233.27 Aligned_cols=192 Identities=21% Similarity=0.248 Sum_probs=157.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||++++.++.+.+..++||||+ +++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~ 140 (260)
T cd08222 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK 140 (260)
T ss_pred CCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee
Confidence 689999999999999999999999 8999998853 245799999999999999999999999999999999999995
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+.++|+|||+++.+..... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 141 ----~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~- 208 (260)
T cd08222 141 ----NNLLKIGDFGVSRLLMGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ- 208 (260)
T ss_pred ----cCCEeecccCceeecCCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-
Confidence 35699999999987644321 123457889999999998888899999999999999999999999653
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.....+..+..... ..+...++.++.++|..||..+|++||++.++.+
T Consensus 209 --~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 209 --NFLSVVLRIVEGPT----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --cHHHHHHHHHcCCC----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 22333333322221 1234567889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=229.13 Aligned_cols=198 Identities=22% Similarity=0.361 Sum_probs=157.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+.+.+..++|+||+ +++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++
T Consensus 58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~--- 133 (264)
T cd06626 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD--- 133 (264)
T ss_pred CCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---
Confidence 689999999999999999999999 9999999974 45689999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.++|+|||++........... .......++..|++||.+.+.. .+.++|||+||+++|++++|..||....
T Consensus 134 ~~~~~kl~d~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 134 HNGVIKLGDFGCAVKLKNNTTTMG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CCCCEEEcccccccccCCCCCccc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 678899999999987654332110 0012357889999999998766 7899999999999999999999997653
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. .......+..... ..+. ....+++.+.+++..||..+|++||++.++.
T Consensus 211 ~--~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 211 N--EFQIMFHVGAGHK-PPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred c--hHHHHHHHhcCCC-CCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 2 1222222222111 1111 1123478899999999999999999988775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=233.15 Aligned_cols=201 Identities=18% Similarity=0.247 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++.+.+. ++.|+||||++++|.+++......+++..++.++.||+.||+|||..|++|+||||+||+++
T Consensus 57 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~-- 134 (287)
T cd07840 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-- 134 (287)
T ss_pred CCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc--
Confidence 68999999999988 89999999997799999875556899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++......... ......++..|++||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 135 -~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 135 -NDGVLKLADFGLARPYTKRNSA------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred -CCCCEEEccccceeeccCCCcc------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 6789999999999876553310 11234568889999987753 578999999999999999999999976543
Q ss_pred cchHHHHHHHHhh----------------------hccchHHHhhcC-CcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEK----------------------KVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~----------------------~~~~~~~~l~~~-~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
......+...... .....+...... ++.++.+++..||..+|++||++.++.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 2211111111000 000111112223 4889999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=237.45 Aligned_cols=206 Identities=21% Similarity=0.205 Sum_probs=153.1
Q ss_pred CCCCcEEEEeeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVE--------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||+++++++.+ ....|+||||++.+|...+......+++..+..++.||+.+|+|||++||+|+||||+|
T Consensus 66 h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~n 145 (311)
T cd07866 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145 (311)
T ss_pred CCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 6899999887654 34579999999888988887556689999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccc----cccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHh
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~ellt 148 (414)
|+++ .++.++|+|||++............ .........++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 146 il~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~ 222 (311)
T cd07866 146 ILID---NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222 (311)
T ss_pred EEEC---CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh
Confidence 9996 7789999999999865432211110 01112345678999999988754 47889999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhh----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
|+.||.+.......+.+...... ............+.+++.+++..|+..+|++||+.
T Consensus 223 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~ 302 (311)
T cd07866 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302 (311)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence 99999875433222222111100 00011111123455788999999999999999998
Q ss_pred HHHH
Q 015018 207 AYLK 210 (414)
Q Consensus 207 ~~l~ 210 (414)
.+++
T Consensus 303 ~ell 306 (311)
T cd07866 303 SDAL 306 (311)
T ss_pred HHHh
Confidence 7764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=240.00 Aligned_cols=198 Identities=18% Similarity=0.198 Sum_probs=157.7
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++...+ ..|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||+
T Consensus 58 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili 136 (330)
T cd07834 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136 (330)
T ss_pred CcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 689999999888775 7899999998899998874 4589999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ .++.++|+|||++.......... .......++..|++||.+.+. .++.++|+||||+++|+|++|..||.+
T Consensus 137 ~---~~~~~~L~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 137 N---SNCDLKICDFGLARGVDPDEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred c---CCCCEEEcccCceEeeccccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 6 66899999999998765533110 112345789999999999887 789999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhh--------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 156 LKAGTKKQKYEKISEKK--------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~--------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
.... +.+..+.... .......+...++.++.++|..||..+|++||+.+++
T Consensus 210 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 210 RDYI---DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred CCHH---HHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 5432 2222222110 0111122334578899999999999999999998776
Q ss_pred H
Q 015018 210 K 210 (414)
Q Consensus 210 ~ 210 (414)
.
T Consensus 287 l 287 (330)
T cd07834 287 L 287 (330)
T ss_pred H
Confidence 5
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=233.06 Aligned_cols=199 Identities=19% Similarity=0.182 Sum_probs=156.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.+.++.++||||++++|.+++......+++..+..++.|++.+|+|||++||+|+||+|+||+++ .
T Consensus 57 ~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~ 133 (282)
T cd07829 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---R 133 (282)
T ss_pred CCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---C
Confidence 6899999999999999999999998899999986556899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.++|+|||+++....... ......++..|+|||.+.+. .++.++|+|||||++|||++|..||.+.....
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 206 (282)
T cd07829 134 DGVLKLADFGLARAFGIPLR-------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206 (282)
T ss_pred CCCEEEecCCcccccCCCcc-------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 78899999999976544221 11234567889999998876 78899999999999999999999997743222
Q ss_pred hHHHHHHHHhh---------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEK---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~---------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+...... ............++.++.+++..||..+|++||++.++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 11111111000 000111122334578899999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=237.77 Aligned_cols=202 Identities=21% Similarity=0.265 Sum_probs=156.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++..+++.|+||||+.++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+||+++ .
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~ 154 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---S 154 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---C
Confidence 5899999999999999999999998899999874 55799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCccc-------ccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCC
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQH-------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.+.++|+|||++..+........ ..........++..|++||.+.+.. ++.++|+|||||++|+|++|..||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 234 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 78899999999987652111000 0001112345788999999987644 689999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhc-----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKV-----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~-----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.... ..+..+..... ..........++.++.+++..|+..+|++||++++++
T Consensus 235 ~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 235 PGENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 875432 22222221100 0111222345678899999999999999999987775
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=241.00 Aligned_cols=200 Identities=17% Similarity=0.178 Sum_probs=153.7
Q ss_pred CCCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||+++++++... .+.||||||++++|.++++. ...+++..+..++.||+.||+|||+++|+||||||+||+
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil 140 (337)
T cd07858 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL 140 (337)
T ss_pred CCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 368999998877654 35899999998899999874 567999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ ..+.++|+|||+++....... ......++..|++||.+.. ..++.++|+|||||++|+|++|+.||.
T Consensus 141 ~~---~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 141 LN---ANCDLKICDFGLARTTSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred Ec---CCCCEEECcCccccccCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 96 678899999999986644221 1134578899999999875 458899999999999999999999997
Q ss_pred CCCccchHHHHHHHHh-----------------------hhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQKYEKISE-----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~-----------------------~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+............+.. .............+++++.++|..||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 211 GKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred CCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 6432111111110000 00011112233567899999999999999999999777653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=229.43 Aligned_cols=194 Identities=22% Similarity=0.277 Sum_probs=154.4
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+. ...++||||+ |++|.+++.. ...+++..++.++.||+.+|+|||++||+|+||||+||+++
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~- 140 (264)
T cd06653 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD- 140 (264)
T ss_pred CCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-
Confidence 68999999988764 4688999999 8999999874 34689999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ ........++..|++||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 141 --~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 141 --SAGNVKLGDFGASKRIQTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred --CCCCEEECcccccccccccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 6778999999999865431110 0111245789999999999988889999999999999999999999976422
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+.. ......++..+++++.+++.+||. ++..||+..++.
T Consensus 215 ---~~~~~~~~~---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 215 ---MAAIFKIAT---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred ---HHHHHHHHc---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 222222221 111223456788999999999999 579999988664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=240.48 Aligned_cols=201 Identities=19% Similarity=0.283 Sum_probs=164.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|+++|..+......||||||| .|++.|++.-.+++|++.++..+....++||+|||...-||||||..|||+.
T Consensus 87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--- 163 (502)
T KOG0574|consen 87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--- 163 (502)
T ss_pred CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---
Confidence 589999999998888999999999 7899999988889999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+..||+|||.|-.+.+...+ .++.+||+.|||||++....|..++||||||+...||..|++||.+.-+..
T Consensus 164 T~G~AKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 164 TDGIAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred ccchhhhhhccccchhhhhHHh-------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 7789999999999888775432 257899999999999999999999999999999999999999998754421
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.. ..|......+. .-++.++.+|.+|++.|+-+.|++|-++. +++++-|.+.
T Consensus 237 AI---FMIPT~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~---~L~~H~Fikn 288 (502)
T KOG0574|consen 237 AI---FMIPTKPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTAL---RLCEHTFIKN 288 (502)
T ss_pred ee---EeccCCCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHH---HHhhhhhhcC
Confidence 11 11111111110 01223567899999999999999998864 4455555544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=251.61 Aligned_cols=195 Identities=18% Similarity=0.258 Sum_probs=164.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+||+++||..-.+ ....||||++ +|+|.+.+.. ....|-......|+.||+.||.||..+++|||||-..|+||.
T Consensus 170 H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla-- 246 (1039)
T KOG0199|consen 170 HPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA-- 246 (1039)
T ss_pred CcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec--
Confidence 6899999988777 6778999999 9999999976 345688999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
....|||+||||.+.+...... |.......-...|+|||.++...++.++|||++||+||||++ |..||.|...
T Consensus 247 -sprtVKI~DFGLmRaLg~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 247 -SPRTVKICDFGLMRALGENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred -ccceeeeecccceeccCCCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 6789999999999987664431 222334455778999999999999999999999999999997 9999999654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+.+++|.+..... -.+.||+.+++++..||..+|++||+|..|++
T Consensus 322 ---~qIL~~iD~~erLp----RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 322 ---IQILKNIDAGERLP----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---HHHHHhccccccCC----CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 44555555333322 24679999999999999999999999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=246.85 Aligned_cols=222 Identities=22% Similarity=0.260 Sum_probs=163.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+.||+||+.|++++.+|+||||+ ||+|-.++-+ -+-|.+..+..++.+|.+++++.|..|||||||||+||||+
T Consensus 688 n~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID--- 763 (1034)
T KOG0608|consen 688 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID--- 763 (1034)
T ss_pred CcceEEEEEEeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---
Confidence 467999999999999999999999 9999998864 45899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEccc--------CCCcc----cccc---------------c--------ccCCCCCCccccchhhh
Q 015018 81 RANQVYIIDFGLAKRYRD--------TATHQ----HIPY---------------R--------ENKNLTGTARYASMNTH 125 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~--------~~~~~----~~~~---------------~--------~~~~~~Gt~~Y~aPE~~ 125 (414)
.+|+|||+||||+.-+.- ...+. +-+. + -.-.++||+.|+|||++
T Consensus 764 rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl 843 (1034)
T KOG0608|consen 764 RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL 843 (1034)
T ss_pred cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh
Confidence 889999999999964321 11000 0000 0 01246899999999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 126 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 126 ~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
....|+..+|+||.|||||||+.|+.||....+.....++.. .. ....-..|.+++.|..++|.+++. .+++|..
T Consensus 844 ~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---w~-~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG 918 (1034)
T KOG0608|consen 844 ARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---WR-NFLHIPYQGNLSKEALDLIQKLCC-SADSRLG 918 (1034)
T ss_pred cccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---hh-hccccccccccCHHHHHHHHHHhc-Chhhhhc
Confidence 999999999999999999999999999987655433322211 11 111112466788888888876553 4667753
Q ss_pred HHHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 015018 206 YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 239 (414)
Q Consensus 206 ~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~~ 239 (414)
-. -.+- -....+...+||..+..+.++
T Consensus 919 kn-----g~d~--vKaHpfFkgIDfsslRkq~Ap 945 (1034)
T KOG0608|consen 919 KN-----GADQ--VKAHPFFKGIDFSSLRKQRAP 945 (1034)
T ss_pred cc-----chhh--hhcCccccccchHhhhhccCC
Confidence 11 1111 122355667788887655443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=231.80 Aligned_cols=209 Identities=19% Similarity=0.226 Sum_probs=156.6
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCC
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIK 70 (414)
+|||.+++.+...+. ..||+++|+ .|+|.+.+..+ +..+++.++++|+.+|++||++||+.. +.|||||
T Consensus 77 s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiK 156 (302)
T KOG2345|consen 77 SPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIK 156 (302)
T ss_pred CcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCC
Confidence 477777766655443 489999999 99999998755 346999999999999999999999998 9999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccC--CCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHH
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDT--ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~--~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~e 145 (414)
|.|||++ ..+.++|.|||.+....-. ..+.+....+......|..|.|||.+.- ...+.++|||||||+||.
T Consensus 157 P~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 157 PANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred cceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence 9999997 6799999999998754321 1112222233345678999999999974 456899999999999999
Q ss_pred HHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 146 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 146 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
|+.|.-||......... ..-.+...++..+ -...+++.+.++|+.|++.||.+||+..+|+..+.++.
T Consensus 234 ~mf~~sPfe~~~~~GgS-laLAv~n~q~s~P---~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 234 MMFGESPFERIYQQGGS-LALAVQNAQISIP---NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHcCCcchHHhhcCCe-EEEeeeccccccC---CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 99999999642110000 0000111111111 01237899999999999999999999999998887763
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=251.90 Aligned_cols=189 Identities=19% Similarity=0.269 Sum_probs=160.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+||++.+..++..+...|||||||-|+-.|++.-..+++-+.++..|+.+.+.||+|||+.+.||||||..|||++ .
T Consensus 85 HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e 161 (948)
T KOG0577|consen 85 HPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---E 161 (948)
T ss_pred CCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---C
Confidence 6999999999999999999999998888899888888999999999999999999999999999999999999997 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.+.|||+|||.|..... .+.|+||+.|||||+++. ..|+-++||||||++..||...++|+.++++
T Consensus 162 ~g~VKLaDFGSAsi~~P-----------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 162 PGLVKLADFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred CCeeeeccccchhhcCc-----------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 89999999999875433 356899999999999974 4588999999999999999999999988755
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. ..| .|.....++.- ...++..|+.|+..|+.+-|.+||+.++|.
T Consensus 231 MS--ALY-HIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 231 MS--ALY-HIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred HH--HHH-HHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 32 222 23322222211 234678899999999999999999987765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=225.60 Aligned_cols=188 Identities=22% Similarity=0.293 Sum_probs=157.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+..+++.|+||||+ +++|.+++.. ...+++..+..++.||+.+|.|||+.+++|+||||+||+++
T Consensus 52 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~--- 127 (250)
T cd05123 52 HPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD--- 127 (250)
T ss_pred CCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---
Confidence 689999999999999999999999 9999999974 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||++........ ......++..|++||.+.+...+.++|+|+||+++|++++|..||.....
T Consensus 128 ~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-- 198 (250)
T cd05123 128 ADGHIKLTDFGLAKELSSEGS-------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-- 198 (250)
T ss_pred CCCcEEEeecCcceecccCCC-------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--
Confidence 678899999999987644321 12345789999999999988889999999999999999999999966432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
.+.+..+..... .+...++.++.+++..||..+|++||+..+
T Consensus 199 -~~~~~~~~~~~~-----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 199 -KEIYEKILKDPL-----RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -HHHHHHHhcCCC-----CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 333333333211 234456899999999999999999999854
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=250.24 Aligned_cols=190 Identities=22% Similarity=0.279 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++|.........|+||||+ |+.|.+++...+ .+.+.++..++.|++.+++|||+++|||||||.+||||+
T Consensus 114 HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~--- 189 (596)
T KOG0586|consen 114 HPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD--- 189 (596)
T ss_pred CcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---
Confidence 699999999999999999999999 999999998655 555599999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.+..+||+|||++..+..... ..+++|++.|+|||++.|.+| +..+|+|++|+++|-|+.|.+||+|..
T Consensus 190 ~~mnikIaDfgfS~~~~~~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-- 259 (596)
T KOG0586|consen 190 ENMNIKIADFGFSTFFDYGLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-- 259 (596)
T ss_pred cccceeeeccccceeeccccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--
Confidence 667799999999988764332 246899999999999999887 589999999999999999999998742
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+..-+++...++.. .--+..+..++|..++-++|.+|++.+++.+
T Consensus 260 -lk~Lr~rvl~gk~rI-----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 -LKELRPRVLRGKYRI-----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -cccccchheeeeecc-----cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 233333333333322 2234578889999999999999999887753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=241.06 Aligned_cols=191 Identities=21% Similarity=0.303 Sum_probs=151.7
Q ss_pred CCCCcEEEEeeEeCCE------EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGDY------NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~------~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||++++..+..++. .|+||||+|++|.+++. ...+++..+..++.||+.+|+|||+.||+||||||+||+
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil 150 (343)
T cd07851 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 150 (343)
T ss_pred CCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 5888888877766554 89999999999999987 357999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.++|+|||++...... .....++..|++||.+.+ ..++.++|||||||++|++++|+.||.
T Consensus 151 l~---~~~~~kL~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 151 VN---EDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred EC---CCCCEEEcccccccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 96 6788999999999765432 134578889999999865 367899999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+... .+.+..+..... ......+...+++++.++|..|+..+|++||++.+
T Consensus 218 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 218 GSDH---IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCCh---HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 6432 222222221100 00111223356889999999999999999999887
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
|+
T Consensus 295 ll 296 (343)
T cd07851 295 AL 296 (343)
T ss_pred Hh
Confidence 64
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.78 Aligned_cols=194 Identities=20% Similarity=0.244 Sum_probs=152.2
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.. +.+.|+||||++++|..+++ ...++...+..++.||+.||+|||+++|+||||||.|||++
T Consensus 68 hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~--- 142 (328)
T cd07856 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN--- 142 (328)
T ss_pred CCCeeeEeeeEecCCCcEEEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---
Confidence 6999999998876 56889999999889999887 45789999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++...... .....++..|++||.+.+ ..++.++|+|||||++|+|++|..||.+....
T Consensus 143 ~~~~~~l~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 143 ENCDLKICDFGLARIQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred CCCCEEeCccccccccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6788999999998754321 123567889999998766 56899999999999999999999999764321
Q ss_pred chHHHHHHH------------Hh-----------hhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKI------------SE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i------------~~-----------~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......... .. ..........+..++.++.++|..|+..+|++||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111111100 00 0011122234456788999999999999999999987663
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=254.64 Aligned_cols=204 Identities=20% Similarity=0.304 Sum_probs=168.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFL 65 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~giv 65 (414)
+|||+.+...+......++|+||+ .|+|.+++..+. ..++..+.+.++.||+.|++||+++.+|
T Consensus 361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 689999999999999999999999 999999998554 2499999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCC-CCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
||||-..|||+. .+..+||+|||+|+...+... |...... .-...|||||.+....|+.++||||+|++||
T Consensus 441 HRDLAaRNVLi~---~~~~~kIaDFGlar~~~~~~~-----y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~ 512 (609)
T KOG0200|consen 441 HRDLAARNVLIT---KNKVIKIADFGLARDHYNKDY-----YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW 512 (609)
T ss_pred chhhhhhhEEec---CCCEEEEccccceeccCCCCc-----eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence 999999999996 678999999999986544322 2111111 1345699999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
||++ |..||.+... ....++.+.+.... +.+..|++++.++|..||+.+|++||+|.++.+.|..++..
T Consensus 513 EifsLG~~PYp~~~~--~~~l~~~l~~G~r~----~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 513 EIFTLGGTPYPGIPP--TEELLEFLKEGNRM----EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHhhCCCCCCCCCCc--HHHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 9998 9999988432 12224444443332 24567899999999999999999999999999999997653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=245.54 Aligned_cols=207 Identities=14% Similarity=0.224 Sum_probs=169.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.|||++|+..|..++..||||||+ .|+|.+++....-+ +.....+.|+.||+.||+||.+.+||||||.+.|+|++
T Consensus 594 hPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~-- 671 (807)
T KOG1094|consen 594 HPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD-- 671 (807)
T ss_pred CCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec--
Confidence 699999999999999999999999 99999999865323 35666778999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ell--tG~~Pf~~~~ 157 (414)
...++||+|||+++.+-.... |+.....+-..+|||+|.+.-.+++.++|+|+||+++||++ +...||..+.
T Consensus 672 -~e~~iKiadfgmsR~lysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 672 -GEFTIKIADFGMSRNLYSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred -CcccEEecCcccccccccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 889999999999996544332 33334567789999999999999999999999999999976 4789998875
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
+....+....+....-...+...+.-||.++.++|..||..+-.+||+|++|...|.+.
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 54433333333333333333334567899999999999999999999999999888664
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=237.13 Aligned_cols=201 Identities=18% Similarity=0.194 Sum_probs=149.7
Q ss_pred CCCCcEEEEeeEeC--------------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015018 2 AAGIPNLRWFGVEG--------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 67 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--------------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHR 67 (414)
+|||+++++.+... .+.|+||||++++|.+++. ...+++..+..++.||+.||+|||+.||+||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~ 138 (342)
T cd07854 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHR 138 (342)
T ss_pred CCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 58888888655443 4679999999889998886 4579999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~el 146 (414)
||||+||+++ ..+..++|+|||+++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 139 dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 139 DLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKG----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCCHHHEEEc--CCCceEEECCcccceecCCcccccc----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 9999999996 3456789999999986543221110 1122467889999998764 5578899999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHH----------------------hhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKIS----------------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~----------------------~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
++|..||.+.............. ..........+...++.++.+++..||..+|++||
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 99999997654321111110000 00011112233346778999999999999999999
Q ss_pred CHHHHH
Q 015018 205 DYAYLK 210 (414)
Q Consensus 205 ~~~~l~ 210 (414)
++.+++
T Consensus 293 t~~ell 298 (342)
T cd07854 293 TAEEAL 298 (342)
T ss_pred CHHHHh
Confidence 987774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.40 Aligned_cols=194 Identities=20% Similarity=0.258 Sum_probs=151.8
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++.+..+. +.|+||||+|++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus 73 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nil 150 (343)
T cd07880 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLA 150 (343)
T ss_pred CCCccceeeeecCCccccccceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 689999998887654 459999999999999887 457999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ ..+.++|+|||++...... .....++..|++||.+.+ ..++.++|+|||||++|++++|..||.
T Consensus 151 l~---~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 151 VN---EDCELKILDFGLARQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred Ec---CCCCEEEeecccccccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 96 6788999999998754331 123567899999999876 457899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.........+.++... .....+..+...++.++.++|..|+..||.+||+..++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 65332111111111000 000112223356788899999999999999999987765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=237.38 Aligned_cols=190 Identities=19% Similarity=0.255 Sum_probs=148.4
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||++++.++.... ..|+||||+..+|..++ +..+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 73 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIl 149 (342)
T cd07879 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149 (342)
T ss_pred CCCccchhheecccccCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 689999998877543 45999999987887765 347999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.++|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 150 l~---~~~~~kL~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 150 VN---EDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred EC---CCCCEEEeeCCCCcCCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 96 6789999999998754221 123577899999999876 458899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhh--------------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEK--------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~--------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+.... ..+..+... ........+...++.++.++|..||+.+|++||++++
T Consensus 217 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e 293 (342)
T cd07879 217 GKDYL---DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293 (342)
T ss_pred CCCHH---HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 74321 112111110 0001111222356788999999999999999999887
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 294 ~l 295 (342)
T cd07879 294 AL 295 (342)
T ss_pred Hh
Confidence 75
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=235.30 Aligned_cols=192 Identities=21% Similarity=0.283 Sum_probs=149.1
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||++++..+... ...|++++++|++|.++++ ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 151 (345)
T cd07877 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 151 (345)
T ss_pred CCCcccceeeeeeecccccccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 368999999887643 3478999999999999887 34799999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
+++ .++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus 152 ll~---~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 152 AVN---EDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred EEc---CCCCEEEeccccccccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 996 6788999999998754321 124578899999999876 46788999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 154 QGLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
.+..... .+..+..... ...........+.++.++|..|+..+|++||+..
T Consensus 219 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 219 PGTDHID---QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCHHH---HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 7643221 1111111000 0001111224577899999999999999999976
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 296 e~l 298 (345)
T cd07877 296 QAL 298 (345)
T ss_pred HHh
Confidence 654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=232.69 Aligned_cols=198 Identities=18% Similarity=0.329 Sum_probs=160.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl 76 (414)
||||+++|+..-.+.-.||.||+|..||..+.++- ...+++.-+-.|+.-.+.||+||-+. .||||||||.|||+
T Consensus 122 cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl 201 (361)
T KOG1006|consen 122 CPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL 201 (361)
T ss_pred CcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE
Confidence 89999999998888888999999999998877632 45799999999999999999999864 89999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+ ..|.|||||||++-.+.+.-. ...-.|-..|||||-+.. ..|+.++||||||++|||+.||..||.
T Consensus 202 d---r~G~vKLCDFGIcGqLv~SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 202 D---RHGDVKLCDFGICGQLVDSIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred e---cCCCEeeecccchHhHHHHHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 6 889999999999977665432 123478889999999873 348899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccchH-HHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
+.+. ..+.+..+.....+... ..-|-++...+..+|.-|+.+|-.+||.|.+|++.
T Consensus 271 ~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 271 KWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred hHHH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 8643 33334444433333221 12234577899999999999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=234.22 Aligned_cols=195 Identities=19% Similarity=0.252 Sum_probs=152.6
Q ss_pred CcEEEEeeEeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee-----
Q 015018 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----- 78 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~----- 78 (414)
++++..++....+.|||+|++|.|+.++++.. -.+|+...+..++.||+.+++|||+.+++|.||||+|||+..
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 67888889999999999999999999999753 357999999999999999999999999999999999999852
Q ss_pred ----cC--------CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 79 ----GR--------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 79 ----~~--------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
.+ +...|+|+|||.|+...... ...+.|..|.|||+++|..++..+||||+||||+|+
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 11 13469999999997643322 356889999999999999999999999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhhccchHH----------------------------HhhcC----------CcHHH
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE----------------------------ALCRG----------YPTEF 188 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~----------------------------~l~~~----------~p~e~ 188 (414)
++|...|+.-.+.....+.++|........+. +.|+- --.++
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 99999998755433333444443211000000 00100 01458
Q ss_pred HHHHHHHHcCCCCCCCCHHHH
Q 015018 189 ASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 189 ~~li~~c~~~dp~~RP~~~~l 209 (414)
.+|++.++..||.+|+++.++
T Consensus 383 fDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred HHHHHHHHccCccccccHHHH
Confidence 899999999999999996655
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=227.92 Aligned_cols=217 Identities=19% Similarity=0.281 Sum_probs=170.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|.++-++..|+.+...|+|.||+ |++|.-.+++ .++++++.+..+..+|+.+|.|||++|||+||||.+|+|++
T Consensus 310 ~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld--- 385 (593)
T KOG0695|consen 310 NPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD--- 385 (593)
T ss_pred CCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---
Confidence 477888899999999999999999 9998766663 67999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC--CCc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG--LKA 158 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~--~~~ 158 (414)
..+.+||+|+|+++.--.+.. -..+++||+.|+|||++.|.+|+..+|+|+|||+|+||+.|+.||+- +..
T Consensus 386 aeghikltdygmcke~l~~gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred cCCceeecccchhhcCCCCCc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 889999999999986433222 23578999999999999999999999999999999999999999963 222
Q ss_pred c---chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 159 G---TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 159 ~---~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
. +..-.++.|.++.+. ++..++.....+++..+++||.+|.... +..-|.++ .+.++.-..||+.+..
T Consensus 459 ~d~ntedylfqvilekqir-----iprslsvkas~vlkgflnkdp~erlgc~-~~~g~~di---k~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIR-----IPRSLSVKASHVLKGFLNKDPKERLGCR-PQTGFSDI---KSHAFFRSIDWDLLEQ 529 (593)
T ss_pred cccchhHHHHHHHhhhccc-----ccceeehhhHHHHHHhhcCCcHHhcCCC-cccchhhh---hcchhhhhCCHHHHhh
Confidence 1 122233444554443 3445667788899999999999997532 11122222 2334455679998865
Q ss_pred ccc
Q 015018 236 QQS 238 (414)
Q Consensus 236 ~~~ 238 (414)
++.
T Consensus 530 k~v 532 (593)
T KOG0695|consen 530 KQV 532 (593)
T ss_pred ccc
Confidence 443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=247.98 Aligned_cols=202 Identities=13% Similarity=0.227 Sum_probs=171.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++|...-...+...||.||| .|+|..++....+.|+..++.-+.+.|+.|+.||-+.++|||||-..|||++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN--- 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN--- 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---
Confidence 699999999999999999999999 9999999988888999999999999999999999999999999999999995
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.+-.+|++||||++.+.+.... +.....-.-..+|.|||.+....++..+||||+|+||||.+. |..||.++.+
T Consensus 766 snLvCKVsDFGLSRvledd~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN- 840 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN- 840 (996)
T ss_pred cceEEEeccccceeecccCCCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-
Confidence 6778899999999987654310 111112223578999999999999999999999999999875 9999988643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.+.+..|.+....+. +-+||..+.+||..||++|-..||.|++|...|.+++
T Consensus 841 --QdVIkaIe~gyRLPp----PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 841 --QDVIKAIEQGYRLPP----PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred --HHHHHHHHhccCCCC----CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 344445554443322 3479999999999999999999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=249.04 Aligned_cols=89 Identities=24% Similarity=0.463 Sum_probs=83.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++..+..+++.||||||+ |++|.+++.. ...+++..++.|+.||+.||+|||.++||||||||+||||+
T Consensus 63 hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~--- 138 (669)
T cd05610 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS--- 138 (669)
T ss_pred CCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---
Confidence 689999999999999999999999 9999999975 45789999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeE
Q 015018 81 RANQVYIIDFGLAK 94 (414)
Q Consensus 81 ~~~~vkL~DFGla~ 94 (414)
..+.++|+|||+++
T Consensus 139 ~~g~vkL~DFGls~ 152 (669)
T cd05610 139 NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCEEEEeCCCCc
Confidence 67889999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=211.80 Aligned_cols=195 Identities=24% Similarity=0.307 Sum_probs=157.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.++||++++.++..+...++|||++ +++|.+++... ..+++..+..++.|++.+|.|||..+|+|+||+|.||+++
T Consensus 45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~-- 121 (244)
T smart00220 45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD-- 121 (244)
T ss_pred CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC--
Confidence 3689999999999999999999999 66999999753 3499999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.++|+|||++....... ......++..|++||.+.+..++.++|+|+||+++|++++|..||.....
T Consensus 122 -~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~- 191 (244)
T smart00220 122 -EDGHVKLADFGLARQLDPGG--------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ- 191 (244)
T ss_pred -CCCcEEEccccceeeecccc--------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-
Confidence 56899999999998765532 12345788899999999988889999999999999999999999976321
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....++.+........ .....++.++.+++..|+..+|++||++.++.+
T Consensus 192 -~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 192 -LLELFKKIGKPKPPFP--PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -HHHHHHHHhccCCCCc--cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 2222222222221110 011117889999999999999999999888764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=257.83 Aligned_cols=198 Identities=14% Similarity=0.155 Sum_probs=141.3
Q ss_pred CCcEEEEee-------EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 4 GIPNLRWFG-------VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 4 ~I~~l~~~g-------~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
||.++++++ .+.+..+++||+++.+|.++++.....+++.+++.|+.||+.||+|||++|||||||||+||||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl 113 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVM 113 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEE
Confidence 566666655 3345678899999999999997656679999999999999999999999999999999999999
Q ss_pred ee----------------cCCCCeEEEeeeceeEEcccCCC--------ccccccc-ccCCCCCCccccchhhhcCCCCC
Q 015018 77 GL----------------GRRANQVYIIDFGLAKRYRDTAT--------HQHIPYR-ENKNLTGTARYASMNTHLGIEQS 131 (414)
Q Consensus 77 ~~----------------~~~~~~vkL~DFGla~~~~~~~~--------~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s 131 (414)
+. ....+.+||+|||+++....... ....++. ......||+.|||||++.+..++
T Consensus 114 ~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 193 (793)
T PLN00181 114 SSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSN 193 (793)
T ss_pred cccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCC
Confidence 52 01245567777777764321100 0000000 01124689999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 132 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 132 ~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.++|||||||+||||++|..|+... ...+..+....... ..... ..+...++..||..+|.+||++.+++
T Consensus 194 ~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 194 CASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred chhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999998887532 11122222111111 11112 24567888999999999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=241.88 Aligned_cols=193 Identities=20% Similarity=0.330 Sum_probs=158.6
Q ss_pred CCCCcEEEEeeEe-----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVE-----GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~-----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
+||++.+|++|.. ++..||||||| |||..|+++.. +..+.+..+..|++.++.||.+||...++|||||-.||
T Consensus 75 hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~Ni 154 (953)
T KOG0587|consen 75 HPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNV 154 (953)
T ss_pred CCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceE
Confidence 6899999998874 67899999999 99999999743 67899999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-----CCchhHHHHHHHHHHHHHhC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRG 149 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~~~DvwSlGvvl~elltG 149 (414)
|++ ..+.|||+|||.+..+...-. ...+.+||+.|||||++...+ |+.++|+||||++..||-.|
T Consensus 155 LLT---~e~~VKLvDFGvSaQldsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 155 LLT---ENAEVKLVDFGVSAQLDSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred EEe---ccCcEEEeeeeeeeeeecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 997 889999999999987765332 236789999999999998654 67899999999999999999
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
.+|+.++.+. ..+.+|........ .-++.+.++|.++|..|+.+|++.||...+|
T Consensus 225 ~PPl~DmHPm---raLF~IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 225 APPLCDMHPM---RALFLIPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CCCccCcchh---hhhccCCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 9999876542 11222222221111 1134567899999999999999999986554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=202.04 Aligned_cols=167 Identities=17% Similarity=0.179 Sum_probs=128.1
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCccccc
Q 015018 27 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 106 (414)
Q Consensus 27 ~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 106 (414)
|+|.+++...+..|++.+++.|+.||+.||+|||+++ ||+|||++ .++.+++ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc------
Confidence 6899999866678999999999999999999999998 99999996 6677888 99998654321
Q ss_pred ccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHH--HhhcCC
Q 015018 107 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 184 (414)
Q Consensus 107 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 184 (414)
..||+.|||||++.+..++.++|||||||++|||++|..||...... .+.+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 26899999999999999999999999999999999999999764321 12222222111111000 001112
Q ss_pred cH--HHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 185 PT--EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 185 p~--e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
+. ++.+++..||..+|++||++.++.+.+.....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 23 69999999999999999999998887766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=236.00 Aligned_cols=192 Identities=19% Similarity=0.285 Sum_probs=158.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCC-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~s-L~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+.+...++..+..|+|||-+.|+ |+-++......|++.....+..||+.||.|||.++|||.||||+|||+....
T Consensus 622 HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~ 701 (888)
T KOG4236|consen 622 HPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS 701 (888)
T ss_pred CCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC
Confidence 699999999999999999999999555 4555555567899999999999999999999999999999999999997655
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.-.+|||||||+|+.+..... ....+||+.|+|||++....|.+.-|+||+|||+|--|.|..||....
T Consensus 702 ~FPQvKlCDFGfARiIgEksF--------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--- 770 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSF--------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--- 770 (888)
T ss_pred CCCceeeccccceeecchhhh--------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---
Confidence 667999999999998876442 245799999999999999999999999999999999999999996432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
+.-+.|....+..+. .-+.++..+..+||..+++..-.+|-+.+
T Consensus 771 --dIndQIQNAaFMyPp-~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 771 --DINDQIQNAAFMYPP-NPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred --chhHHhhccccccCC-CchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 222344443333221 22456778899999999999888887644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=255.30 Aligned_cols=199 Identities=13% Similarity=0.183 Sum_probs=149.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH---~~givHRDIKP~NILl 76 (414)
.+|||+++++++.+++..||||||+ +++|.++++ .+++..+..|+.||+.||+||| +.+|+||||||+||++
T Consensus 741 ~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 3799999999999999999999999 999999996 4899999999999999999999 6799999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ .....++. ||........ ....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 817 ~---~~~~~~~~-~~~~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 817 D---GKDEPHLR-LSLPGLLCTD-----------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred C---CCCceEEE-eccccccccC-----------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 6 44445543 6655432211 2236889999999999999999999999999999999999999543
Q ss_pred Cccc-hHHHHHHHHh--hh----ccchHHH---hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 157 KAGT-KKQKYEKISE--KK----VSTSIEA---LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 157 ~~~~-~~~~~~~i~~--~~----~~~~~~~---l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.... ......+... .. ....+.. .......++.+++..||+.+|++||++.++.+.|++...
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2111 0111111000 00 0000000 000112467789999999999999999999999987753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=227.34 Aligned_cols=201 Identities=21% Similarity=0.281 Sum_probs=155.5
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~--givHRDIKP~NILl~ 77 (414)
+|-||++|+++.- .+.+|-|+||| |.+|.-+++. .+-++++++..|+.||+.+|.||.+. .|||-||||.||||-
T Consensus 526 HpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv 604 (775)
T KOG1151|consen 526 HPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV 604 (775)
T ss_pred cceeeeeeeeeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe
Confidence 5789999999875 45679999999 8888777774 77899999999999999999999986 599999999999998
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC----CCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.+...|.|||+||||++.+.+.......-..-.....||.+|++||++.-. ..+.++||||+|||+|.++.|+.||
T Consensus 605 ~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 605 NGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred cCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 888889999999999998776543322222234568899999999998743 3578999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhh-hccchHHH-h--hcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 154 QGLKAGTKKQKYEKISEK-KVSTSIEA-L--CRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~-~~~~~~~~-l--~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
..... .+ .|.+. .+....+. + -+.+..+...||..|++.+-++|.+..+|
T Consensus 685 Ghnqs---QQ---dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 685 GHNQS---QQ---DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred CCchh---HH---HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 65211 11 11111 11100010 1 12356789999999999999999886655
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=243.38 Aligned_cols=198 Identities=19% Similarity=0.248 Sum_probs=152.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCH---HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~---~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++|+.-++..+.||+.|+|..+|.++++.....+.. ...+.+..|++.||++||+.+||||||||+||||..
T Consensus 562 H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~ 641 (903)
T KOG1027|consen 562 HPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISV 641 (903)
T ss_pred CCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEc
Confidence 69999999999999999999999999999999853122221 345778899999999999999999999999999985
Q ss_pred c--CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 015018 79 G--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQG 155 (414)
Q Consensus 79 ~--~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~ 155 (414)
. +....++|+|||+++++..... .+....+..||-+|+|||++........+||||||||+|+.++ |..||..
T Consensus 642 ~~~~~~~ra~iSDfglsKkl~~~~s----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 642 PSADGTLRAKISDFGLSKKLAGGKS----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cCCCcceeEEecccccccccCCCcc----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 3 2335789999999998865432 2333567899999999999999888899999999999999998 5999965
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... .-..|........ .+...-..+..+||..|++.+|..||++.++.
T Consensus 718 ~~~-----R~~NIl~~~~~L~--~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 718 SLE-----RQANILTGNYTLV--HLEPLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHH-----hhhhhhcCcccee--eeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 322 2122222221111 11111112889999999999999999987764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=214.26 Aligned_cols=151 Identities=23% Similarity=0.327 Sum_probs=128.6
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~g~sL~~ll~~~----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+.|...+.. +..+||++||..-+|+++|+.. .+.++...+..|..||+.|+.|||++=|+||||||.||||
T Consensus 86 h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlv 165 (438)
T KOG0666|consen 86 HPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILV 165 (438)
T ss_pred CCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEE
Confidence 5788877666665 8889999999999999999854 3569999999999999999999999999999999999999
Q ss_pred ee-cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 77 GL-GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 77 ~~-~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.- +...|.|||+|||+++.+.++-. |.......+-|.+|.|||.++|.. |+...|||++|||+.||++-.+.|.
T Consensus 166 mgdgperG~VKIaDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 166 MGDGPERGRVKIADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eccCCccCeeEeecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 63 23348999999999999877532 233445578899999999999864 8999999999999999999998887
Q ss_pred CC
Q 015018 155 GL 156 (414)
Q Consensus 155 ~~ 156 (414)
+.
T Consensus 242 g~ 243 (438)
T KOG0666|consen 242 GR 243 (438)
T ss_pred ch
Confidence 63
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=234.01 Aligned_cols=146 Identities=25% Similarity=0.343 Sum_probs=125.6
Q ss_pred CCCCcEEEEeeEeC------CEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVEG------DYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~~------~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+||||++++.-.+. +..++||||| ||||..+++.. ...|++.+++.+...+..||.|||++|||||||||.
T Consensus 70 h~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~ 149 (732)
T KOG4250|consen 70 HPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPG 149 (732)
T ss_pred chhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCC
Confidence 68999998765543 4679999999 99999999743 346999999999999999999999999999999999
Q ss_pred cEEEeecCCC-CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCC
Q 015018 73 NFLMGLGRRA-NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 73 NILl~~~~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~ 150 (414)
||++-.+.+. ...||+|||.|+.+.+.. ....++||..|++||+... ..|+.-+|+|||||++|++.||.
T Consensus 150 NIvl~~Gedgq~IyKLtDfG~Arel~d~s--------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 150 NIVLQIGEDGQSIYKLTDFGAARELDDNS--------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred cEEEeecCCCceEEeeecccccccCCCCC--------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 9998655433 456899999999887754 2356899999999999984 78899999999999999999999
Q ss_pred CCCCC
Q 015018 151 LPWQG 155 (414)
Q Consensus 151 ~Pf~~ 155 (414)
+||.-
T Consensus 222 lPF~p 226 (732)
T KOG4250|consen 222 LPFIP 226 (732)
T ss_pred CCCCc
Confidence 99953
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=204.90 Aligned_cols=158 Identities=23% Similarity=0.314 Sum_probs=134.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~ 77 (414)
||.++.+|.....+...||.||.|..||..+.+. .++.+++..+-+|+..++.||+|||++ .+||||+||.||||+
T Consensus 104 CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 104 CPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN 183 (282)
T ss_pred CCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc
Confidence 7999999998888889999999999999887642 377899999999999999999999986 899999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC----CCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
..|+|||||||++-.+.+.-.. ....|-..|||||.+..+ .|+-++||||||+.+.||.+++.||
T Consensus 184 ---~~GqVKiCDFGIsG~L~dSiAk--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 184 ---YDGQVKICDFGISGYLVDSIAK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred ---cCCcEEEcccccceeehhhhHH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 8899999999999887764321 125788999999998743 5889999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhh
Q 015018 154 QGLKAGTKKQKYEKISEKK 172 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~ 172 (414)
... .+..+.+..+.+..
T Consensus 253 ~~w--~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 253 ESW--GTPFQQLKQVVEEP 269 (282)
T ss_pred ccc--CCHHHHHHHHhcCC
Confidence 765 35556665555443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.62 Aligned_cols=209 Identities=22% Similarity=0.268 Sum_probs=170.4
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceecC
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-----K---SFLHRD 68 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-----~---givHRD 68 (414)
++||..+......++ ..|||.||. .|||.|+++. ..++.+..++++..++.||++||. + .|.|||
T Consensus 264 HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 264 HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 467777765554433 579999999 9999999984 689999999999999999999995 2 499999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC------CCCchhHHHHHHHH
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYV 142 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~~~DvwSlGvv 142 (414)
||..|||+ ++++.+.|+|||||-..........+ ..+..+||.+|||||++... +.-..+||||||.|
T Consensus 342 lKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi---~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 342 LKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDI---PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred cccccEEE---ccCCcEEEeeceeeEEecccCCcccC---CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 99999999 58899999999999887665433333 23567999999999998742 23467999999999
Q ss_pred HHHHHhC----------CCCCCCCCccc--hHHHHHHHHhhhccchHHHhhcCCc--HHHHHHHHHHHcCCCCCCCCHHH
Q 015018 143 LMYFLRG----------SLPWQGLKAGT--KKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 143 l~elltG----------~~Pf~~~~~~~--~~~~~~~i~~~~~~~~~~~l~~~~p--~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
|||+... ++||.++.+.+ ..++.+.++..+..+.++..+...| ..+.++|+.||..+|.-|.++-.
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 9999753 79998876554 3566666777777777777776665 46889999999999999999999
Q ss_pred HHHHHHHHHH
Q 015018 209 LKRLFRDLFI 218 (414)
Q Consensus 209 l~~~l~~~~~ 218 (414)
|++.|.++.+
T Consensus 496 iKKtl~~l~~ 505 (513)
T KOG2052|consen 496 IKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHhc
Confidence 9999998863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=236.29 Aligned_cols=186 Identities=18% Similarity=0.147 Sum_probs=128.2
Q ss_pred EeCCEEEEEEecC-CCCHHHHHHHcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 13 VEGDYNVLVIDLL-GPSLEDLFNFCSRKL-------------------SLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 13 ~~~~~~~lVmE~~-g~sL~~ll~~~~~~l-------------------s~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
..++..||||||+ +++|.+++......+ ....+..|+.||+.||+|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 4567889999999 899999987432221 23446689999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----------------------C
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----------------------Q 130 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----------------------~ 130 (414)
|||++ ...+.+||+|||+|+.+..... .....+.+++.|+|||.+.... +
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99996 2357899999999986543221 1124568899999999764322 3
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhc-------------cchHH---HhhcCCcHHHHHHHHH
Q 015018 131 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------------STSIE---ALCRGYPTEFASYFHY 194 (414)
Q Consensus 131 s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------~~~~~---~l~~~~p~e~~~li~~ 194 (414)
..++|||||||+||||+++.+++... ..+....+..... ..... .+.+.......+||..
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 34569999999999999987775431 1111111111000 00000 0011112345589999
Q ss_pred HHcCCCCCCCCHHHHH
Q 015018 195 CRSLRFDDKPDYAYLK 210 (414)
Q Consensus 195 c~~~dp~~RP~~~~l~ 210 (414)
|+..||.+||++.+++
T Consensus 433 mL~~dP~kR~ta~e~L 448 (566)
T PLN03225 433 MMRFKGRQRISAKAAL 448 (566)
T ss_pred HccCCcccCCCHHHHh
Confidence 9999999999987665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=240.11 Aligned_cols=185 Identities=21% Similarity=0.284 Sum_probs=134.8
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeece
Q 015018 15 GDYNVLVIDLL-GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 92 (414)
Q Consensus 15 ~~~~~lVmE~~-g~sL~~ll~~~~~~l-s~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGl 92 (414)
.-+.||=|||| ...|.+++.+ +... ....+.+++.||++||.|+|++|||||||||.||+++ ..+.|||+|||+
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGL 743 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEc---CCCCeeeccccc
Confidence 35789999999 5555555553 4333 4788999999999999999999999999999999997 889999999999
Q ss_pred eEEcc------cC--C--Cc-ccccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 93 AKRYR------DT--A--TH-QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 93 a~~~~------~~--~--~~-~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
|+... +. . .. ..-.-......+||..|+|||++.+.. |+.|.|+||||+||+||+. ||.-.
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-- 818 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-- 818 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--
Confidence 98621 10 0 00 000111234679999999999998765 9999999999999999987 56432
Q ss_pred cchHHHHHHHHhhhccchHHHhh-cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~-~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+..+....++.. ..+. +.+| +-..+|+.+++.||.+||++.+|+
T Consensus 819 MERa~iL~~LR~g~iP~~-~~f~~~~~~-~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 819 MERASILTNLRKGSIPEP-ADFFDPEHP-EEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred HHHHHHHHhcccCCCCCC-cccccccch-HHHHHHHHHhcCCCccCCCHHHHh
Confidence 233333444443333332 1122 2333 457899999999999999998875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=196.29 Aligned_cols=198 Identities=19% Similarity=0.238 Sum_probs=159.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+.||+++++.--.+...-+|+|||..+|..++..+++.++.+.+..++.|+++||.|+|+++++||||||+|+||. .
T Consensus 60 hknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ 136 (292)
T KOG0662|consen 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---R 136 (292)
T ss_pred hcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---c
Confidence 4799999999999999999999999999999999999999999999999999999999999999999999999996 8
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
++.+||+|||+++.+.- |.+.....+-|.+|.+|.++.|.. |+...|+||.||++.|+.. |++.|.|.+..
T Consensus 137 ngelkladfglarafgi-------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 137 NGELKLADFGLARAFGI-------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred CCcEEecccchhhhcCC-------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 89999999999986643 344445567899999999999866 7899999999999999986 89999886554
Q ss_pred chHHHHHHHHhhhccc---------------------hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 160 TKKQKYEKISEKKVST---------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~---------------------~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
+....+.+........ ....+.+.+...-+++++.++.-+|..|.+++..
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 4444433332211111 1112222233445788888888899999887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=203.66 Aligned_cols=188 Identities=19% Similarity=0.206 Sum_probs=145.0
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEc
Q 015018 17 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96 (414)
Q Consensus 17 ~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~ 96 (414)
..||||++|..+|..++.....+|++.++..++.+++.||.|+|...|+|||+|++|+||+ +++.+||+|||+++.+
T Consensus 98 t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFGlar~f 174 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFGLARAF 174 (376)
T ss_pred eeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeeccccccce
Confidence 4799999999999999986677899999999999999999999999999999999999996 7899999999999887
Q ss_pred ccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccc
Q 015018 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 175 (414)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 175 (414)
........-. ....+-|.+|.+||.+.|. +|+...|||..||||.||+++.+-+++.........+..++-..-..
T Consensus 175 s~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 175 STSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 6654322211 2456779999999999975 58999999999999999999999998743322222222221110000
Q ss_pred -------------------------hHHHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 176 -------------------------SIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 176 -------------------------~~~~l~~--~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.++...+ .-.++..+|++.++.+||.+|++.++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 0000011 0135788999999999999999987653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=207.36 Aligned_cols=203 Identities=15% Similarity=0.270 Sum_probs=168.0
Q ss_pred CCCCcEEEEeeE-eCCEEEEEEecC-CCCHHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFC-------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~-~~~~~~lVmE~~-g~sL~~ll~~~-------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+||+..+.+... +.+..+.++.++ -++|..++..| .+.++..+...++.|++.|++|||.+||||.||-..
T Consensus 346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaR 425 (563)
T KOG1024|consen 346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAAR 425 (563)
T ss_pred CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhh
Confidence 578888876655 456788899999 68999999855 345889999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~ 151 (414)
|++|+ +.-+|||+|=.+++.+...+.+.. .....-...||++|.+....|+..+|+|||||+||||++ |+.
T Consensus 426 NCvId---d~LqVkltDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 426 NCVID---DQLQVKLTDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred cceeh---hheeEEeccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCC
Confidence 99996 678999999999987766543321 112345788999999999999999999999999999998 999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
||...+ ..+++..+.+..... -+-+||.|+..+|..||.+.|++||+++++...|.+...+
T Consensus 498 PyaeID---PfEm~~ylkdGyRla----QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 498 PYAEID---PFEMEHYLKDGYRLA----QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred CccccC---HHHHHHHHhccceec----CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 998754 455555555554432 2458999999999999999999999999999999887654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=216.00 Aligned_cols=206 Identities=21% Similarity=0.268 Sum_probs=158.7
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceec
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHR 67 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~---------~givHR 67 (414)
++||++++..-..++ ..|||++|. .|+|.++++ ...+++....+|+..|++||+|||+ ..|+||
T Consensus 263 h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHR 340 (534)
T KOG3653|consen 263 HENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHR 340 (534)
T ss_pred chhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccc
Confidence 578888887766655 779999999 999999998 5689999999999999999999996 359999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-C-----CchhHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-Q-----SRRDDLESLGY 141 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~-----s~~~DvwSlGv 141 (414)
|||..|||| +.+....|+|||||..+..... ....-..+||.+|||||++.|.- + -.+.||||+|.
T Consensus 341 DlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 341 DLKSKNVLV---KNDLTCCIADFGLALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred cccccceEE---ccCCcEEeeccceeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 999999999 4889999999999998864321 12233479999999999998642 1 25689999999
Q ss_pred HHHHHHhC------------CCCCCCC--CccchHHHHHHHHhhhccchHHHhh--cCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 142 VLMYFLRG------------SLPWQGL--KAGTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 142 vl~elltG------------~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
|||||++. ++||+.. ......++-+.+..++..+.+...+ .....-+.+.++.||+.|++-|.+
T Consensus 413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhh
Confidence 99999874 2344311 0112333444455555555444333 334567999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 015018 206 YAYLKRLFRDLF 217 (414)
Q Consensus 206 ~~~l~~~l~~~~ 217 (414)
+.-+.+.+.++.
T Consensus 493 A~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 493 AGCVEERMAELM 504 (534)
T ss_pred hHHHHHHHHHHh
Confidence 988888887774
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-26 Score=224.98 Aligned_cols=145 Identities=23% Similarity=0.285 Sum_probs=128.0
Q ss_pred CCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~--ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
|+++|+-.|...+++|||||-+..+|.++++..++. |.+..|..|+.||+.||..|-.+||+|.||||+||||. ..
T Consensus 495 Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~ 572 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ES 572 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cC
Confidence 567778888899999999999999999999977654 88899999999999999999999999999999999997 45
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+||||||.|........ ..+.-+-.|.|||+++|..|+..-|+||+||+||||.+|+..|.|....
T Consensus 573 k~iLKLCDfGSA~~~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cceeeeccCccccccccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 67899999999977655432 2345677899999999999999999999999999999999999986543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=228.96 Aligned_cols=202 Identities=18% Similarity=0.229 Sum_probs=169.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+||+++|..++.... .-||++|+ +|.|.|+++....++-.+..+.|..||++||.|||++++|||||-..|+||.
T Consensus 756 dHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk-- 832 (1177)
T KOG1025|consen 756 DHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK-- 832 (1177)
T ss_pred CCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec--
Confidence 4789999999998776 78999999 9999999998888899999999999999999999999999999999999994
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
....|||.|||+++........-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..|++++..
T Consensus 833 -sP~hvkitdfgla~ll~~d~~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 833 -SPNHVKITDFGLAKLLAPDEKEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred -CCCeEEEEecchhhccCcccccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 8899999999999977654432111 22344678999999999999999999999999999998 9999999765
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
......+++-.. + .-+..|+.++..+|..||..|++.||+|.++...|..++.
T Consensus 907 ~eI~dlle~geR--L-----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 907 EEIPDLLEKGER--L-----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhhHHHhcccc--C-----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 444433332211 1 1234688999999999999999999999999999987753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=206.97 Aligned_cols=194 Identities=19% Similarity=0.210 Sum_probs=149.2
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+||+.++.++.-.+ ..|+|||+|..+|..++.. .++-+++..|.+|+++|+.|||+.||+||||||+||+
T Consensus 74 ~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsniv 150 (369)
T KOG0665|consen 74 HKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIV 150 (369)
T ss_pred ccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccce
Confidence 478999988877543 5699999999999999873 6788899999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+. ..+.+||+|||+|+.-.... ....++.|.-|.|||++.+..+...+||||+||++.||++|...|.|
T Consensus 151 v~---~~~~lKi~dfg~ar~e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 151 VN---SDCTLKILDFGLARTEDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred ec---chhheeeccchhhcccCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 95 78899999999998644321 12456889999999999999999999999999999999999999987
Q ss_pred CCccchHHHHHHHHh----------------------hhccchHHHhhcC------------CcHHHHHHHHHHHcCCCC
Q 015018 156 LKAGTKKQKYEKISE----------------------KKVSTSIEALCRG------------YPTEFASYFHYCRSLRFD 201 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~----------------------~~~~~~~~~l~~~------------~p~e~~~li~~c~~~dp~ 201 (414)
.+..+...+...... +.......++.+. -....++++..|+-.+|+
T Consensus 220 ~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 220 KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 544333322211110 0011111111111 123467899999999999
Q ss_pred CCCCHHHH
Q 015018 202 DKPDYAYL 209 (414)
Q Consensus 202 ~RP~~~~l 209 (414)
+|.+.+++
T Consensus 300 ~Risv~da 307 (369)
T KOG0665|consen 300 KRISVDDA 307 (369)
T ss_pred hcccHHHH
Confidence 99996554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=184.60 Aligned_cols=162 Identities=27% Similarity=0.386 Sum_probs=142.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.++|++++.++......++|||++ |++|.+++......++...+..++.+++.+|++||++|++|+||+|.||++.
T Consensus 50 ~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~--- 126 (215)
T cd00180 50 HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--- 126 (215)
T ss_pred CCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---
Confidence 478999999999999999999999 6999999985445799999999999999999999999999999999999996
Q ss_pred C-CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 81 R-ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 81 ~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
. .+.++|+|||.+........ ......+...|++||.+... .++.+.|+|+||++++++
T Consensus 127 ~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------ 187 (215)
T cd00180 127 SDNGKVKLADFGLSKLLTSDKS-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------ 187 (215)
T ss_pred CCCCcEEEecCCceEEccCCcc-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------
Confidence 4 68899999999987655321 11235688899999999887 788999999999999998
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
.++.+++..|+..+|++||++.++.+.
T Consensus 188 ---------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468889999999999999998887653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=208.34 Aligned_cols=77 Identities=25% Similarity=0.434 Sum_probs=68.5
Q ss_pred CCCCCcEEEEeeE----eCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~----~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NI 74 (414)
|..+|++|++.|. ++.++|||+|++|.+|..+|++++ +.+++..|..|++||+.||.|||. +||||.||||+||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 3467899887655 588999999999999999998774 569999999999999999999996 5999999999999
Q ss_pred EEe
Q 015018 75 LMG 77 (414)
Q Consensus 75 Ll~ 77 (414)
|+.
T Consensus 220 Ll~ 222 (590)
T KOG1290|consen 220 LLC 222 (590)
T ss_pred eee
Confidence 994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=216.70 Aligned_cols=141 Identities=24% Similarity=0.376 Sum_probs=127.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~--g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++||+++..||++++|.||+||-. |.+|.++|.. ...+++.++..|+.|++.|+++||+.||||||||-+|+.++
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd-- 704 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD-- 704 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEe--
Confidence 689999999999999999999999 6688899884 66899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.+|.+||+|||.|...... +...++||..|+|||++.|..| +...|||+||++||.++....||.+
T Consensus 705 -~~g~~klidfgsaa~~ksg---------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 705 -SNGFVKLIDFGSAAYTKSG---------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -cCCeEEEeeccchhhhcCC---------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8899999999998765543 2356899999999999999987 5788999999999999999999854
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=191.64 Aligned_cols=197 Identities=21% Similarity=0.303 Sum_probs=147.3
Q ss_pred eeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEee
Q 015018 11 FGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 89 (414)
Q Consensus 11 ~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~D 89 (414)
.|+..++.+++|||+ -|+|..-+. ...+-+.....++.|++.||+|||++++||||||.+||||-. .+...|||||
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcD 166 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCD 166 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeee
Confidence 466778999999999 999998776 346889999999999999999999999999999999999953 3446899999
Q ss_pred eceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCCccc-hHH
Q 015018 90 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQ 163 (414)
Q Consensus 90 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~-~~~ 163 (414)
||+.++.+..- ....-+..|.+||...... ..+..|+|.||+++|.+++|.+||+...-.+ ..-
T Consensus 167 FG~t~k~g~tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 167 FGLTRKVGTTV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred cccccccCcee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 99987654422 1234567789999875322 3577899999999999999999998532211 122
Q ss_pred HHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 164 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 164 ~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
.+++....+.. ..+.....+.+....+++.-+..++.+|-...+.++...+...+.-
T Consensus 237 ~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 237 EWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred HHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 23333333332 3344555677888999999999999999666666666665555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-24 Score=199.12 Aligned_cols=137 Identities=22% Similarity=0.373 Sum_probs=113.7
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcc
Q 015018 18 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97 (414)
Q Consensus 18 ~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 97 (414)
.|+|.|+|..+|..+|- ..+.++.+.+.-+.+||++||+|||+.+|+||||||.|+|+. .+..+||||||+|+...
T Consensus 132 iYV~TELmQSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccc
Confidence 46778888888888876 367899999999999999999999999999999999999995 78889999999998765
Q ss_pred cCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHH
Q 015018 98 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 164 (414)
Q Consensus 98 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 164 (414)
..+. .++ ...+-|.-|.|||++.|. .|+...||||+|||+.||+..+..|+...+....+.
T Consensus 208 ~d~~-~hM-----TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 208 QRDR-LNM-----THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred hhhh-hhh-----HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 4332 221 234568889999999985 489999999999999999999999987654433333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=207.47 Aligned_cols=184 Identities=19% Similarity=0.170 Sum_probs=130.1
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 15 GDYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 15 ~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
....||||||+ +++|.++++... ..+++..++.++.||+.+|+|||.++|+|||||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 35689999999 999999886321 134677889999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC--------------------
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-------------------- 130 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-------------------- 130 (414)
|+|||++ .++.++|+|||++........ . ......+|+.|++||.+.....
T Consensus 337 p~NILl~---~~~~~kL~DFGla~~~~~~~~-----~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~y 407 (507)
T PLN03224 337 PENLLVT---VDGQVKIIDFGAAVDMCTGIN-----F-NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLY 407 (507)
T ss_pred hHhEEEC---CCCcEEEEeCcCccccccCCc-----c-CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhc
Confidence 9999996 668899999999975433211 0 0112345889999999864321
Q ss_pred --CchhHHHHHHHHHHHHHhCCC-CCCCCCccchH-HHH-------HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 131 --SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKK-QKY-------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 131 --s~~~DvwSlGvvl~elltG~~-Pf~~~~~~~~~-~~~-------~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
..+.|+||+||++++|++|.+ ||.+....+.. ..+ ..+...... + .+.+.++++..+++..++..+
T Consensus 408 g~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~--~-~~~d~~s~~~~dLi~~LL~~~ 484 (507)
T PLN03224 408 GRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD--F-SLLDRNKEAGWDLACKLITKR 484 (507)
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC--c-ccccccChHHHHHHHHHhccC
Confidence 124699999999999999886 77653221111 111 111111111 1 123456788999999999876
Q ss_pred C---CCCCCHHHHH
Q 015018 200 F---DDKPDYAYLK 210 (414)
Q Consensus 200 p---~~RP~~~~l~ 210 (414)
+ .+|+++++++
T Consensus 485 ~~~~~~RlSa~eaL 498 (507)
T PLN03224 485 DQANRGRLSVGQAL 498 (507)
T ss_pred CCCcccCCCHHHHh
Confidence 6 6799977664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-23 Score=185.20 Aligned_cols=196 Identities=15% Similarity=0.204 Sum_probs=144.9
Q ss_pred CCCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
|+|||+++++.-.+. ....||+|++ ..+...+.. .|+..++..++.||+.||.|+|++||+|||+||.|++|+
T Consensus 91 gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId 166 (338)
T KOG0668|consen 91 GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID 166 (338)
T ss_pred CCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec
Confidence 899999999987764 4568999999 777776665 688999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC-
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG- 155 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~- 155 (414)
.....++|+|+|||..+..... .+..+.+.-|--||.+... .|+..-|+|||||+|..|+..+-||..
T Consensus 167 --h~~rkLrlIDWGLAEFYHp~~e--------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 167 --HELRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred --hhhceeeeeecchHhhcCCCce--------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 4557899999999988765432 1233445556678988754 478999999999999999998888853
Q ss_pred CCccchHHHHHHHHhh------------hccchHHH------------hh-----cCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 156 LKAGTKKQKYEKISEK------------KVSTSIEA------------LC-----RGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~------------~~~~~~~~------------l~-----~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
-+..++.-++.++.-. .+....+. +. .-..++..+|+..++..|-.+|+++
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa 316 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA 316 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch
Confidence 3333332222222110 01111111 10 1125788899999999999999997
Q ss_pred HHHH
Q 015018 207 AYLK 210 (414)
Q Consensus 207 ~~l~ 210 (414)
.+..
T Consensus 317 kEam 320 (338)
T KOG0668|consen 317 KEAM 320 (338)
T ss_pred HHHh
Confidence 6653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-22 Score=193.48 Aligned_cols=150 Identities=26% Similarity=0.397 Sum_probs=122.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
|.-||+++..++..++.+++||||+ .....+++. .++..++.+++..++.||.++|.+|||||||||.|||.+
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n-- 166 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN-- 166 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--
Confidence 6789999999999999999999999 777777776 578999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCC----------------Ccc---------------------cccccccCCCCCCccccch
Q 015018 80 RRANQVYIIDFGLAKRYRDTA----------------THQ---------------------HIPYRENKNLTGTARYASM 122 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~----------------~~~---------------------~~~~~~~~~~~Gt~~Y~aP 122 (414)
...+.-.|+|||||..+.... .+. ...........||++|.||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 455677899999997221100 000 0011122356799999999
Q ss_pred hhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 123 NTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 123 E~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
|++.... ++.+.||||.|||+..+++++.||...
T Consensus 247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred HHHhhccCcCCccceeeccceeehhhccccccccC
Confidence 9988654 789999999999999999999999653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-21 Score=174.86 Aligned_cols=145 Identities=29% Similarity=0.384 Sum_probs=125.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+||++++.++...+..+++||++ +++|.+++......+++..+..++.|++.+|.+||.++++|+||+|.||+++
T Consensus 56 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~--- 132 (225)
T smart00221 56 HPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG--- 132 (225)
T ss_pred CCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---
Confidence 589999999999999999999999 7799999985432389999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.++|+|||++..+...... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 133 MDGLVKLADFGLARFIHRDLAA------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCCEEEeeCceeeEecCcccc------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 5689999999999877553210 11345778899999999 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=198.37 Aligned_cols=195 Identities=17% Similarity=0.209 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+||||-++..+.-.+..||+|||| |++|.++.. -..++++.++...++..+.||+|||++|=+|||||-.|||++
T Consensus 71 h~nivay~gsylr~dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt--- 146 (829)
T KOG0576|consen 71 HPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT--- 146 (829)
T ss_pred CcChHHHHhhhhhhcCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---
Confidence 589999999999999999999999 899999876 367999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.||+.|||.+..+...-. ..+.++||+.|||||+-. ...|...+|+|++|+...|+-.-+.|...+.
T Consensus 147 d~gDvklaDfgvsaqitati~-------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 147 DEGDVKLADFGVSAQITATIA-------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred ccCceeecccCchhhhhhhhh-------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 889999999999887665332 225789999999999864 4558899999999999999988888876654
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+. +.+.-.....+..+..+-...+.+.|.+|++.|+.++|.+||+.+.++
T Consensus 220 pm---r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 220 PM---RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred hH---HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 32 222212222222211122234568899999999999999999987664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=205.15 Aligned_cols=201 Identities=20% Similarity=0.224 Sum_probs=150.9
Q ss_pred CCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCC
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 82 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~ 82 (414)
|||+.......+..-.+-+||||..+|..++.. ...++..++..++.||+.||.|||+.||.|||||++|+|+. ..
T Consensus 381 ~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~ 456 (601)
T KOG0590|consen 381 PNIIETLDIVQEIDGILQSMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---EN 456 (601)
T ss_pred CchhhhHHHHhhcccchhhhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cC
Confidence 444333333333333333499993399999873 45899999999999999999999999999999999999997 77
Q ss_pred CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 83 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 83 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~-~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
+.+||+|||.+..+.-..... ........|+..|+|||++.+.+|.+ ..||||.|++++.|++|+.||.-....+.
T Consensus 457 g~lki~Dfg~~~vf~~~~e~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 457 GILKIIDFGAASVFRYPWEKN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred CceEEeecCcceeeccCcchh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 899999999998765433211 11345789999999999999999974 57999999999999999999976544332
Q ss_pred HH-HHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 162 KQ-KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 162 ~~-~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. ............-...+...+|.+.+.+|-.+++.+|.+|.+.++|.
T Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 534 SFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred chhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 21 11111222223334455667899999999999999999999976654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-18 Score=164.27 Aligned_cols=204 Identities=29% Similarity=0.380 Sum_probs=152.4
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+.++..+......+++++++ +++|.+++.... ..+....+..+..|++.+++|+|..+++||||||+||++.
T Consensus 59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~--- 135 (384)
T COG0515 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD--- 135 (384)
T ss_pred ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---
Confidence 6999999998888889999999 899997777433 2799999999999999999999999999999999999996
Q ss_pred CCC-eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 81 RAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 81 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..+ .++++|||+++.+.......... .......|+..|++||.+.+ ..+....|+|++|+++++++.|..||...
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 136 RDGRVVKLIDFGLAKLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred CCCCeEEEeccCcceecCCCCcccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 445 79999999998665433211100 12356799999999999998 57889999999999999999999998765
Q ss_pred Ccc-chHHHHHHHHhhhccchHHHhhcCC----cHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 157 KAG-TKKQKYEKISEKKVSTSIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 157 ~~~-~~~~~~~~i~~~~~~~~~~~l~~~~----p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... ...+....+................ ...+.+++..|+..+|..|.+......
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 215 KNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 431 1222223222222110011111111 257889999999999999988655543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=169.54 Aligned_cols=188 Identities=18% Similarity=0.214 Sum_probs=143.9
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC-CCCeEEEeeeceeE
Q 015018 16 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 94 (414)
Q Consensus 16 ~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~-~~~~vkL~DFGla~ 94 (414)
...|+||..+..+|..++- .+..+..+...+..|+++++.|||.+||.|||+|.+||||.+++ ....++|.|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 3579999999999999986 66889999999999999999999999999999999999998763 33578899999985
Q ss_pred EcccCCCccccccccc-CCCCCCccccchhhhcCCCC------CchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 015018 95 RYRDTATHQHIPYREN-KNLTGTARYASMNTHLGIEQ------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 167 (414)
Q Consensus 95 ~~~~~~~~~~~~~~~~-~~~~Gt~~Y~aPE~~~~~~~------s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 167 (414)
.. ...+...||... ...-|....||||+....+- -.++|.|+.|.+.||++....||.+.-..... ...
T Consensus 394 Ad--~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~ 469 (598)
T KOG4158|consen 394 AD--DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRT 469 (598)
T ss_pred ec--cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhh
Confidence 42 233344555433 34668889999999875431 24899999999999999999999762111000 011
Q ss_pred HHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Q 015018 168 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 213 (414)
Q Consensus 168 i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l 213 (414)
.....++.+.+.+|+.+++++..+++.||.+|++..-....+
T Consensus 470 ----Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 470 ----YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ----hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 112334456778999999999999999999999865444444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=166.18 Aligned_cols=161 Identities=22% Similarity=0.255 Sum_probs=111.4
Q ss_pred EEEEEecCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeec
Q 015018 18 NVLVIDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 91 (414)
Q Consensus 18 ~~lVmE~~g~sL~~ll~~~---~~~---ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFG 91 (414)
.|++|+.+-++|.+++... ... +.....+.+..|+++.+++||..||||+||||+||+++ .+|.++|.||+
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~---~~G~v~Lg~F~ 190 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLD---QDGGVFLGDFS 190 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GG
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEc---CCCCEEEcChH
Confidence 3789999999999987532 212 33444566779999999999999999999999999997 78999999999
Q ss_pred eeEEcccCCCcccccccccCCCCCCccccchhhhcC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHH
Q 015018 92 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 163 (414)
Q Consensus 92 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~ 163 (414)
.......... . ...+..|.+||.... ..++.+.|.|+||+++|.|+++.+||..........
T Consensus 191 ~~~r~g~~~~-------~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~ 260 (288)
T PF14531_consen 191 SLVRAGTRYR-------C---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE 260 (288)
T ss_dssp GEEETTEEEE-------G---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG
T ss_pred HHeecCceee-------c---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc
Confidence 9887655221 0 234577899997643 247889999999999999999999998653321110
Q ss_pred HHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCC
Q 015018 164 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 203 (414)
Q Consensus 164 ~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~R 203 (414)
. .-..|.++|+.++.||..+++.+|++|
T Consensus 261 ~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 W------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp G------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred c------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 0 113467899999999999999999887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-19 Score=178.67 Aligned_cols=204 Identities=19% Similarity=0.229 Sum_probs=159.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|.++++++.++.+...+++++++ |+.|..-+.. ...+++..+..+...++-+++++|+.+|+|||+|++||++.
T Consensus 56 ~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld--- 131 (612)
T KOG0603|consen 56 TPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL--- 131 (612)
T ss_pred CCceeeeeeeeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---
Confidence 578999999999999999999999 8888776653 56799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..|.+++.|||+.+..-... ..+||..|||||+++ ......|.||||+++++|++|..||.+
T Consensus 132 ~~Ghi~~tdfglske~v~~~-----------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----- 193 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEK-----------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----- 193 (612)
T ss_pred ccCccccCCchhhhHhHhhh-----------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----
Confidence 78999999999998654422 128999999999999 446789999999999999999999977
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~--~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~ 238 (414)
+....|...+... +..+..+..+++.+++..+|.+|... +.+.++.++. +....+|+.+..++.
T Consensus 194 --~~~~~Il~~~~~~-----p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~-------f~~~i~~~~l~~r~~ 259 (612)
T KOG0603|consen 194 --DTMKRILKAELEM-----PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE-------FFQSIDWNELEARSR 259 (612)
T ss_pred --HHHHHHhhhccCC-----chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc-------hheeeeHhhHhhcCC
Confidence 2233333322221 22345678889999999999988754 3344443333 345678987766554
Q ss_pred ccC
Q 015018 239 QVS 241 (414)
Q Consensus 239 ~~~ 241 (414)
+.+
T Consensus 260 ~~~ 262 (612)
T KOG0603|consen 260 PPP 262 (612)
T ss_pred CCC
Confidence 433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=167.06 Aligned_cols=209 Identities=16% Similarity=0.220 Sum_probs=163.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~gi-vHRDIKP~NILl~~~ 79 (414)
+.|+.++++.+.++...++|-+|| .|+|.|++.....+++......+..+|+.||+|||.-.| +|+.++..|++++
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd-- 83 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD-- 83 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee--
Confidence 468999999999999999999999 999999998778889999999999999999999998765 9999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-------CCchhHHHHHHHHHHHHHhCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------~s~~~DvwSlGvvl~elltG~~P 152 (414)
....+||.|||+......... +.......-...|.|||.+.+.. .+.+.|+||+|++++|+++.+.|
T Consensus 84 -~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 84 -SRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred -eeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 789999999999876542100 01112223567799999998742 35679999999999999999999
Q ss_pred CCCCCcc-chHHHHHHHHhhh---ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 153 WQGLKAG-TKKQKYEKISEKK---VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 153 f~~~~~~-~~~~~~~~i~~~~---~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
|...... ...+.+.++.... ..+.+.... .+++++..++..||..+|++||+++.+...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9874322 2233444444312 222222222 5677899999999999999999999999988887754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-18 Score=170.11 Aligned_cols=172 Identities=24% Similarity=0.342 Sum_probs=130.8
Q ss_pred CEEEEEEecC-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeece
Q 015018 16 DYNVLVIDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 92 (414)
Q Consensus 16 ~~~~lVmE~~-g~sL~~ll~~--~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGl 92 (414)
.|.||.|++| ..+|++++.. .....++-..+.++.|+..+++| ++.+|||+||-||++. .+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 4789999999 9999999962 24457888899999999999999 9999999999999996 667899999999
Q ss_pred eEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhh
Q 015018 93 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 171 (414)
Q Consensus 93 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 171 (414)
........+ ..-++.....-.||..||+||.+.+..|+.++|||+||++|+|++. -...|.. ...+..+...
T Consensus 403 ~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDG 475 (516)
T ss_pred eeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcC
Confidence 987655431 1112223346789999999999999999999999999999999998 3433322 1112222222
Q ss_pred hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 172 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 172 ~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
.++ +....++|. -..|++.++...|.+||
T Consensus 476 ~ip---~~~~~d~p~-e~~ll~~lls~~p~~RP 504 (516)
T KOG1033|consen 476 IIP---PEFLQDYPE-EYTLLQQLLSPSPEERP 504 (516)
T ss_pred CCC---hHHhhcCcH-HHHHHHHhcCCCcccCc
Confidence 222 123334554 36899999999999999
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.3e-18 Score=180.25 Aligned_cols=197 Identities=16% Similarity=0.123 Sum_probs=140.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+||+..+.-.-+.+...|||-+|+..+|+|-+. .++ +..-+..+|+.||++||..+|..||+|+|||.+||||+
T Consensus 80 ~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT--- 154 (1431)
T KOG1240|consen 80 APNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT--- 154 (1431)
T ss_pred CCcccchHHHHHhhHHHHHHHHHHhhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---
Confidence 467777766667777889999999999999886 444 67788999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCC-cccccccccCCCCCCccccchhhhcCC----------C-CCchhHHHHHHHHHHHHHh
Q 015018 81 RANQVYIIDFGLAKRYRDTAT-HQHIPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----------~-~s~~~DvwSlGvvl~ellt 148 (414)
.=+-++|+||-..+..--+.+ .....|. ..+-.--.+|+|||-+... . .+++.||||+||+++||++
T Consensus 155 SWNW~~LtDFAsFKPtYLPeDNPadf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 155 SWNWLYLTDFASFKPTYLPEDNPADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eechhhhhcccccCCccCCCCCcccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 667789999987764322111 1111111 1223345679999988641 1 4678999999999999987
Q ss_pred -CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCC-cHHHHHHHHHHHcCCCCCCCCHHHHHHH
Q 015018 149 -GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRL 212 (414)
Q Consensus 149 -G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~-p~e~~~li~~c~~~dp~~RP~~~~l~~~ 212 (414)
|++||.- ...-.|.... ....+.+.+.+ ...++.++..|++.||.+|.++++.++-
T Consensus 234 Eg~PlF~L----SQL~aYr~~~----~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 234 EGRPLFTL----SQLLAYRSGN----ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCCCcccH----HHHHhHhccC----ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 8999842 1111222211 11122222222 2468999999999999999998776544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=176.47 Aligned_cols=147 Identities=24% Similarity=0.375 Sum_probs=112.1
Q ss_pred HHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCc----cccc----ccccCCCCCCccccch
Q 015018 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH----QHIP----YRENKNLTGTARYASM 122 (414)
Q Consensus 51 Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~----~~~~----~~~~~~~~Gt~~Y~aP 122 (414)
+++.+++|||..||||||+||+|.||. .-+.+|+.|||+.++....... .+|. -.-.+..+||+.|.||
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 447899999999999999999999996 7899999999999764221111 1110 0113467999999999
Q ss_pred hhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC
Q 015018 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 202 (414)
Q Consensus 123 E~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~ 202 (414)
|++....|+..+|+|++|+|+||++.|..||.|..+ .+.+..+....... .+. -..+|.|.++++.+++..+|..
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~w-pE~-dea~p~Ea~dli~~LL~qnp~~ 302 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEW-PEE-DEALPPEAQDLIEQLLRQNPLC 302 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccc-ccc-CcCCCHHHHHHHHHHHHhChHh
Confidence 999999999999999999999999999999998533 34443333322211 111 2357899999999999999999
Q ss_pred CCC
Q 015018 203 KPD 205 (414)
Q Consensus 203 RP~ 205 (414)
|--
T Consensus 303 Rlg 305 (1205)
T KOG0606|consen 303 RLG 305 (1205)
T ss_pred hcc
Confidence 973
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=147.81 Aligned_cols=195 Identities=12% Similarity=0.129 Sum_probs=147.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NILl~ 77 (414)
+|||..+...+....+.+++..|| -++|+.++... +--++..++.+++.+|++|++|||+.. |.---|....++|+
T Consensus 246 hpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid 325 (448)
T KOG0195|consen 246 HPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID 325 (448)
T ss_pred CCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec
Confidence 699999999999999999999999 99999999753 234788899999999999999999864 44445777778885
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCC---chhHHHHHHHHHHHHHhCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s---~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.+ -...+-+.|--++.. + ....-.+.||+||.+...+.+ +.+|+|||++++|||.|...||.
T Consensus 326 ed-ltarismad~kfsfq-------------e-~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 326 ED-LTARISMADTKFSFQ-------------E-VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred ch-hhhheecccceeeee-------------c-cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 22 112233344332221 1 223457899999999865533 57899999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.+.+...- .+|. +......+++++...+.+||..|+..||.+||.|+.+.-+|+++.
T Consensus 391 dlspmecg---mkia---leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 391 DLSPMECG---MKIA---LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCchhhh---hhhh---hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 87654322 2222 223333456788899999999999999999999999999998763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=145.44 Aligned_cols=142 Identities=17% Similarity=0.099 Sum_probs=102.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI-KP~NILl~~ 78 (414)
+.++||+++.+ +..|++|||+ |.+|...+.. ....++.|++.+|++||.+||+|||| ||+|||++
T Consensus 60 ~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~- 126 (218)
T PRK12274 60 GLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ- 126 (218)
T ss_pred CCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc-
Confidence 35789999876 3459999999 8888754321 12457889999999999999999999 79999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcc-cccccc-----cCCCCCCccccchhhhcCC-CCC-chhHHHHHHHHHHHHHhCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQ-HIPYRE-----NKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~-~~~~~~-----~~~~~Gt~~Y~aPE~~~~~-~~s-~~~DvwSlGvvl~elltG~ 150 (414)
.++.++|+|||+|.......... ...++. .-....++.|+.|+...-. ..+ .+.++++.|+.+|.++|+.
T Consensus 127 --~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 127 --EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred --CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence 56789999999998654322100 000000 0012367788888765533 233 5679999999999999999
Q ss_pred CCCCCCC
Q 015018 151 LPWQGLK 157 (414)
Q Consensus 151 ~Pf~~~~ 157 (414)
++..+..
T Consensus 205 ~~~~~~~ 211 (218)
T PRK12274 205 VLHWEDN 211 (218)
T ss_pred CCccccC
Confidence 9886543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-16 Score=169.48 Aligned_cols=199 Identities=22% Similarity=0.292 Sum_probs=146.7
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec--
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-- 79 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~-- 79 (414)
+.|.+++......+-.+||+||. .|+|.++++ ..+.+++..+..++.||+..|+.||..+|||+||||+|+||.+.
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC
Confidence 34556666666677789999999 999999999 57789999999999999999999999999999999999999752
Q ss_pred --CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 --RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.....++|||||.+.-+.--.... ..+...+|-.+-.+|+..|..+++..|.|-|+.+++.||.|+.-= ..
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~ 905 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VK 905 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hc
Confidence 224579999999986543322111 124567888999999999999999999999999999999986321 11
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+..+. ....+..+++. .-..+|+..+|+.+-+.=|...+|+..|+..+...
T Consensus 906 ~g~~~~---------~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 906 NGSSWM---------VKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred CCccee---------ccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 111000 01111111110 23456677777766677788899998888887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.7e-16 Score=152.90 Aligned_cols=113 Identities=23% Similarity=0.272 Sum_probs=84.3
Q ss_pred CCCCc-EEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEee
Q 015018 2 AAGIP-NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~-~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI-KP~NILl~~ 78 (414)
++||+ +++++ ...||||||+ |++|... . ... ...++.|++.+|+|||++||+|||| ||+|||++
T Consensus 80 h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~- 146 (365)
T PRK09188 80 GIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-R----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG- 146 (365)
T ss_pred CCCCCcEEEEc----CCcEEEEEccCCCCHHHh-C----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc-
Confidence 46766 56553 3469999999 8888632 1 111 1467899999999999999999999 99999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccc-cccccCCCCCCccccchhhhcCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHI-PYRENKNLTGTARYASMNTHLGIE 129 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~ 129 (414)
.++.+||+|||+|+.+........+ .+.......+++.|++||++.-.+
T Consensus 147 --~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 147 --PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred --CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 5678999999999987664432222 223335678899999999987544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.7e-15 Score=134.10 Aligned_cols=74 Identities=22% Similarity=0.255 Sum_probs=62.9
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEc
Q 015018 19 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96 (414)
Q Consensus 19 ~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yL-H~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~ 96 (414)
+|||||+ |++|...+.. ...++..+++.++.||+.+|.|| |+.||+||||||+|||++ .+.++|+|||+|...
T Consensus 93 ~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----CCcEEEEEccccccC
Confidence 8999999 6666544322 46899999999999999999999 799999999999999995 367999999999754
Q ss_pred c
Q 015018 97 R 97 (414)
Q Consensus 97 ~ 97 (414)
.
T Consensus 168 ~ 168 (190)
T cd05147 168 D 168 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-15 Score=138.47 Aligned_cols=114 Identities=18% Similarity=0.358 Sum_probs=85.6
Q ss_pred CCCCcEEEEeeEeC--------CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVEG--------DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--------~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
.|||+.+..++... ...+|||||+ |.+|.++.. +++ ....+++.+|..||..||+||||||.
T Consensus 94 ~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~ 164 (232)
T PRK10359 94 SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKG 164 (232)
T ss_pred HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChH
Confidence 47888888886654 3479999999 889988742 333 24569999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHH
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ell 147 (414)
||+++ .++ ++|+|||....+..... .-...+...+..++|+|+|||.+..+.
T Consensus 165 Nili~---~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVS---KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEe---CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99996 455 99999998875532211 011334445667899999999887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-14 Score=130.15 Aligned_cols=88 Identities=15% Similarity=0.165 Sum_probs=70.4
Q ss_pred CCCCcEEEEeeEeCC---EEE-EEEecCC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVEGD---YNV-LVIDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~---~~~-lVmE~~g---~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL-~yLH~~givHRDIKP~N 73 (414)
.|||+++|++++++. +.| +||||+| ++|.++++. ..+++. ..++.|++.++ +|||+++||||||||+|
T Consensus 60 h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~N 135 (210)
T PRK10345 60 WSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQN 135 (210)
T ss_pred CcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 589999999999874 544 8999954 899999974 356665 35678888888 99999999999999999
Q ss_pred EEEeecC-CCCeEEEeeecee
Q 015018 74 FLMGLGR-RANQVYIIDFGLA 93 (414)
Q Consensus 74 ILl~~~~-~~~~vkL~DFGla 93 (414)
||++... ....++|+||+.+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEeccCCCCCcEEEEECCCC
Confidence 9997432 3358999995544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.5e-14 Score=127.40 Aligned_cols=75 Identities=21% Similarity=0.319 Sum_probs=63.3
Q ss_pred EEEEEecC-CCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 18 NVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 18 ~~lVmE~~-g~sL~~-ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.||||||+ |+++.. .+. ...++...+..++.|++.+|.+||. +||+||||||+|||++ .+.++|+|||+++
T Consensus 92 ~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~~~~~liDFG~a~ 165 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----DGKPYIIDVSQAV 165 (190)
T ss_pred CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----CCCEEEEEcccce
Confidence 48999999 554433 343 3568899999999999999999999 9999999999999995 5789999999998
Q ss_pred Eccc
Q 015018 95 RYRD 98 (414)
Q Consensus 95 ~~~~ 98 (414)
....
T Consensus 166 ~~~~ 169 (190)
T cd05145 166 ELDH 169 (190)
T ss_pred ecCC
Confidence 6543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-14 Score=152.67 Aligned_cols=198 Identities=22% Similarity=0.270 Sum_probs=152.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll-~~~~~~ls~~~v~~ia~Qll~gL~yLH-~~givHRDIKP~NILl~~ 78 (414)
++|++.++....+.++.++++++. |+++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~- 158 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD- 158 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc-
Confidence 568999999999999999999999 99998888 432226778889999999999999999 99999999999999996
Q ss_pred cCCCC-eEEEeeeceeEEccc-CCCcccccccccCCCCC-CccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 79 GRRAN-QVYIIDFGLAKRYRD-TATHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 79 ~~~~~-~vkL~DFGla~~~~~-~~~~~~~~~~~~~~~~G-t~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
..+ .+++.|||+|..+.. ..... ......| ++.|++||.+.+.. .....|+||.|+++.-+++|.+||.
T Consensus 159 --~s~~~l~~~df~~At~~~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 159 --ESGSALKIADFGLATAYRNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred --cCCCcccCCCchhhccccccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 455 899999999998876 22211 1234567 99999999999854 4678999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...... +.|......+.. .-...+..+.....+++..++..++..|.+.+++.
T Consensus 232 ~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 232 FPSRKD--GRYSSWKSNKGR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccc--ccceeecccccc-cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 654322 222222222111 01123455667788888888888899998866653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=119.44 Aligned_cols=84 Identities=29% Similarity=0.518 Sum_probs=70.3
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+||+....++.+.+..++||||+ |.+|.+++.... . .+..++.+|+.+|.+||..+++|+|++|.|||++
T Consensus 59 ~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---- 129 (211)
T PRK14879 59 AGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---- 129 (211)
T ss_pred CCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----
Confidence 45555455555667789999999 999999987422 2 8889999999999999999999999999999995
Q ss_pred CCeEEEeeeceeEE
Q 015018 82 ANQVYIIDFGLAKR 95 (414)
Q Consensus 82 ~~~vkL~DFGla~~ 95 (414)
.+.++|+|||++..
T Consensus 130 ~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCEEEEECCcccC
Confidence 57799999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-12 Score=115.97 Aligned_cols=80 Identities=25% Similarity=0.480 Sum_probs=64.7
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 82 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~ 82 (414)
||+....++.+.+..+|||||+ |++|.+++.... . .++.|++.+|.+||..|++|+|++|.||+++ .
T Consensus 58 ~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~ 125 (199)
T TIGR03724 58 GVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----D 125 (199)
T ss_pred CCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----C
Confidence 3333333445566679999999 999999876321 1 7899999999999999999999999999995 5
Q ss_pred CeEEEeeeceeEE
Q 015018 83 NQVYIIDFGLAKR 95 (414)
Q Consensus 83 ~~vkL~DFGla~~ 95 (414)
+.++|+|||++..
T Consensus 126 ~~~~liDfg~a~~ 138 (199)
T TIGR03724 126 DKLYLIDFGLGKY 138 (199)
T ss_pred CcEEEEECCCCcC
Confidence 7899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.2e-12 Score=120.82 Aligned_cols=85 Identities=20% Similarity=0.275 Sum_probs=67.6
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEeecCC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g-ivHRDIKP~NILl~~~~~ 81 (414)
.+|+++.+. ..||||||+ |.+|..++.. ...+....+..++.||+.+|++||..| |+||||||+||+++
T Consensus 113 ~~p~~~~~~----~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~---- 183 (237)
T smart00090 113 PVPKPIAWR----RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH---- 183 (237)
T ss_pred CCCeeeEec----CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE----
Confidence 456666542 248999999 6677655422 345777778899999999999999999 99999999999995
Q ss_pred CCeEEEeeeceeEEcc
Q 015018 82 ANQVYIIDFGLAKRYR 97 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~ 97 (414)
.+.++|+|||++....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 5679999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.5e-12 Score=132.97 Aligned_cols=81 Identities=27% Similarity=0.555 Sum_probs=70.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+||+..+.++.+.+..+|||||+ |++|.+++. ....++.|++.+|.+||+.||+||||||+|||++
T Consensus 395 ~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~--- 462 (535)
T PRK09605 395 RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR--- 462 (535)
T ss_pred ccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---
Confidence 467777777777777889999999 999999875 3567899999999999999999999999999993
Q ss_pred CCCeEEEeeeceeEE
Q 015018 81 RANQVYIIDFGLAKR 95 (414)
Q Consensus 81 ~~~~vkL~DFGla~~ 95 (414)
.+.++|+|||+++.
T Consensus 463 -~~~~~liDFGla~~ 476 (535)
T PRK09605 463 -DDRLYLIDFGLGKY 476 (535)
T ss_pred -CCcEEEEeCccccc
Confidence 56899999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-11 Score=116.30 Aligned_cols=82 Identities=20% Similarity=0.279 Sum_probs=64.0
Q ss_pred CcEEEEeeEeC-C---EEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 5 IPNLRWFGVEG-D---YNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 5 I~~l~~~g~~~-~---~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|+.+.++... . ..+||||++ | .+|.+++.. ..++... +.||+.+|.+||++||+||||||+|||++
T Consensus 104 vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~- 176 (239)
T PRK01723 104 VPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD- 176 (239)
T ss_pred CceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc-
Confidence 46666654432 2 235999999 6 699998863 4566543 57899999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEE
Q 015018 79 GRRANQVYIIDFGLAKR 95 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~ 95 (414)
.++.++|+|||.+..
T Consensus 177 --~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 --PDGKFWLIDFDRGEL 191 (239)
T ss_pred --CCCCEEEEECCCccc
Confidence 456899999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-11 Score=111.24 Aligned_cols=72 Identities=18% Similarity=0.314 Sum_probs=60.5
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 17 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 17 ~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
..++||||+ |++|..+.. ......++.+|+.++.++|..||+||||||+||+++ .++.++|+|||++..
T Consensus 105 ~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---~~~~~~liDfg~~~~ 174 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---DDEKIYIIDWPQMVS 174 (198)
T ss_pred CceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---CCCcEEEEECCcccc
Confidence 458999999 888876543 134667889999999999999999999999999996 578999999999965
Q ss_pred ccc
Q 015018 96 YRD 98 (414)
Q Consensus 96 ~~~ 98 (414)
...
T Consensus 175 ~~~ 177 (198)
T cd05144 175 TDH 177 (198)
T ss_pred CCC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.4e-11 Score=120.58 Aligned_cols=195 Identities=17% Similarity=0.155 Sum_probs=148.2
Q ss_pred CCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEee
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~----gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++.++.+..+...++.||-.|+||.+|..+......-++...+..+..++.. ||..+|..+++|-|+||+||++.
T Consensus 178 ~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~- 256 (524)
T KOG0601|consen 178 ENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT- 256 (524)
T ss_pred ccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc-
Confidence 4566667778889999999999999999988766666888999999999999 99999999999999999999996
Q ss_pred cCCC-CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRA-NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+ ...+++|||+...+.+..... .+...+...|...|++||..++. ++..+|++++|.++++..++..+...-+
T Consensus 257 --~~~~s~~~~df~~v~~i~~~~~~~--~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 257 --SDWTSCKLTDFGLVSKISDGNFSS--VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred --cccceeecCCcceeEEccCCcccc--ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCC
Confidence 45 788999999999988755322 12222344788999999998864 6789999999999999888765554321
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. .+..++. ...-.++|.+...++...+..+++.++-.|++.+.+.
T Consensus 332 ~~-~W~~~r~------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 332 NS-SWSQLRQ------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CC-Ccccccc------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 1111111 1133456777777888888888888888777765553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-10 Score=98.61 Aligned_cols=81 Identities=22% Similarity=0.396 Sum_probs=69.9
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEee
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGL 78 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~---givHRDIKP~NILl~~ 78 (414)
.++|+++.++..++..+++|||+ |..+..+ +......++.+++.+|++||.. +++|+||+|.||+++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~- 123 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD- 123 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-
Confidence 57899999988888999999999 6666543 5567788899999999999985 799999999999996
Q ss_pred cCCCCeEEEeeeceeE
Q 015018 79 GRRANQVYIIDFGLAK 94 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~ 94 (414)
..+.++++|||++.
T Consensus 124 --~~~~~~l~Df~~~~ 137 (155)
T cd05120 124 --DGKILGIIDWEYAG 137 (155)
T ss_pred --CCcEEEEEeccccc
Confidence 46889999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-10 Score=103.27 Aligned_cols=75 Identities=24% Similarity=0.349 Sum_probs=58.2
Q ss_pred EEEEEEecC-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 17 YNVLVIDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 17 ~~~lVmE~~-g~sL~-~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..+|||||+ |+.+. ..+.... .. ..+..++.|++.++.++|. .+|+||||||+||+++ .+.++|+|||.+
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~~~~liDfg~a 161 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DGKVYIIDVPQA 161 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CCcEEEEECccc
Confidence 359999999 63322 1222111 11 6788999999999999999 9999999999999995 678999999999
Q ss_pred EEccc
Q 015018 94 KRYRD 98 (414)
Q Consensus 94 ~~~~~ 98 (414)
.....
T Consensus 162 ~~~~~ 166 (187)
T cd05119 162 VEIDH 166 (187)
T ss_pred ccccC
Confidence 76544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.6e-10 Score=103.42 Aligned_cols=86 Identities=17% Similarity=0.268 Sum_probs=66.1
Q ss_pred CCCcEEEEeeEeCCEEEEEEecCCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEeec
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLLGPS-LE-DLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~g~s-L~-~ll~~~~~~ls~~~v~~ia~Qll~gL~yL-H~~givHRDIKP~NILl~~~ 79 (414)
-.+|+++.+ ...+|||||+|++ +. ..++ ...++..++..+..|++..|..| |..||||+||++.|||+.
T Consensus 88 v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-- 159 (197)
T cd05146 88 IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-- 159 (197)
T ss_pred CCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE--
Confidence 357888865 4569999999543 21 1223 22456667788889999999998 899999999999999994
Q ss_pred CCCCeEEEeeeceeEEccc
Q 015018 80 RRANQVYIIDFGLAKRYRD 98 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~ 98 (414)
.+.++|+|||.+.....
T Consensus 160 --~~~v~iIDF~qav~~~h 176 (197)
T cd05146 160 --DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred --CCcEEEEECCCceeCCC
Confidence 46799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-10 Score=123.39 Aligned_cols=212 Identities=21% Similarity=0.160 Sum_probs=154.9
Q ss_pred EEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEE
Q 015018 9 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87 (414)
Q Consensus 9 ~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL 87 (414)
+..+......+|||+|+ |++|...+.. ....+.+-+..+...+...++|||...++|||++|.|+|+. ..+..++
T Consensus 870 ~~s~~~rsP~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l 945 (1205)
T KOG0606|consen 870 FPSFPCRSPLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPL 945 (1205)
T ss_pred cCCCCCCCCcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCccc
Confidence 33445677889999999 8899988874 34677777778888899999999999999999999999996 7788999
Q ss_pred eeeceeEEcccCC---Cc---------------------ccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHH
Q 015018 88 IDFGLAKRYRDTA---TH---------------------QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143 (414)
Q Consensus 88 ~DFGla~~~~~~~---~~---------------------~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl 143 (414)
.|||+........ .. ..-..+......||+.|.+||...+......+|+|++|+++
T Consensus 946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhh
Confidence 9998554322110 00 00011223457899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 015018 144 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 223 (414)
Q Consensus 144 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~ 223 (414)
++.++|..||... ...+.++.|....+.-. ......+.+..+++...+..++.+|..+.-- ....+..
T Consensus 1026 ~e~l~g~pp~na~---tpq~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~ 1093 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAE---TPQQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHP 1093 (1205)
T ss_pred hhhhcCCCCCCCc---chhhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccc-------cccccCC
Confidence 9999999999763 44555555554443321 1223456788999999999999999764311 1234456
Q ss_pred CCCcccccccccc
Q 015018 224 FDYVFDWTILKYQ 236 (414)
Q Consensus 224 ~d~~~~w~~~~~~ 236 (414)
+....+|+.+..+
T Consensus 1094 ~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1094 FFQDVDWENLALQ 1106 (1205)
T ss_pred ccCCCCccccccc
Confidence 6677899887644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.9e-09 Score=109.46 Aligned_cols=86 Identities=23% Similarity=0.484 Sum_probs=65.1
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCCceecCCCCCcEEEeecCCC
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKSFLHRDIKPDNFLMGLGRRA 82 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~-gL~yLH~~givHRDIKP~NILl~~~~~~ 82 (414)
||++|+.... ..+|||||+ |.+|.++.......++ ...++.+++. .+..+|..|++|+|+||.||++. .+
T Consensus 222 vP~v~~~~~~--~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~---~~ 293 (437)
T TIGR01982 222 VPEVYWDRTS--ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVL---KD 293 (437)
T ss_pred eCCEehhhcC--CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEEC---CC
Confidence 6666654433 369999999 9999887653222233 3456666665 47889999999999999999995 67
Q ss_pred CeEEEeeeceeEEccc
Q 015018 83 NQVYIIDFGLAKRYRD 98 (414)
Q Consensus 83 ~~vkL~DFGla~~~~~ 98 (414)
+.++|+|||++..+..
T Consensus 294 g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 294 GKIIALDFGIVGRLSE 309 (437)
T ss_pred CcEEEEeCCCeeECCH
Confidence 8899999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=97.56 Aligned_cols=90 Identities=22% Similarity=0.214 Sum_probs=70.7
Q ss_pred CcEEEEeeEe-----CCEEEEEEecC-CC-CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 5 IPNLRWFGVE-----GDYNVLVIDLL-GP-SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 5 I~~l~~~g~~-----~~~~~lVmE~~-g~-sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|.+..+++. ....+||||++ |. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||+
T Consensus 92 tP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl 171 (268)
T PRK15123 92 TMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLL 171 (268)
T ss_pred CCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEE
Confidence 4455555543 23578999999 54 799998643 3456777888999999999999999999999999999999
Q ss_pred ee----cCCCCeEEEeeeceeE
Q 015018 77 GL----GRRANQVYIIDFGLAK 94 (414)
Q Consensus 77 ~~----~~~~~~vkL~DFGla~ 94 (414)
.. +.....++||||+.++
T Consensus 172 ~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 172 HLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eccccCCCCCceEEEEECCccc
Confidence 73 1235689999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.1e-08 Score=91.58 Aligned_cols=91 Identities=21% Similarity=0.331 Sum_probs=73.3
Q ss_pred CcEEEEeeEeC----CEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 5 IPNLRWFGVEG----DYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 5 I~~l~~~g~~~----~~~~lVmE~~-g~-sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|+...+++.. ...+||+|++ |. +|.+++.... .++......++.+++..+.-||..||+|+|+++.|||+..
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~ 153 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDP 153 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeC
Confidence 66777777662 2458999999 53 7999987532 3777788899999999999999999999999999999974
Q ss_pred cCCCCeEEEeeeceeEEc
Q 015018 79 GRRANQVYIIDFGLAKRY 96 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~ 96 (414)
+.....+.|+||+.++..
T Consensus 154 ~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 154 DDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCCceeEEEEcchhceeC
Confidence 443458999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=91.31 Aligned_cols=78 Identities=24% Similarity=0.448 Sum_probs=59.4
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 82 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~ 82 (414)
++|.||. .+.+...|+|||+ |..|.+++... . ..++..+=.-+.-||..||||+||.+.||+++ +
T Consensus 62 ~~P~v~d--vD~~~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~ 127 (204)
T COG3642 62 PVPIVYD--VDPDNGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----G 127 (204)
T ss_pred CCCeEEE--EcCCCCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEe----C
Confidence 3455544 4555668999999 77888888743 2 34455555667779999999999999999995 4
Q ss_pred CeEEEeeeceeEE
Q 015018 83 NQVYIIDFGLAKR 95 (414)
Q Consensus 83 ~~vkL~DFGla~~ 95 (414)
+.++++||||+..
T Consensus 128 ~~i~~IDfGLg~~ 140 (204)
T COG3642 128 GRIYFIDFGLGEF 140 (204)
T ss_pred CcEEEEECCcccc
Confidence 5599999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.4e-08 Score=102.08 Aligned_cols=132 Identities=17% Similarity=0.159 Sum_probs=101.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH-~~givHRDIKP~NILl~~~~ 80 (414)
+|+|.+++...+.++..|||.|.+-+ |..+++. ++...+...+.||+.||-||| +++++|++|--..|+|+
T Consensus 68 HP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn--- 139 (690)
T KOG1243|consen 68 HPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN--- 139 (690)
T ss_pred CchhhhhhhhhcccCceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---
Confidence 79999999999999999999999954 5666664 347778888999999999997 67899999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~ 150 (414)
..|.+||.+|.++........ ......--..|..|+.+...+ ...|.|-|||++++++.|.
T Consensus 140 ~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 140 ESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred CCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 889999999999875443221 011122233355565544322 3469999999999999983
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=94.46 Aligned_cols=191 Identities=13% Similarity=0.193 Sum_probs=130.7
Q ss_pred CCEEEEEEecC-CC-CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEE
Q 015018 15 GDYNVLVIDLL-GP-SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87 (414)
Q Consensus 15 ~~~~~lVmE~~-g~-sL~~ll~~~-----~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL 87 (414)
+...-++|..+ |. -+.++++-. -..+.++.+++.+..|+.+.+-||..|.+-+|+.++|||++ +...|.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEE
Confidence 33467889988 54 333343211 22488999999999999999999999999999999999997 7788999
Q ss_pred eeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcc--
Q 015018 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG-- 159 (414)
Q Consensus 88 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG-~~Pf~~~~~~-- 159 (414)
+|=.......+ .+ ....-+|...|.+||... +.+-+...|.|-||+++++++.| +.||.|....
T Consensus 159 VdsDsfqi~~n-g~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 159 VDSDSFQINAN-GT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred EcccceeeccC-Cc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 88554332211 11 113458999999999865 44556788999999999999885 9999885432
Q ss_pred --chHH-HHH-------H-HHhhhccchHHHhhcCCcHHHHHHHHHHHcCC--CCCCCCHHHHHHHHHHH
Q 015018 160 --TKKQ-KYE-------K-ISEKKVSTSIEALCRGYPTEFASYFHYCRSLR--FDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 --~~~~-~~~-------~-i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d--p~~RP~~~~l~~~l~~~ 216 (414)
...+ .+. + -.......+.+.-+.-+|+.+..++.+|+..- +.-||+.+.....|..+
T Consensus 231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111 000 0 00111122222233457899999999999643 56899977666555444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.2e-09 Score=98.88 Aligned_cols=190 Identities=13% Similarity=0.177 Sum_probs=123.8
Q ss_pred CCcEEEEeeEeCCE-----EEEEEecC-CCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCC
Q 015018 4 GIPNLRWFGVEGDY-----NVLVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD 72 (414)
Q Consensus 4 ~I~~l~~~g~~~~~-----~~lVmE~~-g~sL~~ll~---~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~ 72 (414)
||++++.++.+..+ ..++.||+ -++|..+++ ++...+..+.-.+|+.||+.||.|||+.. |+|+++..+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 56777777766544 68999999 999999986 44566889999999999999999999985 999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
-|++. .++.|||.- +--..... .....+ -.+...-.+-+.|.+||.=.....+..+|||+||....+|..+..-
T Consensus 208 tifiq---~ngLIkig~-~ap~s~h~-s~~~~~-~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 208 TIFIQ---HNGLIKIGS-VAPDSTHP-SVNSTR-EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred heeec---CCceEEecc-cCccccch-hhhhhh-HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 99995 666555421 11100000 000000 1122234677889999877666667789999999988898776543
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
-... .. ++. .+......+--+.. .--+.++..|++-.|..||++..+
T Consensus 282 ~tns--eS---~~~--~ee~ia~~i~~len---~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 282 STNS--ES---KVE--VEENIANVIIGLEN---GLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred cCCC--cc---eee--hhhhhhhheeeccC---ccccCcCcccccCCCCCCcchhhh
Confidence 2111 00 010 01111111101111 123568899999999999997655
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-08 Score=89.38 Aligned_cols=75 Identities=24% Similarity=0.480 Sum_probs=57.4
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEee
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGL 78 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~gi-----vHRDIKP~NILl~~ 78 (414)
+|++++++. ...++|||++ |.++.+. .. ....+..+++..|+.||..++ +|+|++|.||+++
T Consensus 55 ~P~~~~~~~--~~~~lv~e~i~G~~l~~~------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 55 GPKLYYFDP--ETGVLITEFIEGSELLTE------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred CCceEEEeC--CCCeEEEEecCCCccccc------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 577776654 3358999999 7776543 11 123456899999999999885 9999999999995
Q ss_pred cCCCCeEEEeeeceeE
Q 015018 79 GRRANQVYIIDFGLAK 94 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~ 94 (414)
.+.++|+|||.+.
T Consensus 123 ---~~~~~liDf~~a~ 135 (170)
T cd05151 123 ---DGRLWLIDWEYAG 135 (170)
T ss_pred ---CCeEEEEeccccc
Confidence 4579999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.8e-08 Score=100.69 Aligned_cols=85 Identities=21% Similarity=0.441 Sum_probs=57.9
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~-----ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
||++|+-+.. ..+|||||+ |..|.++-...... +....+..++.| ++..||+|+|+||.||++..
T Consensus 225 VP~v~~d~st--~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~ 295 (537)
T PRK04750 225 VPEVYWDYCS--ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSY 295 (537)
T ss_pred cceeecccCC--CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEec
Confidence 6777765533 458999999 99998753211222 333334444444 44689999999999999973
Q ss_pred c-CCCCeEEEeeeceeEEccc
Q 015018 79 G-RRANQVYIIDFGLAKRYRD 98 (414)
Q Consensus 79 ~-~~~~~vkL~DFGla~~~~~ 98 (414)
+ ...+.++++|||++..+..
T Consensus 296 ~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 296 DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCCCCCeEEEEecceEEECCH
Confidence 2 1223899999999987754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.3e-07 Score=84.65 Aligned_cols=89 Identities=17% Similarity=0.261 Sum_probs=66.0
Q ss_pred CcEEEEeeEeCCEEEEEEecCCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 5 IPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~g~--sL~~ll~~~~~~-ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|+|+ +.+-...+|+|||+.+ ++.+++...... ........++.+|=..|.-||..+|+|+||...||++..+..
T Consensus 74 ~P~l~--~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~ 151 (229)
T KOG3087|consen 74 APRLI--FIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGN 151 (229)
T ss_pred CceEE--EEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCC
Confidence 45554 4455556899999954 888888643333 333333678888888999999999999999999999974444
Q ss_pred CCeEEEeeeceeEE
Q 015018 82 ANQVYIIDFGLAKR 95 (414)
Q Consensus 82 ~~~vkL~DFGla~~ 95 (414)
.-.+.|+|||++..
T Consensus 152 ~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 QITPILIDFGLSSV 165 (229)
T ss_pred cCceEEEeecchhc
Confidence 45569999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-08 Score=90.62 Aligned_cols=84 Identities=25% Similarity=0.385 Sum_probs=54.2
Q ss_pred CCcEEEEeeEeCCEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEeecC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~g--~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~y-LH~~givHRDIKP~NILl~~~~ 80 (414)
++|+++.+. ..+|||||++ |.....+... .++......++.+++..+.. +|..||||+||.+.|||++
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--- 141 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--- 141 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---
Confidence 478887553 2489999997 5433333321 22245567778888885555 5799999999999999996
Q ss_pred CCCeEEEeeeceeEEcc
Q 015018 81 RANQVYIIDFGLAKRYR 97 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~ 97 (414)
.+.++|||||.+....
T Consensus 142 -~~~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 -DGKVYIIDFGQAVDSS 157 (188)
T ss_dssp -TTCEEE--GTTEEETT
T ss_pred -cceEEEEecCcceecC
Confidence 3489999999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.2e-08 Score=98.83 Aligned_cols=182 Identities=19% Similarity=0.156 Sum_probs=124.0
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.+++..+..+...+..||-.||| ++++...+ .....+++...+.+..|++.++.++|++.++|+|+||.||++..+
T Consensus 326 ~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~-- 402 (524)
T KOG0601|consen 326 LPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND-- 402 (524)
T ss_pred cccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--
Confidence 45566556666667778999999 88877665 345678999999999999999999999999999999999999621
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCcccc--chhhhcCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKA 158 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~--aPE~~~~~~~s~~~DvwSlGvvl~elltG~-~Pf~~~~~ 158 (414)
+...++.|||+...+.-.. ....+.-+++ ++.......+..+.|+++||.-+.+.+++. +++.+..-
T Consensus 403 ~~~~~~~~~~~~t~~~~~~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~ 472 (524)
T KOG0601|consen 403 GFFSKLGDFGCWTRLAFSS----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS 472 (524)
T ss_pred hhhhhccccccccccceec----------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc
Confidence 2677899999986422111 1223344444 455555566788999999999999988875 44433110
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 209 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l 209 (414)
..+...... ...+...++..+.+.+...++..||.+.++
T Consensus 473 -------~~i~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 473 -------LTIRSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred -------eeeeccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 111111110 112233566777777777888777765544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.5e-07 Score=96.89 Aligned_cols=160 Identities=13% Similarity=0.190 Sum_probs=107.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCccccccccc-----CCCC
Q 015018 41 SLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-----KNLT 114 (414)
Q Consensus 41 s~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~-----~~~~ 114 (414)
..+.+..=+.+++.||.|+|. .++||+.|.|++|.+. ..+.+||+.|+++........ .|+.+. ....
T Consensus 97 aTe~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~---~p~~~yd~~lp~~~~ 170 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTE---YPFSEYDPPLPLLLQ 170 (700)
T ss_pred cccHhhhhhhcccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCc---cccccCCCCCChhhc
Confidence 334444445677799999996 5899999999999996 788999999998765433111 121111 1234
Q ss_pred CCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHH
Q 015018 115 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 193 (414)
Q Consensus 115 Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~ 193 (414)
-...|.+||++.+..-+..+|+|||||++|.+.. |+.-+..... .. +.................++|+|+.+-+.
T Consensus 171 ~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~---~~~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 171 PHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LL---SYSFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred cCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCC-cc---hhhhhhcccccccccccccCcHHHHHHHH
Confidence 5678999999999778899999999999999884 5444433211 11 11111111111111223578999999999
Q ss_pred HHHcCCCCCCCCHHHHH
Q 015018 194 YCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 194 ~c~~~dp~~RP~~~~l~ 210 (414)
.++..+...||+...+.
T Consensus 247 k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHhcCCcccCcchhhhh
Confidence 99999999999655543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-06 Score=76.79 Aligned_cols=92 Identities=11% Similarity=0.056 Sum_probs=70.3
Q ss_pred CCCCCcEEEEeeEeC----CEEEEEEecCC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 1 MAAGIPNLRWFGVEG----DYNVLVIDLLG--PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 1 g~p~I~~l~~~g~~~----~~~~lVmE~~g--~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
|.| +|++..+.... -..+||+|-++ .+|.+++.... .+.+......+..+|+..|.-||+.|+.|+|+.+.|
T Consensus 80 GvP-VP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~kh 158 (216)
T PRK09902 80 GVI-VPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRH 158 (216)
T ss_pred CCC-CCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhh
Confidence 456 77777444332 23689999886 69999876321 256777788999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeE
Q 015018 74 FLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~ 94 (414)
||+..++ .-.|.+|||.-++
T Consensus 159 Ill~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 159 IYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred eeecCCC-CeeEEEEEhhccc
Confidence 9996321 2359999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-06 Score=79.92 Aligned_cols=88 Identities=22% Similarity=0.308 Sum_probs=65.6
Q ss_pred CCcEEEEeeEeCC---EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 015018 4 GIPNLRWFGVEGD---YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------ 61 (414)
Q Consensus 4 ~I~~l~~~g~~~~---~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~------------------ 61 (414)
.+|+++.+..... ..|+||||+ |.+|.+.+. ...++......++.+++..|..||+
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 4688888777643 668999999 877776543 1357777777788888888888873
Q ss_pred --------------------------------------CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 --------------------------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 --------------------------------------~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
..++|+|+++.|||++.+ ..+.+.|+||+.+.
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236899999999999621 14568999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.9e-05 Score=78.40 Aligned_cols=160 Identities=19% Similarity=0.278 Sum_probs=112.0
Q ss_pred CCCCcEEEEeeEe----CCEEEEEEecC--CCCHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015018 2 AAGIPNLRWFGVE----GDYNVLVIDLL--GPSLEDLFNF--------------CSRKLSLKTVLMLADQMINRVEFVHS 61 (414)
Q Consensus 2 ~p~I~~l~~~g~~----~~~~~lVmE~~--g~sL~~ll~~--------------~~~~ls~~~v~~ia~Qll~gL~yLH~ 61 (414)
++||++++..+.. +.-.++|++|+ .++|.++.-. .+.+.++..++.++.||..||.++|+
T Consensus 332 h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs 411 (655)
T KOG3741|consen 332 HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS 411 (655)
T ss_pred cCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh
Confidence 5789999887773 45689999999 6788887521 13457889999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHH
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 141 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGv 141 (414)
.|+.=+-|.+.+||+. ....|+|.-.|+.-.+..... +.+ +.-.+.|.-.||.
T Consensus 412 sGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d~~---------------------~~l---e~~Qq~D~~~lG~ 464 (655)
T KOG3741|consen 412 SGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQEDPT---------------------EPL---ESQQQNDLRDLGL 464 (655)
T ss_pred cCceeecccHhHeEee---CcceEEEecccceeeecCCCC---------------------cch---hHHhhhhHHHHHH
Confidence 9999999999999996 445788877776544333210 111 1123679999999
Q ss_pred HHHHHHhCCCC-CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC
Q 015018 142 VLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 202 (414)
Q Consensus 142 vl~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~ 202 (414)
+++.|.+|..- |... ..+.+ -+..+...+..++++++.++....+++
T Consensus 465 ll~aLAt~~~ns~~~d----~~~~s----------~~~~I~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 465 LLLALATGTENSNRTD----STQSS----------HLTRITTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred HHHHHhhccccccccc----chHHH----------HHHHhhhhhhHHHHHHHHHHHhcCccc
Confidence 99999998542 2211 11111 112233446677888888888888775
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.8e-06 Score=77.92 Aligned_cols=67 Identities=28% Similarity=0.515 Sum_probs=52.5
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 16 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 16 ~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
...+|||||+ |..|.++.. +++ .++..|...|.-||..|++|+|+.|.||++. ++.++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence 4557999999 877776543 232 2446677889999999999999999999995 5669999998654
Q ss_pred E
Q 015018 95 R 95 (414)
Q Consensus 95 ~ 95 (414)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.6e-05 Score=81.41 Aligned_cols=91 Identities=22% Similarity=0.345 Sum_probs=68.5
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec-CC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RR 81 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~-~~ 81 (414)
.||+|||.+... .+|+|||| |..+.|+-......++...+...+.++.. +.|-..|++|.|-.|.||++..+ ..
T Consensus 265 ~VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 265 LVPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred eCCeehhhcCcc--eEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCC
Confidence 389998887654 49999999 87776664433567888877766666543 44455689999999999999743 34
Q ss_pred CCeEEEeeeceeEEccc
Q 015018 82 ANQVYIIDFGLAKRYRD 98 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~ 98 (414)
+..+.+.|||+...+..
T Consensus 341 ~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccEEEEcccccccccH
Confidence 67899999999876654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=4.5e-05 Score=79.65 Aligned_cols=87 Identities=22% Similarity=0.440 Sum_probs=64.8
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCC
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 83 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~ 83 (414)
||++||-+...+ +|+|||+ |.-+.++.......++.+.+.....++. +..+-..|++|.|.+|.||++. .++
T Consensus 230 VP~V~we~t~~~--VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~---~~g 302 (517)
T COG0661 230 VPKVYWEYTTRR--VLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVR---SDG 302 (517)
T ss_pred eceeehhccCCc--EEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEe---cCC
Confidence 788888666554 9999999 8888888532345677555554444433 3444458999999999999996 678
Q ss_pred eEEEeeeceeEEccc
Q 015018 84 QVYIIDFGLAKRYRD 98 (414)
Q Consensus 84 ~vkL~DFGla~~~~~ 98 (414)
.+.+.|||+...+..
T Consensus 303 ~i~~lDfGi~g~l~~ 317 (517)
T COG0661 303 RIVLLDFGIVGRLDP 317 (517)
T ss_pred cEEEEcCcceecCCH
Confidence 999999999876654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=9.9e-05 Score=69.48 Aligned_cols=75 Identities=23% Similarity=0.321 Sum_probs=57.7
Q ss_pred EEEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 17 YNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 17 ~~~lVmE~~g~sL~--~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..+|||||+|.... -.++ .-.+...++..+..+++..+.-|-. .++||+||..-|||++ .+.++|||||.|
T Consensus 140 ~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~~p~iID~~Qa 213 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DGEPYIIDVSQA 213 (268)
T ss_pred CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CCeEEEEECccc
Confidence 46899999965411 1122 2234445788889999999999887 8999999999999994 688999999988
Q ss_pred EEcc
Q 015018 94 KRYR 97 (414)
Q Consensus 94 ~~~~ 97 (414)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 6544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00033 Score=63.85 Aligned_cols=86 Identities=21% Similarity=0.239 Sum_probs=67.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCC-CCHHHH----HHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLG-PSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g-~sL~~l----l~~~~~~ls~~~v~~ia~Qll~gL~yLH~---~givHRDIKP~N 73 (414)
.++||+++++| |+ ++|.|+++ +++... .+ -...++..+.+|+.|++..+++|+. ..+.-.|++++|
T Consensus 19 ~~~~pk~lG~C--G~--~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~n 92 (188)
T PF12260_consen 19 SEPFPKLLGSC--GR--FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDN 92 (188)
T ss_pred CCCCCCeeeEC--CC--EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHH
Confidence 46899998776 33 78999995 455421 11 1246899999999999999999997 347889999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEc
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRY 96 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~ 96 (414)
|-+. .++.+|++|...+...
T Consensus 93 fgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 93 FGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred eEEe---CCCcEEEEechhcchh
Confidence 9996 6678999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00057 Score=64.38 Aligned_cols=29 Identities=21% Similarity=0.195 Sum_probs=24.2
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+.|.|||++ ..+.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~---~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVD---PGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEe---CCcEEEEEEccccc
Confidence 489999999999996 45567899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00025 Score=67.63 Aligned_cols=71 Identities=20% Similarity=0.370 Sum_probs=54.1
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 16 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 16 ~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
+..++|||++ |--|..+ +++.+....++..|+.-+.-+-..||||+|+.+-||+++ .++.++++||-.+.
T Consensus 180 nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~dg~~~vIDwPQ~v 250 (304)
T COG0478 180 NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDGDIVVIDWPQAV 250 (304)
T ss_pred ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cCCCEEEEeCcccc
Confidence 4568999999 6444432 224555666677777777777799999999999999996 77899999997654
Q ss_pred E
Q 015018 95 R 95 (414)
Q Consensus 95 ~ 95 (414)
.
T Consensus 251 ~ 251 (304)
T COG0478 251 P 251 (304)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0013 Score=61.63 Aligned_cols=28 Identities=29% Similarity=0.450 Sum_probs=23.4
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+.|.||+++ ..+ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~---~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITS---GKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEc---CCC-cEEEechhcC
Confidence 478999999999996 444 8999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0023 Score=58.82 Aligned_cols=81 Identities=21% Similarity=0.347 Sum_probs=63.5
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-C------CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-G------PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g------~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|+++|++-++.--.-+|+|.+ + .+|.+++. ...++. .+ ...+-+-.+||-+.+|+.+||+|.||+
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIV 150 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEE
Confidence 57999999999998889999976 2 47888886 345665 33 344445567888999999999999999
Q ss_pred EeecCCCC-eEEEee
Q 015018 76 MGLGRRAN-QVYIID 89 (414)
Q Consensus 76 l~~~~~~~-~vkL~D 89 (414)
+....... .++|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 98765555 788999
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0025 Score=63.26 Aligned_cols=74 Identities=24% Similarity=0.292 Sum_probs=60.7
Q ss_pred EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeecCCCCeEEEeeec
Q 015018 13 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG 91 (414)
Q Consensus 13 ~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~~~~~~~vkL~DFG 91 (414)
.+..|.|++|++.|+.|.-+- --..++++.|+.+.+..+.-+..+ .+-|||+.-.|||| ..|+|.||||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEee
Confidence 446689999999998876432 235788899999998888777765 68899999999999 37899999999
Q ss_pred eeEE
Q 015018 92 LAKR 95 (414)
Q Consensus 92 la~~ 95 (414)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=9.5e-05 Score=77.35 Aligned_cols=137 Identities=16% Similarity=0.092 Sum_probs=100.9
Q ss_pred CCC-CcEEEEeeEeCCEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAG-IPNLRWFGVEGDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~-I~~l~~~g~~~~~~~lVmE~~-g~-sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.|| .+..+..++.+++.+++|+++ ++ +....+....-.|.......+...-.++|++||+.-=+||| ||+.
T Consensus 292 ~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-- 365 (829)
T KOG0576|consen 292 NPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-- 365 (829)
T ss_pred CCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc--
Confidence 466 455555666788999999999 44 33333322222345555566667778899999988779999 8887
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
..+.++..||+....+.... ....+.+|+.+++||+.....+..+.|+|++++-..++--|-+|-.
T Consensus 366 --s~~~~~~~~~~v~~~L~~~~--------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 366 --SEEEVKLLDFAVPPQLTRTM--------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --cccccccccccCCcccCccc--------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 45788999999987765543 1246789999999999999999999999999986666666665553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0026 Score=59.71 Aligned_cols=30 Identities=30% Similarity=0.573 Sum_probs=24.0
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+++|+|+.+.|||++ ..+..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~---~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQ---DGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEE---CCCEEEEEeCcccC
Confidence 3589999999999996 34445699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.018 Score=52.80 Aligned_cols=31 Identities=32% Similarity=0.542 Sum_probs=20.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
..++|+|+.|.|||++ ..++.|.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceee--eccceeEEEecccce
Confidence 4599999999999996 345666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.015 Score=65.25 Aligned_cols=182 Identities=16% Similarity=0.149 Sum_probs=112.0
Q ss_pred CCCcEEEEeeEeCCEEEEE----EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 3 AGIPNLRWFGVEGDYNVLV----IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lV----mE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|+..++.++......-++ .++| +-++.+++.. -..++..+++.+..++++||+|+|+....|.-|...-..-.
T Consensus 242 ~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~ 320 (1351)
T KOG1035|consen 242 DNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKES 320 (1351)
T ss_pred ccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccccc
Confidence 4566666666554433333 3456 6677766653 45789999999999999999999998555544443321111
Q ss_pred ecCCCCeEEEe--eeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCC--chhHHHHHHHHHHHHHhCCCCC
Q 015018 78 LGRRANQVYII--DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 78 ~~~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s--~~~DvwSlGvvl~elltG~~Pf 153 (414)
.....+.+.+. ||+..+.+.+..... ...-+..+.++|........ +..|+|.||..+..+..|..+-
T Consensus 321 ~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 321 TVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDIS 392 (1351)
T ss_pred ccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccc
Confidence 11234455555 888877665543211 12344556667766655544 4479999999999888765432
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. . .....-++..+..+..+....|+.-+.++|+...++.
T Consensus 393 ~~----------~-------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 393 EK----------S-------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred cc----------c-------cchhhhhccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 11 0 0111112222333788889999999999999866554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.012 Score=65.48 Aligned_cols=32 Identities=22% Similarity=0.401 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
.+||+|+++.|||+..+ ....+-|+||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~-~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPT-EDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCC-CCeEEEEEeeecccc
Confidence 49999999999999621 123457999999864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.27 Score=49.31 Aligned_cols=28 Identities=21% Similarity=0.484 Sum_probs=23.2
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..++|+|+.+.||++. ...++++|+.++
T Consensus 192 ~~llHGDl~~gNi~~~----~~~~~~iD~e~~ 219 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVS----EHETKVIDPEFA 219 (370)
T ss_pred ceeeeccCCcccEEEc----CCCCEEEcCccc
Confidence 4689999999999994 345889999765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.0038 Score=71.44 Aligned_cols=127 Identities=12% Similarity=-0.036 Sum_probs=94.2
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-----CceecCCCCCcEEEeecCCCCeEEE
Q 015018 17 YNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK-----SFLHRDIKPDNFLMGLGRRANQVYI 87 (414)
Q Consensus 17 ~~~lVmE~~-g~sL~~ll~~~~---~~ls~~~v~~ia~Qll~gL~yLH~~-----givHRDIKP~NILl~~~~~~~~vkL 87 (414)
..|.+|+++ +|.+.+++-+.. ..++..-+.....+.+....-+|.. --+|++||+-|.+|. .+..||+
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV---tny~v~~ 1381 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV---TNYNVKL 1381 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee---cCCcccc
Confidence 347788888 888888875332 2344444444444446666776754 278999999999995 6678999
Q ss_pred eeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 88 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.++|+.+....... ..+...+++-|+.+++....+++.++|+|..++.+|+...|..+|
T Consensus 1382 gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999983222111 234568889999999999999999999999999999998888777
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.031 Score=57.97 Aligned_cols=78 Identities=18% Similarity=0.103 Sum_probs=50.3
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhh---hccchHHH-hhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 132 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---KVSTSIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 132 ~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---~~~~~~~~-l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
+++|||++|.++.++..|..-|..+........+.+.... ......+. +--.+++.+.++...|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 3999999999999999998888765443333322222111 11111111 1134678889999999999999998765
Q ss_pred HH
Q 015018 208 YL 209 (414)
Q Consensus 208 ~l 209 (414)
++
T Consensus 190 ~~ 191 (725)
T KOG1093|consen 190 EL 191 (725)
T ss_pred HH
Confidence 54
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.022 Score=56.89 Aligned_cols=72 Identities=24% Similarity=0.313 Sum_probs=56.6
Q ss_pred EEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 18 NVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 18 ~~lVmE~~g~sL~--~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH-~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+|||+|+|.+=+ -.++ +-.++...+..+-.|++.-+.-|. .+++||.||.--|+|+ ..|.++|||.+.+.
T Consensus 239 hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 239 HVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----HDGKLYIIDVSQSV 312 (520)
T ss_pred ceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----ECCEEEEEEccccc
Confidence 4899999965433 2233 446777788888888888887775 5799999999999999 68999999998765
Q ss_pred E
Q 015018 95 R 95 (414)
Q Consensus 95 ~ 95 (414)
.
T Consensus 313 E 313 (520)
T KOG2270|consen 313 E 313 (520)
T ss_pred c
Confidence 4
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.015 Score=57.21 Aligned_cols=69 Identities=17% Similarity=0.328 Sum_probs=51.3
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 16 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 16 ~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
+.-|+|||++ |-.|..+-+ --+ +..+...|+.-+--|-..|+||+|..--||+|. .++.+++|||-...
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~----v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRH----VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---DDDKIVVIDFPQMV 250 (465)
T ss_pred cceeeHHHhhcccceeeeee----cCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEe---cCCCEEEeechHhh
Confidence 3458999999 877766543 122 333455566666777889999999999999995 67889999996543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.15 Score=49.96 Aligned_cols=30 Identities=30% Similarity=0.388 Sum_probs=24.4
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++||+|+.|.|||+. .+..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE---CCceEEEEeccccc
Confidence 4899999999999995 33445799999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.1 Score=50.98 Aligned_cols=30 Identities=33% Similarity=0.515 Sum_probs=25.1
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6899999999999996 44556899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.12 Score=50.14 Aligned_cols=29 Identities=38% Similarity=0.729 Sum_probs=24.4
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+++|+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5789999999999996 3 568999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.71 E-value=1.7 Score=44.51 Aligned_cols=28 Identities=18% Similarity=0.437 Sum_probs=22.1
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..++|+||.+.||+++ .+.++++|..++
T Consensus 230 ~~L~HGDl~~g~i~~~----~~~~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVT----PDSTQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEc----CCCceEecchhh
Confidence 3589999999999995 344888887654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.093 Score=48.84 Aligned_cols=29 Identities=31% Similarity=0.519 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEEeecCC-CCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~-~~~vkL~DFGla~ 94 (414)
.++|+|+.+.|||++ . ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~---~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYN---EEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEe---CCCCCEEEEEcccCC
Confidence 599999999999996 3 3679999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.81 Score=46.69 Aligned_cols=28 Identities=21% Similarity=0.455 Sum_probs=23.7
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..++|+|+.+.|||+. .+.++|+||.++
T Consensus 223 ~~l~HgDl~~gni~~~----~~~~~viD~E~a 250 (401)
T PRK09550 223 EALLHGDLHTGSIFVT----EEETKVIDPEFA 250 (401)
T ss_pred CceeeccCCcccEEee----CCCcEEEecccc
Confidence 4699999999999995 346899999865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.43 E-value=0.19 Score=48.82 Aligned_cols=32 Identities=28% Similarity=0.480 Sum_probs=24.6
Q ss_pred CceecCCCCCcEEEeec-CCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~-~~~~~vkL~DFGla~ 94 (414)
.++|+|+.+.|||+..+ ...+.++|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999610 003679999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.40 E-value=0.2 Score=48.37 Aligned_cols=30 Identities=30% Similarity=0.428 Sum_probs=24.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 4799999999999996 44556899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.30 E-value=1.5 Score=44.64 Aligned_cols=28 Identities=18% Similarity=0.427 Sum_probs=23.9
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..+||+||.|.||+++ ...+|++|..+|
T Consensus 227 ~aLlHGDlHtGSI~v~----~~~~kvIDpEFA 254 (409)
T PRK12396 227 QALIHGDLHTGSVFVK----NDSTKVIDPEFA 254 (409)
T ss_pred hhhccCcCCCCCEEec----CCceEEEccccc
Confidence 4699999999999995 456999998776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.72 E-value=0.22 Score=49.69 Aligned_cols=30 Identities=27% Similarity=0.563 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+++.|||++ ...+.++|+||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 589999999999996 234679999998775
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.22 E-value=0.29 Score=47.23 Aligned_cols=48 Identities=21% Similarity=0.342 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 44 TVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 44 ~v~~ia~Qll~gL~yLH~~--givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+...+..+-..+.-++.. -++|.|+.|+|+|++ ..+.++|+||..|.
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg 182 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence 3444555666666666654 589999999999995 55899999998774
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.53 Score=42.58 Aligned_cols=75 Identities=23% Similarity=0.395 Sum_probs=51.8
Q ss_pred CCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC--CcEEEeecC
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP--DNFLMGLGR 80 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP--~NILl~~~~ 80 (414)
.-|+||.++.+ ++.|||+ |..|.++... .+-++++ .+++.---|-..||-|..|.- .||++
T Consensus 77 ~~p~vy~yg~~----~i~me~i~G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv---- 140 (201)
T COG2112 77 VTPEVYFYGED----FIRMEYIDGRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLV---- 140 (201)
T ss_pred CCceEEEechh----hhhhhhhcCcchhhhhhc----ccHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEe----
Confidence 35778777764 4559999 8899887652 1334443 344444445667999999975 56776
Q ss_pred CCCeEEEeeeceeE
Q 015018 81 RANQVYIIDFGLAK 94 (414)
Q Consensus 81 ~~~~vkL~DFGla~ 94 (414)
.++.++||||..|+
T Consensus 141 ~~~~~~iIDFd~At 154 (201)
T COG2112 141 NDRDVYIIDFDSAT 154 (201)
T ss_pred cCCcEEEEEccchh
Confidence 45589999999886
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.11 E-value=0.32 Score=44.86 Aligned_cols=37 Identities=30% Similarity=0.612 Sum_probs=31.4
Q ss_pred HHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 49 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 49 a~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
+.+|.+-|..+|..||+-+|+|+.|..=+ +|+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCccccccCC--------EEEecccC
Confidence 46788889999999999999999998632 69999864
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.86 E-value=0.27 Score=44.70 Aligned_cols=28 Identities=25% Similarity=0.449 Sum_probs=23.3
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
-.+|+|+.|.||+++ .++ ++|+||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~---~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHS---ASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEE---CCC-EEEEeCCccc
Confidence 368999999999995 334 8899999875
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.55 E-value=0.64 Score=42.38 Aligned_cols=33 Identities=24% Similarity=0.457 Sum_probs=25.1
Q ss_pred CCceecCCCCCcEEEeecCC--CCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRR--ANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~--~~~vkL~DFGla~ 94 (414)
..++|+|+.+.||++..+.. ...+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 46899999999999963221 1268999998764
|
subfamily of choline kinases |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=89.36 E-value=0.27 Score=46.61 Aligned_cols=28 Identities=25% Similarity=0.423 Sum_probs=23.4
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+.|.||+++ .++ ++|+||+.|.
T Consensus 147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEe---CCC-CEEEeccccC
Confidence 589999999999996 333 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.00 E-value=0.57 Score=45.79 Aligned_cols=29 Identities=24% Similarity=0.462 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
+++|+|+.+.|||++ .++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD---ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc---CCCCEEEEEhhhcc
Confidence 799999999999995 55678999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.47 E-value=0.86 Score=45.36 Aligned_cols=61 Identities=25% Similarity=0.247 Sum_probs=36.0
Q ss_pred EEEEEEecCCCCHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCCCCcEEEe
Q 015018 17 YNVLVIDLLGPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 17 ~~~lVmE~~g~sL~~ll~----~~~~~ls~~~v~~ia~Qll~gL~yLH----~~givHRDIKP~NILl~ 77 (414)
...|||++.-++-..+-. +.+-..-.+-+..++.||+.-.--+- ..+++|-||||+|||+=
T Consensus 245 GnIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 313 (434)
T PF05445_consen 245 GNIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF 313 (434)
T ss_pred CcEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence 457899988444333211 11222234456667777754331122 24699999999999995
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.19 E-value=0.89 Score=45.08 Aligned_cols=62 Identities=23% Similarity=0.232 Sum_probs=39.0
Q ss_pred CCEEEEEEecCCCCHHH-----HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh----CCceecCCCCCcEEEe
Q 015018 15 GDYNVLVIDLLGPSLED-----LFNFCSRKLSLKTVLMLADQMINRVEFVHS----KSFLHRDIKPDNFLMG 77 (414)
Q Consensus 15 ~~~~~lVmE~~g~sL~~-----ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~----~givHRDIKP~NILl~ 77 (414)
++-..|||++.-++-.. ..+ .+-.--.+-+..++.||+.-.-.+-+ .+++|-||||+||||-
T Consensus 247 drGnIIIfPLArcSadkv~~~~~~e-~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 247 DRGNIIIFPLARCSADKVTEENAAE-LGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred cCCcEEEEehhhcccccCCHHHHHH-cCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 34568999987443222 222 12222345567778888765544433 3699999999999995
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=88.15 E-value=0.67 Score=42.49 Aligned_cols=31 Identities=35% Similarity=0.665 Sum_probs=20.5
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
.+.|.||.+.|||+. ...+.++||||..|..
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 588999999999992 3678999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.77 E-value=1.3 Score=41.72 Aligned_cols=37 Identities=27% Similarity=0.379 Sum_probs=31.0
Q ss_pred HHHHHHHHh--CCceecCCCCCcEEEeecCCCCeEEEeeece
Q 015018 53 INRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 92 (414)
Q Consensus 53 l~gL~yLH~--~givHRDIKP~NILl~~~~~~~~vkL~DFGl 92 (414)
++.|..+|+ .+.+|+|..|+||+-+ +.|.+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D---~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCD---KFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeec---CCCCEEecChhh
Confidence 467888894 4799999999999986 888999999654
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.68 E-value=0.71 Score=45.88 Aligned_cols=28 Identities=36% Similarity=0.552 Sum_probs=23.2
Q ss_pred ceecCCCCCcEEEeecCCCC-eEEEeeeceeE
Q 015018 64 FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 94 (414)
Q Consensus 64 ivHRDIKP~NILl~~~~~~~-~vkL~DFGla~ 94 (414)
+||.|+.|.||+++ ... .+-++||+.+.
T Consensus 199 iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 99999999999996 333 47899999764
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=87.21 E-value=1.1 Score=44.42 Aligned_cols=71 Identities=20% Similarity=0.242 Sum_probs=53.7
Q ss_pred EEEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 17 YNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 17 ~~~lVmE~~g~sL~--~ll~~~~~~ls~~~v~~ia~Qll~gL~yL-H~~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
..+|||-|+|..=. --++ +-.|+..+....-.|+...+.-| |++-+||.||.--|+|. ..+.|.+||...+
T Consensus 357 khvLVMsFiGd~~~aAPkLK--~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw----~~gKvw~IDVsQs 430 (531)
T KOG2269|consen 357 KHVLVMSFIGDQGLAAPKLK--NVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLW----TPGKVWVIDVSQS 430 (531)
T ss_pred cceEEEEeecCCCCCCcccc--ccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhhee----cCCceEEEechhc
Confidence 34899999964311 1222 34588888888888998888877 46789999999999999 4668999998655
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=87.18 E-value=0.48 Score=45.77 Aligned_cols=30 Identities=30% Similarity=0.482 Sum_probs=23.6
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|++|.|||++. ....+-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeC--CCCEEEEECcHhcc
Confidence 4899999999999961 13345699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.82 E-value=0.87 Score=45.00 Aligned_cols=28 Identities=29% Similarity=0.323 Sum_probs=23.0
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++||+|+.+.|||+. . .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~---d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR---D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc---C--CcEEEeCCCCC
Confidence 4689999999999993 2 47799999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=85.34 E-value=1.5 Score=43.45 Aligned_cols=29 Identities=28% Similarity=0.666 Sum_probs=24.6
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 64 ivHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
++|.|+.+.|||++ ..++.+++|||..|.
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccC
Confidence 78999999999996 234679999999874
|
|
| >KOG2464 consensus Serine/threonine kinase (haspin family) [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=84.23 E-value=2.4 Score=40.18 Aligned_cols=63 Identities=25% Similarity=0.323 Sum_probs=50.4
Q ss_pred EeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEe
Q 015018 10 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMG 77 (414)
Q Consensus 10 ~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~ 77 (414)
..+....+..++++..+..|..+ .--+..++..++.|+...+.-..+. ++.|||+.+.|||+.
T Consensus 109 ~~~~~q~~~~~~~~~~~~~l~~~-----~~~~~~~~~si~~q~~~~l~i~~~~~~~~hrdl~~gnili~ 172 (246)
T KOG2464|consen 109 FSGDAQLYLALVVEKGGLGLEHY-----KLESKNQALSIFWQLVLSLAIAEKSLGFEHRDLHLGNILIK 172 (246)
T ss_pred cccccceeeEEEEecCCccceec-----ccccHHHHHHHHHHHHHHHHHhhhhhcccccccCcCcEEEe
Confidence 33445567778888887776655 2456788999999999999998865 899999999999996
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 414 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-164 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-108 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-107 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-107 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-78 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-77 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-77 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-77 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-77 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-76 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-76 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 6e-24 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 6e-24 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 1e-23 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-22 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 4e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 414 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 0.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-171 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-168 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-166 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-160 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-150 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-148 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-15 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-15 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-15 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-15 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-14 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-14 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-13 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-12 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-12 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-12 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-11 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-11 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-11 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-11 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-11 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-10 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-10 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-10 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-10 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-10 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-10 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-10 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-10 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-10 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-10 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-10 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-10 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-09 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-09 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-09 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-09 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-09 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-09 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-09 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-09 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-09 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-09 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-09 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-09 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-08 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-08 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-08 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-08 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-08 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-08 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-08 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-08 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-08 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-08 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-08 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-08 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-08 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-08 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-08 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-08 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-08 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-08 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-08 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 9e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 9e-08 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-07 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-07 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-07 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-07 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-07 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-07 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-07 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-07 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-07 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-07 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-07 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-07 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-07 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-07 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-07 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 9e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-07 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-04 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-06 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-06 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-06 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-06 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-06 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-06 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-06 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-06 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-05 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-05 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-05 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-05 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-05 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-05 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-05 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-05 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-04 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-04 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-04 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-04 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-04 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-04 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-04 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-04 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 573 bits (1477), Expect = 0.0
Identities = 315/412 (76%), Positives = 355/412 (86%), Gaps = 4/412 (0%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYAS+N
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEALCRG
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRG 243
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV-ST 242
YPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+ S
Sbjct: 244 YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASA 303
Query: 243 PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQK 302
P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+KQK
Sbjct: 304 PPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQK 360
Query: 303 SPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPGAF 362
+P+ ND +FSK+ ++S+ N L S S R +S + ++PSR R TDASPGAF
Sbjct: 361 APVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGAF 420
Query: 363 QKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 414
++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 421 RRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-171
Identities = 139/266 (52%), Positives = 182/266 (68%), Gaps = 3/266 (1%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIP + +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 64 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
++RD+KP+NFL+G + ++IIDF LAK Y D T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241
+P E A+Y Y R L F +KPDY YL++LF DLF R+G+ FDY +DW + +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 242 TPARAIGPGAGPSSGMPPAAANVDRQ 267
+ Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-168
Identities = 146/232 (62%), Positives = 173/232 (74%), Gaps = 2/232 (0%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 64 FLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 246
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233
G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 247 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-166
Identities = 183/231 (79%), Positives = 214/231 (92%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HSK+
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS+N
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
THLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC+G
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 245
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 234
YP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-160
Identities = 68/249 (27%), Positives = 120/249 (48%), Gaps = 8/249 (3%)
Query: 4 GIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 59
G+P G+ Y +++D G L+ ++ +++ S KTVL L+ ++++ +E++
Sbjct: 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI 168
Query: 60 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
H ++H DIK N L+ +QVY++D+GLA RY H+ + GT +
Sbjct: 169 HEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEF 227
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 179
S++ H G+ SRR DLE LGY ++ +L G LPW+ K + KI ++ S+
Sbjct: 228 TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMD 287
Query: 180 LC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 236
C P E A Y + L + +KP Y L+ + G + D D ++++
Sbjct: 288 KCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENG 347
Query: 237 QSQVSTPAR 245
+ T +
Sbjct: 348 GLKAKTITK 356
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 428 bits (1103), Expect = e-150
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 10/236 (4%)
Query: 4 GIPNLRWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHS 61
IP FGV + Y LV+ LG SL+ + + LS ++VL +A ++++ +EF+H
Sbjct: 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARY 119
++H ++ +N + + +QV + +G A RY + +H+ Y E G +
Sbjct: 178 NEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS--GKHVAYVEGSRSPHEGDLEF 234
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 179
SM+ H G SRR DL+SLGY ++ +L G LPW T+ +K
Sbjct: 235 ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG 294
Query: 180 LCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 232
C + Y +L +++KP YA L+ L +
Sbjct: 295 PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 423 bits (1090), Expect = e-148
Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 15/244 (6%)
Query: 4 GIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 59
GIP G+ Y +V++ LG L+ + + TVL L +M++ +E++
Sbjct: 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFKKSTVLQLGIRMLDVLEYI 167
Query: 60 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
H ++H DIK N L+G +QVY+ D+GL+ RY H+ K GT +
Sbjct: 168 HENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF 226
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KAGTKKQKYEKISEKKVSTS 176
S++ H G+ SRR D+E LGY ++ +L G LPW+ + K + E S
Sbjct: 227 TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL 286
Query: 177 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 236
A E A + SL +D+KP+Y LK++ I G D++ K Q
Sbjct: 287 KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP-----LDFST-KGQ 340
Query: 237 QSQV 240
V
Sbjct: 341 SINV 344
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 22/146 (15%), Positives = 43/146 (29%), Gaps = 23/146 (15%)
Query: 19 VLVIDLLGPSLEDLFNFCSR------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
+L++ LE LF+ + + +L Q+I + SK +H PD
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQ 130
N + ++ + D + + YA
Sbjct: 224 NLFIM---PDGRLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATF 270
Query: 131 SRRDDLESLGYVLMY-FLRGSLPWQG 155
+ + LG + +Y LP+
Sbjct: 271 THALNAWQLG-LSIYRVWCLFLPFGL 295
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 36/163 (22%), Positives = 59/163 (36%), Gaps = 30/163 (18%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DL ++ +K + M+ V +H +H D+KP NFL+ G + +I
Sbjct: 94 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLI 149
Query: 89 DFGLAKRYRDTATHQHIPYRENKNLTGTARYAS-----------MNTHLGIEQSRRDDLE 137
DFG+A + + T + GT Y N + S + D+
Sbjct: 150 DFGIANQMQPDTTSVVK-----DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 138 SLG---YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 177
SLG Y + Y G P+Q + + K I +
Sbjct: 205 SLGCILYYMTY---GKTPFQQII--NQISKLHAIIDPNHEIEF 242
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 28/174 (16%), Positives = 53/174 (30%), Gaps = 16/174 (9%)
Query: 19 VLVIDLLGPSLEDLFNF------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
+ + +L+ + L L L Q+I + +H +H ++P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR 132
+ ++ + V++ F R E L S + +
Sbjct: 236 DIVLD---QRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 133 RDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 183
D +LG +++Y LP E I S K + + AL G
Sbjct: 293 SFDAWALG-LVIYWIWCADLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 26/161 (16%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DL ++ +K + M+ V +H +H D+KP NFL+ G + +I
Sbjct: 113 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLI 168
Query: 89 DFGLAKRYRDTATHQHIPYRENKNLTGTARYAS-----------MNTHLGIEQSRRDDLE 137
DFG+A + + T + GT Y N + S + D+
Sbjct: 169 DFGIANQMQPDTTSVVK-----DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 138 SLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 177
SLG ++Y G P+Q + + K I +
Sbjct: 224 SLG-CILYYMTYGKTPFQQII--NQISKLHAIIDPNHEIEF 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 35/160 (21%), Positives = 58/160 (36%), Gaps = 24/160 (15%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DL ++ +K + M+ V +H +H D+KP NFL+ G + +I
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLI 196
Query: 89 DFGLAKRYRDTATHQHIPYRENKNLTGTARYAS-----------MNTHLGIEQSRRDDLE 137
DFG+A + + T + G Y N + S + D+
Sbjct: 197 DFGIANQMQPDTTSVVK-----DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 138 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 177
SLG +L Y G P+Q + + K I +
Sbjct: 252 SLGCILYYMTYGKTPFQQII--NQISKLHAIIDPNHEIEF 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 47/242 (19%), Positives = 76/242 (31%), Gaps = 53/242 (21%)
Query: 31 DLFNFCSRK-----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
L+ L L++ ++ + + +HR+IKP N + +G V
Sbjct: 95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 86 Y-IIDFGLAKRYRDTATHQHIPYRENKNLT---GTARYAS--------MNTHLGIEQSRR 133
Y + DFG A+ D ++ GT Y + +
Sbjct: 155 YKLTDFGAARELED-----------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 134 DDLESLGYVLMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASY 191
DL S+G V Y GSLP++ + K+ KI K S +I + +
Sbjct: 204 VDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 192 FHYCRSLRFDDKPDYAYLKRLFRDL---FIREGFQFD----YVFD------WTILKYQQS 238
D P L R + L + + D + FD IL S
Sbjct: 263 G---------DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313
Query: 239 QV 240
Sbjct: 314 HH 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 26/180 (14%), Positives = 52/180 (28%), Gaps = 29/180 (16%)
Query: 19 VLVIDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
+ + +L+ L L L Q+I + +H +H ++P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 73 NFLMGLGRRANQVYIIDFGLAKRY-RDTATHQHIPYRENKNLTGTARYAS-----MNTHL 126
+ ++ + V++ F R + + + H
Sbjct: 241 DIVLD---QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHH 290
Query: 127 GIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 183
+ D +LG + +Y+ LP E I S K + + AL G
Sbjct: 291 PTLMTFAFDTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 43/224 (19%), Positives = 71/224 (31%), Gaps = 43/224 (19%)
Query: 31 DLFNFCSRK-----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
L+ L L++ ++ + + +HR+IKP N + +G V
Sbjct: 95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 86 Y-IIDFGLAKRYRDTATHQHIPYRENKNLT---GTARYAS--------MNTHLGIEQSRR 133
Y + DFG A+ D ++ GT Y + +
Sbjct: 155 YKLTDFGAARELED-----------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 134 DDLESLGYVLMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASY 191
DL S+G V Y GSLP++ + K+ KI K S +I + +
Sbjct: 204 VDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 192 FHYCRSLRFDDKPDYAYLKRLFRDL---FIREGFQFDYVFDWTI 232
D P L R + L + + D W
Sbjct: 263 G---------DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 12 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70
E D LV++ + GP+L + LS+ T + +Q+++ ++ H +HRDIK
Sbjct: 80 DEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138
Query: 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 130
P N L+ + I DFG+AK +T+ Q ++ GT +Y S EQ
Sbjct: 139 PQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHVLGTVQYFSP------EQ 183
Query: 131 SR------RDDLESLGYVLMY-FLRGSLPWQG 155
++ D+ S+G +++Y L G P+ G
Sbjct: 184 AKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 37/197 (18%)
Query: 6 PN-LRWFGVEGDYNV--LVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMINRV 56
PN +R++ E + ++L +L+DL + + + L Q+ + V
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 57 EFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKRYRDTATHQHIP 106
+HS +HRD+KP N L G ++ I DFGL K+ Q
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG---QSSF 185
Query: 107 YRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLK 157
N +GT+ + S N +R D+ S+G + Y++ +G P+
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHPF---- 240
Query: 158 AGTKKQKYEKISEKKVS 174
G K + I S
Sbjct: 241 -GDKYSRESNIIRGIFS 256
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 15/160 (9%)
Query: 6 PN-LRWFGVEGDYNV--LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
PN +R+F E D + I+L +L++ + L Q + + +HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 63 SFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 120
+ +HRD+KP N L M + I DFGL K+ + + GT +
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWI 193
Query: 121 S---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 155
+ ++ + D+ S G + Y++ GS P+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 11/146 (7%)
Query: 11 FGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69
FG + + L+ G L + L+ + + Q+ + ++ H+ HRD+
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAGATHRDV 160
Query: 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 129
KP+N L+ + Y++DFG+A D Q N GT Y +
Sbjct: 161 KPENILVS---ADDFAYLVDFGIASATTDEKLTQ------LGNTVGTLYYMAPERFSESH 211
Query: 130 QSRRDDLESLGYVLMYFLRGSLPWQG 155
+ R D+ +L VL L GS P+QG
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 25/135 (18%), Positives = 48/135 (35%), Gaps = 29/135 (21%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G SL+ +KL + + +++ + ++HS ++ D+KP+N ++ Q+
Sbjct: 168 GQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEEQL 220
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR-----RDDLESLG 140
+ID G R L GT + + E R D+ ++G
Sbjct: 221 KLIDLGAVSRINSFGY-----------LYGTPGFQAP------EIVRTGPTVATDIYTVG 263
Query: 141 YVLMYFLRGSLPWQG 155
L G
Sbjct: 264 RTLAALTLDLPTRNG 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 21/124 (16%)
Query: 39 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
++ K + + + F H +HRD+KP N ++ N V ++DFG+A+ D
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIAD 168
Query: 99 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSL 151
+ + + GTA+Y S EQ+R R D+ SLG ++Y L G
Sbjct: 169 SGN----SVTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEP 217
Query: 152 PWQG 155
P+ G
Sbjct: 218 PFTG 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 37/228 (16%), Positives = 75/228 (32%), Gaps = 49/228 (21%)
Query: 31 DLFNFCSRK-----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
DL + ++ L + L + + + ++H +HRD+KP+N ++ G +
Sbjct: 104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRD---DLE 137
IID G AK + T GT +Y + + +EQ + D
Sbjct: 164 KIIDLGYAKELDQ-----------GELCTEFVGTLQYLAPEL-----LEQKKYTVTVDYW 207
Query: 138 SLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 196
S G L + G P+ + ++ +K + I Y
Sbjct: 208 SFG-TLAFECITGFRPFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTG 252
Query: 197 SLRF-DDKPDYAYLKRLFRDL---FIREGFQFDYVFDWTILKYQQSQV 240
+++F P +L + +++ + T +
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 29/130 (22%), Positives = 51/130 (39%), Gaps = 14/130 (10%)
Query: 28 SLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 84
+L + K L+ +L L + +E +H+K + HRD+KP N L+G Q
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQ 172
Query: 85 VYIIDFGLAKRYRDTAT--HQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESL 139
++D G + Q + ++ T Y + + R D+ SL
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 140 G---YVLMYF 146
G Y +M+
Sbjct: 233 GCVLYAMMFG 242
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 24/136 (17%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
+L DL + + L Q++ + ++HS+ +HRD+KP N + + V
Sbjct: 99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNV 155
Query: 86 YIIDFGLAKRYRDTATHQHIP----YRENKNLT---GTARYAS--MNTHLGIEQSRRDDL 136
I DFGLAK + + + NLT GTA Y + + ++ + +
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNE 210
Query: 137 E----SLG---YVLMY 145
+ SLG + ++Y
Sbjct: 211 KIDMYSLGIIFFEMIY 226
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 45/130 (34%), Positives = 64/130 (49%), Gaps = 27/130 (20%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
++ N + + HSK +HRDIKP+N L+G A ++ I DFG + H P
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRR 164
Query: 111 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 164
+L GT Y M IE D DL SLG VL Y FL G P++ A T ++
Sbjct: 165 TDLCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQET 215
Query: 165 YEKISEKKVS 174
Y++IS + +
Sbjct: 216 YKRISRVEFT 225
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183
Query: 111 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 166
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235
Query: 167 KISEKKVS 174
K + K+ +
Sbjct: 236 KATYKEPN 243
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 10/85 (11%)
Query: 43 KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTAT 101
L + Q+ VEF+HSK +HRD+KP N F + V + DFGL
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 219
Query: 102 HQHIPYRENKNLT-----GTARYAS 121
Q + T GT Y S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 24/130 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+++ + ++H +HRD+KP+N L+ + + IIDFGL+ + +
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------- 185
Query: 111 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 164
K+ GTA Y + E D+ S G V++Y L G P+ G +
Sbjct: 186 KDKIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDI 235
Query: 165 YEKISEKKVS 174
+K+ + K +
Sbjct: 236 LKKVEKGKYT 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 21/71 (29%), Positives = 38/71 (53%), Gaps = 9/71 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+ + +H +++H D+KP+N + +R+N++ +IDFGL P +
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSV 313
Query: 111 KNLTGTARYAS 121
K TGTA +A+
Sbjct: 314 KVTTGTAEFAA 324
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 35/130 (26%), Positives = 55/130 (42%), Gaps = 27/130 (20%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
++ + + + H + +HRDIKP+N LMG ++ I DFG + H P
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRR 169
Query: 111 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 164
+ + GT Y M IE D DL G VL Y FL G P+ + + +
Sbjct: 170 RTMCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTET 220
Query: 165 YEKISEKKVS 174
+ +I +
Sbjct: 221 HRRIVNVDLK 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 29/127 (22%), Positives = 59/127 (46%), Gaps = 11/127 (8%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+ + + ++H++ HRDIKP+NFL ++ ++ ++DFGL+K + ++
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT- 233
Query: 111 KNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 167
GT + + + + D S G VL++ L G++P+ G +
Sbjct: 234 --KAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPG---VNDADTISQ 287
Query: 168 ISEKKVS 174
+ KK+
Sbjct: 288 VLNKKLC 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 23/108 (21%), Positives = 50/108 (46%), Gaps = 18/108 (16%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
V++ + + D+F + L+ + ++ Q+ ++F+HS + H DI+P+N
Sbjct: 77 VMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
+ RR++ + II+FG A++ + P + L Y +
Sbjct: 133 IIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEYYA 171
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 13/106 (12%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFV 59
+ + +VLV +L +L + N + + V+ A +M+ +E V
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 60 HSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKRYR 97
H +H DIKPDNF++G G + +ID G + +
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 32/137 (23%)
Query: 31 DLFNFCSRKLSLKTVL--MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DLF++ + K L Q++ ++ HS+ +HRDIK +N L + R +I
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLI 182
Query: 89 DFGLAKRYRDTATHQHIPYRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG- 140
DFG D GT Y+ S + + + + SLG
Sbjct: 183 DFGSGALLHDEPYT-----------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGI 227
Query: 141 --YVLMYFLRGSLPWQG 155
Y ++ G +P++
Sbjct: 228 LLYDMVC---GDIPFER 241
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 7e-10
Identities = 35/124 (28%), Positives = 49/124 (39%), Gaps = 23/124 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+I + ++HS LHRD+ N L+ R + I DFGLA +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHE 167
Query: 111 KNLT--GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 165
K+ T GT Y S + T D+ SLG + Y L G P+ T K
Sbjct: 168 KHYTLCGTPNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTL 221
Query: 166 EKIS 169
K+
Sbjct: 222 NKVV 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 24/84 (28%), Positives = 32/84 (38%), Gaps = 8/84 (9%)
Query: 43 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 102
L + Q+ VEF+HSK +HRD+KP N + V + DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEE 174
Query: 103 QHIPYRENKNLT-----GTARYAS 121
Q + GT Y S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMS 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 24/130 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-------- 195
Query: 111 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 164
K GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 196 KERLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEI 245
Query: 165 YEKISEKKVS 174
K+ + K +
Sbjct: 246 LRKVEKGKYT 255
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 27/138 (19%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
VL+++ L G +LF+ + + +S V+ Q ++ +H S +H DIKP+N
Sbjct: 124 VLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS----MNTHLGIE 129
+ ++A+ V IIDFGLA + P K T TA +A+ +G
Sbjct: 180 IMC-ETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 130 QSRRDDLESLGYVLMYFL 147
D+ ++G VL Y L
Sbjct: 231 T----DMWAIG-VLGYVL 243
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 16/121 (13%)
Query: 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 116
+++ ++ +HRD+KPDN L+ V+I DF +A + GT
Sbjct: 129 DYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQI--------TTMAGT 177
Query: 117 ARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKK 172
Y + ++ G S D SLG V Y LRG P+ + + K+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236
Query: 173 V 173
V
Sbjct: 237 V 237
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 26/85 (30%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
KL L L +Q+ V+++HSK ++RD+KP N + QV I DFGL
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 97 RDTATHQHIPYRENKNLTGTARYAS 121
++ GT RY S
Sbjct: 173 KNDGKRTRS--------KGTLRYMS 189
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 40/192 (20%), Positives = 79/192 (41%), Gaps = 13/192 (6%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
SL + K +K ++ +A Q ++++H+KS +HRD+K +N + N V I
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKI 161
Query: 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLM 144
DFGLA + + + L+G+ + + + S + D+ + G VL
Sbjct: 162 GDFGLAT-----EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 145 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 204
+ G LP+ + + Q E + +S + + P C + D++P
Sbjct: 217 ELMTGQLPYSNINN--RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
Query: 205 DYAYLKRLFRDL 216
+ + +L
Sbjct: 275 SFPRILAEIEEL 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
EG L +L GPSL+ L V + + +HS+ +H D+KP N
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQ 103
+G + + DFGL +
Sbjct: 188 IFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 28/100 (28%), Positives = 42/100 (42%), Gaps = 16/100 (16%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF--------LHRDIKPDNFLMGLG 79
SL D S L K++L LA ++ + +H++ F HRD+K N L+
Sbjct: 121 SLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--- 175
Query: 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ I D GLA ++ IP GT RY
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIP---PNTRVGTKRY 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 6/102 (5%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
+ + ++F+H+K HRD+KP+N L + + V I DF L + I E
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 111 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 147
G+A Y + + DL SLG V++Y L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 24/130 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 111 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 164
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230
Query: 165 YEKISEKKVS 174
+++ K +
Sbjct: 231 LKRVETGKYA 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 9/69 (13%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA+RY+ P +
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKL 245
Query: 111 KNLTGTARY 119
K GT +
Sbjct: 246 KVNFGTPEF 254
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 32/137 (23%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
DLF+F + + L + Q++ V H+ LHRDIK +N L + ++ +I
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLI 192
Query: 89 DFGLAKRYRDTATHQHIPYRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG- 140
DFG +DT GT Y+ + + G + SLG
Sbjct: 193 DFGSGALLKDTVYT-----------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGI 237
Query: 141 --YVLMYFLRGSLPWQG 155
Y ++ G +P++
Sbjct: 238 LLYDMVC---GDIPFEH 251
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 36/128 (28%), Positives = 54/128 (42%), Gaps = 20/128 (15%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
+++ V + H + HRD+KP+NFL + + +IDFGLA R++
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------- 165
Query: 111 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 166
+ GT Y S + G E D S G V+MY L G P+ T +
Sbjct: 166 RTKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVML 217
Query: 167 KISEKKVS 174
KI E +
Sbjct: 218 KIREGTFT 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 24/107 (22%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
+L+++ G ++F+ C + +S V+ L Q++ V ++H + +H D+KP
Sbjct: 105 ILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
N L+ + I+DFG++++ E + + GT Y
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIMGTPEY 199
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 37/151 (24%), Positives = 59/151 (39%), Gaps = 35/151 (23%)
Query: 20 LVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77
LV++ G L+ LF F R L + Q+++ V ++ K +HRDIK +N +
Sbjct: 106 LVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV-- 162
Query: 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT---GTARYA-----SMNTHLGIE 129
+ + +IDFG A K GT Y N + G E
Sbjct: 163 IAEDFT-IKLIDFGSAAYLER-----------GKLFYTFCGTIEYCAPEVLMGNPYRGPE 210
Query: 130 QSRRDDLESLG---YVLMYFLRGSLPWQGLK 157
++ SLG Y L++ P+ L+
Sbjct: 211 L----EMWSLGVTLYTLVF---EENPFCELE 234
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 13/93 (13%)
Query: 31 DLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVY 86
+LF+F ++K SL + Q+++ V ++H+K H D+KP+N ++ L + +
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIK 159
Query: 87 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
+IDFGLA D KN+ GT +
Sbjct: 160 LIDFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 19/128 (14%)
Query: 51 QMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 109
++N ++H+ K+ HRD+KP N LM + +V + DFG ++ D
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVDKKIK------- 208
Query: 110 NKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 166
GT + ++ + D+ SLG + +Y +P+ + + +
Sbjct: 209 --GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL--KISLVELFN 263
Query: 167 KISEKKVS 174
I K +
Sbjct: 264 NIRTKNIE 271
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 24/130 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-------- 205
Query: 111 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 164
++ GTA Y + E ++ D+ S G V+MY L G P+ G +
Sbjct: 206 RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---QNDQDI 255
Query: 165 YEKISEKKVS 174
+K+ + K
Sbjct: 256 IKKVEKGKYY 265
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 24/100 (24%), Positives = 41/100 (41%), Gaps = 16/100 (16%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLG 79
SL D N ++++ ++ LA + + +H + + HRD+K N L+
Sbjct: 126 SLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 180
Query: 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ I D GLA R+ I + GT RY
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRVGTKRY 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74
VL+++L+ G +LF+F + K SL Q+++ V ++HSK H D+KP+N
Sbjct: 84 VLILELVSGG----ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 75 LM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ ++ +IDFG+A + KN+ GT +
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEF--------KNIFGTPEF 177
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 19/107 (17%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74
VL+++L+ G +LF+F ++K SL + Q+++ V ++H+K H D+KP+N
Sbjct: 91 VLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 75 LMGLGRRAN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ L + + +IDFGLA D KN+ GT +
Sbjct: 147 ML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 8e-09
Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 29/128 (22%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ +++H +HRD+K N + +V I DFGLA + + Y
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK---------VEYDGE 170
Query: 111 KNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKK 162
+ GT Y S H S D+ S+G +MY L G P++ K
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLK 221
Query: 163 QKYEKISE 170
+ Y +I +
Sbjct: 222 ETYLRIKK 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 8e-09
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + ++ + R + V + Q + V F H + +HRD+KP+N L+
Sbjct: 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT-- 136
Query: 80 RRANQVYIIDFGLAKRYR---DTATHQ 103
+ + + + DFG A+ D +
Sbjct: 137 -KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 20 LVIDLLGPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76
+ +LL +L +L F + SL V A ++ ++ +H +H D+KP+N L+
Sbjct: 176 MTFELLSMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 77 GLGRRANQVYIIDFGLA 93
R + + +IDFG +
Sbjct: 234 KQQGR-SGIKVIDFGSS 249
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 17/106 (16%)
Query: 19 VLVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74
+L+++L+ G +LF+F + K SL + Q++N V ++HS H D+KP+N
Sbjct: 90 ILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 75 LMG-LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ ++ IIDFGLA + KN+ GT +
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------KNIFGTPEF 183
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 14/100 (14%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
++++ V +H +HRD+KP+N L ++ IIDFG A+ +N
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DN 163
Query: 111 KNLT---GTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147
+ L T YA+ DL SLG V++Y +
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 16/100 (16%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF--------LHRDIKPDNFLMGLG 79
SL D L + L + + + + +H + F HRD+K N L+
Sbjct: 92 SLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--- 146
Query: 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
++ Q I D GLA + + + N GT RY
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVG---NNPRVGTKRY 183
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 8 LRWF---GVEGDYNVLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHS 61
L F G G + V+V ++LG +L L + R + L V ++ Q++ ++++H
Sbjct: 92 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR 149
Query: 62 K-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLA 93
+ +H DIKP+N LM + Q+ I D G A
Sbjct: 150 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 17/49 (34%), Positives = 28/49 (57%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
QM+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 1e-08
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L+ L + C L T Q++N + + H + LHRD+KP N L+
Sbjct: 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN-- 134
Query: 80 RRANQVYIIDFGLAKRYRD---TATHQ 103
R ++ I DFGLA+ + TH+
Sbjct: 135 -REGELKIADFGLARAFGIPVRKYTHE 160
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 33/124 (26%), Positives = 53/124 (42%), Gaps = 21/124 (16%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q+++ V++ H K +HRD+K +N L L N + I DFG + +
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV-----------G 167
Query: 111 KNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 166
L G YA+ G + D+ SLG +L + GSLP+ G K+ E
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKELRE 224
Query: 167 KISE 170
++
Sbjct: 225 RVLR 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 2/71 (2%)
Query: 31 DLFNF-CSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
+LF+ +L T + QM+ V+++H +HRD+KP+N L+ + I
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 89 DFGLAKRYRDT 99
DFG +K +T
Sbjct: 285 DFGHSKILGET 295
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 3/79 (3%)
Query: 29 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
L L + K +L + + ++N + ++H LHRD+K N L+ R + +
Sbjct: 110 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLA 166
Query: 89 DFGLAKRYRDTATHQHIPY 107
DFGLA+ + Q Y
Sbjct: 167 DFGLARAFSLAKNSQPNRY 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 24/140 (17%), Positives = 50/140 (35%), Gaps = 15/140 (10%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G +L + L + +A +++ + ++H+K LH+D+K N G+ V
Sbjct: 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----V 168
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY---------ASMNTHLGIEQSRRDDL 136
I DFGL + + + G + + + S+ D+
Sbjct: 169 VITDFGLFSISGVLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226
Query: 137 ESLGYVLMYFLRGSLPWQGL 156
+LG + P++
Sbjct: 227 FALGTIWYELHAREWPFKTQ 246
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + + ++ D L + V Q+IN + F HS + +HRDIKP+N L+
Sbjct: 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS-- 158
Query: 80 RRANQVYIIDFGLAKRYR---DTATHQ 103
++ V + DFG A+ + +
Sbjct: 159 -QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 15/49 (30%), Positives = 30/49 (61%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 2e-08
Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L+ F+ C+ L + V Q++ + F HS++ LHRD+KP N L+
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN-- 135
Query: 80 RRANQVYIIDFGLAKRYRD---TATHQ 103
R ++ + +FGLA+ + + +
Sbjct: 136 -RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 18/128 (14%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
+I +E++H + +HRDIKP N L+G + I DFG++ ++ +
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKGSDALLS------ 195
Query: 111 KNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 166
N GT + + T + D+ ++G L F+ G P+ +
Sbjct: 196 -NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFMD---ERIMCLHS 250
Query: 167 KISEKKVS 174
KI + +
Sbjct: 251 KIKSQALE 258
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 29/128 (22%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ +++H +HRD+K N L V I DFGLA + + Y
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VEYDGE 196
Query: 111 KNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKK 162
+ GT Y S H S D+ S+G +MY L G P++ K
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLK 247
Query: 163 QKYEKISE 170
+ Y +I +
Sbjct: 248 ETYLRIKK 255
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 24/133 (18%), Positives = 45/133 (33%), Gaps = 22/133 (16%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGL 78
SL + + LA + + ++H+ + HRD+ N L+
Sbjct: 98 SLXKYLS--LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV-- 153
Query: 79 GRRANQVYIIDFGLAKRYRDTATHQHIPY-RENKNLTGTARY-------ASMNTHLGIEQ 130
+ I DFGL+ R + + GT RY ++N
Sbjct: 154 -KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 131 SRRDDLESLGYVL 143
++ D+ +LG +
Sbjct: 213 LKQVDMYALGLIY 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + + L+ + + L + + Q++ V H LHRD+KP N L+
Sbjct: 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-- 153
Query: 80 RRANQVYIIDFGLAKRYRD---TATHQ 103
+ + DFGLA+ + + TH+
Sbjct: 154 -SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 23/130 (17%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLVA 190
Query: 111 KNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQK 164
GT + + G D+ G V+++ L G LP + GTK++
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKERL 240
Query: 165 YEKISEKKVS 174
+E I + K
Sbjct: 241 FEGIIKGKYK 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 30/149 (20%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 14 EGDYNVLVI-DLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS--FLHRD 68
G L++ +L L + + LS TVL + Q V+ +H + +HRD
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRD-----TATHQHIPYRENKNLTGTARYAS-- 121
+K +N L+ + + DFG A + + E T Y +
Sbjct: 164 LKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
Query: 122 -MNTHLGIEQSRRDDLESLG---YVLMYF 146
++ + + D+ +LG Y+L +
Sbjct: 221 IIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 39/130 (30%), Positives = 51/130 (39%), Gaps = 19/130 (14%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 111 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 165
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 166 EKISEKKVST 175
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 16/48 (33%), Positives = 27/48 (56%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q++ + + HS +HR++KP+N L+ + V + DFGLA D
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77
LV D + LE + S L+ + ML + +E++H LHRD+KP+N L+
Sbjct: 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD 146
Query: 78 LGRRANQVYIIDFGLAKRYRD---TATHQ 103
+ + DFGLAK + THQ
Sbjct: 147 ---ENGVLKLADFGLAKSFGSPNRAYTHQ 172
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 15/96 (15%), Positives = 36/96 (37%), Gaps = 14/96 (14%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQV 85
L + + L L + +E++ +++ +HRD++ N + V
Sbjct: 107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166
Query: 86 Y--IIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
+ DFGL+++ + + L G ++
Sbjct: 167 CAKVADFGLSQQSVHSVS----------GLLGNFQW 192
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 24/72 (33%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAK 94
+ +S++ + Q+IN V F HS+ LHRD+KP N L+ + + + I DFGLA+
Sbjct: 126 NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
Query: 95 RYRD---TATHQ 103
+ TH+
Sbjct: 186 AFGIPIRQFTHE 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 22/87 (25%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV + L L+ + C +++ V + Q++ + + H + LHRD+KP N L+
Sbjct: 77 LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI--- 133
Query: 80 RRANQVYIIDFGLAKRYRD---TATHQ 103
++ + DFGLA+ T ++
Sbjct: 134 NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 21/69 (30%), Positives = 34/69 (49%), Gaps = 5/69 (7%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
L +T+ L Q + ++F+H+ +HRD+KP+N L+ V + DFGLA+ Y
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIY 170
Query: 97 RD--TATHQ 103
T
Sbjct: 171 SYQMALTPV 179
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 25/143 (17%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF----------LHRDIKPDNFLMG 77
SL D + +S + +A+ M + ++H HRDIK N L+
Sbjct: 108 SLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL- 164
Query: 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY-----ASMNTHLGIEQSR 132
+ I DFGLA ++ + + GT RY + +
Sbjct: 165 --KNNLTACIADFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 133 RDDLESLGYVLMYFLRGSLPWQG 155
R D+ ++G VL G
Sbjct: 218 RIDMYAMGLVLWELASRCTAADG 240
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 19/150 (12%)
Query: 31 DLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 89
DL N S + K +++ ++ +HS F+HRD+KPDN L+ ++ + + D
Sbjct: 155 DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLAD 211
Query: 90 FGLAKRYRDTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY 145
FG + + GT Y S + R D S+G V +Y
Sbjct: 212 FGTCMKMNKEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLY 264
Query: 146 -FLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
L G P+ A + Y KI K S
Sbjct: 265 EMLVGDTPF---YADSLVGTYSKIMNHKNS 291
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 24/133 (18%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 109
+ VE++H++ +HRD+KP N L + I DFG AK+ R E
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------E 173
Query: 110 NKNLT---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTK 161
N L TA + + D+ SLG VL+Y L G P+ T
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTP 228
Query: 162 KQKYEKISEKKVS 174
++ +I K S
Sbjct: 229 EEILARIGSGKFS 241
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 6/69 (8%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
+ L + Q++ + F HS LHRD+KP N L+ + + DFGLA+ +
Sbjct: 98 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFG 154
Query: 98 D---TATHQ 103
T TH+
Sbjct: 155 VPVRTYTHE 163
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 39/130 (30%), Positives = 51/130 (39%), Gaps = 19/130 (14%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 111 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 165
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 166 EKISEKKVST 175
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/151 (19%), Positives = 60/151 (39%), Gaps = 28/151 (18%)
Query: 29 LEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
++++ + ++ + Q+I+ +E++HS+ +H+DIKP N L L + I
Sbjct: 94 MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKI 150
Query: 88 IDFGLAKRYRDTATHQHIPYRENKNLT---GTARYAS------MNTHLGIEQSRRDDLES 138
G+A+ P+ + G+ + ++T G + D+ S
Sbjct: 151 SALGVAEALH--------PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWS 198
Query: 139 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 169
G L G P++G + +E I
Sbjct: 199 AGVTLYNITTGLYPFEG---DNIYKLFENIG 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 13/48 (27%), Positives = 25/48 (52%), Gaps = 3/48 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 13/124 (10%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
++++ +E++H K +HRD+KP+N L+ + I DFG AK +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQA-----RA 189
Query: 111 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 169
+ GTA+Y S + DL +LG ++Y + G P+ +AG + ++KI
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RAGNEYLIFQKII 245
Query: 170 EKKV 173
+ +
Sbjct: 246 KLEY 249
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 7/74 (9%)
Query: 31 DLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 86
DLF + + +L Q+ ++ VH + LHRDIK N + + V
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQ 165
Query: 87 IIDFGLAKRYRDTA 100
+ DFG+A+ T
Sbjct: 166 LGDFGIARVLNSTV 179
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 16/49 (32%), Positives = 28/49 (57%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
Q++ + + HS +HR++KP+N L+ + V + DFGLA D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 5/66 (7%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD- 98
+ +T+ + Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQ 173
Query: 99 -TATHQ 103
T
Sbjct: 174 MALTSV 179
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 9/66 (13%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 110
Q++ ++++H +HRDIK DN L + + + I DFG +KR
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------T 180
Query: 111 KNLTGT 116
+ TGT
Sbjct: 181 ETFTGT 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 16/48 (33%), Positives = 31/48 (64%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q+++ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 25/136 (18%), Positives = 50/136 (36%), Gaps = 5/136 (3%)
Query: 8 LRWF---GVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSK- 62
L F GV G + +V ++LG L + L L V + Q++ ++++H+K
Sbjct: 107 LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
+H DIKP+N L+ + + + + +R
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 123 NTHLGIEQSRRDDLES 138
+ + + DL +
Sbjct: 227 PKNAEKLKVKIADLGN 242
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 6/72 (8%)
Query: 35 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
R L L V Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+
Sbjct: 100 NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLAR 156
Query: 95 RYRD---TATHQ 103
+ T + +
Sbjct: 157 AFGIPVNTFSSE 168
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 15/44 (34%), Positives = 25/44 (56%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
+ ++++HS + HRD+KP+N L R + + DFG AK
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 14/49 (28%), Positives = 25/49 (51%), Gaps = 3/49 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPG 253
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 5/70 (7%)
Query: 31 DLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 88
+LF++ K ++ Q+I +E+ H +HRD+KP+N L L N V I
Sbjct: 94 ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIA 150
Query: 89 DFGLAKRYRD 98
DFGL+ D
Sbjct: 151 DFGLSNIMTD 160
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 15/48 (31%), Positives = 25/48 (52%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
+ ++F+HS + HRD+KP+N L + + + DFG AK
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 1/61 (1%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKR 95
+L V L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+
Sbjct: 122 PVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 96 Y 96
+
Sbjct: 182 F 182
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 15/48 (31%), Positives = 24/48 (50%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q++ V H +HR++KP+N L+ + V + DFGLA
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 8/79 (10%)
Query: 20 LVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNF 74
LV ++L +L DL NF R +SL A QM + F+ + S +H D+KP+N
Sbjct: 133 LVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 75 LMGLGRRANQVYIIDFGLA 93
L+ +R + + I+DFG +
Sbjct: 191 LLCNPKR-SAIKIVDFGSS 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 15/48 (31%), Positives = 25/48 (52%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
+ ++++HS + HRD+KP+N L R + + DFG AK
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 16/49 (32%), Positives = 25/49 (51%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
Q++ V ++H +HRD+KP+N L + I DFGL+K
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 5/91 (5%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G SL L L L Q + +E++H++ LH D+K DN L L ++
Sbjct: 134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL--LSSDGSRA 190
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLTGT 116
+ DFG A + + + + GT
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 21/155 (13%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
S + A ++I +E +H++ ++RD+KP N L+ V I D GLA +
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF 342
Query: 97 RDTATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 154
H GT Y A G+ D SLG +++ LRG P++
Sbjct: 343 SKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRGHSPFR 392
Query: 155 GLKAGTKKQKYEKISEKKV------STSIEALCRG 183
K K + V S + +L G
Sbjct: 393 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 17/97 (17%)
Query: 28 SLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRA 82
SL ++ + + + Q V ++HS K+ +HRD+KP N L L
Sbjct: 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL--LVAGG 142
Query: 83 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
+ I DFG A + T N G+A +
Sbjct: 143 TVLKICDFGTACDIQTHMT----------NNKGSAAW 169
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 26/169 (15%)
Query: 29 LEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGR 80
L + +++ L + VL + Q+ ++ H +S LHRD+KP N +
Sbjct: 94 LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--- 150
Query: 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 140
V + DFGLA+ + K GT Y S + + + D+ SLG
Sbjct: 151 GKQNVKLGDFGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 141 YVLMYFL-RGSLPWQG-----LKAGTKKQKYEKISEKKVSTSIEALCRG 183
L+Y L P+ L ++ K+ +I + S + +
Sbjct: 204 -CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 43/196 (21%), Positives = 68/196 (34%), Gaps = 41/196 (20%)
Query: 31 DLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
DL S+ ++ + +++ ++ VH ++HRDIKPDN L+ R + +
Sbjct: 147 DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRL 203
Query: 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLG 140
DFG + R T + + GT Y A D +LG
Sbjct: 204 ADFGSCLKLRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 141 YVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199
V Y G P+ A + + Y KI K S+ + G P E R
Sbjct: 258 -VFAYEMFYGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEE-------ARDF- 305
Query: 200 FDDKPDYAYLKRLFRD 215
++RL
Sbjct: 306 ---------IQRLLCP 312
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 40/236 (16%), Positives = 71/236 (30%), Gaps = 70/236 (29%)
Query: 13 VEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINR-----VEFVHSKSFLH 66
+E NVL + L F S + + ++ +I V +H S +
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 67 RDIK------PDNFLMGLGRRANQVY----IID----------FGLAKRYRDTATHQHIP 106
+ K P +L + N+ I+D L Y D + HI
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 107 YRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 165
+ HL IE R L + ++ FL +K ++
Sbjct: 479 H-----------------HLKNIEHPERMTLFRMVFLDFRFLE------------QKIRH 509
Query: 166 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIR 219
+ + + + L + Y Y D+ P Y +RL + F+
Sbjct: 510 DSTAWNASGSILNTL-----QQLKFYKPYI----CDNDPKY---ERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 28/301 (9%), Positives = 80/301 (26%), Gaps = 97/301 (32%)
Query: 16 DYNVLV----IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDI 69
+Y L+ + PS+ ++ +L + A ++R++ + L +
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-L 147
Query: 70 KPDNFL----M-GLG----------------RRANQVYIIDFGLAKRYRDTATH-QHIPY 107
+P + + G G + +++ ++ Q + Y
Sbjct: 148 RPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 108 RENKNLTGTARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF---- 146
+ + N T + ++S + H + RR ++++ F
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC 266
Query: 147 ------------------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGY 184
+ + + + K + + L
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 185 P----------TEFASYFHYCRSLRFD----------DKPDYAYLKRLFRDLFIREGFQF 224
P + + + + + D + + A +++F L + F
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPP 383
Query: 225 D 225
Sbjct: 384 S 384
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 42/153 (27%), Positives = 61/153 (39%), Gaps = 22/153 (14%)
Query: 31 DLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 87
DL S+ +L + +M+ ++ VH ++HRDIKPDN LM + +
Sbjct: 160 DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRL 216
Query: 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYV 142
DFG + + T Q + GT Y S +E + D SLG V
Sbjct: 217 ADFGSCLKLMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-V 269
Query: 143 LMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
MY L G P+ A + + Y KI K
Sbjct: 270 CMYEMLYGETPFY---AESLVETYGKIMNHKER 299
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 15/54 (27%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 104
+++ +++ HS +HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 3/48 (6%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 98
Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/91 (25%), Positives = 34/91 (37%), Gaps = 21/91 (23%)
Query: 20 LVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76
+V +LLG S D F L + +A Q+ V F+HS H D+KP+N L
Sbjct: 94 IVFELLGLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 77 ----------------GLGRRANQVYIIDFG 91
+ ++DFG
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 21/91 (23%)
Query: 20 LVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76
+ +LLG + + NF + L V +A Q+ + + F+H H D+KP+N L
Sbjct: 99 IAFELLGKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 77 ----------------GLGRRANQVYIIDFG 91
+ + + DFG
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 4/99 (4%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G +L + + + A + + + ++HS + +HRD+ N L+ V
Sbjct: 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNV 147
Query: 86 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+ DFGLA R Q R K RY +
Sbjct: 148 VVADFGLA-RLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 18/44 (40%), Positives = 26/44 (59%), Gaps = 2/44 (4%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q++ + ++HS HRDIKP N L L + + +IDFG AK
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 18/100 (18%), Positives = 38/100 (38%), Gaps = 19/100 (19%)
Query: 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQ 84
L + + +++ ++ A Q+ + ++H + +HRD+K N L+
Sbjct: 92 PLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149
Query: 85 VY-----IIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
+ I DFGLA+ + T + G +
Sbjct: 150 LSNKILKITDFGLAREWHRT---------TKMSAAGAYAW 180
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 17/47 (36%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 18/66 (27%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRE 109
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ ++A P +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 110 NKNLTG 115
+
Sbjct: 176 QSGMVE 181
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 21/79 (26%), Positives = 35/79 (44%), Gaps = 8/79 (10%)
Query: 28 SLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRAN 83
L + ++ L +TV Q+ + +E +HS+ +HRDIKP N F+
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATG 173
Query: 84 QVYIIDFGLAKRYRDTATH 102
V + D GL + + T
Sbjct: 174 VVKLGDLGLGRFFSSKTTA 192
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 21/96 (21%), Positives = 44/96 (45%), Gaps = 14/96 (14%)
Query: 28 SLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRAN 83
SL L + +L + L +A + + ++H+++ +HR++K N L+ +
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKY 176
Query: 84 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
V + DFGL++ T + +K+ GT +
Sbjct: 177 TVKVCDFGLSRLKAST-------FLSSKSAAGTPEW 205
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 20/110 (18%), Positives = 43/110 (39%), Gaps = 34/110 (30%)
Query: 20 LVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76
L+ + LGPSL ++ N+ ++ + + +++ + ++ S H D+KP+N L+
Sbjct: 113 LIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 77 ----------------------GLGRRANQVYIIDFGLAKRYRDTATHQH 104
++ + +IDFG AT +
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKS 213
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 19/44 (43%), Positives = 25/44 (56%), Gaps = 2/44 (4%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q+ V F+HS HRDIKP N L + + N + + DFG AK
Sbjct: 149 QLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLKLCDFGSAK 190
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/115 (20%), Positives = 35/115 (30%), Gaps = 30/115 (26%)
Query: 26 GPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRR 81
G SL D + R +S + L Q+ + ++HS S +H DIKP N F+
Sbjct: 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIP 154
Query: 82 ANQVYII---------------DFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
D G R G +R+ +
Sbjct: 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-----------EEGDSRFLA 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 39/127 (30%), Positives = 58/127 (45%), Gaps = 20/127 (15%)
Query: 49 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPY 107
A Q++ E++HS ++RD+KP+N L+ + + + DFG AKR + T T
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWT------ 197
Query: 108 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 166
L GT + L ++ D +LG VL+Y G P+ A Q YE
Sbjct: 198 -----LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FADQPIQIYE 248
Query: 167 KISEKKV 173
KI KV
Sbjct: 249 KIVSGKV 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 34/139 (24%), Positives = 55/139 (39%), Gaps = 26/139 (18%)
Query: 56 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 112
+E +H + ++RD+KP+N L+ G + I D GLA + T K
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHG------HIRISDLGLAVHVPEGQT--------IKG 344
Query: 113 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK-YEKISE 170
GT Y + + D +LG L+Y + G P+Q K K+++ + E
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 171 KKV----STSIEA--LCRG 183
S +A LC
Sbjct: 404 VPEEYSERFSPQARSLCSQ 422
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 31/141 (21%), Positives = 57/141 (40%), Gaps = 29/141 (20%)
Query: 56 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 112
+E +H ++ ++RD+KP+N L+ G V I D GLA + + K
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDG------NVRISDLGLAV---------ELKAGQTKT 346
Query: 113 LT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK-YEKI 168
GT + + LG E D +LG V +Y + P++ + ++ +++
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 169 SEKKV----STSIEA--LCRG 183
E+ V S + C
Sbjct: 406 LEQAVTYPDKFSPASKDFCEA 426
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 24/83 (28%), Positives = 41/83 (49%), Gaps = 8/83 (9%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV+ + DL K S + + L QM+ ++++HS +HRD+KP N +
Sbjct: 106 LVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV--- 159
Query: 80 RRAN-QVYIIDFGLAKRYRDTAT 101
+ ++ I+DFGLA+ T
Sbjct: 160 -NEDCELKILDFGLARHADAEMT 181
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 5e-05
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 38/128 (29%)
Query: 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 116
E++HSK ++RD+KP+N L L + + + I DFG AK D L GT
Sbjct: 120 EYLHSKDIIYRDLKPENIL--LDKNGH-IKITDFGFAKYVPDVT----------YTLCGT 166
Query: 117 ARYASMNTHLGIEQSRRDDLESLGY----------VLMY-FLRGSLPWQGLKAGTKKQKY 165
Y + E + + Y +L+Y L G P+ + Y
Sbjct: 167 PDY------IAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTY 212
Query: 166 EKISEKKV 173
EKI ++
Sbjct: 213 EKILNAEL 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 21/75 (28%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
+V++L+ +L +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 107 IVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 160
Query: 80 RRAN-QVYIIDFGLA 93
+++ + I+DFGLA
Sbjct: 161 -KSDCTLKILDFGLA 174
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 16/52 (30%), Positives = 30/52 (57%), Gaps = 5/52 (9%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 101
QM+ + ++H+ +HRD+KP N + + ++ I+DFGLA++ T
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N +
Sbjct: 111 LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--- 165
Query: 80 RRAN-QVYIIDFGLAKRYRDTAT 101
+ ++ I+DFGLA+ D T
Sbjct: 166 -NEDCELKILDFGLARHTADEMT 187
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 18/74 (24%), Positives = 34/74 (45%), Gaps = 3/74 (4%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
S+ D+ ++ L+ + + + +E++H +HRDIK N L+
Sbjct: 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHA 164
Query: 86 YIIDFGLAKRYRDT 99
+ DFG+A + DT
Sbjct: 165 KLADFGVAGQLTDT 178
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 19/80 (23%), Positives = 34/80 (42%), Gaps = 7/80 (8%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV++ S DL + L + + + + ++HS + +HRD+K N L+
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE- 189
Query: 80 RRANQVYIIDFG----LAKR 95
V + DFG +A
Sbjct: 190 --PGLVKLGDFGSASIMAPA 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 17/46 (36%), Positives = 23/46 (50%), Gaps = 4/46 (8%)
Query: 51 QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
Q+I + +H S HRDIKP N L + + + DFG AK
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAK 180
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 18/44 (40%), Positives = 27/44 (61%), Gaps = 5/44 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 93
Q+I ++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 19/68 (27%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 26 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 85
G +++ + R L+ + ++ QM+ + F+HSK +HRD+K N LM +
Sbjct: 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDI 156
Query: 86 YIIDFGLA 93
+ DFG++
Sbjct: 157 RLADFGVS 164
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/43 (37%), Positives = 26/43 (60%), Gaps = 2/43 (4%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93
Q++ ++++HS + LHRD+KP N + + I DFGLA
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 21/79 (26%), Positives = 33/79 (41%), Gaps = 10/79 (12%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAKRYRDTATHQHIPY 107
++ F+H +HRD+KP N L NQ V + DFGLA R ++ +I
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA-RTINSEKDTNIVN 189
Query: 108 RENKNLTGTARYASMNTHL 126
+N ++ L
Sbjct: 190 DLEENEEPGPHNKNLKKQL 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 13/44 (29%), Positives = 21/44 (47%), Gaps = 5/44 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 93
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 8/95 (8%), Positives = 23/95 (24%), Gaps = 18/95 (18%)
Query: 28 SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQ 84
SL + L + + + A M + F+H+ + + ++
Sbjct: 95 SLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--- 151
Query: 85 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
I + ++ +
Sbjct: 152 ARISMADVKFSFQSPGR------------MYAPAW 174
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 20/46 (43%), Positives = 26/46 (56%), Gaps = 9/46 (19%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 93
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 22/75 (29%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 20 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79
LV++L+ +L +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 144 LVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 197
Query: 80 RRAN-QVYIIDFGLA 93
+++ + I+DFGLA
Sbjct: 198 -KSDCTLKILDFGLA 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 27 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 86
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 87 IIDFGLAKR-YRD 98
I DFGLA+ Y+D
Sbjct: 234 ICDFGLARDIYKD 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 34/142 (23%), Positives = 52/142 (36%), Gaps = 37/142 (26%)
Query: 57 EFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---RYRDTATHQHIPYREN 110
+F+HSK ++RD+K DN L+ G + I DFG+ K
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMCKENMLGDAKTN--------- 176
Query: 111 KNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 167
T GT Y + LG + + D S G VL+Y L G P+ G +++ +
Sbjct: 177 ---TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG---QDEEELFHS 229
Query: 168 ISEKKV------STSIEALCRG 183
I + L
Sbjct: 230 IRMDNPFYPRWLEKEAKDLLVK 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 37/143 (25%)
Query: 56 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---RYRDTATHQHIPYRE 109
+ F+ SK ++RD+K DN ++ G + I DFG+ K T
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMCKENIWDGVTTK-------- 179
Query: 110 NKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 166
T GT Y + + D + G VL+Y L G P++G + + ++
Sbjct: 180 ----TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG---EDEDELFQ 231
Query: 167 KISEKKV----STSIEA--LCRG 183
I E V S S EA +C+G
Sbjct: 232 SIMEHNVAYPKSMSKEAVAICKG 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 17/37 (45%), Positives = 21/37 (56%), Gaps = 3/37 (8%)
Query: 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93
EF+HS +HRDIK DN L+G V + DFG
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFC 163
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 39/170 (22%)
Query: 31 DLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQV 85
DL + + + A ++ + F+ SK ++RD+K DN ++ G +
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HI 481
Query: 86 YIIDFGLAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLG 140
I DFG+ K T T GT Y + + D + G
Sbjct: 482 KIADFGMCKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529
Query: 141 YVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 183
VL+Y L G P++G + + ++ I E V S A+C+G
Sbjct: 530 -VLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 17/44 (38%), Positives = 27/44 (61%), Gaps = 5/44 (11%)
Query: 51 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 93
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 37/142 (26%), Positives = 58/142 (40%), Gaps = 37/142 (26%)
Query: 57 EFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---RYRDTATHQHIPYREN 110
E++HS+ ++RDIK +N ++ G + I DFGL K T
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLCKEGISDGATMK--------- 163
Query: 111 KNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 167
T GT Y + + R D LG V+MY + G LP+ ++ +E
Sbjct: 164 ---TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN---QDHERLFEL 216
Query: 168 ISEKKV----STSIEA--LCRG 183
I +++ + S EA L G
Sbjct: 217 ILMEEIRFPRTLSPEAKSLLAG 238
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 12/37 (32%), Positives = 21/37 (56%), Gaps = 3/37 (8%)
Query: 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93
++H++ +HRDIK D+ L+ +V + DFG
Sbjct: 155 AYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFC 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 30/143 (20%), Positives = 50/143 (34%), Gaps = 37/143 (25%)
Query: 56 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK---RYRDTATHQHIPYRE 109
+ F+H K ++RD+K DN L+ G + DFG+ K T
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGMCKEGICNGVTTA-------- 182
Query: 110 NKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 166
T GT Y + + D ++G VL+Y L G P++ + +E
Sbjct: 183 ----TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLCGHAPFEA---ENEDDLFE 234
Query: 167 KISEKKV------STSIEALCRG 183
I +V + +
Sbjct: 235 AILNDEVVYPTWLHEDATGILKS 257
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 15/146 (10%), Positives = 30/146 (20%), Gaps = 41/146 (28%)
Query: 11 FGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69
++V + + G SL+++ S + + + H
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 129
P + V + A
Sbjct: 156 HPSRVRVS---IDGDVVLAYPA----TMPDANP--------------------------- 181
Query: 130 QSRRDDLESLGYVLMYFLRGSLPWQG 155
+DD+ +G L L P
Sbjct: 182 ---QDDIRGIGASLYALLVNRWPLPE 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 28/129 (21%)
Query: 57 EFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 113
E +H ++RDIK +N L+ G V + DFGL+K + + +
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK--------EFVADETERAY 218
Query: 114 T--GTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-TKKQKY 165
GT Y + G +++ D SLG VLMY L G+ P+ ++ +
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG-VLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 166 EKISEKKVS 174
+I + +
Sbjct: 276 RRILKSEPP 284
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 414 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.81 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.56 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.41 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.07 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.73 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.5 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.8 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 94.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 90.11 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 87.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 83.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 82.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.44 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 80.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.31 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-70 Score=563.29 Aligned_cols=409 Identities=78% Similarity=1.251 Sum_probs=221.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.++|+.+++++.++++.||||||+|++|.++++.+.+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+..
T Consensus 62 ~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 141 (483)
T 3sv0_A 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (483)
T ss_dssp STTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG
T ss_pred CCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCC
Confidence 57899999999999999999999999999999988889999999999999999999999999999999999999965557
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.+||+|||+++.+.......++++.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+......
T Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 78999999999999888777777777777889999999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccccccC
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 241 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~~~~ 241 (414)
.+.+.++........++.++.++|.++.+||..||..+|++||++++|+++|++++...+++++..+||+..+.++.+.+
T Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~ 301 (483)
T 3sv0_A 222 KQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIA 301 (483)
T ss_dssp HHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC------
T ss_pred HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcccccccc
Confidence 99999999999989999999999999999999999999999999999999999999999999999999999887766554
Q ss_pred C-CCCCCCCCCCCCCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCCCcccccccc
Q 015018 242 T-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMMSSY 320 (414)
Q Consensus 242 ~-p~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~r~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
. |++..++...++... ++....+++++.++++.++|++.+ +|+.+++....|+++++++++.++++.++|.+++++
T Consensus 302 ~~p~~~~~~~~~~s~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (483)
T 3sv0_A 302 SAPPRAVGHGAGPSGLA-PPALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISAS 378 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCCCCCCCCCCCCCCC-CccccccccCccccccccCCcccc--cccCCcccccccccccccCCCCCCcccccccccccc
Confidence 4 333333333333333 334456777777888888888753 788889999999999999999999999999999998
Q ss_pred ccc-cCCCccccccccCCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCcccCCCcccccCcccccccccccccc
Q 015018 321 NLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLR 399 (414)
Q Consensus 321 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (414)
+++ |++++||+.++|+||++.. ++..+++++|+++++|++..+.++.||+++..+.++|+++++|++++++|||+|||
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 457 (483)
T 3sv0_A 379 NFLGRSSGSSRRPAVSSSRDVMP-IDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALK 457 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccCCccccccccccccccC-CCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhh
Confidence 877 9999999999999999865 55667778999999999878888999999999899999999999999999999999
Q ss_pred cccceeccCCCccCC
Q 015018 400 GIESLHFNNNERVHH 414 (414)
Q Consensus 400 ~~~~~~~~~~~~~~~ 414 (414)
|||+|+|++|+|+||
T Consensus 458 ~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 458 GIEGLNFDGDERVQY 472 (483)
T ss_dssp ---------------
T ss_pred hhhhcccCCchHHHH
Confidence 999999999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=353.50 Aligned_cols=209 Identities=21% Similarity=0.257 Sum_probs=173.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++++++.||||||| |++|.++++. .+.|++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 109 HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--- 184 (336)
T 4g3f_A 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS--- 184 (336)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---
T ss_pred CCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---
Confidence 799999999999999999999999 9999999985 45899999999999999999999999999999999999996
Q ss_pred CCC-eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++ .+||+|||+|+.+........ ......++||+.|||||++.+..|+.++|||||||+||||++|+.||.+....
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp TTSCCEEECCCTTCEEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred CCCCEEEEeeCCCCeEccCCCcccc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 444 699999999998754322111 11123468999999999999999999999999999999999999999886544
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
.. +.++.... .....++..+++++.+||..||..||.+||++.+|++.|...+...+
T Consensus 263 ~~---~~~i~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 263 PL---CLKIASEP--PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CC---HHHHHHSC--CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HH---HHHHHcCC--CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 33 33343332 22334567899999999999999999999999999999988886654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=350.91 Aligned_cols=213 Identities=17% Similarity=0.255 Sum_probs=179.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++++++.||||||| ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 91 HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~--- 166 (311)
T 4aw0_A 91 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN--- 166 (311)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---
Confidence 799999999999999999999999 9999999985 45899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.|||+|||+|+.+...... ....+++||+.|||||++.+..|+.++|||||||++|+|++|+.||.+. +
T Consensus 167 ~~g~vKl~DFGla~~~~~~~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~ 238 (311)
T 4aw0_A 167 EDMHIQITDFGTAKVLSPESKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---N 238 (311)
T ss_dssp TTSCEEECCCTTCEECCTTTTC-----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCCEEEEEcCCceecCCCCCc-----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---C
Confidence 7789999999999987543221 1234679999999999999999999999999999999999999999873 5
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
..+.+.+|...... ++..+++++.+||..||..||.+||+++++... ..+ ....+...++|+.+..
T Consensus 239 ~~~~~~~i~~~~~~-----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 239 EGLIFAKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLHQ 304 (311)
T ss_dssp HHHHHHHHHHTCCC-----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGGG
T ss_pred HHHHHHHHHcCCCC-----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHhcC
Confidence 56667777665543 345688999999999999999999998775321 111 1234455679988754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=347.16 Aligned_cols=204 Identities=20% Similarity=0.290 Sum_probs=165.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+ +..||||||| |++|.+++.....++++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 91 HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~--- 166 (307)
T 3omv_A 91 HVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH--- 166 (307)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---
T ss_pred CCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---
Confidence 6999999998765 4679999999 9999999986677899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+|+........ .......||+.|||||++.+. .|+.++|||||||+||||++|+.||.+..
T Consensus 167 ~~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 167 EGLTVKIGDFGLATVKSRWSGS-----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp TTEEEEECCCSSCBC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCcEEEeeccCceecccCCcc-----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 7789999999999865432211 112456899999999999754 48999999999999999999999998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
. .......+........+..+...+|+++.+||..||+.||++||++.+|.+.|+.+
T Consensus 242 ~--~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 242 N--RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp C--HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred h--HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3 22233333333333344456678999999999999999999999999999888765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.35 Aligned_cols=228 Identities=61% Similarity=1.099 Sum_probs=210.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
++|||+++++++.++++.||||||+|++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~--- 139 (330)
T 2izr_A 63 SGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG--- 139 (330)
T ss_dssp SCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---
T ss_pred CCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---
Confidence 47999999999999999999999999999999987778999999999999999999999999999999999999997
Q ss_pred CCCe-----EEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQ-----VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~-----vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+. +||+|||+++.+.......+.+++......||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 140 RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 3343 99999999998877666666666666788999999999999999999999999999999999999999999
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccc
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 232 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~ 232 (414)
.......+.+..+.........+.++..+| ++.+++..||..+|.+||++++|.+.|++++.+.++..+..+||+.
T Consensus 220 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 220 LKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred cccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 887788888888888888778888888899 9999999999999999999999999999999999999999999984
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=354.38 Aligned_cols=192 Identities=21% Similarity=0.215 Sum_probs=166.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++++++++++.||||||| |++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 82 HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-- 159 (350)
T 4b9d_A 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-- 159 (350)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC--
T ss_pred CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC--
Confidence 699999999999999999999999 99999999754 34689999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.|||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.
T Consensus 160 -~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--- 228 (350)
T 4b9d_A 160 -KDGTVQLGDFGIARVLNSTVE-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--- 228 (350)
T ss_dssp -TTCCEEECSTTEESCCCHHHH-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred -CCCCEEEcccccceeecCCcc-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---
Confidence 778999999999987644221 113457999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+.++....... +...+++++.+||..||..||++||++++++
T Consensus 229 ~~~~~~~~i~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 275 (350)
T 4b9d_A 229 SMKNLVLKIISGSFPP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275 (350)
T ss_dssp SHHHHHHHHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHcCCCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 4556666666655432 3457899999999999999999999987764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.04 Aligned_cols=204 Identities=23% Similarity=0.327 Sum_probs=174.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 68 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~------------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRD 68 (414)
+|||+++++++.+++..||||||| ||+|.+++... ...|++.+++.|+.||+.||+|||+++|||||
T Consensus 74 HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 153 (299)
T 4asz_A 74 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRD 153 (299)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCc
Confidence 799999999999999999999999 99999999753 24699999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt 148 (414)
|||+||||+ .++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||++|||++
T Consensus 154 lKp~NILl~---~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 154 LATRNCLVG---ENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp CSGGGEEEC---GGGCEEECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCHhhEEEC---CCCcEEECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 999999996 678999999999986544322 111234569999999999999999999999999999999998
Q ss_pred -CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 149 -GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 149 -G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
|+.||.+.. ..+.+..+...... ..+..+|+++.+||..||+.||++||++++|.+.|+++....
T Consensus 226 ~G~~Pf~~~~---~~~~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 226 YGKQPWYQLS---NNEVIECITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp TTCCTTTTSC---HHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 999998854 34555566554432 234678999999999999999999999999999999886543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.61 Aligned_cols=210 Identities=21% Similarity=0.306 Sum_probs=173.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++++++.||||||| |++|.+++.. .+.|++.++..|+.||+.||+|||++|||||||||+|||++
T Consensus 85 HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--- 160 (304)
T 3ubd_A 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD--- 160 (304)
T ss_dssp CTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---
T ss_pred CCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---
Confidence 799999999999999999999999 9999999985 45899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+...+... ...+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+. +
T Consensus 161 ~~g~vKl~DFGla~~~~~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~ 230 (304)
T 3ubd_A 161 EEGHIKLTDFGLSKESIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---D 230 (304)
T ss_dssp TTSCEEEESSEEEEC-----C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCCEEecccccceeccCCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---C
Confidence 778999999999986544322 124578999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 237 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~--~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~ 237 (414)
..+.+..+...... ++..+++++.+||..||+.||++||++. .+.+++++ .+...+||+.+..++
T Consensus 231 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H-------p~f~~idw~~l~~~~ 297 (304)
T 3ubd_A 231 RKETMTMILKAKLG-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH-------SFFSTIDWNKLYRRE 297 (304)
T ss_dssp HHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS-------GGGTTCCHHHHHTTC
T ss_pred HHHHHHHHHcCCCC-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC-------ccccCCCHHHHHhCC
Confidence 55666666655443 3456899999999999999999999852 23333332 233456898765443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=349.04 Aligned_cols=192 Identities=17% Similarity=0.273 Sum_probs=165.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++++++.||||||| |++|.+++.. ..|++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 130 HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--- 204 (346)
T 4fih_A 130 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT--- 204 (346)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---
Confidence 799999999999999999999999 9999999974 5799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.|||+|||+|+.+..... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+. +
T Consensus 205 ~~g~vKl~DFGla~~~~~~~~-------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~ 274 (346)
T 4fih_A 205 HDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---P 274 (346)
T ss_dssp TTCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---C
T ss_pred CCCCEEEecCcCceecCCCCC-------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---C
Confidence 778999999999998765332 124679999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... + ..+..+++++.+||..||..||++||++++++
T Consensus 275 ~~~~~~~i~~~~~~~-~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 275 PLKAMKMIRDNLPPR-L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp HHHHHHHHHHSSCCC-C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHHHHHcCCCCC-C-CccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 445555554432111 1 12346789999999999999999999987764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=344.71 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=165.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 66 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~--------------~~ls~~~v~~ia~Qll~gL~yLH~~givH 66 (414)
+|||+++++++.+++..||||||| ||+|.++++... .+|++.+++.|+.||+.||+|||+++|||
T Consensus 102 HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH 181 (329)
T 4aoj_A 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181 (329)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 799999999999999999999999 999999997432 35999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
|||||+||||+ .++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||
T Consensus 182 RDLKp~NILl~---~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 182 RDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp SCCCGGGEEEE---TTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccHhhEEEC---CCCcEEEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHH
Confidence 99999999997 788999999999987644322 1122346799999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 147 LR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 147 lt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
++ |+.||.+.. ..+.+..+...... ..+..+|+++.+||..||+.||++||++++|.+.|+.+..
T Consensus 254 lt~G~~Pf~~~~---~~~~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 254 FTYGKQPWYQLS---NTEAIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HTTSCCTTCSSC---HHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCC---HHHHHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 98 999998754 34455555544322 2346789999999999999999999999999999988763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.59 Aligned_cols=232 Identities=63% Similarity=1.051 Sum_probs=209.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec-
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG- 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~- 79 (414)
++|||++++.++.++.+.||||||+|++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 143 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN 143 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS
T ss_pred cCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCC
Confidence 4689999999999999999999999999999998777789999999999999999999999999999999999999632
Q ss_pred -CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 -RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.....+||+|||+++.+.........++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 144 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred CCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 1234599999999998877665555555566778899999999999999999999999999999999999999999877
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccc
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 232 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~ 232 (414)
....+.+..+...........++..+|+++.+++..||+.+|++||++++|.+.|++++.+.+...+..+||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 224 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred cccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 77778888887777777778888899999999999999999999999999999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.79 Aligned_cols=189 Identities=24% Similarity=0.262 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++++++++++.|||||||+++|.+++.. ..++++..+..++.||+.||+|||++||+||||||+||||+ .
T Consensus 72 HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~ 147 (275)
T 3hyh_A 72 HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---E 147 (275)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---T
T ss_pred CCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---C
Confidence 6999999999999999999999999999999975 56899999999999999999999999999999999999996 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+|+....... ..+..||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+. +
T Consensus 148 ~~~vkl~DFGla~~~~~~~~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~ 216 (275)
T 3hyh_A 148 HLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---S 216 (275)
T ss_dssp TCCEEECCSSCC-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCEEEeecCCCeecCCCCc--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---C
Confidence 78999999999987654321 235789999999999999886 58999999999999999999999773 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+...... ++..+++++.+||..||+.||++||++++++
T Consensus 217 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil 261 (275)
T 3hyh_A 217 IPVLFKNISNGVYT-----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIM 261 (275)
T ss_dssp HHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 45566666655433 3456889999999999999999999977664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=326.92 Aligned_cols=232 Identities=78% Similarity=1.391 Sum_probs=209.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.++|+.+..++.++++.||||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+..+..
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~ 143 (296)
T 4hgt_A 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp STTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGG
T ss_pred CCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCC
Confidence 45678888888999999999999999999999877788999999999999999999999999999999999999954446
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.+||+|||+++...........++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 144 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 4hgt_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh
Confidence 78899999999998877666556666666778999999999999999999999999999999999999999998776666
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.+.+..+...........++..+|+++.+++..||+.+|++||+++++.+.|++++.+.+...++.+||+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 224 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 666777777777777788888999999999999999999999999999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.40 Aligned_cols=192 Identities=17% Similarity=0.264 Sum_probs=165.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.++++. ..|++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 207 HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~--- 281 (423)
T 4fie_A 207 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT--- 281 (423)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---
T ss_pred CCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---
Confidence 799999999999999999999999 9999999974 4799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.|||+|||+|+.+..... ...+++||+.|||||++.+..|+.++|||||||++|||++|..||.+. +
T Consensus 282 ~~g~vKl~DFGla~~~~~~~~-------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~ 351 (423)
T 4fie_A 282 HDGRVKLSDFGFCAQVSKEVP-------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---P 351 (423)
T ss_dssp TTCCEEECCCTTCEECCSSCC-------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---C
T ss_pred CCCCEEEecCccceECCCCCc-------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---C
Confidence 778999999999998755332 124678999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..|....... ...+..+++++.+||..||..||++||++++|+
T Consensus 352 ~~~~~~~i~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 352 PLKAMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp HHHHHHHHHHSCCCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHHHHHHHHcCCCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 444555554432111 112356889999999999999999999987764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.60 Aligned_cols=199 Identities=18% Similarity=0.205 Sum_probs=170.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFL 65 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~giv 65 (414)
+|||+++++++.+++..||||||| +|+|.+++... ...|++.+++.|+.||+.||+|||+++||
T Consensus 88 HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii 167 (308)
T 4gt4_A 88 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV 167 (308)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 699999999999999999999999 99999999642 13599999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~e 145 (414)
||||||+||||+ .++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+|||
T Consensus 168 HRDLK~~NILl~---~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~E 239 (308)
T 4gt4_A 168 HKDLATRNVLVY---DKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239 (308)
T ss_dssp CSCCSGGGEEEC---GGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCCccccceEEC---CCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHH
Confidence 999999999996 678999999999986644322 112345689999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 146 FLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 146 llt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
|++ |..||.+.. ..+.+..+....... .+..||+++.+||..||+.||++||++.+|.+.|+.
T Consensus 240 l~t~g~~Pf~~~~---~~~~~~~i~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 240 VFSYGLQPYCGYS---NQDVVEMIRNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHTTTCCTTTTCC---HHHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhCCCCCCCCCC---HHHHHHHHHcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 998 899998854 345555555544322 356799999999999999999999999999988864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=323.69 Aligned_cols=232 Identities=78% Similarity=1.391 Sum_probs=208.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.++|+.+..++.++++.||||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+..
T Consensus 64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 143 (296)
T 3uzp_A 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp STTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG
T ss_pred CCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCC
Confidence 35678888888999999999999999999999877788999999999999999999999999999999999999964446
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
.+.+||+|||+++...........++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 3uzp_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence 78899999999998877665555555566778999999999999999999999999999999999999999998766666
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.+.+..+...........++..+|+++.+++..||+.||++||++++|.+.|++++...+...+.++||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 224 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp SSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred hhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 666777777777777778888999999999999999999999999999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=332.43 Aligned_cols=191 Identities=18% Similarity=0.271 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NI 74 (414)
+|||+++++++.+ +++.||||||| |++|.++++. ...+++..+..|+.||+.||+|||+++ ||||||||+||
T Consensus 84 HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NI 162 (290)
T 3fpq_A 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp CTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGE
T ss_pred CCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhe
Confidence 7999999999875 45789999999 9999999985 568999999999999999999999998 99999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
||+ ..++.+||+|||+|+...... ..+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.
T Consensus 163 Ll~--~~~g~vKl~DFGla~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 163 FIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp EES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eEE--CCCCCEEEEeCcCCEeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 995 246799999999997433221 235689999999999876 59999999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.. ...+.+..+....... .+...+++++.+||..||..||++||++++++
T Consensus 231 ~~~--~~~~~~~~i~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 231 ECQ--NAAQIYRRVTSGVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TCS--SHHHHHHHHTTTCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCC--cHHHHHHHHHcCCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 643 3344445554433222 23456788999999999999999999987764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.24 Aligned_cols=233 Identities=28% Similarity=0.552 Sum_probs=186.7
Q ss_pred CCCCcEEEEeeEeC----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++++.+. .+.||||||+|++|.+++......+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 107 YLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186 (364)
T ss_dssp CCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence 69999999998875 67899999999999999987778899999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+ ..+.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 187 ~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YK-NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SS-CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cC-CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 32 46789999999999876544332222222345679999999999999999999999999999999999999998643
Q ss_pred ccchHHHHHHHH-hhhccchHHHhh--cCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 158 AGTKKQKYEKIS-EKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 158 ~~~~~~~~~~i~-~~~~~~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
............ .......+.... ..+|.++.+++..||..+|++||++++|.+.|++++...++..+..+||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 322211111111 111111111111 67899999999999999999999999999999999999999999999999765
Q ss_pred c
Q 015018 235 Y 235 (414)
Q Consensus 235 ~ 235 (414)
.
T Consensus 346 ~ 346 (364)
T 3op5_A 346 N 346 (364)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=339.63 Aligned_cols=205 Identities=19% Similarity=0.270 Sum_probs=170.3
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
+|||+++++++.+ ++..||||||| ||+|.++++.. ...+++.+++.|+.||+.||+|||+++|
T Consensus 127 hpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~i 206 (353)
T 4ase_A 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 206 (353)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCe
Confidence 4899999998866 46789999999 99999999743 2348999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
|||||||+||||+ .++.+||+|||+|+.+..... +.......||+.|||||++.+..|+.++|||||||+||
T Consensus 207 iHRDLK~~NILl~---~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 207 IHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 278 (353)
T ss_dssp CCSCCSGGGEEEC---GGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ecCccCccceeeC---CCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHH
Confidence 9999999999996 678999999999987644322 11234567999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
||++ |..||.+.... ......+...... ..+..+|+++.++|..||+.||++||++.+|.+.|+++++..
T Consensus 279 El~t~G~~Pf~~~~~~--~~~~~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 279 EIFSLGASPYPGVKID--EEFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHTTTSCCSSTTCCCS--HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCCCCHH--HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 9998 99999886432 2223333333221 234568999999999999999999999999999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=325.16 Aligned_cols=213 Identities=20% Similarity=0.220 Sum_probs=161.8
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecC
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRD 68 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~--------givHRD 68 (414)
+|||+++++++.+++ ..||||||| |++|.++++. ..+++..++.|+.|++.||+|||++ +|||||
T Consensus 56 HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred CCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 699999999998754 679999999 9999999984 5799999999999999999999987 999999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC------CCCchhHHHHHHHH
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYV 142 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~~~DvwSlGvv 142 (414)
|||+||||+ .++.+||+|||+|+.......... .......||+.|||||++.+. .++.++|||||||+
T Consensus 134 lKp~NILl~---~~~~~Ki~DFGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 134 LKSKNILVK---KNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp CCGGGEEEC---TTSCEEECCCTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CCcccEEEC---CCCCEEEEeCCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence 999999996 778999999999987755332111 112346899999999999865 35779999999999
Q ss_pred HHHHHhCCCCCC----------CCCcc--chHHHHHHHHhhhccchHHHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 143 LMYFLRGSLPWQ----------GLKAG--TKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 143 l~elltG~~Pf~----------~~~~~--~~~~~~~~i~~~~~~~~~~~l~~--~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
||||++|..||. +.... ...+....+........++..+. .++..+.+|+..||+.||++||++.+
T Consensus 208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 999999976653 22211 22233333333333322222222 23467899999999999999999999
Q ss_pred HHHHHHHHHHHhCC
Q 015018 209 LKRLFRDLFIREGF 222 (414)
Q Consensus 209 l~~~l~~~~~~~~~ 222 (414)
|.+.|+++...++.
T Consensus 288 i~~~L~~l~~~~~i 301 (303)
T 3hmm_A 288 IKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHHHC---
T ss_pred HHHHHHHHHHHcCC
Confidence 99999998765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=346.15 Aligned_cols=210 Identities=22% Similarity=0.293 Sum_probs=177.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.+++.++.||||||| ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 251 HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld--- 326 (689)
T 3v5w_A 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--- 326 (689)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---
T ss_pred CCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---
Confidence 699999999999999999999999 9999999985 45899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.|||+|||+|+.+..... .+.+||+.|||||++. +..|+.++|||||||+||||++|..||.+....
T Consensus 327 ~~G~vKL~DFGlA~~~~~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 327 EHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp TTSCEEECCCTTCEECSSCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred CCCCEEecccceeeecCCCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 788999999999998754322 4579999999999996 567999999999999999999999999876555
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-----~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... ++..+++++.+||..||..||.+|++ +++|+ ...+...+||+.+.
T Consensus 398 ~~~~i~~~i~~~~~~-----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~----------~HpfF~~idW~~l~ 462 (689)
T 3v5w_A 398 DKHEIDRMTLTMAVE-----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMVF 462 (689)
T ss_dssp CHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT----------TSGGGTTCCHHHHH
T ss_pred HHHHHHHhhcCCCCC-----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh----------cCccccCCCHHHHH
Confidence 555555555444332 34578899999999999999999997 34442 23455678999876
Q ss_pred ccccc
Q 015018 235 YQQSQ 239 (414)
Q Consensus 235 ~~~~~ 239 (414)
.++.+
T Consensus 463 ~~~~~ 467 (689)
T 3v5w_A 463 LQKYP 467 (689)
T ss_dssp TTCSC
T ss_pred cCCCC
Confidence 54443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=318.52 Aligned_cols=202 Identities=20% Similarity=0.246 Sum_probs=155.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++.+++.++.||||||| |++|.++++ .+++.++..|+.||+.||+|||++|||||||||+||||+
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~-- 151 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN-- 151 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--
Confidence 4799999999999999999999999 899999985 599999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccc---------------------cccccCCCCCCccccchhhhcCCC-CCchhHHH
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHI---------------------PYRENKNLTGTARYASMNTHLGIE-QSRRDDLE 137 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~---------------------~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~Dvw 137 (414)
...+.+||+|||+|+...+....... ........+||+.|+|||++.+.. |+.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 34479999999999876543221100 001123468999999999998764 89999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhc------------------------------------c-------
Q 015018 138 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------------------S------- 174 (414)
Q Consensus 138 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------------------~------- 174 (414)
|+||++|||++|+.||..... ..+.+..|....- .
T Consensus 232 SlG~il~ell~G~~Pf~~~~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~ 309 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLT 309 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------
T ss_pred hhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccc
Confidence 999999999999999965432 2222222211000 0
Q ss_pred ------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 175 ------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 175 ------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
......+..+++++.+||..||..||.+|+++++++
T Consensus 310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 000012345788999999999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=323.33 Aligned_cols=199 Identities=19% Similarity=0.223 Sum_probs=159.2
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.. .++.|||||||+++|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||
T Consensus 112 HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl 190 (398)
T 4b99_A 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL 190 (398)
T ss_dssp CTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccc
Confidence 6999999998764 467899999998889999974 668999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+|+.+....... .....+++||+.|||||++.+.. ++.++||||+||++|||++|+.||.
T Consensus 191 ~~---~~~~~Ki~DFGla~~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 191 VN---ENCELKIGDFGMARGLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp EC---TTCCEEECCCTTCBCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cC---CCCCEEEeecceeeecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 96 77899999999998764432111 11234679999999999998864 6899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+... .+.+..|..... ......+..++++++.+||..||..||.+||++++
T Consensus 265 g~~~---~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 265 GKNY---VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp CSSH---HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCH---HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 8543 333333332211 11233445567899999999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 342 ~L 343 (398)
T 4b99_A 342 AL 343 (398)
T ss_dssp HT
T ss_pred Hh
Confidence 53
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=310.57 Aligned_cols=197 Identities=23% Similarity=0.288 Sum_probs=144.0
Q ss_pred CCCCcEEEEeeEeCC------------EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015018 2 AAGIPNLRWFGVEGD------------YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLH 66 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------------~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givH 66 (414)
+|||+++++.+.+.+ +.||||||| |++|.++++... .......++.|+.||+.||+|||++||||
T Consensus 62 HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiH 141 (299)
T 4g31_A 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMH 141 (299)
T ss_dssp CTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCcc
Confidence 799999999987644 579999999 999999998432 13556778999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccc-----cccccCCCCCCccccchhhhcCCCCCchhHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 141 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGv 141 (414)
|||||+||||+ .++.+||+|||+|+.+......... ......+.+||+.|||||++.+..|+.++|||||||
T Consensus 142 RDlKp~NILl~---~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 218 (299)
T 4g31_A 142 RDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGL 218 (299)
T ss_dssp CCCCGGGEEEC---TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHH
T ss_pred ccCcHHHeEEC---CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHH
Confidence 99999999996 6789999999999877553321110 011223568999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 142 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 142 vl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
++|||++ ||.+.. .....+..+....... .....+++..+||..||+.||.+||++.+++
T Consensus 219 ilyell~---Pf~~~~--~~~~~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 219 ILFELLY---PFSTQM--ERVRTLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHHHHS---CCSSHH--HHHHHHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcc---CCCCcc--HHHHHHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 9999996 885421 1222333333333322 2223346678899999999999999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.35 Aligned_cols=196 Identities=18% Similarity=0.256 Sum_probs=168.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.++++++.||||||| |++|.+++......|++.++..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 213 hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~- 291 (573)
T 3uto_A 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK- 291 (573)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-
T ss_pred CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-
Confidence 799999999999999999999999 999999997556689999999999999999999999999999999999999622
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+|+.+..... ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~~--------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~ 360 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---N 360 (573)
T ss_dssp SCCCEEECCCSSCEECCTTSE--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---S
T ss_pred CCCCEEEeeccceeEccCCCc--------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---C
Confidence 347899999999998755332 13468999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..|........ ...+..+++++.+||..||..||.+||++++++
T Consensus 361 ~~~~~~~i~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 361 DDETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp HHHHHHHHHTTCCCCC-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 4556666665443322 234567899999999999999999999987764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.79 Aligned_cols=228 Identities=25% Similarity=0.444 Sum_probs=182.1
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.++|+++++++.. +.+.||||||+|++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~-- 193 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD-- 193 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE--
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc--
Confidence 3567888999987 7899999999999999999864 36899999999999999999999999999999999999997
Q ss_pred CCCC--eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRAN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 194 -~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 -PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp -TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred -CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 555 89999999998765533222111122244689999999999999999999999999999999999999998754
Q ss_pred ccchHHHHHHHH--hhhccchHHH--hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 158 AGTKKQKYEKIS--EKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 158 ~~~~~~~~~~i~--~~~~~~~~~~--l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
... ........ .......... ....+++++.+++..||..||.+||++++|.+.|++++...+...+.++||+..
T Consensus 273 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 351 (352)
T 2jii_A 273 PNT-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV 351 (352)
T ss_dssp TCH-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred cCH-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence 221 11111111 1111110000 013568999999999999999999999999999999999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.40 Aligned_cols=214 Identities=29% Similarity=0.526 Sum_probs=168.7
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||+++++++.+ +.+.||||||+|++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184 (345)
T ss_dssp SCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence 36999999999998 7899999999999999999753 389999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+.+ ..+.+||+|||+++.+..................||..|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 185 ~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 185 GYK-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp ESS-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred ccC-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 732 1238999999999987653322111112224568999999999999999999999999999999999999999653
Q ss_pred Cccch-HHHHHHHHhhhccchHHHhhc--CCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 157 KAGTK-KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 157 ~~~~~-~~~~~~i~~~~~~~~~~~l~~--~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
..... ...............+..... .+|+++.++|..||..+|++||++++|.+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 22111 111111112222222223332 7899999999999999999999999999988764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=299.61 Aligned_cols=205 Identities=16% Similarity=0.268 Sum_probs=172.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++.+++..||||||+ |++|.+++.... ..+++.+++.++.||+.||+|||++||
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 224 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3799999999999999999999999 899999997543 358999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+||||+ .++.+||+|||+++.+..... +.......+|+.|+|||++.+..++.++|||||||++|
T Consensus 225 vHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 225 IHRDLAARNVLVT---ENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp ECSCCCGGGEEEC---TTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred eccccchhhEEEC---CCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999999999996 778999999999987654332 11223457789999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
||++ |..||.+..... .+..+...... ..+..++.++.++|..||..+|++||++.+|.+.|+.++...
T Consensus 297 ellt~g~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEE---LFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHTTSCCSSTTCCGGG---HHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHH---HHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999 999998854332 23333332221 234568899999999999999999999999999999988643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=301.73 Aligned_cols=215 Identities=18% Similarity=0.258 Sum_probs=173.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++++++++++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~-- 187 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-- 187 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC--
Confidence 3799999999999999999999999 9999999875 46899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA- 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~- 158 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 188 -~~g~ikL~DFGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~ 259 (396)
T 4dc2_A 188 -SEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259 (396)
T ss_dssp -TTSCEEECCCTTCBCCCCTTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-
T ss_pred -CCCCEEEeecceeeecccCCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccc
Confidence 778999999999975332221 22457899999999999999999999999999999999999999975422
Q ss_pred -----cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH---HHHHHHHHHHHHhCCCCCCcccc
Q 015018 159 -----GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDW 230 (414)
Q Consensus 159 -----~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~---~l~~~l~~~~~~~~~~~d~~~~w 230 (414)
......+..+...... ++..++.++.+||..||..||.+||++. .+.+++.+ .+...++|
T Consensus 260 ~~~~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H-------pff~~i~w 327 (396)
T 4dc2_A 260 DNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDW 327 (396)
T ss_dssp -----CCHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS-------TTTTTCCH
T ss_pred cccchhhHHHHHHHHhccccC-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC-------ccccCCCH
Confidence 1222334444443332 3456889999999999999999999862 34444433 34456799
Q ss_pred cccccccc
Q 015018 231 TILKYQQS 238 (414)
Q Consensus 231 ~~~~~~~~ 238 (414)
+.+..++.
T Consensus 328 ~~l~~~~~ 335 (396)
T 4dc2_A 328 DMMEQKQV 335 (396)
T ss_dssp HHHHTTCS
T ss_pred HHHHcCCC
Confidence 88765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=290.16 Aligned_cols=204 Identities=23% Similarity=0.362 Sum_probs=167.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 70 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~--- 145 (294)
T 4eqm_A 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID--- 145 (294)
T ss_dssp BTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred CCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---
Confidence 699999999999999999999999 8999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 146 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--- 216 (294)
T 4eqm_A 146 SNKTLKIFDFGIAKALSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--- 216 (294)
T ss_dssp TTSCEEECCCSSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---
T ss_pred CCCCEEEEeCCCccccccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 778999999999975543221 11234679999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 218 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-~~~~l~~~l~~~~~ 218 (414)
......+............+...+|+++.++|..||..||.+|| +++++.+.|+.++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 23333333344444444556678999999999999999999999 88888888876653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=288.47 Aligned_cols=208 Identities=16% Similarity=0.227 Sum_probs=168.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.++++.....+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 66 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~--- 142 (310)
T 3s95_A 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR--- 142 (310)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---
T ss_pred CcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---
Confidence 699999999999999999999999 9999999987778899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccc-------cccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.++.+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~ 222 (310)
T 3s95_A 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222 (310)
T ss_dssp TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCC
Confidence 7788999999999876543321100 000112568999999999999999999999999999999999999999
Q ss_pred CCCCccchHH--HHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 154 QGLKAGTKKQ--KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 154 ~~~~~~~~~~--~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.......... ...... ...+...+|+++.+++..||+.||++||++.+|.+.|+.+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 223 PDYLPRTMDFGLNVRGFL-------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TTTSCBCTTSSBCHHHHH-------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhhHHHHhhhhhccc-------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 7643321110 001101 1112457889999999999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=288.14 Aligned_cols=193 Identities=20% Similarity=0.306 Sum_probs=161.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..||||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-- 150 (297)
T 3fxz_A 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-- 150 (297)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC--
Confidence 3799999999999999999999999 9999999984 4799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 151 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 221 (297)
T 3fxz_A 151 -MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP- 221 (297)
T ss_dssp -TTCCEEECCCTTCEECCSTTC-------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -CCCCEEEeeCCCceecCCccc-------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 678999999999987654332 12356899999999999999999999999999999999999999987532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+....... ......++.++.++|..||..||++||++++++
T Consensus 222 --~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 222 --LRALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp --HHHHHHHHHHCSCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --HHHHHHHHhCCCCC--CCCccccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 22222222221111 012345789999999999999999999987774
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.01 Aligned_cols=211 Identities=19% Similarity=0.239 Sum_probs=169.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++++.++.||||||+ |++|.+++.. .+.+++..+..|+.||+.||+|||++||+||||||+||||+
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-- 158 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD-- 158 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC--
Confidence 3799999999999999999999999 9999999975 46899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 159 -~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--- 227 (353)
T 3txo_A 159 -HEGHCKLADFGMCKEGICNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--- 227 (353)
T ss_dssp -TTSCEEECCCTTCBCSCC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCCEEEccccceeecccCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---
Confidence 778999999999975332221 124568999999999999989999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH---HHHHHHHHHHHhCCCCCCcccccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQ 236 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~---l~~~l~~~~~~~~~~~d~~~~w~~~~~~ 236 (414)
+..+.+..+...... +...+++++.++|..||..||.+||++.. ..+++++ .+...++|..+...
T Consensus 228 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h-------p~f~~~~w~~l~~~ 295 (353)
T 3txo_A 228 NEDDLFEAILNDEVV-----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH-------PFFKEIDWAQLNHR 295 (353)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS-------GGGTTCCHHHHHTT
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC-------CcccCCCHHHHhcC
Confidence 445566666655443 23457899999999999999999999711 1222322 33455689876544
Q ss_pred c
Q 015018 237 Q 237 (414)
Q Consensus 237 ~ 237 (414)
+
T Consensus 296 ~ 296 (353)
T 3txo_A 296 Q 296 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=292.45 Aligned_cols=203 Identities=15% Similarity=0.245 Sum_probs=169.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--- 185 (325)
T 3kul_A 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD--- 185 (325)
T ss_dssp CTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred CCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---
Confidence 699999999999999999999999 9999999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+....... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~- 260 (325)
T 3kul_A 186 SNLVCKVSDFGLSRVLEDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN- 260 (325)
T ss_dssp TTCCEEECCCSSCEECC----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-
T ss_pred CCCCEEECCCCcccccccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 67899999999998775532211 11223456889999999999999999999999999999998 9999987533
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+.+..+...... .....+|.++.++|..||..||++||++.+|.+.|+.++.
T Consensus 261 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 261 --RDVISSVEEGYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3333433333221 1235689999999999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=292.19 Aligned_cols=206 Identities=19% Similarity=0.276 Sum_probs=170.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+++.++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 63 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 139 (337)
T 1o6l_A 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-- 139 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC--
Confidence 3799999999999999999999999 9999999875 45899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 140 -~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--- 208 (337)
T 1o6l_A 140 -KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--- 208 (337)
T ss_dssp -TTSCEEECCCTTCBCSCCTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCCEEEeeccchhhcccCCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---
Confidence 778999999999975433221 124568999999999999999999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... ++..+++++.++|..||..||.+|| ++++|+ ++ .+...++|..+.
T Consensus 209 ~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~---~h-------~~f~~~~~~~~~ 273 (337)
T 1o6l_A 209 DHERLFELILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM---EH-------RFFLSINWQDVV 273 (337)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH---TS-------GGGTTCCHHHHH
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH---cC-------CCcCCCCHHHHH
Confidence 344455555544332 3456889999999999999999999 665553 22 334456888764
Q ss_pred c
Q 015018 235 Y 235 (414)
Q Consensus 235 ~ 235 (414)
.
T Consensus 274 ~ 274 (337)
T 1o6l_A 274 Q 274 (337)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.13 Aligned_cols=211 Identities=18% Similarity=0.238 Sum_probs=173.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|+|++++..+++.++.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~--- 155 (353)
T 2i0e_A 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--- 155 (353)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---
T ss_pred CCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---
Confidence 699999999999999999999999 9999999975 35799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+. +
T Consensus 156 ~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~ 225 (353)
T 2i0e_A 156 SEGHIKIADFGMCKENIWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---D 225 (353)
T ss_dssp TTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCcEEEEeCCcccccccCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---C
Confidence 778999999999975432221 124578999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCcccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~--~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~ 238 (414)
..+.+..+...... ++..++.++.++|..||..||.+||++. .+.+++++ .+...++|+.+..++.
T Consensus 226 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h-------~~f~~~~w~~l~~~~~ 293 (353)
T 2i0e_A 226 EDELFQSIMEHNVA-----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH-------AFFRYIDWEKLERKEI 293 (353)
T ss_dssp HHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS-------GGGTTCCHHHHHTTCS
T ss_pred HHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC-------ccccCCCHHHHHhCCC
Confidence 45566666654432 3456889999999999999999999641 23333332 3344578987754433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=297.91 Aligned_cols=211 Identities=19% Similarity=0.245 Sum_probs=174.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+++.++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+
T Consensus 97 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-- 173 (373)
T 2r5t_A 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-- 173 (373)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--
T ss_pred CCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC--
Confidence 4799999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 174 -~~g~ikL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--- 242 (373)
T 2r5t_A 174 -SQGHIVLTDFGLCKENIEHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--- 242 (373)
T ss_dssp -TTSCEEECCCCBCGGGBCCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred -CCCCEEEeeCccccccccCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---
Confidence 778999999999975332211 124578999999999999999999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-HHHHHHHHHHHhCCCCCCccccccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILKYQQ 237 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~-l~~~l~~~~~~~~~~~d~~~~w~~~~~~~ 237 (414)
+..+.+..+...... +...++.++.++|..||..||.+||+..+ +.+++. ..+...++|+.+..++
T Consensus 243 ~~~~~~~~i~~~~~~-----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~-------h~~f~~~~w~~l~~~~ 309 (373)
T 2r5t_A 243 NTAEMYDNILNKPLQ-----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS-------HVFFSLINWDDLINKK 309 (373)
T ss_dssp BHHHHHHHHHHSCCC-----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT-------SGGGTTCCHHHHHTTC
T ss_pred CHHHHHHHHHhcccC-----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC-------CccccCCCHHHHHhCC
Confidence 445566666654432 34568899999999999999999998642 223322 2344567898765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.82 Aligned_cols=204 Identities=20% Similarity=0.288 Sum_probs=172.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.++++.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 175 (350)
T 1rdq_E 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-- 175 (350)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC--
Confidence 4799999999999999999999999 9999999975 35799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 176 -~~g~~kL~DFg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--- 241 (350)
T 1rdq_E 176 -QQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--- 241 (350)
T ss_dssp -TTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCCEEEcccccceeccCCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---
Confidence 77899999999998764421 3468999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-----~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... ++..++.++.++|..||..||.+||+ +++|+ . ..+....+|..+.
T Consensus 242 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~---~-------h~~f~~~~w~~~~ 306 (350)
T 1rdq_E 242 QPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---N-------HKWFATTDWIAIY 306 (350)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---T-------SGGGTTCCHHHHH
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH---h-------CcCcCCCCHHHHh
Confidence 445566666655432 34568899999999999999999997 44443 2 2344567898765
Q ss_pred cc
Q 015018 235 YQ 236 (414)
Q Consensus 235 ~~ 236 (414)
..
T Consensus 307 ~~ 308 (350)
T 1rdq_E 307 QR 308 (350)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=287.32 Aligned_cols=204 Identities=20% Similarity=0.284 Sum_probs=171.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++.+.+.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 64 ~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 140 (318)
T 1fot_A 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-- 140 (318)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--
T ss_pred CCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc--
Confidence 3799999999999999999999999 8999999985 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus 141 -~~g~~kL~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--- 206 (318)
T 1fot_A 141 -KNGHIKITDFGFAKYVPDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--- 206 (318)
T ss_dssp -TTSCEEECCCSSCEECSSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred -CCCCEEEeecCcceecCCc----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---
Confidence 7789999999999875432 13468999999999999999999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... +...++.++.++|..|+..||.+|| ++++|+ . ..+...++|+.+.
T Consensus 207 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~---~-------hp~f~~~~~~~~~ 271 (318)
T 1fot_A 207 NTMKTYEKILNAELR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK---N-------HPWFKEVVWEKLL 271 (318)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH---T-------SGGGSSCCHHHHH
T ss_pred CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh---c-------CccccCCCHHHHH
Confidence 445556666554432 2356789999999999999999999 555443 2 2334567888765
Q ss_pred cc
Q 015018 235 YQ 236 (414)
Q Consensus 235 ~~ 236 (414)
.+
T Consensus 272 ~~ 273 (318)
T 1fot_A 272 SR 273 (318)
T ss_dssp TT
T ss_pred hC
Confidence 43
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.74 Aligned_cols=210 Identities=22% Similarity=0.334 Sum_probs=170.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++++++++++.||||||+ |++|.+++...+..+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 120 hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld--- 196 (412)
T 2vd5_A 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD--- 196 (412)
T ss_dssp TTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---
Confidence 689999999999999999999999 9999999987667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-------CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
..+.+||+|||+++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 197 ~~g~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 197 RCGHIRLADFGSCLKLRADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp TTSCEEECCCTTCEECCTTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCEEEeechhheeccCCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 7789999999999876543321 123468999999999998 356899999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC---CHHHHHHHHHHHHHHhCCCCCCcccc
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRLFRDLFIREGFQFDYVFDW 230 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP---~~~~l~~~l~~~~~~~~~~~d~~~~w 230 (414)
.+. +..+.+.++.........+.+...+++++.+||..||. +|.+|+ ++++|+ . ..+...++|
T Consensus 271 ~~~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~---~-------Hpff~~i~w 336 (412)
T 2vd5_A 271 YAD---STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR---T-------HPFFFGLDW 336 (412)
T ss_dssp CCS---SHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH---T-------SGGGTTCCS
T ss_pred CCC---CHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh---c-------CCCcCCCCH
Confidence 874 44555666654332222223345789999999999998 999985 655553 2 233456789
Q ss_pred cccc
Q 015018 231 TILK 234 (414)
Q Consensus 231 ~~~~ 234 (414)
+.+.
T Consensus 337 ~~l~ 340 (412)
T 2vd5_A 337 DGLR 340 (412)
T ss_dssp TTST
T ss_pred HHHh
Confidence 8764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.18 Aligned_cols=211 Identities=22% Similarity=0.286 Sum_probs=173.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++......+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 133 hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~--- 209 (437)
T 4aw2_A 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD--- 209 (437)
T ss_dssp TTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---
Confidence 699999999999999999999999 9999999986567899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.+||+|||+++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+
T Consensus 210 ~~g~vkL~DFGla~~~~~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLMEDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp TTSCEEECCCTTCEECCTTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCEEEcchhhhhhcccCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 7789999999999876543321 123468999999999997 45689999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~--RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
. +..+.+.++........++..+..+++++.+||..|+..++++ |++++++++ ..+...++|+.+
T Consensus 284 ~---~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l 350 (437)
T 4aw2_A 284 E---SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNI 350 (437)
T ss_dssp S---SHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTG
T ss_pred C---ChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHH
Confidence 4 4455566665433222222333468899999999999888777 888766542 234456789877
Q ss_pred c
Q 015018 234 K 234 (414)
Q Consensus 234 ~ 234 (414)
.
T Consensus 351 ~ 351 (437)
T 4aw2_A 351 R 351 (437)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=289.93 Aligned_cols=201 Identities=20% Similarity=0.287 Sum_probs=160.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~--~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NILl 76 (414)
+|||+++++++.+.+..||||||+ |++|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 93 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll 172 (309)
T 3p86_A 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172 (309)
T ss_dssp CTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE
T ss_pred CCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE
Confidence 699999999999999999999999 8999999974321 3999999999999999999999999 9999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ .++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 173 ~---~~~~~kL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 173 D---KKYTVKVCDFGLSRLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp C---TTCCEEECCCC------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred e---CCCcEEECCCCCCcccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6 678999999999975443221 123468999999999999999999999999999999999999999875
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.. .+.+..+...... ..++..+++++.++|..||..+|.+||++++|.+.|+.++.
T Consensus 243 ~~---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 243 NP---AQVVAAVGFKCKR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CH---HHHHHHHHHSCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CH---HHHHHHHHhcCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33 3333333222111 12346789999999999999999999999999999998874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=284.01 Aligned_cols=203 Identities=19% Similarity=0.271 Sum_probs=159.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++. ++..||||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 74 ~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 150 (281)
T 1mp8_A 74 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-- 150 (281)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC--
Confidence 3799999999874 55679999999 8899999987666899999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 151 -~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 151 -SNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp -ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred -CCCCEEECccccccccCcccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 568999999999987654321 11223467889999999999999999999999999999996 9999988654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.. .+..+...... .+...+|+++.+++..||..+|++||++.+|.+.|++++...
T Consensus 224 ~~---~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 224 ND---VIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp GG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---HHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 33 23333332221 234578999999999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.28 Aligned_cols=213 Identities=17% Similarity=0.257 Sum_probs=171.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++++++..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 144 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-- 144 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC--
Confidence 3799999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA- 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~- 158 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 145 -~~g~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 216 (345)
T 3a8x_A 145 -SEGHIKLTDYGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216 (345)
T ss_dssp -TTSCEEECCGGGCBCSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-
T ss_pred -CCCCEEEEeccccccccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccc
Confidence 778999999999975432221 12456899999999999999999999999999999999999999975322
Q ss_pred -----cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH---HHHHHHHHHHHHhCCCCCCcccc
Q 015018 159 -----GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDW 230 (414)
Q Consensus 159 -----~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~---~l~~~l~~~~~~~~~~~d~~~~w 230 (414)
......+..+...... ++..++.++.++|..||..||.+||++. .+.+++.+ .+...++|
T Consensus 217 ~~~~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h-------p~f~~~~w 284 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDW 284 (345)
T ss_dssp ------CHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS-------GGGTTCCH
T ss_pred cccccccHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC-------CccCCCCH
Confidence 1222333444433322 3456889999999999999999999852 23333332 34456789
Q ss_pred cccccc
Q 015018 231 TILKYQ 236 (414)
Q Consensus 231 ~~~~~~ 236 (414)
+.+..+
T Consensus 285 ~~~~~~ 290 (345)
T 3a8x_A 285 DMMEQK 290 (345)
T ss_dssp HHHHTT
T ss_pred HHHHhC
Confidence 876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.52 Aligned_cols=208 Identities=19% Similarity=0.262 Sum_probs=174.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||++++.++.+++..||||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 3799999999999999999999999 889999998643 359999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+||||+ .++.+||+|||+++....... +.......+|..|+|||++.+..++.++|||||||++|
T Consensus 213 vH~Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 213 IHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp CCSCCCGGGEEEC---TTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEc---CCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9999999999996 678999999999986654322 11223457889999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 223 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~ 223 (414)
+|++ |..||.+.. ..+....+...... .....++.++.+++..||..+|++||++.+|.+.|+.++.....+
T Consensus 285 ellt~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 285 EIFTLGGSPYPGVP---VEELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHTTSCCSSTTCC---HHHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHhCCCCCCCCCC---HHHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 9999 999998753 33333333333221 123568899999999999999999999999999999998766543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.15 Aligned_cols=201 Identities=21% Similarity=0.232 Sum_probs=168.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++++.||||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~ 152 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecC
Confidence 4799999999999999999999999 9999999874 5679999999999999999999999999999999999998522
Q ss_pred -CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 -RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
...+.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 153 SGNPESIRICDFGFAKQLRAENG-------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp SCSGGGEEECCCTTCEECBCTTC-------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred CCCcCeEEEEECCCcccCcCCCC-------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 1224699999999987654332 12346889999999999988889999999999999999999999987655
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+..+.+..+........ ...+..+++++.+||..||..||++||++.+++
T Consensus 226 ~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp SCHHHHHHHHHHCCCCCC-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHccCCcccC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 566666666665554322 123456889999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.25 Aligned_cols=206 Identities=16% Similarity=0.255 Sum_probs=170.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
.+|||+++++++.++...||||||+ |++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 132 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 211 (367)
T 3l9p_A 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211 (367)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhh
Confidence 3799999999999999999999999 999999997543 459999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~P 152 (414)
|||+.+.....+||+|||+++.+..... +.......||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 212 Ill~~~~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 212 CLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEEecCCCCceEEECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9997544556799999999975533221 112234578999999999999999999999999999999998 9999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
|.+.. ..+.+..+...... ..+..+|.++.+|+..||+.+|.+||++.+|.+.|+.+..
T Consensus 287 f~~~~---~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 287 YPSKS---NQEVLEFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp STTCC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC---HHHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 98743 33444444433222 1245788999999999999999999999999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=290.07 Aligned_cols=196 Identities=21% Similarity=0.263 Sum_probs=166.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+..+.
T Consensus 74 hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred CcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC
Confidence 699999999999999999999999 9999999974 56899999999999999999999999999999999999996221
Q ss_pred -CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
....+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--- 221 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--- 221 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---
T ss_pred CCccCEEEEecCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---
Confidence 112799999999987655321 23568999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+..+....... ....+..+++++.+||..||..||.+||++++++
T Consensus 222 ~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 222 TKQETLANITAVSYDF-DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp SHHHHHHHHHTTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHhcCCCC-CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 4455556655544332 2344567899999999999999999999987764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.97 Aligned_cols=198 Identities=17% Similarity=0.183 Sum_probs=165.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++++.+++..||||||| |++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 85 hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLA 164 (351)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEe
Confidence 799999999999999999999999 89998877532 34699999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+.....+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 165 ~~~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~- 236 (351)
T 3c0i_A 165 SKENSAPVKLGGFGVAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT- 236 (351)
T ss_dssp SSSTTCCEEECCCTTCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-
T ss_pred cCCCCCcEEEecCcceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-
Confidence 544456699999999987755322 123468999999999999999999999999999999999999999873
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+........ ...+..+++++.+||..||..||++||++.++++
T Consensus 237 ---~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 237 ---KERLFEGIIKGKYKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---HHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHHcCCCCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2344455544443322 2334678999999999999999999999887753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=283.49 Aligned_cols=199 Identities=18% Similarity=0.229 Sum_probs=164.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.||||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 78 hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~ 154 (311)
T 3niz_A 78 HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---S 154 (311)
T ss_dssp CTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---T
T ss_pred CCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---C
Confidence 6999999999999999999999998899999986666799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 155 ~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 155 DGALKLADFGLARAFGIPVR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp TCCEEECCCTTCEETTSCCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred CCCEEEccCcCceecCCCcc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 78999999999987654322 1234578999999999987 568999999999999999999999999876655
Q ss_pred hHHHHHHHHhhhc----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKV----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+..... ......+...+++++.+||..||..||.+||++++++
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 5444433322111 1122234456788999999999999999999987765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=288.15 Aligned_cols=198 Identities=19% Similarity=0.243 Sum_probs=167.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+.+..||||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 59 ~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~ 138 (321)
T 1tki_A 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR 138 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred CCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC
Confidence 3799999999999999999999999 899999997655679999999999999999999999999999999999999621
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 139 -~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--- 206 (321)
T 1tki_A 139 -RSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--- 206 (321)
T ss_dssp -SCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred -CCCCEEEEECCCCeECCCCCc--------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---
Confidence 268899999999987654321 12357899999999999988999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+.+..+........ ...+..++.++.+++..||..||.+||++.++++
T Consensus 207 ~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 207 TNQQIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SHHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC-hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34455555555544332 3345678999999999999999999999877643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.25 Aligned_cols=207 Identities=20% Similarity=0.273 Sum_probs=171.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++++.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 152 (345)
T 1xjd_A 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-- 152 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC--
Confidence 4799999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus 153 -~~g~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--- 221 (345)
T 1xjd_A 153 -KDGHIKIADFGMCKENMLGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--- 221 (345)
T ss_dssp -TTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCCEEEeEChhhhhcccCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---
Confidence 778999999999975432221 124578999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH-HHHHHHHHHHHHhCCCCCCcccccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQ 236 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~-~l~~~l~~~~~~~~~~~d~~~~w~~~~~~ 236 (414)
+..+.+..+...... +...+++++.++|..||..||.+||++. +|+ . ..+...++|+.+...
T Consensus 222 ~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~---~-------hp~f~~~~w~~l~~~ 284 (345)
T 1xjd_A 222 DEEELFHSIRMDNPF-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR---Q-------HPLFREINWEELERK 284 (345)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG---G-------SGGGTTCCHHHHHTT
T ss_pred CHHHHHHHHHhCCCC-----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH---c-------CccccCCCHHHHhhC
Confidence 344555555544322 2346789999999999999999999975 332 1 233445788876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.11 Aligned_cols=205 Identities=21% Similarity=0.359 Sum_probs=159.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++ ..+..++||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~--- 154 (289)
T 3og7_A 79 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH--- 154 (289)
T ss_dssp CTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---
Confidence 68999999865 455679999999 8999999976677899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+++........ .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+..
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 155 EDNTVKIGDFGLATEKSRWSGS-----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp TTTEEEECCCC-----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCCCEEEccceecccccccccc-----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 6789999999999765432211 1123467999999999997 5668889999999999999999999998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
. ..+....+...........+...+|+++.+++..||..+|++||++.++.+.|+++.
T Consensus 230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 230 N--RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C--HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h--HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 3 333444444555555555566789999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.40 Aligned_cols=203 Identities=21% Similarity=0.327 Sum_probs=169.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHH
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRV 56 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls~~~v~~ia~Qll~gL 56 (414)
.+|||+++++++.+++..||||||+ |++|.+++.... ..+++.+++.++.||+.||
T Consensus 108 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 187 (343)
T 1luf_A 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187 (343)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHH
Confidence 3799999999999999999999999 899999997642 5799999999999999999
Q ss_pred HHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHH
Q 015018 57 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 136 (414)
Q Consensus 57 ~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dv 136 (414)
+|||++||+||||||+|||++ .++.+||+|||+++....... +.......+|+.|+|||++.+..++.++||
T Consensus 188 ~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 259 (343)
T 1luf_A 188 AYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDV 259 (343)
T ss_dssp HHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhCCeecCCCCcceEEEC---CCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCccccc
Confidence 999999999999999999996 678999999999976543221 112234678999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 137 ESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 137 wSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
|||||++|+|++ |..||.+.. ..+.+..+...... .++..+|.++.+++..||..+|++||++.++.+.|++
T Consensus 260 ~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 260 WAYGVVLWEIFSYGLQPYYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCcCCCCC---hHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 999999999998 999998753 33344444433322 2345789999999999999999999999999999988
Q ss_pred HHH
Q 015018 216 LFI 218 (414)
Q Consensus 216 ~~~ 218 (414)
+..
T Consensus 333 ~~~ 335 (343)
T 1luf_A 333 MCE 335 (343)
T ss_dssp TTC
T ss_pred HHh
Confidence 764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=295.30 Aligned_cols=203 Identities=18% Similarity=0.255 Sum_probs=169.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 171 hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~--- 247 (377)
T 3cbl_A 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT--- 247 (377)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred CCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---
Confidence 699999999999999999999999 8999999986666799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 248 ~~~~~kl~DfG~s~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~- 321 (377)
T 3cbl_A 248 EKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN- 321 (377)
T ss_dssp TTCCEEECCGGGCEECTTSEEE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-
T ss_pred CCCcEEECcCCCceecCCCcee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 6789999999999865432210 01112346788999999998889999999999999999998 9999987543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+....+...... ..+..+|+++.++|..||+.||++||++++|.+.|+++..+
T Consensus 322 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 322 --QQTREFVEKGGRL----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2333333322211 12456899999999999999999999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.79 Aligned_cols=199 Identities=20% Similarity=0.195 Sum_probs=168.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 68 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~ 146 (444)
T 3soa_A 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146 (444)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS
T ss_pred CCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc
Confidence 3799999999999999999999999 9999999875 5679999999999999999999999999999999999999754
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 147 ~~~~~vkL~DFG~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--- 216 (444)
T 3soa_A 147 LKGAAVKLADFGLAIEVEGEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--- 216 (444)
T ss_dssp STTCCEEECCCSSCBCCCTTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred CCCCcEEEccCceeEEecCCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---
Confidence 4568899999999976654322 123468999999999999999999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+..+.+..+......... ..+..+++++.+||..||..||.+||++.++++
T Consensus 217 ~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 217 DQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp SHHHHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cHHHHHHHHHhCCCCCCc-cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 445555555555443322 233568899999999999999999999887754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=283.61 Aligned_cols=203 Identities=15% Similarity=0.270 Sum_probs=170.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHH
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVE 57 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls~~~v~~ia~Qll~gL~ 57 (414)
+|||+++++++.+++..|+||||+ |++|.+++.... ..+++.+++.++.||+.||+
T Consensus 85 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 164 (314)
T 2ivs_A 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164 (314)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHH
T ss_pred CCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHH
Confidence 799999999999999999999999 899999997532 23899999999999999999
Q ss_pred HHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHH
Q 015018 58 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 137 (414)
Q Consensus 58 yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dvw 137 (414)
|||++||+||||||+|||++ .++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||
T Consensus 165 ~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 165 YLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 99999999999999999997 6789999999999876543321 122345778999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 138 SLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 138 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
||||++|+|++ |..||.+..... .+..+...... .....+++++.+++..||..||++||++.+|.+.|+++
T Consensus 237 slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPPER---LFNLLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH---HHHHhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999 999998765432 22333322211 23457899999999999999999999999999999998
Q ss_pred HHH
Q 015018 217 FIR 219 (414)
Q Consensus 217 ~~~ 219 (414)
+.+
T Consensus 310 ~~~ 312 (314)
T 2ivs_A 310 MVK 312 (314)
T ss_dssp HHT
T ss_pred Hhh
Confidence 753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.87 Aligned_cols=190 Identities=19% Similarity=0.216 Sum_probs=158.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.+|||+++++++.+++..||||||++++|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||++
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~--- 191 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG--- 191 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---
Confidence 47999999999999999999999999999999987777899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---- 258 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---- 258 (311)
T ss_dssp GGGCEEECCCTTCEECC--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----
T ss_pred CCCCEEEccceeeeecccCCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----
Confidence 678999999999987654321 234579999999999987 6899999999999999999997666442
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+..+..... ...+...+++++.++|..||..||++||+++++++
T Consensus 259 --~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 --EGWQQLRQGYL---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HHHHHHTTTCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cHHHHHhccCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 12222222222 23455678999999999999999999999887753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.74 Aligned_cols=201 Identities=15% Similarity=0.145 Sum_probs=155.7
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
++|||+++++++.. +.+.||||||| |++|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||
T Consensus 113 ~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni 192 (400)
T 1nxk_A 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192 (400)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceE
Confidence 47999999998876 67889999999 89999999754 24699999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
||+....++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 193 ll~~~~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 193 LYTSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp EESSSSTTCCEEECCCTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEecCCCCccEEEEecccccccCCCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 997433478999999999987543221 234688999999999999999999999999999999999999998
Q ss_pred CCCccch-HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+...... ......+......... ..+..++.++.+||..||..||++||++.+++
T Consensus 265 ~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 265 SNHGLAISPGMKTRIRMGQYEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp CCTTCSSCCSHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCccccccHHHHHHHHcCcccCCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 7543221 1122233333222111 12356889999999999999999999977664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.43 Aligned_cols=208 Identities=20% Similarity=0.299 Sum_probs=172.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.+..||||||+ |++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+||||+
T Consensus 74 hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~--- 149 (384)
T 4fr4_A 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD--- 149 (384)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---
Confidence 799999999999999999999999 9999999984 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 150 ~~g~vkL~DFG~a~~~~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 150 EHGHVHITDFNIAAMLPRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TTSCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCCCEEEeccceeeeccCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 778999999999987654321 245789999999999974 458899999999999999999999998765
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 236 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~ 236 (414)
.....+.+..+...... +...++.++.+||..||..+|.+||+ +++|+ ...+...++|+.....
T Consensus 222 ~~~~~~~~~~~~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~----------~hp~f~~~~w~~~~~~ 286 (384)
T 4fr4_A 222 STSSKEIVHTFETTVVT-----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ----------NFPYMNDINWDAVFQK 286 (384)
T ss_dssp TSCHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH----------TSGGGTTCCHHHHHTT
T ss_pred CccHHHHHHHHhhcccC-----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH----------cChhhhcCCHHHHHhC
Confidence 55555555554433322 23567899999999999999999998 44432 2244556788876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=287.25 Aligned_cols=189 Identities=21% Similarity=0.285 Sum_probs=161.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 73 hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~--- 148 (328)
T 3fe3_A 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD--- 148 (328)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---
Confidence 799999999999999999999999 9999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+.... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--- 217 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGG--------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--- 217 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSC--------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CCCCEEEeeccCceecCCCC--------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---
Confidence 77899999999997654322 12356899999999999988875 8999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+....+...... ++..+++++.+++..||..||.+||++++++
T Consensus 218 ~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 218 NLKELRERVLRGKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred CHHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 334444555444332 2345789999999999999999999987764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=290.14 Aligned_cols=196 Identities=21% Similarity=0.246 Sum_probs=165.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++...
T Consensus 87 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~ 165 (362)
T 2bdw_A 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165 (362)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS
T ss_pred CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence 699999999999999999999999 8999998874 56799999999999999999999999999999999999997544
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 166 ~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~ 234 (362)
T 2bdw_A 166 KGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---D 234 (362)
T ss_dssp TTCCEEECCCTTCBCCTTCCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCCEEEeecCcceEecCCcc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---C
Confidence 456799999999986654221 23468999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+......... ..+..+++++.+||..||..||++||++.+++
T Consensus 235 ~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 235 QHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp HHHHHHHHHHTCCCCCT-TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHhCCCCCCc-ccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 34455555544433221 22356789999999999999999999987765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=280.21 Aligned_cols=203 Identities=16% Similarity=0.258 Sum_probs=171.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+++..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~--- 154 (283)
T 3gen_A 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN--- 154 (283)
T ss_dssp CTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---
T ss_pred CCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---
Confidence 689999999999999999999999 9999999986567899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.++|+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~- 227 (283)
T 3gen_A 155 DQGVVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN- 227 (283)
T ss_dssp TTSCEEECSTTGGGGBCCHHH------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred CCCCEEEcccccccccccccc------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-
Confidence 778999999999975543211 12234567889999999999999999999999999999998 9999987543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+....+...... .....+++++.+++..||..+|.+||++.++++.|.+++.++
T Consensus 228 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 228 --SETAEHIAQGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --hHHHHHHhcccCC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 3333444333221 123457899999999999999999999999999999988653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=282.71 Aligned_cols=208 Identities=22% Similarity=0.238 Sum_probs=158.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC
Confidence 4799999999999999999999999 8999999975 4579999999999999999999999999999999999999743
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.....+||+|||++.....................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 333459999999987654322111111112234579999999999975 457889999999999999999999998
Q ss_pred CCCccc------------hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGT------------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~------------~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..... ....+..+........ ......++.++.+||..||..||.+||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccccccccccccccchhHHHHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 754322 2233444444433222 223456889999999999999999999987775
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=287.32 Aligned_cols=201 Identities=21% Similarity=0.245 Sum_probs=147.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++.+.||||||+ |++|.+++.. ...+++.++..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~ 142 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC
Confidence 5899999999999999999999999 8999999985 5689999999999999999999999999999999999999743
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA- 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~- 158 (414)
.....+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 143 ~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 215 (325)
T 3kn6_A 143 NDNLEIKIIDFGFARLKPPDNQ-------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215 (325)
T ss_dssp ---CEEEECCCTTCEECCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred CCcccEEEeccccceecCCCCC-------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 3444899999999987654322 12345789999999999999999999999999999999999999987432
Q ss_pred ---cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 ---GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ---~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+.+..+........ ...+..+++++.+||..||..||.+||++++++
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 216 LTCTSAVEIMKKIKKGDFSFE-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp --CCCHHHHHHHHTTTCCCCC-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred cccccHHHHHHHHHcCCCCCC-cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 223344455444433222 223456889999999999999999999977663
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=277.99 Aligned_cols=201 Identities=18% Similarity=0.254 Sum_probs=169.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 64 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~--- 140 (269)
T 4hcu_A 64 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--- 140 (269)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---
Confidence 699999999999999999999999 8999999986667799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-- 212 (269)
T 4hcu_A 141 ENQVIKVSDFGMTRFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-- 212 (269)
T ss_dssp GGGCEEECCTTGGGGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred CCCCEEecccccccccccccc------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--
Confidence 667899999999975433211 12234567889999999999999999999999999999999 999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+.+..+...... .....+++++.+++..||..+|.+||++.++.+.|+++..
T Consensus 213 -~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 213 -NSEVVEDISTGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -HHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCccC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 33344444332211 1234578999999999999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=295.77 Aligned_cols=195 Identities=21% Similarity=0.275 Sum_probs=163.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++++++++++.||||||+ |++|.+++.. ..+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 127 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~-- 202 (410)
T 3v8s_A 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-- 202 (410)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC--
Confidence 4799999999999999999999999 9999999974 4799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
..+.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+
T Consensus 203 -~~g~ikL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 203 -KSGHLKLADFGTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp -TTSCEEECCCTTCEECCTTSE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -CCCCEEEeccceeEeeccCCc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 778999999999987654321 1123578999999999998765 78999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCC--CCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~--RP~~~~l~ 210 (414)
. +..+.+.++.........+ ....++.++.+||..|+..+|.+ ||++++|+
T Consensus 276 ~---~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 276 D---SLVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp S---SHHHHHHHHHTHHHHCCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred C---ChhhHHHHHHhccccccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 4 4455566665433211111 12368899999999999988888 99987764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=276.61 Aligned_cols=200 Identities=15% Similarity=0.189 Sum_probs=168.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++...|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~--- 138 (268)
T 3sxs_A 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD--- 138 (268)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---
T ss_pred CCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---
Confidence 699999999999999999999999 9999999987666799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++....... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 139 ~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~- 211 (268)
T 3sxs_A 139 RDLCVKVSDFGMTRYVLDDQY------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN- 211 (268)
T ss_dssp TTCCEEECCTTCEEECCTTCE------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred CCCCEEEccCccceecchhhh------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-
Confidence 778999999999987655332 11234567888999999999899999999999999999998 9999987533
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.+....+...... .....+++++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 212 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 212 --SEVVLKVSQGHRL----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --HHHHHHHHTTCCC----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --HHHHHHHHcCCCC----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3333333332221 123457899999999999999999999999999987764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=281.76 Aligned_cols=196 Identities=19% Similarity=0.233 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 73 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS
T ss_pred CCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC
Confidence 699999999999999999999999 9999999974 56799999999999999999999999999999999999996321
Q ss_pred -CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
....+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--- 220 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--- 220 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---
T ss_pred CCCCCEEEEECCCCeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---
Confidence 223799999999987654221 23467999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+.+..+....... ....+..++.++.+||..||..||++||++.+++
T Consensus 221 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 221 TKQETLANVSAVNYEF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp SHHHHHHHHHHTCCCC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHhcCCCc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 3344444444433322 2344567899999999999999999999987775
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=290.44 Aligned_cols=203 Identities=14% Similarity=0.242 Sum_probs=158.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 105 h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--- 181 (373)
T 2qol_A 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--- 181 (373)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---
Confidence 799999999999999999999999 9999999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 182 ~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-- 255 (373)
T 2qol_A 182 SNLVCKVSDFGLGRVLEDDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-- 255 (373)
T ss_dssp TTCCEEECCC--------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--
T ss_pred CCCCEEECcCccccccccCCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 67899999999998765432111 01122356788999999999999999999999999999997 999998753
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+.+..+....... ....+|.++.+++..||+.+|.+||++.++.+.|+.++.
T Consensus 256 -~~~~~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 256 -NQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -HHHHHHHHHTTEECC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCCCC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 233333333322211 234688999999999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.82 Aligned_cols=205 Identities=19% Similarity=0.242 Sum_probs=168.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHH
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVE 57 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~----------------------~ls~~~v~~ia~Qll~gL~ 57 (414)
++|||+++++++.+++..||||||+ |++|.+++..... .+++..++.++.||+.||+
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4799999999999999999999999 8999999975432 3899999999999999999
Q ss_pred HHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHH
Q 015018 58 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 137 (414)
Q Consensus 58 yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dvw 137 (414)
|||++||+||||||+|||++ .++.+||+|||++..+..... ........||+.|+|||++.+..++.++|||
T Consensus 187 ~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 187 FLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHhCCcccCCCChhhEEEc---CCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999999999999997 778999999999986654322 1122345678899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 138 SLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 138 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
||||++|+|++ |..||.+..... .+..+....... .....+++++.+++..||..||.+||++.+|.+.|+.+
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDA---NFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccCCcHH---HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 99999999998 999998864322 122222222111 12346789999999999999999999999999999988
Q ss_pred HHH
Q 015018 217 FIR 219 (414)
Q Consensus 217 ~~~ 219 (414)
+..
T Consensus 333 ~~~ 335 (344)
T 1rjb_A 333 LAD 335 (344)
T ss_dssp C--
T ss_pred HHH
Confidence 754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=280.68 Aligned_cols=206 Identities=20% Similarity=0.295 Sum_probs=170.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSK 62 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~-----------------~ls~~~v~~ia~Qll~gL~yLH~~ 62 (414)
.+|||++++.++.+++..||||||+ |++|.+++..... .+++..++.++.||+.||+|||++
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4799999999999999999999999 8899999975432 499999999999999999999999
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHH
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 142 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvv 142 (414)
||+||||||+|||++ .++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||++
T Consensus 165 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 165 NCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp TCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CeecCCCccceEEEc---CCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999999999999997 678999999999986654322 112234567889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 143 LMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 143 l~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
+|+|++ |..||.+...... ....+.. .... .....+|.++.+++..||..||.+||++.++.+.|++++...
T Consensus 237 l~ellt~g~~p~~~~~~~~~--~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSK--FYKMIKE-GFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHH--HHHHHHH-TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCcccchhH--HHHHhcc-CCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999998 9999987643221 1222222 1111 123467899999999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=282.65 Aligned_cols=214 Identities=20% Similarity=0.268 Sum_probs=166.4
Q ss_pred CCCCCcEEEEeeEeC----CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cceec
Q 015018 1 MAAGIPNLRWFGVEG----DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHR 67 (414)
Q Consensus 1 g~p~I~~l~~~g~~~----~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~--------givHR 67 (414)
.+|||++++.++.+. ...||||||+ |++|.++++. ..+++..++.++.||+.||+|||++ ||+||
T Consensus 89 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp CCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred cCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 379999999999987 7899999999 8899999974 4799999999999999999999999 99999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCch------hHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGY 141 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~------~DvwSlGv 141 (414)
||||+|||++ .++.+||+|||+++.+......... ......||+.|+|||++.+..+... +|||||||
T Consensus 167 Dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 167 DLKSKNILVK---KNGTCCIADLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCCGGGEEEC---TTSCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred ccchHHEEEC---CCCCEEEEeCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 9999999996 6789999999999876554322111 1235689999999999988766654 99999999
Q ss_pred HHHHHHhC----------CCCCCCCCccch-HHHHHH-HHhhhccchHH--HhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 142 VLMYFLRG----------SLPWQGLKAGTK-KQKYEK-ISEKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 142 vl~elltG----------~~Pf~~~~~~~~-~~~~~~-i~~~~~~~~~~--~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
++|||++| ..||........ ...... +.......... .....+++++.+++..||..||.+||++.
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 99999999 788876543322 222222 11111111111 11235678899999999999999999999
Q ss_pred HHHHHHHHHHHHhCC
Q 015018 208 YLKRLFRDLFIREGF 222 (414)
Q Consensus 208 ~l~~~l~~~~~~~~~ 222 (414)
++.+.|+.+....+.
T Consensus 321 ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 321 RVKKTLAKMSESQDI 335 (337)
T ss_dssp HHHHHHHHHHHTTTC
T ss_pred HHHHHHHHHHhhccc
Confidence 999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=279.59 Aligned_cols=196 Identities=21% Similarity=0.296 Sum_probs=158.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.||||||++++|.+++..+...+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 59 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~ 135 (288)
T 1ob3_A 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---R 135 (288)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---T
T ss_pred CCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---C
Confidence 6999999999999999999999997799999987777899999999999999999999999999999999999996 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 207 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPVR-------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA- 207 (288)
T ss_dssp TSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred CCCEEEeECccccccCcccc-------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 78999999999976543211 12345789999999999864 5899999999999999999999999875432
Q ss_pred hHHHHHHHHhhhc------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.+..+..... ......+...+++++.++|..||..||++||++++++
T Consensus 208 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 208 --DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp --HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 22222221100 0011233456889999999999999999999987764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=291.83 Aligned_cols=202 Identities=21% Similarity=0.217 Sum_probs=156.5
Q ss_pred CCCCCcEEEEeeEeCC--EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGD--YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~--~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++++..++ +.|||||||+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~- 143 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN- 143 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc-
Confidence 5899999999998654 7899999998899999974 5899999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcc-cc-------------cccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHH
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQ-HI-------------PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVL 143 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~-~~-------------~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl 143 (414)
.++.+||+|||+++.+....... .. .........||+.|+|||++.+ ..++.++|||||||++
T Consensus 144 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 221 (388)
T 3oz6_A 144 --AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221 (388)
T ss_dssp --TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred --CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHH
Confidence 77899999999998764321100 00 0111235689999999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCCccchHHHHHHHHhhhccchH---------------------------------H-------H--hh
Q 015018 144 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI---------------------------------E-------A--LC 181 (414)
Q Consensus 144 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---------------------------------~-------~--l~ 181 (414)
|||++|+.||.+..... .+..+......... . . ..
T Consensus 222 ~ell~g~~pf~~~~~~~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (388)
T 3oz6_A 222 GEILCGKPIFPGSSTMN---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298 (388)
T ss_dssp HHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred HHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence 99999999998854332 23322211000000 0 0 01
Q ss_pred cCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 182 ~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+++++.+||..||..||++||++++++
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l 327 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDAL 327 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHh
Confidence 26788999999999999999999987664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=285.33 Aligned_cols=200 Identities=17% Similarity=0.236 Sum_probs=164.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++. .++||||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 76 h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~--- 151 (327)
T 3poz_A 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK--- 151 (327)
T ss_dssp BTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---
Confidence 699999999999876 57888888 9999999987777899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+....... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 152 ~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 152 TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp ETTEEEECCTTHHHHHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCCEEEccCcceeEccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 67889999999998765433211 1233567889999999999999999999999999999999 99999886543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.... .+...... .....++.++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 227 ~~~~---~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 227 EISS---ILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp GHHH---HHHTTCCC----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 3222 22221111 123457899999999999999999999999999998875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=284.66 Aligned_cols=209 Identities=18% Similarity=0.221 Sum_probs=164.0
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------Ccee
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLH 66 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~----------givH 66 (414)
+|||++++.++.++. ..||||||+ +++|.++++. ..+++..++.++.||+.||+|||+. ||+|
T Consensus 77 hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH 154 (322)
T 3soc_A 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154 (322)
T ss_dssp CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEEC
T ss_pred CCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEe
Confidence 699999999998854 469999999 8999999974 4699999999999999999999999 9999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-----CCCchhHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGY 141 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~~~DvwSlGv 141 (414)
|||||+|||++ ..+.+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||
T Consensus 155 ~Dlkp~Nill~---~~~~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 155 RDIKSKNVLLK---NNLTACIADFGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp SCCSGGGEEEC---TTCCEEECCCTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred CCCChHhEEEC---CCCeEEEccCCcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 99999999996 6789999999999876553321 122346899999999999874 4556889999999
Q ss_pred HHHHHHhCCCCCCCCCccc-------------hHHHHHHHHhhhccchHHHhh--cCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 142 VLMYFLRGSLPWQGLKAGT-------------KKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 142 vl~elltG~~Pf~~~~~~~-------------~~~~~~~i~~~~~~~~~~~l~--~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
++|+|++|+.||.+..... .......+........+...+ ..++.++.+||..||+.||++||++
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence 9999999999998743321 111122222222222111111 1234679999999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 015018 207 AYLKRLFRDLFIRE 220 (414)
Q Consensus 207 ~~l~~~l~~~~~~~ 220 (414)
.++.+.|+.+....
T Consensus 307 ~ell~~L~~l~~~~ 320 (322)
T 3soc_A 307 GCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999987554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=277.93 Aligned_cols=195 Identities=18% Similarity=0.224 Sum_probs=160.5
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.... +.++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 73 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 152 (308)
T 3g33_A 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 152 (308)
T ss_dssp CTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEE
T ss_pred CCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 799999999998865 689999999889999998543 23999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 153 ~~---~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 153 VT---SGGTVKLADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp EC---TTSCEEECSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred Ec---CCCCEEEeeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 96 778999999999975543221 2345789999999999999999999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... ...+..+.... .......+...+++++.+||..||..||++||++.+++
T Consensus 222 ~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 222 NSE---ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SSH---HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCH---HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 543 33333332211 01122344567889999999999999999999987764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=289.64 Aligned_cols=205 Identities=19% Similarity=0.255 Sum_probs=166.9
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHHcCC-----------------------------------------
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNFCSR----------------------------------------- 38 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~~~~----------------------------------------- 38 (414)
+|||++++.++.+.+ +.|+||||+ |++|.+++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 699999999988754 589999999 8999999975432
Q ss_pred ------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 39 ------------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 39 ------------------------~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEecccee
Confidence 199999999999999999999999999999999999996 67889999999998
Q ss_pred EcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhc
Q 015018 95 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 173 (414)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 173 (414)
....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..... .....+.....
T Consensus 242 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~ 314 (359)
T 3vhe_A 242 DIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR 314 (359)
T ss_dssp CTTSCTT-----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCC
T ss_pred eeccccc-----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCC
Confidence 6544322 112345678999999999999999999999999999999998 999998754322 22222222211
Q ss_pred cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 174 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 174 ~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
. ..+..+++++.+++..||..+|.+||++.++.+.|+.++...
T Consensus 315 ~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1 123567899999999999999999999999999999988643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.81 Aligned_cols=211 Identities=18% Similarity=0.236 Sum_probs=175.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.|+|+++++++++.++.||||||+ |++|.+++.. ...|++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 401 ~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~--- 476 (674)
T 3pfq_A 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD--- 476 (674)
T ss_dssp CTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---
T ss_pred CCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---
Confidence 689999999999999999999999 9999999985 35799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+. +
T Consensus 477 ~~g~ikL~DFGla~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~ 546 (674)
T 3pfq_A 477 SEGHIKIADFGMCKENIWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---D 546 (674)
T ss_dssp SSSCEEECCCTTCEECCCTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCcEEEeecceeeccccCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---C
Confidence 778999999999986443221 124578999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 238 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~--~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~~~ 238 (414)
..+.+..|...... ++..+++++.+||..||..||.+||++ ....++++ ..+...++|+.+..++.
T Consensus 547 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~-------h~ff~~i~w~~l~~~~~ 614 (674)
T 3pfq_A 547 EDELFQSIMEHNVA-----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-------HAFFRYIDWEKLERKEI 614 (674)
T ss_dssp HHHHHHHHHSSCCC-----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS-------SGGGSSCCHHHHTTTCS
T ss_pred HHHHHHHHHhCCCC-----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc-------CccccCCCHHHHHhCCC
Confidence 55666666665443 345688999999999999999999986 12222222 23455679988765443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.62 Aligned_cols=215 Identities=19% Similarity=0.245 Sum_probs=172.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.+ +..||||||+ |++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 394 ~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-- 470 (613)
T 2ozo_A 394 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-- 470 (613)
T ss_dssp CCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc--
Confidence 37999999999976 5689999999 9999999976667799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+...... +.......+++.|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 471 -~~~~vkL~DFGla~~~~~~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 471 -NRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp -ETTEEEECCCSTTTTCC------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred -CCCcEEEeeccCcccccCCCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 6789999999999765432210 111123456789999999999999999999999999999998 9999988654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccc
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 230 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w 230 (414)
.+.+..+...... .....+|+++.+||..||..+|++||++.+|.+.|++++...+...+...++
T Consensus 546 ---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~l 610 (613)
T 2ozo_A 546 ---PEVMAFIEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSAL 610 (613)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSC
T ss_pred ---HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccce
Confidence 3334444433321 2345789999999999999999999999999999999998877665544444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=287.66 Aligned_cols=201 Identities=17% Similarity=0.190 Sum_probs=163.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+ +..++||||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 73 ~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~-- 149 (325)
T 3kex_A 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK-- 149 (325)
T ss_dssp CCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES--
T ss_pred CCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC--
Confidence 37999999998874 5678999999 9999999986556899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.+||+|||+++.+....... ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 150 -~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 150 -SPSQVQVADFGVADLLPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp -SSSCEEECSCSGGGGSCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred -CCCeEEECCCCcccccCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 67889999999998765433211 1234578889999999999999999999999999999999 9999988654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
... ...+...... .....++.++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 224 ~~~---~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 224 AEV---PDLLEKGERL----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp THH---HHHHHTTCBC----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHH---HHHHHcCCCC----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 322 2222222111 123457789999999999999999999999999998774
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=275.71 Aligned_cols=208 Identities=20% Similarity=0.276 Sum_probs=172.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++ ..+..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 ~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-- 144 (287)
T 1u59_A 68 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-- 144 (287)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--
T ss_pred CCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc--
Confidence 379999999999 555689999999 8899999976567799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 145 -~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 145 -NRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp -ETTEEEECCCTTCEECTTCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred -CCCCEEECcccceeeeccCcce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 6689999999999877543221 111234567899999999998889999999999999999998 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 223 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~ 223 (414)
.+....+...... .+...+|+++.++|..||..+|.+||++.++.+.|+.++...+.+
T Consensus 220 ---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 220 ---PEVMAFIEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---HHHHHHHhcCCcC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 3333333333221 234578999999999999999999999999999999998766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=276.40 Aligned_cols=197 Identities=20% Similarity=0.349 Sum_probs=156.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g---ivHRDIKP~NILl~ 77 (414)
+|||++++.++.+++..|+||||+ |++|.+++. .+.+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~ 142 (271)
T 3dtc_A 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142 (271)
T ss_dssp CTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEES
T ss_pred CCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEe
Confidence 699999999999999999999999 999999986 568999999999999999999999999 89999999999996
Q ss_pred ecC-----CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 78 LGR-----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 78 ~~~-----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
... ..+.+||+|||+++.+..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 143 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 213 (271)
T 3dtc_A 143 QKVENGDLSNKILKITDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213 (271)
T ss_dssp SCCSSSCCSSCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred cccccccccCcceEEccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 321 267899999999986544321 235799999999999999999999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
|.+... ......+....... .....+|+++.+++..||..+|.+||++.++.+.|++
T Consensus 214 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 214 FRGIDG---LAVAYGVAMNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TTTSCH---HHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCH---HHHHHhhhcCCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 987532 22222222222221 2345788999999999999999999999999988864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=280.06 Aligned_cols=210 Identities=18% Similarity=0.195 Sum_probs=160.8
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.. ..+.||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 70 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~- 148 (295)
T 3ugc_A 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE- 148 (295)
T ss_dssp CTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred CCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc-
Confidence 6999999998754 45689999999 9999999987666799999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++........ ........++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 149 --~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 149 --NENRVKIGDFGLTKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp --ETTEEEECCCCSCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred --CCCeEEEccCcccccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 6689999999999876543211 1112345678889999999999999999999999999999999999965311
Q ss_pred c---------chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 G---------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~---------~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
. ........+...............+|+++.+++..||..+|++||++.+|.+.|+.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0 00000000000000000111245689999999999999999999999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=281.57 Aligned_cols=204 Identities=14% Similarity=0.214 Sum_probs=164.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.+..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 105 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~--- 181 (333)
T 1mqb_A 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN--- 181 (333)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---
Confidence 699999999999999999999999 8899999987667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++......... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~- 256 (333)
T 1mqb_A 182 SNLVCKVSDFGLSRVLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN- 256 (333)
T ss_dssp TTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred CCCcEEECCCCcchhhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-
Confidence 67899999999998765432111 01123456889999999999999999999999999999998 9999977532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+.+..+...... .....+|.++.+++..||..+|.+||++.++.+.|++++..
T Consensus 257 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 257 --HEVMKAINDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHHHCCCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3333444333221 12346889999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.22 Aligned_cols=199 Identities=19% Similarity=0.238 Sum_probs=158.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec-
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG- 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~- 79 (414)
+|||++++.++...++.||||||+|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+..
T Consensus 95 h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 95 NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp GGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred CCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence 789999999999999999999999999999998543 459999999999999999999999999999999999999621
Q ss_pred ---------------------CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHH
Q 015018 80 ---------------------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138 (414)
Q Consensus 80 ---------------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwS 138 (414)
...+.+||+|||+++...... ....||+.|+|||++.+..++.++||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHH
Confidence 136789999999998654322 3468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchH--------------------------------------HHh
Q 015018 139 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI--------------------------------------EAL 180 (414)
Q Consensus 139 lGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~l 180 (414)
|||++|+|++|+.||.+.........+..+......... ..+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 999999999999999875433222222221110000000 000
Q ss_pred hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 181 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 181 ~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....++++.+||..||+.||.+||++++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 112237788999999999999999988775
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.79 Aligned_cols=204 Identities=20% Similarity=0.268 Sum_probs=167.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||+ +|||||||||+||||+
T Consensus 207 h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~-- 283 (446)
T 4ejn_A 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-- 283 (446)
T ss_dssp CTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC--
T ss_pred CCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC--
Confidence 699999999999999999999999 9999999875 4589999999999999999999998 9999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 284 -~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--- 352 (446)
T 4ejn_A 284 -KDGHIKITDFGLCKEGIKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--- 352 (446)
T ss_dssp -SSSCEEECCCCCCCTTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCCEEEccCCCceeccCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---
Confidence 678999999999975333221 124578999999999999999999999999999999999999999774
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+..+...... ++..+++++.+||..||..||.+|| ++++++ ++ .+...++|....
T Consensus 353 ~~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell---~h-------p~f~~~~~~~~~ 417 (446)
T 4ejn_A 353 DHEKLFELILMEEIR-----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM---QH-------RFFAGIVWQHVY 417 (446)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH---TS-------GGGTTCCHHHHH
T ss_pred CHHHHHHHHHhCCCC-----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHH---hC-------ccccCCCHHHHh
Confidence 334444554443332 3456889999999999999999999 766654 22 233456787654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.22 Aligned_cols=200 Identities=17% Similarity=0.241 Sum_probs=160.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++. .++||+++ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 76 hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~--- 151 (327)
T 3lzb_A 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK--- 151 (327)
T ss_dssp BTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---
Confidence 699999999998876 67888888 9999999987777899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.+||+|||+++.+....... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 152 ~~~~~kL~DfG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 152 TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp ETTEEEECCTTC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCCEEEccCcceeEccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 66889999999998765433211 1234567889999999999999999999999999999999 99999886543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
...+ .+...... .....++.++.+++..||..+|.+||++.+|.+.|+.+.
T Consensus 227 ~~~~---~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 227 EISS---ILEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp GHHH---HHHTTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HHHcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3222 22222111 123457899999999999999999999999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=276.12 Aligned_cols=197 Identities=18% Similarity=0.213 Sum_probs=159.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.||||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 60 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~ 136 (292)
T 3o0g_A 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---R 136 (292)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---T
T ss_pred CCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence 6999999999999999999999998888888877778899999999999999999999999999999999999996 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... +
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~ 207 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--D 207 (292)
T ss_dssp TSCEEECCCTTCEECCSCCS-------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--S
T ss_pred CCCEEEeecccceecCCccc-------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--C
Confidence 78999999999987654322 224468899999999998766 7999999999999999999888864322 2
Q ss_pred hHHHHHHHHhhhccc------------------------hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVST------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... ....+...++.++.+|+..||..||++||++++++
T Consensus 208 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 233333332211110 01112235788999999999999999999987765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=280.83 Aligned_cols=206 Identities=16% Similarity=0.268 Sum_probs=172.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||++++.++.+++..||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3799999999999999999999999 889999997532 248999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|
T Consensus 179 vH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 179 IHRDLAARNVLVT---ENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp ECSCCSGGGEEEC---TTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred eCCCCccceEEEc---CCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999999999996 678999999999987654332 11223456789999999999988999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
+|++ |..||.+.. ..+.+..+...... .....++.++.+++..||..+|.+||++.+|.+.|+.++....
T Consensus 251 ellt~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 251 EIFTLGGSPYPGIP---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHTTSCCSSTTCC---HHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhCCCCCcCcCC---HHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 9999 999998753 23333333333221 2345688999999999999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=287.00 Aligned_cols=206 Identities=14% Similarity=0.187 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..||||||+ |++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||||+
T Consensus 85 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~-- 162 (389)
T 3gni_B 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-- 162 (389)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 799999999999999999999999 99999999754 36799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||++.....................||..|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 163 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 163 -VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp -TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred -CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 77899999999988765433222111122234589999999999988 578999999999999999999999998754
Q ss_pred ccchHHHHHHHHhh--------------------------------------hccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 158 AGTKKQKYEKISEK--------------------------------------KVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 158 ~~~~~~~~~~i~~~--------------------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
.............. ........+...+++++.+||..||..|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 43222111000000 0000011233557889999999999999
Q ss_pred CCCCCCHHHHH
Q 015018 200 FDDKPDYAYLK 210 (414)
Q Consensus 200 p~~RP~~~~l~ 210 (414)
|.+||++++++
T Consensus 322 P~~Rpta~ell 332 (389)
T 3gni_B 322 PDARPSASTLL 332 (389)
T ss_dssp TTTSCCHHHHT
T ss_pred cccCCCHHHHh
Confidence 99999987764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=280.01 Aligned_cols=196 Identities=20% Similarity=0.251 Sum_probs=158.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-----~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++.+++..||||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 62 hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~ 141 (317)
T 2pmi_A 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI 141 (317)
T ss_dssp BTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE
Confidence 699999999999999999999999889999986432 469999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ .++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus 142 ~---~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 142 N---KRGQLKLGDFGLARAFGIPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp C---TTCCEEECCCSSCEETTSCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c---CCCCEEECcCccceecCCCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 6 678999999999987654221 12345789999999999874 589999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhcc------------------------ch-----HHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 156 LKAGTKKQKYEKISEKKVS------------------------TS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~------------------------~~-----~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
.... +.+..+...... .. .......++.++.+||..||..||++||++
T Consensus 212 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 212 TNDE---EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp SSHH---HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CChH---HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 5432 223332221000 00 001123578899999999999999999998
Q ss_pred HHHH
Q 015018 207 AYLK 210 (414)
Q Consensus 207 ~~l~ 210 (414)
++++
T Consensus 289 ~e~l 292 (317)
T 2pmi_A 289 KQAL 292 (317)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 7664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=281.13 Aligned_cols=207 Identities=21% Similarity=0.260 Sum_probs=165.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 80 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~--- 155 (327)
T 3a62_A 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN--- 155 (327)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---
T ss_pred CCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---
Confidence 699999999999999999999999 8999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~ 225 (327)
T 3a62_A 156 HQGHVKLTDFGLCKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---N 225 (327)
T ss_dssp TTSCEEECCCSCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---S
T ss_pred CCCcEEEEeCCcccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---C
Confidence 678999999999976433221 123468999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~--~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
..+.+..+...... +...+++++.++|..||..+|.+||++. .+.+++.+-+ ...++|+...
T Consensus 226 ~~~~~~~i~~~~~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~-------f~~~~~~~~~ 289 (327)
T 3a62_A 226 RKKTIDKILKCKLN-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF-------FRHINWEELL 289 (327)
T ss_dssp HHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG-------GSSCCHHHHH
T ss_pred HHHHHHHHHhCCCC-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc-------ccCCCHHHHh
Confidence 34445555544332 3356789999999999999999999432 3334444332 2346777654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=278.53 Aligned_cols=205 Identities=20% Similarity=0.250 Sum_probs=165.8
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.+. +..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~- 160 (302)
T 4e5w_A 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE- 160 (302)
T ss_dssp CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc-
Confidence 69999999999876 6789999999 8899999976677899999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++........ +.......||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 161 --~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 234 (302)
T 4e5w_A 161 --SEHQVKIGDFGLTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234 (302)
T ss_dssp --ETTEEEECCCTTCEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred --CCCCEEECcccccccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh
Confidence 6689999999999877654321 1123456789999999999999999999999999999999999998743210
Q ss_pred -----------cch-HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 -----------GTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 -----------~~~-~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
... ......+.... .......+++++.+++..||..||.+||++.++.+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhccC----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 11111111111 11123568899999999999999999999999999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=284.81 Aligned_cols=202 Identities=18% Similarity=0.278 Sum_probs=168.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
++|||+++++++.+++..||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 86 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 165 (322)
T 1p4o_A 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 165 (322)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred CCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCc
Confidence 4799999999999999999999999 899999987432 467999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G 149 (414)
|+|||++ .++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 166 p~NIli~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 166 ARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp GGGEEEC---TTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred cceEEEc---CCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999996 678999999999976543221 112234567899999999999999999999999999999999 8
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..||.+.. ..+....+...... .....+|.++.++|..||..+|.+||++.++.+.|++.+
T Consensus 238 ~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 238 EQPYQGLS---NEQVLRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CCTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCccccCC---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 99998753 33334444333322 234578999999999999999999999999999887764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=278.24 Aligned_cols=192 Identities=16% Similarity=0.273 Sum_probs=161.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..++..||||||+ |++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--- 175 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT--- 175 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---
Confidence 699999999999999999999999 999999987 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--- 245 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--- 245 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred CCCcEEEeeeeeeeecccCcc-------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 678999999999987654321 1235689999999999999999999999999999999999999997743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+........ .....+++++.+++..||..||++||++.+++
T Consensus 246 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 246 PVQAMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp HHHHHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3333444333222111 11235789999999999999999999987775
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=282.12 Aligned_cols=199 Identities=18% Similarity=0.245 Sum_probs=157.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.+++..||||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 59 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~ 135 (324)
T 3mtl_A 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---E 135 (324)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---T
T ss_pred CCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---C
Confidence 6999999999999999999999998899999987777899999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 136 ~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 136 RGELKLADFGLARAKSIPTK-------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp TCCEEECSSSEEECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCEEEccCcccccccCCcc-------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 78999999999986543221 1234578999999999987 568999999999999999999999998854433
Q ss_pred hHHHHHHHHhhhcc----------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~----------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+...... .........+++++.+||..||..||.+||++++++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 22222222111100 111223346788999999999999999999987765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=274.17 Aligned_cols=204 Identities=18% Similarity=0.307 Sum_probs=168.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++ ..+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~-- 151 (291)
T 1xbb_A 76 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-- 151 (291)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe--
Confidence 369999999999 566789999999 8999999985 56799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||+++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 152 -~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 152 -TQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp -ETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred -CCCcEEEccCCcceeeccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 66899999999998765433211 11223457889999999999889999999999999999999 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+....+...... .++..+|+++.+++..||..||.+||++.++.+.|++++...
T Consensus 227 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 227 ---SEVTAMLEKGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 3333333332221 234578999999999999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=280.33 Aligned_cols=208 Identities=18% Similarity=0.200 Sum_probs=162.4
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceec
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHR 67 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH--------~~givHR 67 (414)
.+|||++++.++.+ ....||||||+ +++|.++++ ...+++..++.++.||+.||+||| +++|+||
T Consensus 60 ~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp CCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred cCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 37999999988654 35689999999 899999996 558999999999999999999999 9999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC------CCCchhHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGY 141 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~~~DvwSlGv 141 (414)
||||+|||++ .++.+||+|||+++.......... .......||+.|+|||++.+. .++.++|||||||
T Consensus 138 Dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 138 DLKSKNILVK---KNGQCCIADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp CCCGGGEEEC---TTSCEEECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred CCChHhEEEc---CCCCEEEeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 9999999996 678999999999987655433211 112345899999999999876 4457999999999
Q ss_pred HHHHHHhC----------CCCCCCCCccc-hHHHHHHHHh-hhccc--hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 142 VLMYFLRG----------SLPWQGLKAGT-KKQKYEKISE-KKVST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 142 vl~elltG----------~~Pf~~~~~~~-~~~~~~~i~~-~~~~~--~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
++|||++| ..||....... ....+..+.. ..... ....+...++.++.+++..||+.||.+||++.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999 88997654322 2222222221 11111 11112234568899999999999999999999
Q ss_pred HHHHHHHHH
Q 015018 208 YLKRLFRDL 216 (414)
Q Consensus 208 ~l~~~l~~~ 216 (414)
++.+.|+++
T Consensus 292 ~i~~~L~~i 300 (301)
T 3q4u_A 292 RIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.61 Aligned_cols=197 Identities=19% Similarity=0.277 Sum_probs=165.2
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.+.+ ..||||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 245 h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~- 323 (450)
T 1k9a_A 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS- 323 (450)
T ss_dssp CTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-
T ss_pred CCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC-
Confidence 699999999987765 789999999 8999999986544 379999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 324 --~~~~~kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 324 --EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --TTSCEEECCCTTCEECC----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred --CCCCEEEeeCCCcccccccc----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 67899999999998543321 22367889999999999999999999999999999998 999998865
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..... ..+...... ..+..+|+++.++|..||..||++||++.+|.+.|+++..
T Consensus 392 ~~~~~---~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 392 LKDVV---PRVEKGYKM----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TTTHH---HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH---HHHHcCCCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 54333 233322111 2345789999999999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=281.07 Aligned_cols=203 Identities=15% Similarity=0.292 Sum_probs=158.9
Q ss_pred CCCCcEEEEeeEeCCEE------EEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015018 2 AAGIPNLRWFGVEGDYN------VLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 69 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~------~lVmE~~-g~sL~~ll~~~~-----~~ls~~~v~~ia~Qll~gL~yLH~~givHRDI 69 (414)
+|||++++.++...+.. |+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||
T Consensus 84 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Di 163 (323)
T 3qup_A 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL 163 (323)
T ss_dssp CTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence 69999999999887766 9999999 899999986431 25999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-
Q 015018 70 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR- 148 (414)
Q Consensus 70 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt- 148 (414)
||+|||++ .++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 164 kp~NIli~---~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 164 AARNCMLA---EDMTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp SGGGEEEC---TTSCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEEc---CCCCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999996 678999999999987654322 112234567889999999999999999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
|..||.+..... .+..+...... .....+++++.+++..||..||++||++.++.+.|++++..
T Consensus 236 g~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 236 GQTPYAGIENAE---IYNYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp SCCTTTTCCGGG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccccChHH---HHHHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999998865432 23333332221 12356889999999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.62 Aligned_cols=198 Identities=22% Similarity=0.199 Sum_probs=166.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+.+..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 144 ~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 223 (373)
T 2x4f_A 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR 223 (373)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET
T ss_pred CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC
Confidence 3699999999999999999999999 899999887656679999999999999999999999999999999999999532
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 224 -~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-- 292 (373)
T 2x4f_A 224 -DAKQIKIIDFGLARRYKPREK--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-- 292 (373)
T ss_dssp -TTTEEEECCCSSCEECCTTCB--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred -CCCcEEEEeCCCceecCCccc--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 457899999999987754321 234579999999999999999999999999999999999999998753
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+........ ......+++++.+||..||..||.+||+++++++
T Consensus 293 -~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 293 -DAETLNNILACRWDLE-DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -HHHHHHHHHHTCCCSC-SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHhccCCCC-hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3444555554433221 2234578999999999999999999999887764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=279.40 Aligned_cols=203 Identities=20% Similarity=0.268 Sum_probs=167.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++.++++.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 163 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 163 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3799999999999999999999999 899999997432 479999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|
T Consensus 164 vH~dlkp~NIl~~---~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 164 IHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp ECSCCSGGGEEEC---GGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cCCCCccceEEEc---CCCeEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9999999999996 66799999999997432211 122346788999999999988999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
+|++ |..||.+.. ..+.+..+...... .....+++++.++|..||..+|.+||+++++.+.|..++....
T Consensus 233 ellt~g~~pf~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 233 EIVSLGGTPYCGMT---CAELYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHTTSCCTTTTCC---HHHHHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHcCCCCCCCCCc---HHHHHHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 9998 999998753 33333333322111 1234678999999999999999999999999999999986543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.60 Aligned_cols=202 Identities=16% Similarity=0.172 Sum_probs=165.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++ ..|+||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 71 ~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-- 147 (281)
T 3cc6_A 71 DHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-- 147 (281)
T ss_dssp CCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE--
T ss_pred CCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC--
Confidence 379999999998755 468999999 8999999987677899999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 148 -~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 148 -SPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp -ETTEEEECCCCGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred -CCCcEEeCccCCCcccccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 668999999999876544221 11234567889999999999999999999999999999998 9999987554
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
..... .+...... .....+++++.+++..||..+|++||++.++.+.|++++..
T Consensus 221 ~~~~~---~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 221 KDVIG---VLEKGDRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp GGHHH---HHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH---HHhcCCCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 33322 22222111 12346889999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=283.14 Aligned_cols=210 Identities=19% Similarity=0.252 Sum_probs=165.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++.+++..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-- 193 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-- 193 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC--
Confidence 3799999999999999999999999 8999999975 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 194 -~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 194 -SNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp -TTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred -CCCcEEEeeCCCCeecccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 6789999999999876543221 12345799999999999863 47899999999999999999999998654
Q ss_pred ccchH-HHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCccccc
Q 015018 158 AGTKK-QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWT 231 (414)
Q Consensus 158 ~~~~~-~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~ 231 (414)
..... .....+..... .++..++..+.+||..||..||.+|| ++++++ ++.+ ...++|.
T Consensus 267 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell---~h~~-------f~~~~~~ 331 (355)
T 1vzo_A 267 EKNSQAEISRRILKSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK---EHLF-------FQKINWD 331 (355)
T ss_dssp SCCCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH---TSGG-------GTTCCHH
T ss_pred ccchHHHHHHHHhccCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH---cCcc-------hhcCChh
Confidence 33322 22222222211 23456789999999999999999999 655553 3322 2345777
Q ss_pred cccc
Q 015018 232 ILKY 235 (414)
Q Consensus 232 ~~~~ 235 (414)
.+..
T Consensus 332 ~l~~ 335 (355)
T 1vzo_A 332 DLAA 335 (355)
T ss_dssp HHHT
T ss_pred Hhhh
Confidence 6543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.64 Aligned_cols=205 Identities=19% Similarity=0.278 Sum_probs=168.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLH 66 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-------------~~~ls~~~v~~ia~Qll~gL~yLH~~givH 66 (414)
.+|||+++++++.+++..||||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+|
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 187 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 3799999999999999999999999 88999998643 346899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHH
Q 015018 67 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 67 RDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~el 146 (414)
|||||+|||++ .++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|+|
T Consensus 188 ~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 188 RDVAARNVLLT---NGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp SCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEC---CCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99999999997 678999999999986654322 1122345678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 147 LR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 147 lt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
++ |..||.+...... +..+....... ..+..+|.++.+++..||..+|.+||++.++.+.|+++...
T Consensus 260 ~t~g~~p~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSK---FYKLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TTTSCCSSTTCCSSHH---HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHH---HHHHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 98 9999987543322 22222222111 12345789999999999999999999999999999988764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=289.82 Aligned_cols=196 Identities=21% Similarity=0.209 Sum_probs=164.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++...||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 107 hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~- 185 (387)
T 1kob_A 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK- 185 (387)
T ss_dssp STTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-
T ss_pred CcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-
Confidence 699999999999999999999999 999999997555689999999999999999999999999999999999999521
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 186 ~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--- 254 (387)
T 1kob_A 186 KASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--- 254 (387)
T ss_dssp TCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---
T ss_pred CCCceEEEecccceecCCCcc--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---
Confidence 346799999999987654321 123479999999999999999999999999999999999999998743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... ....+..+++++.+||..||..||.+||++.+++
T Consensus 255 ~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 255 DLETLQNVKRCDWEF-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp HHHHHHHHHHCCCCC-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCC-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 344444444433221 1223456889999999999999999999987775
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=283.67 Aligned_cols=197 Identities=20% Similarity=0.217 Sum_probs=155.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++...
T Consensus 107 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~ 185 (349)
T 2w4o_A 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA 185 (349)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS
T ss_pred CCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC
Confidence 699999999999999999999999 8999999874 55799999999999999999999999999999999999997434
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 255 (349)
T 2w4o_A 186 PDAPLKIADFGLSKIVEHQVL--------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-- 255 (349)
T ss_dssp TTCCEEECCCC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--
T ss_pred CCCCEEEccCccccccCcccc--------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--
Confidence 578999999999986543221 2346799999999999999999999999999999999999999976432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+..+....... ....+..++.++.+||..||..||++||++.+++
T Consensus 256 ~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 256 DQFMFRRILNCEYYF-ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp HHHHHHHHHTTCCCC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cHHHHHHHHhCCCcc-CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 233444444433221 2233457889999999999999999999987664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.09 Aligned_cols=195 Identities=23% Similarity=0.306 Sum_probs=160.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 64 hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--- 139 (323)
T 3tki_A 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD--- 139 (323)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred CCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---
Confidence 699999999999999999999999 8899998863 55799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||+++.+...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 140 ERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp TTCCEEECCCTTCEECEETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred CCCCEEEEEeeccceeccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 6789999999999876543221 11235689999999999988775 78899999999999999999999875443
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. .+.......... .....++.++.+||..||..||.+||++++++
T Consensus 215 ~~--~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 215 CQ--EYSDWKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp SH--HHHHHHTTCTTS---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HH--HHHHHhcccccC---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 22 222222221111 12346789999999999999999999987764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.59 Aligned_cols=206 Identities=15% Similarity=0.250 Sum_probs=159.4
Q ss_pred CCCCcEEEEeeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++. .++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 149 hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 226 (373)
T 3c1x_A 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-- 226 (373)
T ss_dssp CTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred CCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC--
Confidence 699999999865 456889999999 8999999986667799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+....... ........+|..|+|||++.+..++.++|||||||++|||++ |.+||.+...
T Consensus 227 -~~~~~kL~DFG~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 227 -EKFTVKVADFGLARDMYDKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -TTCCEEECCC------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred -CCCCEEEeecccccccccccccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 67899999999998664432111 111234567889999999999999999999999999999999 7888987654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
..... .+...... .....+|.++.++|..||..+|++||++.++.+.|++++...
T Consensus 303 ~~~~~---~~~~~~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 303 FDITV---YLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp SCHHH---HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHH---HHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 43322 22222211 123468899999999999999999999999999999998543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=268.47 Aligned_cols=196 Identities=21% Similarity=0.225 Sum_probs=164.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 3799999999999999999999999 8999998875 4579999999999999999999999999999999999999544
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.++|+|||++..+..... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+..
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-- 211 (277)
T 3f3z_A 143 SPDSPLKLIDFGLAARFKPGKM--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-- 211 (277)
T ss_dssp STTCCEEECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred CCCCcEEEEecccceeccCccc--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--
Confidence 4778999999999987654322 2345799999999998765 8999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+........ ......+++++.+++..||+.||.+||++.+++
T Consensus 212 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 212 -DSEVMLKIREGTFTFP-EKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp -HHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred -HHHHHHHHHhCCCCCC-chhhhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3444445444443322 233456889999999999999999999987764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=271.12 Aligned_cols=201 Identities=19% Similarity=0.267 Sum_probs=168.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+++..|+||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 62 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~--- 138 (267)
T 3t9t_A 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--- 138 (267)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---
T ss_pred CCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---
Confidence 699999999999999999999999 8999999987667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.++|+|||+++...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-- 210 (267)
T 3t9t_A 139 ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-- 210 (267)
T ss_dssp GGGCEEECCTTGGGGBCCHH------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred CCCCEEEccccccccccccc------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--
Confidence 66889999999987543321 111234567889999999999899999999999999999999 999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+....+...... .....++.++.+++..||..+|++||++.++.+.|+++..
T Consensus 211 -~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 211 -NSEVVEDISTGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -HHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCcC----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33334444332211 1234578999999999999999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=277.51 Aligned_cols=204 Identities=21% Similarity=0.317 Sum_probs=155.0
Q ss_pred CCCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||+++++++.... +.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 70 ~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp CCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 3799999999988654 459999999 8999999975 457999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ .++.+||+|||+++.+...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 149 ~~---~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 149 IS---ATNAVKVMDFGIARAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp EE---TTSCEEECCCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ec---CCCCEEEeeccCcccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 97 6788999999999876543221 1122346799999999999999999999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-HHHHHHHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDL 216 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-~~~l~~~l~~~ 216 (414)
... ......+..... .........++.++.++|..||+.||++||+ .+.+...+...
T Consensus 222 ~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 222 DSP---VSVAYQHVREDP-IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SSH---HHHHHHHHHCCC-CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCh---HHHHHHHhcCCC-CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 532 222222222222 2233445678999999999999999999996 44444444433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=270.00 Aligned_cols=197 Identities=21% Similarity=0.249 Sum_probs=165.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+.
T Consensus 64 h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 142 (284)
T 3kk8_A 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 142 (284)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS
T ss_pred CCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC
Confidence 699999999999999999999999 8999988874 45799999999999999999999999999999999999997544
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
....+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+. .
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~ 211 (284)
T 3kk8_A 143 KGAAVKLADFGLAIEVNDSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---D 211 (284)
T ss_dssp TTCCEEECCCTTCEECCSSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCcEEEeeceeeEEcccCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC---c
Confidence 556699999999987654322 23467999999999999999999999999999999999999999774 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+......... .....+++++.+++..||..||++||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 212 QHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHHTCCCCCT-TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhHHHHHHHhccccCCc-hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 34444444444332221 223568899999999999999999999877743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=276.03 Aligned_cols=205 Identities=15% Similarity=0.244 Sum_probs=165.9
Q ss_pred CCCCcEEEEee-EeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFG-VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g-~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++ ..++..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 85 h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~-- 162 (298)
T 3f66_A 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-- 162 (298)
T ss_dssp CTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC--
Confidence 69999999985 4566889999999 8899999986677899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++........ .........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+...
T Consensus 163 -~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 163 -EKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp -TTCCEEECSCGGGCCCSCGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred -CCCCEEECcccccccccccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 7789999999999866543211 1122344678899999999999999999999999999999999 6777766544
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.... ..+...... .....+|.++.+++..||..+|++||++.++.+.|+.++..
T Consensus 239 ~~~~---~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 239 FDIT---VYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TTHH---HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH---HHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3322 222222211 12346789999999999999999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=283.38 Aligned_cols=210 Identities=16% Similarity=0.188 Sum_probs=167.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++++.+++..|+||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 94 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp CTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred CCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 699999999999999999999999 899999886432 3599999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 174 ---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 174 ---ENFVPKITDFGISKKGTELDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp ---TTCCEEECCCTTCEECSSSSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ---CCCCEEEeeccccccccccccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 7789999999999875443221 11234568999999999999999999999999999999999999998754
Q ss_pred ccchHHHHHHH----Hhhhccch-----HHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKI----SEKKVSTS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 158 ~~~~~~~~~~i----~~~~~~~~-----~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
........... ........ ...+...++.++.+++..||..||++||++.++.+.|+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 43221111111 11111100 0111223467899999999999999999999999999988753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.03 Aligned_cols=204 Identities=19% Similarity=0.341 Sum_probs=170.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~-- 145 (288)
T 3kfa_A 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-- 145 (288)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC--
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc--
Confidence 699999999999999999999999 89999999864 34599999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.++|+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 146 -~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 146 -ENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp -GGGCEEECCCCGGGTSCSSSS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred -CCCCEEEccCccceeccCCcc------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 667899999999976543221 11234567889999999999999999999999999999999 9999987654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
... ...+...... .....+|+++.+++..||..||.+||++.++.+.|+.++....
T Consensus 219 ~~~---~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 219 SQV---YELLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp GGH---HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHH---HHHHhccCCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 332 2222222111 2235688999999999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=282.51 Aligned_cols=194 Identities=20% Similarity=0.292 Sum_probs=153.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++.++++.|||||+.+++|.+++.. ...+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---- 142 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---- 142 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----
T ss_pred CCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----
Confidence 4899999999999999999999779999999985 56899999999999999999999999999999999999995
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----------CCCCchhHHHHHHHHHHHHHhCC
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltG~ 150 (414)
++.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 143 ~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 143 DGMLKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp TTEEEECCCSSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred CCcEEEeecccccccCccccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 578999999999866443221 11234679999999999975 66889999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.||.+... ....+..+....... .+...++.++.+|+..||..||.+||++.+++
T Consensus 218 ~pf~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 218 TPFQQIIN--QISKLHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp CTTTTCCS--HHHHHHHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred Ccchhhhh--HHHHHHHHhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 99976432 222233322222111 22345678999999999999999999987764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=283.35 Aligned_cols=202 Identities=18% Similarity=0.194 Sum_probs=164.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~----~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
++||++++..+..++..||||||+ |++|.++++. ....+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 589999999999999999999999 9999999975 35679999999999999999999999999999999999999
Q ss_pred ee--------cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh
Q 015018 77 GL--------GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 148 (414)
Q Consensus 77 ~~--------~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt 148 (414)
+. +...+.+||+|||+|+.+....... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 63 1126899999999998765322211 1245689999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCC-CCHHHHHHHHHHHHHHh
Q 015018 149 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 149 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~R-P~~~~l~~~l~~~~~~~ 220 (414)
|+.||....... .......... ..++.+.+++..|++.+|.+| |++++|.+.|++++...
T Consensus 281 g~~pf~~~~~~~----------~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 281 GTYMKVKNEGGE----------CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp SSCCCEEEETTE----------EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCccccCCCCc----------eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 999996532211 0011111111 235789999999999999999 47999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=273.51 Aligned_cols=198 Identities=16% Similarity=0.256 Sum_probs=160.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NILl~~ 78 (414)
+|||++++.++.+.. +|||||+ |++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 82 h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 82 HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp CTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC
T ss_pred CCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec
Confidence 699999999987766 6999999 89999998766778999999999999999999999999 999999999999963
Q ss_pred cC--CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc--CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 79 GR--RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 79 ~~--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
+. ....+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCCceeEEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 21 1123999999999744331 23468999999999994 4557899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
...... ......+....... .+...+|+++.++|..||+.||.+||+++++.+.|++
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 230 EYSYGK-IKFINMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp TCCCCH-HHHHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccccH-HHHHHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 755432 22223333222221 2345789999999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.23 Aligned_cols=200 Identities=19% Similarity=0.347 Sum_probs=168.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 275 hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-- 352 (495)
T 1opk_A 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-- 352 (495)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC--
Confidence 699999999999999999999999 899999998643 5699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 353 -~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 353 -ENHLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp -GGGCEEECCTTCEECCTTCCE------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred -CCCcEEEeecccceeccCCce------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 678999999999987644221 12234567889999999999899999999999999999998 9999988654
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
... +..+...... ..+..+|+++.+||..||..+|++||++.+|.+.|+.++
T Consensus 426 ~~~---~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 426 SQV---YELLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp GGH---HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH---HHHHHcCCCC----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 332 2222222111 234578999999999999999999999999999998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=286.64 Aligned_cols=194 Identities=19% Similarity=0.288 Sum_probs=154.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++..+++.|||||+.+++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+||||.
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---- 189 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---- 189 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----
T ss_pred CCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----
Confidence 5899999999999999999999779999999985 45899999999999999999999999999999999999994
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----------CCCCchhHHHHHHHHHHHHHhCC
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltG~ 150 (414)
++.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 190 DGMLKLIDFGIANQMQPDTTS-----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp SSCEEECCCSSSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred CCeEEEEecCccccccCCCcc-----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 478999999999876443211 11234689999999999976 36889999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.||.+... ....+..+....... .+...++.++.+||..||..||.+||++.+++
T Consensus 265 ~Pf~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 265 TPFQQIIN--QISKLHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp CTTTTCCC--HHHHHHHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CcchhhhH--HHHHHHHHhCccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 99976432 223333333322211 12344578999999999999999999987664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.89 Aligned_cols=200 Identities=18% Similarity=0.350 Sum_probs=165.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++. ++..||||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+
T Consensus 242 h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~-- 318 (454)
T 1qcf_A 242 HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-- 318 (454)
T ss_dssp CTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC--
T ss_pred CCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC--
Confidence 699999999886 56789999999 99999999733 24799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++...... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 319 -~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 319 -ASLVCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp -TTCCEEECSTTGGGGBCCHH------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred -CCCcEEEeeCCCceEcCCCc------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 67899999999997654321 111233467889999999998899999999999999999999 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+.+..+...... ..+..+|+++.++|..||..||++||++++|.+.|++++.
T Consensus 392 ---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 392 ---PEVIRALERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---HHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 3333443332221 1235789999999999999999999999999999987764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=269.86 Aligned_cols=190 Identities=22% Similarity=0.286 Sum_probs=158.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~-- 143 (279)
T 3fdn_A 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-- 143 (279)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC--
T ss_pred CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc--
Confidence 3699999999999999999999999 8999999875 35799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 144 -~~~~~~l~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 210 (279)
T 3fdn_A 144 -SAGELKIADFGWSVHAPSSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--- 210 (279)
T ss_dssp -TTSCEEECSCCEESCC-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred -CCCCEEEEeccccccCCccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---
Confidence 77899999999985443321 23457999999999999999999999999999999999999999864
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+.+..+...... ++..+++++.++|..||..+|.+||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 211 TYQETYKRISRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp SHHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHhCCCC-----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 333444444433322 23457899999999999999999999776653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=279.06 Aligned_cols=206 Identities=16% Similarity=0.255 Sum_probs=168.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~------~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
.+|||+++++++.+.+..||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~N 170 (327)
T 2yfx_A 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 170 (327)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhH
Confidence 3799999999999999999999999 999999998643 359999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~P 152 (414)
||++.+.....++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 171 Ili~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 171 CLLTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEEecCCCcceEEECccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9997544566799999999875433221 111234568999999999999999999999999999999998 9999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
|.+.. ..+.+..+...... .....++.++.++|..||..+|.+||++.+|.+.|..+..
T Consensus 246 ~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 246 YPSKS---NQEVLEFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp STTCC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcC---HHHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 97743 33333333333221 1345688999999999999999999999999999987764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=276.67 Aligned_cols=209 Identities=21% Similarity=0.246 Sum_probs=163.5
Q ss_pred CCCCCcEEEEeeEeCC--EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGD--YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~--~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||++++.++.+.. +.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 65 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 144 (319)
T 4euu_A 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (319)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 3699999999988765 889999999 899999997543 23999999999999999999999999999999999999
Q ss_pred Eeec-CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc--------CCCCCchhHHHHHHHHHHHH
Q 015018 76 MGLG-RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 76 l~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~s~~~DvwSlGvvl~el 146 (414)
+..+ ...+.+||+|||+++.+..... .....||..|+|||++. +..++.++|||||||++|+|
T Consensus 145 l~~~~~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp EEECTTSCEEEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred EeccCCCCceEEEccCCCceecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 8433 2556799999999987655332 13457999999999987 56789999999999999999
Q ss_pred HhCCCCCCCCCcc-chHHHHHHHHhhhccchH--------------------HHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 147 LRGSLPWQGLKAG-TKKQKYEKISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 147 ltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~--------------------~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
++|..||...... ...+.+.++........+ ..+...++..+.+++..||+.||++||+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence 9999999764432 223334444333221100 0112234578999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 015018 206 YAYLKRLFRDLF 217 (414)
Q Consensus 206 ~~~l~~~l~~~~ 217 (414)
++++.+-..+-.
T Consensus 297 ~~ell~h~~d~~ 308 (319)
T 4euu_A 297 FDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHhhhccHHHh
Confidence 988877766543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=273.24 Aligned_cols=207 Identities=14% Similarity=0.211 Sum_probs=167.6
Q ss_pred CCCCCcEEEEeeEeCCEE-EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYN-VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~-~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||+++++++.+.+.. ++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 ~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~- 158 (298)
T 3pls_A 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD- 158 (298)
T ss_dssp CCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-
Confidence 379999999999876655 9999999 9999999986677899999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~-~Pf~~~~ 157 (414)
.++.+||+|||+++.+...... .........+|..|+|||.+.+..++.++|||||||++|+|++|. +||.+..
T Consensus 159 --~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 159 --ESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp --TTCCEEECCTTSSCTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred --CCCcEEeCcCCCcccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 6789999999999765432211 112234567899999999999999999999999999999999954 5554433
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
... ....+...... .....+++++.+++..||..+|.+||++.++.+.|++++...
T Consensus 234 ~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 234 PFD---LTHFLAQGRRL----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp GGG---HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHH---HHHHhhcCCCC----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 322 22222222211 123467899999999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=274.47 Aligned_cols=191 Identities=18% Similarity=0.275 Sum_probs=157.0
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+ +++.||||||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~- 171 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG- 171 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC-
Confidence 6999999999987 67899999999 889887654 45799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 172 --~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 172 --EDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp --TTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --CCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 678999999999987654322 113458999999999998765 37889999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. .......+........ ....+++++.++|..||..||++||++.+++
T Consensus 243 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 243 ER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp SS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 43 2333333333222211 1246889999999999999999999988774
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=276.96 Aligned_cols=210 Identities=18% Similarity=0.223 Sum_probs=165.9
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++.+ ....||||||+ +++|.+++.. ..+++..++.++.||+.+|+|||++||+||||||+|||++
T Consensus 92 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~- 168 (318)
T 3lxp_A 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD- 168 (318)
T ss_dssp CTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-
T ss_pred CcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc-
Confidence 6899999999998 47889999999 8999999974 4699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+...... ........+|..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 169 --~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 169 --NDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp --TTCCEEECCGGGCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred --CCCCEEECCccccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 6788999999999887553321 1122345788999999999999999999999999999999999999975321
Q ss_pred c--------chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 G--------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~--------~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
. ........+............+..++.++.+||..||..||.+||++.++.+.|+.+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1 0000000111100001111224568899999999999999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=278.11 Aligned_cols=206 Identities=18% Similarity=0.262 Sum_probs=168.1
Q ss_pred CCCCcEEEEeeEeCC-EEEEEEecC-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 2 AAGIPNLRWFGVEGD-YNVLVIDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-~~~lVmE~~-g~sL~~ll~~~~~~---------------ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
+|||+++++++...+ ..|+||||+ |++|.+++...... +++..++.++.||+.||+|||++||
T Consensus 90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 169 (316)
T 2xir_A 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 169 (316)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 699999999987754 589999999 88999999854322 8999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
+||||||+|||++ ..+.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 170 ~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (316)
T 2xir_A 170 IHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241 (316)
T ss_dssp CCSCCSGGGEEEC---GGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ccccCccceEEEC---CCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHH
Confidence 9999999999996 668899999999986544322 11123456889999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
+|++ |..||.+..... .....+...... .....+++++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 242 ~l~t~g~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 242 EIFSLGASPYPGVKIDE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHTTSCCSSTTCCCSH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhCCCCCCcccchhH--HHHHHhccCccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 9998 999998754322 222222222111 1234578999999999999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=273.95 Aligned_cols=194 Identities=22% Similarity=0.287 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 74 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~--- 149 (321)
T 2a2a_A 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL--- 149 (321)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---
T ss_pred CCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---
Confidence 699999999999999999999999 9999999974 56799999999999999999999999999999999999996
Q ss_pred CCC----eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 81 RAN----QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 81 ~~~----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..+ .++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 150 ~~~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 150 DKNIPIPHIKLIDFGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CTTSSSCCEEECCCTTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCCCCcCCEEEccCccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 333 799999999987654321 23457999999999999999999999999999999999999999774
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+.+..+...... ....+...+++++.++|..||..||++||+++++++
T Consensus 222 ---~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 222 ---TKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ---SHHHHHHHHHTTCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ---CHHHHHHHHHhcccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 334444444443332 223445678999999999999999999999887753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.89 Aligned_cols=197 Identities=18% Similarity=0.185 Sum_probs=158.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+.|||++++..+...++.||||||++++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~-- 234 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK-- 234 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES--
T ss_pred CCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc--
Confidence 3579999999999999999999999889999997643 4599999999999999999999999999999999999996
Q ss_pred CCCCe--EEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 80 RRANQ--VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 80 ~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..+. +||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 235 -~~~~~~vkL~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 235 -QQGRSGIKVIDFGSSCYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp -STTSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cCCCcceEEeecccceecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4444 9999999997654321 34689999999999999999999999999999999999999998864
Q ss_pred ccchHHHHHHHHhhhcc---------------------------------------------------chHHHhhcCCcH
Q 015018 158 AGTKKQKYEKISEKKVS---------------------------------------------------TSIEALCRGYPT 186 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~---------------------------------------------------~~~~~l~~~~p~ 186 (414)
.......+......... .....+....++
T Consensus 304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 383 (429)
T 3kvw_A 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383 (429)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence 43222222211100000 001112223478
Q ss_pred HHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 187 EFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 187 e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
++.+||..||..||++||++++++
T Consensus 384 ~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 384 LFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHCCCChhhCCCHHHHh
Confidence 899999999999999999988775
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=270.34 Aligned_cols=202 Identities=19% Similarity=0.360 Sum_probs=167.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.+ +..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 67 h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~-- 143 (279)
T 1qpc_A 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-- 143 (279)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc--
Confidence 6999999998864 4579999999 99999998632 23699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
..+.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 144 -~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 144 -DTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp -TTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred -CCCCEEECCCcccccccCccc------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 678999999999987654321 11234567889999999998889999999999999999999 9999987533
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+.+..+...... ..+..+|+++.+++..||..+|++||++++|.+.|++++...
T Consensus 217 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 217 ---PEVIQNLERGYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHhcccCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 3333333332111 224578899999999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=277.71 Aligned_cols=217 Identities=15% Similarity=0.198 Sum_probs=161.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 88 h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~--- 164 (319)
T 2y4i_B 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--- 164 (319)
T ss_dssp CTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---
T ss_pred CCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---
Confidence 699999999999999999999999 8999999986566799999999999999999999999999999999999994
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---------CCCCchhHHHHHHHHHHHHHhCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---------~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
++.++|+|||+++......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 165 -~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 165 -NGKVVITDFGLFSISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp ---CCEECCCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred -CCCEEEeecCCccccccccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 5689999999987543221110 0111234569999999999975 347889999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccc
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 230 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w 230 (414)
||.+.. ....+..+....... .....+|.++.+++..||..+|++||++.++.+.|+++..+.....+....|
T Consensus 242 p~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 242 PFKTQP---AEAIIWQMGTGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp SSSSCC---HHHHHHHHHTTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CCCCCC---HHHHHHHhccCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 998743 233333333322211 1123578999999999999999999999999999998876554433444444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=270.02 Aligned_cols=206 Identities=24% Similarity=0.311 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~--~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+++..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~- 167 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD- 167 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc-
Confidence 699999999999999999999999 99999998743 45699999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||+++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...
T Consensus 168 --~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 168 --EAFTAKISDFGLARASEKFAQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp --TTCCEEECCCTTCEECCSCSSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred --CCCcEEEeecccccccccccccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 67899999999998765432211 1234679999999999876 478999999999999999999999987554
Q ss_pred cchHHHHHHHHhhhccchHHH--------hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEA--------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~--------l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
......+......... .+.. ....++.++.+++..||..+|.+||++.++.+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEK-TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSBTTHHHHHHHTTSC-CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHHHHHHHhhhhhh-hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 3322222111111111 1111 11224578999999999999999999999999998763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=279.03 Aligned_cols=197 Identities=18% Similarity=0.268 Sum_probs=160.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.+++..||||||+ |++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC
Confidence 599999999999999999999999 8899998753 24679999999999999999999999999999999999999743
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-- 237 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-- 237 (327)
T ss_dssp TTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred CCCCcEEEeeCccccccCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 3368999999999987654321 234679999999999999999999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... .......+++++.++|..||..||++||++++++
T Consensus 238 -~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 238 -NQETYLNISQVNVDY-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp -HHHHHHHHHHTCCCC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred -chHHHHHHHhccccc-CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 344444444433322 2233456889999999999999999999987764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.20 Aligned_cols=202 Identities=20% Similarity=0.284 Sum_probs=157.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 93 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~--- 168 (309)
T 2h34_A 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS--- 168 (309)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---
Confidence 699999999999999999999999 8899999985 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||++........ .......||..|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 240 (309)
T 2h34_A 169 ADDFAYLVDFGIASATTDEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-- 240 (309)
T ss_dssp TTSCEEECSCCC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--
T ss_pred CCCCEEEecCccCcccccccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--
Confidence 678999999999976654321 112345799999999999999999999999999999999999999987432
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 218 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-~~~~l~~~l~~~~~ 218 (414)
. .+........ .....+...+|.++.++|..||..||++|| ++++|.+.|+..+.
T Consensus 241 -~-~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 241 -S-VMGAHINQAI-PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -H-HHHHHHHSCC-CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -H-HHHHHhccCC-CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1 2222222111 122344567899999999999999999999 99999999887753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=282.69 Aligned_cols=201 Identities=14% Similarity=0.162 Sum_probs=138.5
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
++|||++++.++.. +.+.||||||+ |++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 80 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NI 159 (336)
T 3fhr_A 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159 (336)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 47999999999887 56789999999 889999998543 4699999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++.+...+.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 160 ll~~~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 160 LYTSKEKDAVLKLTDFGFAKETTQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp EESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEecCCCceEEEeccccceecccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 997544567799999999987654221 34578999999999998889999999999999999999999997
Q ss_pred CCCccchHHH-HHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQK-YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~~-~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+......... ...+....... .......++.++.+||..||..||.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 231 SNTGQAISPGMKRRIRLGQYGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------------------CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccchhhhhhHHHhhhcccccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 6543221111 11111111111 11123468899999999999999999999877653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.23 Aligned_cols=189 Identities=19% Similarity=0.254 Sum_probs=159.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++.++.+++..||||||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 113 hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~ 189 (348)
T 1u5q_A 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---E 189 (348)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---T
T ss_pred CCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---C
Confidence 6999999999999999999999998899999876677899999999999999999999999999999999999997 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
++.+||+|||+++.... .....||+.|+|||++. +..++.++|||||||++|||++|..||.+...
T Consensus 190 ~~~~kL~DfG~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 190 PGLVKLGDFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp TTEEEECCCTTCBSSSS-----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCEEEeeccCceecCC-----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 78999999999975432 13468999999999985 45688999999999999999999999977532
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+........ ....+++++.++|..||..+|.+||++++++
T Consensus 259 ---~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 259 ---MSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp ---HHHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ---HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 233333333222111 1346789999999999999999999988775
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.76 Aligned_cols=189 Identities=23% Similarity=0.234 Sum_probs=157.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.+.+..||||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 68 hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~ 143 (336)
T 3h4j_B 68 HPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---D 143 (336)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---T
T ss_pred CCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---C
Confidence 6999999999999999999999999999998875 45799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....
T Consensus 144 ~~~~kl~DFG~s~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 144 NLNVKIADFGLSNIMTDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp TCCEEECCSSCTBTTTTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred CCCEEEEEeccceeccCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 7899999999997654322 1234689999999999998776 789999999999999999999998743221
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. .. .......++..+++++.++|..||..||.+||++++++
T Consensus 216 ~~---~~-----i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 216 LF---KK-----VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp CB---CC-----CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred HH---HH-----HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 11 11 11111123455789999999999999999999987664
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=279.38 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=158.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE 150 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC
Confidence 699999999999999999999999 8999999987655699999999999999999999999999999999999997332
Q ss_pred C-----CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhC-CCCC
Q 015018 81 R-----ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRG-SLPW 153 (414)
Q Consensus 81 ~-----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG-~~Pf 153 (414)
. .+.+||+|||++...... ....||..|+|||++.+ ..++.++|||||||++|+|++| ..||
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccccccceeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 1 122999999998643221 22457889999999988 6789999999999999999995 5555
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..... ...... .... ..+...++.++.+++..||+.||.+||++.++.+.|++++.
T Consensus 220 ~~~~~---~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 220 SALDS---QRKLQF-YEDR-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTSCH---HHHHHH-HHTT-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cccch---HHHHHH-hhcc-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 44322 111111 1111 11234567899999999999999999999999999987753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.77 Aligned_cols=200 Identities=19% Similarity=0.338 Sum_probs=161.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.+ +..||||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 238 hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-- 314 (452)
T 1fmk_A 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-- 314 (452)
T ss_dssp CTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC--
Confidence 6999999998876 6689999999 89999999643 45699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 315 -~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 315 -ENLVCKVADFGLARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp -GGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred -CCCCEEECCCccceecCCCce------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 668999999999986643221 11233467889999999999999999999999999999999 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+.+..+...... .....+|+++.++|..||..+|++||++++|.+.|++++.
T Consensus 388 ---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 388 ---REVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 3334443332211 1235789999999999999999999999999999988763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=269.38 Aligned_cols=195 Identities=24% Similarity=0.337 Sum_probs=155.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++++.+.+..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+.
T Consensus 79 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~ 158 (285)
T 3is5_A 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158 (285)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEES
T ss_pred CchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEe
Confidence 699999999999999999999999 88999988532 46899999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+...+.+||+|||+++.+..... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 159 ~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 159 DTSPHSPIKIIDFGLAELFKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp SSSTTCCEEECCCCCCCC------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCCCEEEEeeecceecCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 544568899999999976544221 23457999999999986 468999999999999999999999998753
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. .+....+....... ...+..+++++.+++..||..||.+||++.+++
T Consensus 230 ~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 230 L---EEVQQKATYKEPNY--AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp H---HHHHHHHHHCCCCC--CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred H---HHHHhhhccCCccc--ccccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 2 22222222222111 112345789999999999999999999988775
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.60 Aligned_cols=203 Identities=21% Similarity=0.266 Sum_probs=166.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++ .++||||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~-- 155 (291)
T 1u46_A 79 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-- 155 (291)
T ss_dssp CCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE--
T ss_pred CCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc--
Confidence 3799999999998776 78999999 8999999986666799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||++.......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 156 -~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~- 229 (291)
T 1u46_A 156 -TRDLVKIGDFGLMRALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN- 229 (291)
T ss_dssp -ETTEEEECCCTTCEECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred -CCCCEEEccccccccccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-
Confidence 66899999999998775433211 11234567889999999999889999999999999999999 999998753
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..+.+..+....... .....+|.++.+++..||..+|++||++.++.+.|+++.
T Consensus 230 --~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 230 --GSQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --HHHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --HHHHHHHHHccCCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 333444443322211 123568999999999999999999999999999988774
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=301.84 Aligned_cols=202 Identities=18% Similarity=0.318 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++..+ ..+|||||+ |++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 429 hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~--- 503 (635)
T 4fl3_A 429 NPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV--- 503 (635)
T ss_dssp CTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---
T ss_pred CCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---
Confidence 69999999998754 578999999 9999999975 56899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+...... +.......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 504 ~~~~~kL~DFGla~~~~~~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~- 578 (635)
T 4fl3_A 504 TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG- 578 (635)
T ss_dssp ETTEEEECCTTHHHHTTC-----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-
T ss_pred CCCCEEEEEcCCccccccCccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 6689999999999866543211 111233467889999999999999999999999999999998 9999988543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+....+...... .+...+|+++.+||..||..||++||++++|.+.|++++..
T Consensus 579 --~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 579 --SEVTAMLEKGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3333333333221 23457899999999999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=269.09 Aligned_cols=207 Identities=21% Similarity=0.284 Sum_probs=160.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||++++.++.+++..++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~ 169 (310)
T 2wqm_A 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169 (310)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE
Confidence 3699999999999999999999999 8899999864 35679999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ .++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 170 ~---~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 170 T---ATGVVKLGDLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp C---TTSCEEECCC-------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred c---CCCCEEEEeccceeeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 6 678999999999986544221 113457899999999999999999999999999999999999999764
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhC
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 221 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~ 221 (414)
.. ........+........ ....++.++.++|..||..||.+||++.++.+.|+++.....
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 240 KM-NLYSLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -C-CHHHHHHHHHTTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ch-hHHHHHHHhhcccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 32 22233333333222211 124678999999999999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=272.84 Aligned_cols=199 Identities=18% Similarity=0.187 Sum_probs=157.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
.++|++++.++.+.++.||||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++...
T Consensus 76 ~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp TTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred ceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 457999999999999999999999999999997543 3699999999999999999999999999999999999996321
Q ss_pred C----------------CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 81 R----------------ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 81 ~----------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
. .+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 1 567999999999865432 13468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccchHHHHHHHHhhhccch--------------------------HHHh----------hcCCcHHH
Q 015018 145 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS--------------------------IEAL----------CRGYPTEF 188 (414)
Q Consensus 145 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~l----------~~~~p~e~ 188 (414)
+|++|..||.+.........+..+........ .... ...+++++
T Consensus 226 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 99999999987544332323322221100000 0000 11235789
Q ss_pred HHHHHHHHcCCCCCCCCHHHHH
Q 015018 189 ASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 189 ~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+||..||..||.+||++.+++
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHHHHHHhCcCcccccCHHHHh
Confidence 9999999999999999987774
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=271.65 Aligned_cols=198 Identities=19% Similarity=0.236 Sum_probs=154.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ +++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~--- 136 (311)
T 4agu_A 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT--- 136 (311)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCccchhheeecCCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---
Confidence 699999999999999999999999 777877776 366799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSD-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp TTSCEEECCCTTCEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCCCEEEeeCCCchhccCccc-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 678999999999987654322 1234578999999999986 56799999999999999999999999886443
Q ss_pred chHHHHHHHHhhhc-----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKV-----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~-----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+........ ..........++.++.+++..||..||.+||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 210 DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 32222222111100 0111222356889999999999999999999987765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.35 Aligned_cols=203 Identities=16% Similarity=0.304 Sum_probs=160.1
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecC-CCCHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLL-GPSLEDLFNF-----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~-g~sL~~ll~~-----~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
+|||++++.++.+.+ +.|+||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+|||||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 174 (313)
T 3brb_A 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA 174 (313)
T ss_dssp CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCS
T ss_pred CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 699999999988765 359999999 8999999853 24569999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-C
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-G 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G 149 (414)
|+|||++ .++.+||+|||+++.+..... +.......+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 175 p~NIli~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 175 ARNCMLR---DDMTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp GGGEEEC---TTSCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cceEEEc---CCCcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 9999996 678999999999987654321 112234567889999999999999999999999999999999 9
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
..||.+..... .+..+...... .....+++++.+++..||..+|.+||++.+|++.|++++..
T Consensus 247 ~~p~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHE---MYDYLLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGG---HHHHHHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHH---HHHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99998754432 23333332221 23457889999999999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=279.71 Aligned_cols=206 Identities=20% Similarity=0.218 Sum_probs=165.3
Q ss_pred CCCCcEEEEeeE--eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~--~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++. +....||||||+ |++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 83 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~- 161 (327)
T 3lxl_A 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE- 161 (327)
T ss_dssp CTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred CCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC-
Confidence 689999998776 567899999999 9999999986566799999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++......... .......||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 162 --~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 162 --SEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp --ETTEEEECCGGGCEECCTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred --CCCCEEEcccccceecccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 67889999999998775433211 122345789999999999999999999999999999999999999965321
Q ss_pred cc-----------h-HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GT-----------K-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~-----------~-~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.. . ......+.... .......+++++.+++..||..||.+||++.+|.+.|+.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhhhhcccccccccHHHHHHHhhccc----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 0 01111111111 111235688999999999999999999999999999988864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=276.44 Aligned_cols=195 Identities=21% Similarity=0.227 Sum_probs=164.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++....+.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~-- 234 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-- 234 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 4799999999999999999999999 8899999974 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC------CCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.++.++|+|||++..+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 235 -~~~~ikl~DfG~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 235 -DNMQIRLSDFGFSCHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp -TTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCCEEEEecCcccccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 778999999999987654321 2346899999999998743 5788999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+. .....+..+.......... .+..++.++.++|..||..||.+||++.++++
T Consensus 306 ~~~---~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 306 WHR---RQILMLRMIMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCS---SHHHHHHHHHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC---CHHHHHHHHHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 764 3344455555544433322 34578899999999999999999999887753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=280.12 Aligned_cols=197 Identities=19% Similarity=0.218 Sum_probs=148.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 74 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~ 152 (361)
T 3uc3_A 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152 (361)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS
T ss_pred CCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 3799999999999999999999999 9999999875 4579999999999999999999999999999999999999621
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~-~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.+||+|||+++...... ......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+...
T Consensus 153 -~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 153 -PAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -SSCCEEECCCCCC-----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred -CCceEEEeecCccccccccC--------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 22359999999997433211 1234579999999999998887655 8999999999999999999987544
Q ss_pred cc-hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GT-KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~-~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. ....+..+........ ....+++++.+||..||..+|.+||++.+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 273 (361)
T 3uc3_A 224 PRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIK 273 (361)
T ss_dssp CCCHHHHHHHHHTTCCCCC---TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCC---CcCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 32 2333333333222111 1125789999999999999999999987664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.25 Aligned_cols=212 Identities=18% Similarity=0.195 Sum_probs=170.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||+++++.++++++.||||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 242 ~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld- 320 (576)
T 2acx_A 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD- 320 (576)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe-
Confidence 3799999999999999999999999 999999987543 3499999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 321 --~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 321 --DHGHIRISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp --TTSCEEECCCTTCEECCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred --CCCCeEEEecccceecccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 778999999999987654321 1345899999999999999999999999999999999999999987654
Q ss_pred cch-HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 159 GTK-KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 159 ~~~-~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~--~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
... .+.+..+..... .+...+++++.+||..||..||.+||++. .+.+++.+ .+...++|..+..
T Consensus 391 ~~~~~~i~~~i~~~~~-----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H-------pfF~~i~w~~l~~ 458 (576)
T 2acx_A 391 KIKREEVERLVKEVPE-----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH-------PLFKKLNFKRLGA 458 (576)
T ss_dssp CCCHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS-------GGGTTCCHHHHHT
T ss_pred chhHHHHHHHhhcccc-----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC-------hhhccCCHHHHhc
Confidence 332 333333333222 13356889999999999999999999431 23333332 3334568887654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=268.96 Aligned_cols=189 Identities=16% Similarity=0.152 Sum_probs=155.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
.+|||+++++++.++++.||||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 3799999999999999999999999 88999999753 2679999999999999999999999999999999999999
Q ss_pred eecC----------------CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHH
Q 015018 77 GLGR----------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESL 139 (414)
Q Consensus 77 ~~~~----------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSl 139 (414)
+.+. ....++|+|||++....... ...||..|+|||++.+. .++.++|||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 6432 44579999999998765422 24699999999999876 56689999999
Q ss_pred HHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 140 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 140 Gvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
||++|+|++|..|+... .....+..... ..+...+++++.+++..||..||++||++.+++
T Consensus 218 G~il~~l~~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNG------DQWHEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHHHHTTCCCCCSSS------HHHHHHHTTCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhcCCCCCcch------hHHHHHHcCCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 99999999998877542 12233333222 234467899999999999999999999988774
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=293.76 Aligned_cols=212 Identities=18% Similarity=0.251 Sum_probs=171.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
+|||+++++++++.++.||||||+ |++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 244 hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~ 323 (543)
T 3c4z_A 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323 (543)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe
Confidence 699999999999999999999999 99999998754 34699999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 324 ---~~g~vkL~DFGla~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 324 ---DDGNVRISDLGLAVELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp ---TTSCEEECCCTTCEECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ---CCCCEEEeecceeeeccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 778999999999987654332 1234689999999999999999999999999999999999999998754
Q ss_pred cc-chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH--HHHHHHHHHHHhCCCCCCcccccccc
Q 015018 158 AG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 158 ~~-~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~--l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
.. ...+.+..+...... ++..++.++.++|..||..||.+||++.+ +.+++.+ .+...++|..+.
T Consensus 394 ~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H-------pff~~i~w~~l~ 461 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVT-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH-------PLFRDISWRQLE 461 (543)
T ss_dssp CCCCHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS-------GGGTTCCHHHHH
T ss_pred cchhHHHHHHHHhhcccC-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC-------ccccCCCHHHHH
Confidence 32 234444444443322 23568899999999999999999997532 1223222 334456887764
Q ss_pred c
Q 015018 235 Y 235 (414)
Q Consensus 235 ~ 235 (414)
.
T Consensus 462 ~ 462 (543)
T 3c4z_A 462 A 462 (543)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.58 Aligned_cols=198 Identities=21% Similarity=0.191 Sum_probs=153.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec--
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-- 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~-- 79 (414)
+|||++++.++.+++..||||||++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 92 h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 92 HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC---
T ss_pred CCCcceEEEEEecCCEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC
Confidence 6999999999999999999999998899999985 5579999999999999999999999999999999999999632
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
...+.+||+|||+++.+..... ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.+...
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp --CCEEEECCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CccceEEECcCCCccccCCccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 2345699999999976543221 123457899999999998754 89999999999999999999999987543
Q ss_pred cchHHHHHHHHhhhc-------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKV-------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~-------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+..... ......+...+++++.+||..||..||.+||++++++
T Consensus 244 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 244 ---IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp ---HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 233333322110 0011122233778999999999999999999987764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.44 Aligned_cols=196 Identities=20% Similarity=0.287 Sum_probs=165.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.++...||||||| |++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++..
T Consensus 94 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 172 (494)
T 3lij_A 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172 (494)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred CCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC
Confidence 3799999999999999999999999 9999998864 4579999999999999999999999999999999999999754
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 173 ~~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--- 240 (494)
T 3lij_A 173 EKDALIKIVDFGLSAVFENQKK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ--- 240 (494)
T ss_dssp STTCCEEECCCTTCEECBTTBC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CCCCcEEEEECCCCeECCCCcc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---
Confidence 4567799999999987754321 234679999999999874 6899999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+.+..+......... ..+..+++++.+||..||..+|.+||++.+++
T Consensus 241 ~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 241 TDQEILRKVEKGKYTFDS-PEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp SHHHHHHHHHHTCCCCCS-GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHhCCCCCCc-hhcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 334555555554443222 23457899999999999999999999988875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=275.78 Aligned_cols=191 Identities=22% Similarity=0.292 Sum_probs=162.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 99 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-- 175 (335)
T 2owb_A 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-- 175 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC--
T ss_pred CCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc--
Confidence 4799999999999999999999999 8999999875 45899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 176 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-- 245 (335)
T 2owb_A 176 -EDLEVKIGDFGLATKVEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-- 245 (335)
T ss_dssp -TTCCEEECCCTTCEECCSTTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred -CCCCEEEeeccCceecccCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--
Confidence 678899999999987653321 1234679999999999999999999999999999999999999997643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+...... +...++.++.++|..||..||++||++++|+
T Consensus 246 -~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 246 -LKETYLRIKKNEYS-----IPKHINPVAASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp -HHHHHHHHHHTCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred -HHHHHHHHhcCCCC-----CCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 33344444433222 3356789999999999999999999977664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=268.25 Aligned_cols=195 Identities=9% Similarity=0.131 Sum_probs=161.5
Q ss_pred CCCCcEEEEeeEeC--CEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG--DYNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~--~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NIL 75 (414)
+|||+++++++.+. ++.|+||||+ |++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 66 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil 145 (271)
T 3kmu_A 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145 (271)
T ss_dssp CTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEE
T ss_pred CCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEE
Confidence 69999999999887 7889999999 8999999985433 5999999999999999999999999 999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCc---hhHHHHHHHHHHHHHhCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR---RDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~---~~DvwSlGvvl~elltG~~P 152 (414)
++ .++.++|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..|
T Consensus 146 ~~---~~~~~~l~~~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 146 ID---EDMTARISMADVKFSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp EC---TTSCEEEEGGGSCCTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred Ec---CCcceeEEeccceeeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 96 678899999988653221 2357899999999999766544 79999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
|.+... .+....+....... .++..+++++.+++..||..||++||+++++.+.|+++.
T Consensus 211 ~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 211 FADLSN---MEIGMKVALEGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTTSCH---HHHHHHHHHSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccCh---HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 987533 23333333222221 234578999999999999999999999999999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.97 Aligned_cols=197 Identities=20% Similarity=0.283 Sum_probs=163.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+....||||||| |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 79 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~ 157 (486)
T 3mwu_A 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (486)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC
Confidence 3799999999999999999999999 9999998865 4589999999999999999999999999999999999999654
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--- 225 (486)
T 3mwu_A 158 EKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--- 225 (486)
T ss_dssp STTCCEEECSCSCTTTBCCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CCCCCEEEEECCcCeECCCCC--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 456789999999997554322 1234689999999999987 4899999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+.+..+.........+ .+..+++++.+||..||..+|.+||++.++++
T Consensus 226 ~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 226 NEYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SHHHHHHHHHHTCCCSCSG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3445555555554433222 23567899999999999999999999877653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.07 Aligned_cols=206 Identities=17% Similarity=0.188 Sum_probs=150.3
Q ss_pred CCCCCcEEEEeeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVE-----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||+++++++.. ....||||||++++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+|||
T Consensus 110 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NIL 188 (458)
T 3rp9_A 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188 (458)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCCCCCceEEEEecCCcccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEE
Confidence 37999999999854 357899999999999999974 567999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccc-c-------------------ccccCCCCCCccccchhhhc-CCCCCchh
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHI-P-------------------YRENKNLTGTARYASMNTHL-GIEQSRRD 134 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~-~-------------------~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~ 134 (414)
|+ .++.+||+|||+++........... + .......+||+.|+|||++. +..++.++
T Consensus 189 l~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 265 (458)
T 3rp9_A 189 VN---QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265 (458)
T ss_dssp EC---TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred EC---CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence 96 7789999999999876532211000 0 01224568899999999874 56699999
Q ss_pred HHHHHHHHHHHHHh-----------CCCCCCCCCcc-----------------chHHHHHHHHhhh--------------
Q 015018 135 DLESLGYVLMYFLR-----------GSLPWQGLKAG-----------------TKKQKYEKISEKK-------------- 172 (414)
Q Consensus 135 DvwSlGvvl~ellt-----------G~~Pf~~~~~~-----------------~~~~~~~~i~~~~-------------- 172 (414)
|||||||+||||++ |..+|.+.... .....+..+.+..
T Consensus 266 DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 345 (458)
T 3rp9_A 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345 (458)
T ss_dssp HHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH
T ss_pred HHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH
Confidence 99999999999998 67777653210 0011111111100
Q ss_pred ------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 173 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 173 ------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+......+++++.+||..||..||.+||++++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L 395 (458)
T 3rp9_A 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395 (458)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 00111223345689999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=275.03 Aligned_cols=203 Identities=19% Similarity=0.166 Sum_probs=157.5
Q ss_pred CCCCcEEEEeeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVE--------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||++++.++.+ ++..||||||++++|.+.+......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 75 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 154 (351)
T 3mi9_A 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 154 (351)
T ss_dssp CTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence 6899999999887 45789999999889999888666789999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
||++ .++.+||+|||+++.+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 155 Il~~---~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 155 VLIT---RDGVLKLADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp EEEC---TTSCEEECCCTTCEECCCCSSSS---CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEc---CCCCEEEccchhccccccccccc---ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 9996 67899999999998775432211 112245678999999999986 4579999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHh-----------------------h-cCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEAL-----------------------C-RGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l-----------------------~-~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
|.+.........+..+............ . ...++++.+||..||..||.+||++++
T Consensus 229 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 9885433322222222111111000000 0 012678999999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 309 ~l 310 (351)
T 3mi9_A 309 AL 310 (351)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=266.39 Aligned_cols=189 Identities=16% Similarity=0.236 Sum_probs=161.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 73 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--- 148 (284)
T 2vgo_A 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG--- 148 (284)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---
T ss_pred CCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---
Confidence 699999999999999999999999 8899999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||++....... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--- 216 (284)
T 2vgo_A 149 YKGELKIADFGWSVHAPSLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--- 216 (284)
T ss_dssp TTCCEEECCCTTCEECSSSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---
T ss_pred CCCCEEEecccccccCcccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---
Confidence 67889999999997654322 134679999999999999999999999999999999999999997643
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.......+...... +...++.++.++|..||..+|.+||+++++++
T Consensus 217 ~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 217 HTETHRRIVNVDLK-----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHHHHTTCCC-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhHHHHHHhccccC-----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 33333333332221 33567899999999999999999999877653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.39 Aligned_cols=196 Identities=18% Similarity=0.168 Sum_probs=161.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.+.+..||||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~ 147 (346)
T 1ua2_A 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---E 147 (346)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---T
T ss_pred CCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---C
Confidence 6999999999999999999999997799999986666799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--- 217 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--- 217 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred CCCEEEEecccceeccCCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---
Confidence 78999999999976543221 12346789999999999765 48899999999999999999999998753
Q ss_pred hHHHHHHHHhhhcc-----------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVS-----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~-----------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+...... .....+...++.++.+||..||..||.+||++++++
T Consensus 218 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 218 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 33333443332111 112234456789999999999999999999987764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=268.03 Aligned_cols=191 Identities=22% Similarity=0.292 Sum_probs=162.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-- 149 (294)
T 2rku_A 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-- 149 (294)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--
T ss_pred CCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc--
Confidence 4799999999999999999999999 8999999875 45899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 150 -~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-- 219 (294)
T 2rku_A 150 -EDLEVKIGDFGLATKVEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-- 219 (294)
T ss_dssp -TTCCEEECCCTTCEECCSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred -CCCCEEEEeccCceecccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 678899999999987653222 1234679999999999999889999999999999999999999997743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+...... +...++.++.+++..||..||++||+++++.
T Consensus 220 -~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 220 -LKETYLRIKKNEYS-----IPKHINPVAASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp -HHHHHHHHHTTCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred -HHHHHHHHhhccCC-----CccccCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 33334444333221 3456789999999999999999999977664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=275.15 Aligned_cols=201 Identities=21% Similarity=0.301 Sum_probs=156.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------------------------------CCCCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------------------------------SRKLS 41 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------------------------------~~~ls 41 (414)
+|||++++.++.++++.||||||+ |++|.++++.. ...++
T Consensus 87 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (345)
T 3hko_A 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166 (345)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHH
T ss_pred CCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence 699999999999999999999999 99999988411 11246
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccc
Q 015018 42 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121 (414)
Q Consensus 42 ~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 121 (414)
+..+..++.||+.||+|||++||+||||||+|||++.+ ....+||+|||+++.+....... ........||+.|+|
T Consensus 167 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~a 242 (345)
T 3hko_A 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVA 242 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccc---cccccccCCCccccC
Confidence 78899999999999999999999999999999999621 22389999999999775533211 112245679999999
Q ss_pred hhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 122 MNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 122 PE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
||++.+ ..++.++|||||||++|+|++|..||.+... .+.+..+......... .....+++++.++|..||..+
T Consensus 243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSC
T ss_pred chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCC
Confidence 999976 6788999999999999999999999987543 3344444443332211 123457899999999999999
Q ss_pred CCCCCCHHHHH
Q 015018 200 FDDKPDYAYLK 210 (414)
Q Consensus 200 p~~RP~~~~l~ 210 (414)
|.+||++.+++
T Consensus 319 p~~Rps~~~~l 329 (345)
T 3hko_A 319 VDERFDAMRAL 329 (345)
T ss_dssp TTTSCCHHHHH
T ss_pred hhHCCCHHHHh
Confidence 99999987664
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=268.04 Aligned_cols=192 Identities=20% Similarity=0.303 Sum_probs=162.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||++++.++.+++..||||||+ |++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-- 153 (303)
T 3a7i_A 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-- 153 (303)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC--
Confidence 4799999999999999999999999 889999987 46899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++..+..... ......||..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 154 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 224 (303)
T 3a7i_A 154 -EHGEVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP- 224 (303)
T ss_dssp -TTSCEEECCCTTCEECBTTBC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -CCCCEEEeecccceecCcccc-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-
Confidence 678999999999987654322 12346799999999999999999999999999999999999999977532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.+....+..... ..+...++.++.+++..||..+|.+||++.++++
T Consensus 225 --~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 225 --MKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp --HHHHHHHHHSCC----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHHhhcCCC----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 223333332221 1234578999999999999999999999887754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=270.13 Aligned_cols=196 Identities=17% Similarity=0.251 Sum_probs=162.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.+++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-- 159 (314)
T 3com_A 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN-- 159 (314)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC--
Confidence 4799999999999999999999999 8899999986677899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 160 -~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 230 (314)
T 3com_A 160 -TEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP- 230 (314)
T ss_dssp -TTCCEEECCCTTCEECBTTBS-------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred -CCCCEEEeecccchhhhhhcc-------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 678899999999987654322 12346799999999999999999999999999999999999999987532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
......+....... ......++.++.++|..||..||.+||++.++++
T Consensus 231 --~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 231 --MRAIFMIPTNPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --HHHHHHHHHSCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHHHHHHhcCCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22222222211111 0123357899999999999999999999877743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=276.04 Aligned_cols=214 Identities=21% Similarity=0.236 Sum_probs=168.3
Q ss_pred CCCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceec
Q 015018 1 MAAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHR 67 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH--------~~givHR 67 (414)
.+|||++++.++.... +.|+||||+ +++|.++++. ..+++..++.++.||+.||+||| +++|+||
T Consensus 94 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred CCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 3799999999999876 889999999 8899999974 47999999999999999999999 8999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC------CCchhHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGY 141 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~~~DvwSlGv 141 (414)
||||+||||+ .++.+||+|||+++.......... .......||+.|+|||++.+.. ++.++|||||||
T Consensus 172 Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 172 DLKSKNILVK---KNGTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp CCSGGGEEEC---TTSCEEECCCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEC---CCCCEEEEECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 9999999996 678999999999987655432111 0124568999999999998763 336899999999
Q ss_pred HHHHHHhC----------CCCCCCCCccc--hHHHHHHHHhhhccchHHHh--hcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 142 VLMYFLRG----------SLPWQGLKAGT--KKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 142 vl~elltG----------~~Pf~~~~~~~--~~~~~~~i~~~~~~~~~~~l--~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
++|+|++| ..||....... .......+........+... ...++..+.+++..||..+|++||++.
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 99999999 88997754322 22233333332222221111 123457899999999999999999999
Q ss_pred HHHHHHHHHHHHhCC
Q 015018 208 YLKRLFRDLFIREGF 222 (414)
Q Consensus 208 ~l~~~l~~~~~~~~~ 222 (414)
++.+.|+++....+.
T Consensus 326 ~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 326 RIKKTLSQLSQQEGI 340 (342)
T ss_dssp HHHHHHHHHHHTTC-
T ss_pred HHHHHHHHHHHHhcC
Confidence 999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=284.40 Aligned_cols=196 Identities=20% Similarity=0.225 Sum_probs=154.1
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+|||+++++++.. ..+.+|||||++++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+
T Consensus 106 hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 185 (420)
T 1j1b_A 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185 (420)
T ss_dssp CTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGG
T ss_pred CCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence 6999999888753 235789999998788877653 3578999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~ 151 (414)
||||+ ...+.+||+|||+++.+..... .....||..|+|||++.+. .++.++|||||||+||||++|+.
T Consensus 186 NILl~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 186 NLLLD--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp GEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hEEEe--CCCCeEEeccchhhhhcccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 99996 2346789999999987654321 2346899999999999875 68999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccc------------------------hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVST------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
||.+.... +.+..+....... ....+...+++++.+||..||..||.+||++.
T Consensus 256 pf~~~~~~---~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~ 332 (420)
T 1j1b_A 256 IFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332 (420)
T ss_dssp SSCCSSHH---HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCHH---HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH
Confidence 99885432 2222222210000 01112345689999999999999999999987
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 333 e~l 335 (420)
T 1j1b_A 333 EAC 335 (420)
T ss_dssp HHH
T ss_pred HHh
Confidence 664
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=278.51 Aligned_cols=185 Identities=20% Similarity=0.267 Sum_probs=146.6
Q ss_pred EeCCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEee
Q 015018 13 VEGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 89 (414)
Q Consensus 13 ~~~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~D 89 (414)
.++.+.+|||||++++|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++ ...+.+||+|
T Consensus 108 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~D 185 (383)
T 3eb0_A 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCD 185 (383)
T ss_dssp --CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECC
T ss_pred CCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEE
Confidence 34556899999998898888753 367899999999999999999999999999999999999995 3468999999
Q ss_pred eceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 015018 90 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 168 (414)
Q Consensus 90 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 168 (414)
||+++.+..... .....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+ .+..+
T Consensus 186 fg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i 254 (383)
T 3eb0_A 186 FGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID---QLVRI 254 (383)
T ss_dssp CTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred CCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH---HHHHH
Confidence 999987654332 23467899999999998754 8999999999999999999999998854332 22222
Q ss_pred Hhhhc------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 169 SEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 169 ~~~~~------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..... ......+...+|.++.+||..||..+|.+||++.+++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 255 IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 21100 0111123456889999999999999999999988775
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.32 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=165.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.+.++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...
T Consensus 84 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 162 (484)
T 3nyv_A 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162 (484)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC
Confidence 3799999999999999999999999 9999999874 5689999999999999999999999999999999999999644
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 163 ~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--- 230 (484)
T 3nyv_A 163 SKDANIRIIDFGLSTHFEASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--- 230 (484)
T ss_dssp STTCCEEECCTTHHHHBCCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CCCCcEEEEeeeeeEEcccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---
Confidence 4678999999999976544321 123579999999999987 6899999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+..+.........+ .+..+++++.+||..||..+|.+||++.+++
T Consensus 231 ~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 231 NEYDILKKVEKGKYTFELP-QWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp SHHHHHHHHHHCCCCCCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3445555555554433222 2346889999999999999999999987765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=269.48 Aligned_cols=196 Identities=19% Similarity=0.234 Sum_probs=161.1
Q ss_pred CCCCCcEEEEeeE-----eCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~-----~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
++|||+++++++. .+...+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Ni 151 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHe
Confidence 4799999999987 567889999999889999997643 4599999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ .++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 152 li~---~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 152 LVT---SSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp EEC---TTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEc---CCCCEEEecCcccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 996 67899999999997654321 1234689999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+... ...+..+.... ....+..+...++.++.+||..||..||++||++.+++
T Consensus 221 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 221 GSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCH---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 7543 33333333211 01122344567899999999999999999999987764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=286.72 Aligned_cols=195 Identities=19% Similarity=0.264 Sum_probs=164.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++.+.||||||| |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence 799999999999999999999999 9999998875 45799999999999999999999999999999999999997433
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
....+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~ 251 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ---N 251 (504)
T ss_dssp CCSSEEECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCccEEEEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC---C
Confidence 334799999999987654321 234679999999999875 5899999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+.......... .+..+++++.+||..||..||.+||++++++
T Consensus 252 ~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 252 DQDIIKKVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp HHHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 445556665554433322 3467899999999999999999999987764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=286.99 Aligned_cols=190 Identities=21% Similarity=0.260 Sum_probs=162.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.+..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 75 HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~--- 150 (476)
T 2y94_A 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD--- 150 (476)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---
T ss_pred CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---
Confidence 799999999999999999999999 9999999874 56799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..
T Consensus 151 ~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-- 220 (476)
T 2y94_A 151 AHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-- 220 (476)
T ss_dssp TTCCEEECCCSSCEECCTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred cCCCeEEEeccchhhcccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--
Confidence 678999999999987654321 234689999999999998765 689999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
....+.++...... ....+++++.+||..||..||.+||+++++++
T Consensus 221 -~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 221 -VPTLFKKICDGIFY-----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -SHHHHHHHHTTCCC-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHhcCCcC-----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 33445555544332 23457899999999999999999999877653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=276.89 Aligned_cols=213 Identities=15% Similarity=0.173 Sum_probs=155.7
Q ss_pred CCCCCcEEEEeeEe-----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------Cce
Q 015018 1 MAAGIPNLRWFGVE-----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFL 65 (414)
Q Consensus 1 g~p~I~~l~~~g~~-----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~---------giv 65 (414)
.+|||++++..+.. ....||||||+ |++|.++++. ..+++..++.++.||+.||+|||++ ||+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv 142 (336)
T 3g2f_A 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142 (336)
T ss_dssp CCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE
T ss_pred cCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhcccccccccee
Confidence 36899999875432 33678999999 9999999974 4569999999999999999999999 999
Q ss_pred ecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCccc-ccccccCCCCCCccccchhhhcC-------CCCCchhHHH
Q 015018 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLE 137 (414)
Q Consensus 66 HRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~-~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~~~Dvw 137 (414)
||||||+||||+ ..+.+||+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||
T Consensus 143 H~Dikp~Nill~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 143 HRDLNSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp CSSCSGGGEEEC---TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred ecccccceEEEc---CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 999999999996 678999999999987754321110 01112234679999999999987 3456789999
Q ss_pred HHHHHHHHHHhCCCCCCCCCccch--------------HHHHHH-HHhhhccchHHHhhc---CCcHHHHHHHHHHHcCC
Q 015018 138 SLGYVLMYFLRGSLPWQGLKAGTK--------------KQKYEK-ISEKKVSTSIEALCR---GYPTEFASYFHYCRSLR 199 (414)
Q Consensus 138 SlGvvl~elltG~~Pf~~~~~~~~--------------~~~~~~-i~~~~~~~~~~~l~~---~~p~e~~~li~~c~~~d 199 (414)
||||++|||++|..||........ ...+.. +........+...+. .+++++.+||..||..|
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999999999777643221110 000111 111111111111111 13457999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 015018 200 FDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 200 p~~RP~~~~l~~~l~~~~~ 218 (414)
|++||++.++.+.|++++.
T Consensus 300 P~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMM 318 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred hhhCcchHHHHHHHHHHHH
Confidence 9999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=264.03 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=161.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.+.
T Consensus 67 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145 (283)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred CCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC
Confidence 699999999999999999999999 8999999975 45799999999999999999999999999999999999996321
Q ss_pred -CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
....++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 215 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-- 215 (283)
T ss_dssp SSSCCEEECCCTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred CCCCceEEEecccceeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--
Confidence 223899999999987654321 134579999999999999999999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+...... .....+..+++++.+++..||..||.+||++.++.+
T Consensus 216 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 216 -KQETLTNISAVNYD-FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -HHHHHHHHHTTCCC-CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHhHhcccC-CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 33444444433322 223445678999999999999999999999888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=270.08 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=155.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~--~ls~~~v~~ia~Qll~gL~yLH~---~givHRDIKP~NI 74 (414)
.+|||+++++++.+ ..||||||+ |++|.+++..... .++...++.++.||+.||+|||+ +||+||||||+||
T Consensus 59 ~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI 136 (307)
T 2eva_A 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136 (307)
T ss_dssp CCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred CCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence 37999999988774 479999999 9999999974332 48899999999999999999999 8999999999999
Q ss_pred EEeecCCCC-eEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 75 LMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 75 Ll~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
|++ .++ .+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 137 ll~---~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 137 LLV---AGGTVLKICDFGTACDIQTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp EEE---TTTTEEEECCCCC----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred EEe---CCCCEEEEccccccccccccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 997 444 58999999997654321 2346999999999999999999999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
...... .......+..... ..+...+|.++.+++..||..+|++||+++++.+.|+.+.
T Consensus 204 ~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 204 DEIGGP-AFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TTTCSS-HHHHHHHHHTTCC----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred hhhCcc-HHHHHHHHhcCCC----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 865432 2222222222211 1234578999999999999999999999999999998875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=268.80 Aligned_cols=198 Identities=19% Similarity=0.271 Sum_probs=158.1
Q ss_pred CCCCcEEEEeeEeC-CEEEEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEG-DYNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-~~~~lVmE~~-g~sL~~ll~~~~~-~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+. +..|+||||+ |++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 73 h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~- 151 (278)
T 1byg_A 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS- 151 (278)
T ss_dssp CTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe-
Confidence 69999999986554 4789999999 7899999975432 389999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.++|+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 152 --~~~~~~l~Dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 152 --EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp --TTSCEEECCCCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred --CCCcEEEeeccccccccccc----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 67899999999997654322 23467889999999999999999999999999999998 999998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
... ....+..... ......+|+++.+++..||..||.+||++.++.+.|+++...
T Consensus 220 ~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 220 LKD---VVPRVEKGYK----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp GGG---HHHHHTTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHhcCCC----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 322 2222222211 123457899999999999999999999999999999988654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.00 Aligned_cols=199 Identities=19% Similarity=0.208 Sum_probs=153.5
Q ss_pred CCCCcEEEEeeE----eCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~----~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NIL 75 (414)
+|||++++..+. ++.+.||||||++++|.+.+... ...+++..++.|+.||+.||+|||++ ||+||||||+|||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIl 179 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEE
T ss_pred cceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHee
Confidence 578999999888 56789999999988888877644 36799999999999999999999998 9999999999999
Q ss_pred EeecC----------------------------------------------CCCeEEEeeeceeEEcccCCCcccccccc
Q 015018 76 MGLGR----------------------------------------------RANQVYIIDFGLAKRYRDTATHQHIPYRE 109 (414)
Q Consensus 76 l~~~~----------------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 109 (414)
|+.+. ....+||+|||+++......
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--------- 250 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--------- 250 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---------
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---------
Confidence 96221 11379999999998765422
Q ss_pred cCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHHHHhhhccchH---------
Q 015018 110 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSI--------- 177 (414)
Q Consensus 110 ~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~--------- 177 (414)
....||..|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+..+.........
T Consensus 251 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 329 (397)
T 1wak_A 251 -TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329 (397)
T ss_dssp -CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred -ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence 34579999999999999999999999999999999999999998654322 11222222111100000
Q ss_pred ----------------------HH------hhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 178 ----------------------EA------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 178 ----------------------~~------l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. +...++.++.+||..||..||++||++++++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 00 0112346788999999999999999988775
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.11 Aligned_cols=195 Identities=19% Similarity=0.295 Sum_probs=149.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLM 76 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl 76 (414)
++|||+++++++.+++..||||||++++|.+++.. ....+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 64 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~ 143 (290)
T 3fme_A 64 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 143 (290)
T ss_dssp CCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE
T ss_pred CCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 47999999999999999999999998799888754 356899999999999999999999998 99999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhh----cCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
+ ..+.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 144 ~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 144 N---ALGQVKMCDFGISGYLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp C---TTCCEEBCCC-----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred C---CCCCEEEeecCCccccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 6 678999999999987654321 1234799999999996 556789999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
|..... ....+.......... .....++.++.+++..||..+|++||++.++++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 213 YDSWGT--PFQQLKQVVEEPSPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCSC--HHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccCc--hHHHHHHHhccCCCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 976422 222233222222211 112467899999999999999999999888754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=268.97 Aligned_cols=191 Identities=20% Similarity=0.277 Sum_probs=139.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.++++.||||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 70 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~--- 146 (278)
T 3cok_A 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT--- 146 (278)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---
T ss_pred CCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---
Confidence 699999999999999999999999 8899999986667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 147 RNMNIKIADFGLATQLKMPHE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp TTCCEEECCCTTCEECC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred CCCCEEEEeecceeeccCCCC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 678999999999987653221 1124578999999999999889999999999999999999999998654321
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+..+..... .+...++.++.++|..||..||++||++++++
T Consensus 220 ---~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 220 ---TLNKVVLADY-----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp -------CCSSCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ---HHHHHhhccc-----CCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 1121111111 12345789999999999999999999987775
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=269.99 Aligned_cols=195 Identities=20% Similarity=0.236 Sum_probs=162.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+....
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~ 143 (304)
T 2jam_A 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE 143 (304)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS
T ss_pred CCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC
Confidence 699999999999999999999999 8999999875 45799999999999999999999999999999999999995434
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.++|+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 144 ~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--- 211 (304)
T 2jam_A 144 ENSKIMITDFGLSKMEQNGI---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--- 211 (304)
T ss_dssp TTCCEEBCSCSTTCCCCCBT---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---
T ss_pred CCCCEEEccCCcceecCCCc---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---
Confidence 67889999999986543211 123468999999999999999999999999999999999999997743
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... ...+...+++++.++|..||..||.+||++++++
T Consensus 212 ~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 212 ESKLFEKIKEGYYEF-ESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp HHHHHHHHHHCCCCC-CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHcCCCCC-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 344444544433221 1223457889999999999999999999987664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.01 Aligned_cols=192 Identities=18% Similarity=0.275 Sum_probs=157.9
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.... ..||||||+|++|.++++. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIl 160 (367)
T 1cm8_A 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160 (367)
T ss_dssp BTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEE
Confidence 699999999988763 4599999999999999984 57999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 161 l~---~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 161 VN---EDCELKILDFGLARQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp EC---TTCCEEECCCTTCEECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred Ec---CCCCEEEEeeecccccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 96 6789999999999875432 234689999999999987 678999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+.... +.+..+..... ......+...+++++.+|+..||..||.+||++++
T Consensus 228 ~~~~~---~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 228 GSDHL---DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp CSSHH---HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCHH---HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 75432 22232222110 11122334567899999999999999999999877
Q ss_pred HHH
Q 015018 209 LKR 211 (414)
Q Consensus 209 l~~ 211 (414)
+++
T Consensus 305 ~l~ 307 (367)
T 1cm8_A 305 ALA 307 (367)
T ss_dssp HHH
T ss_pred Hhc
Confidence 643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=274.73 Aligned_cols=210 Identities=18% Similarity=0.189 Sum_probs=148.3
Q ss_pred CCCCCcEEEEeeE--------eCCEEEEEEecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecC
Q 015018 1 MAAGIPNLRWFGV--------EGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRD 68 (414)
Q Consensus 1 g~p~I~~l~~~g~--------~~~~~~lVmE~~g~sL~~ll~~--~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRD 68 (414)
++|||++++.++. .....|+||||++++|.+++.. ....+++..++.|+.||+.||+|||++| |+|||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~D 163 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEcc
Confidence 4899999999884 3456899999998899999864 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccc-----cccccCCCCCCccccchhhh---cCCCCCchhHHHHHH
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLG 140 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~---~~~~~s~~~DvwSlG 140 (414)
|||+||||+ .++.+||+|||+++.+......... .........||+.|+|||++ .+..++.++||||||
T Consensus 164 ikp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG 240 (337)
T 3ll6_A 164 LKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240 (337)
T ss_dssp CCGGGCEEC---TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH
T ss_pred CCcccEEEC---CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH
Confidence 999999996 6789999999999876543211100 00112245799999999998 566788999999999
Q ss_pred HHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 141 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 141 vvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
|++|+|++|..||.+.... .+....... .....++.++.+|+..||+.+|.+||++.++.+.|+.+....
T Consensus 241 ~il~el~~g~~p~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 241 CILYLLCFRQHPFEDGAKL-------RIVNGKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp HHHHHHHHSSCCC-------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCCcchhHH-------HhhcCcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 9999999999999763221 111111111 112456788999999999999999999999999999998765
Q ss_pred CCC
Q 015018 221 GFQ 223 (414)
Q Consensus 221 ~~~ 223 (414)
+..
T Consensus 311 ~~~ 313 (337)
T 3ll6_A 311 NVN 313 (337)
T ss_dssp TCC
T ss_pred CCC
Confidence 443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=273.54 Aligned_cols=183 Identities=19% Similarity=0.191 Sum_probs=155.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~-sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.++++.+|||||+ ++ +|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++
T Consensus 88 h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-- 164 (335)
T 3dls_A 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA-- 164 (335)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc--
Confidence 699999999999999999999998 44 99999974 55799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 165 -~~~~~kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 165 -EDFTIKLIDFGSAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp -TTSCEEECCCTTCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred -CCCcEEEeecccceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence 678999999999987654322 123579999999999998876 7899999999999999999999976322
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ..... .....+++++.+||..||..||++||++++++
T Consensus 236 ~---------~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell 273 (335)
T 3dls_A 236 T---------VEAAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273 (335)
T ss_dssp G---------TTTCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred H---------Hhhcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1 01111 12335789999999999999999999977664
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=277.23 Aligned_cols=194 Identities=19% Similarity=0.296 Sum_probs=155.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~ 78 (414)
.+|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 89 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~- 166 (360)
T 3eqc_A 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 166 (360)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-
T ss_pred CCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC-
Confidence 3799999999999999999999999 8899999975 45799999999999999999999996 999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 167 --~~~~~kl~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 167 --SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp --TTCCEEECCCCCCHHHHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred --CCCCEEEEECCCCccccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 67889999999987553321 1346899999999999999999999999999999999999999976432
Q ss_pred cchHHHH---------------------------------------HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCC
Q 015018 159 GTKKQKY---------------------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLR 199 (414)
Q Consensus 159 ~~~~~~~---------------------------------------~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~d 199 (414)
......+ ..+....... .....++.++.+||..||..|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSS
T ss_pred HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcC
Confidence 2111110 0000000000 001246889999999999999
Q ss_pred CCCCCCHHHHH
Q 015018 200 FDDKPDYAYLK 210 (414)
Q Consensus 200 p~~RP~~~~l~ 210 (414)
|.+||++++++
T Consensus 313 P~~Rpt~~ell 323 (360)
T 3eqc_A 313 PAERADLKQLM 323 (360)
T ss_dssp TTTSCCHHHHH
T ss_pred hhhCCCHHHHh
Confidence 99999987774
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=272.24 Aligned_cols=211 Identities=18% Similarity=0.185 Sum_probs=164.4
Q ss_pred CCCCcEEEEeeEeCC--EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVEGD--YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~--~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||++++.++...+ ..+|||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 101 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~- 179 (326)
T 2w1i_A 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE- 179 (326)
T ss_dssp CTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE-
T ss_pred CCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc-
Confidence 699999999877644 789999999 8999999987667799999999999999999999999999999999999997
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 180 --~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 180 --NENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp --ETTEEEECCCTTCEECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred --CCCcEEEecCcchhhcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 66899999999998775433211 112335678889999999998899999999999999999999999864210
Q ss_pred c---------chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 159 G---------TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 159 ~---------~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
. ........+.+.............+|.++.++|..||..+|++||++.+|.+.|+.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000000001000000000112456889999999999999999999999999999988653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.43 Aligned_cols=200 Identities=20% Similarity=0.354 Sum_probs=165.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||++++.++.+ +..||||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 321 hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-- 397 (535)
T 2h8h_A 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-- 397 (535)
T ss_dssp CTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc--
Confidence 6999999998876 6789999999 88999999643 45699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+.... +.......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 398 -~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 398 -ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp -GGGCEEECCTTSTTTCCCHH------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred -CCCcEEEcccccceecCCCc------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 66889999999997554311 111234567889999999999999999999999999999999 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.+.+..+...... .....+|+++.+||..||..+|++||++++|.+.|++++.
T Consensus 471 ---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 471 ---REVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 3334444332211 1245789999999999999999999999999999987753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=278.77 Aligned_cols=199 Identities=16% Similarity=0.200 Sum_probs=154.4
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~g~sL~~ll~---~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+|||+++++++.. ..+.||||||+.++|...+. .....+++..+..|+.||+.||+|||++||+||||||+
T Consensus 91 h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp CTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 6999999998854 33589999999777666553 23668999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~ 151 (414)
||||+ ...+.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 171 Nill~--~~~~~~kL~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 171 NLLLD--PPSGVLKLIDFGSAKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp GEEEE--TTTTEEEECCCTTCEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred HEEEc--CCCCcEEEeeCCCcccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99995 3578999999999987654322 2346889999999999875 58999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhc--------------------cch-HHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKV--------------------STS-IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~--------------------~~~-~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
||.+.........+.+...... ... ...+...+++++.+||..||..||.+||++.+++
T Consensus 241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 9988543222222211110000 001 1122345789999999999999999999987664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=274.28 Aligned_cols=205 Identities=17% Similarity=0.205 Sum_probs=160.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~---givHRDIKP~NI 74 (414)
+|||+++++++.+++..||||||+ |++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 699999999999999999999999 89999999753 23499999999999999999999999 999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 166 l~~---~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 166 LLD---EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EEC---TTCCEEECCCSSCEECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred EEC---CCCCEEeccCccccccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 996 6789999999999876543321 1234569999999999998899999999999999999999999995
Q ss_pred CCC-----ccchHHHHHHHHhh-hccchH-----HHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 155 GLK-----AGTKKQKYEKISEK-KVSTSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 155 ~~~-----~~~~~~~~~~i~~~-~~~~~~-----~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
... .............. ...... ......++.++.+++..||+.+|.+||++.++.+.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 311 00111110000000 000000 00111234789999999999999999999999988864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=269.39 Aligned_cols=198 Identities=18% Similarity=0.193 Sum_probs=155.3
Q ss_pred CCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec--
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-- 79 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~-- 79 (414)
++|+.++.++...++.||||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+...
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp SCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 35899999999999999999999888888876543 579999999999999999999999999999999999999422
Q ss_pred --------------CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHH
Q 015018 80 --------------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 145 (414)
Q Consensus 80 --------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~e 145 (414)
...+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred cccccccccccccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence 256889999999998654322 34689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccchHHHHHHHHhhhccch--------------------------HHHhh----------cCCcHHHH
Q 015018 146 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTS--------------------------IEALC----------RGYPTEFA 189 (414)
Q Consensus 146 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~l~----------~~~p~e~~ 189 (414)
|++|..||.+.........+..+........ ....+ ...+.++.
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 9999999987544332323322221100000 00000 01245889
Q ss_pred HHHHHHHcCCCCCCCCHHHHH
Q 015018 190 SYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 190 ~li~~c~~~dp~~RP~~~~l~ 210 (414)
+||..||..||.+||++++++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHT
T ss_pred HHHHHHhcCChhhCcCHHHHh
Confidence 999999999999999987764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=261.57 Aligned_cols=193 Identities=20% Similarity=0.266 Sum_probs=161.0
Q ss_pred CCCCcEEEEeeEe----------------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015018 2 AAGIPNLRWFGVE----------------GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS 63 (414)
Q Consensus 2 ~p~I~~l~~~g~~----------------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~g 63 (414)
+|||++++.++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++|
T Consensus 63 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 142 (284)
T 2a19_B 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK 142 (284)
T ss_dssp CTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6899999988765 45689999999 88999999753 467999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHH
Q 015018 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143 (414)
Q Consensus 64 ivHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl 143 (414)
|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++
T Consensus 143 i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 143 LINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp EECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred eeeccCCHHHEEEc---CCCCEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 99999999999997 678899999999987655321 1345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 144 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 144 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
|+|++|..||.. ....+..+.... +...++.++.++|..||..||.+||++.++.+.|..+.
T Consensus 212 ~~l~~~~~~~~~-----~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 212 AELLHVCDTAFE-----TSKFFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHSCCSSHHH-----HHHHHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHhcCCcchh-----HHHHHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999988843 112222222211 23467899999999999999999999999998887663
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.76 Aligned_cols=193 Identities=19% Similarity=0.235 Sum_probs=148.1
Q ss_pred CCCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||+++++++... ...||||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 119 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI 195 (464)
T 3ttj_A 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195 (464)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence 379999999998654 4679999999878888775 3599999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
||+ .++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 196 ll~---~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 196 VVK---SDCTLKILDFGLARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp EEC---TTSCEEECCCCCC-----CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEe---CCCCEEEEEEEeeeecCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 996 678999999999987644221 234689999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccc-------------------------hHHHhhcC------------CcHHHHHHHHHHHc
Q 015018 155 GLKAGTKKQKYEKISEKKVST-------------------------SIEALCRG------------YPTEFASYFHYCRS 197 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l~~~------------~p~e~~~li~~c~~ 197 (414)
+.... +.+.++.+..... ....+... .++++.+||..||.
T Consensus 265 g~~~~---~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 265 GRDYI---DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp CSSHH---HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCHH---HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 85433 2333332211100 00011000 14678999999999
Q ss_pred CCCCCCCCHHHHH
Q 015018 198 LRFDDKPDYAYLK 210 (414)
Q Consensus 198 ~dp~~RP~~~~l~ 210 (414)
.||++||++++++
T Consensus 342 ~dP~~R~ta~e~L 354 (464)
T 3ttj_A 342 IDPAKRISVDDAL 354 (464)
T ss_dssp SSTTTSCCHHHHH
T ss_pred CChhhCCCHHHHh
Confidence 9999999987664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=270.35 Aligned_cols=183 Identities=23% Similarity=0.287 Sum_probs=140.0
Q ss_pred EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeecee
Q 015018 17 YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 93 (414)
Q Consensus 17 ~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla 93 (414)
+.||||||| |++|.++++... ...++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcc
Confidence 489999999 999999998532 2366777999999999999999999999999999999996 6789999999999
Q ss_pred EEcccCCCcccc-----cccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 015018 94 KRYRDTATHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 168 (414)
Q Consensus 94 ~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 168 (414)
+........... .+.......||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~ 286 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDV 286 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHH
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHh
Confidence 987654321110 01223456899999999999999999999999999999999998776522 22222222
Q ss_pred HhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 169 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 169 ~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...... .....+++++.++|..||+.||.+||+++++++
T Consensus 287 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 287 RNLKFP----LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HTTCCC----HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hccCCC----cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 222222 223345678899999999999999999887753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=263.82 Aligned_cols=194 Identities=18% Similarity=0.202 Sum_probs=161.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++++.||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-- 158 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-- 158 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc--
Confidence 4899999999999999999999999 8999999975 45899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc------CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.++.++|+|||++........ .....||..|+|||++. ...++.++||||||+++|+|++|..||
T Consensus 159 -~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 229 (298)
T 1phk_A 159 -DDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229 (298)
T ss_dssp -TTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCcEEEecccchhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence 678899999999987654321 23457999999999986 456789999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.. .......+......... .....++.++.+++..||..||.+||++.+++
T Consensus 230 ~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 230 WHRK---QMLMLRMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp CCSS---HHHHHHHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred cCcc---HHHHHHHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 7743 33344444443332211 12346889999999999999999999987774
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=274.16 Aligned_cols=200 Identities=19% Similarity=0.207 Sum_probs=160.4
Q ss_pred CCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++... ...|+||||++++|.++++. ..+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 84 h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161 (364)
T ss_dssp CTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE
Confidence 69999999988765 47899999998899999974 579999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ .++.+||+|||+++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 162 ~---~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 162 N---TTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp C---TTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C---CCCCEEEEeCcceEecCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 6 67889999999998765432211 11234689999999998764 4589999999999999999999999988
Q ss_pred CCccchHHHHHHHHhhh-----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.........+..+.... .......+...++.++.+||..||..||.+||++.+++
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp SSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 65544443332221111 11122344467889999999999999999999987664
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=296.84 Aligned_cols=203 Identities=19% Similarity=0.271 Sum_probs=167.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++. ++..||||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 449 ~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~-- 525 (656)
T 2j0j_A 449 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-- 525 (656)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe--
Confidence 3799999999885 45689999999 8999999987666799999999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~ 158 (414)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 526 -~~~~vkL~DFG~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 526 -SNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp -ETTEEEECCCCCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred -CCCCEEEEecCCCeecCCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 678999999999986644321 11223467889999999999999999999999999999997 9999987543
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
.+.+..+...... .++..+|+++.++|..||..||.+||++.+|.+.|++++...
T Consensus 599 ---~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 599 ---NDVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 3344444433222 134578999999999999999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=283.44 Aligned_cols=211 Identities=21% Similarity=0.249 Sum_probs=166.2
Q ss_pred CCCCCcEEEEeeEeCC--EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGD--YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~--~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||+++++++.+.+ +.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 65 ~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 144 (396)
T 4eut_A 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (396)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEE
Confidence 3699999999988765 789999999 899999997432 23999999999999999999999999999999999999
Q ss_pred Eeec-CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--------CCCCchhHHHHHHHHHHHH
Q 015018 76 MGLG-RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 76 l~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~~~DvwSlGvvl~el 146 (414)
+..+ ...+.+||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 l~~~~~~~~~~kL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp EEECTTSCEEEEECCGGGCEECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeecCCCceeEEEecCCCceEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 8433 2456799999999987654321 234679999999999875 4567899999999999999
Q ss_pred HhCCCCCCCCCc-cchHHHHHHHHhhhccchH--------------------HHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 147 LRGSLPWQGLKA-GTKKQKYEKISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 147 ltG~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~--------------------~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
++|..||..... ....+.+.++........+ ..+...++..+.+++..||..||++||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 999999976443 2233444444433221100 0112334678999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 015018 206 YAYLKRLFRDLFIR 219 (414)
Q Consensus 206 ~~~l~~~l~~~~~~ 219 (414)
++++.+.+.+++.+
T Consensus 297 ~~e~l~~l~~il~~ 310 (396)
T 4eut_A 297 FDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999888754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=271.22 Aligned_cols=198 Identities=21% Similarity=0.255 Sum_probs=153.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ +++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 83 h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~--- 158 (331)
T 4aaa_A 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS--- 158 (331)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred CCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---
Confidence 699999999999999999999999 666666655 466899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPGE-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp TTSCEEECCCTTC-------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCCcEEEEeCCCceeecCCcc-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 678999999999986544321 12345789999999999875 6899999999999999999999999875432
Q ss_pred chHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.....+...... ............+++++.+||..||..||++||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 305 (331)
T 4aaa_A 232 DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305 (331)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred HHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh
Confidence 222111111000 001122233456889999999999999999999987664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=263.19 Aligned_cols=196 Identities=23% Similarity=0.301 Sum_probs=159.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-- 139 (276)
T 2yex_A 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-- 139 (276)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc--
Confidence 3699999999999999999999999 8899998863 45799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.++|+|||++..+...... .......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+...
T Consensus 140 -~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 140 -ERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp -TTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred -cCCCEEEeeCCCccccCCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 6788999999999876543211 11234679999999999988765 7789999999999999999999987544
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... .+..+....... .....++.++.+++..||..||.+||++++++
T Consensus 214 ~~~--~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 214 SCQ--EYSDWKEKKTYL---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp TSH--HHHHHHTTCTTS---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HHH--HHHHhhhccccc---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 322 222222221111 12346789999999999999999999987774
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.04 Aligned_cols=205 Identities=16% Similarity=0.193 Sum_probs=150.8
Q ss_pred CCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++... +..||||||++++|.++++. ...+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 84 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl 162 (432)
T 3n9x_A 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162 (432)
T ss_dssp CTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE
Confidence 69999999999876 57899999998899999974 5679999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccc---------------cccccCCCCCCccccchhhh-cCCCCCchhHHHHHH
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLG 140 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~---------------~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~~~DvwSlG 140 (414)
+ .++.+||+|||+++........... .........||+.|+|||++ .+..++.++||||||
T Consensus 163 ~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG 239 (432)
T 3n9x_A 163 N---QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239 (432)
T ss_dssp C---TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred C---CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHH
Confidence 6 7789999999999976543211000 00112457899999999986 456699999999999
Q ss_pred HHHHHHHhCCCCC-----------CCCCcc--------------chHHHHHHHHhh------------------------
Q 015018 141 YVLMYFLRGSLPW-----------QGLKAG--------------TKKQKYEKISEK------------------------ 171 (414)
Q Consensus 141 vvl~elltG~~Pf-----------~~~~~~--------------~~~~~~~~i~~~------------------------ 171 (414)
|++|||++|..|| .+.... .....+..+.+.
T Consensus 240 ~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 319 (432)
T 3n9x_A 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319 (432)
T ss_dssp HHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred HHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC
Confidence 9999999854444 332100 001111111110
Q ss_pred --hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 172 --KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 172 --~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
............+++++.+||..||..||.+||++++++
T Consensus 320 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 360 (432)
T 3n9x_A 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360 (432)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 011122233456889999999999999999999987664
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.84 Aligned_cols=194 Identities=14% Similarity=0.198 Sum_probs=153.3
Q ss_pred CCCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
++|||++++.++.+ ..+.+|||||+ +++|.++++ .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 89 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~ 164 (330)
T 3nsz_A 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164 (330)
T ss_dssp TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence 47999999999998 77899999999 899999886 489999999999999999999999999999999999996
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.....+||+|||+++.+..... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 165 --~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 165 --HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp --TTTTEEEECCCTTCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred --CCCCEEEEEeCCCceEcCCCCc--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2334899999999987654322 234579999999999987 66899999999999999999999999543
Q ss_pred CccchHHHHHHHHhhhccc---------------hHH-----------------HhhcCCcHHHHHHHHHHHcCCCCCCC
Q 015018 157 KAGTKKQKYEKISEKKVST---------------SIE-----------------ALCRGYPTEFASYFHYCRSLRFDDKP 204 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~---------------~~~-----------------~l~~~~p~e~~~li~~c~~~dp~~RP 204 (414)
.. ....+..+....... ... .....+++++.+||..||..||.+||
T Consensus 235 ~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 235 HD--NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp SS--HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred Cc--hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence 22 111111111110000 000 01122689999999999999999999
Q ss_pred CHHHHH
Q 015018 205 DYAYLK 210 (414)
Q Consensus 205 ~~~~l~ 210 (414)
++++++
T Consensus 313 ta~e~l 318 (330)
T 3nsz_A 313 TAREAM 318 (330)
T ss_dssp CHHHHH
T ss_pred CHHHHh
Confidence 987775
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=272.78 Aligned_cols=145 Identities=26% Similarity=0.324 Sum_probs=128.1
Q ss_pred CCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEeec
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH--~~givHRDIKP~NILl~~~ 79 (414)
++|++++.++...++.||||||++++|.+++.... ..+++..+..++.||+.||+||| ..|||||||||+||||+.+
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp GGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST
T ss_pred eeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC
Confidence 46999999999999999999999889999997653 56999999999999999999999 5799999999999999521
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 196 -~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 196 -KRSAIKIVDFGSSCQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp -TSCCEEECCCTTCEETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -CCCcEEEEeccCceeccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 35789999999998764421 346899999999999999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=271.47 Aligned_cols=197 Identities=22% Similarity=0.267 Sum_probs=159.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++..++ .|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 73 ~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence 4799999999987766 79999999 8899998874 5689999999999999999999999999999999999999744
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.....+||+|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred CCCCeEEEccCccceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 3445699999999987644221 12346899999999974 456889999999999999999999999875
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...... ...+..... .....++..+++++.++|..||..||++||++++++
T Consensus 223 ~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 223 RTQVSL--KDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp TCSSCH--HHHHHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred chHHHH--HHHHHhCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 433221 222222222 223445677899999999999999999999988775
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.13 Aligned_cols=205 Identities=17% Similarity=0.179 Sum_probs=157.4
Q ss_pred CCCCCcEEEEeeEeC-----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEG-----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~-----~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
.+|||++++.++..+ ...|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil 144 (353)
T 2b9h_A 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144 (353)
T ss_dssp CCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 369999999987764 67899999998899999974 57999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCccccc---ccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
++ .++.+||+|||+++.+.......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 145 ~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 145 IN---SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp EC---TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred Ec---CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence 96 67889999999998765432211100 011234689999999998865 678999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhh------------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 152 PWQGLKAGTKKQKYEKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
||.+.........+..+... ........+...+++++.++|..||..||.+||+++
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 99875432222111111100 001123344567899999999999999999999987
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 302 ell 304 (353)
T 2b9h_A 302 EAL 304 (353)
T ss_dssp HHH
T ss_pred HHh
Confidence 764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=262.56 Aligned_cols=196 Identities=21% Similarity=0.253 Sum_probs=157.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
.+|||+++++++.+.+..++||||+ |++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 77 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 156 (295)
T 2clq_A 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156 (295)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE
Confidence 3799999999999999999999999 899999997543 3567999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
...+.++|+|||+++....... ......||..|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 157 --~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 157 --TYSGVLKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp --TTTCCEEECCTTTCEESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred --CCCCCEEEeecccccccCCCCC-------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 2368999999999987654221 123467999999999998644 78999999999999999999999976
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... ............ ...++..+++++.++|..||..||++||+++++.
T Consensus 228 ~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 228 LGEP--QAAMFKVGMFKV---HPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp GSSH--HHHHHHHHHHCC---CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCch--hHHHHhhccccc---cccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 4321 111111111111 1123457889999999999999999999987764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=283.72 Aligned_cols=197 Identities=21% Similarity=0.263 Sum_probs=152.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||++++.++.. +..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 198 ~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC
Confidence 37999999998754 4579999999 9999988763 5689999999999999999999999999999999999999744
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.....+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSSCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCcceEEEeecccceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 4456799999999976543221 234689999999999864 56788999999999999999999999865
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..... ....+..... ......+..+++++.+||..||..||.+||++++++
T Consensus 348 ~~~~~--~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 348 RTQVS--LKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp SSSCC--HHHHHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cchHH--HHHHHhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 43222 1222233222 233445667899999999999999999999987765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=283.38 Aligned_cols=167 Identities=14% Similarity=0.118 Sum_probs=135.8
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeee
Q 015018 18 NVLVIDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 90 (414)
Q Consensus 18 ~~lVmE~~g~sL~~ll~~~~~~ls-------~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DF 90 (414)
.||||||++++|.+++... ..++ +..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus 175 ~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DF 250 (377)
T 3byv_A 175 RFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250 (377)
T ss_dssp EEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCG
T ss_pred EEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEec
Confidence 7999999988999999753 2344 488888999999999999999999999999999996 6789999999
Q ss_pred ceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 91 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 91 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
|+++..... .....| +.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 251 G~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 251 EHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp GGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred hhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence 999864331 124567 999999999987 8999999999999999999999999764321
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
. ....+...+..+|+++.+||..||..||++||++.++++
T Consensus 320 ~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 320 G------------GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp C------------CSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred c------------chhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 1 111111223678999999999999999999999988764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=277.66 Aligned_cols=194 Identities=20% Similarity=0.282 Sum_probs=144.3
Q ss_pred CCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++... ...|+|||++|++|.++++ ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 87 hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 164 (367)
T 2fst_X 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 164 (367)
T ss_dssp CTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEE
Confidence 69999999988654 5679999999999999987 368999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 165 l~---~~~~~kL~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 165 VN---EDCELKILDFGLARHTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp EC---TTCCEEECC-------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred EC---CCCCEEEeecccccccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 96 6789999999999865432 134689999999999987 678999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.........+...... ........+..++++++.+||..||..||.+||++++++
T Consensus 232 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 85443222222211100 001122334456789999999999999999999987664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=267.08 Aligned_cols=196 Identities=20% Similarity=0.326 Sum_probs=152.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..||||||++..+..++......+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~-- 159 (318)
T 2dyl_A 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-- 159 (318)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC--
T ss_pred CCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC--
Confidence 47999999999999999999999998888888876677899999999999999999999996 999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.++.+||+|||++..+..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 160 -~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 160 -ERGQIKLCDFGISGRLVDDKA--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp -TTSCEEECCCTTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCCCEEEEECCCchhccCCcc--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 678999999999976544221 12357999999999995 4568899999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
... ...+.+..+........ .....++.++.++|..||..||.+||++++|++
T Consensus 231 ~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 231 NCK--TDFEVLTKVLQEEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp TCC--SHHHHHHHHHHSCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCC--ccHHHHHHHhccCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 643 22333333333222111 112357899999999999999999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.05 Aligned_cols=191 Identities=18% Similarity=0.268 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NI 74 (414)
+|||++++.++.. +.+.||||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||
T Consensus 84 h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Ni 162 (290)
T 1t4h_A 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred CCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHE
Confidence 6999999998875 56789999999 8999999975 467999999999999999999999999 99999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ ...+.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 163 l~~--~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 163 FIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp EES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEE--CCCCCEEEeeCCCcccccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 995 356799999999986433221 124579999999998875 58999999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+... ..+.+..+...... ..+...+++++.++|..||..||.+||++++++
T Consensus 231 ~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 231 ECQN--AAQIYRRVTSGVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TCSS--HHHHHHHHTTTCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CcCc--HHHHHHHHhccCCc---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 7432 33333333332222 223456778999999999999999999988775
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=260.53 Aligned_cols=190 Identities=20% Similarity=0.247 Sum_probs=152.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+|||++
T Consensus 70 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--- 145 (276)
T 2h6d_A 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD--- 145 (276)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---
T ss_pred CCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---
Confidence 699999999999999999999999 8999999975 45799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--- 214 (276)
T 2h6d_A 146 AHMNAKIADFGLSNMMSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--- 214 (276)
T ss_dssp TTSCEEECCCCGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CCCCEEEeecccccccCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---
Confidence 678999999999876543221 123578999999999998765 68999999999999999999999764
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
...+.+..+...... +...++.++.+++..||+.||.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 215 HVPTLFKKIRGGVFY-----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHhhcCccc-----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 333344444332221 23567899999999999999999999877654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=264.29 Aligned_cols=198 Identities=19% Similarity=0.232 Sum_probs=155.4
Q ss_pred CCCCcEEEEee--------------EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015018 2 AAGIPNLRWFG--------------VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 67 (414)
Q Consensus 2 ~p~I~~l~~~g--------------~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHR 67 (414)
+|||++++.++ .+....|+||||++++|.+++. ...+++..+..++.||+.||+|||++||+||
T Consensus 67 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 144 (320)
T 2i6l_A 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHR 144 (320)
T ss_dssp CTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred CCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 69999999876 3457889999999889999987 4679999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYF 146 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~el 146 (414)
||||+|||++ ..++.+||+|||+++......... .......+|..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 145 dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 145 DLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp CCSGGGEEEE--TTTTEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEc--CCCCeEEEccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHH
Confidence 9999999996 345789999999998654321111 11233567999999999876 6789999999999999999
Q ss_pred HhCCCCCCCCCccchHHHHHHHHhhh-------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCC
Q 015018 147 LRGSLPWQGLKAGTKKQKYEKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD 201 (414)
Q Consensus 147 ltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~ 201 (414)
++|+.||.+... .+.+..+.... .......++..++.++.++|..||..||+
T Consensus 219 ~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (320)
T 2i6l_A 219 LTGKTLFAGAHE---LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295 (320)
T ss_dssp HHSSCSSCCSSH---HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG
T ss_pred HhCCCCCCCCCH---HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc
Confidence 999999987543 22222222211 11122344567899999999999999999
Q ss_pred CCCCHHHHH
Q 015018 202 DKPDYAYLK 210 (414)
Q Consensus 202 ~RP~~~~l~ 210 (414)
+||++++++
T Consensus 296 ~Rpt~~ell 304 (320)
T 2i6l_A 296 DRLTAEEAL 304 (320)
T ss_dssp GSCCHHHHH
T ss_pred ccCCHHHHh
Confidence 999987764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=266.06 Aligned_cols=202 Identities=21% Similarity=0.280 Sum_probs=155.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-------~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||++++.++..++..|+||||+ |++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 72 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp CTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred CCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 699999999999999999999999 9999999874 24569999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
||++ .++.++|+|||++.......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 152 il~~---~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 152 ILLG---EDGSVQIADFGVSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp EEEC---TTCCEEECCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEEc---CCCCEEEEeccchheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9996 67899999999987554321100 0111234679999999999976 5689999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccc-----hHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~-----~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
|.+....... .......... ....+...++.++.+++..||..||.+||++.++++
T Consensus 227 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 227 YHKYPPMKVL---MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTTSCGGGHH---HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccCchhhHH---HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9875443221 1111111111 111234568899999999999999999999887753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=266.59 Aligned_cols=195 Identities=18% Similarity=0.302 Sum_probs=151.8
Q ss_pred CCCCCcEEEEeeEe------CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 1 MAAGIPNLRWFGVE------GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 1 g~p~I~~l~~~g~~------~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
++|||+++++++.. .+..||||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 158 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence 37999999999987 56899999999 78999999754 357999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHH
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~ell 147 (414)
|||++ .++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|+
T Consensus 159 NIl~~---~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 159 NVLLT---ENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp GEEEC---TTCCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred HEEEc---CCCCEEEeeCcCceecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 99996 678899999999876543221 123457999999999997 556889999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+|..||.+... ...+..+....... .....++.++.++|..||..||.+||+++++++
T Consensus 229 ~g~~p~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 229 EGAPPLCDMHP---MRALFLIPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSSCTTTTSCH---HHHHHHHHHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCcH---HHHHHHhhcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99999976432 22333332222111 123467899999999999999999999877754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=265.91 Aligned_cols=194 Identities=20% Similarity=0.292 Sum_probs=152.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.|||||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---- 161 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---- 161 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----
T ss_pred CCceEEEEEEeecCCEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----
Confidence 5899999999999999999999779999999985 56899999999999999999999999999999999999995
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-----------CCCCchhHHHHHHHHHHHHHhCC
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~~DvwSlGvvl~elltG~ 150 (414)
++.+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 162 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 162 DGMLKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp TTEEEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCeEEEeeccccccccCcccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 478999999999865443211 11234579999999999976 46788999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.||..... ....+..+....... .+...++.++.++|..||..||.+||++.+++
T Consensus 237 ~pf~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 237 TPFQQIIN--QISKLHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp CTTTTCCS--HHHHHHHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CchhhHHH--HHHHHHHHHhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 99976532 222222222222111 22345688999999999999999999987664
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-32 Score=260.16 Aligned_cols=193 Identities=16% Similarity=0.255 Sum_probs=155.9
Q ss_pred CCCCcEEEEee--EeCCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFG--VEGDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g--~~~~~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++ .+....||||||+.+.|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~- 143 (305)
T 2wtk_C 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT- 143 (305)
T ss_dssp CTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-
T ss_pred CCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc-
Confidence 69999999988 445688999999966688887653 45799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC--CchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
.++.++|+|||++.......... ......||..|+|||++.+... +.++||||||+++|+|++|..||.+.
T Consensus 144 --~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 144 --TGGTLKISALGVAEALHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp --TTCCEEECCCTTCEECCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --CCCcEEeeccccccccCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 67899999999998765422111 1234579999999999987554 78999999999999999999999874
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+.+..+..... .+...++.++.+++..||..||.+||++++++
T Consensus 217 ---~~~~~~~~i~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 262 (305)
T 2wtk_C 217 ---NIYKLFENIGKGSY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262 (305)
T ss_dssp ---SHHHHHHHHHHCCC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ---hHHHHHHHHhcCCC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 33444444444332 13456889999999999999999999987765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=271.15 Aligned_cols=193 Identities=19% Similarity=0.259 Sum_probs=145.2
Q ss_pred CCCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||+++++++...+ ..||||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 158 (371)
T 2xrw_A 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158 (371)
T ss_dssp CCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence 3699999999988765 789999999888998886 3699999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++ .++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 159 l~~---~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 159 VVK---SDCTLKILDFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp EEC---TTSCEEECCCCC------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEc---CCCCEEEEEeeccccccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 996 67899999999998654321 1234689999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccc-------------------------hHHHhh------------cCCcHHHHHHHHHHHc
Q 015018 155 GLKAGTKKQKYEKISEKKVST-------------------------SIEALC------------RGYPTEFASYFHYCRS 197 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l~------------~~~p~e~~~li~~c~~ 197 (414)
+... .+.+..+....... ....+. ..++.++.+||..||.
T Consensus 228 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 228 GTDH---IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp CSSH---HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCH---HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 7533 23333332211000 000000 0125689999999999
Q ss_pred CCCCCCCCHHHHH
Q 015018 198 LRFDDKPDYAYLK 210 (414)
Q Consensus 198 ~dp~~RP~~~~l~ 210 (414)
.||.+||++++++
T Consensus 305 ~dP~~R~t~~e~l 317 (371)
T 2xrw_A 305 IDASKRISVDEAL 317 (371)
T ss_dssp SSGGGSCCHHHHH
T ss_pred CChhhCCCHHHHh
Confidence 9999999977654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=272.09 Aligned_cols=195 Identities=17% Similarity=0.173 Sum_probs=150.5
Q ss_pred CCCCcEEEEeeEe-----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVE-----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~-----~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||++++.++.. ..+.||||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167 (362)
T ss_dssp CTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence 6999999998854 34789999999889999998656689999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ ..+.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 168 ~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 168 A---DNNDITICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp C---TTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c---CCCCEEEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 6 678899999999975443221 234578999999999987 6789999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhhcc---------------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 156 LKAGTKKQKYEKISEKKVS---------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~---------------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
... ...+..+...... .....+...+++++.+||..||..||.+||++.+
T Consensus 237 ~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 237 STF---YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp SSH---HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCH---HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 543 2233332221111 1122334567889999999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 314 ll 315 (362)
T 3pg1_A 314 AL 315 (362)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=265.49 Aligned_cols=195 Identities=21% Similarity=0.293 Sum_probs=156.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..|+||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-- 151 (302)
T 2j7t_A 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT-- 151 (302)
T ss_dssp CCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC--
T ss_pred CCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC--
Confidence 3799999999999999999999999 8999999887677899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
.++.++|+|||++....... .......||..|+|||++. +..++.++||||||+++|+|++|..||.
T Consensus 152 -~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 223 (302)
T 2j7t_A 152 -LEGDIRLADFGVSAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223 (302)
T ss_dssp -TTSCEEECCCHHHHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCCCEEEEECCCCccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence 67889999999875432211 1123457999999999984 6678899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... ...+..+........ .....++.++.++|..||..||.+||++.+++
T Consensus 224 ~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 224 ELNP---MRVLLKIAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp TSCH---HHHHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred cCCH---HHHHHHHhccCCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 7533 233333333222111 11345789999999999999999999988775
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=268.48 Aligned_cols=197 Identities=16% Similarity=0.161 Sum_probs=153.3
Q ss_pred CCCCCcEEEEeeEeCC-------EEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecC
Q 015018 1 MAAGIPNLRWFGVEGD-------YNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRD 68 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~-------~~~lVmE~~g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH--~~givHRD 68 (414)
.+|||++++.++.... +.||||||++++|.+.+.. ....+++..+..++.||+.||.||| ++||+|||
T Consensus 77 ~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~D 156 (360)
T 3e3p_A 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156 (360)
T ss_dssp CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSC
T ss_pred CCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCc
Confidence 3799999999886533 4899999997787766542 3567999999999999999999999 99999999
Q ss_pred CCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHH
Q 015018 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 69 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~ell 147 (414)
|||+||||+ ..++.+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 157 lkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell 226 (360)
T 3e3p_A 157 IKPHNVLVN--EADGTLKLCDFGSAKKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226 (360)
T ss_dssp CCGGGEEEE--TTTTEEEECCCTTCBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEe--CCCCcEEEeeCCCceecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999996 2368999999999987654322 23467899999999997655 899999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhccc---h--------------------HHHh----hcCCcHHHHHHHHHHHcCCC
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVST---S--------------------IEAL----CRGYPTEFASYFHYCRSLRF 200 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~---~--------------------~~~l----~~~~p~e~~~li~~c~~~dp 200 (414)
+|..||.+... ...+..+....... . ...+ ...+++++.+||..||..||
T Consensus 227 ~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 227 LGEPIFRGDNS---AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred hCCCCcCCCCh---HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 99999987543 23333332211100 0 0111 12256899999999999999
Q ss_pred CCCCCHHHHH
Q 015018 201 DDKPDYAYLK 210 (414)
Q Consensus 201 ~~RP~~~~l~ 210 (414)
.+||++.+++
T Consensus 304 ~~Rpt~~e~l 313 (360)
T 3e3p_A 304 EERMKPYEAL 313 (360)
T ss_dssp GGSCCHHHHT
T ss_pred cccCCHHHHh
Confidence 9999987664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=265.24 Aligned_cols=193 Identities=22% Similarity=0.280 Sum_probs=157.0
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCC
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~---~~~ls~~~v~~ia~Qll~gL~yLH~~g-----ivHRDIK 70 (414)
+|||+++++++.+ +...|+||||+ |++|.+++... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 64 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp CTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 6999999997754 67899999999 88999998743 345999999999999999999999999 9999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~ 150 (414)
|+|||++ .++.+||+|||+++....... ......||..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 144 p~NIl~~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 144 PANVFLD---GKQNVKLGDFGLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp GGGEEEC---SSSCEEECCCCHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred hhhEEEc---CCCCEEEecCchheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999996 678899999999876543221 012346899999999999999999999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.||.+.. ..+....+...... .+...++.++.++|..||..+|.+||++++|.+
T Consensus 214 ~p~~~~~---~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 214 PPFTAFS---QKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CSSCCSS---HHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccC---HHHHHHHHhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 9998753 33344444443332 234578899999999999999999999888764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.11 Aligned_cols=181 Identities=14% Similarity=0.115 Sum_probs=141.1
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEee
Q 015018 16 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 89 (414)
Q Consensus 16 ~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v------~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~D 89 (414)
...||||||++++|.+++...+..+....+ +.++.||+.||+|||++|||||||||+||||+ .++.+||+|
T Consensus 161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~D 237 (371)
T 3q60_A 161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237 (371)
T ss_dssp EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEC---TTSCEEECC
T ss_pred eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEEC---CCCCEEEEe
Confidence 448999999999999999865555666666 78889999999999999999999999999996 678999999
Q ss_pred eceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 015018 90 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 167 (414)
Q Consensus 90 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 167 (414)
||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .+..
T Consensus 238 FG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~ 306 (371)
T 3q60_A 238 VSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SWKR 306 (371)
T ss_dssp GGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-CCCB
T ss_pred cceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-chhh
Confidence 99998764321 13467799999999987 67999999999999999999999999876332110 0000
Q ss_pred HH--hhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 168 IS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 168 i~--~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+. ...........+..+++++.+||..||..||++||++.+++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00 00000111112357899999999999999999999988775
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=261.28 Aligned_cols=197 Identities=20% Similarity=0.281 Sum_probs=161.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+.+..|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~ 157 (287)
T 2wei_A 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (287)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred cCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC
Confidence 3699999999999999999999999 9999998864 4579999999999999999999999999999999999999754
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.....+||+|||++........ .....||..|+|||++.+. ++.++||||||+++|+|++|..||.+..
T Consensus 158 ~~~~~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-- 226 (287)
T 2wei_A 158 EKDCDIKIIDFGLSTCFQQNTK--------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-- 226 (287)
T ss_dssp STTCCEEECSTTGGGTBCCCSS--------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred CCcccEEEeccCcceeecCCCc--------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC--
Confidence 4456899999999875543221 1234689999999998864 8999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+....+.......... ....++.++.++|..||..+|++||++.++++
T Consensus 227 -~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 227 -EYDILKRVETGKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -HHHHHHHHHHCCCCCCSG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHcCCCCCCch-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 334444444443322221 23568899999999999999999999887764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=274.64 Aligned_cols=199 Identities=22% Similarity=0.283 Sum_probs=152.6
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NIL 75 (414)
+|||++++.++...+ +.+||||++|++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+|||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 589999999988654 88999999999999999764 45699999999999999999999998 9999999999999
Q ss_pred Eeec---CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 76 MGLG---RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 76 l~~~---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
|+.. .....+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred EeccCCCcCcceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 9643 233589999999998765422 235789999999999999999999999999999999999999
Q ss_pred CCCCCccc---hHHHHHHHHhhhccch------------------------------HH-------HhhcCCcHHHHHHH
Q 015018 153 WQGLKAGT---KKQKYEKISEKKVSTS------------------------------IE-------ALCRGYPTEFASYF 192 (414)
Q Consensus 153 f~~~~~~~---~~~~~~~i~~~~~~~~------------------------------~~-------~l~~~~p~e~~~li 192 (414)
|.+..... ....+..+.......+ +. .+...+++++.+||
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 98643211 1112222211100000 00 01123457899999
Q ss_pred HHHHcCCCCCCCCHHHHH
Q 015018 193 HYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 193 ~~c~~~dp~~RP~~~~l~ 210 (414)
..||..||++||++++++
T Consensus 315 ~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp GGGGCSSTTTCBCHHHHH
T ss_pred HHHhccCccccCCHHHHh
Confidence 999999999999987764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=265.66 Aligned_cols=184 Identities=23% Similarity=0.319 Sum_probs=156.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+.|||+++++++.+++..++|||++ + ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~- 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID- 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe-
Confidence 4699999999999999999999999 4 899999975 46899999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
...+.+||+|||+++....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 184 -~~~~~~kL~Dfg~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 184 -LNRGELKLIDFGSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp -TTTTEEEECCCTTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred -CCCCCEEEeeCccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 3567899999999987654321 34579999999999987665 688999999999999999999996521
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+..... .+...+++++.++|..||..||++||++++|+
T Consensus 254 ---------~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 254 ---------EIIRGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp ---------HHHHCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---------hhhcccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1111111 12357899999999999999999999988775
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=269.85 Aligned_cols=208 Identities=17% Similarity=0.206 Sum_probs=158.6
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
.+|||++++.++.. ....|+||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~ 163 (317)
T 2buj_A 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT 163 (317)
T ss_dssp CCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 37999999998873 44789999999 8899999875 3567999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCccc--ccccccCCCCCCccccchhhhcCCC---CCchhHHHHHHHHHHHHH
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFL 147 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~~DvwSlGvvl~ell 147 (414)
|||++ ..+.+||+|||++........... ..........||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 164 NIl~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 164 NILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp GEEEC---TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred HEEEc---CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 99996 678999999999876543211000 0000112345799999999998654 688999999999999999
Q ss_pred hCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 148 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
+|..||......... ....+.. ... ......++.++.++|..||..||.+||++.++.+.|+.+
T Consensus 241 ~g~~p~~~~~~~~~~-~~~~~~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 241 FGEGPYDMVFQKGDS-VALAVQN-QLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HSSCTTHHHHHTTSC-HHHHHHC-C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hCCCChhhhhcccch-hhHHhhc-cCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 999999642111100 0111111 111 011246789999999999999999999999999888765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=270.16 Aligned_cols=198 Identities=16% Similarity=0.300 Sum_probs=139.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFL 75 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~----~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NIL 75 (414)
++|||+++++++.+++..||||||+.++|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||
T Consensus 79 ~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIl 158 (327)
T 3aln_A 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNIL 158 (327)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEE
T ss_pred CCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEE
Confidence 47999999999999999999999997799988863 256899999999999999999999999 9999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhh----cCCCCCchhHHHHHHHHHHHHHhCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
++ .++.+||+|||+++.+..... .....||..|+|||++ .+..++.++|||||||++|+|++|..
T Consensus 159 l~---~~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 159 LD---RSGNIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp EE---TTTEEEECCCSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred Ec---CCCCEEEccCCCceecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 97 778999999999976543221 1234799999999998 45668999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
||.+.... .+.+..+...............+++++.+++..||..||++||++.+|++
T Consensus 228 pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 228 PYPKWNSV--FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCC---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchH--HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99764321 11111111111111111122468899999999999999999999988754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=270.25 Aligned_cols=190 Identities=19% Similarity=0.277 Sum_probs=152.0
Q ss_pred CCCCcEEEEeeEeCCEE------EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~------~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++...+.. |+||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 100 h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 176 (371)
T 4exu_A 100 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 176 (371)
T ss_dssp CTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeE
Confidence 69999999999887755 9999999889888764 46999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 177 l~---~~~~~kL~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 177 VN---EDCELKILDFGLARHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp EC---TTCCEEECSTTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred EC---CCCCEEEEecCcccccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 96 77889999999998654321 34678999999999987 678999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhh--------------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKK--------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~--------------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+.... +.+..+.... .......+...+++++.+||..||..||++||++++
T Consensus 244 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 320 (371)
T 4exu_A 244 GKDYL---DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320 (371)
T ss_dssp CSSHH---HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCChH---HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence 75432 2222222110 011222344567899999999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 321 ll 322 (371)
T 4exu_A 321 AL 322 (371)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=277.21 Aligned_cols=205 Identities=16% Similarity=0.186 Sum_probs=147.1
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecCCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLLGPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 71 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~g~sL~~ll~~~--------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP 71 (414)
+|||++++.++.. +.+.||||||++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||
T Consensus 77 hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp 156 (405)
T 3rgf_A 77 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156 (405)
T ss_dssp CTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred CCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCH
Confidence 6999999999854 7799999999988999988632 12499999999999999999999999999999999
Q ss_pred CcEEEeec-CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhC
Q 015018 72 DNFLMGLG-RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRG 149 (414)
Q Consensus 72 ~NILl~~~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG 149 (414)
+||||... ...+.+||+|||+++.+..... +........||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 157 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 232 (405)
T 3rgf_A 157 ANILVMGEGPERGRVKIADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232 (405)
T ss_dssp GGEEECCSSTTTTCEEECCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred HHeEEecCCCCCCcEEEEECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence 99999532 3568999999999987654221 11122456899999999999874 489999999999999999999
Q ss_pred CCCCCCCCccc------hHHHHHHHHhhhccc---------------------------------hHHHhhcCCcHHHHH
Q 015018 150 SLPWQGLKAGT------KKQKYEKISEKKVST---------------------------------SIEALCRGYPTEFAS 190 (414)
Q Consensus 150 ~~Pf~~~~~~~------~~~~~~~i~~~~~~~---------------------------------~~~~l~~~~p~e~~~ 190 (414)
..||.+..... ....+..+....... .+.......+.++.+
T Consensus 233 ~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (405)
T 3rgf_A 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312 (405)
T ss_dssp SCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHH
T ss_pred CCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHH
Confidence 99997643210 112222221110000 000011123678999
Q ss_pred HHHHHHcCCCCCCCCHHHHH
Q 015018 191 YFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 191 li~~c~~~dp~~RP~~~~l~ 210 (414)
||..||..||.+||++++++
T Consensus 313 Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 313 LLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHccCCcccCCCHHHHh
Confidence 99999999999999987664
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=279.21 Aligned_cols=201 Identities=16% Similarity=0.200 Sum_probs=149.2
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
++|||++++.++.++.+.|||||||+++|.+++......+....++.++.||+.||+|||++||+||||||+||||+...
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC
Confidence 47999999999999999999999998899999986665677777889999999999999999999999999999996432
Q ss_pred --CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc---CCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 015018 81 --RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQ 154 (414)
Q Consensus 81 --~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~~DvwSlGvvl~ellt-G~~Pf~ 154 (414)
....+||+|||+++........ +.......||+.|+|||++. +..++.++|||||||++|||++ |..||.
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp TTTBCCEEECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CCCceeEEEecccceeeccCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 2246789999999876543211 11224568999999999998 4567889999999999999999 999996
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... .+ ...+.. .............+..+.+||..||..||.+||++++++
T Consensus 232 ~~~~---~~-~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 232 KSLQ---RQ-ANILLG-ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp STTT---HH-HHHHTT-CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhH---HH-HHHHhc-cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 5322 11 111111 111000000112345688999999999999999988775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=258.48 Aligned_cols=184 Identities=20% Similarity=0.274 Sum_probs=150.8
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEec-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~-~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++++.+.+..++|||+ + +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID- 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE-
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe-
Confidence 379999999999999999999999 5 8999999975 45799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
..++.+||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 174 -~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~- 242 (312)
T 2iwi_A 174 -LRRGCAKLIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD- 242 (312)
T ss_dssp -TTTTEEEECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred -CCCCeEEEEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-
Confidence 356789999999998765432 1345799999999999876664 5899999999999999999999652
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+..... .+...++.++.++|..||..+|++||+++++.
T Consensus 243 --------~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 243 --------QEILEAEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp --------HHHHHTCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --------HHHhhhcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11122111 13356889999999999999999999988775
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=276.15 Aligned_cols=202 Identities=20% Similarity=0.250 Sum_probs=146.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~------ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||+++++.+.++++.|||||||+++|.+++...... .++..++.++.||+.||+|||++||+||||||+||
T Consensus 67 ~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NI 146 (434)
T 2rio_A 67 DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146 (434)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 479999999999999999999999988999999743211 13334678999999999999999999999999999
Q ss_pred EEeec----------CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-------CCCCchhHHH
Q 015018 75 LMGLG----------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLE 137 (414)
Q Consensus 75 Ll~~~----------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~~~Dvw 137 (414)
||+.. .....+||+|||+++.+........ .......||+.|+|||++.+ ..++.++|||
T Consensus 147 Ll~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp EEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred EEecCcccccccccCCCceEEEEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99732 2345899999999998755322110 01234579999999999976 5689999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccc-hHHHh-hcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 138 SLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST-SIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 138 SlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l-~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
||||++|||++ |..||.+.... . ..+....... ....+ ...++.++.++|..||..||.+||++.+++
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~--~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSR--E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTH--H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCchhh--H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 99999999998 99999764321 1 1122211111 00000 112457899999999999999999988775
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=256.17 Aligned_cols=200 Identities=18% Similarity=0.203 Sum_probs=148.4
Q ss_pred CCCCcEEEEeeEe-------------CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015018 2 AAGIPNLRWFGVE-------------GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 67 (414)
Q Consensus 2 ~p~I~~l~~~g~~-------------~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHR 67 (414)
+|||++++.++.+ ....|+||||+ |++|.+++......+++..++.++.||+.||+|||++||+||
T Consensus 61 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 140 (303)
T 1zy4_A 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHR 140 (303)
T ss_dssp CTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred chHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 6899999988765 45789999999 899999998766678999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCccc-----c--cccccCCCCCCccccchhhhcCC-CCCchhHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-----I--PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESL 139 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~-----~--~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSl 139 (414)
||||+|||++ .++.+||+|||+++.......... . .........||..|+|||++.+. .++.++|||||
T Consensus 141 dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 141 DLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CCCGGGEEEC---TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred cCCHHhEEEc---CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 9999999996 678899999999976543211000 0 01112346799999999999865 68999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 140 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 140 Gvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
||++|+|++ ||... ....+.+..+..... .....+...++.++.+++..||..||.+||++.++.
T Consensus 218 G~il~~l~~---p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 218 GIIFFEMIY---PFSTG--MERVNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp HHHHHHHHS---CCSSH--HHHHHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHh---ccCCc--hhHHHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 999999998 66431 112222333322211 111223456778899999999999999999988775
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=263.91 Aligned_cols=196 Identities=15% Similarity=0.207 Sum_probs=159.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~l------l~~~-~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~ 72 (414)
+|||+++++++.+++..|+||||+ |++|.++ +... ...+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 699999999999999999999999 8899988 5422 5679999999999999999999999 99999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCc-hhHHHHHHHHHHHHHhCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~-~~DvwSlGvvl~elltG~ 150 (414)
|||++ .++.++|+|||++....... .....||..|+|||++.+. .++. ++|||||||++|+|++|.
T Consensus 182 Nil~~---~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 182 NILMD---KNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp GEEEC---TTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred hEEEc---CCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 99996 77899999999998765431 2346899999999999987 5655 999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchH--------------HHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSI--------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~--------------~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
.||.+.... .+.+..+......... ......++.++.+++..||..||.+||+++++++
T Consensus 250 ~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 250 VPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999875431 3334444333222110 0112568899999999999999999999877753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.97 Aligned_cols=190 Identities=20% Similarity=0.274 Sum_probs=150.4
Q ss_pred CCCCcEEEEeeEeCCE------EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGDY------NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~------~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++..... .|+||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 82 h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl 158 (353)
T 3coi_A 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158 (353)
T ss_dssp CTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEe
Confidence 6999999999887654 49999999888887764 46999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 ~~---~~~~~kl~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 159 VN---EDCELKILDFGLARHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp EC---TTCCEEECSTTCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred EC---CCCcEEEeecccccCCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 96 6789999999998754321 134578999999999987 678999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+.... +.+..+..... ...+..+...+++++.++|..||..||++||++++
T Consensus 226 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 226 GKDYL---DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp SSCHH---HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCHH---HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 75432 22222221100 01112233467899999999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 303 ~l 304 (353)
T 3coi_A 303 AL 304 (353)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.16 Aligned_cols=168 Identities=15% Similarity=0.154 Sum_probs=138.4
Q ss_pred EEEEEEecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeee
Q 015018 17 YNVLVIDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 90 (414)
Q Consensus 17 ~~~lVmE~~g~sL~~ll~~~------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DF 90 (414)
..|++|++++++|.++++.+ ...+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+||
T Consensus 179 ~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~---~~~~~kL~DF 255 (413)
T 3dzo_A 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 255 (413)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCG
T ss_pred ceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEe---cCCeEEEEec
Confidence 56899999999999999533 44588889999999999999999999999999999999996 6778999999
Q ss_pred ceeEEcccCCCcccccccccCCCCCCccccchhhh----------cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 91 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 91 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
|+++..... .....| +.|+|||++ .+..++.++|||||||++|+|++|+.||.+.....
T Consensus 256 G~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 256 EHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324 (413)
T ss_dssp GGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS
T ss_pred cceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 999875442 134577 999999999 55568889999999999999999999997743211
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
. ...+...+..+|+++.+||..||..||++||++.+++
T Consensus 325 ~------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 325 G------------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp C------------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred h------------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 1 1111112357899999999999999999999977664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=254.88 Aligned_cols=181 Identities=16% Similarity=0.181 Sum_probs=140.0
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~-~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
++|||++++.++.+ +.+.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 69 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 148 (299)
T 3m2w_A 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148 (299)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 47999999999887 77899999999 889999998643 4699999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++.....+.++|+|||++..... ..++.++|||||||++|+|++|..||.
T Consensus 149 l~~~~~~~~~~kl~Dfg~a~~~~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 149 LYTSKRPNAILKLTDFGFAKETTG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp EESSSSTTCCEEECCCTTCEECTT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEecCCCCCcEEEecccccccccc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 997443478899999999875321 235778999999999999999999997
Q ss_pred CCCccchHHHH-HHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQKY-EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~~~-~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+.......... ..+..... .........+++++.++|..||..||.+||++.++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 200 SNHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp C-------CCSCCSSCTTCC-SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcchhhhHHHHHHHhhccc-cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 64321100000 00000111 1111223568999999999999999999999877653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=243.14 Aligned_cols=175 Identities=11% Similarity=0.074 Sum_probs=141.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||+ |++|.++++. .....+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 89 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~-- 163 (286)
T 3uqc_A 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS-- 163 (286)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE--
T ss_pred CCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc--
Confidence 4799999999999999999999999 8999999863 346678999999999999999999999999999999997
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+++| |++ .++.++|||||||++|+|++|+.||.+....
T Consensus 164 -~~g~~kl~~~~---------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 164 -IDGDVVLAYPA---------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp -TTSCEEECSCC---------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred -CCCCEEEEecc---------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 67888887543 222 3688999999999999999999999875432
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
.......+... ........+...+|+++.++|..||+.||.+| ++.++.+.|+++.
T Consensus 209 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 209 SGLAPAERDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CCSEECCBCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhHHHHHHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 21100000001 11222345567899999999999999999999 9999999998875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=272.89 Aligned_cols=184 Identities=15% Similarity=0.183 Sum_probs=148.4
Q ss_pred CCCCcEEEEeeEeCCE-----EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGDY-----NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~-----~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.+.+. .||||||+ |++|.+++.. .+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 138 hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIl 214 (681)
T 2pzi_A 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIM 214 (681)
T ss_dssp CTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeE
Confidence 7999999999998665 79999999 8999987752 7999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
|+ .+.+||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+
T Consensus 215 l~----~~~~kl~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 215 LT----EEQLKLIDLGAVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EC----SSCEEECCCTTCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred Ee----CCcEEEEecccchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 95 348999999999876442 2457999999999998754 8899999999999999999999876
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 218 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-~~~~l~~~l~~~~~ 218 (414)
....... .... ...+++++.++|..||..||.+|| +.+.+...|...+.
T Consensus 279 ~~~~~~~----------~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 279 RYVDGLP----------EDDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp EECSSCC----------TTCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccccc----------cccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 3221100 0000 011357899999999999999999 57777777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=270.97 Aligned_cols=208 Identities=16% Similarity=0.211 Sum_probs=155.0
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~-g~sL~~ll~~~~--~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+|||++++.++.. ++..||||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+
T Consensus 71 HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~ 150 (676)
T 3qa8_A 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150 (676)
T ss_dssp BTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCST
T ss_pred CCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 6999999998765 77889999999 999999998543 26999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~P 152 (414)
|||++.+.....++|+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P 222 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred HeEeecCCCceeEEEcccccccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 99998544445699999999987644321 2346899999999999999999999999999999999999999
Q ss_pred CCCCCccch------HHHHHHHH-hhh---------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH-----HHH
Q 015018 153 WQGLKAGTK------KQKYEKIS-EKK---------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-----LKR 211 (414)
Q Consensus 153 f~~~~~~~~------~~~~~~i~-~~~---------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~-----l~~ 211 (414)
|.+...... ......+. ... .......+...++.++.++|..||..||.+||++.+ +.+
T Consensus 223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 975311000 00000000 000 000011122346789999999999999999999866 334
Q ss_pred HHHHHH
Q 015018 212 LFRDLF 217 (414)
Q Consensus 212 ~l~~~~ 217 (414)
.+.+++
T Consensus 303 ~l~~iL 308 (676)
T 3qa8_A 303 ALDSIL 308 (676)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 455554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-30 Score=251.94 Aligned_cols=174 Identities=16% Similarity=0.110 Sum_probs=128.7
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeecC------------
Q 015018 15 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGR------------ 80 (414)
Q Consensus 15 ~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH-~~givHRDIKP~NILl~~~~------------ 80 (414)
+++.||||||+ +++|.+.+. .+.+++..++.|+.||+.||+||| ++|||||||||+||||+.+.
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred cCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 78899999999 886655553 357999999999999999999999 99999999999999997432
Q ss_pred -----CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHH-HHHHHhCCCCCC
Q 015018 81 -----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQ 154 (414)
Q Consensus 81 -----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvv-l~elltG~~Pf~ 154 (414)
....+||+|||+|+.+... ...||+.|+|||++.+.. +.++|||||+++ .++++.|..||.
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERDG------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEETT------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccccCCCceEEEeeccccEecCCC------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 1128999999999876542 247999999999999876 899999998877 667888999985
Q ss_pred CCCccchHHHHHHHHhh-hc-cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEK-KV-STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~-~~-~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.. ........+... .. ......+...+++++.+||..||..| ++++++
T Consensus 279 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 279 NVL--WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHH--HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred chh--hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 410 001111222211 00 01111233456789999999999976 665554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=254.22 Aligned_cols=134 Identities=16% Similarity=0.185 Sum_probs=99.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
++|||+++++|+++...||||||+ |++|.+++.. ..+++.. .|+.||+.||+|||++|||||||||+||||+
T Consensus 301 ~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~--- 373 (569)
T 4azs_A 301 GFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD--- 373 (569)
T ss_dssp TCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---
T ss_pred CCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---
Confidence 689999999999999999999999 9999999985 5678765 4789999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~ 150 (414)
.++.|||+|||+|+....... ...+.+||+.||+||++.+. +...+|+|++|+++++++++.
T Consensus 374 ~dg~vKL~DFGlAr~~~~~~~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 374 ARQHARLIDFGSIVTTPQDCS-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TTSCEEECCCTTEESCC---C-------CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCCCEEEeecccCeeCCCCCc-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 778999999999987654322 12346899999999999874 567899999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-21 Score=205.39 Aligned_cols=138 Identities=21% Similarity=0.211 Sum_probs=112.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+.+..||||||+ |++|.++++. ++.|+.||+.+|+|||++||+||||||+|||++
T Consensus 398 h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~--- 465 (540)
T 3en9_A 398 DFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465 (540)
T ss_dssp GGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---
T ss_pred CCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---
Confidence 689996666666778889999999 8999999873 678999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
. .+||+|||+++..........-.+.....+.||+.|||||++.+ ..|+...|+|+..+-..+-+.++-+|
T Consensus 466 ~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 466 K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3 99999999999875532211000111235689999999999987 55777889999998888888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-16 Score=149.75 Aligned_cols=68 Identities=19% Similarity=0.359 Sum_probs=58.6
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 16 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 16 ~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
+..||||||+ |++|.+ +. ......++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl~DFG~a~ 240 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 240 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEECCCTTCE
T ss_pred cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEEEECCCCe
Confidence 4459999999 889987 32 134567999999999999999999999999999995 6889999999986
Q ss_pred E
Q 015018 95 R 95 (414)
Q Consensus 95 ~ 95 (414)
.
T Consensus 241 ~ 241 (282)
T 1zar_A 241 E 241 (282)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=8e-14 Score=131.69 Aligned_cols=80 Identities=24% Similarity=0.365 Sum_probs=64.2
Q ss_pred CCcEEEEeeEeCCEEEEEEecCC--C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEE
Q 015018 4 GIPNLRWFGVEGDYNVLVIDLLG--P----SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLM 76 (414)
Q Consensus 4 ~I~~l~~~g~~~~~~~lVmE~~g--~----sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH-~~givHRDIKP~NILl 76 (414)
++|.++.+ +..||||||+| + +|.++... +++..+..++.||+.+|.||| ++|||||||||+|||+
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl 204 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY 204 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 35556543 24589999994 2 78776542 335578899999999999999 9999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEc
Q 015018 77 GLGRRANQVYIIDFGLAKRY 96 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~ 96 (414)
+ . .++|+|||+|...
T Consensus 205 ~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 I---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp S---S--SEEECCCTTCEET
T ss_pred c---C--cEEEEECcccccC
Confidence 5 3 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-11 Score=123.55 Aligned_cols=71 Identities=17% Similarity=0.223 Sum_probs=55.9
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCCC-------CeEEEeee
Q 015018 19 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-------NQVYIIDF 90 (414)
Q Consensus 19 ~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~~-------~~vkL~DF 90 (414)
||||||+ |..|..+.. ......++.||+.+|.+||.+|||||||||.|||++.+... ..++||||
T Consensus 187 ~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~ 259 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF 259 (397)
T ss_dssp EEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred eEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence 7999999 777754422 23456788999999999999999999999999999754211 14899999
Q ss_pred ceeEEc
Q 015018 91 GLAKRY 96 (414)
Q Consensus 91 Gla~~~ 96 (414)
+.+...
T Consensus 260 ~Q~V~~ 265 (397)
T 4gyi_A 260 PQMVSM 265 (397)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=2e-08 Score=93.86 Aligned_cols=83 Identities=16% Similarity=0.272 Sum_probs=67.3
Q ss_pred CCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------
Q 015018 3 AGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------- 61 (414)
Q Consensus 3 p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-------------------- 61 (414)
..||+++.++.+++..|+|||++ |.+|.+.+. +......++.++...|..||.
T Consensus 70 ~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~ 143 (263)
T 3tm0_A 70 LPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELD 143 (263)
T ss_dssp SCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHH
T ss_pred CCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHH
Confidence 46899999999999999999999 889877531 222345788999999999998
Q ss_pred ---------------------------------------CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 ---------------------------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ---------------------------------------~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
..++|+|++|.|||++ ....+.|+||+.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 144 YLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999995 34456799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=4.5e-08 Score=93.90 Aligned_cols=141 Identities=17% Similarity=0.219 Sum_probs=89.8
Q ss_pred CcEEEEeeEeCC---EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------
Q 015018 5 IPNLRWFGVEGD---YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------- 61 (414)
Q Consensus 5 I~~l~~~g~~~~---~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~------------------- 61 (414)
||+++..+..++ ..|+||+++ |.+|.+... ..++..+...++.|++..|..||.
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~ 151 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKIN 151 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHH
Confidence 778887776554 458999999 878765332 257888888999999999999996
Q ss_pred ---------------------------------------CCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCc
Q 015018 62 ---------------------------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 102 (414)
Q Consensus 62 ---------------------------------------~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 102 (414)
..++|+|++|.|||++.+ ....+.|+||+.+..... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~-~~D 229 (304)
T 3sg8_A 152 EDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDP-DND 229 (304)
T ss_dssp HHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECT-THH
T ss_pred HHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCCh-HHH
Confidence 137999999999999721 145678999999875322 110
Q ss_pred ccccccccCCCCCC---------ccccc-hhhhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 103 QHIPYRENKNLTGT---------ARYAS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 103 ~~~~~~~~~~~~Gt---------~~Y~a-PE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
...-.... ...+. ..+.. |+.... .....++|++++++|.+.+|..+|
T Consensus 230 l~~~~~~~-~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDD-EEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTT-TSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhc-cccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000000 00000 00011 111110 012258999999999999998876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.50 E-value=7.2e-08 Score=89.24 Aligned_cols=78 Identities=17% Similarity=0.129 Sum_probs=59.8
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-------------------- 63 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g-------------------- 63 (414)
||+++.++..++..|+|||++ |.+|. .. ..+ ...++.+++..|..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 788999998888899999999 77773 21 122 2356677777788887643
Q ss_pred --------------------------------------ceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 64 --------------------------------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 64 --------------------------------------ivHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
++|+|++|.|||++ .++.+.|+|||.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999995 44456699999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.46 E-value=2e-07 Score=91.46 Aligned_cols=89 Identities=16% Similarity=0.259 Sum_probs=69.8
Q ss_pred CCCcEEEEeeEeC---CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 015018 3 AGIPNLRWFGVEG---DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS----------------- 61 (414)
Q Consensus 3 p~I~~l~~~g~~~---~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~----------------- 61 (414)
..||+++.++.+. ...|+|||++ |..|.+. .-..++......++.+++..|..||.
T Consensus 98 vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~ 174 (359)
T 3dxp_A 98 VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY 174 (359)
T ss_dssp SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred CCCCcEEEECCCCCccCCeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence 3589999998877 4589999999 7666431 12357888889999999999999997
Q ss_pred -----------------------------------------CCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 62 -----------------------------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 62 -----------------------------------------~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
..++|+|+++.|||++.+. ...+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence 3689999999999996221 13468999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.2e-05 Score=75.19 Aligned_cols=82 Identities=18% Similarity=0.236 Sum_probs=61.3
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------- 62 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~--------------------- 62 (414)
||+++.++.+++..|||||++ |.++.+..... ......++.++...|..||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 899999999999999999999 87887765421 122334555666666666631
Q ss_pred -------------------------------------CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 -------------------------------------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 -------------------------------------givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+.+.|||++ ..+.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 178999999999996 44556799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=4.3e-05 Score=73.29 Aligned_cols=89 Identities=26% Similarity=0.294 Sum_probs=61.7
Q ss_pred CCcEEEEeeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------
Q 015018 4 GIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK------------------- 62 (414)
Q Consensus 4 ~I~~l~~~g~-~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~------------------- 62 (414)
.||+++.++. ..+..|+|||++ |..|.+..- ..++......++.|+...|..||..
T Consensus 73 ~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~ 149 (306)
T 3tdw_A 73 NIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKI 149 (306)
T ss_dssp BCCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHH
T ss_pred CCCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHH
Confidence 4788888885 456789999999 877765321 1345556666666666666666642
Q ss_pred -----------------------------------------CceecCCCCCcEEEeecCCCCe-EEEeeeceeEE
Q 015018 63 -----------------------------------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKR 95 (414)
Q Consensus 63 -----------------------------------------givHRDIKP~NILl~~~~~~~~-vkL~DFGla~~ 95 (414)
.++|+|+++.|||++.+...+. +.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 150 LLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999962111244 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0001 Score=71.75 Aligned_cols=30 Identities=20% Similarity=0.326 Sum_probs=25.0
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
..++|+|+.+.|||++ ....+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~---~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYR---DFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEE---TTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEe---CCcEEEEEcccccc
Confidence 4699999999999996 34457899999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.011 Score=53.76 Aligned_cols=140 Identities=13% Similarity=0.124 Sum_probs=87.7
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCccccc
Q 015018 28 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 106 (414)
Q Consensus 28 sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 106 (414)
+|.++++..+.+|+++++..++.|.+..|.-+-. +.-..+=+-|..|+|. .+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc------------
Confidence 7999999889999999999999999999887622 1212333446788885 667666553 1110
Q ss_pred ccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcH
Q 015018 107 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 186 (414)
Q Consensus 107 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 186 (414)
.....+.+||... ...+.+.=|||||+++|.-+--.+|=.- ...+++
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-------------------------E~eLS~ 144 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-------------------------ERELSP 144 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-------------------------EECCCH
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-------------------------chhhCH
Confidence 1122344666542 2346788999999999998874444211 124567
Q ss_pred HHHHHHHHHHcC-------------------------CCCCCCCHHHHHHHHHHH
Q 015018 187 EFASYFHYCRSL-------------------------RFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 187 e~~~li~~c~~~-------------------------dp~~RP~~~~l~~~l~~~ 216 (414)
++..||..|... .+..|.+++++.++.+..
T Consensus 145 ~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 145 PLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp HHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 777777777644 234666777776666544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00098 Score=63.77 Aligned_cols=30 Identities=27% Similarity=0.557 Sum_probs=25.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
..++|+|+++.|||++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG---ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC---GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe---CCCcEEEEehhhcc
Confidence 5799999999999995 35679999999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0048 Score=59.20 Aligned_cols=34 Identities=38% Similarity=0.468 Sum_probs=26.4
Q ss_pred CCceecCCCCCcEEEeecCC-CCeEEEeeeceeEE
Q 015018 62 KSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKR 95 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~-~~~vkL~DFGla~~ 95 (414)
..++|+|+.+.|||+..+.. .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 46999999999999962110 25789999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.013 Score=55.48 Aligned_cols=29 Identities=24% Similarity=0.390 Sum_probs=24.3
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
.++|+|+.+.||+. .++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD----TGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE----CCCCEEEEecccccC
Confidence 48999999999995 456789999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.014 Score=57.37 Aligned_cols=30 Identities=17% Similarity=0.354 Sum_probs=24.8
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
..++|+|+.+.|||+. .+.++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~----~~~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFAS----EHETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEEC----SSCEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEe----CCCeEEEeCccccc
Confidence 5799999999999995 33589999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.072 Score=51.04 Aligned_cols=27 Identities=15% Similarity=0.266 Sum_probs=23.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPS 28 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~s 28 (414)
...||+++.++..++..|+|||++ |..
T Consensus 90 ~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 90 SINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp SSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred CCCcceEEEEeecCCceEEEEEeccCCC
Confidence 356899999999888999999999 654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.66 E-value=0.045 Score=54.35 Aligned_cols=32 Identities=13% Similarity=0.331 Sum_probs=26.4
Q ss_pred HhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 60 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 60 H~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
+...++|+|+++.|||++ .+ .++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~---~~-~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT---QD-STQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEEC---SS-CEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEe---CC-CCEEEeCccccc
Confidence 356799999999999995 33 399999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.48 E-value=0.078 Score=50.17 Aligned_cols=40 Identities=20% Similarity=0.350 Sum_probs=29.4
Q ss_pred HHHHHHHHHh-------CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 52 MINRVEFVHS-------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 52 ll~gL~yLH~-------~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
+...+++|.. .+++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3445556653 3699999999999996 34445799999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.11 E-value=0.18 Score=47.69 Aligned_cols=29 Identities=24% Similarity=0.259 Sum_probs=24.2
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~----~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR----D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES----S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc----C-CCEEEECCCCCc
Confidence 4589999999999995 2 789999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.04 E-value=0.33 Score=46.95 Aligned_cols=29 Identities=24% Similarity=0.442 Sum_probs=23.8
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
.++|+|+++.|||++ .+.+.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~----~~~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINT----NKCLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEEC----C-CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEec----CCcEEEEEecCCCC
Confidence 589999999999994 34589999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=87.09 E-value=0.34 Score=46.55 Aligned_cols=31 Identities=32% Similarity=0.555 Sum_probs=26.1
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeEE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 95 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~ 95 (414)
..++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 4699999999999995 446799999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=83.47 E-value=0.78 Score=46.20 Aligned_cols=15 Identities=20% Similarity=0.310 Sum_probs=13.8
Q ss_pred CceecCCCCCcEEEe
Q 015018 63 SFLHRDIKPDNFLMG 77 (414)
Q Consensus 63 givHRDIKP~NILl~ 77 (414)
.++|+|+.+.|||+.
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999996
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=82.61 E-value=0.48 Score=47.21 Aligned_cols=33 Identities=27% Similarity=0.499 Sum_probs=24.1
Q ss_pred CceecCCCCCcEEEeecCC-------------------------CCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLGRR-------------------------ANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~-------------------------~~~vkL~DFGla~~ 95 (414)
.++|+|+.+.|||+..+.. .+.+.||||..|..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 4899999999999973210 15789999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=80.45 E-value=0.79 Score=44.96 Aligned_cols=33 Identities=27% Similarity=0.488 Sum_probs=25.3
Q ss_pred CceecCCCCCcEEEeec-CCCCeEEEeeeceeEE
Q 015018 63 SFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKR 95 (414)
Q Consensus 63 givHRDIKP~NILl~~~-~~~~~vkL~DFGla~~ 95 (414)
.++|+|+.+.|||+..+ ...+.+.|+||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999632 1136899999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 414 | ||||
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-70 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-19 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-17 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-17 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-17 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-17 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-17 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-17 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-17 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-15 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-15 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-15 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-14 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-14 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-14 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-14 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-14 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-13 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-13 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-13 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-13 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-13 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-13 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-13 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-12 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-12 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-12 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-12 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-12 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-12 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-12 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-11 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-11 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-11 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-11 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-11 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-10 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-10 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-10 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-10 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-10 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-10 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-09 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-09 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-08 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-08 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-08 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-07 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 221 bits (563), Expect = 3e-70
Identities = 146/232 (62%), Positives = 173/232 (74%), Gaps = 2/232 (0%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
GIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 64 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233
G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (549), Expect = 6e-68
Identities = 183/235 (77%), Positives = 216/235 (91%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
IP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++HSK+F
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYAS+NT
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 125 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 184
HLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE LC+GY
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 185 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 239
P+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 2e-19
Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 20/221 (9%)
Query: 6 PNL-RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
N+ + G + +V G SL + K + ++ +A Q ++++H+K
Sbjct: 64 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
S +HRD+K +N + V I DFGLA + + L+G+ + +
Sbjct: 124 SIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWMAP 175
Query: 123 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 179
++ S + D+ + G VL + G LP+ + + Q + +S +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSK 233
Query: 180 LCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 216
+ P C + D++P + A ++ L R L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 1e-17
Identities = 37/210 (17%), Positives = 76/210 (36%), Gaps = 23/210 (10%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 62
I + ++ + G SL+ + + ++ + + ++ +I + ++ K
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
+HRD+KP N L+ ++ + DFG++ + D+ + + GT Y S
Sbjct: 125 KIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMSP 172
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 182
G S + D+ S+G L+ G P A + + +E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VEGDAA 224
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRL 212
P + S D +P A + L
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (198), Expect = 1e-17
Identities = 32/171 (18%), Positives = 63/171 (36%), Gaps = 13/171 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
L + + + + L ++++ +E++H K
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+HRD+KP+N L+ + I DFG AK + + GTA+Y S
Sbjct: 129 IIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVSPE 180
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (195), Expect = 2e-17
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 15/170 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L + + L+++ K + ++ N + + HSK
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 128 IHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEM 175
Query: 125 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 80.1 bits (197), Expect = 3e-17
Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ NL + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
G D+ S+G + L G P+ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 80.1 bits (197), Expect = 3e-17
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 13/171 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ NL + VL+++ L G L D K+S V+ Q ++ +H S
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+H DIKP+N + ++A+ V IIDFGLA + + T TA +A+
Sbjct: 148 IVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPE 198
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
D+ ++G + L G P+ G + + +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 5e-17
Identities = 30/174 (17%), Positives = 65/174 (37%), Gaps = 19/174 (10%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
I L + ++I+ G +++ + R L+ + ++ Q ++ + ++H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+HRD+K N L + + DFG++ + T + + GT + +
Sbjct: 131 IIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPE 180
Query: 124 THLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 172
+ R D+ SLG L+ P L + KI++ +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 5e-17
Identities = 36/171 (21%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
I +L + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
H DI+P+N + RR++ + II+FG A++ + + + Y +
Sbjct: 123 IGHFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPE 173
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
H S D+ SLG ++ L G P+ T +Q E I + +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYT 221
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 9e-16
Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 18/217 (8%)
Query: 6 PNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
P + R GV + + +LV+++ G L ++ + V L Q+ ++++ K
Sbjct: 69 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
+F+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 129 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAP 181
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+ S R D+ S G + L G P++ + + I + K
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECP 234
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218
P E + C +++D+PD+ +++ R +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 42/213 (19%), Positives = 72/213 (33%), Gaps = 14/213 (6%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
+ L + ++ SL D L T+ A Q+ + ++ SK F
Sbjct: 73 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRD+ N L+ + V I DFGL + H Y ++ + + +
Sbjct: 133 IHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCAPES 185
Query: 125 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
S D G L G PW GL Q KI ++ C
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRPEDC-- 240
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216
P + + C + + +D+P + L+ +
Sbjct: 241 -PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 2e-15
Identities = 29/147 (19%), Positives = 57/147 (38%), Gaps = 10/147 (6%)
Query: 11 FGVEGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 68
++V++ L G L + + + + + + + ++++HS + HRD
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136
Query: 69 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 128
+KP+N L R + + DFG AK + Y T Y +
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEVLGPE 188
Query: 129 EQSRRDDLESLGYVLMYFLRGSLPWQG 155
+ + D+ SLG ++ L G P+
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 2e-15
Identities = 34/171 (19%), Positives = 68/171 (39%), Gaps = 16/171 (9%)
Query: 6 PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 62
P L ++ L + + +LF SR+ + + ++++ +E++HS+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
++RDIK +N ++ + + I DFGL K GT Y +
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEYLAP 174
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 173
+ R D LG V+ + G LP+ ++ +E I +++
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 73.5 bits (180), Expect = 3e-15
Identities = 31/186 (16%), Positives = 60/186 (32%), Gaps = 22/186 (11%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
R + LV++ S DL + L + + + + ++HS +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRD+K N L+ V + DFG A + GT + +
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAPEV 182
Query: 125 HLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKVSTS 176
L +++ + D D+ SLG + P + A + + + + S
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 177 IEALCR 182
Sbjct: 243 FRNFVD 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 5e-15
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 18/182 (9%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHS 61
G+ L + D VL+++ P DLF+F + + L + Q++ V H+
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
LHRDIK +N L + ++ +IDFG +DT GT Y+
Sbjct: 129 CGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------GTRVYSP 177
Query: 122 MNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 180
R + SLG +L + G +P++ + + + ++VS+ + L
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVSSECQHL 234
Query: 181 CR 182
R
Sbjct: 235 IR 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 1e-14
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 15/186 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
+ EG+ L ++ + Q++ V ++H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
HRDIKP+N L+ + + I DFGLA +R + + + GT Y +
Sbjct: 125 THRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPEL 176
Query: 125 HLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 177
E + D+ S G VL L G LPW + K++K KK+ ++
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 178 EALCRG 183
AL
Sbjct: 237 LALLHK 242
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 2e-14
Identities = 40/222 (18%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 6 PNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
P + R G+ E + +LV+++ + + +R + K ++ L Q+ ++++ +
Sbjct: 68 PYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
F+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 128 FVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPE 180
Query: 124 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 182
+ S + D+ S G ++ G P++G+ + + + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA---- 233
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF---IREG 221
G P E + C + +++P +A ++ R+ + + EG
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 3e-14
Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 21/217 (9%)
Query: 6 PNL-RWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
L R + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 180
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 181 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (172), Expect = 4e-14
Identities = 38/185 (20%), Positives = 68/185 (36%), Gaps = 19/185 (10%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
I N + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 177
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 178 EALCR 182
Sbjct: 247 RDFLN 251
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 69.8 bits (170), Expect = 4e-14
Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 9/143 (6%)
Query: 14 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72
G +V++ + G +L D+ + ++ K + + + F H +HRD+KP
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 140
Query: 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR 132
N ++ N V ++DFG+A+ D+ + + GTA+Y S G
Sbjct: 141 NIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIGTAQYLSPEQARGDSVDA 193
Query: 133 RDDLESLGYVLMYFLRGSLPWQG 155
R D+ SLG VL L G P+ G
Sbjct: 194 RSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 6e-14
Identities = 37/152 (24%), Positives = 61/152 (40%), Gaps = 12/152 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ ++ + V++ L G L C K L A ++I ++F+HSK
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
++RD+K DN L+ + + I DFG+ K + GT Y +
Sbjct: 124 IVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAPE 173
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
LG + + D S G +L L G P+ G
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 8e-14
Identities = 47/218 (21%), Positives = 73/218 (33%), Gaps = 13/218 (5%)
Query: 11 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70
+ LV D L L + K +L + + ++N + ++H LHRD+K
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144
Query: 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 130
N L+ R + + DFGLA+ + Q Y N T Y LG
Sbjct: 145 AANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVTLWYRPPELLLGERD 198
Query: 131 -SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 189
DL G ++ S QG T++ + IS+ S + E E
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSITPEVWPNVDNYELY 255
Query: 190 SYFHYCRSLRFDDKPDYAYLKR--LFRDLFIREGFQFD 225
+ + K R DL I + D
Sbjct: 256 EKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 67.4 bits (164), Expect = 3e-13
Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 10/168 (5%)
Query: 7 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 65
L+ + LV DL+ L D LS K + ++ + +H + +
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 66 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 125
HRD+KP+N L+ + + DFG + + + + + + + H
Sbjct: 133 HRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189
Query: 126 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 173
G + D+ S G ++ L GS P+ + I
Sbjct: 190 PGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (163), Expect = 3e-13
Identities = 37/213 (17%), Positives = 73/213 (34%), Gaps = 17/213 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L E +++ L L L ++++ A Q+ + ++ SK F
Sbjct: 70 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRDI N L+ + V + DFGL++ D+ ++ ++ + +
Sbjct: 130 VHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWMAPES 180
Query: 125 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
+ D+ G + L G P+QG+ +I + +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE----RLPMPPN 233
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216
P S C + +P + LK +
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.4 bits (164), Expect = 3e-13
Identities = 38/172 (22%), Positives = 70/172 (40%), Gaps = 15/172 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 62
I L G + L++ L+ S +LF+ K + + L Q+++ V+++H
Sbjct: 69 IVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
+HRD+KP+N L +++ I DFGL+K + GT Y +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAP 178
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
S+ D S+G + L G P+ + +E+I + +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.4 bits (164), Expect = 4e-13
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 16/170 (9%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I + + +++D + S++ A ++ +E++HSK
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
++RD+KP+N L+ + + I DFG AK D L GT Y +
Sbjct: 126 IYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAPEV 172
Query: 125 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 174
++ D S G ++ L G P+ + YEKI ++
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 6e-13
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 18/212 (8%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
E ++ + L + +T+ + Q++ ++F+HS +HRD+KP N
Sbjct: 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 133
L+ + Q+ + DFGLA+ Y + T Y + L +
Sbjct: 147 ILVT---SSGQIKLADFGLARIYSFQMALTSV--------VVTLWYRAPEVLLQSSYATP 195
Query: 134 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 193
DL S+G + R ++G + + KI + E R ++
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252
Query: 194 YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
D + L +DL + + F+
Sbjct: 253 KSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (163), Expect = 6e-13
Identities = 42/216 (19%), Positives = 74/216 (34%), Gaps = 25/216 (11%)
Query: 17 YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
Y LV+D + ++ + SR L + V + Q+ + ++HS HRDIKP N
Sbjct: 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYRENKNLTGTARYASMNTHLGIE 129
L + + DFG AK+ + YR + + G Y
Sbjct: 153 L--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY---------- 200
Query: 130 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 189
+ D+ S G VL L G + G + + +I + + + E + P
Sbjct: 201 -TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 190 SYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
F ++ + K L ++
Sbjct: 257 FKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.4 bits (164), Expect = 6e-13
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 13/170 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I + + D ++DL+ S + A ++I +E +H++
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 128
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
++RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 129 VYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEV 176
Query: 125 HL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 173
G+ D SLG +L LRG P++ K K + V
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 66.4 bits (161), Expect = 7e-13
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 19/156 (12%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L VLV + L L+ L + C L T Q++N + + H +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH-----QHIPYRENKNLTGTARY 119
LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+ +Y
Sbjct: 122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
S D+ S+G + + G+ + G
Sbjct: 179 -----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.4 bits (161), Expect = 9e-13
Identities = 36/181 (19%), Positives = 68/181 (37%), Gaps = 16/181 (8%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
LS L +A Q+ + ++ + F+HRD+ N L+G V I DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNI 190
Query: 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG 155
Y+ + N R+ + + D+ + G VL G P+ G
Sbjct: 191 YSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215
+ ++ + + + E P E + C S D+P + + R+ +
Sbjct: 246 M---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 216 L 216
+
Sbjct: 299 M 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 9/164 (5%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
+ L + ++ + L D + + +L Q+ + ++ +
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRD+ N L+ V I DFGLAK H + ++ ++ +
Sbjct: 133 VHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMALES 184
Query: 125 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 167
L + + D+ S G + + GS P+ G+ A EK
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 1e-12
Identities = 37/215 (17%), Positives = 79/215 (36%), Gaps = 18/215 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLS-LKTVLMLADQMINRVEFVHSKS 63
+ L E ++ + SL D + K L ++ +A Q+ + + +V +
Sbjct: 74 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
++HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 134 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPE 184
Query: 124 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 182
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP---- 237
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217
P C +++P + YL+ D F
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 1e-12
Identities = 30/143 (20%), Positives = 54/143 (37%), Gaps = 12/143 (8%)
Query: 40 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 99
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSD 217
Query: 100 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKA 158
+ Y N ++ + + + + D+ S G +L G P+ G+
Sbjct: 218 SN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-- 270
Query: 159 GTKKQKYEKISEKKVSTSIEALC 181
+ K+ +
Sbjct: 271 -PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 1e-12
Identities = 30/170 (17%), Positives = 64/170 (37%), Gaps = 16/170 (9%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKP 71
VLV +L+ + + + +K + Q++ ++F+H+++ +HRD+K
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 142
Query: 72 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 131
DN + V I D GLA R + K + GT + + + +
Sbjct: 143 DNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEFMAPEMYEE-KYD 190
Query: 132 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
D+ + G ++ P+ Q Y +++ S + +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFDKVA 238
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.4 bits (159), Expect = 1e-12
Identities = 39/180 (21%), Positives = 68/180 (37%), Gaps = 24/180 (13%)
Query: 5 IPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 58
I ++ +V++ G L + +++ L + VL + Q+ ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 59 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 113
H +S LHRD+KP N + V + DFGLA+ + K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 114 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 173
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 2e-12
Identities = 28/170 (16%), Positives = 64/170 (37%), Gaps = 14/170 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ L + ++ + + L + + + +L + + +E++ SK
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
FLHRD+ N L+ V + DFGL++ D + R++
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPE 171
Query: 124 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 172
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 65.2 bits (158), Expect = 2e-12
Identities = 23/170 (13%), Positives = 63/170 (37%), Gaps = 10/170 (5%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ +L + +++ + + SL+ + ++ ++ + + ++++ +
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 148
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
++HRD+ N L+ + DFGL++ D + Y R+ +
Sbjct: 149 YVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPE 203
Query: 124 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 172
+ + D+ S G V+ + G P+ + T + I +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 6e-12
Identities = 47/224 (20%), Positives = 76/224 (33%), Gaps = 21/224 (9%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L LV D + LE + S L+ + + +E++H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
LHRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 122 LHRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPEL 171
Query: 125 HLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
G D+ ++G +L L G + + +I E + + E
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW--- 225
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIREGFQFD 225
+ S Y F P + DL I+ F F+
Sbjct: 226 --PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 63.7 bits (154), Expect = 8e-12
Identities = 33/229 (14%), Positives = 76/229 (33%), Gaps = 22/229 (9%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L + + + D + L+ + +++ +++ HS
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGI 150
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
+HRD+KP N + + ++ +ID+GLA+ Y + + +
Sbjct: 151 MHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPEL 200
Query: 125 HLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
+ + D+ SLG +L + P+ + +I++ + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 184 YPTEFASYFH-------YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
Y E F+ R RF + + D + + ++D
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.9 bits (152), Expect = 2e-11
Identities = 26/118 (22%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AKR +
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192
Query: 98 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155
GT + L ++ D +LG ++ G P+
Sbjct: 193 GRTWTLC----------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 2e-11
Identities = 43/214 (20%), Positives = 74/214 (34%), Gaps = 15/214 (7%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
+ LV L+G L L ++ LS + Q++ ++++HS + LHRD+KP N
Sbjct: 82 QMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 139
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN-THLGIEQSR 132
L+ + I DFGLA+ H T Y + ++
Sbjct: 140 LLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----YVATRWYRAPEIMLNSKGYTK 192
Query: 133 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY- 191
D+ S+G +L L + G + I S S E L + +Y
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 192 FHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
+ + DL + + F+
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 3e-11
Identities = 41/222 (18%), Positives = 74/222 (33%), Gaps = 15/222 (6%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS 63
I L + LV + L L+ + + L + Q++ + F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEI 173
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 183
S D+ SLG + + + G ++ + +I + + T E + G
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWPG 229
Query: 184 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
+ + + R D L R L + + +D
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.2 bits (148), Expect = 3e-11
Identities = 40/218 (18%), Positives = 75/218 (34%), Gaps = 27/218 (12%)
Query: 6 PNL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 59
NL + GV E +V + + SL D L + L +L + + +E++
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 60 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 119
+F+HRD+ N L+ N + DFGL K T ++
Sbjct: 120 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKW 166
Query: 120 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 178
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD 223
Query: 179 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216
G P C L +P + L+ +
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 9e-11
Identities = 36/175 (20%), Positives = 67/175 (38%), Gaps = 12/175 (6%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
+ L +L+++L+ F L+ + Q++N V ++HS
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 65 LHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
H D+KP+N ++ ++ IIDFGLA + ++I GT + +
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FGTPEFVAPE 186
Query: 124 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 178
D+ S+G + L G+ P+ G TK++ +S E
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEFEDE 238
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (144), Expect = 1e-10
Identities = 36/214 (16%), Positives = 75/214 (35%), Gaps = 18/214 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
+ L +E LV + + L D + +T+L + + + ++
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 123
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172
Query: 124 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 182
S + D+ S G ++ G +P++ + + E IS R
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPR 225
Query: 183 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216
T ++C R +D+P ++ L R ++
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 4e-10
Identities = 28/155 (18%), Positives = 65/155 (41%), Gaps = 9/155 (5%)
Query: 5 IPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
+ +L + + + LV+ + L + + ++K ++ Q+ ++F+ SK
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
F+HRD+ N ++ V + DFGLA+ D ++ ++
Sbjct: 150 KFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMAL 203
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 156
+ + + + D+ S G +L + RG+ P+ +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.4 bits (140), Expect = 5e-10
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 17/173 (9%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
E LV++L+ +L +L + + L QM+ ++ +HS +HRD+KP N
Sbjct: 93 EFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR 133
++ + + I+DFGLA+ + T Y + LG+
Sbjct: 150 IVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRYYRAPEVILGMGYKEN 198
Query: 134 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 186
D+ S+G ++ +R + + G ++ K+ E+ + E + + PT
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.4 bits (138), Expect = 6e-10
Identities = 42/216 (19%), Positives = 86/216 (39%), Gaps = 19/216 (8%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 62
+ L ++ + + G L+ L +++S +L +A Q+ + +E++ K
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 122
+F+HRD+ N L+G + V + DFGL++ H + ++ +
Sbjct: 135 NFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAP 185
Query: 123 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 181
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE--- 239
Query: 182 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217
G P + C D+P +A + + F +F
Sbjct: 240 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 7e-10
Identities = 30/153 (19%), Positives = 60/153 (39%), Gaps = 11/153 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
+ L + L++D + + + V + +++ +E +H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
++RDIK +N L+ V + DFGL+K + T + + GT Y + +
Sbjct: 151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC------GTIEYMAPDI 201
Query: 125 HLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 155
G + + D SLG ++ L G+ P+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 9e-10
Identities = 23/117 (19%), Positives = 44/117 (37%), Gaps = 8/117 (6%)
Query: 37 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 96
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDI 195
Query: 97 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
++ + + N ++ + + + D+ S G L
Sbjct: 196 KNDSNYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 9e-10
Identities = 38/183 (20%), Positives = 66/183 (36%), Gaps = 31/183 (16%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLSLKTVLML 48
I NL Y L I+ +L D N + LS + +L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 49 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 108
A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG--- 186
Query: 109 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 167
R+ ++ + + D+ S G +L + G P+ G+ T + YEK
Sbjct: 187 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEK 238
Query: 168 ISE 170
+ +
Sbjct: 239 LPQ 241
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (137), Expect = 9e-10
Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 21/214 (9%)
Query: 14 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73
E + LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N
Sbjct: 94 EFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 151
Query: 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SR 132
+ ++ I+DFGLA+ D T T Y + L ++
Sbjct: 152 LAV---NEDCELKILDFGLARHTDDEMTGYVA----------TRWYRAPEIMLNWMHYNQ 198
Query: 133 RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYF 192
D+ S+G ++ L G + G + + I + E L + +Y
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 193 HYCRSL-RFDDKPDYAYLKRLFRDLFIREGFQFD 225
+ + + + L DL + + D
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 1e-09
Identities = 24/171 (14%), Positives = 61/171 (35%), Gaps = 13/171 (7%)
Query: 6 PNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 61
N+ R GV Y ++I +L+ + S+ ++ + + ++++ +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 121
+++HRD+ N L+ + DFGL++ D + R+ +
Sbjct: 129 MNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTA 181
Query: 122 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 172
+ + D+ S G V+ + + + + I++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 2e-09
Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 21/209 (10%)
Query: 19 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78
LV+ +G L L KL + L QM+ + ++H+ +HRD+KP N +
Sbjct: 99 YLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN- 155
Query: 79 GRRANQVYIIDFGLAKRYRDTATHQ--HIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 136
++ I+DFGLA++ T YR + + RY ++ D+
Sbjct: 156 --EDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY-----------TQTVDI 202
Query: 137 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 196
S+G ++ + G ++G + ++ K++ + ++ L +
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 197 SLRFDDKPDYAYLKRLFRDLFIREGFQFD 225
F A L +L + + D
Sbjct: 263 KKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.3 bits (129), Expect = 9e-09
Identities = 32/185 (17%), Positives = 69/185 (37%), Gaps = 15/185 (8%)
Query: 29 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYI 87
L + + R + L V ++ Q++ ++++H + +H DIKP+N L + + +
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENL 168
Query: 88 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 147
I +A +H T Y S LG D+ S ++ +
Sbjct: 169 IQIKIADLGNACWYDEHYTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223
Query: 148 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207
G ++ + + + + I++ I L P+ Y R+ F+ +
Sbjct: 224 TGDFLFEPDEGHSYTKDDDHIAQ------IIELLGELPSYLLRNGKYTRTF-FNSRGLLR 276
Query: 208 YLKRL 212
+ +L
Sbjct: 277 NISKL 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 2e-08
Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 11/150 (7%)
Query: 5 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 64
I L LV + L+ F+ C+ L + V Q++ + F HS++
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 124
LHRD+KP N L+ R ++ + +FGLA+ + IP R T Y +
Sbjct: 123 LHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPPDV 172
Query: 125 HLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 153
G + S D+ S G + P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (125), Expect = 3e-08
Identities = 29/136 (21%), Positives = 57/136 (41%), Gaps = 12/136 (8%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
+LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 186
Query: 98 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 156
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 187 HIDYYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 157 KAGTKKQKYEKISEKK 172
++ ++ + E
Sbjct: 242 ---PVEELFKLLKEGH 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.9 bits (121), Expect = 4e-08
Identities = 14/91 (15%), Positives = 36/91 (39%), Gaps = 13/91 (14%)
Query: 4 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 63
G+ + + EG+ ++ E + ++ ++ + D ++ V + +
Sbjct: 73 GLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94
+H D+ N L+ ++IIDF +
Sbjct: 124 IVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (123), Expect = 5e-08
Identities = 24/116 (20%), Positives = 46/116 (39%), Gaps = 8/116 (6%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIY 185
Query: 98 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 153
+ + ++ + T + + D+ S G +L
Sbjct: 186 KDPDYVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 9e-08
Identities = 33/180 (18%), Positives = 70/180 (38%), Gaps = 22/180 (12%)
Query: 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR---------KLSLKTVLMLADQMIN 54
+ L +G +++++L+ L+ SL ++ +A ++ +
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 55 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 114
+ ++++ F+HRD+ N ++ V I DFG+ + +T YR+
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKGGKGL 196
Query: 115 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKV 173
R+ S + + D+ S G VL P+QGL + +Q + E +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVMEGGL 253
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 6e-07
Identities = 36/169 (21%), Positives = 56/169 (33%), Gaps = 13/169 (7%)
Query: 38 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 97
KL+L T LA + V + HRD+K N L+ + I D GLA R+
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHD 159
Query: 98 DTATHQHIPYRENKNLTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 151
I + GT RY E +R D+ ++G V R
Sbjct: 160 SATDTIDIAP---NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 152 PWQGLKAGTKKQKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 199
+ S+ V + +C + + + C +LR
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 414 | |||
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.23 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 86.58 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-46 Score=360.04 Aligned_cols=232 Identities=63% Similarity=1.062 Sum_probs=213.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec--
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-- 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~-- 79 (414)
.+||++++.++.++.+.|+||||+|++|.+++......++..+++.++.|++.||+|||++|||||||||+|||++..
T Consensus 60 ~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~ 139 (293)
T d1csna_ 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS 139 (293)
T ss_dssp CTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS
T ss_pred CCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc
Confidence 589999999999999999999999999999998878889999999999999999999999999999999999999742
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
...+.+||+|||+|+.+.........+........||+.|||||++.+..++.++|||||||++|||++|..||.+....
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 23578999999999998876665666666667789999999999999999999999999999999999999999998888
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
...+.+.++...+.......++.++|+++.+++..|+..+|++||+|+.|.++|++++.+.++..+.+|||+.+
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 220 TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp CHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred hHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 88888888888877778888999999999999999999999999999999999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=360.62 Aligned_cols=235 Identities=78% Similarity=1.383 Sum_probs=208.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
.++|+.+++++.+++..++||||+|++|.+.+....+.+++..++.++.||+.||+|||++|||||||||+|||++..+.
T Consensus 62 ~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~ 141 (299)
T d1ckia_ 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 141 (299)
T ss_dssp STTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG
T ss_pred CCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCC
Confidence 46788889999999999999999999999988877889999999999999999999999999999999999999976656
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccch
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 161 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~~ 161 (414)
+..++|+|||+|+.+.+.......+++......||+.|||||++.+..++.++|||||||++|||++|..||.+......
T Consensus 142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp TTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred CceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 77899999999999887666565566667788999999999999999999999999999999999999999998776666
Q ss_pred HHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 015018 162 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 236 (414)
Q Consensus 162 ~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~~ 236 (414)
...+............+.++.++|+++.++|..||..+|++||+|++|.++|++++.+.++..+.+|||+.++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp ---HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred HHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 666666667777777788889999999999999999999999999999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=330.66 Aligned_cols=205 Identities=20% Similarity=0.301 Sum_probs=168.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+ +..||||||| |++|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 63 HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~--- 138 (276)
T d1uwha_ 63 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH--- 138 (276)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---
Confidence 7999999988754 5679999999 8999999986677899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+|+........ .......||+.|||||++.+. .++.++|||||||+||||++|+.||.+..
T Consensus 139 ~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 139 EDLTVKIGDFGLATVKSRWSGS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp TTSSEEECCCCCSCC-----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCEEEccccceeeccccCCc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 7789999999999765432221 122456899999999999754 47899999999999999999999998764
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
. ..+....+...........+...+|+++.+||..||+.||++||++++|.+.|+.+.
T Consensus 214 ~--~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 214 N--RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp C--HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h--HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 3 233344444444444555667789999999999999999999999999999998775
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=325.93 Aligned_cols=189 Identities=22% Similarity=0.287 Sum_probs=165.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 65 hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~--- 140 (263)
T d2j4za1 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG--- 140 (263)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---
Confidence 799999999999999999999999 9999999975 45899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+...... .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +
T Consensus 141 ~~~~~kl~DFG~a~~~~~~~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~ 208 (263)
T d2j4za1 141 SAGELKIADFGWSVHAPSSR---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---T 208 (263)
T ss_dssp TTSCEEECCCCSCSCCCCCC---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---S
T ss_pred CCCCEeecccceeeecCCCc---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---C
Confidence 67899999999997654322 13468999999999999999999999999999999999999999774 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+...... ++..+++++.+||..||..||++||+++++++
T Consensus 209 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 209 YQETYKRISRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHHHTTCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCC-----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 45556666554432 34568899999999999999999999887753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=326.11 Aligned_cols=193 Identities=20% Similarity=0.306 Sum_probs=162.9
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||| |++|.+++.. +.+++.++..|+.||+.||+|||++|||||||||+||||+
T Consensus 75 ~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~-- 150 (293)
T d1yhwa1 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-- 150 (293)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC--
Confidence 3799999999999999999999999 9999998874 4799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 151 -~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-- 220 (293)
T d1yhwa1 151 -MDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-- 220 (293)
T ss_dssp -TTCCEEECCCTTCEECCSTTC-------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--
T ss_pred -CCCcEeeccchhheeeccccc-------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--
Confidence 678999999999998754332 1235689999999999999999999999999999999999999998743
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+........ .....+++++.+||..||..||++||++++++
T Consensus 221 -~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 221 -PLRALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp -HHHHHHHHHHHCSCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred -HHHHHHHHHhCCCCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2333333333221111 12356889999999999999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=328.37 Aligned_cols=213 Identities=17% Similarity=0.243 Sum_probs=174.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 67 HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~--- 142 (288)
T d1uu3a_ 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN--- 142 (288)
T ss_dssp STTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred CCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---
Confidence 799999999999999999999999 8999999875 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+.+....... ......||+.|||||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~ 214 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---N 214 (288)
T ss_dssp TTSCEEECCCTTCEECC---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCceEEecccccceecccCCccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---C
Confidence 77899999999999775432211 123468999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
..+.+.++...... ++..+++++.+||..||..||.+||+++++..... ++ ...+...++|+.+..
T Consensus 215 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~-i~---~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 215 EYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP-LK---AHPFFESVTWENLHQ 280 (288)
T ss_dssp HHHHHHHHHTTCCC-----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH-HH---TSGGGTTCCCTTGGG
T ss_pred HHHHHHHHHcCCCC-----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH-HH---cCCccCCCCHHHhhc
Confidence 55666666655432 34578899999999999999999999888744211 11 223445678987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-41 Score=326.30 Aligned_cols=205 Identities=12% Similarity=0.239 Sum_probs=162.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||| |++|.+++......+++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~--- 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN--- 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---
Confidence 799999999999999999999999 9999999886667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+.......... ........||+.|||||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-- 238 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238 (299)
T ss_dssp TTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred CCCcEEECCcccceEccCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--
Confidence 778999999999987654322111 111233568999999999999999999999999999999998 899998753
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+.+..+....... ....+|+++.+|+..||+.||++||++.+|.+.|+.++.
T Consensus 239 -~~~~~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 239 -NQDVINAIEQDYRLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -HHHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCCCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 344445554433221 245689999999999999999999999999999998864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=323.24 Aligned_cols=195 Identities=23% Similarity=0.304 Sum_probs=161.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||| |++|.+++.. ...+++.++..|+.||+.||+|||++||+||||||+|||++
T Consensus 62 HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~--- 137 (271)
T d1nvra_ 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD--- 137 (271)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---
T ss_pred CCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---
Confidence 799999999999999999999999 8999999863 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+........ .......||+.|||||++.+..+ +.++|||||||++|||++|+.||.+....
T Consensus 138 ~~~~~KL~DFG~a~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 138 ERDNLKISDFGLATVFRYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp TTCCEEECCCTTCEECEETTEE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred CCCCEEEccchhheeeccCCcc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 6788999999999976543321 11245789999999999998876 57899999999999999999999875433
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.. .+..+...... ......+++++.+||..||+.||++||++++++
T Consensus 213 ~~--~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 213 CQ--EYSDWKEKKTY---LNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp SH--HHHHHHTTCTT---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred HH--HHHHHhcCCCC---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 22 22222222111 112346789999999999999999999988763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-41 Score=325.00 Aligned_cols=196 Identities=19% Similarity=0.207 Sum_probs=156.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+|||+....
T Consensus 66 HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~ 144 (307)
T d1a06a_ 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD 144 (307)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred CCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC
Confidence 699999999999999999999999 8999999974 56899999999999999999999999999999999999997545
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|+|++|..||.+. .
T Consensus 145 ~~~~vkl~DFG~a~~~~~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~ 213 (307)
T d1a06a_ 145 EDSKIMISDFGLSKMEDPGSV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---N 213 (307)
T ss_dssp TTCCEEECCC--------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---S
T ss_pred CCceEEEeccceeEEccCCCe--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---C
Confidence 678999999999986644321 23468999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+......... .....+|+++.+||..||..||++||++++++
T Consensus 214 ~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 214 DAKLFEQILKAEYEFDS-PYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp HHHHHHHHHTTCCCCCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhccCCCCCC-ccccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 44555555554443221 23457899999999999999999999987764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=321.05 Aligned_cols=203 Identities=20% Similarity=0.267 Sum_probs=172.1
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++ ..||||||| |++|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 68 HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~--- 143 (285)
T d1u59a_ 68 NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV--- 143 (285)
T ss_dssp CTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---
T ss_pred CCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---
Confidence 79999999998754 579999999 8999999876567899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 144 ~~~~~Kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~- 218 (285)
T d1u59a_ 144 NRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG- 218 (285)
T ss_dssp ETTEEEECCCTTCEECTTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-
T ss_pred cCCceeeccchhhhccccccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-
Confidence 67899999999999875533211 12234679999999999999999999999999999999998 9999988643
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
.+.+..+...... .++..+|+++.+||..||+.+|++||++.+|.+.|++.+..
T Consensus 219 --~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 219 --PEVMAFIEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3444445443332 23467899999999999999999999999999999988754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=318.90 Aligned_cols=201 Identities=18% Similarity=0.302 Sum_probs=168.0
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++ ..||||||| |++|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 67 HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~--- 141 (277)
T d1xbba_ 67 NPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV--- 141 (277)
T ss_dssp CTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---
T ss_pred CCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---
Confidence 79999999998665 468999999 9999999875 66899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.+||+|||+++.+....... .......||+.|||||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 142 ~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-- 215 (277)
T d1xbba_ 142 TQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-- 215 (277)
T ss_dssp ETTEEEECCCTTCEECCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred ccCcccccchhhhhhcccccccc----ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--
Confidence 67899999999999765433211 12234679999999999999999999999999999999997 899998854
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+....+...... .++..+|+++.+||..||+.||++||++++|.+.|++.+.
T Consensus 216 -~~~~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 216 -GSEVTAMLEKGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHcCCCC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 33444444443322 2346789999999999999999999999999998888764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=323.55 Aligned_cols=194 Identities=18% Similarity=0.278 Sum_probs=162.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||| |++|.+++....+.+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 68 HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~--- 144 (288)
T d2jfla1 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT--- 144 (288)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---
Confidence 799999999999999999999999 9999999876677899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
.++.+||+|||+|+....... ......||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+
T Consensus 145 ~~~~~Kl~DFG~a~~~~~~~~-------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 145 LDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp TTSCEEECCCTTCEECHHHHH-------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCEEEEechhhhccCCCcc-------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 678999999999987654221 123568999999999984 45578999999999999999999999988
Q ss_pred CCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.... +.+..+........ .....+++++.+||..||+.||++||++++|+
T Consensus 218 ~~~~---~~~~~i~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 218 LNPM---RVLLKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SCGG---GHHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCHH---HHHHHHHcCCCCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6443 33444444332111 12346889999999999999999999988774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=314.78 Aligned_cols=201 Identities=18% Similarity=0.257 Sum_probs=160.9
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..||||||+ +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+
T Consensus 59 HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~--- 135 (263)
T d1sm2a_ 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--- 135 (263)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---
T ss_pred CCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---
Confidence 799999999999999999999999 9999999876667899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 136 ~~~~~Kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--- 206 (263)
T d1sm2a_ 136 ENQVIKVSDFGMTRFVLDDQYT------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--- 206 (263)
T ss_dssp GGGCEEECSCC------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---
T ss_pred CCCCeEecccchheeccCCCce------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---
Confidence 6789999999999876543321 1234578999999999999999999999999999999999 56666543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
...+.+..+....... .+..+++++.+++..||+.||++||++++|.+.|+++.+
T Consensus 207 ~~~~~~~~i~~~~~~~----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 207 SNSEVVEDISTGFRLY----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCC----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 3444555554432221 235678999999999999999999999999999998854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=326.99 Aligned_cols=200 Identities=19% Similarity=0.235 Sum_probs=166.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHH
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEF 58 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~----------------------~~ls~~~v~~ia~Qll~gL~y 58 (414)
+|||+++++++.+.+..||||||| |++|.++++... ..+++..++.|+.||+.||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 799999999999999999999999 999999997432 248999999999999999999
Q ss_pred HHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHH
Q 015018 59 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 138 (414)
Q Consensus 59 LH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwS 138 (414)
||+++||||||||+|||++ .++.+||+|||+|+......... ......||+.|||||++.+..++.++||||
T Consensus 180 LH~~~IiHRDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS 251 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWS 251 (325)
T ss_dssp HHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHhCCeeeccCchhccccc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccc
Confidence 9999999999999999997 77899999999998765433211 123457899999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 139 LGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 139 lGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
|||++|||++ |..||.+.... +.+.++....... ..+..+|+++.+||..||+.||++||++++|.+.|..
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~~---~~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPVD---ANFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9999999997 89999876442 2223333332221 2345689999999999999999999999999988753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=317.83 Aligned_cols=192 Identities=22% Similarity=0.281 Sum_probs=153.1
Q ss_pred CCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCC
Q 015018 2 AAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIK 70 (414)
Q Consensus 2 ~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~---~~~~ls~~~v~~ia~Qll~gL~yLH~~g-----ivHRDIK 70 (414)
+|||+++++++.+ ++..||||||| |++|.+++.. ....+++..++.++.||+.||+|||+++ |||||||
T Consensus 62 HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK 141 (269)
T d2java1 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141 (269)
T ss_dssp CTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred CCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence 6999999998865 45689999999 9999999863 2567999999999999999999999976 9999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCC
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 150 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~ 150 (414)
|+||||+ .++.+||+|||+|+.+..... ......||+.|||||++.+..++.++|||||||++|||++|+
T Consensus 142 p~NIll~---~~~~vkl~DFG~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 142 PANVFLD---GKQNVKLGDFGLARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp GGGEEEC---TTSCEEECCHHHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred hhhcCcC---CCCcEEEeeccceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 9999996 678999999999987654321 123568999999999999999999999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 151 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 151 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.||.+. +..+.+..+...... .++..+++++.+||..||+.||.+||++++|+
T Consensus 212 ~Pf~~~---~~~~~~~~i~~~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 212 PPFTAF---SQKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CSCCCS---SHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCC---CHHHHHHHHHcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999874 445555666555443 23457899999999999999999999988875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=313.59 Aligned_cols=191 Identities=18% Similarity=0.271 Sum_probs=158.8
Q ss_pred CCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcE
Q 015018 2 AAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNF 74 (414)
Q Consensus 2 ~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~g--ivHRDIKP~NI 74 (414)
+|||+++++++.+ +...||||||| |++|.++++. ...+++.+++.|+.||+.||+|||+++ ||||||||+||
T Consensus 67 HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred CCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 6999999999875 45789999999 9999999975 458999999999999999999999998 99999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
||. ..++.+||+|||+|+...... .....||+.|||||++.+ .++.++|||||||++|||++|+.||.
T Consensus 146 Ll~--~~~~~~Kl~DFGla~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 146 FIT--GPTGSVKIGDLGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp EES--STTSCEEECCTTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred eee--CCCCCEEEeecCcceeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 995 346789999999996433221 234689999999999876 59999999999999999999999997
Q ss_pred CCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 155 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+.. +..+.+..+....... .+...+++++.+||..||+.||++||++++|+
T Consensus 214 ~~~--~~~~~~~~i~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 214 ECQ--NAAQIYRRVTSGVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp TCS--SHHHHHHHHTTTCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Ccc--cHHHHHHHHHcCCCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 643 3344455554433322 23456789999999999999999999988775
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-40 Score=325.12 Aligned_cols=196 Identities=18% Similarity=0.256 Sum_probs=167.7
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++......+++..+..|+.||+.||+|||++|||||||||+||||..+
T Consensus 82 HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~- 160 (350)
T d1koaa2 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK- 160 (350)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-
T ss_pred CCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-
Confidence 699999999999999999999999 999999996556689999999999999999999999999999999999999522
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+.+..... .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +
T Consensus 161 ~~~~vkL~DFG~a~~~~~~~~--------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~ 229 (350)
T d1koaa2 161 RSNELKLIDFGLTAHLDPKQS--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---N 229 (350)
T ss_dssp TSCCEEECCCTTCEECCTTSC--------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCeEEEeecchheecccccc--------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---C
Confidence 357899999999988755332 23468999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+........ ...+..+++++.+||..||..||.+||++++++
T Consensus 230 ~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 230 DDETLRNVKSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp HHHHHHHHHHTCCCSC-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCCC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 4555666655544322 233456889999999999999999999987764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-39 Score=323.38 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=170.3
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.+++..||||||| |++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 65 ~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~-- 141 (364)
T d1omwa3 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-- 141 (364)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--
T ss_pred CCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc--
Confidence 3799999999999999999999999 9999999975 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
..+.+||+|||+|+.+..... ....||+.|+|||++. +..|+.++|||||||++|||++|+.||.+...
T Consensus 142 -~~g~iKl~DFGla~~~~~~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 142 -EHGHVRISDLGLACDFSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp -SSSCEEECCCTTCEECSSSCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred -CCCcEEEeeeceeeecCCCcc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 778999999999987655322 3468999999999997 45689999999999999999999999988655
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCccccccc
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTIL 233 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~-----~~~l~~~l~~~~~~~~~~~d~~~~w~~~ 233 (414)
.........+.... ..++..+++++.+||..||..||.+||+ +++|+ ++ .+...++|..+
T Consensus 212 ~~~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil---~H-------p~f~~i~~~~~ 276 (364)
T d1omwa3 212 KDKHEIDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK---ES-------PFFRSLDWQMV 276 (364)
T ss_dssp SCHHHHHHHSSSCC-----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH---TS-------GGGTTCCHHHH
T ss_pred HHHHHHHHhcccCC-----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH---cC-------ccccCCCHHHH
Confidence 44443333222211 1234578999999999999999999998 34443 22 33445688776
Q ss_pred ccc
Q 015018 234 KYQ 236 (414)
Q Consensus 234 ~~~ 236 (414)
..+
T Consensus 277 ~~~ 279 (364)
T d1omwa3 277 FLQ 279 (364)
T ss_dssp HTT
T ss_pred hcC
Confidence 543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=310.77 Aligned_cols=204 Identities=12% Similarity=0.150 Sum_probs=163.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+.+..++||||| +++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+
T Consensus 68 H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~--- 144 (283)
T d1mqba_ 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN--- 144 (283)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---
Confidence 699999999999999999999999 9999998887778899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+++.+........ ......||+.|||||++.+..++.++|||||||++|||++|..||... ..
T Consensus 145 ~~~~~Kl~DFGla~~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~ 218 (283)
T d1mqba_ 145 SNLVCKVSDFGLSRVLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LS 218 (283)
T ss_dssp TTCCEEECCCCC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CC
T ss_pred CCCeEEEcccchhhcccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CC
Confidence 778999999999987654322111 123457899999999999999999999999999999999965555432 23
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
..+.+..+...... .....+|.++.+||..||+.+|++||++.+|.+.|+.++.
T Consensus 219 ~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 219 NHEVMKAINDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 34445555443322 2345689999999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=322.56 Aligned_cols=198 Identities=18% Similarity=0.283 Sum_probs=156.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~-givHRDIKP~NILl~~ 78 (414)
.+|||+++++++.++++.||||||| |++|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+||||+
T Consensus 62 ~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~- 139 (322)
T d1s9ja_ 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN- 139 (322)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC-
Confidence 3799999999999999999999999 8999999975 45799999999999999999999975 999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+|+.+.+.. ...++||+.|+|||++.+..|+.++||||+||++|||++|+.||.+...
T Consensus 140 --~~~~vkl~DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 140 --SRGEIKLCDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp --TTCCEEECCCCCCHHHHHHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred --CCCCEEEeeCCCccccCCCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 77899999999998664422 2356899999999999999999999999999999999999999987543
Q ss_pred cchHHHHHHHHhh-----------------------hcc----chHHHh--------h-cCCcHHHHHHHHHHHcCCCCC
Q 015018 159 GTKKQKYEKISEK-----------------------KVS----TSIEAL--------C-RGYPTEFASYFHYCRSLRFDD 202 (414)
Q Consensus 159 ~~~~~~~~~i~~~-----------------------~~~----~~~~~l--------~-~~~p~e~~~li~~c~~~dp~~ 202 (414)
............. ... .....+ . ..++.++.+||..||..||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhH
Confidence 2111100000000 000 000000 0 124678999999999999999
Q ss_pred CCCHHHHHH
Q 015018 203 KPDYAYLKR 211 (414)
Q Consensus 203 RP~~~~l~~ 211 (414)
||+++++++
T Consensus 289 R~ta~e~L~ 297 (322)
T d1s9ja_ 289 RADLKQLMV 297 (322)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhh
Confidence 999887754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-40 Score=324.59 Aligned_cols=196 Identities=21% Similarity=0.208 Sum_probs=167.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++.....+|++.+++.|+.||+.||+|||++|||||||||+||||+..
T Consensus 85 HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~- 163 (352)
T d1koba_ 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK- 163 (352)
T ss_dssp STTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-
T ss_pred CCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-
Confidence 699999999999999999999999 999999887556689999999999999999999999999999999999999522
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
..+.|||+|||+|+.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 164 ~~~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~ 232 (352)
T d1koba_ 164 KASSVKIIDFGLATKLNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---D 232 (352)
T ss_dssp TCCCEEECCCTTCEECCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---S
T ss_pred CCCeEEEeecccceecCCCCc--------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---C
Confidence 457899999999998765332 13458999999999999999999999999999999999999999874 3
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+....... ....+..+++++.+||..||..||.+||++++++
T Consensus 233 ~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 233 DLETLQNVKRCDWEF-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp HHHHHHHHHHCCCCC-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 445555555544322 2234467899999999999999999999987774
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=318.86 Aligned_cols=185 Identities=20% Similarity=0.282 Sum_probs=162.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++.++++++.||||||| |++|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 64 hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~--- 139 (337)
T d1o6la_ 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD--- 139 (337)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---
T ss_pred CCCEEEEEeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---
Confidence 799999999999999999999999 9999999875 56899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+. +
T Consensus 140 ~~g~vkl~DFG~a~~~~~~~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~ 209 (337)
T d1o6la_ 140 KDGHIKITDFGLCKEGISDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---D 209 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCCEEEeecccccccccCCc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---C
Confidence 678999999999986544322 123578999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
..+.+..+...... ++..+++++.+||..||..||.+|++
T Consensus 210 ~~~~~~~i~~~~~~-----~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 210 HERLFELILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HHHHHHHHhcCCCC-----CCccCCHHHHHHHHhhccCCchhhcc
Confidence 45556666554433 34678999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-40 Score=317.04 Aligned_cols=189 Identities=17% Similarity=0.261 Sum_probs=159.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|..++. ..+++++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 74 HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~--- 149 (309)
T d1u5ra_ 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--- 149 (309)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---
T ss_pred CCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---
Confidence 799999999999999999999999 777765554 467899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.++.+||+|||+|+.... .....||+.|||||++.+. .|+.++|||||||++|||++|..||.+..
T Consensus 150 ~~~~~Kl~DFG~a~~~~~-----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 150 EPGLVKLGDFGSASIMAP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp TTTEEEECCCTTCBSSSS-----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCCEEEeecccccccCC-----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 778999999999975433 1346899999999999753 47899999999999999999999998743
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
..+.+..+........ ....+++++.+||..||..||.+||+++++++
T Consensus 219 ---~~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 219 ---AMSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---HHHHHHHHHHSCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 3444455554433221 12467899999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=310.89 Aligned_cols=202 Identities=19% Similarity=0.279 Sum_probs=161.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++. ++..||||||+ +++|.+++......+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 67 HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~--- 142 (273)
T d1mp8a_ 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS--- 142 (273)
T ss_dssp CTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---
T ss_pred CCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---
Confidence 799999999986 46789999999 9999998876677899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
..+.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....
T Consensus 143 ~~~~~Kl~DfG~a~~~~~~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 143 SNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp ETTEEEECC-------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCcEEEccchhheeccCCcc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 678999999999987654322 11234578999999999999999999999999999999997 89999886543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHh
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 220 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~~ 220 (414)
+.+..+...... .++.++|+++.+||..||..||++||++.+|.+.|+.++..+
T Consensus 217 ---~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 217 ---DVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ---GHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 344444444332 245678999999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=310.58 Aligned_cols=201 Identities=19% Similarity=0.348 Sum_probs=165.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+ +..||||||+ +++|.+++... ..++++..++.|+.||+.||+|||+++|+||||||+||||+
T Consensus 67 HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~-- 143 (272)
T d1qpca_ 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-- 143 (272)
T ss_dssp CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee--
Confidence 6999999998765 4569999999 99999877532 34699999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL-PWQGLKA 158 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~-Pf~~~~~ 158 (414)
.++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|.. ||...
T Consensus 144 -~~~~~Kl~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-- 214 (272)
T d1qpca_ 144 -DTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-- 214 (272)
T ss_dssp -TTSCEEECCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--
T ss_pred -cccceeeccccceEEccCCcc------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--
Confidence 778999999999998755332 12234679999999999999899999999999999999999554 45442
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
...+.+..+...... ..+..+|+++.+|+..||+.||++||++++|.+.|++.+..
T Consensus 215 -~~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 215 -TNPEVIQNLERGYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHhcCCC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 334444444433222 12457899999999999999999999999999999998854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=324.22 Aligned_cols=202 Identities=15% Similarity=0.154 Sum_probs=161.4
Q ss_pred CCCCCcEEEEeeEe----CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~----~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||+++++++++ +.+.||||||| |++|.+++... ...|++.++..|+.||+.||+|||++||+||||||+||
T Consensus 63 ~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NI 142 (335)
T d2ozaa1 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142 (335)
T ss_dssp TSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccc
Confidence 47999999999876 46789999999 89999999754 35799999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|++.....+.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.
T Consensus 143 ll~~~~~~~~~Kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 143 LYTSKRPNAILKLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp EESCSSTTCCEEECCCTTCEECCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred ccccccccccccccccceeeeccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 997555567899999999987655332 234689999999999999999999999999999999999999998
Q ss_pred CCCccchHH-HHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQ-KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~-~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+........ ....+........ ......+++++.+||..||..||++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 215 SNHGLAISPGMKTRIRMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ETTCC--------CCCSCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHHHhcCCCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 754322211 1111111111111 1122357899999999999999999999877643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-40 Score=313.76 Aligned_cols=201 Identities=18% Similarity=0.285 Sum_probs=166.8
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+++..||||||| +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 72 HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~-- 149 (287)
T d1opja_ 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-- 149 (287)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC--
Confidence 799999999999999999999999 99999998753 56799999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 150 -~~~~~Kl~DFG~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-- 220 (287)
T d1opja_ 150 -ENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-- 220 (287)
T ss_dssp -GGGCEEECCCCCTTTCCSSSSE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred -CCCcEEEccccceeecCCCCce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--
Confidence 6789999999999865443221 1233468999999999999999999999999999999999766664322
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
+..+.+..+...... ..+..+|+++.+|+..||+.||++||++++|.+.|+.++
T Consensus 221 ~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 221 DLSQVYELLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHHHhcCCCC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 233333333332221 234678999999999999999999999999998887764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-39 Score=312.50 Aligned_cols=202 Identities=20% Similarity=0.289 Sum_probs=170.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
.+|||+++++++.++++.||||||| |++|..++.. ...+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 62 ~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~-- 138 (316)
T d1fota_ 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-- 138 (316)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--
T ss_pred cCcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc--
Confidence 3799999999999999999999999 9999998874 66899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+...+.. ....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.
T Consensus 139 -~~g~vkL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--- 204 (316)
T d1fota_ 139 -KNGHIKITDFGFAKYVPDVT----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--- 204 (316)
T ss_dssp -TTSCEEECCCSSCEECSSCB----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred -CCCCEEEecCccceEecccc----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---
Confidence 67899999999998765432 3468999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 234 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~ 234 (414)
+..+.+.++...... ++..+++++.+++..||..||.+|+ ++++|+ ++ .+-..++|+.+.
T Consensus 205 ~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il---~H-------p~f~~i~~~~l~ 269 (316)
T d1fota_ 205 NTMKTYEKILNAELR-----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK---NH-------PWFKEVVWEKLL 269 (316)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH---TS-------GGGSSCCHHHHH
T ss_pred CHHHHHHHHHcCCCC-----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH---cC-------cccccCCHHHHH
Confidence 445556666554432 3456889999999999999999996 555553 22 233446787654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=309.08 Aligned_cols=196 Identities=19% Similarity=0.238 Sum_probs=167.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++.. .+.+++..++.++.||+.||+|||+++||||||||+|||++.+.
T Consensus 72 HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS
T ss_pred CCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC
Confidence 699999999999999999999999 9999999975 45899999999999999999999999999999999999996332
Q ss_pred -CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
....+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--- 219 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--- 219 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred CcccceEecchhhhhhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---
Confidence 224699999999987754322 23568999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+..+........ ......+++++.+||..||..||++||++++++
T Consensus 220 ~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 220 TKQETLANVSAVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp SHHHHHHHHHTTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CHHHHHHHHHhcCCCCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 44555566655544322 334567899999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-39 Score=316.29 Aligned_cols=203 Identities=20% Similarity=0.293 Sum_probs=172.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+....++||||+ |++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 100 hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~--- 175 (350)
T d1rdqe_ 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID--- 175 (350)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred CCcEeecccccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---
Confidence 799999999999999999999999 9999999875 45899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.++.+||+|||+|+...... ....||+.|||||++.+..++.++|||||||++|+|++|..||.+. +
T Consensus 176 ~~g~ikL~DFG~a~~~~~~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~ 242 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---Q 242 (350)
T ss_dssp TTSCEEECCCTTCEECSSCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred CCCCEEeeeceeeeeccccc----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---C
Confidence 67899999999999765422 3468999999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 235 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-----~~~~l~~~l~~~~~~~~~~~d~~~~w~~~~~ 235 (414)
..+.+..+...... .+..+++++.+||..||..||.+|+ ++++|++ ..+....+|..+..
T Consensus 243 ~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----------Hp~f~~~~~~~~~~ 307 (350)
T d1rdqe_ 243 PIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQ 307 (350)
T ss_dssp HHHHHHHHHHCCCC-----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHT
T ss_pred HHHHHHHHhcCCCC-----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc----------CccccCCCHHHHHh
Confidence 45566666655443 2456889999999999999999995 6665532 23344568877653
Q ss_pred c
Q 015018 236 Q 236 (414)
Q Consensus 236 ~ 236 (414)
+
T Consensus 308 ~ 308 (350)
T d1rdqe_ 308 R 308 (350)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=305.36 Aligned_cols=198 Identities=16% Similarity=0.260 Sum_probs=169.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++..|+||||+ +++|.+++......+++..+.+|+.||+.||+|||++||+||||||+|||++
T Consensus 58 HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~--- 134 (258)
T d1k2pa_ 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN--- 134 (258)
T ss_dssp CTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---
T ss_pred CCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---
Confidence 699999999999999999999999 8999999876677899999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-- 206 (258)
T d1k2pa_ 135 DQGVVKVSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-- 206 (258)
T ss_dssp TTCCEEECCCSSCCBCSSSSC------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--
T ss_pred CCCcEEECcchhheeccCCCc------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--
Confidence 778999999999986654332 12234679999999999999999999999999999999998 899998864
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 215 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~ 215 (414)
..+....+...... ..+..+|+++.+||..||+.||++||++++|++.|.+
T Consensus 207 -~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 207 -NSETAEHIAQGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -HHHHHHHHHhCCCC----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 34455555543322 2345788999999999999999999999998877643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=307.76 Aligned_cols=204 Identities=18% Similarity=0.236 Sum_probs=160.4
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.|||++++.++.+ +...|+||||| |++|.+++... ...+++..++.|+.||+.||+|||+++|
T Consensus 76 h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i 155 (299)
T d1ywna1 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 155 (299)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999888765 45689999999 99999999643 2358999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
|||||||+||||+ .++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|
T Consensus 156 vHrDlKp~NILl~---~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ 227 (299)
T d1ywna1 156 IHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227 (299)
T ss_dssp CCSCCCGGGEEEC---GGGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cCCcCCccceeEC---CCCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhcCCCCcccceeehHHHHH
Confidence 9999999999996 6789999999999876543321 1224568999999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
||++| ..||.+.... ......+...... .....+++++.++|..||+.||++||++++|.+.|+++++.
T Consensus 228 ellt~~~~p~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 228 EIFSLGASPYPGVKID--EEFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHTTSCCSSTTCCCS--HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH--HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99986 5688765432 2222233332221 23456889999999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=312.33 Aligned_cols=196 Identities=19% Similarity=0.246 Sum_probs=168.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||| |++|.+++...+..+++.++..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 60 HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~- 138 (321)
T d1tkia_ 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR- 138 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-
T ss_pred CCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-
Confidence 699999999999999999999999 899999998656689999999999999999999999999999999999999632
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
....+||+|||+++....... .....||+.|++||.+.+..++.++|||||||++|+|++|..||.+. +
T Consensus 139 ~~~~ikl~DFG~~~~~~~~~~--------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~ 207 (321)
T d1tkia_ 139 RSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---T 207 (321)
T ss_dssp SCCCEEECCCTTCEECCTTCE--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---S
T ss_pred CceEEEEcccchhhccccCCc--------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---C
Confidence 346899999999987654321 12357899999999999999999999999999999999999999874 4
Q ss_pred hHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+.+..+........ ......+++++.+||..||..||.+||++++++
T Consensus 208 ~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 208 NQQIIENIMNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp HHHHHHHHHHTCCCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhCCCCCC-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 4556666666554432 334567899999999999999999999988774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-38 Score=303.68 Aligned_cols=194 Identities=18% Similarity=0.201 Sum_probs=164.4
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++++.||||||| |++|.++++. ...+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~-- 144 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD-- 144 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc--
Confidence 3799999999999999999999999 9999999975 55899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC------CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPW 153 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~~~DvwSlGvvl~elltG~~Pf 153 (414)
.++.+||+|||+++....... .....||..|++||.+.+ ..++.++||||+||++|+|++|+.||
T Consensus 145 -~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 145 -DDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp -TTCCEEECCCTTCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCCeEEccchheeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 788999999999988754321 234689999999999864 34678999999999999999999999
Q ss_pred CCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 154 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 154 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.. ....+..+......... ....++++++.+|+..||+.+|.+||++++++
T Consensus 216 ~~~~---~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 216 WHRK---QMLMLRMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp CCSS---HHHHHHHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCC---HHHHHHHHHhCCCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 8753 44455555555443222 22346899999999999999999999987764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=310.19 Aligned_cols=190 Identities=21% Similarity=0.267 Sum_probs=164.5
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
++|||+++++++.++++.||||||| |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 61 ~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~-- 137 (320)
T d1xjda_ 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-- 137 (320)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--
T ss_pred CCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec--
Confidence 4799999999999999999999999 9999999975 56899999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 138 -~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--- 206 (320)
T d1xjda_ 138 -KDGHIKIADFGMCKENMLGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--- 206 (320)
T ss_dssp -TTSCEEECCCTTCBCCCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred -CCCceeccccchhhhcccccc-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---
Confidence 778999999999986544322 123468999999999999999999999999999999999999999874
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH-HH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA-YL 209 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~-~l 209 (414)
+..+.+.++...... ++..+++++.+||..||..||.+||++. +|
T Consensus 207 ~~~~~~~~i~~~~~~-----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 207 DEEELFHSIRMDNPF-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp SHHHHHHHHHHCCCC-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CHHHHHHHHHcCCCC-----CCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 445555555544332 3456899999999999999999999974 44
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=305.11 Aligned_cols=203 Identities=18% Similarity=0.256 Sum_probs=172.7
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~---------------~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
.+|||+++++++.+++..|+||||| +++|.+++.... ..+++.+++.++.||+.||+|||+++|
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 4799999999999999999999999 999999996432 459999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
|||||||+|||++ .++.+||+|||+++........ .......||+.|+|||.+.+..|+.++|||||||++|
T Consensus 157 vHrDiKp~NiLl~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 157 IHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228 (299)
T ss_dssp CCSCCSGGGEEEC---TTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred Eeeeecccceeec---CCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHH
Confidence 9999999999996 7789999999999876654321 1224468999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 145 YFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 145 ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
||++ |.+||.+.. ..+.+..+...... ..+..+++++.+||..||+.||.+||++.+|.+.|+.++.
T Consensus 229 ell~~g~~p~~~~~---~~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 229 EIFTLGGSPYPGVP---VEELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHTTSCCSSTTCC---HHHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 9997 799997743 34444554443322 2345789999999999999999999999999999988864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-38 Score=301.51 Aligned_cols=203 Identities=21% Similarity=0.317 Sum_probs=159.6
Q ss_pred CCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||+++++++...+ ..||||||| |++|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+|||+
T Consensus 66 hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll 144 (277)
T d1o6ya_ 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144 (277)
T ss_dssp CTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc
Confidence 799999999988654 489999999 8999998875 5589999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
+ ..+.++|+|||+++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 145 ~---~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 145 S---ATNAVKVMDFGIARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp E---TTSCEEECCCTTCEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred C---ccccceeehhhhhhhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 7 78899999999988664432211 1234568999999999999999999999999999999999999999874
Q ss_pred CccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCC-CHHHHHHHHHHH
Q 015018 157 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL 216 (414)
Q Consensus 157 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP-~~~~l~~~l~~~ 216 (414)
. ..+.+..+...... ........+|+++.++|..||..||.+|| ++++|++.|..+
T Consensus 218 ~---~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 218 S---PVSVAYQHVREDPI-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp S---HHHHHHHHHHCCCC-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C---HHHHHHHHHhcCCC-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 3 33344443333222 22234567899999999999999999999 888887776654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=303.26 Aligned_cols=201 Identities=21% Similarity=0.273 Sum_probs=166.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++ ..+|||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+
T Consensus 70 H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~--- 145 (273)
T d1u46a_ 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--- 145 (273)
T ss_dssp CTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---
T ss_pred CCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---
Confidence 69999999999764 568999999 9999998876677899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+++.......... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 146 ~~~~vkl~DfGl~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--- 218 (273)
T d1u46a_ 146 TRDLVKIGDFGLMRALPQNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--- 218 (273)
T ss_dssp ETTEEEECCCTTCEECCC-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---
T ss_pred cccceeeccchhhhhcccCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---
Confidence 568999999999998755433211 1234568899999999999999999999999999999997 89999875
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
+..+.+..+....... .....+|.++.+||..||..||++||++.+|.+.|+++
T Consensus 219 ~~~~~~~~i~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 219 NGSQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3444455554443322 23457899999999999999999999999999888764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=299.69 Aligned_cols=184 Identities=24% Similarity=0.324 Sum_probs=155.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g-~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
++|||+++++++.+++..|+||||+ + ++|.+++.. ...+++.++..|+.||+.||+|||++|||||||||+|||++
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~- 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID- 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe-
Confidence 3689999999999999999999999 4 588888864 56899999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~~DvwSlGvvl~elltG~~Pf~~~~ 157 (414)
.+.+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 145 -~~~~~vkl~DFG~a~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~- 213 (273)
T d1xwsa_ 145 -LNRGELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213 (273)
T ss_dssp -TTTTEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred -cCCCeEEECccccceeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-
Confidence 345789999999998754432 245689999999999987765 67799999999999999999999752
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
..+..... .+...+|+++.+||..||..||++||++++++
T Consensus 214 --------~~i~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 214 --------EEIIRGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp --------HHHHHCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --------hHHhhccc-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 12222222 13457899999999999999999999988774
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-38 Score=305.91 Aligned_cols=200 Identities=17% Similarity=0.235 Sum_probs=163.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+++. ++|||++ +++|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+
T Consensus 70 HpnIv~l~g~~~~~~~-~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~--- 145 (317)
T d1xkka_ 70 NPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK--- 145 (317)
T ss_dssp CTTBCCEEEEEESSSE-EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---
T ss_pred CCCEeeEEEEEecCCe-eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---
Confidence 7999999999988765 5666777 9999999887778899999999999999999999999999999999999997
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 146 TPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp ETTEEEECCCSHHHHTTTTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred CCCCeEeeccccceecccccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 67899999999998765433211 1234578999999999999999999999999999999998 89999886543
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
. ....+...... ..+..+|+++.+|+..||..||.+||++.+|.+.|..+.
T Consensus 221 ~---~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 221 E---ISSILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp G---HHHHHHHTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHHHHcCCCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 3 23333332221 123568899999999999999999999999988887764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-38 Score=302.91 Aligned_cols=201 Identities=20% Similarity=0.258 Sum_probs=169.0
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSF 64 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------------~~~ls~~~v~~ia~Qll~gL~yLH~~gi 64 (414)
++|||+++++++.+++..||||||+ |++|.+++... ...|++..++.++.||+.||+|||+++|
T Consensus 69 ~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~i 148 (309)
T d1fvra_ 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 148 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCc
Confidence 3799999999999999999999999 99999998632 3579999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHH
Q 015018 65 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 65 vHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ 144 (414)
|||||||+|||++ ..+.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|
T Consensus 149 iHrDlkp~NIL~~---~~~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 149 IHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp ECSCCSGGGEEEC---GGGCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cccccccceEEEc---CCCceEEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999999999996 678999999999986544222 23457999999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 145 YFLRGS-LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 145 elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
||++|. +||.+. +..+.+..+...... .....+|+++.+||..||+.||++||++.+|.+.|++++..
T Consensus 218 ell~~~~~p~~~~---~~~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 218 EIVSLGGTPYCGM---TCAELYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHTTSCCTTTTC---CHHHHHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcCCCCCCCC---CHHHHHHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 999965 677664 445555555543322 23456889999999999999999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=302.82 Aligned_cols=196 Identities=18% Similarity=0.165 Sum_probs=158.6
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||+++++++.++++.||||||+.+.+...+......+++..+..++.||+.||+|||++||+||||||+|||++ .
T Consensus 59 hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~ 135 (299)
T d1ua2a_ 59 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---E 135 (299)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---T
T ss_pred CCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---C
Confidence 6999999999999999999999994444444444567899999999999999999999999999999999999996 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
.+.+||+|||+|+....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus 136 ~~~~KL~DFG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-- 206 (299)
T d1ua2a_ 136 NGVLKLADFGLAKSFGSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-- 206 (299)
T ss_dssp TCCEEECCCGGGSTTTSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred CCccccccCccccccCCCcc-------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--
Confidence 78999999999976554322 12346899999999998754 579999999999999999999999987543
Q ss_pred hHHHHHHHHhhhc-----------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKV-----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~-----------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+..+.+... ......+...+++++.+||..||..||++||++++++
T Consensus 207 -~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 207 -LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp -HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred -HHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 333333332110 1122344456789999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-38 Score=301.18 Aligned_cols=201 Identities=20% Similarity=0.311 Sum_probs=168.4
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHH
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVE 57 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------------~~ls~~~v~~ia~Qll~gL~ 57 (414)
+|||++++.++.+++..++||||+ +++|.+++.... ..+++..++.|+.||+.||+
T Consensus 75 h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 154 (301)
T d1lufa_ 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154 (301)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhh
Confidence 699999999999999999999999 999999986422 24899999999999999999
Q ss_pred HHHhCCceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHH
Q 015018 58 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLE 137 (414)
Q Consensus 58 yLH~~givHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~Dvw 137 (414)
|||+++||||||||+||||+ .++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||
T Consensus 155 ylH~~~ivHrDlKp~NILld---~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVw 226 (301)
T d1lufa_ 155 YLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVW 226 (301)
T ss_dssp HHHHTTCCCSCCSGGGEEEC---GGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred hcccCCeEeeEEcccceEEC---CCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhc
Confidence 99999999999999999996 6788999999999865443221 122356789999999999999999999999
Q ss_pred HHHHHHHHHHhCC-CCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Q 015018 138 SLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 216 (414)
Q Consensus 138 SlGvvl~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~ 216 (414)
||||++|||++|. .||.+. +..+.+..+...... .+...+|+++.+||..||+.+|++||++.+|.+.|+.+
T Consensus 227 S~Gvvl~ell~~~~~p~~~~---~~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 227 AYGVVLWEIFSYGLQPYYGM---AHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cchhhHHHHHccCCCCCCCC---CHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999999985 678764 444555565554432 23567899999999999999999999999999998876
Q ss_pred H
Q 015018 217 F 217 (414)
Q Consensus 217 ~ 217 (414)
.
T Consensus 300 ~ 300 (301)
T d1lufa_ 300 C 300 (301)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=300.87 Aligned_cols=204 Identities=20% Similarity=0.289 Sum_probs=169.2
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKS 63 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~-----------------~~ls~~~v~~ia~Qll~gL~yLH~~g 63 (414)
+|||+++++++.+++..||||||| +++|.+++.... ..+++..++.|+.||+.||+|||+++
T Consensus 86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ 165 (311)
T d1t46a_ 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (311)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 799999999999999999999999 999999986432 25999999999999999999999999
Q ss_pred ceecCCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHH
Q 015018 64 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 143 (414)
Q Consensus 64 ivHRDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl 143 (414)
||||||||+|||++ ..+.++|+|||+++....... +.......||+.|+|||++.+..++.++|||||||++
T Consensus 166 ivHrDLKp~NIl~~---~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 166 CIHRDLAARNILLT---HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (311)
T ss_dssp CCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eeeccccccccccc---ccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHH
Confidence 99999999999997 778999999999987654332 1123456899999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHH
Q 015018 144 MYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 219 (414)
Q Consensus 144 ~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~~ 219 (414)
|||++ |.+||.+.... ..+.++........ ....+|.++.+||..||+.||.+||++++|++.|+..+..
T Consensus 238 ~ellt~g~p~~~~~~~~---~~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVD---SKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHTTTCCSSTTCCSS---HHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHH---HHHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 99998 66667665432 22233333322221 2346789999999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=298.78 Aligned_cols=201 Identities=17% Similarity=0.254 Sum_probs=158.1
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
.+|||+++++++.++ ..||||||| +++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 70 ~h~nIv~~~g~~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~- 147 (285)
T d1fmka3 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG- 147 (285)
T ss_dssp CCTTBCCEEEEECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred ccCCEeEEEEEEecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC-
Confidence 379999999998655 568999999 9999988753 345799999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+...... ......||+.|+|||++....++.++|||||||++|||++|..||...
T Consensus 148 --~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-- 217 (285)
T d1fmka3 148 --ENLVCKVADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-- 217 (285)
T ss_dssp --GGGCEEECCCCTTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--
T ss_pred --CCCcEEEcccchhhhccCCCce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--
Confidence 6689999999999866443221 123457999999999999999999999999999999999965554332
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
....+.+..+...... .....+|+++.++|..||+.||++||++++|.+.|++.+
T Consensus 218 ~~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 218 MVNREVLDQVERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCHHHHHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCHHHHHHHHHhcCCC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2334445555443222 134578999999999999999999999999998887754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=293.43 Aligned_cols=197 Identities=18% Similarity=0.265 Sum_probs=159.1
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 78 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~-~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~ 78 (414)
+|||+++++++.+ .+..||||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||++
T Consensus 59 HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~- 137 (262)
T d1byga_ 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS- 137 (262)
T ss_dssp CTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec-
Confidence 6999999998865 45679999999 99999998643 23599999999999999999999999999999999999996
Q ss_pred cCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015018 79 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 157 (414)
Q Consensus 79 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~ellt-G~~Pf~~~~ 157 (414)
.++.+||+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||++ |++||.+..
T Consensus 138 --~~~~~kl~dfg~s~~~~~~~----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 138 --EDNVAKVSDFGLTKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp --TTSCEEECCCCC----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred --CCCCEeecccccceecCCCC----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 78899999999998654422 23578999999999999999999999999999999998 799998754
Q ss_pred ccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 158 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 158 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
.. +.+..+....... +...+++++.+||..||..||.+||++.+|.+.|+++..
T Consensus 206 ~~---~~~~~i~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 206 LK---DVVPRVEKGYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp GG---GHHHHHTTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHHHHHHcCCCCC----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 33 3444454433322 345688999999999999999999999999999988753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=295.33 Aligned_cols=195 Identities=19% Similarity=0.207 Sum_probs=156.6
Q ss_pred CCCCcEEEEeeEe-----CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVE-----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~-----~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++.. +.+.||+||++ ++.+..........+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 69 HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NIL 148 (305)
T d1blxa_ 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 148 (305)
T ss_dssp CTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEE
Confidence 6999999988753 35789999999 44444444445667999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
++ ..+.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+
T Consensus 149 i~---~~~~~kl~dfg~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 149 VT---SSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp EC---TTCCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ec---CCCCeeecchhhhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 96 77899999999987544322 22457899999999999999999999999999999999999999987
Q ss_pred CCccchHHHHHHHHhhh----------------------ccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~~~----------------------~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
... .+.+..+.... .......+...+++++.+||..||..||++||++++++
T Consensus 218 ~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 218 SSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp SSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCH---HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 543 33333332211 11122334556789999999999999999999987764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=295.35 Aligned_cols=205 Identities=15% Similarity=0.214 Sum_probs=168.0
Q ss_pred CCCCcEEEEeeEe-CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeec
Q 015018 2 AAGIPNLRWFGVE-GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 79 (414)
Q Consensus 2 ~p~I~~l~~~g~~-~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~ 79 (414)
+|||+++++++.+ +...|+||||| +++|.+++......+++..++.++.|++.||.|||+++|+||||||+||||+
T Consensus 87 HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~-- 164 (311)
T d1r0pa_ 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-- 164 (311)
T ss_dssp CTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC--
Confidence 7999999999876 45889999999 9999999986677789999999999999999999999999999999999996
Q ss_pred CCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 80 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 80 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+++......... ........||..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 165 -~~~~~kL~DFG~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-- 238 (311)
T d1r0pa_ 165 -EKFTVKVADFGLARDMYDKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-- 238 (311)
T ss_dssp -TTCCEEECSSGGGCCTTTTTCCC---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----
T ss_pred -CCCCEEEecccchhhcccccccc---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--
Confidence 77899999999998765433221 112334679999999999999999999999999999999999877776532
Q ss_pred chHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Q 015018 160 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 218 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~~ 218 (414)
+..+.+..+....... ....+|+++.+||..||..||++||++.++.+.|+.++.
T Consensus 239 ~~~~~~~~i~~g~~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----CHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCC----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222333333333221 235688999999999999999999999999999998874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=292.44 Aligned_cols=196 Identities=18% Similarity=0.212 Sum_probs=158.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~-~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.++++.||||||+++.+.+++.. ....+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 60 Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~--- 136 (298)
T d1gz8a_ 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN--- 136 (298)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred CCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---
Confidence 6999999999999999999999997777766643 356799999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
.++.+||+|||+|+....... ......||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+...
T Consensus 137 ~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~- 208 (298)
T d1gz8a_ 137 TEGAIKLADFGLARAFGVPVR-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE- 208 (298)
T ss_dssp TTSCEEECSTTHHHHHCCCSB-------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred ccCcceeccCCcceeccCCcc-------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-
Confidence 678999999999976544322 123468999999999987766 47899999999999999999999987533
Q ss_pred chHHHHHHHHhh------------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~------------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
...+..+... ............+++++.+|+..||..||++||++++|+
T Consensus 209 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 209 --IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp --HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --HHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2222222211 011112233456778999999999999999999988775
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-37 Score=294.51 Aligned_cols=215 Identities=20% Similarity=0.195 Sum_probs=165.5
Q ss_pred CCCCCcEEEEeeEeCC----EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceec
Q 015018 1 MAAGIPNLRWFGVEGD----YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHR 67 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~----~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~--------~givHR 67 (414)
.+|||+++++++.+.+ ..||||||| +++|.++++. .++++..++.++.|++.||+|||. +|||||
T Consensus 55 ~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred CCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 3799999999998754 689999999 9999999984 479999999999999999999996 599999
Q ss_pred CCCCCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC------CCchhHHHHHHH
Q 015018 68 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGY 141 (414)
Q Consensus 68 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~~~DvwSlGv 141 (414)
||||+||||+ .++.+||+|||+++.+......... ......||+.|+|||++.+.. ++.++|||||||
T Consensus 133 DlKp~NILl~---~~~~~Kl~DFGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 133 DLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CCCGGGEEEC---TTSCEEECCCTTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred ccCccceEEc---CCCCeEEEecCccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 9999999996 7789999999999987654332211 223568999999999988653 567899999999
Q ss_pred HHHHHHhCCCCCCCCCc------------cchHHHHHHHHhhhccchHHHh--hcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 142 VLMYFLRGSLPWQGLKA------------GTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 142 vl~elltG~~Pf~~~~~------------~~~~~~~~~i~~~~~~~~~~~l--~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
+||||++|..||..... .........+........+... ...++.++.+|+..||..||.+||++.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 99999999887743211 1112222222222222211111 122346799999999999999999999
Q ss_pred HHHHHHHHHHHHhCCC
Q 015018 208 YLKRLFRDLFIREGFQ 223 (414)
Q Consensus 208 ~l~~~l~~~~~~~~~~ 223 (414)
+|.+.|+++..+++++
T Consensus 287 ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 287 RIKKTLSQLSQQEGIK 302 (303)
T ss_dssp HHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHhcCCC
Confidence 9999999998887764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=292.61 Aligned_cols=202 Identities=17% Similarity=0.253 Sum_probs=169.6
Q ss_pred CCCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015018 1 MAAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 70 (414)
Q Consensus 1 g~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~---------~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIK 70 (414)
++|||+++++.+..++..+|||||+ +++|.+++... ...+++..+..++.||+.||.|||+++|||||||
T Consensus 81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk 160 (308)
T d1p4oa_ 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 160 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEc
Confidence 4799999999999999999999999 99999988632 1357999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhC-
Q 015018 71 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG- 149 (414)
Q Consensus 71 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG- 149 (414)
|+||||+ .++.+||+|||+|+........ .......||+.|++||.+.+..++.++||||||+++|||++|
T Consensus 161 ~~NiLld---~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 161 ARNCMVA---EDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp GGGEEEC---TTCCEEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred CCceeec---CCceEEEeecccceeccCCcce-----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999996 7789999999999866543321 112345789999999999999999999999999999999997
Q ss_pred CCCCCCCCccchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Q 015018 150 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 217 (414)
Q Consensus 150 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~~l~~~~ 217 (414)
..||.+. +..+.+..+....... ....+|+++.++|..||+.+|++||++.+|.+.|++.+
T Consensus 233 ~~p~~~~---~~~~~~~~i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 233 EQPYQGL---SNEQVLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCTTTTS---CHHHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCC---CHHHHHHHHHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5888774 4455566655544322 34578899999999999999999999999998886653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-36 Score=285.11 Aligned_cols=196 Identities=21% Similarity=0.296 Sum_probs=155.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecCC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 81 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~~ 81 (414)
+|||++++..+.++++.|+|||++++.+...+....+.+++..+..|+.||+.||+|||+++||||||||+||||+ .
T Consensus 59 hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~ 135 (286)
T d1ob3a_ 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---R 135 (286)
T ss_dssp CTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---T
T ss_pred CCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---C
Confidence 6999999999999999999999996666666665678899999999999999999999999999999999999996 7
Q ss_pred CCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCccc
Q 015018 82 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 160 (414)
Q Consensus 82 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~~~~~~~ 160 (414)
++.+||+|||++........ ......|++.|++||.+.+. .++.++|||||||++|||++|+.||.+...
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-- 206 (286)
T d1ob3a_ 136 EGELKIADFGLARAFGIPVR-------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-- 206 (286)
T ss_dssp TSCEEECCTTHHHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred CCCEEecccccceecccCcc-------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--
Confidence 78999999999986544322 12345789999999999765 468999999999999999999999987543
Q ss_pred hHHHHHHHHhhhcc------------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 161 KKQKYEKISEKKVS------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 161 ~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
.+.+.++...... .........+++++.+||..||..||++||++++|+
T Consensus 207 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 207 -ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp -HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -HHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2223332211000 011223355788999999999999999999988775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=289.11 Aligned_cols=196 Identities=20% Similarity=0.229 Sum_probs=152.2
Q ss_pred CCCCcEEEEeeEe------CCEEEEEEecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015018 2 AAGIPNLRWFGVE------GDYNVLVIDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 72 (414)
Q Consensus 2 ~p~I~~l~~~g~~------~~~~~lVmE~~g~sL~~ll~---~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~ 72 (414)
+|||++++.++.. ..+.|||||||++++.+.+. .....+++..+..|+.||+.||+|||++|||||||||+
T Consensus 72 h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~ 151 (350)
T d1q5ka_ 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151 (350)
T ss_dssp CTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred CCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcc
Confidence 6999999988853 44789999999666655543 23667999999999999999999999999999999999
Q ss_pred cEEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcC-CCCCchhHHHHHHHHHHHHHhCCC
Q 015018 73 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 73 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
||||+ .....+||+|||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.
T Consensus 152 NILl~--~~~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 152 NLLLD--PDTAVLKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp GEEEC--TTTCCEEECCCTTCEECCTTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred eEEEe--cCCCceeEecccchhhccCCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence 99996 2335899999999987654332 235689999999999875 468999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhhccc---h---------------------HHHhhcCCcHHHHHHHHHHHcCCCCCCCCHH
Q 015018 152 PWQGLKAGTKKQKYEKISEKKVST---S---------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYA 207 (414)
Q Consensus 152 Pf~~~~~~~~~~~~~~i~~~~~~~---~---------------------~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~ 207 (414)
||.+... .+.+..+....... . .......+++++.+||..||..||++||++.
T Consensus 222 pf~~~~~---~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 222 IFPGDSG---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp SSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCH---HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 9987543 22233322110000 0 0111234678999999999999999999988
Q ss_pred HHH
Q 015018 208 YLK 210 (414)
Q Consensus 208 ~l~ 210 (414)
+++
T Consensus 299 e~L 301 (350)
T d1q5ka_ 299 EAC 301 (350)
T ss_dssp HHH
T ss_pred HHh
Confidence 764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-35 Score=283.50 Aligned_cols=190 Identities=17% Similarity=0.235 Sum_probs=158.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||+++++++.+....++||||+ |++|.+++.. .+.+.+..+..++.||+.||+|||+++||||||||+||||+
T Consensus 88 ~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~--- 163 (322)
T d1vzoa_ 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD--- 163 (322)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred CCeEEEeeeeeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---
Confidence 589999999999999999999999 9999999975 55788999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKA 158 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~~DvwSlGvvl~elltG~~Pf~~~~~ 158 (414)
.++.+||+|||+++.+...... ......|++.|++||.+.+.. ++.++|||||||+||+|++|..||.+...
T Consensus 164 ~~~~vkL~DFG~a~~~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 164 SNGHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp TTSCEEESCSSEEEECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred CCCCEEEeeccchhhhcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 6789999999999877553321 123468999999999998654 67899999999999999999999988765
Q ss_pred cchHHHHHHHHhhhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCC
Q 015018 159 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 205 (414)
Q Consensus 159 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~ 205 (414)
......+......... .+...+++++.+||..||..||++||+
T Consensus 238 ~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s 280 (322)
T d1vzoa_ 238 KNSQAEISRRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLG 280 (322)
T ss_dssp CCCHHHHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred HHHHHHHHHhcccCCC----CCcccCCHHHHHHHHHHcccCHHHcCC
Confidence 5544444332222111 133568899999999999999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-35 Score=288.26 Aligned_cols=195 Identities=17% Similarity=0.264 Sum_probs=157.2
Q ss_pred CCCCcEEEEeeEeCC------EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~------~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||+++++++...+ +.||||||||.+|..+++ ...|++..++.++.||+.||+|||++|||||||||+|||
T Consensus 76 hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL 153 (346)
T d1cm8a_ 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153 (346)
T ss_dssp BTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCeeEEEEEeccCccccccceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhh
Confidence 699999999988765 569999999999999887 357999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+||+|||+|+...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 154 ~~---~~~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 154 VN---EDCELKILDFGLARQADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp EC---TTCCEEECCCTTCEECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cc---cccccccccccceeccCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 96 78899999999998765432 346899999999999875 46899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhh-----------------------hccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHHH
Q 015018 155 GLKAGTKKQKYEKISEK-----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 211 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~-----------------------~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~~ 211 (414)
+.........+..+... ........+..++++++.+||..||..||.+||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 75432222222111100 0011122233567889999999999999999999887753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=283.71 Aligned_cols=200 Identities=20% Similarity=0.223 Sum_probs=156.2
Q ss_pred CCCCcEEEEeeEeCC-----EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015018 2 AAGIPNLRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 76 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~-----~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl 76 (414)
+|||++++..+.... +.||+|+++|++|.++++. +.+++..+..++.||+.||+|||++|||||||||+||||
T Consensus 65 hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl 142 (345)
T d1pmea_ 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142 (345)
T ss_dssp CTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE
Confidence 689999998887643 4677777779999999974 479999999999999999999999999999999999999
Q ss_pred eecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015018 77 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQG 155 (414)
Q Consensus 77 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~~DvwSlGvvl~elltG~~Pf~~ 155 (414)
+ ..+.+||+|||+++......... .......||+.|+|||++. +..++.++||||+||++|+|++|+.||.+
T Consensus 143 ~---~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 143 N---TTCDLKICDFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp C---TTCCEEECCCTTCEECCGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred C---CCCCEEEcccCceeeccCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 6 67899999999998765543221 1224568999999999985 45678999999999999999999999987
Q ss_pred CCccchHHHHHHHHh-----------------------hhccchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 156 LKAGTKKQKYEKISE-----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 156 ~~~~~~~~~~~~i~~-----------------------~~~~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
....+.......+.. .........+...++.++.+|+..||..||.+||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 543222222111110 0011122344556778999999999999999999988775
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=276.81 Aligned_cols=203 Identities=19% Similarity=0.184 Sum_probs=153.2
Q ss_pred CCCCcEEEEeeEe--------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015018 2 AAGIPNLRWFGVE--------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 73 (414)
Q Consensus 2 ~p~I~~l~~~g~~--------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~N 73 (414)
+|||++++..+.. +.+.||||||+++.+...+......+++..+..++.||+.||+|||++|||||||||+|
T Consensus 68 h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~N 147 (318)
T d3blha1 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147 (318)
T ss_dssp CTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchh
Confidence 6899999988755 44689999999777777766567789999999999999999999999999999999999
Q ss_pred EEEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 015018 74 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLP 152 (414)
Q Consensus 74 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~~DvwSlGvvl~elltG~~P 152 (414)
||++ .++.+||+|||+++.+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 148 ILl~---~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 148 VLIT---RDGVLKLADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp EEEC---TTSCEEECCCTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeec---CCCcEEeeecceeeecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 9996 77899999999998766433211 1223456899999999999865 589999999999999999999999
Q ss_pred CCCCCccchHHHHHHHHhhhccch----------------------HH-Hh-hcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 153 WQGLKAGTKKQKYEKISEKKVSTS----------------------IE-AL-CRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 153 f~~~~~~~~~~~~~~i~~~~~~~~----------------------~~-~l-~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
|.+.........+..+........ .. .+ .....+++.+||..||..||++||++++
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 987544333333222221110000 00 00 0112567889999999999999999876
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 302 lL 303 (318)
T d3blha1 302 AL 303 (318)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-34 Score=277.90 Aligned_cols=196 Identities=14% Similarity=0.192 Sum_probs=151.2
Q ss_pred CCCCCcEEEEeeEe--CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015018 1 MAAGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 77 (414)
Q Consensus 1 g~p~I~~l~~~g~~--~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~ 77 (414)
++|||+++++++.. ..+.|+||||| +++|..+ .+.|++..+..++.||+.||+|||++|||||||||+||||+
T Consensus 88 ~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp TSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 47999999999874 45789999999 8888654 34799999999999999999999999999999999999997
Q ss_pred ecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015018 78 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 156 (414)
Q Consensus 78 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~ 156 (414)
..++.+||+|||+|+....... .....||..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...
T Consensus 164 --~~~~~vkl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 164 --HEHRKLRLIDWGLAEFYHPGQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp --TTTTEEEECCGGGCEECCTTCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred --CCCCeeeecccccceeccCCCc--------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 3345799999999987655332 24568999999999988765 799999999999999999999999764
Q ss_pred Cccch-HHHHHHHHhh----------hcc--ch-----------------HHHhhcCCcHHHHHHHHHHHcCCCCCCCCH
Q 015018 157 KAGTK-KQKYEKISEK----------KVS--TS-----------------IEALCRGYPTEFASYFHYCRSLRFDDKPDY 206 (414)
Q Consensus 157 ~~~~~-~~~~~~i~~~----------~~~--~~-----------------~~~l~~~~p~e~~~li~~c~~~dp~~RP~~ 206 (414)
..... ...+..+... ... .. .......+++++.+||..||..||.+||++
T Consensus 234 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 313 (328)
T d3bqca1 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313 (328)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred chhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH
Confidence 33211 1111111100 000 00 000112357889999999999999999998
Q ss_pred HHHH
Q 015018 207 AYLK 210 (414)
Q Consensus 207 ~~l~ 210 (414)
++++
T Consensus 314 ~e~L 317 (328)
T d3bqca1 314 REAM 317 (328)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7774
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-33 Score=264.79 Aligned_cols=196 Identities=18% Similarity=0.182 Sum_probs=157.3
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~-g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+|||++++.++.+.++.++||+++ |++|..++. ..+.+++..+..++.|++.||+|||++|||||||||+|||+.
T Consensus 60 h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~--- 135 (292)
T d1unla_ 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN--- 135 (292)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred cCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---
Confidence 699999999999999999999999 666666655 578999999999999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCcc
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 159 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~~~~~~ 159 (414)
..+.+||+|||.++....... ......++..|++||++.+.. ++.++|||||||++|||++|..||....
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-- 206 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-- 206 (292)
T ss_dssp TTCCEEECCCTTCEECCSCCS-------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--
T ss_pred cCCceeeeecchhhcccCCCc-------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--
Confidence 678899999999988765332 123456788999999988765 6899999999999999999999975432
Q ss_pred chHHHHHHHHhhhcc------------------------chHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHHHH
Q 015018 160 TKKQKYEKISEKKVS------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 160 ~~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~l~ 210 (414)
+..+.+.++...... .........+++++.+|+..|+..||.+||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 207 DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 333333333321111 111123345678999999999999999999988764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-33 Score=274.55 Aligned_cols=191 Identities=21% Similarity=0.277 Sum_probs=148.3
Q ss_pred CCCCcEEEEeeEeC------CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015018 2 AAGIPNLRWFGVEG------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 75 (414)
Q Consensus 2 ~p~I~~l~~~g~~~------~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NIL 75 (414)
+|||++++..+... .+.|++|+++|++|.+++. .+++++.++..++.||+.||+|||++||+||||||+|||
T Consensus 76 h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NIL 153 (348)
T d2gfsa1 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153 (348)
T ss_dssp CTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccc
Confidence 68999999888632 3445555555999999986 568999999999999999999999999999999999999
Q ss_pred EeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCC-CCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 76 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 76 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
++ .++.+|++|||++...... .....||..|+|||.+.+.. ++.++|||||||++|+|++|+.||.
T Consensus 154 i~---~~~~~kl~dfg~a~~~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 154 VN---EDCELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp EC---TTCCEEECCC----CCTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc---ccccccccccchhcccCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 96 7789999999999765432 23568999999999988765 5899999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhc--------------------------cchHHHhhcCCcHHHHHHHHHHHcCCCCCCCCHHH
Q 015018 155 GLKAGTKKQKYEKISEKKV--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 208 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~e~~~li~~c~~~dp~~RP~~~~ 208 (414)
+.... .....+..... .........++++++.+||..||..||.+||++++
T Consensus 221 ~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 221 GTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp CSSHH---HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCHH---HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 75432 22222222111 11122334567899999999999999999999877
Q ss_pred HH
Q 015018 209 LK 210 (414)
Q Consensus 209 l~ 210 (414)
++
T Consensus 298 lL 299 (348)
T d2gfsa1 298 AL 299 (348)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-33 Score=274.56 Aligned_cols=193 Identities=18% Similarity=0.211 Sum_probs=144.1
Q ss_pred CCCCCcEEEEeeEe------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~------~~~~~lVmE~~g~sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NI 74 (414)
.+|||++++..+.. ..+.|||||||+++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 74 ~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Ni 150 (355)
T d2b1pa1 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150 (355)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccc
Confidence 47999999998863 47899999999777766653 4799999999999999999999999999999999999
Q ss_pred EEeecCCCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015018 75 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 154 (414)
Q Consensus 75 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~Pf~ 154 (414)
|+. .++.++++|||+++...... ......||..|+|||++.+..++.++||||+||++|+|++|+.||.
T Consensus 151 l~~---~~~~~kl~df~~~~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 151 VVK---SDCTLKILDFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp EEC---TTCCEEECCCCC-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccc---cccceeeechhhhhcccccc--------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 996 67889999999988655422 1235689999999999999999999999999999999999999998
Q ss_pred CCCccchHHHHHHHHhhhccc----------h---------------HHH------------hhcCCcHHHHHHHHHHHc
Q 015018 155 GLKAGTKKQKYEKISEKKVST----------S---------------IEA------------LCRGYPTEFASYFHYCRS 197 (414)
Q Consensus 155 ~~~~~~~~~~~~~i~~~~~~~----------~---------------~~~------------l~~~~p~e~~~li~~c~~ 197 (414)
+..... .+.++....... . ... .....++++.+||..|+.
T Consensus 220 ~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 296 (355)
T d2b1pa1 220 GRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_dssp CSSHHH---HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCHHH---HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence 754322 222221111100 0 000 011135678999999999
Q ss_pred CCCCCCCCHHHHH
Q 015018 198 LRFDDKPDYAYLK 210 (414)
Q Consensus 198 ~dp~~RP~~~~l~ 210 (414)
.||++||++++++
T Consensus 297 ~dP~~R~ta~elL 309 (355)
T d2b1pa1 297 IDPAKRISVDDAL 309 (355)
T ss_dssp SSTTTSCCHHHHH
T ss_pred CChhHCcCHHHHh
Confidence 9999999988774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.9e-29 Score=247.68 Aligned_cols=200 Identities=21% Similarity=0.236 Sum_probs=142.2
Q ss_pred CCCCCcEEEEeeEe--CCEEEEEEecC--CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcE
Q 015018 1 MAAGIPNLRWFGVE--GDYNVLVIDLL--GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNF 74 (414)
Q Consensus 1 g~p~I~~l~~~g~~--~~~~~lVmE~~--g~sL~~ll~-~~~~~ls~~~v~~ia~Qll~gL~yLH~-~givHRDIKP~NI 74 (414)
|.|||++++.++.. ..+.++||+++ +........ .....+++..+..++.||+.||+|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 35899999877754 45666777666 444444443 335679999999999999999999998 8999999999999
Q ss_pred EEeecCCC---CeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchhhhcCCCCCchhHHHHHHHHHHHHHhCCC
Q 015018 75 LMGLGRRA---NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 151 (414)
Q Consensus 75 Ll~~~~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~~DvwSlGvvl~elltG~~ 151 (414)
||+..... ..++|+|||.+....... ....||+.|+|||++.+..++.++|+||+||++++|++|+.
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeeccCcccccceeeEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 99743221 358999999998654422 34689999999999999999999999999999999999999
Q ss_pred CCCCCCccch---HHHHHHHHhhhcc-------------------------------ch---HH---HhhcCCcHHHHHH
Q 015018 152 PWQGLKAGTK---KQKYEKISEKKVS-------------------------------TS---IE---ALCRGYPTEFASY 191 (414)
Q Consensus 152 Pf~~~~~~~~---~~~~~~i~~~~~~-------------------------------~~---~~---~l~~~~p~e~~~l 191 (414)
||........ ...+......... .. .. .++...++++.+|
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 9975432111 1111111000000 00 00 0012235789999
Q ss_pred HHHHHcCCCCCCCCHHHHH
Q 015018 192 FHYCRSLRFDDKPDYAYLK 210 (414)
Q Consensus 192 i~~c~~~dp~~RP~~~~l~ 210 (414)
|..|+..||.+||++++++
T Consensus 308 l~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHH
T ss_pred HHHHCCCChhHCcCHHHHh
Confidence 9999999999999987763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.61 E-value=6.3e-17 Score=143.97 Aligned_cols=112 Identities=16% Similarity=0.292 Sum_probs=79.5
Q ss_pred CCCCcEEEEeeEeCCEEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeecC
Q 015018 2 AAGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 80 (414)
Q Consensus 2 ~p~I~~l~~~g~~~~~~~lVmE~~g~-sL~~ll~~~~~~ls~~~v~~ia~Qll~gL~yLH~~givHRDIKP~NILl~~~~ 80 (414)
+++|+..+.+. . .+|||||+++ .+ ..++...+..++.||+.+|+|||++||+||||||+|||++
T Consensus 73 ~~~v~~~~~~~--~--~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--- 137 (191)
T d1zara2 73 GLAVPKVYAWE--G--NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--- 137 (191)
T ss_dssp TSSSCCEEEEE--T--TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---
T ss_pred CCCcceEEEec--C--CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---
Confidence 35677766543 2 2799999943 32 2355666788999999999999999999999999999996
Q ss_pred CCCeEEEeeeceeEEcccCCCcccccccccCCCCCCccccchh-----hhcCCCCCchhHHHHHHHHHH
Q 015018 81 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN-----THLGIEQSRRDDLESLGYVLM 144 (414)
Q Consensus 81 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE-----~~~~~~~s~~~DvwSlGvvl~ 144 (414)
.+.++|+|||+|.....+.. ..|.... .+....|+.++|+||+..-+.
T Consensus 138 -~~~~~liDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 138 -EEGIWIIDFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp -TTEEEECCCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred -CCCEEEEECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 35699999999987644321 1111110 112345788899999876554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.52 E-value=7.6e-05 Score=66.89 Aligned_cols=28 Identities=14% Similarity=0.287 Sum_probs=24.2
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCHHHH
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSLEDL 32 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL~~l 32 (414)
||++++++.+++..|+||+++ |.++.+.
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCcEEEEEecCCceEEEEEeccccccccc
Confidence 789999999999999999999 7776544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.23 E-value=0.00011 Score=65.58 Aligned_cols=25 Identities=16% Similarity=0.145 Sum_probs=21.9
Q ss_pred CcEEEEeeEeCCEEEEEEecC-CCCH
Q 015018 5 IPNLRWFGVEGDYNVLVIDLL-GPSL 29 (414)
Q Consensus 5 I~~l~~~g~~~~~~~lVmE~~-g~sL 29 (414)
||+++..+.+++..|+||+++ |.++
T Consensus 68 vP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 68 CAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCceeeecccccceEEEEEeeecccc
Confidence 899999999999999999999 6554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.82 E-value=0.0037 Score=59.57 Aligned_cols=28 Identities=18% Similarity=0.386 Sum_probs=24.1
Q ss_pred CceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 63 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 63 givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++|+|+.+.|||++ .+.++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~----~~~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFAS----EHETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEEC----SSCEEECCCTTCE
T ss_pred ceeccCCcCCceeEc----CCceEEechhhcc
Confidence 589999999999995 4458999998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.46 E-value=0.021 Score=51.84 Aligned_cols=30 Identities=27% Similarity=0.326 Sum_probs=25.0
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.|+||+|+.++||+++ .+..+-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcc---cccceeEecccccc
Confidence 4799999999999996 44555799999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=86.58 E-value=0.2 Score=45.59 Aligned_cols=28 Identities=25% Similarity=0.281 Sum_probs=22.5
Q ss_pred CCceecCCCCCcEEEeecCCCCeEEEeeeceeE
Q 015018 62 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 94 (414)
Q Consensus 62 ~givHRDIKP~NILl~~~~~~~~vkL~DFGla~ 94 (414)
.++||+|+.+.|||+. ++ ..++||+.+.
T Consensus 192 ~~liHgDlh~~NvL~~----~~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWR----DG-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEES----SS-EEECCCTTCC
T ss_pred ceeecCCCCcccEEEe----CC-ceEEechhcc
Confidence 4689999999999984 33 4589999775
|